<<<<<<< HEAD
{"docstore/metadata": {"14a6ccf9-adc4-49e5-8ca3-54cf2c0b395f": {"doc_hash": "09b4d234138f9b57e5685a6eac891f2e18da20ec6e8be2bf1efd6368070f23f3"}, "a9fb00aa-ed49-403e-93cc-d511dd652924": {"doc_hash": "8e5fb1b72734da275f00946f79fbf82c8f2414cf01d6314a423d0953956dd3a5"}, "00e1f4d8-40cb-4a8d-b9b7-0ffe5460772b": {"doc_hash": "ca9f05d6e98848e49872b98c4daea84f1ac0a1476b9b5a084a599f8b3c2be777"}, "f61aac9e-9e13-4680-a4a7-e6e8edf56f44": {"doc_hash": "c04cbe32b180c8d011f5705fb9d1e9570654fb7f9469ae9c241023f9643ae4b1"}, "1e26bc5e-ec2f-42ef-a8f1-e9b0f103b8b7": {"doc_hash": "de89d2bab8f0b430a1c13ee92e2fd78ab35aff264bee91619845d512f6d454c4"}, "9e571879-7779-4973-a26f-9bee54e85581": {"doc_hash": "d892698587a6576b935ebf0a7a04c73514dd4570edb243a968bcd473cc37671a"}, "fb385b04-79a7-422b-8990-982752371c7f": {"doc_hash": "c92b0830c5c63d6e08b8536b3562859895e9cb14b152c9b44c0fd3f4e4ea09e1"}, "122c97e3-dffe-41ad-8437-e8fa89545303": {"doc_hash": "f2c262d7b088b667dd1c02d1f83afa148ce63ac7f5b855108edc6a344d25f8aa"}, "2ae5c64b-1b24-4b85-96da-80e4cc7fa0a8": {"doc_hash": "efef9c3a4b8acedfb665df23d25ab93d3cc432e388af3be6dc178f4f0a6ceee7"}, "693c0b06-9719-4c6a-960c-02a03da16a44": {"doc_hash": "5c7b9022e1c999cb94ab57a0fcdfc97079f8de77002180c32e4009461a07e7b0"}, "17e044ef-066c-41ff-871f-e0521f9e11a2": {"doc_hash": "dd867f14e8b053c3ea37d78de411e12deed3bb6aae1f18a121a499eee5a559f5"}, "37877ff9-a8e5-48df-8380-a14845889323": {"doc_hash": "46f1327f64c791557a438bc5246a6b0ae526ae000d9c2984f1996db68f01211c"}, "5aad9db2-a8ef-4d10-8fec-22e3cc7e59d3": {"doc_hash": "d997e0aaa8a1b076b4b66338c1051283ada9de4dd3d06bfaff653a7993f99429"}, "e31cf697-ce51-425a-ba7c-87c8f39163d3": {"doc_hash": "757b9123eca604b24e7086cc86fa1203afd53b99696125dbb837663671b9ca04"}, "0593823f-38af-4861-a0ac-b7fbd48f155c": {"doc_hash": "6f655ce3481cc9a0607c5206b2aa02a00c0d38e505b127d93e989bdee64fc7e0"}, "95ed1103-1d3e-455f-ab65-7c4779688d72": {"doc_hash": "a97134d094e358cd3c9d2330048aa0595b6ff46567e666cda170c69e2514513d"}, "96de02c3-7291-4c16-a959-608f2779e66b": {"doc_hash": "ff59c36303182af74655c58f4ec24fdf56743efe5b48af728d1b8f673885b584"}, "f1b6245f-2382-4a9f-b060-90a84d6742f3": {"doc_hash": "172eb709e2ea317d4baeb7eeaec903f0711967c3405b66e21b2bcc85b24c208d"}, "2b000c16-d6dc-4446-bdab-61871dc53a76": {"doc_hash": "5eb9ad9aac513e6532f121898cc639d6a7281f133d48a85c9d6dd33a740489f8"}, "9488d511-9dc9-477f-a799-b6a4fee59970": {"doc_hash": "54cb7dc7a9dc199ae72147c1fc51683c3d024e49723a06abfb9bc5bccdc2e21b"}, "3cdb199d-1952-45a3-b6ca-2f012fe1af8c": {"doc_hash": "878322cccf5e096836054ec8ad568c66132cd5615994d200b4f6bc4d80fe2c92"}, "c67cf8e8-af7d-48fa-882e-4e1b65246104": {"doc_hash": "818052bda4060a62a3bbcd9b510825f68b76c9ef1158cf2f5d8facad375d22cd"}, "958c632e-ed1b-4ba4-8ad2-23b364d5f283": {"doc_hash": "3d235b3e42f47a3db4b5dcfef40cf6649ea89ab8d94a87c263dfff7d26f70f3c"}, "da866fec-39a7-4a28-b0a8-05a51084e888": {"doc_hash": "6430b27445d817c60d2967d212f04a1c13df70345b05aa5cbde8aec64cc78e40"}, "ae7c1f30-0982-4e52-b224-b864a35abc84": {"doc_hash": "b6338ad401f97bebcc89a3e8c1d9bfc0b4a9e3139c3f2e4bcad4557d9f95d6b0"}, "c022ff7d-f31e-41c8-b753-1a7fd81eb16e": {"doc_hash": "696f13506503b92f7bca4a8ac8875936bee33d0e432b9d4c0892c6b90b3cbe6f"}, "6f487232-6a67-4731-a5d3-463a05e75cd5": {"doc_hash": "4589911de7f201d950a74d1e05c703eaac36449c8da95a5560f9d961f3bb3cba"}, "ec47f9ad-0af7-443e-8359-54ce633c73af": {"doc_hash": "ce3788272abc2dc7c2bdf09441e4c301009cdbfec1302b84ed2f4ccc6fb2a258"}, "775d6a96-770e-45ad-abca-3894a3ef93c6": {"doc_hash": "f963b9b184bb267e17bad69b7eb040d489d7b9d7454f4fa70617e09680c86dd4"}, "9beb1dff-f168-4190-b166-3e06141aeab6": {"doc_hash": "90978bad8370aee0a5dfd4a768b80b50bdb09187a9906511e2807d9e9741bcf6"}, "7e9e1716-b5b1-4b20-8557-86a59094c763": {"doc_hash": "04bfdcdafc26d3b57eeeb02903cb40dfcc75db3ea1612a9ccb2b27f8513c7a65"}, "40281847-c6e5-4259-a23a-40c4410315bc": {"doc_hash": "0316a13d2b6bacf67f368299b7ca21adaca086183ace8b77cf8028c3e2ac8d9b"}, "66a20f6a-c2a9-420d-942a-a990d4a07454": {"doc_hash": "856de974a1ab885a7f7dbb3fb94d2bb73009aa7c0397bc89c8a6e7a5dc695d39"}, "99d8fa96-6e3d-4d13-ab2f-981aa9c2a2d4": {"doc_hash": "d0bbea6581263dd876116a70b2710213c653e1b9e3ba748d257f5c78b0c79b96"}, "6383d4b6-dd4c-465d-85b6-9b42d91ad314": {"doc_hash": "feb6085fa466189dadd324a9e7049b710829cbfab15efc69fdecad2f5155a968"}, "d1bc3755-3354-4d41-aadb-b136b720c67a": {"doc_hash": "c2e783f614e7aa8a8f5d8f455d044e5d190cc5a54dcd0bbc4eee1f2a0f05cde2"}, "b8d4fa21-687c-4c6e-a931-7421435cd0c4": {"doc_hash": "385157c5d3405679f845f399bc1f71acf7d952fd64c65b5d42366193736c69d3"}, "28432a3b-116a-41ed-a5ad-4000fc2acd67": {"doc_hash": "8ea2c86ac5413f0fefb68563af67752d4ec327ddb13fdc41d1aa11439643e1c1"}, "84d024b3-a8e4-42d5-9186-068470ec2916": {"doc_hash": "75aa85e9af3dee8fed3294c9f06a15357065b6692faedb4512246a6756d4be0b"}, "cbba637d-3358-4caa-b535-81736f6b7c31": {"doc_hash": "7bc642ba06605f9a4cac3bb2f81961c87b399c5c49d5192f126c0916714eb513"}, "4c2e3729-00b3-46f1-96b4-ed4c443cd555": {"doc_hash": "fbbed6981e5d220887fd5c8ed1ea346a229f5934d1d6ddd3c68a67b9546c8051"}, "924975dc-8582-4cb5-b2af-8c0da4679147": {"doc_hash": "65968cd998fb178fb47fe203c29d176ed6690c123eae4794a1dfa094b82e1c80"}, "d86e3078-b409-44ee-9eec-f0262d5918b6": {"doc_hash": "9b1a891a09a65bf4ba026cfeb4221092eb27dad1dbce035709d704dec36569b8"}, "b39def78-d8b1-4463-8f00-d3a34e39fc34": {"doc_hash": "3a660dff4cf48398dd364a117167e84c7c0b7b70707f42ba1ce77171f638713d"}, "c33a6a4a-e602-444a-b61a-a3aea69fa36c": {"doc_hash": "644e79b2123563e550c2e2e10e252fe5b2f8bb7fb40d2b09484ccabddc323a38"}, "3ddf33ea-bbd8-40cf-9a40-a13154eb2d8a": {"doc_hash": "e1c7fa8c9c468fdbe62a11e75d88dc42e605df8f09b2c5c9336e838e1e65f694"}, "683f29fd-bf98-4be1-bff0-144acc3b7aba": {"doc_hash": "9a8cc50a1b46f68db18047dbe11ceea56b118b15b8cd2cad26be4e6952b33903"}, "af112b94-50a8-4d69-9356-ecb9508f779a": {"doc_hash": "8ec115e5eb068224d9a3511bcea3a0d36fbe12be6a6497300efc04eef48e8b6d"}, "1827f261-8016-4b22-9002-27725a06e5a8": {"doc_hash": "91b5e4ca7f43f0767e7b64ae91295a80db988b14945473ca7d5d810326023d1e"}, "434e9b90-49e9-4270-8fd8-8c7f8355b1b9": {"doc_hash": "78d9a8c34b74cd269686ed732bf20f3edde61a27da6ff7bcfe9cf4c52e5894c2"}, "d55832e2-38b5-4d77-8206-3ba586cdab85": {"doc_hash": "9c0609c2f15f6869ff559b584accbd3d4b75810ea2f17a54d2bdc5856dd4e2ca"}, "a4442ea6-1ec2-433a-a1f6-222537c6037c": {"doc_hash": "3bfd48fd873d1e255ce1276f9ae9bea71cae90a530e84fd25386f1d104574194"}, "a9fcdd22-4318-4c21-9297-ad33b3ab05e6": {"doc_hash": "b1ff097762bd5489d705436c7aac9bf9c2f5e43f32a354a01760edfe602db95e"}, "787f824b-6dcf-4e21-9fc2-2214c55a8f82": {"doc_hash": "ea417547bb167492c674588f9a8148e8492ba1caaef297f4e48bb5b3752a4d2b"}, "220f95f8-ab72-4570-ace2-8cad2bf17f12": {"doc_hash": "51bbe426f10ff64727c41e6fd1125b524b47ec7ff6e7a790054d6d767302f59c"}, "8fa1a5cb-702f-44ed-8d20-15cf24fd6712": {"doc_hash": "abbf93f323fb94de1b66b7acc969d6bb7199fdcc17d0d60598b3437b29db16ea"}, "4801dd2e-a9a8-4f1a-8c33-f7672fc5af5c": {"doc_hash": "b459a404837db7a9a2d1f9d6e2b9703ad7161eeb6ba42e6035f709e3f9dd8038"}, "fe2767ca-bcbe-4841-a796-5de28f1391e7": {"doc_hash": "fca1a004100f88d5f934983b685195a9468f30310a54be80b3890f54983cbe74"}, "3823decb-ee25-45da-9706-27f65d0fb331": {"doc_hash": "81265f169c13f0c24d9338e7e3f87fa2923d2027a2cff0c1563a3765f070e6d4"}, "5d53fa1e-a0a6-4b05-9541-efab54285edf": {"doc_hash": "c9bd1988b8cb25402b21bedd18262439e7c716c473e8cb4d2d986360cb4a8146"}, "6b741be5-f451-4b46-af0a-78678fd1eea6": {"doc_hash": "928d7796d3e30e99b5ce5da10ce5f54142fb308cd73c23571da708eaff9f3a8b"}, "c88d1376-886b-494a-ad5e-6b74033bd3e9": {"doc_hash": "909a39c0cfb7be10ba648a1fbd8fe613762866383d9e5787fc0084742f280257"}, "a712ff43-7bca-43bf-868a-89d9bf93e48d": {"doc_hash": "76a753e061bb0c217fc54d22e81738472a0fd1c92615cbf61bb61353197c7598"}, "4a2f804a-1695-411c-b9b7-8ac1dfc803a6": {"doc_hash": "a4be04b004a49ef5f8e67fd99326b16f6c12001d73f5e2e11d9a819c9e55ac04"}, "5cd068ef-971d-4cf2-9818-f4a8ec479d6e": {"doc_hash": "eebe00df479792697f65b2ce25a8efd873131748003d2cd8b6a123d17f3c9b96"}, "dfe25b23-0dc4-4553-a8f3-fe559fd3dd5d": {"doc_hash": "4be0b6138f1575bde18d82dec116a10020758a9ada12cce672fb5280db40f593"}, "6c7d00d7-118a-499e-999c-be29d4e0207b": {"doc_hash": "d68d35170f5fca10fb896392dc9309922658c6174c0778e298abda2b65609fa4"}, "ff8e3a3b-163e-4483-96b4-7350fb2222d0": {"doc_hash": "696d81695e7f1335c42fb0cd5e90066f0feb46c27708a75ddbc4d8d4a78067b8"}, "bf0af623-9cfd-48f5-90c2-c6b724a2761f": {"doc_hash": "5c742aabc21c2cf496a86d8c153201a39fa5adf8a2e91daa82a6cb1b0ad49eba"}, "c2dd27c3-92f2-422f-8d08-1e9d6a58f358": {"doc_hash": "dda6abdc1857e841cf9463ee193dfc82ccc8fed90472ab9a19859f81db23e087"}, "6ab7796c-e87a-49ee-b455-b323139a8c57": {"doc_hash": "f18847547bef93cc1598edc6507a56968faef1155b741ec0df85ad7ee533ea0c"}, "944aa216-249d-4790-aa83-4b89d655ade2": {"doc_hash": "63c0a72588c019fca1f7daa42fc7780864e4c49d25639981aa152fbd8402ff89"}, "20a8b136-ad7e-45e8-b769-ea2f70521e74": {"doc_hash": "54ccf6323166aa8e1c6b5eaa82881c4ede68c2bf90ad32da2181405918c3f36b"}, "25bedbc1-a1b1-496f-8351-f2950dde364c": {"doc_hash": "36e4304bfbfecfb3f383dcb6af5e6d8c0bfd7c173263b3586802b730d731d99d"}, "5c907214-4dcb-4631-9957-626adebadc17": {"doc_hash": "0adbe920c17df874ea7fae2dbd8a31d751a4af18839d5158b33f8b7697bb5e6f"}, "edc21a16-ad60-4160-84de-767d35769250": {"doc_hash": "0e782e1e54eecfa4ea151cf7498a06d74b55cec01ba872dbe28508ab8263c279"}, "ac053143-cab9-4794-8cbb-15156f592723": {"doc_hash": "82c6af2ac86722ade3e0276c56035303d31cca4f0d1b48044d8dd6ab70d02368"}, "077baa37-fe87-4b00-9673-cf101b756606": {"doc_hash": "16b587ba22906137f5efee47d7377b4432b8e1f7eebb1c01280cd790a2f65729"}, "b2301267-058e-4170-be09-c8814850cb66": {"doc_hash": "f1162e24b9da61a1cd562048456cf85fedcb2e4db54b23ed8ef0e581ac56ea57"}, "8a1d622b-d868-4ed7-b7b1-4172498f64b9": {"doc_hash": "d28fb3a93b0d98eb5d3565404676fa87a35d578b25436013c821b9f353236479"}, "6c5abbfb-a73f-4161-ae7d-1bf6a4e47e83": {"doc_hash": "643e403b98323d29ca6fc64a34ebb1a0a900eecc2cc6f34d9515e72926b07bc9"}, "01afdae3-d63e-47aa-8035-030db717e995": {"doc_hash": "4092929166caf77b9fb53d19708353eaed74ca2f52b3da2070911e37beaebc9b"}, "39f313ef-ca56-4d8c-b05f-42a91d42863e": {"doc_hash": "df14cacd31da377a863c97fa388d1ddf28703731d0660e30e418760d99c12e22"}, "363c52e6-82ab-4c47-a8d5-dc1c1e6baed3": {"doc_hash": "097eb3ff5dea02ac39965d113cabbe78a77d792bcff8225e7018226d12dc8a2d"}, "133886d3-8f01-4983-9821-52af09f60bb1": {"doc_hash": "0c64f5ba239b0d347ceae92b408e5111886048763231fd326b52a9ef79d51f49"}, "24b94878-1d06-4153-be06-28484bcf7d9b": {"doc_hash": "7bdefbf42641073e7918fb1f2bd485714c927871929e73475a4a1e4e4de5872a"}, "669a6811-520b-4bb0-94a1-980ed87c01bb": {"doc_hash": "78598c7a48f4874002b954bee3fafc5ef24ed950b1319a21056b50cc4c8d0125"}, "57dd980d-abd9-4522-9681-924aca506a48": {"doc_hash": "cd1e22e602574a56742ac04f66ad32a1cc877ced9999c3302beb6391824ff568"}, "223937cc-b6c4-46df-b45b-a51c0909b466": {"doc_hash": "151700da6b2dbaccb4ffe64700adc6241dbe5f35698f47183867248a7057db97"}, "397922e5-e697-4b6f-9f2e-a096009ab5d1": {"doc_hash": "a1330926616ec6183e4ceba44df202ce72f2dc30c863d79ce256dc77f95ecd74"}, "6a8d4880-6edd-4f2c-93d2-deb8a85cdaf2": {"doc_hash": "b5909475757fb7d731bb23aaf25a6311a2270b851f5a0d69b5199563fc0c4a3a"}, "1b37ce62-c95f-45ec-b969-fb3d633d0da7": {"doc_hash": "9cd523388a364eaa2ccb82be6b47f72c1cc0d1054334c81d87947012425b734f"}, "5d4ccc26-021d-4f7b-a807-eeab1972a4de": {"doc_hash": "5ba0080cd94f74d3eeeaad0d7a0413a70ae1d29ec9a78fcddec955b40331ea38"}, "d56b54e7-c3d8-4185-b725-5093d27b1629": {"doc_hash": "7af4898d4300f0d1356706d7ecac7f51cb9703ce49de6edb013d649b2df0562a"}, "e5c630d4-ae50-4f77-ab50-87d38da1fb0e": {"doc_hash": "38ccd03f869899b6a0625eb328ade777bd52095e5d21b67a5d9b20d044c657a6"}, "73a64b70-8c31-4f10-b492-7d2d2afd8efb": {"doc_hash": "265dbee6a6d99aec197e423072e7e75268ba2c87497afeb381553e420fd6a287"}, "0cda9d94-b603-40f1-820c-838ab5efd6d3": {"doc_hash": "b061502f6b95636b6d80f3c2fd6842e8639c0589297840d237e58ecbc69f0ec0"}, "e8a3013c-aac6-4742-9a66-a601dd8d98f8": {"doc_hash": "57406cf83528838302426e4a8f3621c1f32d2a2f0999ef51554c1b42663cabe8"}, "5513dd0e-bccc-4598-b687-14f0b19bbac4": {"doc_hash": "8e32fc6ed8a79cfb9cf8e9ccfe26700d8257ff857023b4a0df0ad46a9832bef4"}, "41e310b3-1208-46cf-83ef-64aba2ad4382": {"doc_hash": "cfac4221eb272c390b11c9d4a475812abde5bbf85fec64b1d3cb549538686918"}, "c6a2b542-e34b-45cd-8789-bccf83a33a0f": {"doc_hash": "9d8199b6f9a1915e3679e1b99ae0d6da2283aa2fa920b5cfd01ff79da4cb8207"}, "dc16d311-1fc6-4485-897e-9b8d3095cfbc": {"doc_hash": "18cbccd1f1285cfc551a687d1f00ff0dd6ca575a6fdae8b266ca8cfb0ac91dce"}, "c98ec416-926c-49dc-811e-9bb662b3d812": {"doc_hash": "cfa185f6dce1d8a11e5bf229c4a1c56d49c2b243ff4a95004975373eb69e09c5"}, "6ad48f98-c5d5-4d91-a107-aea4beabbedd": {"doc_hash": "549bcaf8fac276f31eb4b7b79a0458c302b64f8bd688930ae5bbd5097b84b355"}, "7ee4fb5d-64d0-4585-a93f-964612a920fd": {"doc_hash": "42e35a94141b4d69c1a6b13c62fecca4e9299acb642762119a39265e07dcdacd"}, "172c4df3-08ac-4064-b3c1-bb670ebe08a3": {"doc_hash": "700b34e99412106e7d11ae4768c056e01e90eff6feb315f32648dc9e84bfcd52"}, "07fdca8e-6ff5-48f8-9e87-ef347722e862": {"doc_hash": "311186dc908b79e9d7a636013ab7d40c7880ed27c3a5df49ecca14e44a03fa8c"}, "3f6bc6d9-92f4-4dc4-ab73-f5bd6ade218b": {"doc_hash": "96f0283437ad2f9e6e758f2df2cc8835687eee35db4fbbd0be097691d2e6127b"}, "0e520528-c00f-4d9a-b25a-98ba87ec44c9": {"doc_hash": "b863d4c6c8a55ade1937efae4626f01c811ecec62ffd595a44958a0bd958bd11"}, "f9dbc250-95fc-4441-9450-1b1013fc6d65": {"doc_hash": "9961d78bedb700f4592af043c947fee089d99f11eef26d6f19b51a1b940e5284"}, "e4be75e7-986d-4392-b013-12931743b84b": {"doc_hash": "299f4e84dcfc690e1fc20c0d65d394fe9e71904207a78a3d6314fcb39b0e7647"}, "378475f0-c937-49fd-a3bc-036d9f2d20bc": {"doc_hash": "a07690d4ea6c9d27039adba1705dc2a4adc5471cbc3bf9fa881f27dd70ce5d89"}, "7d04bc77-6a78-4880-95f8-426df12ad9e1": {"doc_hash": "4d78ff01c1536cb1600bbc8a84a3da4474245d9a6ebaf2bbc1b0a18a260ef8fc"}, "c6c47d52-c707-413c-98d4-8a4f4b51eb1d": {"doc_hash": "d52dfb7c7677299c0ec9f127f0590dc584ce1d50084654f23fc3c3cfdbe6246c"}, "17b7bf61-fce0-4bba-818c-b4e2a3235982": {"doc_hash": "a788600796e0290054dfcd353227f5cf95e53296e9ee374422530a6d90c1057e"}, "e796e9b8-11ec-41e8-8bd8-36b0face1cac": {"doc_hash": "3ef86034be68103e438c44cee94eb392543a6726a29b0607224f519ebc2c39f7"}, "ad4d6008-a56f-4251-bb50-973032e3da0e": {"doc_hash": "65fde018d77b921924f67d8ed712a891f8f847f53765ec30cff6283d91d543a8"}, "acc3e2b5-a73f-4956-b639-e2e68ffa66db": {"doc_hash": "50123068af407cc6f152c0e0b78af79a9ca74a5e5f6351b2242aa9d23b119c2b"}, "f87bf786-411e-4465-be96-e0942af05730": {"doc_hash": "f35f93b89aac91a5517f1c14fa9267e30b0ea18550eeeff967aa2dfbc96994dd"}, "3db65f1a-9619-4ffc-abda-cbe795458fdb": {"doc_hash": "e894852e287b8b33aa2a3049e4a22a860ca842ecbdd3f9b4fe3aa6a0d5619c2a"}, "8c3ec96d-940a-4e53-b79f-6c89426de550": {"doc_hash": "006edfd14ac03afbf7ad245bd4c2dfcbe56915b22d2ba5e9d1806fbd36e08817"}, "8e670da0-9b15-4e03-86f5-810517dd7da9": {"doc_hash": "2e647612ed618be78d1d9abd4473fe0628f5357e8ad50814f3c0ab38c4893d2f"}, "3da9bd7c-b6bf-4a50-a71e-1c7cd9b402c7": {"doc_hash": "800efade94957adb55e8b271ea9048210588e48fa8dacdd0b8f494757aaa1259"}, "02a60eb7-b165-40e4-af38-f4898efca15a": {"doc_hash": "a31c08e75bbfb1f2a94b9e4266c20cb5c99d7380026a846e9c1ef18c8833114d"}, "ea261dc5-38d3-4fcd-96a5-e2b852b482a4": {"doc_hash": "cb844c03f2043d4ce6f7c6f07c047d213c2d0ffa59cd084628b83bbb12fa7032"}, "3d74a877-8dd5-4a30-96ba-7cff3f8a41b0": {"doc_hash": "45995b2f13f8eac3f28700e2c15148a8e5349a707254c6b1283ef410b875f3d2"}, "a0c81d9c-c7a1-46b5-b811-9659373da46f": {"doc_hash": "4ec2a0117a2b38b6b9896cb7c2cf8ae6ea9487993ed93b7bbcb13bdaa1572fad"}, "9692a391-075f-4f0b-98d2-4f8f725480a8": {"doc_hash": "3acf46da25ef511543cb12db6de55920f379d9cef3d521a81cae84698199a3dc"}, "9c3b9bca-c8d2-4e65-bf4d-2b816ea6cc62": {"doc_hash": "8e30ca8300bc0a9204f566d566eecfb64fceed08e73bba3ba7e2ed6e9b651b30"}, "2b37ed4a-3ae2-4d24-a45f-7ffb0e19330e": {"doc_hash": "62ba376c1171a1031598e5193e0844c78c5ee09f590f588ee20fa8b29b44097a"}, "ab182a08-8508-4847-862e-4108710f3148": {"doc_hash": "edae17af9ed6f190be405a70559ce201d7e4b993cbb6ff895ceb8acc3afba6f7"}, "1b5ff0c6-0c8b-4ba4-bab7-3e599bc10011": {"doc_hash": "25924140c2bb27948cc319f430a4fd6063c3f6b74b94874d5c860764e7f5708b"}, "370ad65f-d6bb-4518-a92e-229fba23c55f": {"doc_hash": "2001d0e09597c30670e67703c25cd7cad05bb72998227bbeb86bca30391211cd"}, "b57a3c3c-4ffc-4e09-90b1-c1d06a66013f": {"doc_hash": "72480e70522d862449da1ed04314cdf3eef9f50054a103f7944f5706dc29b0df"}, "7b4e3869-a70b-4da9-ab75-a91ef80b3856": {"doc_hash": "a0c14c93a889d31e680cf7ac85da66d64c87ee0044665100e565beaa26a73191"}, "3996f212-626a-4ffc-b429-8889f30f4bcb": {"doc_hash": "3f38690b28e6f53474c5138f6a3b492698fc9a79187ad441e3e2ee15b0cc2610"}, "b6cd6c7b-8bf5-4087-be57-529c062dd6c9": {"doc_hash": "80edb3279489bbae821324cf6fe5abf51a49a5fdcf3f127b005be90a3868d4d9"}, "f543d312-d064-4f4c-b941-f1f44e6a03ee": {"doc_hash": "72906c22bef50e258853e2b165b985ff7d2f2e98995188f279e5e0b2e627ab3f"}, "b77f5397-d305-46d3-8437-90cb3f7dd3ca": {"doc_hash": "d6eec574c646a81acfbb2e2e31f4fe72a9c720ded47e42a7c7953f5aa926cd31"}, "22176fa3-040f-47bc-8580-93df4aa4ac27": {"doc_hash": "6cfa945c69cdb63f5534e01788f032656ec44cdbffaa77490492d8b2a0df0f04"}, "75398f3a-efa2-4310-8423-dd4d7a1f8355": {"doc_hash": "e72e55a9d0f4b728ff8fd73f73141ba14b4f59ede9a1546ce192b695360c7826"}, "24b01b60-52aa-45a9-980f-d067873580aa": {"doc_hash": "fc14fdaf1ef39a6bec9484bf9c417b84d49ee441ec2e985dfc613deb0f4415c8"}, "9e82187d-b01c-42e8-a42d-2001eec664aa": {"doc_hash": "5640125a65c5109f4ad4e83e7f8f96cd0609f039d4d6b9fbaebf15de2f94473b"}, "f4c08827-a5e4-4ce3-8276-edb53456d0b0": {"doc_hash": "9bbbc2e24b496e3614eaed1bafb04529b960ec3c2fa8cac3031e912553eb3edf"}, "b981cfd8-6cf9-44de-963e-8a5972d7ca37": {"doc_hash": "5bf1d22b7120d4311613940846d5099db59dfa1bfb259a123d82ea22933b100d"}, "113d8581-213f-43e8-aed5-900ff192ff09": {"doc_hash": "1058c88ea41f71e4807fb24a694b5427b649d7bf22a1d8eea3ca46e455f355dd"}, "2acdd4ac-f378-4deb-aea3-929789f17c98": {"doc_hash": "34a90f02a9026380ece88bb6612ccfdeee7e00820b9ee4821e3ae79445066464"}, "ed66f241-e2d1-4430-b8e6-023fe20e6e5b": {"doc_hash": "cdd7d8adbf4177d3e10a7d4e559866457d3b9c1b32856c2e4f7b11f22d86c0a9"}, "13ae48cf-d631-4a98-a8ea-475ed4ba429d": {"doc_hash": "b5aef1a3dae47c0a63b55eb70f917967aa00c347b62cb1399b627456026ea72d"}, "c3413b1e-a206-4df8-bda3-47659c92df1e": {"doc_hash": "068d04f01e8ae84d5e79ce630870c7f193af2117b1a4dfa0aac4eaa02961921b"}, "41617a3d-7bbc-44b2-9432-80a50602173a": {"doc_hash": "8e9e1502f3e765882d3d504c7e6880880634bd1722ef5c20903cf4e845713615"}, "b88d8e37-166c-4243-9e61-36643f6cb217": {"doc_hash": "0280708caf2090d490532dc770c8d8fadf03e0f88530a43c02c9d3d70af69d4a"}, "750638f3-f142-4260-90ae-2a01cd8f6a98": {"doc_hash": "147ac963dd1a21a2f6c4cc3f1e91ae1d792222baba8caa1680ce9703264d1634"}, "859e2ece-4a3a-4e53-a5cb-e288ae111f9a": {"doc_hash": "9a0d304a6348fb3384d882fd687777d57968da900c63c27deed89f839ae3ecfc"}, "69f580a2-14cd-4a85-a9dd-92a6da0f8c40": {"doc_hash": "069cdbd148c9140c6dec6a5dc888d6adf63b3c741b72a4c42c056a6c8ad7c3ea"}, "19bc9688-6990-4081-97a5-719003016d34": {"doc_hash": "a73e6f0808ac36764db4fcebd90e521f9282520322e6f50b996fd4616e8ff1fb"}, "ad99c96e-9493-40f0-be70-451826ad991d": {"doc_hash": "c252e84c52b9e39fefaa85f48cda0bc2e910c1ac9e076def02e8725a3bae1c1c"}, "914db214-79cb-4a8d-ba6b-c305915eec32": {"doc_hash": "7875c0daf4812c7da4423549521fa71be98204fc2b939f3a726a4330d8858273"}, "88219d14-c539-4858-9a96-3235d32521dc": {"doc_hash": "f1ae722070cb1fab0cbd5e66bdfcc712d0cd972e2c831ad4301768f6f63b214f"}, "0d02bd28-1c95-43f7-bc8d-7bfe6b6ee33d": {"doc_hash": "84c51a50c95b6f2146de916fe2fd40b9b332a29a8236ad87a6b725928a4a0175"}, "6fa9c138-fc86-4e30-950f-7c7e2d4184a2": {"doc_hash": "81d5a2241fe94a3b7b4371c6a53a2d4c670e4b7f407ee47826670f53e8ddaa0a"}, "407584b0-9976-4a08-ae1b-d68443db299a": {"doc_hash": "5325a551886fe7baa0f2b02531cef3d3ea66f2c2160f969e9423268b8634cdfc"}, "5558df91-61ef-4f67-845c-f300b390814b": {"doc_hash": "773dea400721cdae63b0c23653257f59cfaaf4968293ea76c75426f22f2a1909"}, "3d4f1712-1c60-41f0-b5f5-46d7dece8a03": {"doc_hash": "91cbce29d6c1db81f1832359528af9e54ad5454bc5e0e5e3d1e9e7296994d017"}, "7a76f0c3-6db5-46b2-b6c6-f1fcdf1c3160": {"doc_hash": "f083e2964003e4d25522c0b2753586f39a1f9b440f63e520f08045315e4010dd"}, "068f1722-7396-4b97-8aa0-e9ee7ad4c701": {"doc_hash": "b70f9373c1b746077b8c7d9124c40dc5e39dea2d786e4ee6ab20354191ea5cdd"}, "2f6dff5f-1a35-423a-9f23-2640a124e973": {"doc_hash": "e51979564273396713c39148fb2dfff29ed84d2c4d42eb50cc426987ff11ea08"}, "bef26e38-21ed-4aa3-8548-ad97fd0db6e3": {"doc_hash": "6224520969d87416f9970ba2709475ed35705728925c203368e72210013d97da"}, "4404dd4d-1ba0-46fb-9f9c-4b28c4d5ca73": {"doc_hash": "8980c41d1cb1b45a43c49a2a0c75b921ebbf899303dd60450e54d621d7435705"}, "b35da6f0-720d-4d34-a925-5c98c6b06b48": {"doc_hash": "df07943a12dccbd4eb9e39e06110c03cfdfc3959f998d96e9aab7872b82456cc"}, "7a320830-44b5-4f52-a45b-baf28b810782": {"doc_hash": "5d0cca1378024cf49a6c6c8b6fef2ee09511f8f56027875447cb7f063aea3e28"}, "c45b799f-fe40-4f2f-bc79-032d33924c03": {"doc_hash": "56abd08723cde46415ac5c53576af2e896da5950ab6a9c2f8c691637b83c5c37"}, "02f2e1fa-f441-468f-9d72-5ccacdba6435": {"doc_hash": "314c220ac6247fb8a4d04515f5681304b6cb62085ac0ac1a01fba3f0e305ff00"}, "f976e342-68b6-4d58-a9f5-b317cb5dae73": {"doc_hash": "850af3c39d3990091007a35367a8d27fb6398866c30a158df03be8659954f7db"}, "e22f2699-412d-493e-9015-854ae6d940f2": {"doc_hash": "3a3f4ad87f3eac0ff5eaacfa9d4bc70b86eed0df4310bec7da851abe19cc1e1b"}, "a0732593-97f7-43f2-8f50-afcadb61c019": {"doc_hash": "6ac250e1514dd357ad604915dd8cf5f1692ebea2a6f2dd318bedc95620332545"}, "b945d56d-bb36-4ef8-9dae-b23aa4d6e3c1": {"doc_hash": "fc02ac775a317956bc33033d7756a27d9888fa2e5fd3e91fab8155cbd21b2e3d"}, "67d933a3-a709-451f-b837-e1e825e3010a": {"doc_hash": "e3617acf0c8a43bf8b3019c8d2955a5b73ed63832a2772ab47f52a884cc546f9"}, "105d2be9-d4c2-4bdc-b09f-ca1f1a04e0d3": {"doc_hash": "2993782963367f645050d5da95892d0b603f883d2b1ee049cd234eab7c8b0f72"}, "4456f49d-4efb-4041-98ac-c657c9f9f4dd": {"doc_hash": "8e5a7156f496844feccf41642c32bf39f8de0c342964f5c619afd076a48e67ba"}, "5461ee63-5766-428e-a45b-a9a4005935be": {"doc_hash": "fd5d8c76530691d61fee4d7c8ec7a33dc1baec7203b58aa6b65ffaaa3107bf0f"}, "85e0af80-6850-49fd-94e7-a230a676ad63": {"doc_hash": "16fde08b694a1121af1064192571e79abe3ed5928c43166dcd1ea8d3589dfd38"}, "7f47ff51-a533-480d-9484-d036e9228603": {"doc_hash": "02a0cf886295c49ca5bf5b34dc74be4f610225e91d664d78d6d80b9ac8ea849f"}, "2b53c61f-8374-4a6c-8411-f368cfb2feb1": {"doc_hash": "f07a032e8df97c8a235c65ac96d10acb19ff64ea9ce99a8c354080f21c32598d"}, "13bcf40e-6107-4bf3-a587-1df5f08557d7": {"doc_hash": "337e963a6f6309509585c2a0cbab9713d97b298e4672a26513c642136a8f0d6a"}, "8195be23-c577-4652-9cf8-b9bfcaf2ef57": {"doc_hash": "f13d3b3b244649163a45be3b68c69eb26c5c0cf76ecd2821f819e6e9c39d2b1d"}, "984e1d7e-ffff-43c8-bfda-43b4b3d8df75": {"doc_hash": "b68403236ef685f62c62f4c85ebb7b638183695c122dfcd33b8db2c93bf3eb99"}, "396a89f9-dff1-42a1-83ee-79e3394a5e3f": {"doc_hash": "fb15d61e7a24e5ef2b92f4339a99f6495e527e5358cad2cb6251f8324bb60baf"}, "438a5bdc-9619-4337-acee-05db1751c58c": {"doc_hash": "1c505e7d865fbccfc725229e7eb253a20a2513d92e7948cb57ab70b02fa6dd54"}, "f980618a-31d1-4b6f-868b-8abcdcb5cc2b": {"doc_hash": "1a5d4008b5977b1d5b0a92c68b8278b859c19b424e7182768466d3319b23e9e6"}, "05bfc3ca-b0a9-4cde-87a2-d7a00c2d177b": {"doc_hash": "7dd373bba69c2f54c656bd8d4674b3199cb1f23c5af76bd08e16900ff674e8e9"}, "9cd7dfaf-a8e6-4308-8ff3-7bc1e967895d": {"doc_hash": "4151240fbe4e7d6987cfbec0539f2abaf1b37e230ef55ee94534bdb88ca529b8"}, "d1f02a0d-6f60-445a-90c2-3ad6413d5483": {"doc_hash": "6f5c5fbfc4ddd90e1cc75386fe536d573fc717cfb74e445445bc0d0d468d37c2"}, "90e386fd-a358-4593-9f25-96d85c673a06": {"doc_hash": "4d73177ec2d4673d400c9d3fa9111593f029ee4fcf3afa1cd0ffd069a1729865"}, "c9fa4afd-c702-4f97-8091-445e9de12d5d": {"doc_hash": "4ba45cc58f4ca33047bf32b34bbcb5cef90b8119bd4607fd8dc0a470d9389485"}, "60859022-89f9-4c0a-a8c9-964cdc288b51": {"doc_hash": "82ab0a613b88b7bd4acbd402fcbb25e639efcaaac67b544b6b5ffdda72934e4f"}, "e95b1f92-2b42-4a47-ba8e-9e93e16644c8": {"doc_hash": "5fa8597d7b6a0729f8a5ed16d5b98d8fb0e4bdbeec5b8d8aefc91a870f0408bb"}, "92318769-4207-46b6-89ec-25dc17a3dcad": {"doc_hash": "b4b6ddbeb26f2670a1438ef34308980b63260d17e0c81d55e3a89f813495ae78"}, "38348290-10ad-4e34-bbf4-982f05f95872": {"doc_hash": "375d3f0c3e6c54cac6bb7ff6027c6136f2cf249365fa2268d2ca652fa5c9d340"}, "f82a4845-b5d7-48a8-b656-39dd8e3cfd18": {"doc_hash": "bc02fe3fd2dab430a794be4777376c214b7f7dd8a870721e8e3c66db9c59fb5a"}, "2d5ca64f-835e-4902-8691-22c9fe80852e": {"doc_hash": "31edf8e65d5dd8dea7a56e5700459bac512bdf83ee5ad8e7ab1fa494e0ce8b0e"}, "462ed390-a5bb-4a88-bed2-14e6d58c8574": {"doc_hash": "35405c3fc757f8832b3d17059e71fb76e5cd7a8392f75fb0c6449c4a1527dbf6"}, "bddf7fe1-3aa8-43f7-86bb-45ac65f51e93": {"doc_hash": "a6d3cd321454ac3d784643fbe6c43cf68eb0e21475c2c2bf0f7964f09161a7ad"}, "e026b4f4-63cd-4564-b258-fbc67235ebed": {"doc_hash": "d028441ad86778e941ddc9a42775330f3df158d3353c3ce4b77178bc89c2851d"}, "6148d7d0-45ea-49b9-870a-26229e3fbd66": {"doc_hash": "896aeb99b40266917d2a454110d417164c1d42c0be02ca1e88967fdc9e4f8870"}, "f11a0740-be04-4b51-8324-bd5471caec14": {"doc_hash": "f1e056be804534ca16e801eb4e61381b965c1684a6488046a2246ce1c1b84614"}, "a76c8d73-b0ac-4a1b-a1fa-ba10358c253f": {"doc_hash": "54b01e1251827ee88e1938846faf1f8d62f988c80103939678f65bc90823d5a8"}, "c88540a3-b0fb-4c20-81db-2eb46d946c3c": {"doc_hash": "6de056215618ce7ea16f9336f021975a5851d1d6d03b1a685ca9c8ad1d163ed1"}, "51b81ab6-1c4b-41ba-8b28-7e8f6ddd8f36": {"doc_hash": "e80ab3dcf029e133d9adb6537d836481c067a9a1289b833b0c14de92d93eb13a"}, "ab2b6bf3-cc66-41cc-be09-e6fac8cf5437": {"doc_hash": "7803ba2d80bb2ae935305baf0499443ee5f4e1f80579f96bded702a717a33b0b"}, "f95c2d56-fba8-413f-bb76-539a46eae194": {"doc_hash": "3f52babb5695cc86b823928536ee2c0422d39258bd2fc8839c994b05fad3695d"}, "17c30727-0599-43b5-a11f-d1b0c0e13349": {"doc_hash": "0747c26f7b0375b24c11522dcbb1c3ccf2710da964b234a6beec52f0fda14118"}, "84080f9b-e594-4495-be61-bda43cb86874": {"doc_hash": "a6dfae0807e2fe7fc17fed3e753346271ce1292b683c730a3332411b15ca4852"}, "f1a83297-364c-4d19-960a-5849cfeb2cd4": {"doc_hash": "1878f167d5c93165418c91319be2ad5c67f6ef91cb188530dc428701ff28660d"}, "8c9596dc-dc72-4bf2-ae5a-40f5f3a82f82": {"doc_hash": "f9b059992d1161bbeeb897bf5c4f44e75a15e8470279f2ee66056b28f45f14cd"}, "ac278cc6-3d41-4874-b1a5-a98b50157c11": {"doc_hash": "3391f767ae003bafacd60e64610ef9e6e748d18d1f1d00ef526320984906dc7d"}, "88b19485-8cd8-46a4-bac8-5fc415d55591": {"doc_hash": "811d44402902416dee0f69fde9bab892daa3f4b64eb6600acddc563aa0e632cc"}, "54dc3ec4-edc5-4178-a51b-622c5b46fa8c": {"doc_hash": "b7bba3a301d5dafde50423d12dc7efa7427f5e6eb5f8a45e6bedd1c1943158ea"}, "111546b9-b54c-4275-8e79-faec495b1eca": {"doc_hash": "52e67c3445f15d31e0d90eb1eaf00d21f2f08f5500804959a96aa0e2f8253d66"}, "d6887eba-e990-4502-8d6b-543335713268": {"doc_hash": "e4a0d68a9bf795489b71103063671ccfc6c970fc6b9b1a3138ed09c70c0e2acd"}, "32add051-8455-4359-a8f8-249140afe9ac": {"doc_hash": "52eb895b55b202edb09fb5dfcfe272a7052734b2954beb5129b16e56d37b0f04"}, "5f4a2e13-28a6-4ea4-8137-406cdee5896a": {"doc_hash": "8faec1e3beb97dc2d1ba982afdec40721c96eb96b3652e04b2e83f64183a9de8"}, "fe19bb90-70c7-4019-ac18-4a5c7e25a9c8": {"doc_hash": "2474b319d6dd37657ca00a4f1f146c9c19e52e8e31e096678f72965caa3ccf1c"}, "163fe919-1f08-4992-8524-378994cf2710": {"doc_hash": "1107f3f57f7ac3222da1e67d22273f3818619fb6699ef835275bd1411b27bdc5"}, "5571b7ae-8a7a-4e48-ba72-d69822e2b5ac": {"doc_hash": "4a5b918635cc5f3bd5df491a738ae164be96360377bb0dab5b09c7a74c3837ce"}, "6a6bd0f6-1a54-4c5d-8788-dcb74dd37050": {"doc_hash": "2b72ade134625859fe08c26d846d04468c10da4c95ec9daba360340a8557b373"}, "fa0bbb43-4ab6-4b41-9642-bc97fa14c77e": {"doc_hash": "995c5ef76de6fd0827f166045aa47f81826c34dbbe0ed8c4b047a3bc1ba9592c"}, "b338830a-ecbc-4f18-89c9-adcad2e2717e": {"doc_hash": "1820ff678c6e3803cba643d44a4120ed20be204a04cec3e9b6966b1394467b47"}, "290c0cf8-b856-4044-9072-5c0048c37a43": {"doc_hash": "6c67aa4ffb473b49fd68da32dc1e4b8ef0f3abbc654ad715c6ff84b8ca267108"}, "4825ba3c-d08c-4d41-9223-a08769c775d9": {"doc_hash": "fa2a63f70dc9b787d4689b168a08b4f589d77f8f50d878c247d3ce4407fba345"}, "d8d38062-f3eb-4835-ae36-dd0d7fd6d183": {"doc_hash": "461be3d0337e19b58ac7892b46f579a08d7de229446220d916922713bdec4a2e"}, "4564a9dd-e429-4ed5-9825-0c0771978963": {"doc_hash": "264a50fb7bdc6969947d53deac614047216e8a2bce12fe30ea7cc3f228b5e833"}, "bd99c20f-69e8-43d3-930d-accf25948f7b": {"doc_hash": "9720bb7bf7fc20d2cb389c1c7b41a14dbf28be301a29c4b47254f352f83e15fb"}, "b982f1eb-bb73-4014-b42c-0d9ead91f208": {"doc_hash": "4e4bee43a4e71894f011b6dab0cb12a7671f6dba87ad4085e4d51fe5dee992a8"}, "4d56c719-303e-4690-b1dc-7d3d7f15121d": {"doc_hash": "ad93ed0bbca5f7cafd33297db83bdd0347c66307c09e0f9264ec6c1d45143ace"}, "64b1c8b3-ffbd-4c4d-addc-28037590e6b3": {"doc_hash": "fa929325d99cbc2cdd11c3f92b2111b055bd06ead08165447fc958091b2d8e39"}, "0ef94bf5-5747-4298-a23a-72933e177f4c": {"doc_hash": "5c83466a743f76bd675e29f86686b2146245532cd67b9a3dd9a980896cc64d2c"}, "869bebde-2aea-4092-a1a7-d4be83b672bc": {"doc_hash": "8f31bce105b3f337de35ef7700ca067c2286da4dea3e55a67d696a1ce58b3a4c"}, "e56251b3-3291-4ffe-af1f-005219432fc4": {"doc_hash": "fdd265400d53b1b249206029a5a06df1227107b0dccb7984ce6b6137b7a4bbe6"}, "c8a6723f-d212-419e-b817-541a220052f2": {"doc_hash": "8405848e01a08079a117934080a0bfc7a8602277d09c5c9b582fd1f8ec1bab65"}, "e87140bc-4f35-47f1-88a9-8aa52fceb6c4": {"doc_hash": "ca27a87801faed28c873018b59a9e42f5cad0dfad933a67a6f5f592e66d9b689"}, "efe228b3-a57b-4c88-bda8-cfedc4b6c827": {"doc_hash": "a4fe82de102b668a3e1172a4dda5de5669dc112c9db3d5e04b2278e646568848"}, "45ec8dfb-9ae1-4a87-9dfb-0fdabda8c13c": {"doc_hash": "cceeb2c7acf41e0280b1c744b2ad07aa791e8e269ba741f7d6524a11a46667af"}, "1f29fbc4-24eb-4f26-88e9-28bdb11415e5": {"doc_hash": "4fec3f5f37563cd42d846ea9cc41a191a600089533a3ce348fbc63b80d927096"}, "10a6be7f-cb03-4852-824c-03c8bade70e2": {"doc_hash": "2e1ade715b6ac1385736f5c7cce7d7ecad41b7c1eb70b3d62b48fde1a54a060e"}, "b4b4f95b-1bc0-435f-92e6-a6e40f047db9": {"doc_hash": "aa82641905b4d64b21501f84f1fb757ae15eb8f1ce760f9c1c6f627b155c919e"}, "a6f7d8b1-e438-4501-b9c1-657ce418aaa3": {"doc_hash": "47f79bb7c4b93abb8f712663e81eabc81f238e841a79f960f61fc718eabeaa68"}, "cf95c651-0940-4453-9031-d404c5bd9598": {"doc_hash": "f1b8b6d00e559b3398101353c47a68e79154f36d8076906f10665cf7ce76cccc"}, "38c22982-47f7-4f18-8756-a7dce0ba4c52": {"doc_hash": "67b155cc75f40050a9a77313dc4b076b61b44dd4e74f45e1a33c48485d104da6"}, "26b8c868-564d-4499-8164-7a8fd9197c72": {"doc_hash": "48f23045db86f734d12066ee841ec8eabaf5f6c4bccf2b1c0ebb9484487638b6"}, "8b0e86ab-d39a-4503-982f-90873d989124": {"doc_hash": "c76ec2d585bb5423a8cff56d8482322b59d5b3de07966c596ddd51d52ef557de"}, "774b0d83-dda4-4600-85b2-e2b74373fda7": {"doc_hash": "8e4b4a318de3b0b40ae9f2bc469d1daddaacedf230e854a958be1fe121f02fdd"}, "2170c093-23f7-496e-905c-fb5c4467743b": {"doc_hash": "9c7c427b3b54b679ef837c5019e566a227359f48d5e905e85df68c76620229de"}, "225b05f5-8121-42e9-ab24-7704615575cb": {"doc_hash": "a192d3f1c6dc5e23ccedd84fd98f55940cdb475dfd4f6ec8bcec6afab4e5552e"}, "bbc855ec-480a-4ef3-9766-7b13b5820bee": {"doc_hash": "608f7944df64984b1d5ab3777090858be33a0e363fc0b36225e0498922bd9562"}, "0f4cf36a-9b29-4764-9dc8-8a63dcbfe60d": {"doc_hash": "e88d5d033935b4231ed1b9d5dd74293b0d7aff5c3694162b4b8519ab099ea706"}, "515acc1f-8e5f-47fc-a2d0-e5b8b4933852": {"doc_hash": "7bea6e5f0b7b5f30fe2d03d9079f76ba0cd78bf05130fa6711d80e5e83c62eb8"}, "ecc8cbb9-08ed-4bab-9dcb-89d340a64efb": {"doc_hash": "2b63759bfd71ce5af1e69dcf70817bbd008ba05c2ead0db9a3bea5e88dc5a74e"}, "4533ece0-9fe7-42a8-abac-0031b6877b63": {"doc_hash": "d08ff5ad6bb4e262e8182ad1cb1587d2fba22bd73b93ae29f630acb3baedb806"}, "65f9abd4-acec-4ef8-9ecb-3f847693ab1c": {"doc_hash": "94fcddecd16b315e7e306df88916ba33386d97ec21653162d93205852ab0052a"}, "6423f481-8855-43ec-a5f4-01dce88c1d16": {"doc_hash": "81f3cce634fbaea3ffec80bfcb81e3454b0bbd4c7be384a78d70c047ed0278d5"}, "b3aeb5e9-c5a2-45a8-9032-fa277a8e2eb3": {"doc_hash": "2bc85d33c64ae87a122b9e2c01e6e9682ac26e33b0ed9aef324282f5a874df70"}, "32d1ba11-f5b9-4f6d-b62b-4f51ff921348": {"doc_hash": "6113c4de486e74f2e9d19fac3f4cfa6d90998c5b973872fdfcd72fa8b404f92c"}, "5b9de05c-8e61-433c-81e3-45a681f844fd": {"doc_hash": "09b4d234138f9b57e5685a6eac891f2e18da20ec6e8be2bf1efd6368070f23f3", "ref_doc_id": "14a6ccf9-adc4-49e5-8ca3-54cf2c0b395f"}, "d44e44d7-acb2-4066-acac-43712b67d6e1": {"doc_hash": "8e5fb1b72734da275f00946f79fbf82c8f2414cf01d6314a423d0953956dd3a5", "ref_doc_id": "a9fb00aa-ed49-403e-93cc-d511dd652924"}, "e2598b0a-70c2-49da-8e9b-2340df10d018": {"doc_hash": "ca9f05d6e98848e49872b98c4daea84f1ac0a1476b9b5a084a599f8b3c2be777", "ref_doc_id": "00e1f4d8-40cb-4a8d-b9b7-0ffe5460772b"}, "9ce308a7-7c62-4f88-8ea4-e84ee55b203f": {"doc_hash": "c04cbe32b180c8d011f5705fb9d1e9570654fb7f9469ae9c241023f9643ae4b1", "ref_doc_id": "f61aac9e-9e13-4680-a4a7-e6e8edf56f44"}, "f31d1314-4835-4048-8c93-178e3cd9539e": {"doc_hash": "de89d2bab8f0b430a1c13ee92e2fd78ab35aff264bee91619845d512f6d454c4", "ref_doc_id": "1e26bc5e-ec2f-42ef-a8f1-e9b0f103b8b7"}, "499d84ea-f66f-4c05-b834-13e4c69dc3fe": {"doc_hash": "15a032770b85162232185f44af34ba5c03c88f469ed52da8594de1daff96a19f", "ref_doc_id": "9e571879-7779-4973-a26f-9bee54e85581"}, "355ae47d-b296-4f5d-8eee-9ed53ebf5685": {"doc_hash": "c92b0830c5c63d6e08b8536b3562859895e9cb14b152c9b44c0fd3f4e4ea09e1", "ref_doc_id": "fb385b04-79a7-422b-8990-982752371c7f"}, "e341e24e-dca5-4588-9a8f-dd011a23fe25": {"doc_hash": "f2c262d7b088b667dd1c02d1f83afa148ce63ac7f5b855108edc6a344d25f8aa", "ref_doc_id": "122c97e3-dffe-41ad-8437-e8fa89545303"}, "13150958-1f72-4aaa-80bb-d92bfe3fa600": {"doc_hash": "efef9c3a4b8acedfb665df23d25ab93d3cc432e388af3be6dc178f4f0a6ceee7", "ref_doc_id": "2ae5c64b-1b24-4b85-96da-80e4cc7fa0a8"}, "199be439-d1c3-49e1-9448-4030456eeb1d": {"doc_hash": "5c7b9022e1c999cb94ab57a0fcdfc97079f8de77002180c32e4009461a07e7b0", "ref_doc_id": "693c0b06-9719-4c6a-960c-02a03da16a44"}, "fc9a2506-a7cd-4b5e-a8f7-805f43620ccb": {"doc_hash": "dd867f14e8b053c3ea37d78de411e12deed3bb6aae1f18a121a499eee5a559f5", "ref_doc_id": "17e044ef-066c-41ff-871f-e0521f9e11a2"}, "dbb58f28-9c73-4da0-95d7-ce5b96d718b7": {"doc_hash": "46f1327f64c791557a438bc5246a6b0ae526ae000d9c2984f1996db68f01211c", "ref_doc_id": "37877ff9-a8e5-48df-8380-a14845889323"}, "e123f864-afc2-4f86-8543-9e19a264e685": {"doc_hash": "d997e0aaa8a1b076b4b66338c1051283ada9de4dd3d06bfaff653a7993f99429", "ref_doc_id": "5aad9db2-a8ef-4d10-8fec-22e3cc7e59d3"}, "b3a59439-9b24-43cb-8f16-9339d2bb3637": {"doc_hash": "757b9123eca604b24e7086cc86fa1203afd53b99696125dbb837663671b9ca04", "ref_doc_id": "e31cf697-ce51-425a-ba7c-87c8f39163d3"}, "4fde79cb-ef57-4e7c-917a-04af6e2ffb02": {"doc_hash": "6f655ce3481cc9a0607c5206b2aa02a00c0d38e505b127d93e989bdee64fc7e0", "ref_doc_id": "0593823f-38af-4861-a0ac-b7fbd48f155c"}, "f00b6c7e-0d0c-47c9-8275-81d75a67fa11": {"doc_hash": "a97134d094e358cd3c9d2330048aa0595b6ff46567e666cda170c69e2514513d", "ref_doc_id": "95ed1103-1d3e-455f-ab65-7c4779688d72"}, "456b7755-9d8e-45ce-b52f-5046da1d73d3": {"doc_hash": "ff59c36303182af74655c58f4ec24fdf56743efe5b48af728d1b8f673885b584", "ref_doc_id": "96de02c3-7291-4c16-a959-608f2779e66b"}, "491e6864-618b-4449-9f79-d72ad9982619": {"doc_hash": "172eb709e2ea317d4baeb7eeaec903f0711967c3405b66e21b2bcc85b24c208d", "ref_doc_id": "f1b6245f-2382-4a9f-b060-90a84d6742f3"}, "f3a9969b-3680-4bad-96fc-127b6e513428": {"doc_hash": "5eb9ad9aac513e6532f121898cc639d6a7281f133d48a85c9d6dd33a740489f8", "ref_doc_id": "2b000c16-d6dc-4446-bdab-61871dc53a76"}, "d11e61cb-76d3-42dc-90f8-5358177a5566": {"doc_hash": "54cb7dc7a9dc199ae72147c1fc51683c3d024e49723a06abfb9bc5bccdc2e21b", "ref_doc_id": "9488d511-9dc9-477f-a799-b6a4fee59970"}, "e376dcf7-d9c5-40ec-8489-fdf7c1b5a651": {"doc_hash": "878322cccf5e096836054ec8ad568c66132cd5615994d200b4f6bc4d80fe2c92", "ref_doc_id": "3cdb199d-1952-45a3-b6ca-2f012fe1af8c"}, "b942ba09-b042-47be-a5bd-ec8716c913a9": {"doc_hash": "818052bda4060a62a3bbcd9b510825f68b76c9ef1158cf2f5d8facad375d22cd", "ref_doc_id": "c67cf8e8-af7d-48fa-882e-4e1b65246104"}, "4a2fcf76-4fa5-4eaa-b308-505371eceba1": {"doc_hash": "3d235b3e42f47a3db4b5dcfef40cf6649ea89ab8d94a87c263dfff7d26f70f3c", "ref_doc_id": "958c632e-ed1b-4ba4-8ad2-23b364d5f283"}, "7806fe8a-1036-4865-a05b-abe2458d9d37": {"doc_hash": "6430b27445d817c60d2967d212f04a1c13df70345b05aa5cbde8aec64cc78e40", "ref_doc_id": "da866fec-39a7-4a28-b0a8-05a51084e888"}, "a38a1f8e-4f52-4369-bf3c-759dcfdcd828": {"doc_hash": "b6338ad401f97bebcc89a3e8c1d9bfc0b4a9e3139c3f2e4bcad4557d9f95d6b0", "ref_doc_id": "ae7c1f30-0982-4e52-b224-b864a35abc84"}, "fda6dfaf-b1f2-45c6-99dc-5b988448ce81": {"doc_hash": "696f13506503b92f7bca4a8ac8875936bee33d0e432b9d4c0892c6b90b3cbe6f", "ref_doc_id": "c022ff7d-f31e-41c8-b753-1a7fd81eb16e"}, "5cd2b523-c57c-4310-bb88-72df7e964eef": {"doc_hash": "4589911de7f201d950a74d1e05c703eaac36449c8da95a5560f9d961f3bb3cba", "ref_doc_id": "6f487232-6a67-4731-a5d3-463a05e75cd5"}, "06ce1a05-76b7-4b2f-8f94-1f8e8866cd21": {"doc_hash": "ce3788272abc2dc7c2bdf09441e4c301009cdbfec1302b84ed2f4ccc6fb2a258", "ref_doc_id": "ec47f9ad-0af7-443e-8359-54ce633c73af"}, "fbd1da7f-c1a4-43f9-a516-febd99ccda80": {"doc_hash": "f963b9b184bb267e17bad69b7eb040d489d7b9d7454f4fa70617e09680c86dd4", "ref_doc_id": "775d6a96-770e-45ad-abca-3894a3ef93c6"}, "cd6af016-65d6-41b2-8eae-c784b98416b7": {"doc_hash": "90978bad8370aee0a5dfd4a768b80b50bdb09187a9906511e2807d9e9741bcf6", "ref_doc_id": "9beb1dff-f168-4190-b166-3e06141aeab6"}, "a6be55c2-99c4-464f-8d32-587c63ce7e95": {"doc_hash": "04bfdcdafc26d3b57eeeb02903cb40dfcc75db3ea1612a9ccb2b27f8513c7a65", "ref_doc_id": "7e9e1716-b5b1-4b20-8557-86a59094c763"}, "e63f217a-4d26-4651-b103-00c10ef0afd8": {"doc_hash": "0316a13d2b6bacf67f368299b7ca21adaca086183ace8b77cf8028c3e2ac8d9b", "ref_doc_id": "40281847-c6e5-4259-a23a-40c4410315bc"}, "950f8555-3a2d-4fed-9715-0f10800ee457": {"doc_hash": "856de974a1ab885a7f7dbb3fb94d2bb73009aa7c0397bc89c8a6e7a5dc695d39", "ref_doc_id": "66a20f6a-c2a9-420d-942a-a990d4a07454"}, "6886b43e-80eb-40eb-a9b3-536244565b66": {"doc_hash": "d0bbea6581263dd876116a70b2710213c653e1b9e3ba748d257f5c78b0c79b96", "ref_doc_id": "99d8fa96-6e3d-4d13-ab2f-981aa9c2a2d4"}, "a7c5dbc2-3ee4-4e0d-b4cd-2310eb2e5aaf": {"doc_hash": "feb6085fa466189dadd324a9e7049b710829cbfab15efc69fdecad2f5155a968", "ref_doc_id": "6383d4b6-dd4c-465d-85b6-9b42d91ad314"}, "bcb81a3a-8a38-485f-a506-eb9d6c507bce": {"doc_hash": "c2e783f614e7aa8a8f5d8f455d044e5d190cc5a54dcd0bbc4eee1f2a0f05cde2", "ref_doc_id": "d1bc3755-3354-4d41-aadb-b136b720c67a"}, "a5d261ee-2fe7-4be0-82b8-1d37b9e09c0f": {"doc_hash": "385157c5d3405679f845f399bc1f71acf7d952fd64c65b5d42366193736c69d3", "ref_doc_id": "b8d4fa21-687c-4c6e-a931-7421435cd0c4"}, "541f4c3b-28fa-4359-aac4-992e92a12818": {"doc_hash": "8ea2c86ac5413f0fefb68563af67752d4ec327ddb13fdc41d1aa11439643e1c1", "ref_doc_id": "28432a3b-116a-41ed-a5ad-4000fc2acd67"}, "0a324b6f-42cd-41d5-8210-0560b7b7fc08": {"doc_hash": "75aa85e9af3dee8fed3294c9f06a15357065b6692faedb4512246a6756d4be0b", "ref_doc_id": "84d024b3-a8e4-42d5-9186-068470ec2916"}, "fe72fe8a-bf31-408b-b0df-918828ba00f9": {"doc_hash": "7bc642ba06605f9a4cac3bb2f81961c87b399c5c49d5192f126c0916714eb513", "ref_doc_id": "cbba637d-3358-4caa-b535-81736f6b7c31"}, "80808fcb-9373-4a96-9903-254e430c48a4": {"doc_hash": "fbbed6981e5d220887fd5c8ed1ea346a229f5934d1d6ddd3c68a67b9546c8051", "ref_doc_id": "4c2e3729-00b3-46f1-96b4-ed4c443cd555"}, "f416e33e-f7e5-41ec-bf99-71838b49db18": {"doc_hash": "65968cd998fb178fb47fe203c29d176ed6690c123eae4794a1dfa094b82e1c80", "ref_doc_id": "924975dc-8582-4cb5-b2af-8c0da4679147"}, "807165dc-083c-41db-b7df-db046d43c262": {"doc_hash": "9b1a891a09a65bf4ba026cfeb4221092eb27dad1dbce035709d704dec36569b8", "ref_doc_id": "d86e3078-b409-44ee-9eec-f0262d5918b6"}, "e1f62f4a-5c0d-49dd-b70f-0b5792dac4e5": {"doc_hash": "3a660dff4cf48398dd364a117167e84c7c0b7b70707f42ba1ce77171f638713d", "ref_doc_id": "b39def78-d8b1-4463-8f00-d3a34e39fc34"}, "b0a1bc6d-a78c-4b5e-844e-7b3e97a04521": {"doc_hash": "644e79b2123563e550c2e2e10e252fe5b2f8bb7fb40d2b09484ccabddc323a38", "ref_doc_id": "c33a6a4a-e602-444a-b61a-a3aea69fa36c"}, "772bc3ab-7f54-4b60-bae5-2420580a57fe": {"doc_hash": "e1c7fa8c9c468fdbe62a11e75d88dc42e605df8f09b2c5c9336e838e1e65f694", "ref_doc_id": "3ddf33ea-bbd8-40cf-9a40-a13154eb2d8a"}, "18abd933-b6fd-46d2-af2a-1bb78fd37f14": {"doc_hash": "9a8cc50a1b46f68db18047dbe11ceea56b118b15b8cd2cad26be4e6952b33903", "ref_doc_id": "683f29fd-bf98-4be1-bff0-144acc3b7aba"}, "32daf703-5842-4b49-87f5-e283aa213afb": {"doc_hash": "8ec115e5eb068224d9a3511bcea3a0d36fbe12be6a6497300efc04eef48e8b6d", "ref_doc_id": "af112b94-50a8-4d69-9356-ecb9508f779a"}, "675a222f-64af-498d-a6d9-ab968ae48c9a": {"doc_hash": "91b5e4ca7f43f0767e7b64ae91295a80db988b14945473ca7d5d810326023d1e", "ref_doc_id": "1827f261-8016-4b22-9002-27725a06e5a8"}, "945f092e-bc44-4d3d-bbb8-fd802d8120e3": {"doc_hash": "78d9a8c34b74cd269686ed732bf20f3edde61a27da6ff7bcfe9cf4c52e5894c2", "ref_doc_id": "434e9b90-49e9-4270-8fd8-8c7f8355b1b9"}, "2ac9fb92-6f75-4c17-8f95-d219482d99e5": {"doc_hash": "9c0609c2f15f6869ff559b584accbd3d4b75810ea2f17a54d2bdc5856dd4e2ca", "ref_doc_id": "d55832e2-38b5-4d77-8206-3ba586cdab85"}, "46825d9a-c860-4fc0-8047-ef43f21754df": {"doc_hash": "3bfd48fd873d1e255ce1276f9ae9bea71cae90a530e84fd25386f1d104574194", "ref_doc_id": "a4442ea6-1ec2-433a-a1f6-222537c6037c"}, "d76045c4-3a5a-412a-86d8-62c155d082dd": {"doc_hash": "b1ff097762bd5489d705436c7aac9bf9c2f5e43f32a354a01760edfe602db95e", "ref_doc_id": "a9fcdd22-4318-4c21-9297-ad33b3ab05e6"}, "ea5e9aa9-af54-4dea-9388-41cf6899147c": {"doc_hash": "ea417547bb167492c674588f9a8148e8492ba1caaef297f4e48bb5b3752a4d2b", "ref_doc_id": "787f824b-6dcf-4e21-9fc2-2214c55a8f82"}, "ec78ce0c-894f-4996-8e64-9096fea9d4d0": {"doc_hash": "51bbe426f10ff64727c41e6fd1125b524b47ec7ff6e7a790054d6d767302f59c", "ref_doc_id": "220f95f8-ab72-4570-ace2-8cad2bf17f12"}, "0ce92ee2-a14b-4dbd-8cf5-88cf7d97ffb6": {"doc_hash": "abbf93f323fb94de1b66b7acc969d6bb7199fdcc17d0d60598b3437b29db16ea", "ref_doc_id": "8fa1a5cb-702f-44ed-8d20-15cf24fd6712"}, "75f19480-687e-4c61-bca3-a48aca157562": {"doc_hash": "b459a404837db7a9a2d1f9d6e2b9703ad7161eeb6ba42e6035f709e3f9dd8038", "ref_doc_id": "4801dd2e-a9a8-4f1a-8c33-f7672fc5af5c"}, "371511b2-0237-4c51-911b-0a47b10145a7": {"doc_hash": "fca1a004100f88d5f934983b685195a9468f30310a54be80b3890f54983cbe74", "ref_doc_id": "fe2767ca-bcbe-4841-a796-5de28f1391e7"}, "d0bd5f58-03f9-4e15-a8bc-fcaed8e77d6b": {"doc_hash": "81265f169c13f0c24d9338e7e3f87fa2923d2027a2cff0c1563a3765f070e6d4", "ref_doc_id": "3823decb-ee25-45da-9706-27f65d0fb331"}, "2039c74c-e3f7-484c-b828-8d60d39586d4": {"doc_hash": "c9bd1988b8cb25402b21bedd18262439e7c716c473e8cb4d2d986360cb4a8146", "ref_doc_id": "5d53fa1e-a0a6-4b05-9541-efab54285edf"}, "9fce5ad9-406d-40b6-be98-fe6ef376954d": {"doc_hash": "9fa258b705c60df70d6c04edf07e5854c0539f4fe9f558ebfd076a52d9b82813", "ref_doc_id": "6b741be5-f451-4b46-af0a-78678fd1eea6"}, "62363b93-e892-4170-a664-520cd5e97444": {"doc_hash": "909a39c0cfb7be10ba648a1fbd8fe613762866383d9e5787fc0084742f280257", "ref_doc_id": "c88d1376-886b-494a-ad5e-6b74033bd3e9"}, "86cddc1a-fe1a-4ead-bf3a-27518a8820c4": {"doc_hash": "2ba8976e7e005e61be64bffbab6cf4e5f649c4083b6e5e0b036ec5b60adb6199", "ref_doc_id": "a712ff43-7bca-43bf-868a-89d9bf93e48d"}, "26ed5b32-2c9a-4f54-bff3-ab70398191c3": {"doc_hash": "a4be04b004a49ef5f8e67fd99326b16f6c12001d73f5e2e11d9a819c9e55ac04", "ref_doc_id": "4a2f804a-1695-411c-b9b7-8ac1dfc803a6"}, "5af1c24c-31f5-4068-ba14-11a10282d4c8": {"doc_hash": "eebe00df479792697f65b2ce25a8efd873131748003d2cd8b6a123d17f3c9b96", "ref_doc_id": "5cd068ef-971d-4cf2-9818-f4a8ec479d6e"}, "f3ac06f2-a882-4b8b-baa1-09bf99655095": {"doc_hash": "4be0b6138f1575bde18d82dec116a10020758a9ada12cce672fb5280db40f593", "ref_doc_id": "dfe25b23-0dc4-4553-a8f3-fe559fd3dd5d"}, "b5b5ca50-c970-4d36-b0b9-1e5aca132300": {"doc_hash": "d68d35170f5fca10fb896392dc9309922658c6174c0778e298abda2b65609fa4", "ref_doc_id": "6c7d00d7-118a-499e-999c-be29d4e0207b"}, "afb1f413-1a30-42ed-8ffb-39eb6ba26c07": {"doc_hash": "696d81695e7f1335c42fb0cd5e90066f0feb46c27708a75ddbc4d8d4a78067b8", "ref_doc_id": "ff8e3a3b-163e-4483-96b4-7350fb2222d0"}, "af9b4130-cd7a-4cef-972e-fff90bbb81d3": {"doc_hash": "5c742aabc21c2cf496a86d8c153201a39fa5adf8a2e91daa82a6cb1b0ad49eba", "ref_doc_id": "bf0af623-9cfd-48f5-90c2-c6b724a2761f"}, "08af050f-6429-4516-9d65-2fe8422ea4e4": {"doc_hash": "dda6abdc1857e841cf9463ee193dfc82ccc8fed90472ab9a19859f81db23e087", "ref_doc_id": "c2dd27c3-92f2-422f-8d08-1e9d6a58f358"}, "31ff8b85-79af-47a2-92ae-19a05f7f774c": {"doc_hash": "f18847547bef93cc1598edc6507a56968faef1155b741ec0df85ad7ee533ea0c", "ref_doc_id": "6ab7796c-e87a-49ee-b455-b323139a8c57"}, "d33fb733-f0ad-43bb-baec-a265f0b89868": {"doc_hash": "63c0a72588c019fca1f7daa42fc7780864e4c49d25639981aa152fbd8402ff89", "ref_doc_id": "944aa216-249d-4790-aa83-4b89d655ade2"}, "8a0be426-a2ab-4e48-a552-4f39752ab754": {"doc_hash": "54ccf6323166aa8e1c6b5eaa82881c4ede68c2bf90ad32da2181405918c3f36b", "ref_doc_id": "20a8b136-ad7e-45e8-b769-ea2f70521e74"}, "891afd6e-bbe8-4845-a310-f9d4ab71cfe0": {"doc_hash": "36e4304bfbfecfb3f383dcb6af5e6d8c0bfd7c173263b3586802b730d731d99d", "ref_doc_id": "25bedbc1-a1b1-496f-8351-f2950dde364c"}, "0decf59f-7481-4ffc-abd1-6d6dfbb29db3": {"doc_hash": "0adbe920c17df874ea7fae2dbd8a31d751a4af18839d5158b33f8b7697bb5e6f", "ref_doc_id": "5c907214-4dcb-4631-9957-626adebadc17"}, "4e4a559d-7c6c-4a06-b5e0-db68264135ef": {"doc_hash": "0e782e1e54eecfa4ea151cf7498a06d74b55cec01ba872dbe28508ab8263c279", "ref_doc_id": "edc21a16-ad60-4160-84de-767d35769250"}, "c26282cb-dad0-4940-b60d-2f4e55d3fee7": {"doc_hash": "82c6af2ac86722ade3e0276c56035303d31cca4f0d1b48044d8dd6ab70d02368", "ref_doc_id": "ac053143-cab9-4794-8cbb-15156f592723"}, "e4454d62-e57d-4189-af5c-8bcfbd551852": {"doc_hash": "16b587ba22906137f5efee47d7377b4432b8e1f7eebb1c01280cd790a2f65729", "ref_doc_id": "077baa37-fe87-4b00-9673-cf101b756606"}, "07c73815-1a2b-4645-ab83-691a97dc5304": {"doc_hash": "f1162e24b9da61a1cd562048456cf85fedcb2e4db54b23ed8ef0e581ac56ea57", "ref_doc_id": "b2301267-058e-4170-be09-c8814850cb66"}, "c7e8d315-c913-4e47-998a-50863c967507": {"doc_hash": "d28fb3a93b0d98eb5d3565404676fa87a35d578b25436013c821b9f353236479", "ref_doc_id": "8a1d622b-d868-4ed7-b7b1-4172498f64b9"}, "ef84c6d4-a3dd-42de-873b-9bc4688edfcf": {"doc_hash": "643e403b98323d29ca6fc64a34ebb1a0a900eecc2cc6f34d9515e72926b07bc9", "ref_doc_id": "6c5abbfb-a73f-4161-ae7d-1bf6a4e47e83"}, "29010343-be09-4744-b3c4-eedd60d6a740": {"doc_hash": "4092929166caf77b9fb53d19708353eaed74ca2f52b3da2070911e37beaebc9b", "ref_doc_id": "01afdae3-d63e-47aa-8035-030db717e995"}, "91eb9e17-b3a5-400f-988d-02a6e33bc242": {"doc_hash": "df14cacd31da377a863c97fa388d1ddf28703731d0660e30e418760d99c12e22", "ref_doc_id": "39f313ef-ca56-4d8c-b05f-42a91d42863e"}, "48aacfbe-71bd-419b-a806-66ccddcbf4f7": {"doc_hash": "097eb3ff5dea02ac39965d113cabbe78a77d792bcff8225e7018226d12dc8a2d", "ref_doc_id": "363c52e6-82ab-4c47-a8d5-dc1c1e6baed3"}, "52108760-f15f-4428-aa83-976be2b2c5e5": {"doc_hash": "aa14bd02d4c640a73f48bac62a32e7a6f9deb8c25beee385d033ed8ac9d9de78", "ref_doc_id": "133886d3-8f01-4983-9821-52af09f60bb1"}, "87ac8fc3-187b-4db7-ac2a-263b0418e086": {"doc_hash": "7bdefbf42641073e7918fb1f2bd485714c927871929e73475a4a1e4e4de5872a", "ref_doc_id": "24b94878-1d06-4153-be06-28484bcf7d9b"}, "04eec1fb-8277-4365-809d-3c19d0dcdc93": {"doc_hash": "78598c7a48f4874002b954bee3fafc5ef24ed950b1319a21056b50cc4c8d0125", "ref_doc_id": "669a6811-520b-4bb0-94a1-980ed87c01bb"}, "ba8b2fc2-6060-4d5c-aed2-f53ac50710d5": {"doc_hash": "cd1e22e602574a56742ac04f66ad32a1cc877ced9999c3302beb6391824ff568", "ref_doc_id": "57dd980d-abd9-4522-9681-924aca506a48"}, "7ddc064b-f8fa-48fc-a8df-fa3f163df329": {"doc_hash": "151700da6b2dbaccb4ffe64700adc6241dbe5f35698f47183867248a7057db97", "ref_doc_id": "223937cc-b6c4-46df-b45b-a51c0909b466"}, "72f9549a-7d8a-477b-9c57-1cfd5523aa19": {"doc_hash": "a1330926616ec6183e4ceba44df202ce72f2dc30c863d79ce256dc77f95ecd74", "ref_doc_id": "397922e5-e697-4b6f-9f2e-a096009ab5d1"}, "75667090-8348-4dc4-9973-97a8a9ce7247": {"doc_hash": "047f30fc4843b209d98a97b56c8a101f13ff00c15869c78a6def005e54528cf8", "ref_doc_id": "6a8d4880-6edd-4f2c-93d2-deb8a85cdaf2"}, "3fc51538-e0d9-442c-85bb-f0b627074000": {"doc_hash": "da49ef10edd9c415172a2df37d3b65587f112225c10310ac8be9203a90e2fdfd", "ref_doc_id": "6a8d4880-6edd-4f2c-93d2-deb8a85cdaf2"}, "a9d94fcb-f072-4315-a9cf-7ccb3cb6473a": {"doc_hash": "741c6feed539351c92b600a53a1d68a71e3628683c664d8cd30ae88294cec0fa", "ref_doc_id": "1b37ce62-c95f-45ec-b969-fb3d633d0da7"}, "bc7976fa-8dd8-4236-b239-f1ee9c8936dc": {"doc_hash": "5cae4b449b5a83326106d83b1ff90f90ac5676dbf1bf59a6e6bc20021032e7fc", "ref_doc_id": "1b37ce62-c95f-45ec-b969-fb3d633d0da7"}, "d7cdbb8e-7c87-44dd-8020-893ce648d497": {"doc_hash": "486f65efc777dfb40d26c14ad5feaaa87b74e979b1938cd768532f5f66318abd", "ref_doc_id": "1b37ce62-c95f-45ec-b969-fb3d633d0da7"}, "6a3cc64b-c46e-439e-ac00-14b9431ac5dc": {"doc_hash": "1fe2c4fdec0719599adecf5423ed9d61e16e33f27506cc712863f9a904a2b2ee", "ref_doc_id": "5d4ccc26-021d-4f7b-a807-eeab1972a4de"}, "eb20ac43-7c88-49a6-8556-9de55aa92ffa": {"doc_hash": "c80031a78e0fc2132dd67d43b3812872b84c5c532d39242465b26e66c6bcf195", "ref_doc_id": "5d4ccc26-021d-4f7b-a807-eeab1972a4de"}, "885d3304-5c6b-4eb3-82bd-9722cdf60b86": {"doc_hash": "7af4898d4300f0d1356706d7ecac7f51cb9703ce49de6edb013d649b2df0562a", "ref_doc_id": "d56b54e7-c3d8-4185-b725-5093d27b1629"}, "26a045a0-bf4b-4366-94eb-24c9ed86fa37": {"doc_hash": "38ccd03f869899b6a0625eb328ade777bd52095e5d21b67a5d9b20d044c657a6", "ref_doc_id": "e5c630d4-ae50-4f77-ab50-87d38da1fb0e"}, "b40bc3cf-8641-4aae-ad6b-314bd034c9c0": {"doc_hash": "265dbee6a6d99aec197e423072e7e75268ba2c87497afeb381553e420fd6a287", "ref_doc_id": "73a64b70-8c31-4f10-b492-7d2d2afd8efb"}, "f87d4879-36ff-4bee-9281-5f9767f9de70": {"doc_hash": "b061502f6b95636b6d80f3c2fd6842e8639c0589297840d237e58ecbc69f0ec0", "ref_doc_id": "0cda9d94-b603-40f1-820c-838ab5efd6d3"}, "d011d1db-a927-4742-99f7-a8b3e23b1637": {"doc_hash": "57406cf83528838302426e4a8f3621c1f32d2a2f0999ef51554c1b42663cabe8", "ref_doc_id": "e8a3013c-aac6-4742-9a66-a601dd8d98f8"}, "8bef4b59-9f6f-44a9-bed3-5cddc0cd642b": {"doc_hash": "8e32fc6ed8a79cfb9cf8e9ccfe26700d8257ff857023b4a0df0ad46a9832bef4", "ref_doc_id": "5513dd0e-bccc-4598-b687-14f0b19bbac4"}, "aaa069bc-8aac-4ca1-8030-22c72cc207f4": {"doc_hash": "cfac4221eb272c390b11c9d4a475812abde5bbf85fec64b1d3cb549538686918", "ref_doc_id": "41e310b3-1208-46cf-83ef-64aba2ad4382"}, "2455e69c-84ea-41ff-b41f-fdd092624fbc": {"doc_hash": "9d8199b6f9a1915e3679e1b99ae0d6da2283aa2fa920b5cfd01ff79da4cb8207", "ref_doc_id": "c6a2b542-e34b-45cd-8789-bccf83a33a0f"}, "e84d4ae5-33dc-44f6-8734-084f81c8a0a1": {"doc_hash": "18cbccd1f1285cfc551a687d1f00ff0dd6ca575a6fdae8b266ca8cfb0ac91dce", "ref_doc_id": "dc16d311-1fc6-4485-897e-9b8d3095cfbc"}, "ac093db4-59ca-4c1d-8e89-d393daf03d29": {"doc_hash": "cfa185f6dce1d8a11e5bf229c4a1c56d49c2b243ff4a95004975373eb69e09c5", "ref_doc_id": "c98ec416-926c-49dc-811e-9bb662b3d812"}, "bc60cbdf-1089-47fa-9bf6-1f8d28e82387": {"doc_hash": "549bcaf8fac276f31eb4b7b79a0458c302b64f8bd688930ae5bbd5097b84b355", "ref_doc_id": "6ad48f98-c5d5-4d91-a107-aea4beabbedd"}, "588f19ce-0a52-4d00-84c5-b03ea11a3952": {"doc_hash": "26224fd1a8687e5a17116dc74bb3c195659d7dad718302566d7813298a68db12", "ref_doc_id": "7ee4fb5d-64d0-4585-a93f-964612a920fd"}, "eba0d3b4-ebd9-42a2-be7f-240449f16fb3": {"doc_hash": "700b34e99412106e7d11ae4768c056e01e90eff6feb315f32648dc9e84bfcd52", "ref_doc_id": "172c4df3-08ac-4064-b3c1-bb670ebe08a3"}, "374c6610-3aa3-4f55-9966-fcde9e53ad74": {"doc_hash": "311186dc908b79e9d7a636013ab7d40c7880ed27c3a5df49ecca14e44a03fa8c", "ref_doc_id": "07fdca8e-6ff5-48f8-9e87-ef347722e862"}, "d5b230e0-73de-4564-b741-5d0b697c287c": {"doc_hash": "96f0283437ad2f9e6e758f2df2cc8835687eee35db4fbbd0be097691d2e6127b", "ref_doc_id": "3f6bc6d9-92f4-4dc4-ab73-f5bd6ade218b"}, "06504210-8fd0-4029-a41d-f6722897dc06": {"doc_hash": "b863d4c6c8a55ade1937efae4626f01c811ecec62ffd595a44958a0bd958bd11", "ref_doc_id": "0e520528-c00f-4d9a-b25a-98ba87ec44c9"}, "786d1f6b-8ec0-41bb-9dc9-62340c1a73a0": {"doc_hash": "9961d78bedb700f4592af043c947fee089d99f11eef26d6f19b51a1b940e5284", "ref_doc_id": "f9dbc250-95fc-4441-9450-1b1013fc6d65"}, "ad7761cb-a80c-4fd7-b5e6-fdf9c4f5a725": {"doc_hash": "299f4e84dcfc690e1fc20c0d65d394fe9e71904207a78a3d6314fcb39b0e7647", "ref_doc_id": "e4be75e7-986d-4392-b013-12931743b84b"}, "88a3501f-2878-42f6-8b83-9c0caa8df869": {"doc_hash": "a07690d4ea6c9d27039adba1705dc2a4adc5471cbc3bf9fa881f27dd70ce5d89", "ref_doc_id": "378475f0-c937-49fd-a3bc-036d9f2d20bc"}, "cf5b6ee8-7970-47ef-8abe-b1810ee95725": {"doc_hash": "4d78ff01c1536cb1600bbc8a84a3da4474245d9a6ebaf2bbc1b0a18a260ef8fc", "ref_doc_id": "7d04bc77-6a78-4880-95f8-426df12ad9e1"}, "1b6caeb9-9654-42bd-99df-bf9330a09a07": {"doc_hash": "3ecbf3b6cc0ad2edccf0dd7806680033573c166bb2317d0e6c96a940709b15c5", "ref_doc_id": "c6c47d52-c707-413c-98d4-8a4f4b51eb1d"}, "fcbf9325-5c46-4cdc-8227-bb53ee90bac1": {"doc_hash": "a788600796e0290054dfcd353227f5cf95e53296e9ee374422530a6d90c1057e", "ref_doc_id": "17b7bf61-fce0-4bba-818c-b4e2a3235982"}, "97f0e2ad-6974-4e6c-be99-c3939cd10301": {"doc_hash": "3ef86034be68103e438c44cee94eb392543a6726a29b0607224f519ebc2c39f7", "ref_doc_id": "e796e9b8-11ec-41e8-8bd8-36b0face1cac"}, "ba49c84f-eedd-48ca-9211-5cfa528b03b1": {"doc_hash": "65fde018d77b921924f67d8ed712a891f8f847f53765ec30cff6283d91d543a8", "ref_doc_id": "ad4d6008-a56f-4251-bb50-973032e3da0e"}, "e1472f17-927b-451b-952a-6e76e0460da9": {"doc_hash": "50123068af407cc6f152c0e0b78af79a9ca74a5e5f6351b2242aa9d23b119c2b", "ref_doc_id": "acc3e2b5-a73f-4956-b639-e2e68ffa66db"}, "22144d89-14ca-452a-8dde-fff54b9836b0": {"doc_hash": "f35f93b89aac91a5517f1c14fa9267e30b0ea18550eeeff967aa2dfbc96994dd", "ref_doc_id": "f87bf786-411e-4465-be96-e0942af05730"}, "1fd1266c-bb2a-40a5-afa2-a5fd76d9fe1f": {"doc_hash": "e894852e287b8b33aa2a3049e4a22a860ca842ecbdd3f9b4fe3aa6a0d5619c2a", "ref_doc_id": "3db65f1a-9619-4ffc-abda-cbe795458fdb"}, "c91e46e8-1c03-480a-8db2-2ecbd5d01094": {"doc_hash": "e82c6eba2a56980d92b74155bdc804eef0500e7d54998731eac7244891ea726b", "ref_doc_id": "8c3ec96d-940a-4e53-b79f-6c89426de550"}, "5eea5ef0-47fd-416e-aa3d-6506e698417f": {"doc_hash": "2e647612ed618be78d1d9abd4473fe0628f5357e8ad50814f3c0ab38c4893d2f", "ref_doc_id": "8e670da0-9b15-4e03-86f5-810517dd7da9"}, "e2d3cde8-10ee-4377-9d2c-8db35e4b7b08": {"doc_hash": "800efade94957adb55e8b271ea9048210588e48fa8dacdd0b8f494757aaa1259", "ref_doc_id": "3da9bd7c-b6bf-4a50-a71e-1c7cd9b402c7"}, "be844d6a-f89b-424f-894f-4c0a12182fec": {"doc_hash": "a31c08e75bbfb1f2a94b9e4266c20cb5c99d7380026a846e9c1ef18c8833114d", "ref_doc_id": "02a60eb7-b165-40e4-af38-f4898efca15a"}, "d8b9388a-1750-472e-b1a3-fbc493045a79": {"doc_hash": "cb844c03f2043d4ce6f7c6f07c047d213c2d0ffa59cd084628b83bbb12fa7032", "ref_doc_id": "ea261dc5-38d3-4fcd-96a5-e2b852b482a4"}, "086de2c2-c9b7-4ad4-ade5-6aae324119fd": {"doc_hash": "45995b2f13f8eac3f28700e2c15148a8e5349a707254c6b1283ef410b875f3d2", "ref_doc_id": "3d74a877-8dd5-4a30-96ba-7cff3f8a41b0"}, "a136851a-b9eb-4113-8f31-bd99aba2628b": {"doc_hash": "4ec2a0117a2b38b6b9896cb7c2cf8ae6ea9487993ed93b7bbcb13bdaa1572fad", "ref_doc_id": "a0c81d9c-c7a1-46b5-b811-9659373da46f"}, "d7da607f-cc31-4804-9b23-02f157a01fb7": {"doc_hash": "3acf46da25ef511543cb12db6de55920f379d9cef3d521a81cae84698199a3dc", "ref_doc_id": "9692a391-075f-4f0b-98d2-4f8f725480a8"}, "eb1cd267-e344-4453-b477-2c3064243332": {"doc_hash": "8e30ca8300bc0a9204f566d566eecfb64fceed08e73bba3ba7e2ed6e9b651b30", "ref_doc_id": "9c3b9bca-c8d2-4e65-bf4d-2b816ea6cc62"}, "f7f67e78-e038-4129-a82c-9fc06c925527": {"doc_hash": "62ba376c1171a1031598e5193e0844c78c5ee09f590f588ee20fa8b29b44097a", "ref_doc_id": "2b37ed4a-3ae2-4d24-a45f-7ffb0e19330e"}, "82294db1-ce50-46e8-8f5f-12ba8c882bd0": {"doc_hash": "edae17af9ed6f190be405a70559ce201d7e4b993cbb6ff895ceb8acc3afba6f7", "ref_doc_id": "ab182a08-8508-4847-862e-4108710f3148"}, "0f03ae1e-da80-49fb-b968-f332810a2037": {"doc_hash": "25924140c2bb27948cc319f430a4fd6063c3f6b74b94874d5c860764e7f5708b", "ref_doc_id": "1b5ff0c6-0c8b-4ba4-bab7-3e599bc10011"}, "c6175a71-6558-4421-a995-f68383221ed5": {"doc_hash": "2001d0e09597c30670e67703c25cd7cad05bb72998227bbeb86bca30391211cd", "ref_doc_id": "370ad65f-d6bb-4518-a92e-229fba23c55f"}, "06a94c96-5ff3-41dd-8937-5d6e6c270d7c": {"doc_hash": "72480e70522d862449da1ed04314cdf3eef9f50054a103f7944f5706dc29b0df", "ref_doc_id": "b57a3c3c-4ffc-4e09-90b1-c1d06a66013f"}, "094c40b5-e4b3-41f3-86e9-92a92e1b7561": {"doc_hash": "a0c14c93a889d31e680cf7ac85da66d64c87ee0044665100e565beaa26a73191", "ref_doc_id": "7b4e3869-a70b-4da9-ab75-a91ef80b3856"}, "cc37bf71-a09b-4821-8e8b-29181dd76790": {"doc_hash": "3f38690b28e6f53474c5138f6a3b492698fc9a79187ad441e3e2ee15b0cc2610", "ref_doc_id": "3996f212-626a-4ffc-b429-8889f30f4bcb"}, "165129f6-27e1-43ff-8a7a-bd4387182fce": {"doc_hash": "80edb3279489bbae821324cf6fe5abf51a49a5fdcf3f127b005be90a3868d4d9", "ref_doc_id": "b6cd6c7b-8bf5-4087-be57-529c062dd6c9"}, "dd11df96-a684-4447-9909-080c254e68aa": {"doc_hash": "72906c22bef50e258853e2b165b985ff7d2f2e98995188f279e5e0b2e627ab3f", "ref_doc_id": "f543d312-d064-4f4c-b941-f1f44e6a03ee"}, "29a64b12-37e0-434a-aaa6-45e43d80917c": {"doc_hash": "d6eec574c646a81acfbb2e2e31f4fe72a9c720ded47e42a7c7953f5aa926cd31", "ref_doc_id": "b77f5397-d305-46d3-8437-90cb3f7dd3ca"}, "d7f9b65b-fe0e-407d-a907-3ed9071c1670": {"doc_hash": "6cfa945c69cdb63f5534e01788f032656ec44cdbffaa77490492d8b2a0df0f04", "ref_doc_id": "22176fa3-040f-47bc-8580-93df4aa4ac27"}, "5f272308-106c-49f3-a80d-2263ec4bb409": {"doc_hash": "e72e55a9d0f4b728ff8fd73f73141ba14b4f59ede9a1546ce192b695360c7826", "ref_doc_id": "75398f3a-efa2-4310-8423-dd4d7a1f8355"}, "abd7070d-e56b-4d48-ba16-34e3fb2b83fe": {"doc_hash": "fc14fdaf1ef39a6bec9484bf9c417b84d49ee441ec2e985dfc613deb0f4415c8", "ref_doc_id": "24b01b60-52aa-45a9-980f-d067873580aa"}, "29a64d15-9d47-4713-a5c7-2fa3e61274ba": {"doc_hash": "5640125a65c5109f4ad4e83e7f8f96cd0609f039d4d6b9fbaebf15de2f94473b", "ref_doc_id": "9e82187d-b01c-42e8-a42d-2001eec664aa"}, "40036c76-8a47-4e32-bae1-0ca74c4b2f2e": {"doc_hash": "7296a192e324571f3bffcd029eed66eea94200815fa46ca4af3413d41dbc75e4", "ref_doc_id": "f4c08827-a5e4-4ce3-8276-edb53456d0b0"}, "c0a1db20-e1b1-421a-96a6-5e0c94ff9218": {"doc_hash": "5bf1d22b7120d4311613940846d5099db59dfa1bfb259a123d82ea22933b100d", "ref_doc_id": "b981cfd8-6cf9-44de-963e-8a5972d7ca37"}, "d3562c47-c8ca-4a67-94ba-78348b99ceff": {"doc_hash": "1058c88ea41f71e4807fb24a694b5427b649d7bf22a1d8eea3ca46e455f355dd", "ref_doc_id": "113d8581-213f-43e8-aed5-900ff192ff09"}, "7ee3ca39-91c7-4c89-a98e-ed303f7d1195": {"doc_hash": "61fa1d16a8ece8194ba5ec1150967adc85c9200064a7b154dc6b3880548b1745", "ref_doc_id": "2acdd4ac-f378-4deb-aea3-929789f17c98"}, "d914f180-feea-4ce8-9135-5136a55a1003": {"doc_hash": "fcc7bb1c574633c899458ed46d82185a7732dedddabc47791f1fc9532bb19339", "ref_doc_id": "2acdd4ac-f378-4deb-aea3-929789f17c98"}, "88abf969-cfef-4b19-968b-526c8d899f3c": {"doc_hash": "7ebc556232877a53d4d6f9a5643c5db0928e00d446817d7d1dce978e53eaeac0", "ref_doc_id": "ed66f241-e2d1-4430-b8e6-023fe20e6e5b"}, "6ca52343-cda5-4b77-8da1-152957e331a4": {"doc_hash": "b5aef1a3dae47c0a63b55eb70f917967aa00c347b62cb1399b627456026ea72d", "ref_doc_id": "13ae48cf-d631-4a98-a8ea-475ed4ba429d"}, "308b7ae3-d6c5-4417-a817-077160743786": {"doc_hash": "068d04f01e8ae84d5e79ce630870c7f193af2117b1a4dfa0aac4eaa02961921b", "ref_doc_id": "c3413b1e-a206-4df8-bda3-47659c92df1e"}, "499a76c2-35d4-49ca-9a60-f7b40a258cb1": {"doc_hash": "8e9e1502f3e765882d3d504c7e6880880634bd1722ef5c20903cf4e845713615", "ref_doc_id": "41617a3d-7bbc-44b2-9432-80a50602173a"}, "78ad3b48-d9b9-4ab5-9373-56599d31dfe8": {"doc_hash": "5475692bcc299c9359abd20cbe637306c6c4fd910a7172c8e6e3aebcad4aab4e", "ref_doc_id": "b88d8e37-166c-4243-9e61-36643f6cb217"}, "636ba1da-5a62-4daf-891d-1cad6f8c435c": {"doc_hash": "147ac963dd1a21a2f6c4cc3f1e91ae1d792222baba8caa1680ce9703264d1634", "ref_doc_id": "750638f3-f142-4260-90ae-2a01cd8f6a98"}, "00159d76-a4ac-4f09-a8a8-26beaba8d229": {"doc_hash": "9a0d304a6348fb3384d882fd687777d57968da900c63c27deed89f839ae3ecfc", "ref_doc_id": "859e2ece-4a3a-4e53-a5cb-e288ae111f9a"}, "b33f57f4-9b43-4a5c-8aef-5e71df639fce": {"doc_hash": "069cdbd148c9140c6dec6a5dc888d6adf63b3c741b72a4c42c056a6c8ad7c3ea", "ref_doc_id": "69f580a2-14cd-4a85-a9dd-92a6da0f8c40"}, "4ec3ec63-0cf7-43d7-8123-63f45e2230e7": {"doc_hash": "a73e6f0808ac36764db4fcebd90e521f9282520322e6f50b996fd4616e8ff1fb", "ref_doc_id": "19bc9688-6990-4081-97a5-719003016d34"}, "0ede72ee-3f39-4e10-9a6d-79498f4dec67": {"doc_hash": "c252e84c52b9e39fefaa85f48cda0bc2e910c1ac9e076def02e8725a3bae1c1c", "ref_doc_id": "ad99c96e-9493-40f0-be70-451826ad991d"}, "8e9f9677-6643-4a80-b827-8ee5ba2fd4fe": {"doc_hash": "e0b249a0ffa8fd2d7f1915ce9f1f4809a0657b06c7c58cf5e95921854bc5e4aa", "ref_doc_id": "914db214-79cb-4a8d-ba6b-c305915eec32"}, "ab44cfea-2a59-4300-9c76-32519d9c60be": {"doc_hash": "f1ae722070cb1fab0cbd5e66bdfcc712d0cd972e2c831ad4301768f6f63b214f", "ref_doc_id": "88219d14-c539-4858-9a96-3235d32521dc"}, "5bd50250-1640-40b6-8280-d64da0eb0f4a": {"doc_hash": "84c51a50c95b6f2146de916fe2fd40b9b332a29a8236ad87a6b725928a4a0175", "ref_doc_id": "0d02bd28-1c95-43f7-bc8d-7bfe6b6ee33d"}, "099ab0f6-d7e5-4474-9886-e28f5111aa38": {"doc_hash": "81d5a2241fe94a3b7b4371c6a53a2d4c670e4b7f407ee47826670f53e8ddaa0a", "ref_doc_id": "6fa9c138-fc86-4e30-950f-7c7e2d4184a2"}, "16d0ecdd-3e3f-49a4-9c14-e57ebcfccfce": {"doc_hash": "7e5056506cdf8b838fcf3dbd925b63a0014bf6902469eeced9fd09ebae9829b8", "ref_doc_id": "407584b0-9976-4a08-ae1b-d68443db299a"}, "37682d3a-e813-418c-8f09-9f2e3a03927d": {"doc_hash": "773dea400721cdae63b0c23653257f59cfaaf4968293ea76c75426f22f2a1909", "ref_doc_id": "5558df91-61ef-4f67-845c-f300b390814b"}, "6356dc5f-9e9a-40af-9974-75015522595d": {"doc_hash": "91cbce29d6c1db81f1832359528af9e54ad5454bc5e0e5e3d1e9e7296994d017", "ref_doc_id": "3d4f1712-1c60-41f0-b5f5-46d7dece8a03"}, "789f8674-a309-4d58-85b9-929eaf08a7fc": {"doc_hash": "f083e2964003e4d25522c0b2753586f39a1f9b440f63e520f08045315e4010dd", "ref_doc_id": "7a76f0c3-6db5-46b2-b6c6-f1fcdf1c3160"}, "0274a2be-b083-4f35-9298-334313bcd0b0": {"doc_hash": "b70f9373c1b746077b8c7d9124c40dc5e39dea2d786e4ee6ab20354191ea5cdd", "ref_doc_id": "068f1722-7396-4b97-8aa0-e9ee7ad4c701"}, "8cfb4edd-4173-4f75-b1b9-7cd63b047c6f": {"doc_hash": "e51979564273396713c39148fb2dfff29ed84d2c4d42eb50cc426987ff11ea08", "ref_doc_id": "2f6dff5f-1a35-423a-9f23-2640a124e973"}, "ed92e13a-961d-4c45-b4d3-5dd749dad14a": {"doc_hash": "6224520969d87416f9970ba2709475ed35705728925c203368e72210013d97da", "ref_doc_id": "bef26e38-21ed-4aa3-8548-ad97fd0db6e3"}, "7d9e8e0b-bbf0-4b23-a243-f8c918abf811": {"doc_hash": "ea7414a584d196ae42bd60623471b50e35bea29568cc0bc169411f824b982927", "ref_doc_id": "4404dd4d-1ba0-46fb-9f9c-4b28c4d5ca73"}, "0f1e51a3-e754-45b9-ac17-ceb06bce494f": {"doc_hash": "df07943a12dccbd4eb9e39e06110c03cfdfc3959f998d96e9aab7872b82456cc", "ref_doc_id": "b35da6f0-720d-4d34-a925-5c98c6b06b48"}, "3e1ce26e-1547-44b9-abf0-e7a372f3b4c8": {"doc_hash": "5d0cca1378024cf49a6c6c8b6fef2ee09511f8f56027875447cb7f063aea3e28", "ref_doc_id": "7a320830-44b5-4f52-a45b-baf28b810782"}, "d1307b8b-a92e-4222-bfa6-3aee2c75b68b": {"doc_hash": "56abd08723cde46415ac5c53576af2e896da5950ab6a9c2f8c691637b83c5c37", "ref_doc_id": "c45b799f-fe40-4f2f-bc79-032d33924c03"}, "b139a041-da70-4a3e-9b93-db6d841032df": {"doc_hash": "314c220ac6247fb8a4d04515f5681304b6cb62085ac0ac1a01fba3f0e305ff00", "ref_doc_id": "02f2e1fa-f441-468f-9d72-5ccacdba6435"}, "8b8394d1-eaa9-4815-8f94-6d55b517882c": {"doc_hash": "850af3c39d3990091007a35367a8d27fb6398866c30a158df03be8659954f7db", "ref_doc_id": "f976e342-68b6-4d58-a9f5-b317cb5dae73"}, "1797c6c0-231d-4976-bc2b-9508e8df93f0": {"doc_hash": "3a3f4ad87f3eac0ff5eaacfa9d4bc70b86eed0df4310bec7da851abe19cc1e1b", "ref_doc_id": "e22f2699-412d-493e-9015-854ae6d940f2"}, "3b77a8e7-38d9-4870-b541-2327fd89904b": {"doc_hash": "6ac250e1514dd357ad604915dd8cf5f1692ebea2a6f2dd318bedc95620332545", "ref_doc_id": "a0732593-97f7-43f2-8f50-afcadb61c019"}, "130c87c8-187a-4a53-a5fe-0f5db8ebca9c": {"doc_hash": "fc02ac775a317956bc33033d7756a27d9888fa2e5fd3e91fab8155cbd21b2e3d", "ref_doc_id": "b945d56d-bb36-4ef8-9dae-b23aa4d6e3c1"}, "9e571175-d241-4ff4-8671-be5730b434d8": {"doc_hash": "e3617acf0c8a43bf8b3019c8d2955a5b73ed63832a2772ab47f52a884cc546f9", "ref_doc_id": "67d933a3-a709-451f-b837-e1e825e3010a"}, "f51f6974-ed6d-4488-bd3e-752ce70d4483": {"doc_hash": "2993782963367f645050d5da95892d0b603f883d2b1ee049cd234eab7c8b0f72", "ref_doc_id": "105d2be9-d4c2-4bdc-b09f-ca1f1a04e0d3"}, "8c4740ea-586b-4b71-80e2-1144e7b86821": {"doc_hash": "8e5a7156f496844feccf41642c32bf39f8de0c342964f5c619afd076a48e67ba", "ref_doc_id": "4456f49d-4efb-4041-98ac-c657c9f9f4dd"}, "38c696e4-9d0b-4443-8e58-0cee68586adb": {"doc_hash": "fd5d8c76530691d61fee4d7c8ec7a33dc1baec7203b58aa6b65ffaaa3107bf0f", "ref_doc_id": "5461ee63-5766-428e-a45b-a9a4005935be"}, "51510684-50c3-4045-8bbf-925a7c10ac56": {"doc_hash": "16fde08b694a1121af1064192571e79abe3ed5928c43166dcd1ea8d3589dfd38", "ref_doc_id": "85e0af80-6850-49fd-94e7-a230a676ad63"}, "82eb2c76-5674-4eb1-aa5d-5917b567f8b8": {"doc_hash": "02a0cf886295c49ca5bf5b34dc74be4f610225e91d664d78d6d80b9ac8ea849f", "ref_doc_id": "7f47ff51-a533-480d-9484-d036e9228603"}, "c9beac63-c6f6-4118-8761-ea1dfe5e5e13": {"doc_hash": "f07a032e8df97c8a235c65ac96d10acb19ff64ea9ce99a8c354080f21c32598d", "ref_doc_id": "2b53c61f-8374-4a6c-8411-f368cfb2feb1"}, "ac068792-b29e-416e-bf56-ece21004c45b": {"doc_hash": "337e963a6f6309509585c2a0cbab9713d97b298e4672a26513c642136a8f0d6a", "ref_doc_id": "13bcf40e-6107-4bf3-a587-1df5f08557d7"}, "ec75fe94-bd3c-4150-86cf-367b2f03bed4": {"doc_hash": "f13d3b3b244649163a45be3b68c69eb26c5c0cf76ecd2821f819e6e9c39d2b1d", "ref_doc_id": "8195be23-c577-4652-9cf8-b9bfcaf2ef57"}, "9aa55370-666a-4378-9b77-4368fbca90b6": {"doc_hash": "b68403236ef685f62c62f4c85ebb7b638183695c122dfcd33b8db2c93bf3eb99", "ref_doc_id": "984e1d7e-ffff-43c8-bfda-43b4b3d8df75"}, "74424296-8f38-49bd-861f-234d3e4713cd": {"doc_hash": "fb15d61e7a24e5ef2b92f4339a99f6495e527e5358cad2cb6251f8324bb60baf", "ref_doc_id": "396a89f9-dff1-42a1-83ee-79e3394a5e3f"}, "341b1d43-56e1-4780-aa5f-0bbbe1a01eb5": {"doc_hash": "1c505e7d865fbccfc725229e7eb253a20a2513d92e7948cb57ab70b02fa6dd54", "ref_doc_id": "438a5bdc-9619-4337-acee-05db1751c58c"}, "3e5f718d-645a-4684-bcba-32af96bc0e9d": {"doc_hash": "1a5d4008b5977b1d5b0a92c68b8278b859c19b424e7182768466d3319b23e9e6", "ref_doc_id": "f980618a-31d1-4b6f-868b-8abcdcb5cc2b"}, "ad4fd311-6c35-4208-a421-12eadca740b3": {"doc_hash": "7dd373bba69c2f54c656bd8d4674b3199cb1f23c5af76bd08e16900ff674e8e9", "ref_doc_id": "05bfc3ca-b0a9-4cde-87a2-d7a00c2d177b"}, "7c0a7b41-2d43-4c9c-b051-53b95739c7a1": {"doc_hash": "4151240fbe4e7d6987cfbec0539f2abaf1b37e230ef55ee94534bdb88ca529b8", "ref_doc_id": "9cd7dfaf-a8e6-4308-8ff3-7bc1e967895d"}, "02296e0d-7d54-42f2-a853-001c11ab08ba": {"doc_hash": "6f5c5fbfc4ddd90e1cc75386fe536d573fc717cfb74e445445bc0d0d468d37c2", "ref_doc_id": "d1f02a0d-6f60-445a-90c2-3ad6413d5483"}, "f41c09a0-95a1-4984-8783-33e34bca8fac": {"doc_hash": "4d73177ec2d4673d400c9d3fa9111593f029ee4fcf3afa1cd0ffd069a1729865", "ref_doc_id": "90e386fd-a358-4593-9f25-96d85c673a06"}, "49855995-a31b-4a72-9fb8-b000f644b317": {"doc_hash": "4ba45cc58f4ca33047bf32b34bbcb5cef90b8119bd4607fd8dc0a470d9389485", "ref_doc_id": "c9fa4afd-c702-4f97-8091-445e9de12d5d"}, "de7a3bee-82c4-4285-bdef-f9e2e6fe1efd": {"doc_hash": "82ab0a613b88b7bd4acbd402fcbb25e639efcaaac67b544b6b5ffdda72934e4f", "ref_doc_id": "60859022-89f9-4c0a-a8c9-964cdc288b51"}, "6d5511e7-9eaa-40be-a452-caa349dca783": {"doc_hash": "5fa8597d7b6a0729f8a5ed16d5b98d8fb0e4bdbeec5b8d8aefc91a870f0408bb", "ref_doc_id": "e95b1f92-2b42-4a47-ba8e-9e93e16644c8"}, "d0c99200-9795-4e9e-bd19-54dd1e5afb11": {"doc_hash": "b4b6ddbeb26f2670a1438ef34308980b63260d17e0c81d55e3a89f813495ae78", "ref_doc_id": "92318769-4207-46b6-89ec-25dc17a3dcad"}, "9f11e30e-f8fe-4013-a99b-fdddeb7027c1": {"doc_hash": "375d3f0c3e6c54cac6bb7ff6027c6136f2cf249365fa2268d2ca652fa5c9d340", "ref_doc_id": "38348290-10ad-4e34-bbf4-982f05f95872"}, "55ae0dd8-359b-4b5f-b075-30edd2b25d67": {"doc_hash": "bc02fe3fd2dab430a794be4777376c214b7f7dd8a870721e8e3c66db9c59fb5a", "ref_doc_id": "f82a4845-b5d7-48a8-b656-39dd8e3cfd18"}, "4a8b0eb3-49f3-46e6-be04-668f49323d20": {"doc_hash": "31edf8e65d5dd8dea7a56e5700459bac512bdf83ee5ad8e7ab1fa494e0ce8b0e", "ref_doc_id": "2d5ca64f-835e-4902-8691-22c9fe80852e"}, "2ce14f58-c38a-471c-b185-30bb5616be8d": {"doc_hash": "35405c3fc757f8832b3d17059e71fb76e5cd7a8392f75fb0c6449c4a1527dbf6", "ref_doc_id": "462ed390-a5bb-4a88-bed2-14e6d58c8574"}, "e5b1ae4a-d45f-452f-85d9-51a5f3911554": {"doc_hash": "a6d3cd321454ac3d784643fbe6c43cf68eb0e21475c2c2bf0f7964f09161a7ad", "ref_doc_id": "bddf7fe1-3aa8-43f7-86bb-45ac65f51e93"}, "9436c9c3-79cf-44d9-a0e2-47181fadc0a2": {"doc_hash": "d028441ad86778e941ddc9a42775330f3df158d3353c3ce4b77178bc89c2851d", "ref_doc_id": "e026b4f4-63cd-4564-b258-fbc67235ebed"}, "352f9e8c-3bda-4239-8a64-84d06fcc5386": {"doc_hash": "896aeb99b40266917d2a454110d417164c1d42c0be02ca1e88967fdc9e4f8870", "ref_doc_id": "6148d7d0-45ea-49b9-870a-26229e3fbd66"}, "dc95ac83-2f5a-488e-8082-b92e44ff8bef": {"doc_hash": "f1e056be804534ca16e801eb4e61381b965c1684a6488046a2246ce1c1b84614", "ref_doc_id": "f11a0740-be04-4b51-8324-bd5471caec14"}, "a3dfcd71-ddf9-4f04-b94b-47c847275f8a": {"doc_hash": "54b01e1251827ee88e1938846faf1f8d62f988c80103939678f65bc90823d5a8", "ref_doc_id": "a76c8d73-b0ac-4a1b-a1fa-ba10358c253f"}, "db5b2c2f-f47a-4871-9ab3-d513bc79059c": {"doc_hash": "6de056215618ce7ea16f9336f021975a5851d1d6d03b1a685ca9c8ad1d163ed1", "ref_doc_id": "c88540a3-b0fb-4c20-81db-2eb46d946c3c"}, "e21214e3-9842-4833-bf63-07416ea6c064": {"doc_hash": "e80ab3dcf029e133d9adb6537d836481c067a9a1289b833b0c14de92d93eb13a", "ref_doc_id": "51b81ab6-1c4b-41ba-8b28-7e8f6ddd8f36"}, "3b040bb7-cecc-402a-8576-3183143cee74": {"doc_hash": "7803ba2d80bb2ae935305baf0499443ee5f4e1f80579f96bded702a717a33b0b", "ref_doc_id": "ab2b6bf3-cc66-41cc-be09-e6fac8cf5437"}, "0118e949-2b66-4b9c-812b-bac2caa41c4a": {"doc_hash": "3f52babb5695cc86b823928536ee2c0422d39258bd2fc8839c994b05fad3695d", "ref_doc_id": "f95c2d56-fba8-413f-bb76-539a46eae194"}, "50a4baf7-c459-4764-8b33-b606430bea79": {"doc_hash": "0747c26f7b0375b24c11522dcbb1c3ccf2710da964b234a6beec52f0fda14118", "ref_doc_id": "17c30727-0599-43b5-a11f-d1b0c0e13349"}, "a9b8c8ac-64d2-4339-9faa-466970e58fab": {"doc_hash": "a6dfae0807e2fe7fc17fed3e753346271ce1292b683c730a3332411b15ca4852", "ref_doc_id": "84080f9b-e594-4495-be61-bda43cb86874"}, "da22d960-0b73-465d-8068-c22cbd2fdb31": {"doc_hash": "1878f167d5c93165418c91319be2ad5c67f6ef91cb188530dc428701ff28660d", "ref_doc_id": "f1a83297-364c-4d19-960a-5849cfeb2cd4"}, "861d6feb-6dce-4ff6-8d34-96136e858581": {"doc_hash": "f9b059992d1161bbeeb897bf5c4f44e75a15e8470279f2ee66056b28f45f14cd", "ref_doc_id": "8c9596dc-dc72-4bf2-ae5a-40f5f3a82f82"}, "31530e26-7a50-4382-b21e-08ca8dc60824": {"doc_hash": "3391f767ae003bafacd60e64610ef9e6e748d18d1f1d00ef526320984906dc7d", "ref_doc_id": "ac278cc6-3d41-4874-b1a5-a98b50157c11"}, "aa3d75b3-8c4f-4ee6-82fc-c2e842f245d8": {"doc_hash": "811d44402902416dee0f69fde9bab892daa3f4b64eb6600acddc563aa0e632cc", "ref_doc_id": "88b19485-8cd8-46a4-bac8-5fc415d55591"}, "7df63099-eacc-450a-a5fa-29df87a03ff9": {"doc_hash": "b7bba3a301d5dafde50423d12dc7efa7427f5e6eb5f8a45e6bedd1c1943158ea", "ref_doc_id": "54dc3ec4-edc5-4178-a51b-622c5b46fa8c"}, "b1639628-9303-4ad6-af88-6185579a0e7b": {"doc_hash": "52e67c3445f15d31e0d90eb1eaf00d21f2f08f5500804959a96aa0e2f8253d66", "ref_doc_id": "111546b9-b54c-4275-8e79-faec495b1eca"}, "d2c5f090-6a34-4a4f-b77f-09114c236969": {"doc_hash": "e4a0d68a9bf795489b71103063671ccfc6c970fc6b9b1a3138ed09c70c0e2acd", "ref_doc_id": "d6887eba-e990-4502-8d6b-543335713268"}, "c4d883b6-7d29-4d9a-98bb-f4279e5d6656": {"doc_hash": "52eb895b55b202edb09fb5dfcfe272a7052734b2954beb5129b16e56d37b0f04", "ref_doc_id": "32add051-8455-4359-a8f8-249140afe9ac"}, "566ac0ee-590b-434a-8852-b0be8cbaed02": {"doc_hash": "8faec1e3beb97dc2d1ba982afdec40721c96eb96b3652e04b2e83f64183a9de8", "ref_doc_id": "5f4a2e13-28a6-4ea4-8137-406cdee5896a"}, "0fdf221a-5862-43dc-954b-94cbf4016b83": {"doc_hash": "2474b319d6dd37657ca00a4f1f146c9c19e52e8e31e096678f72965caa3ccf1c", "ref_doc_id": "fe19bb90-70c7-4019-ac18-4a5c7e25a9c8"}, "b6f2aa94-3581-4c5d-8eda-2937db37cea5": {"doc_hash": "1107f3f57f7ac3222da1e67d22273f3818619fb6699ef835275bd1411b27bdc5", "ref_doc_id": "163fe919-1f08-4992-8524-378994cf2710"}, "2d9a7a2b-a754-4a21-93a3-189320b32eea": {"doc_hash": "4a5b918635cc5f3bd5df491a738ae164be96360377bb0dab5b09c7a74c3837ce", "ref_doc_id": "5571b7ae-8a7a-4e48-ba72-d69822e2b5ac"}, "d11bb011-74a5-4565-9551-196b9746519b": {"doc_hash": "2b72ade134625859fe08c26d846d04468c10da4c95ec9daba360340a8557b373", "ref_doc_id": "6a6bd0f6-1a54-4c5d-8788-dcb74dd37050"}, "5d7c4e22-bbc4-4349-93b8-e4dd4ac0af89": {"doc_hash": "995c5ef76de6fd0827f166045aa47f81826c34dbbe0ed8c4b047a3bc1ba9592c", "ref_doc_id": "fa0bbb43-4ab6-4b41-9642-bc97fa14c77e"}, "948de473-a10e-4aeb-8662-6f946e0aa8c1": {"doc_hash": "1820ff678c6e3803cba643d44a4120ed20be204a04cec3e9b6966b1394467b47", "ref_doc_id": "b338830a-ecbc-4f18-89c9-adcad2e2717e"}, "449dcd49-684e-4ac5-85e1-cb16cfdceb99": {"doc_hash": "6c67aa4ffb473b49fd68da32dc1e4b8ef0f3abbc654ad715c6ff84b8ca267108", "ref_doc_id": "290c0cf8-b856-4044-9072-5c0048c37a43"}, "7b317736-f021-43db-8e9c-8d0a3bef5d29": {"doc_hash": "fa2a63f70dc9b787d4689b168a08b4f589d77f8f50d878c247d3ce4407fba345", "ref_doc_id": "4825ba3c-d08c-4d41-9223-a08769c775d9"}, "68ce89b4-b29b-4d46-8ace-a8f672f83059": {"doc_hash": "461be3d0337e19b58ac7892b46f579a08d7de229446220d916922713bdec4a2e", "ref_doc_id": "d8d38062-f3eb-4835-ae36-dd0d7fd6d183"}, "b8f129de-39c3-40c1-ae83-0a158653cfb0": {"doc_hash": "264a50fb7bdc6969947d53deac614047216e8a2bce12fe30ea7cc3f228b5e833", "ref_doc_id": "4564a9dd-e429-4ed5-9825-0c0771978963"}, "f8b6fa31-eb40-4074-af9f-c19eb78e0c08": {"doc_hash": "965facc7d0cece5b579b37b6bc1b9f069358fcade258e29745adeebb3845cc6a", "ref_doc_id": "bd99c20f-69e8-43d3-930d-accf25948f7b"}, "1441fca2-ea62-4593-9448-a20ef29dbf38": {"doc_hash": "4e4bee43a4e71894f011b6dab0cb12a7671f6dba87ad4085e4d51fe5dee992a8", "ref_doc_id": "b982f1eb-bb73-4014-b42c-0d9ead91f208"}, "9e90fd0d-24b2-4c49-8339-ee28ecd16ab4": {"doc_hash": "ad93ed0bbca5f7cafd33297db83bdd0347c66307c09e0f9264ec6c1d45143ace", "ref_doc_id": "4d56c719-303e-4690-b1dc-7d3d7f15121d"}, "b1cc1b11-6027-4e0c-989e-c030e463856a": {"doc_hash": "fa929325d99cbc2cdd11c3f92b2111b055bd06ead08165447fc958091b2d8e39", "ref_doc_id": "64b1c8b3-ffbd-4c4d-addc-28037590e6b3"}, "a28bd6c0-a7f4-47f4-a047-1807b23819d3": {"doc_hash": "5c83466a743f76bd675e29f86686b2146245532cd67b9a3dd9a980896cc64d2c", "ref_doc_id": "0ef94bf5-5747-4298-a23a-72933e177f4c"}, "bfcbb936-6fb9-4229-8728-d2673cc235c8": {"doc_hash": "8f31bce105b3f337de35ef7700ca067c2286da4dea3e55a67d696a1ce58b3a4c", "ref_doc_id": "869bebde-2aea-4092-a1a7-d4be83b672bc"}, "5067b158-148c-46af-9065-f9d897c3d64b": {"doc_hash": "fdd265400d53b1b249206029a5a06df1227107b0dccb7984ce6b6137b7a4bbe6", "ref_doc_id": "e56251b3-3291-4ffe-af1f-005219432fc4"}, "56a06701-37d5-46ad-b161-8ff168b102c3": {"doc_hash": "8405848e01a08079a117934080a0bfc7a8602277d09c5c9b582fd1f8ec1bab65", "ref_doc_id": "c8a6723f-d212-419e-b817-541a220052f2"}, "41b5d28a-be93-41da-9a5c-d8f59a9f5ae9": {"doc_hash": "ca27a87801faed28c873018b59a9e42f5cad0dfad933a67a6f5f592e66d9b689", "ref_doc_id": "e87140bc-4f35-47f1-88a9-8aa52fceb6c4"}, "a33cda8a-fbc7-4f38-ac42-6a3487588add": {"doc_hash": "a4fe82de102b668a3e1172a4dda5de5669dc112c9db3d5e04b2278e646568848", "ref_doc_id": "efe228b3-a57b-4c88-bda8-cfedc4b6c827"}, "880771ee-5196-467b-8816-80d435831e61": {"doc_hash": "cceeb2c7acf41e0280b1c744b2ad07aa791e8e269ba741f7d6524a11a46667af", "ref_doc_id": "45ec8dfb-9ae1-4a87-9dfb-0fdabda8c13c"}, "0bbd60e0-004c-4eb7-ac3f-8de695a557b5": {"doc_hash": "4fec3f5f37563cd42d846ea9cc41a191a600089533a3ce348fbc63b80d927096", "ref_doc_id": "1f29fbc4-24eb-4f26-88e9-28bdb11415e5"}, "edf0e5b9-ffdb-4f7b-936d-b034dd8535d6": {"doc_hash": "2e1ade715b6ac1385736f5c7cce7d7ecad41b7c1eb70b3d62b48fde1a54a060e", "ref_doc_id": "10a6be7f-cb03-4852-824c-03c8bade70e2"}, "8838655a-63a4-4dc2-8c1f-522bde4f0740": {"doc_hash": "aa82641905b4d64b21501f84f1fb757ae15eb8f1ce760f9c1c6f627b155c919e", "ref_doc_id": "b4b4f95b-1bc0-435f-92e6-a6e40f047db9"}, "28feba2c-891d-47cb-be2b-a86a3aa49e82": {"doc_hash": "47f79bb7c4b93abb8f712663e81eabc81f238e841a79f960f61fc718eabeaa68", "ref_doc_id": "a6f7d8b1-e438-4501-b9c1-657ce418aaa3"}, "0d4967bb-8653-4066-8855-2d396f9b6cd2": {"doc_hash": "f1b8b6d00e559b3398101353c47a68e79154f36d8076906f10665cf7ce76cccc", "ref_doc_id": "cf95c651-0940-4453-9031-d404c5bd9598"}, "06c5d04a-0b1b-40e3-a870-80cad3495820": {"doc_hash": "67b155cc75f40050a9a77313dc4b076b61b44dd4e74f45e1a33c48485d104da6", "ref_doc_id": "38c22982-47f7-4f18-8756-a7dce0ba4c52"}, "a8a43b54-5850-4afa-8b76-436577015868": {"doc_hash": "48f23045db86f734d12066ee841ec8eabaf5f6c4bccf2b1c0ebb9484487638b6", "ref_doc_id": "26b8c868-564d-4499-8164-7a8fd9197c72"}, "addc2b18-f78a-4fc2-8f81-f83921e99b14": {"doc_hash": "c76ec2d585bb5423a8cff56d8482322b59d5b3de07966c596ddd51d52ef557de", "ref_doc_id": "8b0e86ab-d39a-4503-982f-90873d989124"}, "ad528551-8a0b-4482-889b-6ff37c204d1e": {"doc_hash": "8e4b4a318de3b0b40ae9f2bc469d1daddaacedf230e854a958be1fe121f02fdd", "ref_doc_id": "774b0d83-dda4-4600-85b2-e2b74373fda7"}, "501d9510-273f-408e-a2a9-f81f3a2a8614": {"doc_hash": "9c7c427b3b54b679ef837c5019e566a227359f48d5e905e85df68c76620229de", "ref_doc_id": "2170c093-23f7-496e-905c-fb5c4467743b"}, "e063b7fe-b88f-405b-a1dd-30f131e979b5": {"doc_hash": "a192d3f1c6dc5e23ccedd84fd98f55940cdb475dfd4f6ec8bcec6afab4e5552e", "ref_doc_id": "225b05f5-8121-42e9-ab24-7704615575cb"}, "1c393afd-c939-4f78-b6d7-c5dd369dd304": {"doc_hash": "608f7944df64984b1d5ab3777090858be33a0e363fc0b36225e0498922bd9562", "ref_doc_id": "bbc855ec-480a-4ef3-9766-7b13b5820bee"}, "d20d728f-ca6e-4544-ab08-e609eb9c2b75": {"doc_hash": "e88d5d033935b4231ed1b9d5dd74293b0d7aff5c3694162b4b8519ab099ea706", "ref_doc_id": "0f4cf36a-9b29-4764-9dc8-8a63dcbfe60d"}, "f8723fa3-40cd-40a1-b08d-367612dc9172": {"doc_hash": "7bea6e5f0b7b5f30fe2d03d9079f76ba0cd78bf05130fa6711d80e5e83c62eb8", "ref_doc_id": "515acc1f-8e5f-47fc-a2d0-e5b8b4933852"}, "fbdcfa95-0a3c-4567-ba7f-cc4bf217e145": {"doc_hash": "2b63759bfd71ce5af1e69dcf70817bbd008ba05c2ead0db9a3bea5e88dc5a74e", "ref_doc_id": "ecc8cbb9-08ed-4bab-9dcb-89d340a64efb"}, "a5a41298-6212-4c95-946b-f6a7b30b96c6": {"doc_hash": "d08ff5ad6bb4e262e8182ad1cb1587d2fba22bd73b93ae29f630acb3baedb806", "ref_doc_id": "4533ece0-9fe7-42a8-abac-0031b6877b63"}, "1368478b-4d6d-4185-9682-a1d74521aa60": {"doc_hash": "94fcddecd16b315e7e306df88916ba33386d97ec21653162d93205852ab0052a", "ref_doc_id": "65f9abd4-acec-4ef8-9ecb-3f847693ab1c"}, "84734668-bcdb-476f-bb27-4073ab6eab26": {"doc_hash": "81f3cce634fbaea3ffec80bfcb81e3454b0bbd4c7be384a78d70c047ed0278d5", "ref_doc_id": "6423f481-8855-43ec-a5f4-01dce88c1d16"}, "5ff8c0db-b1aa-4435-a1cc-8f78a58db3a5": {"doc_hash": "2bc85d33c64ae87a122b9e2c01e6e9682ac26e33b0ed9aef324282f5a874df70", "ref_doc_id": "b3aeb5e9-c5a2-45a8-9032-fa277a8e2eb3"}, "d46081fe-63fd-4365-8ac5-29b3202e5af4": {"doc_hash": "6113c4de486e74f2e9d19fac3f4cfa6d90998c5b973872fdfcd72fa8b404f92c", "ref_doc_id": "32d1ba11-f5b9-4f6d-b62b-4f51ff921348"}}, "docstore/data": {"5b9de05c-8e61-433c-81e3-45a681f844fd": {"__data__": {"id_": "5b9de05c-8e61-433c-81e3-45a681f844fd", "embedding": null, "metadata": {"page_label": "1", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "14a6ccf9-adc4-49e5-8ca3-54cf2c0b395f", "node_type": "4", "metadata": {"page_label": "1", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "09b4d234138f9b57e5685a6eac891f2e18da20ec6e8be2bf1efd6368070f23f3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d44e44d7-acb2-4066-acac-43712b67d6e1", "node_type": "1", "metadata": {}, "hash": "44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a", "class_name": "RelatedNodeInfo"}}, "text": "", "start_char_idx": 0, "end_char_idx": 0, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d44e44d7-acb2-4066-acac-43712b67d6e1": {"__data__": {"id_": "d44e44d7-acb2-4066-acac-43712b67d6e1", "embedding": null, "metadata": {"page_label": "2", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "a9fb00aa-ed49-403e-93cc-d511dd652924", "node_type": "4", "metadata": {"page_label": "2", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8e5fb1b72734da275f00946f79fbf82c8f2414cf01d6314a423d0953956dd3a5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5b9de05c-8e61-433c-81e3-45a681f844fd", "node_type": "1", "metadata": {"page_label": "1", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "09b4d234138f9b57e5685a6eac891f2e18da20ec6e8be2bf1efd6368070f23f3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e2598b0a-70c2-49da-8e9b-2340df10d018", "node_type": "1", "metadata": {}, "hash": "44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a", "class_name": "RelatedNodeInfo"}}, "text": "", "start_char_idx": 0, "end_char_idx": 0, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e2598b0a-70c2-49da-8e9b-2340df10d018": {"__data__": {"id_": "e2598b0a-70c2-49da-8e9b-2340df10d018", "embedding": null, "metadata": {"page_label": "3", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "00e1f4d8-40cb-4a8d-b9b7-0ffe5460772b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "ca9f05d6e98848e49872b98c4daea84f1ac0a1476b9b5a084a599f8b3c2be777", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d44e44d7-acb2-4066-acac-43712b67d6e1", "node_type": "1", "metadata": {"page_label": "2", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8e5fb1b72734da275f00946f79fbf82c8f2414cf01d6314a423d0953956dd3a5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9ce308a7-7c62-4f88-8ea4-e84ee55b203f", "node_type": "1", "metadata": {}, "hash": "44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a", "class_name": "RelatedNodeInfo"}}, "text": "", "start_char_idx": 0, "end_char_idx": 0, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9ce308a7-7c62-4f88-8ea4-e84ee55b203f": {"__data__": {"id_": "9ce308a7-7c62-4f88-8ea4-e84ee55b203f", "embedding": null, "metadata": {"page_label": "4", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f61aac9e-9e13-4680-a4a7-e6e8edf56f44", "node_type": "4", "metadata": {"page_label": "4", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "c04cbe32b180c8d011f5705fb9d1e9570654fb7f9469ae9c241023f9643ae4b1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e2598b0a-70c2-49da-8e9b-2340df10d018", "node_type": "1", "metadata": {"page_label": "3", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "ca9f05d6e98848e49872b98c4daea84f1ac0a1476b9b5a084a599f8b3c2be777", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f31d1314-4835-4048-8c93-178e3cd9539e", "node_type": "1", "metadata": {}, "hash": "44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a", "class_name": "RelatedNodeInfo"}}, "text": "", "start_char_idx": 0, "end_char_idx": 0, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f31d1314-4835-4048-8c93-178e3cd9539e": {"__data__": {"id_": "f31d1314-4835-4048-8c93-178e3cd9539e", "embedding": null, "metadata": {"page_label": "5", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "1e26bc5e-ec2f-42ef-a8f1-e9b0f103b8b7", "node_type": "4", "metadata": {"page_label": "5", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "de89d2bab8f0b430a1c13ee92e2fd78ab35aff264bee91619845d512f6d454c4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9ce308a7-7c62-4f88-8ea4-e84ee55b203f", "node_type": "1", "metadata": {"page_label": "4", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "c04cbe32b180c8d011f5705fb9d1e9570654fb7f9469ae9c241023f9643ae4b1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "499d84ea-f66f-4c05-b834-13e4c69dc3fe", "node_type": "1", "metadata": {}, "hash": "07d80dac7c6fff6c9aca48168e483a58e45fa43fc745b17bc94fbaaa0fcdf6fc", "class_name": "RelatedNodeInfo"}}, "text": "", "start_char_idx": 0, "end_char_idx": 0, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "499d84ea-f66f-4c05-b834-13e4c69dc3fe": {"__data__": {"id_": "499d84ea-f66f-4c05-b834-13e4c69dc3fe", "embedding": null, "metadata": {"page_label": "6", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9e571879-7779-4973-a26f-9bee54e85581", "node_type": "4", "metadata": {"page_label": "6", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "d892698587a6576b935ebf0a7a04c73514dd4570edb243a968bcd473cc37671a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f31d1314-4835-4048-8c93-178e3cd9539e", "node_type": "1", "metadata": {"page_label": "5", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "de89d2bab8f0b430a1c13ee92e2fd78ab35aff264bee91619845d512f6d454c4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "355ae47d-b296-4f5d-8eee-9ed53ebf5685", "node_type": "1", "metadata": {}, "hash": "e08657133a6aeb6cd5d3177c6fa3ae2350f7784130ade7358c5f3413d64e6742", "class_name": "RelatedNodeInfo"}}, "text": "Jaypee Brothers Medical Publishers (P) Ltd\nHeadquarters\nJaypee Brothers Medical Publishers (P) Ltd\n4838/24, Ansari Road, Daryaganj\nNew Delhi 1 10 002, India\nPhone: +91-1 1-43574357\nFax: +91-1 1-43574314\nEmail: jaypee@jaypeebrothers.com\nOverseas Offices\nJ.P. Medical Ltd Jaypee-Highlights Medical\nPublishers Inc\n83 Victoria Street, London City of Knowledge, Bld. 235, 2nd\nFloor , Clayton\nSW1H 0HW (UK) Panama City , Panama\nPhone: +44 20 3170 8910 Phone: +1 507-301-0496\nFax: +44 (0)20 3008 6180 Fax: +1 507-301-0499\nEmail: info@jpmedpub.com Email: cservice@jphmedical.com\nJaypee Brothers Medical Publishers\n(P) LtdJaypee Brothers Medical\nPublishers (P) Ltd\n17/1-B Babar Road, Block-B,\nShyamoliBhotahity , Kathmandu, Nepal\nMohammadpur , Dhaka-1207 Phone: +977-9741283608\nBangladesh Email:\nkathmandu@jaypeebrothers.com\nMobile: +08801912003485\nEmail: jaypeedhaka@gmail.com\nWebsite: www .jaypeebrothers.com\nWebsite: www .jaypeedigital.com\n\u00a9 2019, KD Tripathi\nManaging  Editor : M. Tripathi\nThe views and opinions expressed  in this book are solely those of the original\ncontributor(s)/author(s) and do not necessarily represent those of editor(s) of the book.\nAll rights reserved. No part of this publication may be reproduced, stored or transmitted in\nany form or by any means, electronic, mechanical, photocopying, recording or otherwise,\nwithout the prior permission in writing of the publishers.\nAll brand names and product names used in this book are trade names, service marks,\ntrademarks or registered trademarks of their respective owners. The publisher is not\nassociated with any product or vendor mentioned in this book.", "start_char_idx": 2, "end_char_idx": 1627, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "355ae47d-b296-4f5d-8eee-9ed53ebf5685": {"__data__": {"id_": "355ae47d-b296-4f5d-8eee-9ed53ebf5685", "embedding": null, "metadata": {"page_label": "7", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "fb385b04-79a7-422b-8990-982752371c7f", "node_type": "4", "metadata": {"page_label": "7", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "c92b0830c5c63d6e08b8536b3562859895e9cb14b152c9b44c0fd3f4e4ea09e1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "499d84ea-f66f-4c05-b834-13e4c69dc3fe", "node_type": "1", "metadata": {"page_label": "6", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "15a032770b85162232185f44af34ba5c03c88f469ed52da8594de1daff96a19f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e341e24e-dca5-4588-9a8f-dd011a23fe25", "node_type": "1", "metadata": {}, "hash": "6eab12e245f687a939a8e20e3b9a6c165ab9b62d89999be01e261f8e6238c4dc", "class_name": "RelatedNodeInfo"}}, "text": "Medical knowledge and practice change constantly . This book is desig ned to provide\naccurate, authoritative information about the subject matter in question. However , readers\nare advised to check the most current information available on procedures included and\ncheck information from the manufactu rer of each product to be administered, to verify the\nrecommended dose, formula, method  and duration of administration, adverse effects and\ncontraindications. It is the responsibi lity of the practitioner to take all appropriate safety\nprecautions. Neither the publisher nor the author(s)/editor(s) assume any liability for any\ninjury and/or damage to persons or property arising from or related to use of material in this\nbook.\nThis book is sold on the understanding that the publisher is not engaged in providing\nprofessional medic al services. If such advice or services are required, the services of a\ncompetent medical professional should be sought.\nEvery effort has been made where necessary to contact holders of copy right to obtain\npermission to reproduce copyright material. If any have been inadvertently overlooked, the\npublisher will be pleased to make the necessary arrangements at the \ufb01rst opportunity . The\nCD/DVD-ROM  (if any) provided in the sealed envelope with this book is complimentary and\nfree of cost. Not meant for sale .\nInquiries for bulk sales may be solicited at: jaypee@jaypeebrothers.com\nEssentials  of  Medical  Pharmacology\nFirst  Edition : 1985\nSecond  Edition :1988\nThird  Edition : 1994\nFourth  Edition :1999, Updated Reprint: 2001\nFifth  Edition : 2003\nSixth  Edition : 2008\nSeventh  Edition :2013\nReprint : 2014\nEighth  Edition :2019\nRevised and Updated Reprint:  2021, 2023\nISBN: 978-93-5696-432-7\n\uf050\uf072\uf069\uf06e\uf074\uf065\uf064\uf020\uf061\uf074", "start_char_idx": 0, "end_char_idx": 1749, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e341e24e-dca5-4588-9a8f-dd011a23fe25": {"__data__": {"id_": "e341e24e-dca5-4588-9a8f-dd011a23fe25", "embedding": null, "metadata": {"page_label": "8", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "122c97e3-dffe-41ad-8437-e8fa89545303", "node_type": "4", "metadata": {"page_label": "8", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f2c262d7b088b667dd1c02d1f83afa148ce63ac7f5b855108edc6a344d25f8aa", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "355ae47d-b296-4f5d-8eee-9ed53ebf5685", "node_type": "1", "metadata": {"page_label": "7", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "c92b0830c5c63d6e08b8536b3562859895e9cb14b152c9b44c0fd3f4e4ea09e1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "13150958-1f72-4aaa-80bb-d92bfe3fa600", "node_type": "1", "metadata": {}, "hash": "8032ec4deedc56efb2690d2eab58635b0f4867419374f8cbcecf56bf9713bffa", "class_name": "RelatedNodeInfo"}}, "text": "Medical pharma cology is a unique blend of basic pharmacology , clinical\npharmacology and pharmacotherapeutics. The subject is highly dynamic\nwith concepts and priority drugs changing rapidly . Innovations and\ndevelopments are happening at an unprecedented pace. Several new\nmolecular targets for drug action have been identified and novel drugs\nproduced to attack them. On the other hand, a huge body of evidence has\nbeen generated to quantify impact of various drugs and regimens on well\ndefined therapeutic end points, so that practice of medicine is transforming\nfrom \u2018impression based\u2019  to \u2018evidence based\u2019. The present edition focuses on\nevidence based medicine by referring to numerous large randomized trials\nand other studies which have shaped current therapeutic practices. By\nevaluating such evidences, professional bodies, eminent health institutes,\nexpert committees and WHO have formulated therapeutic guidelines for\ntreating many conditions, as well as for use of specific drugs. The latest\nguidelines have been summariz ed and included in the present edition along\nwith other developments and the core content.\nAdopting the \u2018prototype drug\u2019  approach and a structured, systematic and\nuser-friendly format, all chapters have been thoroughly revised and updated.\nIn this edition, drug classifica tions have been presented as eye-catching\ncharts which help create pictorial memory . A new chapter on \u2018Nitric Oxide\nand Vasoactive Peptide Signal Molecules\u2019  has been added along with some\nrecently introduc ed drugs which act through receptors for these molecules or\nby altering their turnover .\nPriority has been accorded to drugs that are marketed in India, and their\nleading brand names are mentioned along with dosage forms. All recently\nreleased drugs are included, while those not commercially available or\ninfrequently used have been excluded or described in small type.", "start_char_idx": 0, "end_char_idx": 1888, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "13150958-1f72-4aaa-80bb-d92bfe3fa600": {"__data__": {"id_": "13150958-1f72-4aaa-80bb-d92bfe3fa600", "embedding": null, "metadata": {"page_label": "9", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "2ae5c64b-1b24-4b85-96da-80e4cc7fa0a8", "node_type": "4", "metadata": {"page_label": "9", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "efef9c3a4b8acedfb665df23d25ab93d3cc432e388af3be6dc178f4f0a6ceee7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e341e24e-dca5-4588-9a8f-dd011a23fe25", "node_type": "1", "metadata": {"page_label": "8", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f2c262d7b088b667dd1c02d1f83afa148ce63ac7f5b855108edc6a344d25f8aa", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "199be439-d1c3-49e1-9448-4030456eeb1d", "node_type": "1", "metadata": {}, "hash": "e62975784dcdff1fe471d85ebd48525c639e7c582f4ae196dbedca069660bf9e", "class_name": "RelatedNodeInfo"}}, "text": "India specific information on drugs and diseases finds a place in relevant\ntopics. Treatment of diseases like TB, leprosy , HIV-AIDS, malaria, Kala-\nazar which are covered under WHO and National Health Programmes are\ndescribed as per the latest recommendations of these organizations. Several\nnew figures, charts, tables and highlight boxes have been adde d and many\nolder ones have been revised/improved. The recent material and data has\nbeen authenticated by quoting its source. A brief list of useful references for\nfurther reading is provided at the end of the book. The \u2018Problem Directed\nStudy\u2019  at the end of most chapters provides an exercise in therapeutic\ndecision making.\nI thank my colleagues and students for providing valuable inputs and\nraising thoughtf ul queries. As ever, the driving force behind this book has\nbeen Shri Jitendar P Vij (Grou p Chairman) and Mr Ankit Vij (Managing\nDirector) of M/s Jaypee Brothers Medical Publishers (P) Ltd, New Delhi,\nIndia. The staff of Jaypee Broth ers, especially Ms Sunita Katla (Executive\nAssistant to Group Chairman and Publishing Manager), Ms Geeta Srivastava\n(Proof Reader),  Mr Manoj Pahuja (Graphic Designer) and Mr Kapil Dev\nSharma (DTP  Operator) deserve special commendation for excellent\nproduction of this text. Coopera tion and participation of my wife has been\npivotal.\nKD Tripathi\nNew Delhi\nJune 2018", "start_char_idx": 0, "end_char_idx": 1370, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "199be439-d1c3-49e1-9448-4030456eeb1d": {"__data__": {"id_": "199be439-d1c3-49e1-9448-4030456eeb1d", "embedding": null, "metadata": {"page_label": "10", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "693c0b06-9719-4c6a-960c-02a03da16a44", "node_type": "4", "metadata": {"page_label": "10", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5c7b9022e1c999cb94ab57a0fcdfc97079f8de77002180c32e4009461a07e7b0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "13150958-1f72-4aaa-80bb-d92bfe3fa600", "node_type": "1", "metadata": {"page_label": "9", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "efef9c3a4b8acedfb665df23d25ab93d3cc432e388af3be6dc178f4f0a6ceee7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fc9a2506-a7cd-4b5e-a8f7-805f43620ccb", "node_type": "1", "metadata": {}, "hash": "dd5af373356ae92ea59f83461d99bc34d79e79a02b6aaac329d5508b6fe086a9", "class_name": "RelatedNodeInfo"}}, "text": "Pharmacology is both a basic and an applied science. It forms the backbone\nof rational therapeutics. Where as the medical student and the prescribing\nphysician are primarily concerned with the applied aspects, correct and\nskilful applicatio n of drugs is impossible without a proper unde rstanding of\ntheir basic pharmacology . Medical pharmacology , therefore, must include\nboth fundamental background and clinical pharmacological information.\nObjective and quantitative data on the use of drugs in man, i.e., relationship\nbetween plasma  concentration and intensity of therapeutic/to xic actions,\nplasma half lives, relative efficacy of different medications and incidence of\nadverse effects etc., are being obtained with the aim of optimising drug\ntherapy . The concepts regarding  mechanism of action of drugs are changing.\nIn addition, new drugs are being introduced in different countries at an\nexplosive pace. A plethora of information thus appears to be important.\nHowever , trying  to impart all this to a medical student would be counter -\nproductive.\nOne of the important aims of this book is to delineate the essential\ninformation about drugs. The opening sentence in each chapter defines the\nclass of drugs considered. A \u2018prototype\u2019  approach has been followed by\ndescribing the representative drug of a class followed by featu res by which\nindividual members differ from it. Leading trade names have been included.\nClinically relevant drug interactions have been mentione d. Clear -cut\nguidelines on selection of drugs  and their clinical status have been outlined\non the basis of current information. Original, simple and self-explanatory\nillustrations, tables and flowcharts have been used with impunity . Selected\nchemical structures are depicted. Recent developments have been\nincorporated. However , discretion has been used in including only few of the\nmultitude of new drugs not yet available in India. This is based on their", "start_char_idx": 0, "end_char_idx": 1946, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "fc9a2506-a7cd-4b5e-a8f7-805f43620ccb": {"__data__": {"id_": "fc9a2506-a7cd-4b5e-a8f7-805f43620ccb", "embedding": null, "metadata": {"page_label": "11", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "17e044ef-066c-41ff-871f-e0521f9e11a2", "node_type": "4", "metadata": {"page_label": "11", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "dd867f14e8b053c3ea37d78de411e12deed3bb6aae1f18a121a499eee5a559f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "199be439-d1c3-49e1-9448-4030456eeb1d", "node_type": "1", "metadata": {"page_label": "10", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5c7b9022e1c999cb94ab57a0fcdfc97079f8de77002180c32e4009461a07e7b0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dbb58f28-9c73-4da0-95d7-ce5b96d718b7", "node_type": "1", "metadata": {}, "hash": "6a7d3f24200236f4e12812ba83c994e5d52d53b0e29f36802c1c2b6e1add0918", "class_name": "RelatedNodeInfo"}}, "text": "likelihood of being marketed soon. The information and views have been\narranged in an orderly sequence of distinct statements.\nI hope this mana geable volume book would serve to dispel awe towards\npharmacology from the minds of medical students and provide a concise and\nuptodate information source for prescribers who wish to remain informed of\nthe current concepts and developments concerning drugs.\nMy sincere thanks are due to my colleagues for their valuable comments\nand suggestions.\nKD Tripathi\nNew Delhi\n1st Jan., 1985", "start_char_idx": 0, "end_char_idx": 526, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "dbb58f28-9c73-4da0-95d7-ce5b96d718b7": {"__data__": {"id_": "dbb58f28-9c73-4da0-95d7-ce5b96d718b7", "embedding": null, "metadata": {"page_label": "12", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "37877ff9-a8e5-48df-8380-a14845889323", "node_type": "4", "metadata": {"page_label": "12", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "46f1327f64c791557a438bc5246a6b0ae526ae000d9c2984f1996db68f01211c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fc9a2506-a7cd-4b5e-a8f7-805f43620ccb", "node_type": "1", "metadata": {"page_label": "11", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "dd867f14e8b053c3ea37d78de411e12deed3bb6aae1f18a121a499eee5a559f5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e123f864-afc2-4f86-8543-9e19a264e685", "node_type": "1", "metadata": {}, "hash": "d14e1a6b04a85796c23cf66847daabd24c4a9658344962922575461464dd5cc7", "class_name": "RelatedNodeInfo"}}, "text": "SECTION 1\nGeneral Pharmacological Principles\n1.Introduc\u0000on, R outes of Drug Adminis tra\u0000on\n2.Pharmac okine \u0000cs: Membr ane T ransport, Ab sorp \u0000on and\nDistribu\u0000on of Drugs\n3.Pharmac okine \u0000cs: Me tabolism and Ex cre\u0000on of Drugs, Kine \u0000cs of\nElimina \u0000on\n4.Pharmac odynamics: Mechanism of Drug Ac\u0000on; R ecep tor\nPharmac ology\n5.Aspects of Pharmac other apy, Clinic al Pharmac ology and Drug\nDevelopmen t\n6.Adverse Drug E \ufb00ects\nSECTION 2\nDrugs Ac\u0000ng on Autonomic Nervous System\nAutonomic Ner vous S ystem: Gener al Consider a\u0000ons\n7.Choliner gic T ransmission and Choliner gic Drugs\n8.An\u0000choliner gic Drugs and Drugs Ac\u0000ng on Aut onomic Ganglia", "start_char_idx": 0, "end_char_idx": 639, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e123f864-afc2-4f86-8543-9e19a264e685": {"__data__": {"id_": "e123f864-afc2-4f86-8543-9e19a264e685", "embedding": null, "metadata": {"page_label": "13", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5aad9db2-a8ef-4d10-8fec-22e3cc7e59d3", "node_type": "4", "metadata": {"page_label": "13", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "d997e0aaa8a1b076b4b66338c1051283ada9de4dd3d06bfaff653a7993f99429", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dbb58f28-9c73-4da0-95d7-ce5b96d718b7", "node_type": "1", "metadata": {"page_label": "12", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "46f1327f64c791557a438bc5246a6b0ae526ae000d9c2984f1996db68f01211c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b3a59439-9b24-43cb-8f16-9339d2bb3637", "node_type": "1", "metadata": {}, "hash": "a33d2a2d24a840837e58bd667c3bcc553525334b51ab6b9d60d98359d9730a65", "class_name": "RelatedNodeInfo"}}, "text": "9.Adrener gic T ransmission and Adr ener gic Drugs\n10. An\u0000adr ener gic Drugs (Adr ener gic R ecep tor An tagonis ts) and Drugs\nfor Glauc oma\nSECTION 3\nAutacoids and Related Drugs\n11. Histamine and An \u0000his taminics\n12. 5-Hy droxytryptamine, its An tagonis ts and Drug Ther apy of Migr aine\n13. Prostaglandins, Leuk otrienes (Eic osanoids) and Pla telet Ac\u0000v a\u0000ng\nFactor\n14. Nons teroidal An \u0000in\ufb02amma tory Drugs and An \u0000pyre\u0000c-Analg esics\n15. An\u0000rheuma toid and An \u0000gout Drugs\nSECTION 4\nRespiratory System Drugs\n16. Drugs f or Cough and Br onchial As thma\nSECTION 5\nHormones and Related Drugs\nIntroduc\u0000on\n17. Anterior Pituit ary Hormones\n18. Thyroid Hormones and Th yroid Inhibit ors\n19. Insulin, Or al An \u0000diabe \u0000c Drugs and Gluc agon\n20. Cor\u0000c osteroids", "start_char_idx": 0, "end_char_idx": 753, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b3a59439-9b24-43cb-8f16-9339d2bb3637": {"__data__": {"id_": "b3a59439-9b24-43cb-8f16-9339d2bb3637", "embedding": null, "metadata": {"page_label": "14", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "e31cf697-ce51-425a-ba7c-87c8f39163d3", "node_type": "4", "metadata": {"page_label": "14", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "757b9123eca604b24e7086cc86fa1203afd53b99696125dbb837663671b9ca04", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e123f864-afc2-4f86-8543-9e19a264e685", "node_type": "1", "metadata": {"page_label": "13", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "d997e0aaa8a1b076b4b66338c1051283ada9de4dd3d06bfaff653a7993f99429", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4fde79cb-ef57-4e7c-917a-04af6e2ffb02", "node_type": "1", "metadata": {}, "hash": "82b63c313a58d0b9f54cd08feb1ab44ed2479d575252f177eb8087c35a2add49", "class_name": "RelatedNodeInfo"}}, "text": "21. Andr ogens and R elated Drugs, Drugs f or Er ec\u0000le Dy sfunc\u0000on\n22. Estrogens, Pr oges\u0000ns and Con tracep \u0000ves\n23. Oxytocin and Other Drugs Ac\u0000ng on Ut erus\n24. Hormones and Drugs A\ufb00 ec\u0000ng Calcium Balance\nSECTION 6\nDrugs Ac\u0000ng on Peripheral (Soma\u0000c)\nNervous System\n25. Skeletal Muscle R elaxants\n26. Local Anaes the\u0000cs\nSECTION 7\nDrugs Ac\u0000ng on Central Nervous System\n27. Gener al Anaes the\u0000cs\n28. Ethyl and Me thyl Alc ohols\n29. Seda \u0000ve-Hypno\u0000cs\n30. An\u0000epilep \u0000c Drugs\n31. An\u0000parkinsonian Drugs\n32. Drugs Used in Men tal Illness: An \u0000psycho\u0000c and An \u0000manic Drugs\n33. Drugs Used in Men tal Illness: An \u0000depr essan t and An \u0000anxiety Drugs\n34. Opioid Analg esics and An tagonis ts\n35. CNS S\u0000mulan ts and Cogni\u0000on Enhancer s\nSECTION 8", "start_char_idx": 0, "end_char_idx": 733, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4fde79cb-ef57-4e7c-917a-04af6e2ffb02": {"__data__": {"id_": "4fde79cb-ef57-4e7c-917a-04af6e2ffb02", "embedding": null, "metadata": {"page_label": "15", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "0593823f-38af-4861-a0ac-b7fbd48f155c", "node_type": "4", "metadata": {"page_label": "15", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6f655ce3481cc9a0607c5206b2aa02a00c0d38e505b127d93e989bdee64fc7e0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b3a59439-9b24-43cb-8f16-9339d2bb3637", "node_type": "1", "metadata": {"page_label": "14", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "757b9123eca604b24e7086cc86fa1203afd53b99696125dbb837663671b9ca04", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f00b6c7e-0d0c-47c9-8275-81d75a67fa11", "node_type": "1", "metadata": {}, "hash": "7038cc4269c90eba55978d7e9fd5d9da5f38b36fcd4f421e297de24bf3c0371b", "class_name": "RelatedNodeInfo"}}, "text": "Cardiovascular Drugs\nCardiac Electr ophysiologic al Consider a\u0000ons\n36. Drugs A\ufb00 ec\u0000ng R enin-Angiot ensin S ystem\n37. Nitric O xide and V asoac\u0000v e Pep\u0000de Signal Molecules\n38. Cardiac Gly cosides and Drugs f or Heart F ailur e\n39. An\u0000arrh ythmic Drugs\n40. An\u0000anginal and Other An \u0000-ischaemic Drugs\n41. An\u0000hypert ensiv e Drugs\nSECTION 9\nDrugs Ac\u0000ng on Kidney\nRelevant Physiology of Urine F orma \u0000on\n42. Diur e\u0000cs\n43. An\u0000diur e\u0000cs\nSECTION 10\nDrugs A\ufb00ec\u0000ng Blood and Blood Forma\u0000on\n44. Haema \u0000nics and Er ythropoie \u0000n\n45. Drugs A\ufb00 ec\u0000ng Coagula \u0000on, Bleeding and Thr ombosis\n46. Hypolipidaemic Drugs\nSECTION 11\nGastrointes\u0000nal Drugs", "start_char_idx": 0, "end_char_idx": 629, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f00b6c7e-0d0c-47c9-8275-81d75a67fa11": {"__data__": {"id_": "f00b6c7e-0d0c-47c9-8275-81d75a67fa11", "embedding": null, "metadata": {"page_label": "16", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "95ed1103-1d3e-455f-ab65-7c4779688d72", "node_type": "4", "metadata": {"page_label": "16", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a97134d094e358cd3c9d2330048aa0595b6ff46567e666cda170c69e2514513d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4fde79cb-ef57-4e7c-917a-04af6e2ffb02", "node_type": "1", "metadata": {"page_label": "15", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6f655ce3481cc9a0607c5206b2aa02a00c0d38e505b127d93e989bdee64fc7e0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "456b7755-9d8e-45ce-b52f-5046da1d73d3", "node_type": "1", "metadata": {}, "hash": "a505b7fb531b2e56e0ad26ba0a5dd208cee89dfd13575c2fc9c90f5afe297627", "class_name": "RelatedNodeInfo"}}, "text": "47. Drugs f or Pep\u0000c Ulcer and Gas troesophag eal R e\ufb02ux Disease\n48. An\u0000eme \u0000c, Pr okine \u0000c and Dig estant Drugs\n49. Drugs f or Cons \u0000pa\u0000on and Diarrhoea\nSECTION 12\nAn\u0000microbial Drugs\n50. An\u0000micr obial Drugs: Gener al Consider a\u0000ons\n51. Sulfonamides, Cotrimo xazole and Quinolones\n52. Beta-Lact am An \u0000bio\u0000cs\n53. Tetracyclines and Chlor amphenic ol (Br oad-Spectrum An \u0000bio\u0000cs)\n54. Aminogly coside An \u0000bio\u0000cs\n55. Macr olide, Linc osamide, Gly copep \u0000de and Other An \u0000bact erial\nAn\u0000bio\u0000cs; Urinar y An \u0000sep \u0000cs\n56. An\u0000tuber cular Drugs\n57. An\u0000lepr o\u0000c Drugs\n58. An\u0000fung al Drugs\n59. An\u0000viral Drugs (Non-r etroviral)\n60. An\u0000viral Drugs (An \u0000-retrovirus)\n61. An\u0000malarial Drugs\n62. An\u0000amoebic and Other An \u0000protozoal Drugs\n63. Anthelmin \u0000c Drugs\nSECTION 13\nChemotherapy of Neoplas\u0000c Diseases\n64. An\u0000cancer Drugs", "start_char_idx": 0, "end_char_idx": 807, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "456b7755-9d8e-45ce-b52f-5046da1d73d3": {"__data__": {"id_": "456b7755-9d8e-45ce-b52f-5046da1d73d3", "embedding": null, "metadata": {"page_label": "17", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "96de02c3-7291-4c16-a959-608f2779e66b", "node_type": "4", "metadata": {"page_label": "17", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "ff59c36303182af74655c58f4ec24fdf56743efe5b48af728d1b8f673885b584", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f00b6c7e-0d0c-47c9-8275-81d75a67fa11", "node_type": "1", "metadata": {"page_label": "16", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a97134d094e358cd3c9d2330048aa0595b6ff46567e666cda170c69e2514513d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "491e6864-618b-4449-9f79-d72ad9982619", "node_type": "1", "metadata": {}, "hash": "fed22abec90f4be6d727d45bcc29d3d2a288e7fcfbc09609c7a691e8f802505a", "class_name": "RelatedNodeInfo"}}, "text": "SECTION 14\nMiscellaneous Drugs\n65. Immunosuppr essan t Drugs\n66. Drugs Ac\u0000ng on Skin and Muc ous Membr anes\n67. An\u0000sep \u0000cs, Disin fectants and E ctopar asi\u0000cides\n68. Chela \u0000ng Ag ents\n69. Vitamins\n70. Vaccines, An \u0000ser a and Immuneglobulins\n71. Drug In terac\u0000ons\nAppendic es\nAppendix 1: Solu\u0000on t o Problem Direct ed Study\nAppendix 2: Prescribing in Pregnancy\nAppendix 3: Drugs in Breas \u0000eeding\nAppendix 4: Drugs and Fix ed Dose Combina\u0000ons Banned in India\nSelect ed R eferences f or Further R eading\nAddi\u0000onal Competency Topics\n\u2022Prescription Writing\n\u2022P-Drugs\n\u2022Drugs used for Criminal Of fences\n\u2022Drug Deaddiction\n\u2022Plasma Expanders\n\u2022Colony Stimulating Factors\n\u2022Antibiotic Stewardship Program\n\u2022Pesticides\n\u2022Insect Repellents", "start_char_idx": 0, "end_char_idx": 721, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "491e6864-618b-4449-9f79-d72ad9982619": {"__data__": {"id_": "491e6864-618b-4449-9f79-d72ad9982619", "embedding": null, "metadata": {"page_label": "18", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f1b6245f-2382-4a9f-b060-90a84d6742f3", "node_type": "4", "metadata": {"page_label": "18", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "172eb709e2ea317d4baeb7eeaec903f0711967c3405b66e21b2bcc85b24c208d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "456b7755-9d8e-45ce-b52f-5046da1d73d3", "node_type": "1", "metadata": {"page_label": "17", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "ff59c36303182af74655c58f4ec24fdf56743efe5b48af728d1b8f673885b584", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f3a9969b-3680-4bad-96fc-127b6e513428", "node_type": "1", "metadata": {}, "hash": "bfffa21a1d832081cc42e26f636d61f38926770ab50896d812d31ef327fb12ad", "class_name": "RelatedNodeInfo"}}, "text": "\u2022Pollutants\n\u2022Food Adulterants\n\u2022Management of Common Poisonings, Bites and Stings\n\u2022National Health Programs\n\u2022Over -the-Counter Drugs\n\u2022Herbal Medicines\n\u2022Pharmacoeconomics\n\u2022Dietary Supplements and Nutraceuticals\n\u2022Drug Regulations, Acts and other Legal Aspects\n\u2022Good Clinical Practice (GCP)\nInde x", "start_char_idx": 0, "end_char_idx": 293, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f3a9969b-3680-4bad-96fc-127b6e513428": {"__data__": {"id_": "f3a9969b-3680-4bad-96fc-127b6e513428", "embedding": null, "metadata": {"page_label": "19", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "2b000c16-d6dc-4446-bdab-61871dc53a76", "node_type": "4", "metadata": {"page_label": "19", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5eb9ad9aac513e6532f121898cc639d6a7281f133d48a85c9d6dd33a740489f8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "491e6864-618b-4449-9f79-d72ad9982619", "node_type": "1", "metadata": {"page_label": "18", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "172eb709e2ea317d4baeb7eeaec903f0711967c3405b66e21b2bcc85b24c208d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d11e61cb-76d3-42dc-90f8-5358177a5566", "node_type": "1", "metadata": {}, "hash": "fe605df74c553e8c4016e2d10d85562f119b9f744500edf8c27acab040bcd428", "class_name": "RelatedNodeInfo"}}, "text": "AAAmino acid\nAbAntibody\nABCATP-binding cassette (transporter)\nABLCAmphotericin B lipid complex\nACAdenylyl cyclase\nACEAngiotensin II converting enzyme\nAChAcetylcholine\nAChEAcetylcholinesterase\nACSAcute coronary syndromes\nACTArtemisinin-based combination therapy\nACTHAdrenocorticotropic hormone\nADAlzheimer\u2019s disease\nADCCAntibody-dependent cellular cytotoxicity\nADEAdverse drug event\nADHAntidiuretic hormone\nADHDAttention deficit hyperactivity disorder\nADPAdenosine diphosphate\nAdrAdrenaline\nADRAdverse drug reaction\nADSAnti diphtheritic serum\nAESAtrial extrasystole\nAFAtrial fibrillation\nAFlAtrial flutter\nAGAntigen\nAGSAntigasgangrene serum\nAHGAntihaemophilic globulin\nAIAromatase inhibitor\nAIDSAcquired immunodeficiency syndrome\nAIPAldosterone induced protein\nALAAlanine\nALSAmyotrophic lateral sclerosis\nAm Amikacin", "start_char_idx": 0, "end_char_idx": 815, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d11e61cb-76d3-42dc-90f8-5358177a5566": {"__data__": {"id_": "d11e61cb-76d3-42dc-90f8-5358177a5566", "embedding": null, "metadata": {"page_label": "20", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9488d511-9dc9-477f-a799-b6a4fee59970", "node_type": "4", "metadata": {"page_label": "20", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "54cb7dc7a9dc199ae72147c1fc51683c3d024e49723a06abfb9bc5bccdc2e21b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f3a9969b-3680-4bad-96fc-127b6e513428", "node_type": "1", "metadata": {"page_label": "19", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5eb9ad9aac513e6532f121898cc639d6a7281f133d48a85c9d6dd33a740489f8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e376dcf7-d9c5-40ec-8489-fdf7c1b5a651", "node_type": "1", "metadata": {}, "hash": "f761f778bc521a0541d5d92127042f1a009b082e8e71b5f78ca46d1c779d0d49", "class_name": "RelatedNodeInfo"}}, "text": "AMAAntimicrobial agent\nAMBAmphotericin B\nampAmpoule\nAMPAdenosine mono phosphate\nAMPA \u03b1-Aminohydroxy methylisoxazole\npropionic acid\nANCAcid neutralizing capacity\nAng-I/II/IIIAngiotensin I/II/III\nANPAtrial natriuretic peptide\nANSAutonomic nervous system\nANUGAcute necrotizing ulcerative gingivitis\nAPAction potential\nAP-1Activator protein-1\nAPCAntigen presenting cell\nAPDAction potential duration\naPTTActivated partial thromboplastin time\nAQAmodiaquine\nARAndrogen receptor\nARBAngiotensin receptor blocker\nARCAIDS related complex\nARSAnti rabies serum\nARTAntiretrovirus therapy\nARVAntiretrovirus (drug)\nASArtesunate\n5-ASA5-Amino salicyclic acid\nASCVDAtherosclerotic cardiovascular disease\nAT-IIIAntithrombin III\nATGAntithymocyte globulin\nATPAdenosine triphosphate\nATPaseAdenosine triphosphatase\nATPIIIAdult treatment panel III\nATSAntitetanic serum\nAUCArea under the plasma concentration-time\ncurve\nA-VAtrioventricular\nAVPArginine vasopressin\nAZTZidovudine\nBALBritish anti lewisite\nBANBritish approved name\nBBBorderline leprosy", "start_char_idx": 0, "end_char_idx": 1022, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e376dcf7-d9c5-40ec-8489-fdf7c1b5a651": {"__data__": {"id_": "e376dcf7-d9c5-40ec-8489-fdf7c1b5a651", "embedding": null, "metadata": {"page_label": "21", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3cdb199d-1952-45a3-b6ca-2f012fe1af8c", "node_type": "4", "metadata": {"page_label": "21", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "878322cccf5e096836054ec8ad568c66132cd5615994d200b4f6bc4d80fe2c92", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d11e61cb-76d3-42dc-90f8-5358177a5566", "node_type": "1", "metadata": {"page_label": "20", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "54cb7dc7a9dc199ae72147c1fc51683c3d024e49723a06abfb9bc5bccdc2e21b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b942ba09-b042-47be-a5bd-ec8716c913a9", "node_type": "1", "metadata": {}, "hash": "dd337390c3c757bcb8a2e05e3ed39750d4f568759fb98dfa18374633285d4096", "class_name": "RelatedNodeInfo"}}, "text": "BBBBlood-brain barrier\nBCGBacillus Calmette Gu\u00e9rin\nBCNUBischloroethyl nitrosourea (Carmustine)\nBCRPBreast cancer resistance protein\nBDTwice daily\n\u03b2-ARK \u03b2 adrenergic receptor kinase\nBHCBenzene hexachloride\nBHPBenign hypertrophy of prostate\nBIBacillary index\nBLBorderline lepromatous leprosy\nBMDBone mineral density\nBMRBasal metabolic rate\nBNPBrain nartriuretic peptide\nBOL2-Bromolysergic acid diethylamide\nBPBlood pressure\nBPNBisphosphonate\nBSABody surface area\nBTBorderline tuberculoid leprosy\nBuChEButyryl cholinesterase\nBW Body weight\nBZDBenzodiazepine\nC-10Decamethonium\nCACatecholamine\nCABCombined androgen blockade\nCaBPCalcium binding protein\nCADCoronary artery disease\nCAM Calmodulin\ncAMP3\u2019, 5\u2019 Cyclic adenosine monophosphate\nCAPCommunity acquired pneumonia\ncapCapsule\nCAseCarbonic anhydrase\nCATComputerized axial tomography\nCBFCerebral blood flow\nCBGCortisol binding globulin\nCBSColloidal bismuth subcitrate\nCCBCalcium channel blocker\nCCNUChloroethyl cyclohexyl nitrosourea\n(lomustine)\nCCR5Chemokine coreceptor 5", "start_char_idx": 0, "end_char_idx": 1018, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b942ba09-b042-47be-a5bd-ec8716c913a9": {"__data__": {"id_": "b942ba09-b042-47be-a5bd-ec8716c913a9", "embedding": null, "metadata": {"page_label": "22", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "c67cf8e8-af7d-48fa-882e-4e1b65246104", "node_type": "4", "metadata": {"page_label": "22", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "818052bda4060a62a3bbcd9b510825f68b76c9ef1158cf2f5d8facad375d22cd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e376dcf7-d9c5-40ec-8489-fdf7c1b5a651", "node_type": "1", "metadata": {"page_label": "21", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "878322cccf5e096836054ec8ad568c66132cd5615994d200b4f6bc4d80fe2c92", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4a2fcf76-4fa5-4eaa-b308-505371eceba1", "node_type": "1", "metadata": {}, "hash": "626d92a862c275425888985a1cccacc59e8d57b225d84ff05f168843dffe2548", "class_name": "RelatedNodeInfo"}}, "text": "CDCollecting duct/Cluster of differentiation\nCDCComplement dependent cytotoxicity\nCFTRCystic fibrosis transport regulator\ncGMP3\u2019, 5\u2019 Cyclic guanosine monophosphate\nCGRPCalcitonin gene related peptide\nCHCholesterol\nChECholinesterase\nCHECholesterol ester\nCHFCongestive heart failure\nChyChylomicron\nChy. rem.Chylomicron remnants\nCICardiac index\nCINVChemotherapy induced nausea and vomiting\nCKDChronic kidney disease\nCLClearance\nCLcrCreatinine clearance\nCm Capreomycin\nCMICell mediated immunity\nCMVCytomegalovirus\nCNSCentral nervous system\nc.o.Cardiac output\nCoEn-ACoenzyme-A\nCOMTCatechol-O-methyl transferase\nCOXCyclooxygenase\nc.p.s.Cycles per second\nCPSComplex partial seizures\nCPZChlorpromazine\nCQChloroquine\nCRABPCellular retinoic acid binding protein\nCRBPCellular retinol binding protein\nCrDCrohn\u2019s disease\nCREBCyclic AMP response element binding protein\nCRFCorticotropin releasing factor\nCSCycloserine\nCSFCerebrospinal fluid\nCTLCytotoxic T-lymphocytes\nCTZChemoreceptor trigger zone\nCVCardiovascular\nCVPCentral venous pressure", "start_char_idx": 0, "end_char_idx": 1027, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4a2fcf76-4fa5-4eaa-b308-505371eceba1": {"__data__": {"id_": "4a2fcf76-4fa5-4eaa-b308-505371eceba1", "embedding": null, "metadata": {"page_label": "23", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "958c632e-ed1b-4ba4-8ad2-23b364d5f283", "node_type": "4", "metadata": {"page_label": "23", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3d235b3e42f47a3db4b5dcfef40cf6649ea89ab8d94a87c263dfff7d26f70f3c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b942ba09-b042-47be-a5bd-ec8716c913a9", "node_type": "1", "metadata": {"page_label": "22", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "818052bda4060a62a3bbcd9b510825f68b76c9ef1158cf2f5d8facad375d22cd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7806fe8a-1036-4865-a05b-abe2458d9d37", "node_type": "1", "metadata": {}, "hash": "ed605f1dbaebc1d69b34d9688fa6aceca9dafbdd19d8ad592f956d0dec79ec13", "class_name": "RelatedNodeInfo"}}, "text": "CVSCardiovascular system\nCWDCell wall deficient\nCYP450Cytochrome P450\nDADopamine\nDA-B12Deoxyadenosyl cobalamin\nDADDelayed after-depolarization\nDAGDiacyl glycerol\nDAM Diacetyl monoxime\nDAMPDiphenyl acetoxy-N-methyl piperidine\nmethiodide\nDATDopamine transporter\ndDAVPDesmopressin\nDDSDiamino diphenyl sulfone (Dapsone)\nDDTDichloro diphenyl trichloroethane\nDECDiethyl carbamazine citrate\nDHADihydroartemisinin\nDHEDihydroergotamine\nDHFADihydro folic acid\nDHFRaseDihydrofolate reductase\nDHPDihydropyridine\nDHTDihydrotestosterone\nDIDiabetes insipidus\nDITDiiodotyrosine\ndlDecilitre\nDLEDisseminated lupus erythematosus\nDMADimethoxy amphetamine\nDMARDDisease modifying antirheumatic drug\nDMCM Dimethoxyethyl-carbomethoxy- \u03b2-carboline \nDMPADepot medroxyprogesterone acetate\nDMPPDimethyl phenyl piperazinium\nDMTDimethyl tryptamine/Divalent metal transporter\nDNADeoxyribose nucleic acid\nDOCDeoxycholate\nDOCADesoxy corticosterone acetate\nDOM Dimethoxymethyl amphetamine\ndopaDihydroxyphenyl alanine\nDOPAC3, 4, Dihydroxyphenyl acetic acid\nDOSSDioctyl sulfosuccinate\nDOTSDirectly observed treatment short course\nDPDDihydropyrimidine dehydrogenase", "start_char_idx": 0, "end_char_idx": 1128, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7806fe8a-1036-4865-a05b-abe2458d9d37": {"__data__": {"id_": "7806fe8a-1036-4865-a05b-abe2458d9d37", "embedding": null, "metadata": {"page_label": "24", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "da866fec-39a7-4a28-b0a8-05a51084e888", "node_type": "4", "metadata": {"page_label": "24", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6430b27445d817c60d2967d212f04a1c13df70345b05aa5cbde8aec64cc78e40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4a2fcf76-4fa5-4eaa-b308-505371eceba1", "node_type": "1", "metadata": {"page_label": "23", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3d235b3e42f47a3db4b5dcfef40cf6649ea89ab8d94a87c263dfff7d26f70f3c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a38a1f8e-4f52-4369-bf3c-759dcfdcd828", "node_type": "1", "metadata": {}, "hash": "e596d8986cc32d2a219773585a6a6bbfdb5e645a18fa2fc13474d7586476f96b", "class_name": "RelatedNodeInfo"}}, "text": "DPP-4Dipeptidyl peptidase-4\nDPTDiphtheria-pertussis-tetanus triple antigen\nDRCDose-response curve\nDRIDirect renin inhibitor\nDSTDrug sensitivity testing (for TB)\nDTDistal tubule\nDT-DADiphtheria-tetanus double antigen\nd-TCd-Tubocurarine\nDTICDacarbazine\nDTPADiethylene triamine pentaacetic acid\nDVTDeep vein thrombosis\nDYNDynorphin\nEEthambutol\nEACAEpsilon amino caproic acid\nEADEarly after-depolarization\nECEEndothelin converting enzyme\ne.c.f.Extracellular fluid\nECGElectrocardiogram\nECTElectroconvulsive therapy\nEDErectile dysfunction\nEDRFEndothelium dependent relaxing factor\nEDTAEthylene diamine tetraacetic acid\nEEGElectroencephalogram\nEFEjection fraction\nEGFEpidermal growth factor\nELAM-1Endothelial leukocyte adhesion molecule-1\n\u03b2-END \u03b2-Endorphin\neNOSEndothelial nitric oxide synthase\nENSEnteric nervous system\nENTExtraneuronal amine transporter\nEPACcAMP regulated guanine nucleotide\nexchange factors\nEPECEnteropathogenic E. coli\nEPOErythropoietin\nEPPEnd plate potential\nEPSPExcitatory postsynaptic potential\nEREstrogen receptor\nERAEndothelin receptor antagonist\nERPEffective refractory period\nESExtrasystole", "start_char_idx": 0, "end_char_idx": 1111, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a38a1f8e-4f52-4369-bf3c-759dcfdcd828": {"__data__": {"id_": "a38a1f8e-4f52-4369-bf3c-759dcfdcd828", "embedding": null, "metadata": {"page_label": "25", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ae7c1f30-0982-4e52-b224-b864a35abc84", "node_type": "4", "metadata": {"page_label": "25", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b6338ad401f97bebcc89a3e8c1d9bfc0b4a9e3139c3f2e4bcad4557d9f95d6b0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7806fe8a-1036-4865-a05b-abe2458d9d37", "node_type": "1", "metadata": {"page_label": "24", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6430b27445d817c60d2967d212f04a1c13df70345b05aa5cbde8aec64cc78e40", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fda6dfaf-b1f2-45c6-99dc-5b988448ce81", "node_type": "1", "metadata": {}, "hash": "7b6a4220efde8e8b87d8301f2052272df134584509b04b3354c816023cda411c", "class_name": "RelatedNodeInfo"}}, "text": "ESRErythrocyte sedimentation rate\nETEndothelin\nETECEnterotoxigenic E. coli\nEtoEthionamide\nFAFolic acid\nFADFlavin adenine dinucleotide\n5-FC5-Flucytosine\nFDCFixed dose combination\nFDTFixed duration therapy (of leprosy)\nFEV1Forced expiratory volume in 1 second\nFFAFree fatty acid\nFKBPFK 506 (tacrolimus) binding protein\nFLAPFive-lipoxygenase activating protein\nFMNFavin mononucleotide\nFPFerroportin\nFQFluoroquinolone\nFRaseFolate reductase\nFSHFollicle stimulating hormone\n5-FU5-Fluorouracil\nGGenetic\nGABAGamma amino butyric acid\nGATGABA-transporter\nGCGuanylyl cyclase\nGCPGood clinical practice\nG-CSFGranulocyte colony stimulating factor\nGDPGuanosine diphosphate\nGERDGastroesophageal reflux disease\ng.f.Glomerular filtration\ng.f.r.Glomerular filtration rate\nGHGrowth hormone\nGHRHGrowth hormone releasing hormone\nGHRIHGrowth hormone release inhibitory hormone\nGIPGastric inhibitory peptide/Glucose-\ndependent insulinotropic polypeptide\ng.i.t.Gastrointestinal tract\nGITSGastrointestinal therapeutic system\nGLPGlucagon-like peptide\nGLUTGlucose transporter\nGM-CSFGranulocyte macrophage colony\nstimulating factor\nGnRHGonadotropin releasing hormone", "start_char_idx": 0, "end_char_idx": 1137, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "fda6dfaf-b1f2-45c6-99dc-5b988448ce81": {"__data__": {"id_": "fda6dfaf-b1f2-45c6-99dc-5b988448ce81", "embedding": null, "metadata": {"page_label": "26", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "c022ff7d-f31e-41c8-b753-1a7fd81eb16e", "node_type": "4", "metadata": {"page_label": "26", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "696f13506503b92f7bca4a8ac8875936bee33d0e432b9d4c0892c6b90b3cbe6f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a38a1f8e-4f52-4369-bf3c-759dcfdcd828", "node_type": "1", "metadata": {"page_label": "25", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b6338ad401f97bebcc89a3e8c1d9bfc0b4a9e3139c3f2e4bcad4557d9f95d6b0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5cd2b523-c57c-4310-bb88-72df7e964eef", "node_type": "1", "metadata": {}, "hash": "b81e74d510f6710636f8290713e8abefaccb075f31c97d46ea85f1b348e1d28e", "class_name": "RelatedNodeInfo"}}, "text": "GPCRG-protein coupled receptor\nG-6-PDGlucose-6-phosphate dehydrogenase\nGPIGlobus pallidus interna\nGSTGlutathione-S-transferase\nGTCSGeneralised tonic-clonic seizures\nGTNGlyceryl trinitrate\nGTPGuanosine triphosphate\nHIsoniazid (Isonicotinic acid hydrazide)\nHAPHospital acquired pneumonia\nHbHaemoglobin\nHBVHepatitis B virus\nHCGHuman chorionic gonadotropin\nHCVHepatitis C virus\nHDCVHuman diploid cell vaccine\nHDLHigh density lipoprotein\nHETEHydroxyeicosa tetraenoic acid\n5-HIAA5-Hydroxyindole acetic acid\nHIVHuman immunodeficiency virus\nHLAHuman leucocyte antigen\nHMG-CoAHydroxymethyl glutaryl coenzyme A\nHMW High molecular weight\nHPA axisHypothalamo-pituitary-adrenal axis\nHPETEHydroperoxy eicosatetraenoic acid\nhrHour\nHRHeart rate\nHRIGHuman rabies immuneglobulin\nHRTHormone replacement therapy\n5-HT5-Hydroxytryptamine\n5-HTP5-Hydroxytryptophan\nHVAHomovanillic acid\nIIndeterminate leprosy\nIAPIslet amyloid polypeptide\nIBDInflammatory bowel disease\nIBSIrritable bowel syndrome\nICAM-1Intracellular adhesion molecule-1\nICSHInterstitial cell stimulating hormone\ni.d.Intradermal (injection)\nIDLIntermediate density lipoprotein\nIFNInterferon", "start_char_idx": 0, "end_char_idx": 1131, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5cd2b523-c57c-4310-bb88-72df7e964eef": {"__data__": {"id_": "5cd2b523-c57c-4310-bb88-72df7e964eef", "embedding": null, "metadata": {"page_label": "27", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "6f487232-6a67-4731-a5d3-463a05e75cd5", "node_type": "4", "metadata": {"page_label": "27", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4589911de7f201d950a74d1e05c703eaac36449c8da95a5560f9d961f3bb3cba", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fda6dfaf-b1f2-45c6-99dc-5b988448ce81", "node_type": "1", "metadata": {"page_label": "26", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "696f13506503b92f7bca4a8ac8875936bee33d0e432b9d4c0892c6b90b3cbe6f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "06ce1a05-76b7-4b2f-8f94-1f8e8866cd21", "node_type": "1", "metadata": {}, "hash": "f8fb9b3d4582f1e5ac458bca656fc3c44251a90a6271097a19145596db436bca", "class_name": "RelatedNodeInfo"}}, "text": "IGImmuneglobulin\nIGFInsulin-like growth factor\nILInterleukin\nILEUIsoleucine\ni.m.Intramuscular\nINHIsonicotinic acid hydrazide\nINRInternational normalized ratio\ni.o.t.Intraocular tension\nIP3Inositol trisphosphate\nIP4Inositol tetrakisphosphate\nIPSPInhibitory postsynaptic potential\nIPVInactivated poliomyelitis vaccine\nIRSInsulin response substrate\nISAIntrinsic sympathomimetic activity\nISHIsolated systolic hypertension\nIUInternational unit\nIUCDIntrauterine contraceptive device\ni.v.Intravenous\nJAKJanus-kinase\nKm Kanamycin\nKTZKetoconazole\nLALocal anaesthetic\nLCATLecithin cholesterol acyl transferase\nLC3-KATLong chain 3-ketoacyl-CoA-thiolase\nLDLLow density lipoprotein\nLESLower esophageal sphincter\nleu-ENKLeucine enkephalin\nLHLuteinizing hormone\nliqLiquid\nLLLepromatous leprosy\nLMW Low molecular weight\nLOXLipoxygenase\nLSDLysergic acid diethylamide\nLTLeukotriene\nLVFLeft ventricular failure\nMAbsMonoclonal antibodies\nMACMinimal alveolar concentration\nMACMycobacterium avium complex\nMAOMonoamine oxidase\nMAPMuscle action potential", "start_char_idx": 0, "end_char_idx": 1030, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "06ce1a05-76b7-4b2f-8f94-1f8e8866cd21": {"__data__": {"id_": "06ce1a05-76b7-4b2f-8f94-1f8e8866cd21", "embedding": null, "metadata": {"page_label": "28", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ec47f9ad-0af7-443e-8359-54ce633c73af", "node_type": "4", "metadata": {"page_label": "28", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "ce3788272abc2dc7c2bdf09441e4c301009cdbfec1302b84ed2f4ccc6fb2a258", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5cd2b523-c57c-4310-bb88-72df7e964eef", "node_type": "1", "metadata": {"page_label": "27", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4589911de7f201d950a74d1e05c703eaac36449c8da95a5560f9d961f3bb3cba", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fbd1da7f-c1a4-43f9-a516-febd99ccda80", "node_type": "1", "metadata": {}, "hash": "8ccb37a52a02cd5154d7fecdc6d307529b06a4b85b2bfc05a6e607810f8ca6cc", "class_name": "RelatedNodeInfo"}}, "text": "MAPKinaseMitogen activated protein kinase\nmaxMaximum\nMBCMinimum bactericidal concentration\nMBLMultibacillary leprosy\nMCIMild cognitive impairment\nMDIManic depressive illness\nMDMAMethylene dioxy methamphetamine\nMDRMultidrug resistant\nMDTMultidrug therapy (of leprosy)\nmet-ENKMethionine enkephalin\nmEqmilliequivalent\nmethyl B12Methyl cobalamin\nMfMicrofilariae\nMFMultifactorial\nMHCMajor histocompatibility complex\nMHTMethylene dioxy methamphetamine\nMIMyocardial infarction\nMICMinimal inhibitory concentration\nMIFMigration inhibitory factor\nminMinimum\nMITMonoiodo tyrosine\nMLCKMyosin light chain kinase\nMMFMycophenolate mofetil\n6-MP6-Mercaptopurine\nMPPTMethylprednisolone pulse therapy\nMPTP4-methyl-4-phenyltetrahydro pyridine\nMQMefloquine\nMRP2Multidrug resistance associated protein-2\nMRSAMethicillin resistant Staphylococcus aureus\nMSHMelanocyte stimulating hormone\nmTORMammalian target of rapamycin\nMtxMethotrexate\nmVmillivolt\nMW Molecular weight\nNANoradrenaline\nNABQIN-acetyl-p-benzoquinoneimine\nNADPNicotinamide adenine dinucleotide phosphate\nNADPHReduced nicotinamide adenine dinucleotide\nphosphate", "start_char_idx": 0, "end_char_idx": 1100, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "fbd1da7f-c1a4-43f9-a516-febd99ccda80": {"__data__": {"id_": "fbd1da7f-c1a4-43f9-a516-febd99ccda80", "embedding": null, "metadata": {"page_label": "29", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "775d6a96-770e-45ad-abca-3894a3ef93c6", "node_type": "4", "metadata": {"page_label": "29", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f963b9b184bb267e17bad69b7eb040d489d7b9d7454f4fa70617e09680c86dd4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "06ce1a05-76b7-4b2f-8f94-1f8e8866cd21", "node_type": "1", "metadata": {"page_label": "28", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "ce3788272abc2dc7c2bdf09441e4c301009cdbfec1302b84ed2f4ccc6fb2a258", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cd6af016-65d6-41b2-8eae-c784b98416b7", "node_type": "1", "metadata": {}, "hash": "c4ec0bf87963e3508257f9287e48b8d9e5b0f3a8b2853a833256137c2ef82813", "class_name": "RelatedNodeInfo"}}, "text": "NAGN-acetyl glucosamine\nNAM N-acetyl muramic acid\nNANCNonadrenergic noncholinergic\nNAPAN-acetyl procainamide\nNaSSANoradrenergic and specific serotonergic\nantidepressant\nNATN-acetyl transferase\nNCEPNational cholesterol education programme\nNEENorethindrone enanthate\nNEPNeutral endopeptidase (Neprolysin)\nNETNorepinephrine transporter\nNFATNuclear factor of activated T-cell\nNF \u03baBNuclear factor \u03baB\nNICENational Institute for Health and Care Excellence (UK)\nNISNa+ (sodium)-iodide symporter\nNLEPNational leprosy eradication programme\nNMDAN-methyl-D-aspartate\nnNOSNeural nitric oxide synthase\nNNRTINonnucleoside reverse transcriptase\ninhibitor\nNPYNeuropeptide-Y\nNRNicotinic receptor\nN-REM Non rapid eye movement (sleep)\nNRTINucleoside reverse transcriptase inhibitor\nNSAIDNonsteroidal antiinflammatory drug\nNSTEMINon ST-segment elevation myocardial\ninfarction\nNTSNucleus tractus solitarius\nNVBDCPNational vector borne diseases control\nprogramme\nNYHANew York Heart Association\nOATOrganic anion transporter\nOATPOrganic anion transporting polypeptide\nOCOral contraceptive\nOCDObsessive-compulsive disorder\nOCTOrganic cation transporter\nODOnce daily\nOPGOsteoprotegerin\nOPVOral poliomyelitis vaccine\nORSOral rehydration salt (solution)", "start_char_idx": 0, "end_char_idx": 1224, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "cd6af016-65d6-41b2-8eae-c784b98416b7": {"__data__": {"id_": "cd6af016-65d6-41b2-8eae-c784b98416b7", "embedding": null, "metadata": {"page_label": "30", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9beb1dff-f168-4190-b166-3e06141aeab6", "node_type": "4", "metadata": {"page_label": "30", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "90978bad8370aee0a5dfd4a768b80b50bdb09187a9906511e2807d9e9741bcf6", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fbd1da7f-c1a4-43f9-a516-febd99ccda80", "node_type": "1", "metadata": {"page_label": "29", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f963b9b184bb267e17bad69b7eb040d489d7b9d7454f4fa70617e09680c86dd4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a6be55c2-99c4-464f-8d32-587c63ce7e95", "node_type": "1", "metadata": {}, "hash": "711a431e20298696667c8efae495441a81f5f6fcf49c2684bcb5fd8c3c9fede6", "class_name": "RelatedNodeInfo"}}, "text": "ORTOral rehydration therapy\nPABAParaamino benzoic acid\nPAEPost antibiotic effect\nPAFPlatelet activating factor\nPAHPulmonary arterial hypertension\nPAI-1Plasminogen activator inhibitor-1\n2-PAM Pralidoxime\nPANPrimary afferent neurone\nPASParaamino salicylic acid\nPBIProtein bound iodine\nPBLPaucibacillary leprosy\nPBPsPenicillin binding proteins\nPCAPatient controlled anaesthesia\nPCEVPurified chick embryo cell vaccine (rabies)\nPCIPercutaneous coronary intervention\nPCPAParachloro phenylalanine\nPDParkinsons\u2019s disease\nPDEPhosphodiesterase\nPEPulmonary embolism\nPEMAPhenylethyl malonamide\nPEPPostexposure prophylaxis\nPFPurkinje fibre\nPFORPyruvate: ferredoxin oxidoreductase\nPGProstaglandin\nPGI2Prostacyclin\nPgpP-glycoprotein\nPIProtease inhibitor\nPIGPhosphatidyl inositol glycan\nPIP2Phosphatidyl inositol-4,5-bisphosphate\nPKAProtein kinase: cAMP dependent\nPKCProtein kinase C\nPLAPhospholipase A\nPLCPhospholipase C\nPl. ph.Platelet phospholipid\npMDIpressurized multidose inhaler\nPnGPenicillin G\nPOMCPro-opio melanocortin\nPONVPostoperative nausea and vomiting\nPPPartial pressure", "start_char_idx": 0, "end_char_idx": 1067, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a6be55c2-99c4-464f-8d32-587c63ce7e95": {"__data__": {"id_": "a6be55c2-99c4-464f-8d32-587c63ce7e95", "embedding": null, "metadata": {"page_label": "31", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "7e9e1716-b5b1-4b20-8557-86a59094c763", "node_type": "4", "metadata": {"page_label": "31", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "04bfdcdafc26d3b57eeeb02903cb40dfcc75db3ea1612a9ccb2b27f8513c7a65", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cd6af016-65d6-41b2-8eae-c784b98416b7", "node_type": "1", "metadata": {"page_label": "30", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "90978bad8370aee0a5dfd4a768b80b50bdb09187a9906511e2807d9e9741bcf6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e63f217a-4d26-4651-b103-00c10ef0afd8", "node_type": "1", "metadata": {}, "hash": "1fe371863c7c4eac8188a0c236c6fb6b64ff742731d17db23753a6d1fcd3c7de", "class_name": "RelatedNodeInfo"}}, "text": "PPAR \u03b3Paroxysome proliferator-activated\nreceptor \u03b3\nPPHPost partum haemorrhage\nPPIProton pump inhibitor\nppm Part per million\nPPNGPenicillinase producing N. gonorrhoeae\nPRAPlasma renin activity\nPrEPPre-exposure prophylaxis (of HIV)\nPRFProlactin releasing factor\nPRIHProlactin release inhibitory hormone\nPSVTParoxysmal supra-ventricular tachycardia\nPTProximal tubule\nPTCAPercutaneous transluminal coronary\nangioplasty\nPTHParathyroid hormone\nPTMAPhenyl trimethyl ammonium\nPTPPost-tetanic potentiation\nPTSDPost-traumatic stress disorder\nPTZPentylenetetrazol\nPUV APsoralen-Ultraviolet A\nPVRVPurified verocell rabies vaccine\nQIDFour times a day\nRRifampin (Rifampicin)\nRANKReceptor for activation of nuclear factor \u03baB\nRANKLRANK ligand\nRASRenin-angiotensin system\nRBCRed blood cells\nRBPRetinol binding protein\nRCRespiratory centre\nRCTRandomized clinical trial\nREReticuloendothelial\nREM Rapid eye movement (sleep)\nRGSRegulator of G-protein synthesis\nRIGRabies immuneglobulin\nRIMAReversible inhibitor of MAO-A\nrINNRecommended international\nnonproprietary name\nRMPResting membrane potential", "start_char_idx": 0, "end_char_idx": 1078, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e63f217a-4d26-4651-b103-00c10ef0afd8": {"__data__": {"id_": "e63f217a-4d26-4651-b103-00c10ef0afd8", "embedding": null, "metadata": {"page_label": "32", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "40281847-c6e5-4259-a23a-40c4410315bc", "node_type": "4", "metadata": {"page_label": "32", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "0316a13d2b6bacf67f368299b7ca21adaca086183ace8b77cf8028c3e2ac8d9b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a6be55c2-99c4-464f-8d32-587c63ce7e95", "node_type": "1", "metadata": {"page_label": "31", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "04bfdcdafc26d3b57eeeb02903cb40dfcc75db3ea1612a9ccb2b27f8513c7a65", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "950f8555-3a2d-4fed-9715-0f10800ee457", "node_type": "1", "metadata": {}, "hash": "fda55a1f44afa8b511b61dcb0de17f0a9530e210859e70d1312ad7cc2a9db5c4", "class_name": "RelatedNodeInfo"}}, "text": "RNARibonucleic acid\nRNTCPRevised National Tuberculosis Control\nProgramme\nRPRefractory period\nRTFResistance transfer factor\nRTKsReceptor tyrosine kinases\nRXRRetinoid X receptor\nRyRRyanodine receptor\nSStreptomycin\nSASinoauricular (node)\nSABESubacute bacterial endocarditis\ns.c.Subcutaneous\nSCCShort course chemotherapy (of tuberculosis)\nSChSuccinylcholine\nSCIDSevere combined immunodeficiency disease\nSERCASarcoplasmic-endoplasmic reticular calcium\nATPase\nSERDsSelective estrogen receptor down regulators\nSERM Selective estrogen receptor modulator\nSERTSerotonin transporter\nSGASecond generation antihistaminic\nSGLTSodium-glucose transporter\nSHBGSex hormone binding globulin\nSIADHSyndrome of inappropriate ADH secretion\ns.l.Sublingual\nSLCSolute carrier\nSLESystemic lupus erythematosus\nSMONSubacute myelo-optic neuropathy\nSNPSingle nucleotide polymorphism\nSN-PCSubstantia nigra-pars compacta\nSN-PRSubstantia nigra-pars reticularis\nSNRISerotonin and noradrenaline reuptake\ninhibitor\ns.o.s.as required\nS/PSulfonamide + pyrimethamine\nSPSubstance P\nSPFSun protection factor\nSPRM Selective progesterone receptor modulator\nSPSSimple partial seizures\nSRSustained release", "start_char_idx": 0, "end_char_idx": 1159, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "950f8555-3a2d-4fed-9715-0f10800ee457": {"__data__": {"id_": "950f8555-3a2d-4fed-9715-0f10800ee457", "embedding": null, "metadata": {"page_label": "33", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "66a20f6a-c2a9-420d-942a-a990d4a07454", "node_type": "4", "metadata": {"page_label": "33", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "856de974a1ab885a7f7dbb3fb94d2bb73009aa7c0397bc89c8a6e7a5dc695d39", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e63f217a-4d26-4651-b103-00c10ef0afd8", "node_type": "1", "metadata": {"page_label": "32", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "0316a13d2b6bacf67f368299b7ca21adaca086183ace8b77cf8028c3e2ac8d9b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6886b43e-80eb-40eb-a9b3-536244565b66", "node_type": "1", "metadata": {}, "hash": "811d722ccf6520cc9a929ce53b5429efc22058131620e8774746e316db4abda8", "class_name": "RelatedNodeInfo"}}, "text": "SRS-ASlow reacting substance of anaphylaxis\nSSGSodium stibogluconate\nSSISurgical site infection\nSSRIsSelective serotonin reuptake inhibitors\nSTATSignal transducer and activator of\ntranscription\nSTEMIST-segment elevation myocardial infarction\nStKStreptokinase\nSUSulfonylurea\nSULTSulfotransferase\nSURSulfonyl urea receptor\nsuspSuspension\nSVRSustained viral response\nSWDShift work disorder\nSWSSlow wave sleep\nsyrSyrup\nt\u00bdHalf life\nT3Triiodothyronine\nT4Thyroxine\ntabTablet\nTABTyphoid, paratyphoid A and B vaccine\nTALThick ascending limb (loop of Henle)\nTBTubercle bacilli\nTBGThyroxine binding globulin\nTCIITranscobalamin II\nTCAsTricyclic antidepressants\nTCID50Tissue culture infectious dose 50%\nTDM Therapeutic drug monitoring\nTDSThree times a day\nTfTransferrin\nTGTriglyceride\n6-TG6-Thioguanine\nTGF- \u03b2Transforming growth factor \u03b2\nTHCTetrahydrocannabinol\nTHFATetrahydro folic acid\nThio TEPATriethylene thiophosphoramide\nTHRThreonine\nTIAsTransient ischaemic attacks\nTNF- \u03b1Tumour necrosis factor \u03b1\nTODTarget organ damage", "start_char_idx": 0, "end_char_idx": 1012, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6886b43e-80eb-40eb-a9b3-536244565b66": {"__data__": {"id_": "6886b43e-80eb-40eb-a9b3-536244565b66", "embedding": null, "metadata": {"page_label": "34", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "99d8fa96-6e3d-4d13-ab2f-981aa9c2a2d4", "node_type": "4", "metadata": {"page_label": "34", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "d0bbea6581263dd876116a70b2710213c653e1b9e3ba748d257f5c78b0c79b96", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "950f8555-3a2d-4fed-9715-0f10800ee457", "node_type": "1", "metadata": {"page_label": "33", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "856de974a1ab885a7f7dbb3fb94d2bb73009aa7c0397bc89c8a6e7a5dc695d39", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a7c5dbc2-3ee4-4e0d-b4cd-2310eb2e5aaf", "node_type": "1", "metadata": {}, "hash": "8a445bf30ef2af44aae8d0680a5c3e9cd02eb653201c7cacc566713b1ede3e6b", "class_name": "RelatedNodeInfo"}}, "text": "TOFTrain-of-four\nt-PATissue plasminogen activator\nTPMTThiopurine methyl transferase\nt.p.r.Total peripheral resistance\nTRThyroid hormone receptor\nTREThyroid hormone response element\nTRHThyrotropin releasing hormone\nTSHThyroid stimulating hormone\nTTTuberculoid leprosy\nTTSTransdermal therapeutic system\nTXThromboxane\nUUnit\nUAUnstable angina\nUDPUridine diphosphate\nUFHUnfractionated heparin\nUGDPUniversity group diabetic programme\nUGTUDP-glucuronosyl transferase\nUSANUnited States adopted name\nUTUrea transporter\nUTIUrinary tract infection\nvVolt\nVVolume of distribution\nVALValine\nVAPVentilator associated pneumonia\nVDRVit D receptor\nVESVentricular extrasystole\nVFVentricular fibrillation\nVIPVasoactive intestinal peptide\nVitVitamin\nVKORVitamin K epoxide reductase\nVLVisceral leishmaniasis\nVLDLVery low density lipoprotein\nVMAVanillyl mandelic acid\nVMATVesicular monoamine transporter\nVREVancomycin resistant enterococci\nVRSAVancomycin resistant Staphylococcus aureus\nVRUTVasopressin regulated urea transporter\nVTVentricular tachycardia\nVTEVenous thromboembolism", "start_char_idx": 0, "end_char_idx": 1058, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a7c5dbc2-3ee4-4e0d-b4cd-2310eb2e5aaf": {"__data__": {"id_": "a7c5dbc2-3ee4-4e0d-b4cd-2310eb2e5aaf", "embedding": null, "metadata": {"page_label": "35", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "6383d4b6-dd4c-465d-85b6-9b42d91ad314", "node_type": "4", "metadata": {"page_label": "35", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "feb6085fa466189dadd324a9e7049b710829cbfab15efc69fdecad2f5155a968", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6886b43e-80eb-40eb-a9b3-536244565b66", "node_type": "1", "metadata": {"page_label": "34", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "d0bbea6581263dd876116a70b2710213c653e1b9e3ba748d257f5c78b0c79b96", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bcb81a3a-8a38-485f-a506-eb9d6c507bce", "node_type": "1", "metadata": {}, "hash": "7c334e3cefbbf80dfeceec88acb52fa1581619d94d08fba2eac589cd1a919ee1", "class_name": "RelatedNodeInfo"}}, "text": "vWFvon Willebrand factor\nWBCWhite blood cells\nWCVsWater channel containing vesicles\nWHOWorld Health Organization\nWPW Wolff-Parkinson-White syndrome\nXDR-TBExtensively drug resistant-TB\nZPyrazinamide\nZE(syndrome)\nZollinger-Ellison (syndrome)", "start_char_idx": 0, "end_char_idx": 239, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "bcb81a3a-8a38-485f-a506-eb9d6c507bce": {"__data__": {"id_": "bcb81a3a-8a38-485f-a506-eb9d6c507bce", "embedding": null, "metadata": {"page_label": "36", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "d1bc3755-3354-4d41-aadb-b136b720c67a", "node_type": "4", "metadata": {"page_label": "36", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "c2e783f614e7aa8a8f5d8f455d044e5d190cc5a54dcd0bbc4eee1f2a0f05cde2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a7c5dbc2-3ee4-4e0d-b4cd-2310eb2e5aaf", "node_type": "1", "metadata": {"page_label": "35", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "feb6085fa466189dadd324a9e7049b710829cbfab15efc69fdecad2f5155a968", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a5d261ee-2fe7-4be0-82b8-1d37b9e09c0f", "node_type": "1", "metadata": {}, "hash": "24883e05ebb404fca00bc95afb945e3678e06015542b8688fe5285f1a5a422bb", "class_name": "RelatedNodeInfo"}}, "text": "INTRODUCTION\nPharmacology\nPharmacology is the science of drugs (Greek: Pharmacon \u2014drug; logos \u2014\ndiscourse in). In a broad sense, it deals with interaction of exogenously\nadministered chemical molecules with living systems, and any single\nchemical substance which can produce a biological response is a \u2018drug\u2019.\nPharmacology encompasses all aspects of knowledge about drugs, but most\nimportantly those that are relev ant to effective and safe use of drugs for\nmedicinal purposes.\nFor thousands of years most drugs were crude natural products of\nunknown composition and limited efficacy . Only the overt effects of these\nsubstances on the body were rather imprecisely known, but how the same\nwere produced was entirely unknown. Animal experiments, primarily aimed\nat under standing physiological processes, were started in the 18th century .\nThese were pioneered by F. Magendie and Claude Bernard, who also\nadapted them to study effects of certain drugs. Pharmacology as an\nexperimental science was ushered by Rudolf Buchheim who founded the\nfirst institute of pharmacology in 1847 in Germany . In the later part of the\n19th century , Oswald Schmiedeber g, regarded as the \u2018father of\npharmacology\u2019, together with his many disciples like J Langley , T Frazer , P\nEhrlich, AJ Clark, JJ Abel propounded some of the fundamenta l concepts in\npharmacology . Since then drugs have been purified, chemically", "start_char_idx": 0, "end_char_idx": 1396, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a5d261ee-2fe7-4be0-82b8-1d37b9e09c0f": {"__data__": {"id_": "a5d261ee-2fe7-4be0-82b8-1d37b9e09c0f", "embedding": null, "metadata": {"page_label": "37", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b8d4fa21-687c-4c6e-a931-7421435cd0c4", "node_type": "4", "metadata": {"page_label": "37", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "385157c5d3405679f845f399bc1f71acf7d952fd64c65b5d42366193736c69d3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bcb81a3a-8a38-485f-a506-eb9d6c507bce", "node_type": "1", "metadata": {"page_label": "36", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "c2e783f614e7aa8a8f5d8f455d044e5d190cc5a54dcd0bbc4eee1f2a0f05cde2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "541f4c3b-28fa-4359-aac4-992e92a12818", "node_type": "1", "metadata": {}, "hash": "90b874c5ec0c1ae00e8f544563daaa7dcf8f5c1ddd44c84ff2f238af2255dc3f", "class_name": "RelatedNodeInfo"}}, "text": "characterized and a vast variety of highly potent and selectiv e new drugs\nhave been developed. The mechanism of action including molecular target of\nmany drugs has been elucidated. This has been possible due to prolific\ngrowth of pharmacology which forms the backbone of rational therapeutics.\nThe two main divisions of pharmacology are pharmacodynamics and\npharmacokinetics.\nPharmacodynamics (Greek: dynamis \u2014power) \u2014What the drug does to\nthe body .\nThis includes physiological and biochemical effects of drugs and their\nmechanism of action at organ system/subcellular/macromolecular levels, e.g.\n\u2014Adrenaline \u2192 interaction with adrenoceptors \u2192 G-protein mediated\nstimulation of cell membrane bound adenylyl cyclase \u2192 increased\nintracellular cyclic 3\u00b4,5\u00b4AMP  \u2192 cardiac stimulation, hepatic glycogenolysis\nand hyper glycaemia, etc.\nPharmacokinetics  (Greek: Kinesis \u2014movement)\u2014What the body does to\nthe drug.\nThis refers to movement of the drug in and alteration of the drug by the\nbody; includes absorption, distribution, binding/localization/storage,\nbiotransformation and excretion of the drug, e.g. paracetamol is rapidly and\nalmost completely absorbed orally attaining peak blood levels at 30\u201360 min;\n25% bound to plasma proteins, widely and almost uniformly distributed in\nthe body  (volume of distribution ~ 1L/kg); extensively metabolized in the\nliver, primarily by glucuronide and sulfate conjugation into inactive\nmetabolites which are excreted in urine; has a plasma half life (t\u00bd) of 2\u20133\nhours and a clearance value of 5 ml/kg/min.\nDrug (French: Drogue \u2014a dry herb) It is the single active chemical entity\npresent in a medicine that is used for diagnosis, prevention, treatment/cur e\nof a disease .\nThis disease oriented definition of drug does not include contraceptives or\nuse of drugs for improvement of health. The WHO (1966) has given a more\ncomprehensive definition\u2014\u201c Drug is any substance or product that is used\nor is intended to be used to modify or explor e physiologica l systems or\npathological states for the benefit of the r ecipient .\u201d", "start_char_idx": 0, "end_char_idx": 2062, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "541f4c3b-28fa-4359-aac4-992e92a12818": {"__data__": {"id_": "541f4c3b-28fa-4359-aac4-992e92a12818", "embedding": null, "metadata": {"page_label": "38", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "28432a3b-116a-41ed-a5ad-4000fc2acd67", "node_type": "4", "metadata": {"page_label": "38", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8ea2c86ac5413f0fefb68563af67752d4ec327ddb13fdc41d1aa11439643e1c1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a5d261ee-2fe7-4be0-82b8-1d37b9e09c0f", "node_type": "1", "metadata": {"page_label": "37", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "385157c5d3405679f845f399bc1f71acf7d952fd64c65b5d42366193736c69d3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0a324b6f-42cd-41d5-8210-0560b7b7fc08", "node_type": "1", "metadata": {}, "hash": "242af44311981acc916d82bd8e754a16684e90bdd6c890eaa8234b7ec39b45f4", "class_name": "RelatedNodeInfo"}}, "text": "The term \u2018drugs\u2019  is being also used to mean addictive/abu sed/illicit\nsubstances. However , this restricted and derogatory sense usage is\nunfortunate degradation of a time honoured term, and \u2018drug\u2019  should refer to\na substance that has some health promoting/therapeutic/diagnostic\napplication. Nevertheless, to avoid any misinterpretation, the term\n\u2018medicine\u2019  is being employed to designate such a substance in place of the\nterm \u2018drug\u2019.\nSome other important aspects of pharmacology are:\nPharmacotherapeutics  It is the application of pharmacological\ninformation together with knowledge of the disease for its prevention,\nmitigation or cure. Selection of the most appropriate drug, dosage and\nduration of treatment taking into account the stage of disease and the specific\nfeatures of a patient are a part of pharmacotherapeutics.\nClinical pharmacology  It is the scientific study of drugs (both old and\nnew) in man. It includes pharmacodynamic and pharmacokinetic\ninvestigation in healthy volunteers as well as in patients. Evaluation of\nefficacy and safety of drugs and comparative trials with other forms of\ntreatment; surve illance of patterns of drug use, adverse effects, etc. are also\npart of clinical pharmacology .\nThe aim of clinical pharmacology is to generate data for optimum use of\ndrugs and the practice of \u2018evidence based medicine\u2019.\nChemotherapy  It is the treatment of systemic infection/malignancy with\nspecific drugs that have selective toxicity for the infecting\norganism/malignant cell with no/minimal ef fects on the host cells.\nDrugs in general, can thus be divided into:\nPharmacodynamic  agents  These are designed to have pharmacodynamic\neffects in the recipient.\nChemotherapeutic  agents  These are designed to inhibit/kill invading\nparasites/malignant cell, but have no/minimal pharmacodynamic effects in\nthe recipient.", "start_char_idx": 0, "end_char_idx": 1847, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0a324b6f-42cd-41d5-8210-0560b7b7fc08": {"__data__": {"id_": "0a324b6f-42cd-41d5-8210-0560b7b7fc08", "embedding": null, "metadata": {"page_label": "39", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "84d024b3-a8e4-42d5-9186-068470ec2916", "node_type": "4", "metadata": {"page_label": "39", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "75aa85e9af3dee8fed3294c9f06a15357065b6692faedb4512246a6756d4be0b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "541f4c3b-28fa-4359-aac4-992e92a12818", "node_type": "1", "metadata": {"page_label": "38", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8ea2c86ac5413f0fefb68563af67752d4ec327ddb13fdc41d1aa11439643e1c1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fe72fe8a-bf31-408b-b0df-918828ba00f9", "node_type": "1", "metadata": {}, "hash": "3277abf809eb929ff6e74fd3edb4e489d3601a1d5f1b2cfaa3148dbe8b63c186", "class_name": "RelatedNodeInfo"}}, "text": "Pharmacy  It is the art and science of compounding and dispensing drugs or\npreparing suitable dosage form s for administration of drugs to man or\nanimals. It includes collecti on, identification, purification, isolation,\nsynthesis, standardization and quality control of medicinal substances. The\nlarge scale manufacture of drugs is called Pharmaceutics , which is prima rily\na technological science.\nToxicology  It is the study of poisonous effect of drugs and other chemicals\n(household, environmental pollu tant, industrial, agricultural, homicidal) with\nemphasis on detection, prevention and treatment of poison ings. It also\nincludes the study of adverse effects of drugs, since the same substance can\nbe a drug or a poison, depending on the dose.\nNATURE OF DRUGS\nAll drugs are chemical entities with simple or complex molecules. While\nmajority are organic compounds, some are purely inorganic, like lithium\ncarbonate, ferrous sulfate, magnesium hydroxide, etc. Organic drugs may be\nweakly acidic (aspirin, penicillin) or weakly basic (morphine, chloroquine)\nor nonelectrolytes (alcohol, diethyl-ether). Most drugs are normally solids,\ne.g. paracetamol, propranolol, furosemide, ampicillin, etc., but some such as\nethanol, glycery l trinitrate, propofol, castor oil are liquids, and few like\nnitrous oxide are gaseous.\nThe molecular weight of majority of drugs falls in the range of 100-1000\nD, becau se molecules smaller than 100 D do not generally have sufficiently\nspecific features  in terms of shape, size, configuration, chirality , distribution\nof charges, etc. to selectively bind to only one/few closely related target\nbiomolecules, to the exclusion of others. On the other hand, larger molecules\nthan 1000 D do not readily pass through membranes/barriers in the body to\nreach the target sites in variou s tissues/cells. However , few drugs are as\nsmall as lithium ion (7D), and some like heparin (10-20 KD), gonadotropins\n(>30 KD), enzymes, proteins, antibodies (>50 KD) are much bigger . Bulky\nmolecule drugs have to be administered parenterally .\nDrugs are generally perceived to be chemical substances foreign to the\nbody (Xenobiotics). However , many endogenous chemicals like hormones,", "start_char_idx": 0, "end_char_idx": 2205, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "fe72fe8a-bf31-408b-b0df-918828ba00f9": {"__data__": {"id_": "fe72fe8a-bf31-408b-b0df-918828ba00f9", "embedding": null, "metadata": {"page_label": "40", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "cbba637d-3358-4caa-b535-81736f6b7c31", "node_type": "4", "metadata": {"page_label": "40", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "7bc642ba06605f9a4cac3bb2f81961c87b399c5c49d5192f126c0916714eb513", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0a324b6f-42cd-41d5-8210-0560b7b7fc08", "node_type": "1", "metadata": {"page_label": "39", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "75aa85e9af3dee8fed3294c9f06a15357065b6692faedb4512246a6756d4be0b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "80808fcb-9373-4a96-9903-254e430c48a4", "node_type": "1", "metadata": {}, "hash": "7525d51ac9c5497f9775e9bd273d1a2902dc7a4ea3d04f3f7962414024e6bf11", "class_name": "RelatedNodeInfo"}}, "text": "autacoids, metabolites and nutrients are also used as drugs. Chemical\ncongeners of these metabolites/signal molecules are an important class of\ndrugs which act by modifying the synthesis, storage, degradation or action of\nthese metabolites/signal molecules.\nSOURCES OF DRUGS\nDrugs are obtained from a variety of sources:\n1.Plants  Many plants contain biological ly active substances and are the\noldest source of drugs. Clues about medicinal plants were obtained from\ntraditional syste ms of medicine prevalent in various parts of the world;\ne.g. use of opium, belladonna, ephedra, cinchona, curare, foxglove,\nsarpagandha, qinghaosu has been learnt from Egyptian, Greek, Aztec,\nAyurvedic, Chinese and other systems of medicine. Chemically the\nactive ingredients of plants fall in several categories:\na.Alkaloids:  These are alkaline nitrogen ous bases having potent\nactivity , and are the most important category of vegetable origin\ndrugs. Prominent examples are: morphine, atropine, ephedrine,\nnicotine, ergotamine, reserpine, quinine, vincristine, etc. They are\nmostly used as their water soluble hydrochloride/ sulfate salts.\nb.Glycosides:  These compounds consist of a heterocyclic nonsugar\nmoiety (aglycone) linked to a sugar moiety through ether linkage.\nCardiac glycosides (digoxin, ouabain) are the best known glycosidic\ndrugs. The active principle of senna and similar plant purgatives are\nanthraquinone glycosides. Aminoglycosides (gentamicin, etc.) are\nantibiotics obtained from micro organisms, and have an aminosugar\nin place of a sugar moiety .\nc.Oils:  These are viscous, inflammable liquids, insoluble in water .\nFixed (nonvolatile) oils are calorie yielding triglycerides of higher\nfatty acids; mostly used for food and as emollients, e.g. groundnut\noil, coconut oil, sesame oil, etc. Castor oil is a stimulant purgative.\nEssential  (volatil e) oils, mostly obtained from flowers or leaves by\nsteam distillatio n are aromatic (fragrant) terpene hydrocarbons  that\nhave no food value. They are used as flavouring agents,\ncarminatives, counterirritants and astringents; examples are", "start_char_idx": 0, "end_char_idx": 2096, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "80808fcb-9373-4a96-9903-254e430c48a4": {"__data__": {"id_": "80808fcb-9373-4a96-9903-254e430c48a4", "embedding": null, "metadata": {"page_label": "41", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "4c2e3729-00b3-46f1-96b4-ed4c443cd555", "node_type": "4", "metadata": {"page_label": "41", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fbbed6981e5d220887fd5c8ed1ea346a229f5934d1d6ddd3c68a67b9546c8051", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fe72fe8a-bf31-408b-b0df-918828ba00f9", "node_type": "1", "metadata": {"page_label": "40", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "7bc642ba06605f9a4cac3bb2f81961c87b399c5c49d5192f126c0916714eb513", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f416e33e-f7e5-41ec-bf99-71838b49db18", "node_type": "1", "metadata": {}, "hash": "c05804e5aea1282615258234f0e23900d35c636114333cc4ae24947fd62a4b72", "class_name": "RelatedNodeInfo"}}, "text": "eucalyptus oil, pepermint oil, nilgiri oil, etc. Clove oil is used to allay\ndental pain. Menthol, thymol, camphor are volatile oils that are solids\nat room temperature.\nMineral oils are not plant products, but obtained from petroleum;\nliquid paraf fin is a lubricant laxative, soft and hard paraf fin are used\nas emollient and as ointment bases.\nOther plant products like tanins are astringent; gums are demulcents and act\nas suspending agents in liquid dosage forms. Glycerine is a viscous, sweet\nliquid used as vehicle for gum/throat paint. Resins and balsam s are used as\nantiseptic and in cough mixtures . The antimalarial drug artemisinin is a\nsesquiterpene endoperoxide obtained from a Chinese plant.\n2.Animals  Though animal parts have been used as cures since early times,\nit was exploratio n of activity of organ extracts in the late 19th and early\n20th century that led to introdu ction of animal products into medicine,\ne.g. adrenaline, thyroxine, insulin, liver extract (vit. B12). Antisera and\nfew vaccines are also produced from animals.\n3.Microbes  Most antibiotics are obtained from fungi, actinomycetes and\nbacteria, e.g. penicillin, gentamicin, tetracycline, erythromycin,\npolymyxin B, actinomycin D (anticancer). Some enzymes, e.g. diastase\nfrom a fungus and streptokinase from streptococci have a microbial\nsource. Vaccines are produced by the use of microbes.\n4.Minerals  Few minerals, e.g. iron salts, calcium salts, lithium carbonate,\nmagnesium/aluminium hydroxide, iodine are used as medicinal\nsubstances.\n5.Synthetic  chemistry  Synthe tic chemistry made its debut in the 19th\ncentury , and is now the largest source of medicines. Synthetic drugs have\nthe advantage of purity and uniformity of the product. They can be\nmanufactured in any quantity as per need, in contrast to drugs from\nnatural sources whose availability may be limited. Not only diverse\ncongeners of naturally obtained drugs (atropine substitutes, adrener gic \uf0622\nagonists, synthetic glucocorticoids/progestins/cephalosporins, etc.) have\nbeen introduced to achieve greater selectivity of action or even novel\ntype of activity , but many entirely synthetic families of drugs, e.g.", "start_char_idx": 0, "end_char_idx": 2171, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f416e33e-f7e5-41ec-bf99-71838b49db18": {"__data__": {"id_": "f416e33e-f7e5-41ec-bf99-71838b49db18", "embedding": null, "metadata": {"page_label": "42", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "924975dc-8582-4cb5-b2af-8c0da4679147", "node_type": "4", "metadata": {"page_label": "42", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "65968cd998fb178fb47fe203c29d176ed6690c123eae4794a1dfa094b82e1c80", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "80808fcb-9373-4a96-9903-254e430c48a4", "node_type": "1", "metadata": {"page_label": "41", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fbbed6981e5d220887fd5c8ed1ea346a229f5934d1d6ddd3c68a67b9546c8051", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "807165dc-083c-41db-b7df-db046d43c262", "node_type": "1", "metadata": {}, "hash": "7fd8cc48b7285a559c2c65a6381614e167979251842121bea469a0da1063d4d0", "class_name": "RelatedNodeInfo"}}, "text": "benzodiazepines, thiazides, benzimidazoles, fluoroquinolones, etc. have\nbeen produced. Many drugs are being synthesized to target specific\nbiomolecules, e.g. ACE inhibitors, glycoprotein IIb/IIIa receptor\nantagonists, HIV-reverse transc riptase inhibitors, etc. Synthe tic drugs\nthat are chiral can also be produced as single active enantiomer products,\nwhich may be therapeutically superior .\n6.Biotechnology  Several drugs, especially peptides and proteins are now\nproduced by recombinant DNA  technology , e.g. human growth hormone,\nhuman insulin, altaplase, interferon, etc. Monoclonal antibodies,\nregulator peptide s, erythropoieti n and other growth factors are the newer\ndrugs of biotechnological origin. Protein therapeu tics is rapidly\nexpanding, because specifically designed and customized proteins can\nnow be produced.\nDRUG NOMENCLA TURE\nA drug generally has three categories of names:\n(a)Chemical  name  It describes the substance chemically , e.g. 1-\n(Isopropylamino)-3-(1-naphthyloxy) propan-2-ol for propranolol. This is\ncumbersome and not suitable for use in prescribing. A code name, e.g. RO\n15-1788 (later named flumazenil) may be assigned by the manufacturer for\nconvenience and simplicity before an approved name is coined.\n(b)Non-proprietary  name  It is the name accepted by a competent scientific\nbody/authority , e.g. the United States Adopted Name (USAN) by the USAN\ncouncil. Similar ly, there is the British Approved name (BAN) of a drug. The\nnon-proprietary names of newer drugs are kept uniform by an agreement to\nuse the Recommended International Nonproprietary Name (rINN) in all\nmember countri es of the WHO . The BAN of older drugs as well has now\nbeen modified to be commensurate with rINN. However , many older drugs\nstill have more than one non-proprietary names, e.g. \u2018meperidine\u2019  and\n\u2018pethidine\u2019  or \u2018lidocaine\u2019  and \u2018lignocaine\u2019  for the same drugs. Until the drug\nis included in a pharmacopoeia, the nonproprietary name may also be called\nthe approved name . After its appearance in the official publication, it\nbecomes the official name .", "start_char_idx": 0, "end_char_idx": 2080, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "807165dc-083c-41db-b7df-db046d43c262": {"__data__": {"id_": "807165dc-083c-41db-b7df-db046d43c262", "embedding": null, "metadata": {"page_label": "43", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "d86e3078-b409-44ee-9eec-f0262d5918b6", "node_type": "4", "metadata": {"page_label": "43", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9b1a891a09a65bf4ba026cfeb4221092eb27dad1dbce035709d704dec36569b8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f416e33e-f7e5-41ec-bf99-71838b49db18", "node_type": "1", "metadata": {"page_label": "42", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "65968cd998fb178fb47fe203c29d176ed6690c123eae4794a1dfa094b82e1c80", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e1f62f4a-5c0d-49dd-b70f-0b5792dac4e5", "node_type": "1", "metadata": {}, "hash": "e11866949d3df652897eeb770c2bde8bf597c85d1459c43b9bda4307ae9ebb69", "class_name": "RelatedNodeInfo"}}, "text": "In common parlance, the term generic name  is used in place of\nnonproprietary name. Etymologically this is incorrect: \u2018generic\u2019  should be\napplied to the chemical or pharmacological group (or genus) of the\ncompound, e.g. phenothiazines, tricyclic antidepressants, aminoglycoside\nantibiotics, etc. However , this misnomer is widely accepted and used even in\nofficial parlance.\n(c)Proprietary  ( Brand ) name  It is the name assigned by the\nmanufacturer(s) and is his property or trade mark. One drug may have\nmultiple proprietary names, e.g. AMCARD, AMLOGARD, AMLOCOR, AMLONG,\nAMLOPIN, AMLOVAS, STAMLO for amlodipine from different manufacturers.\nBrand names are designed to be catchy , short, easy to remember and often\nsuggestive, e.g. LOPRESOR suggesting drug for lowering blood pressure.\nBrand names generally differ in different countries, e.g. timolol maleate eye\ndrops are marketed as TIMOPTIC in USA  but as GLUCOMOL in India. Even\nthe same manufacturer may market the same drug under different brand\nnames in different countries. In addition, combined formulation s have their\nown multiple brand names. This is responsible for much confu sion in drug\nnomenclature.\nThere are many arguments for using the nonproprietary name in\nprescribing: uniformity , conven ience, economy and better comprehension\n(propranolol, sotalol, timolol, pindolol, metoprolol, acebutolol, atenolol are\nall \u03b2 blockers, but their brand names have no such similarity). Drugs\nmarketed under nonproprietary name (called generic products) are much\ncheaper than their branded counterparts, partly because the manufacturer\ninvests a lot of money in promoting the brand name. However , when a drug\nis prescribed by the generic name, the chemist is free to dispense the generic\nproduct from any manufacturer , but not so when the drug is prescribed by a\nbrand name. Thus, when it is important to ensure consistency of the product\nin terms of quality and bioavailability , etc. and especially when official\ncontrol over quality of manufactured products is not rigorous, it is better to\nprescribe by the dependable brand name.\nDRUG COMPENDIA", "start_char_idx": 0, "end_char_idx": 2114, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e1f62f4a-5c0d-49dd-b70f-0b5792dac4e5": {"__data__": {"id_": "e1f62f4a-5c0d-49dd-b70f-0b5792dac4e5", "embedding": null, "metadata": {"page_label": "44", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b39def78-d8b1-4463-8f00-d3a34e39fc34", "node_type": "4", "metadata": {"page_label": "44", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3a660dff4cf48398dd364a117167e84c7c0b7b70707f42ba1ce77171f638713d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "807165dc-083c-41db-b7df-db046d43c262", "node_type": "1", "metadata": {"page_label": "43", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9b1a891a09a65bf4ba026cfeb4221092eb27dad1dbce035709d704dec36569b8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b0a1bc6d-a78c-4b5e-844e-7b3e97a04521", "node_type": "1", "metadata": {}, "hash": "433b1911278caaf0f4aecee506b23c2f53a67b8ce9b689d9043d9051e0ce9e9a", "class_name": "RelatedNodeInfo"}}, "text": "These are compilations of information on drugs in the form of monographs;\nwithout going into the theoretic al concepts, mechanisms of action and other\naspects which help in understanding the subject. Pharmacopoeias  and\nFormularies  are broughtout by the Govern ment in a country , hold legal\nstatus and are called official compendia. In addition, some non-of ficial\ncompendia are published by professional bodies, which are supplementary\nand dependable sources of information about drugs.\nPharmacopoeias  They contain description of chemical structure, molecular\nweight, physical and chemical characteristics, solubility , identification and\nassay methods, standards of purity , storage conditions and dosage forms of\nofficially approved drugs in a country . They are useful to drug manufacturers\nand regulatory authorities, but not to doctors, most of whom  never see a\npharmacopoeia. Examples are Indian (IP), British (BP), European (Eur P),\nUnited States (USP) pharmacopoeias.\nFormularies  Generally produ ced in easily carried booklet form, they list\nindications, dose, dosage forms, contraindications, precautions, adverse\neffects and stora ge of selected drugs that are available for medicinal use in a\ncountry . Drugs are categorized by their therapeutic class. Some rational\nfixed-dose drug combinations are included. A brief commentary on the drug\nclass and clinical conditions in which they are used generally precedes\nspecifics of individual drugs. Brief guidelines for treatment  of selected\nconditions are provided. While British National Formulary (BNF) also lists\nbrand names with costs, the National Formulary of India (NFI) does not\ninclude these. Most formularies have informative appendices as well.\nFormularies can be considerably helpful to prescribers.\nMartindale : The  Complete  Drug  Reference  ( Extraphar macopoeia )\nPublished every 2\u20133 years by the Royal Pharmaceutical Society of Great\nBritain, this non-of ficial compendium is an exhaustive and updated\ncompilation of unbiased information on medicines used/registered all over\nthe world. It includes new launches and contains pharmaceutical,\npharmacological as well as therapeutic information on drugs , which can\nserve as a reliable reference book.", "start_char_idx": 0, "end_char_idx": 2230, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b0a1bc6d-a78c-4b5e-844e-7b3e97a04521": {"__data__": {"id_": "b0a1bc6d-a78c-4b5e-844e-7b3e97a04521", "embedding": null, "metadata": {"page_label": "45", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "c33a6a4a-e602-444a-b61a-a3aea69fa36c", "node_type": "4", "metadata": {"page_label": "45", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "644e79b2123563e550c2e2e10e252fe5b2f8bb7fb40d2b09484ccabddc323a38", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e1f62f4a-5c0d-49dd-b70f-0b5792dac4e5", "node_type": "1", "metadata": {"page_label": "44", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3a660dff4cf48398dd364a117167e84c7c0b7b70707f42ba1ce77171f638713d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "772bc3ab-7f54-4b60-bae5-2420580a57fe", "node_type": "1", "metadata": {}, "hash": "1e082e880f1ec013efb4c858d4c4e4284bc2c065a451364494367b0e7935107d", "class_name": "RelatedNodeInfo"}}, "text": "Physicians  Desk  Reference  ( PDR ) and Drug : Facts  and  Comparisons\n(both from USA), etc. are other useful non-of ficial compendia.\nESSENTIAL  MEDICINES (DRUGS) CONCEPT\nThe WHO has defined Essential Medicines (drugs) as \u201cthos e that satisfy the\npriority healthcare needs of the population.\u201d They are selected with due\nregard to public health relevance, evidence on efficacy and safety , and\ncomparative cost effectiveness. Essential medicines are intended to be\navailable within the context of functioning health systems at all times and in\nadequate amoun ts, in appropriate dosage forms, with assured quality and\nadequate information, and at a price the individual and the community can\nafford.\nIt has been realized that only a handful of medicines out of the multitude\navailable can meet the health care needs of majority of the people in any\ncountry , and that many well tested and cheaper medicines are equally (or\nmore) efficacious and safe as their newer more expensive congeners. For\noptimum utilization of resources, governments (especially in developing\ncountries) should concentrate on these medicines by identify ing them as\nEssential medicines . The WHO has laid down criteria to guide selection of\nan essential medicine.*\n(a) Adequate data on its efficacy and safety should be available from clinical studies.\n(b) It should be available in a form in which quality, including bioavailability, and stability\non storage can be assured.\n(c) Its choice should depend upon pattern of prevalent diseases; availability of facilities and\ntrained personnel; financial resources; genetic, demographic and environmental factors.\n(d) In case of two or more similar medicines, choice should be made on the basis of their\nrelative efficacy, safety, quality, price and availability. Cost-benefit ratio should be a major\nconsideration.\n(e) Choice may also be influenced by comparative pharmacokinetic properties and local\nfacilities for manufacture and storage.\n(f) Most essential medicines should be single compounds. Fixed ratio combination products\nshould be included only when dosage of each ingredient meets the requirements of a defined\npopulation group, and when the combination has a proven advantage in therapeutic effect,\nsafety, adherence or in decreasing the emergence of drug resistance.\n(g) Selection of essential medicines should be a continuous process which should take into\naccount the changing priorities for public health action, epidemiological conditions as well", "start_char_idx": 0, "end_char_idx": 2484, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "772bc3ab-7f54-4b60-bae5-2420580a57fe": {"__data__": {"id_": "772bc3ab-7f54-4b60-bae5-2420580a57fe", "embedding": null, "metadata": {"page_label": "46", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3ddf33ea-bbd8-40cf-9a40-a13154eb2d8a", "node_type": "4", "metadata": {"page_label": "46", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e1c7fa8c9c468fdbe62a11e75d88dc42e605df8f09b2c5c9336e838e1e65f694", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b0a1bc6d-a78c-4b5e-844e-7b3e97a04521", "node_type": "1", "metadata": {"page_label": "45", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "644e79b2123563e550c2e2e10e252fe5b2f8bb7fb40d2b09484ccabddc323a38", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "18abd933-b6fd-46d2-af2a-1bb78fd37f14", "node_type": "1", "metadata": {}, "hash": "cc7753f7fb11ae0c900e878c9dc654f2a4ea6acd81a1336132336b330eb57e2d", "class_name": "RelatedNodeInfo"}}, "text": "as availability of better medicines/formulations and progress in pharmacological knowledge.\n(h)Recently, it has been emphasized to select essential medicines based on rationally\ndeveloped treatment guidelines.\nTo guide the member countries,  the WHO brought out its first Model List\nof Essential Drugs along with their dosage forms and strengths in 1977\nwhich could be adopted after suitable modifications according to local\nneeds. This has been revised from time to time and the current is the 20th list\n(2017)$ which has 433 medicines, including 25 fixed dose drug\ncombinations (FDCs). India produced its National Essential Drugs List in\n1996, and has revised it in 2011, and now in 2015 with the title \u201cNational\nList of Essential Medicines\u201d.\u00a3 The latest list includes 376 medicines, of\nwhich 20 are FDCs. These medicines have been marked into 3 categories for\nbeing available at primary , secondary and tertiary levels of health care\nfacility .\nAdoption of the essential medi cines list for procurement and supply of\nmedicines, especially in the public sector healthcare system, has resulted in\nimproved availability of medic ines, cost saving and more rationa l use of\ndrugs.\n*The use of Essential Drugs (including the 8th model list of essential drugs); WHO\nTechnical report series 850, 1995, Geneva.\n$www.who.int>20th\u2014essential med-list (pub. 6 Jun 2017).\n\u00a3National list of Essential Medicines (2015) [http//www.cdsco.nic.in]\nPrescription and non-prescription drugs\nAs per drug rules, majority of drugs including all antibiotics must be sold in\nretail only against a prescription issued to a patient by a registered medical\npractitioner . These are called \u2018prescription drugs\u2019, and in India they have\nbeen placed in the schedule H of the Drugs and Cosmetic Rules (1945) as\namended from time to time. However , few drugs like simple analgesics\n(paracetamol aspirin), antacids, laxatives (senna, lactulose), vitamins, ferrous\nsalts, etc. are considered relatively harmless, and can be procur ed without a\nprescription. These are \u2018non-prescription\u2019  or \u2018over -the-counter \u2019 (OTC) drugs;\ncan be sold even by grocery stores.", "start_char_idx": 0, "end_char_idx": 2125, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "18abd933-b6fd-46d2-af2a-1bb78fd37f14": {"__data__": {"id_": "18abd933-b6fd-46d2-af2a-1bb78fd37f14", "embedding": null, "metadata": {"page_label": "47", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "683f29fd-bf98-4be1-bff0-144acc3b7aba", "node_type": "4", "metadata": {"page_label": "47", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9a8cc50a1b46f68db18047dbe11ceea56b118b15b8cd2cad26be4e6952b33903", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "772bc3ab-7f54-4b60-bae5-2420580a57fe", "node_type": "1", "metadata": {"page_label": "46", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e1c7fa8c9c468fdbe62a11e75d88dc42e605df8f09b2c5c9336e838e1e65f694", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "32daf703-5842-4b49-87f5-e283aa213afb", "node_type": "1", "metadata": {}, "hash": "65a78aab076c2139b0f673b83bc723cbaebe1b609fc7212fd1c713d04918dbff", "class_name": "RelatedNodeInfo"}}, "text": "Orphan Drugs These are drugs or biological products for diagnosis/treatment/ prevention\nof a rare disease or condition, or a more common disease (endemic only in resource poor\ncountries or areas) for which there is no reasonable expectation that the cost of developing\nand marketing it will be recovered from the sales of that drug. As per Orphan Drug\nAmendment (1983) Act of USA, a rare disease/condition is one that affects less than 0.2\nmillion people in the USA. Though these drugs may be life saving for some patients, they\nare commercially difficult to obtain as a medicinal product. Governments in developed\ncountries offer tax benefits and other incentives to pharmaceutical companies for developing\nand marketing orphan drugs. Orphan drug status has been awarded to many drugs in the\nUSA, Europe and some other countries. Few examples of drugs granted \u2018Orphan Drug\u2019\nstatus are listed in the box.\nAbridged list of Orphan drugs\nAzacitidine Icatibant\nBevacizumab Iloprost\nBortezomib Nilotinib\nBusulfan Paromomycin\nCarboprost Rifaximin\nClofazimine Rituximab\nColchicine Sodium stibogluconate\nEltrombopag Sodium thiosulfate\nFomivirsen ThioTEPA\nDOSAGE FORMS OF DRUGS\nDosage form is a product suitab le for administration of a drug to a patient.\nEvery active ingredient (drug ) has to be formulated by adding other\nsubstances (excipients, diluents, preservatives, vehicles, etc.) according to a\nspecific recipe and packaged into a specific \u2018dosage form\u2019  such as tablet,\nelixir , ointment, injection vial, etc. which is then administered to the subject.\nThe dosage form provides body to the drug, demarkates single doses,\nprotects the active ingredient(s) , and makes it suitable for administration in\nvarious ways. The important dosage forms are briefly described below .", "start_char_idx": 0, "end_char_idx": 1773, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "32daf703-5842-4b49-87f5-e283aa213afb": {"__data__": {"id_": "32daf703-5842-4b49-87f5-e283aa213afb", "embedding": null, "metadata": {"page_label": "48", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "af112b94-50a8-4d69-9356-ecb9508f779a", "node_type": "4", "metadata": {"page_label": "48", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8ec115e5eb068224d9a3511bcea3a0d36fbe12be6a6497300efc04eef48e8b6d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "18abd933-b6fd-46d2-af2a-1bb78fd37f14", "node_type": "1", "metadata": {"page_label": "47", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9a8cc50a1b46f68db18047dbe11ceea56b118b15b8cd2cad26be4e6952b33903", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "675a222f-64af-498d-a6d9-ab968ae48c9a", "node_type": "1", "metadata": {}, "hash": "8510c7f4eae1b5aef35173387f03130adf228c16ba010ed79fbe7a3c9d89c111", "class_name": "RelatedNodeInfo"}}, "text": "Solid dosage forms\n1.Powders  The drug is in a dry and finely pulverised state. If the drug is\nfor oral administ ration, each dose has to be wrapped separately or packed\nin sachets; therefore this dosag e form is inconvenient and unpopular\nexcept when the quantity is several grams, e.g. oral rehydration salts.\nPowders for topical application (dusting powders) are supplied  as bulk\npowders in meta llic or plastic containers with holes for sprinkling.\nEffervescent powders  contain granulated sod. bicarbonate and citric or\ntartaric acid. They react when dissolved in water to liberate CO2 causing\nbubbling.\n2.Tablets  The drug is powdered or granulated, mixed with binding agents,\nand other excipients, and compressed/moulded into discoid, oblong or\nother shapes suitable for swallo wing. The tablet may be plain  or sugar\ncoated or film coated. Other specialized types of tablets are:\nChewable tablets \u2014can be chewed and swallowed, ingredients must be\npleasent tasting.\nDispersible tablets \u2014the tablet is dropped in a small quantity of water ,\nwherein it disperses quickly; the solution is then gulped.\nSublingual table ts\u2014put under the tongue, the drug is rapidly absorbed\nfrom the mouth.\nEnteric coated tablet \u2014the tablet is coated with a material that does not\ndissolve in the acidic medium of the stomach; the tablet disintegrates\nonly on reaching the duodenum.\nSustained/Extended release tablets \u2014These contain drug particles which\nare coated to dissolve at different rates. The active ingredient is made\navailable for absorption over a longer period of time. The duration of\naction of short acting (2-6 hours) drugs can be extended to 12 hours or\nmore.\nContr olled release tablets \u2014A semiperme able membrane  controls the\nrelease of the drug \u2013 prolonging its duration of action.\n3.Pills These are archaic dosage forms in which the drug powder is mixed\nwith honey/syrup to make a sticky mass. This is then rolled into", "start_char_idx": 0, "end_char_idx": 1926, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "675a222f-64af-498d-a6d9-ab968ae48c9a": {"__data__": {"id_": "675a222f-64af-498d-a6d9-ab968ae48c9a", "embedding": null, "metadata": {"page_label": "49", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "1827f261-8016-4b22-9002-27725a06e5a8", "node_type": "4", "metadata": {"page_label": "49", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "91b5e4ca7f43f0767e7b64ae91295a80db988b14945473ca7d5d810326023d1e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "32daf703-5842-4b49-87f5-e283aa213afb", "node_type": "1", "metadata": {"page_label": "48", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8ec115e5eb068224d9a3511bcea3a0d36fbe12be6a6497300efc04eef48e8b6d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "945f092e-bc44-4d3d-bbb8-fd802d8120e3", "node_type": "1", "metadata": {}, "hash": "f426daf03d4867183bff6fe6e7ff26efb86e0a147d237af3e9490178959e21cc", "class_name": "RelatedNodeInfo"}}, "text": "spherical/oval bodies meant to be swallowed. The term is often loosely\napplied to tablets as well.\n4.Capsules  These are water soluble cylindrical containers made of gelatin\nwhich are filled with powdered or liquid medicament. The container\ndissolves on swallowing so that the drug is released in the stomach. Soft\ngelatine capsules dissolve very rapidly and generally contain liquid\nmedicament.  Enteric  coated capsules are designed to dissolve only on\nreaching the ileum. Spansules are extended release capsules which are\npacked with granules of the drug having different coatings to dissolve\nover a range of time periods.\n5.Lozenges  These are table t-like bodies of various shapes containing the\ndrug along with a suitable gum,  sweetening and flavouring agents. They\nare to be retained in the mouth and allowed to dissolve slowly , providing\nthe drug for local action in the mouth and throat.\n6.Suppositories  These are conical bullet- shaped dosage forms for\ninsertion into the anal canal, in which the drug is mixed with a\nmouldable firm base that melts at body temperature and releases the\ncontained drug. Oval or suitably  shaped bodies for vaginal insertion are\ncalled \u2018pessaries \u2019, while elongated pencil-like cones meant for insertion\ninto male or female urethra are called bougies .\nLiquid dosage forms\n1.Aqueous  solutions  They contain the drug dissolved in water , and may\nbe meant for oral, topical or parenteral administration. Oral drug\nsolutions often contain sweeten ing and flavouring agents. Preservatives\nhave to be mostly added because shelf-life of watery solutions is short.\n2.Suspensions  are dispersion of insoluble drugs in water with the help of\na suspending agent. Emulsions  are uniform mixtures of two immiscible\nliquids (mostly oil and water) in which droplets of one (dispersed phase)\nare suspended in the other (continuous phase) with the help of an\namphiphilic emulsifying agent. Milk is a naturally occurring emulsion.\nBoth suspensions and emulsions tend to settle down on keeping; should\nbe shaken thoroughly before use.", "start_char_idx": 0, "end_char_idx": 2061, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "945f092e-bc44-4d3d-bbb8-fd802d8120e3": {"__data__": {"id_": "945f092e-bc44-4d3d-bbb8-fd802d8120e3", "embedding": null, "metadata": {"page_label": "50", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "434e9b90-49e9-4270-8fd8-8c7f8355b1b9", "node_type": "4", "metadata": {"page_label": "50", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "78d9a8c34b74cd269686ed732bf20f3edde61a27da6ff7bcfe9cf4c52e5894c2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "675a222f-64af-498d-a6d9-ab968ae48c9a", "node_type": "1", "metadata": {"page_label": "49", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "91b5e4ca7f43f0767e7b64ae91295a80db988b14945473ca7d5d810326023d1e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2ac9fb92-6f75-4c17-8f95-d219482d99e5", "node_type": "1", "metadata": {}, "hash": "51f2273d20bd0485b8b8828fe22f92c8bfab542541faac4153dfb5e98b2952c4", "class_name": "RelatedNodeInfo"}}, "text": "3.Elixirs  are hydro-alcoholic solutions of drugs, usually sweetened with\nsyrup and flavoured by fruit extracts. Syrups  have higher concentration\nof sugar and are thicker in consistency . Drugs that deteriorate in aqueous\nmedium can be dispensed as \u2018dry syrups\u2019 which is reconstituted by\nadding water and shaking. The reconstituted syrup must be used within a\nfew days. Linctus is a viscous syrupy liquid meant to be licked slowly\nfor soothing the throat. It generally has menthol to impart cooling\nsensation, and an antitussive.\n4.Drops  These are relatively more concentrated solutions of medicaments\nmeant for oral ingestion or external application to eye, nose or ear canal.\nOral drops are the preferred dosage form for infants and young children.\nEye/nasal drops should be isotonic. Eye drops need sterilization. Drops\nare supplied in vials with a nozzle or alongwith a dropper for accurate\ndosing.\n5.Lotions  These are soluti ons, suspension s or emulsions meant for externa l\napplication to the skin without rubbing. They generally have soothing,\ncooling, protective or emollien t property and are better suited than\ncreams or ointments for hairy skin. Liniments are similar preparations\nwhich generally  contain counterirritants, and are to be rubbed on the skin\nto relieve pain and cause rubefaction.\n6.Injections  These are sterile solutions or suspensions in aqueous or oily\nmedium for subcutaneous or intramuscular administration. Only aqueous\nsolutions (not suspensions) are suitable for intravenous (i.v.) injection,\nbecause particles in suspension and oils injected i.v. can cause embolism.\nInjections are supplied in sealed glass ampoules  or air tight rubber\ncapped vials. Ampoules are broken just before injection, and usually\ncontain a single dose. Drug from the vial is sucked in a syringe by\npiercing the rubber cap. Vials may be single or multi-dose. Drugs which\nare unsta ble in solution are supplied as dry powder vials. Sterile solvent\nis injected in the vial just before it is to be administered, and the\ndissolved/suspended drug is then sucked out into the syringe. Some\ndrugs like insulin are also supplied in prefilled syringes and pen\ninjectors. Large volume i.v. infusions are marketed in\nglass/polypropylene bottles.", "start_char_idx": 0, "end_char_idx": 2249, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2ac9fb92-6f75-4c17-8f95-d219482d99e5": {"__data__": {"id_": "2ac9fb92-6f75-4c17-8f95-d219482d99e5", "embedding": null, "metadata": {"page_label": "51", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "d55832e2-38b5-4d77-8206-3ba586cdab85", "node_type": "4", "metadata": {"page_label": "51", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9c0609c2f15f6869ff559b584accbd3d4b75810ea2f17a54d2bdc5856dd4e2ca", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "945f092e-bc44-4d3d-bbb8-fd802d8120e3", "node_type": "1", "metadata": {"page_label": "50", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "78d9a8c34b74cd269686ed732bf20f3edde61a27da6ff7bcfe9cf4c52e5894c2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "46825d9a-c860-4fc0-8047-ef43f21754df", "node_type": "1", "metadata": {}, "hash": "7b8ac1224a55ce533c41016ac38502800dfae99be83eb1d7a3d8b63767794ac2", "class_name": "RelatedNodeInfo"}}, "text": "Semisolid dosage forms\n1.Ointments  These are greasy semisolid preparations meant for external\napplication to the skin, eye, nasal mucosa, ear or anal canal. The drug is\nincorporated in an oily base, such as soft or hard paraf fin, wool fat, bee\u2019s\nwax, etc. Ointme nts are not suita ble for oozing surfaces, because they are\nmore occlusive and donot allow evaporation of water . Rather they are\ngood for dry, chronic lesions. Creams  are similar to ointment but the\nbase is a water in oil emulsion. The medicament is better absorbed into\nthe skin from creams than from  ointments, and creams are cosmetically\nmore acceptable than ointments.\n2.Pastes  These are nongreasy preparations of thick consistency containing\nhydrophilic adhesive powders such as starch, prepared chalk,\naluminium/magnesium hydroxid e, zinc oxide, carboxy methylcellulose,\netc. whic h swell by absorbing water. Pastes may contain viscous nonoily\nliquids like glycerol or propylene glycol. Pastes can be applied to\ninflamed or excoriated skin, oozing surfaces and mucous membranes.\nToothpastes are items of persona l hygiene, and medicated toothpastes are\nextensively used in dentistry .\n3.Gels  The medicament is incorporated in a viscous colloidal solution of\ngelatin or similar material and is usually dispensed in collapsible tubes.\nThey are meant for external application to the skin or mucosa and\nprovide longer duration contact, but are nongreasy and washable with\nwater . Gels are suitable for application to hairy skin, and are commonly\napplied to oral ulcers because they are better retained than aqueous\nsolutions.\nInhalations\nDrugs which are gases or volati le liquids can be administered by inhalation\ncarried into air or oxygen with the help of a mouth piece, face mask, hood or\nendotracheal tube. Nonvolatile liquids and fine particle solids can be\naerosolized using a metered dose inhaler , jet nebulizer , rotahaler or spinhaler\nfor inhalation through the mouth. Pressurized meter ed dose inhalers\n(PMDIs) are hand-held devices which use a propellant, mostly", "start_char_idx": 0, "end_char_idx": 2047, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "46825d9a-c860-4fc0-8047-ef43f21754df": {"__data__": {"id_": "46825d9a-c860-4fc0-8047-ef43f21754df", "embedding": null, "metadata": {"page_label": "52", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "a4442ea6-1ec2-433a-a1f6-222537c6037c", "node_type": "4", "metadata": {"page_label": "52", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3bfd48fd873d1e255ce1276f9ae9bea71cae90a530e84fd25386f1d104574194", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2ac9fb92-6f75-4c17-8f95-d219482d99e5", "node_type": "1", "metadata": {"page_label": "51", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9c0609c2f15f6869ff559b584accbd3d4b75810ea2f17a54d2bdc5856dd4e2ca", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d76045c4-3a5a-412a-86d8-62c155d082dd", "node_type": "1", "metadata": {}, "hash": "826bd2569cab064fe4a5fbf7d0486b1f6923c9bde3e42a5905860747cd0189b4", "class_name": "RelatedNodeInfo"}}, "text": "hydrofluoroalkane (HFA), and deliver a specified dose of the drug in aerosol\nform per actuation. Jet nebu lizers produce a mist of the drug solution\ngenerated by pressurized air or oxygen. Rotahaler  is also a portab le device\nin which a capsule (rotacap) containing very fine powder of the drug is\npunctured durin g actuation and the released particles are aerosolized by the\ninspiratory airflo w of the patien t. A propellant can also be used in some spin\nhalers. Efficacy of the aerosolized drug depends on the particle size: 1\u20135 \uf06dm\ndiameter particles deposit on the bronchioles and effectively deliver the\ndrug. Larger particles settle on the oropharynx, while <1 \uf06dm particles donot\nsettle anywhere and are exhaled out.\nROUTES OF DRUG ADMINISTRA TION\nMost drugs can be administer ed by a variety of routes. The choice of\nappropriate route in a given situation depends both on drug as well as patient\nrelated factors.  Mostly common sense considerations, feasibility and\nconvenience dictate the route to be used.\nRoutes can be broadly divided into those for (a) Local action and (b)\nSystemic action.\nFactors governing choice of route\n1. Physical and chemical properties of the drug (solid/liquid/gas;\nsolubility, stability, pH, irritancy).\n2. Site of desired action\u2014localized and approachable or\ngeneralized and not approachable.\n3. Rate and extent of absorption of the drug from different routes.\n4. Effect of digestive juices and \ufb01rst pass metabolism on the\ndrug.\n5. Rapidity with which the response is desired (routine treatment\nor emergency).\n6. Accuracy of dosage required (i.v. and inhalational can provide\n\ufb01ne tuning).\n7. Condition of the patient (unconscious, vomiting).", "start_char_idx": 0, "end_char_idx": 1681, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d76045c4-3a5a-412a-86d8-62c155d082dd": {"__data__": {"id_": "d76045c4-3a5a-412a-86d8-62c155d082dd", "embedding": null, "metadata": {"page_label": "53", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "a9fcdd22-4318-4c21-9297-ad33b3ab05e6", "node_type": "4", "metadata": {"page_label": "53", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b1ff097762bd5489d705436c7aac9bf9c2f5e43f32a354a01760edfe602db95e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "46825d9a-c860-4fc0-8047-ef43f21754df", "node_type": "1", "metadata": {"page_label": "52", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3bfd48fd873d1e255ce1276f9ae9bea71cae90a530e84fd25386f1d104574194", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ea5e9aa9-af54-4dea-9388-41cf6899147c", "node_type": "1", "metadata": {}, "hash": "1008348b71c87cdab4b3bdd7791b2de4aef08253f21d8cd4ee6ba4cbfd257705", "class_name": "RelatedNodeInfo"}}, "text": "LOCAL  ROUTES\nThese routes can only be used for localized lesions at accessible sites and for\ndrugs whose systemic absorpti on from these sites is minimal or absent.\nThus, high concentrations are attained at the desired site without exposing\nthe rest of the body . Systemic side effects or toxicity are consequently absent\nor minimal. For drugs (in suitable dosage forms) that are absorbed from\nthese sites/routes, the same can serve as systemic route of administration,\ne.g. glyceryl trinitrate (GTN) applied on the skin as ointment or transdermal\npatch for angina pectoris. The local routes are:\n1.Topical  This refers to external applicatio n of the drug to the surface for\nlocalized action . It is often more convenient as well as reassuring to the\npatient. Drugs can be efficiently delivered to the localized lesions on skin,\noropharyngeal/ nasal mucosa, eyes, ear canal, anal canal or vagina in the\nform of lotion , ointment, cream, powder , rinse, paints, drops, spray ,\nlozengens, suppositories or pesseries. Nonabsorbable drugs given orally for\naction on g.i. mucosa (sucralfate, vancomycin), inhalation of drugs for action\non bronchi (salbutamol, cromolyn sodium) and irrigating solutions/jellys\n(povidone iodin e, lidocaine) applied to urethra are other forms of topical\nmedication.\n2.Deeper tissues  Certain deep areas can be approached by using a\nsyringe and needle, but the drug should be in such a form that systemic\nabsorption is slow, e.g. intra-articular injection (hydrocortisone acetate in\nknee joint), infiltration around a nerve or intrathecal injection (lidocaine),\nretrobulbar injection (hydrocortisone acetate behind the eyeball).\n3.Arterial suppl y Close intra-arterial injection is used for contrast media\nin angiography; anticancer drugs can be infused in femoral or brachial artery\nto localise the ef fect for limb malignancies.\nSYSTEMIC ROUTES\nThe drug administered through  systemic routes is intended to be absorbed\ninto the blood stream and distributed all over, including the site of action,\nthrough circulation ( see Fig. 1.1).", "start_char_idx": 0, "end_char_idx": 2062, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ea5e9aa9-af54-4dea-9388-41cf6899147c": {"__data__": {"id_": "ea5e9aa9-af54-4dea-9388-41cf6899147c", "embedding": null, "metadata": {"page_label": "54", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "787f824b-6dcf-4e21-9fc2-2214c55a8f82", "node_type": "4", "metadata": {"page_label": "54", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "ea417547bb167492c674588f9a8148e8492ba1caaef297f4e48bb5b3752a4d2b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d76045c4-3a5a-412a-86d8-62c155d082dd", "node_type": "1", "metadata": {"page_label": "53", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b1ff097762bd5489d705436c7aac9bf9c2f5e43f32a354a01760edfe602db95e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ec78ce0c-894f-4996-8e64-9096fea9d4d0", "node_type": "1", "metadata": {}, "hash": "44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a", "class_name": "RelatedNodeInfo"}}, "text": "1.Oral\nOral ingestion is the oldest and commonest mode of drug administration. It\nis safer, more convenient, does not need assistance, noninvasive, often\npainless, the medicament need not be sterile and so is cheaper . Both solid\ndosage forms (powders, tablets, capsules, spansules, dragees, moulded\ntablets, gastrointestinal therapeutic systems\u2014GIT s) and liquid dosage forms\n(elixirs, syrups, emulsions, mixtures) can be given orally .\nLimitations of oral route of administration\n\u2022Action of drugs is slower and thus not suitable for emergencies.\n\u2022Unpalatable drugs (chloramphenicol) are dif\ufb01cult to administer; drug\nmay be \ufb01lled in capsules to circumvent this.\n\u2022May cause nausea and vomiting.\n\u2022Cannot be used for uncooperative/unconscious/vomiting patient.\n\u2022Absorption of the drug may be variable and erratic; certain drugs are\nnot absorbed (streptomycin).\n\u2022Others are destroyed by digestive juices (penicillin G, insulin) or in\nliver (GTN, testosterone, lidocaine).", "start_char_idx": 0, "end_char_idx": 968, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ec78ce0c-894f-4996-8e64-9096fea9d4d0": {"__data__": {"id_": "ec78ce0c-894f-4996-8e64-9096fea9d4d0", "embedding": null, "metadata": {"page_label": "55", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "220f95f8-ab72-4570-ace2-8cad2bf17f12", "node_type": "4", "metadata": {"page_label": "55", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "51bbe426f10ff64727c41e6fd1125b524b47ec7ff6e7a790054d6d767302f59c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ea5e9aa9-af54-4dea-9388-41cf6899147c", "node_type": "1", "metadata": {"page_label": "54", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "ea417547bb167492c674588f9a8148e8492ba1caaef297f4e48bb5b3752a4d2b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0ce92ee2-a14b-4dbd-8cf5-88cf7d97ffb6", "node_type": "1", "metadata": {}, "hash": "9355eb17ed3ac023385846e82bccb6642bcb7375ac51cc4d326cdebe29e75511", "class_name": "RelatedNodeInfo"}}, "text": "", "start_char_idx": 0, "end_char_idx": 0, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0ce92ee2-a14b-4dbd-8cf5-88cf7d97ffb6": {"__data__": {"id_": "0ce92ee2-a14b-4dbd-8cf5-88cf7d97ffb6", "embedding": null, "metadata": {"page_label": "56", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "8fa1a5cb-702f-44ed-8d20-15cf24fd6712", "node_type": "4", "metadata": {"page_label": "56", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "abbf93f323fb94de1b66b7acc969d6bb7199fdcc17d0d60598b3437b29db16ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ec78ce0c-894f-4996-8e64-9096fea9d4d0", "node_type": "1", "metadata": {"page_label": "55", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "51bbe426f10ff64727c41e6fd1125b524b47ec7ff6e7a790054d6d767302f59c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "75f19480-687e-4c61-bca3-a48aca157562", "node_type": "1", "metadata": {}, "hash": "2a7f83c46644c46cfe9b7609d3463ce3328fffc0d6e1c5ad7590ef17cf83a170", "class_name": "RelatedNodeInfo"}}, "text": "Fig. 1.1: Vascular pathway of drugs absorbed from various systemic routes of\nadministration and sites of \ufb01rst pass metabolism\nNote : Total drug absorbed orally is subjected to \ufb01rst pass metabolism in intestinal\nwall and liver, while approximately half of that absorbed from rectum passes\nthrough liver. Drug entering from any systemic route is exposed to \ufb01rst pass\nmetabolism in lungs, but its extent is minor for most drugs.\n2.Sublingual (s.l.) or buccal\nThe tablet or pellet containing the drug is placed under the tongue or crushed\nin the mouth and spread over the buccal mucosa. Only lipid soluble and non-\nirritating drugs can be so administered. Absorption is relatively rapid\u2014\naction can be produced in minutes. Though it is somewhat inconvenient, one\ncan spit the drug after the desired effect has been obtained. The chief\nadvantage is that liver is bypassed and drugs with high first pass metabolism\ncan be absorbed directly into systemic circulation. Drugs given sublingually\nare\u2014GTN, buprenorphine, desamino-oxytocin.\n3.Rectal\nCertain irritant and unpleasant drugs can be put into rectum as suppositories\nor retent ion enema for systemic effect. This route can also be used when the\npatient is having  recurrent vomiting or is unconscious. However , it is rather\ninconvenient and embarrassing; absorption is slower , irregular and often\nunpredictable, though diazepam  solution and paracetamol suppository are\nrapidly and dependably absor bed from the rectum in children. Drug\nabsorbed into external haemorrhoidal veins (about 50%) bypasses liver, but\nnot that absorbed into internal haemorrhoidal veins. Rectal inflammation can\nresult from irrita nt drugs. Diazepam, indomethacin, paracetamol, ergotamine\nand few other drugs are some times given rectally .\n4.Cutaneous\nHighly lipid soluble drugs can be applied over the skin for slow and\nprolonged absorption. The liver is also bypassed. The drug can be\nincorporated in an ointment and applied over specified area of skin.\nAbsorption of the drug can be enhanced by rubbing the preparation, by using\nan oily base and by an occlusive dressing.", "start_char_idx": 0, "end_char_idx": 2103, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "75f19480-687e-4c61-bca3-a48aca157562": {"__data__": {"id_": "75f19480-687e-4c61-bca3-a48aca157562", "embedding": null, "metadata": {"page_label": "57", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "4801dd2e-a9a8-4f1a-8c33-f7672fc5af5c", "node_type": "4", "metadata": {"page_label": "57", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b459a404837db7a9a2d1f9d6e2b9703ad7161eeb6ba42e6035f709e3f9dd8038", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0ce92ee2-a14b-4dbd-8cf5-88cf7d97ffb6", "node_type": "1", "metadata": {"page_label": "56", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "abbf93f323fb94de1b66b7acc969d6bb7199fdcc17d0d60598b3437b29db16ea", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "371511b2-0237-4c51-911b-0a47b10145a7", "node_type": "1", "metadata": {}, "hash": "44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a", "class_name": "RelatedNodeInfo"}}, "text": "Transdermal therapeutic systems (TTS)  These are devic es in the form\nof adhesive patches of various shapes and sizes (5\u201320 cm2) which deliver the\ncontained drug at a constant rate into systemic circulation via the stratum\ncorneum (Fig. 1.2). The drug (in solution or bound to a polymer) is held in a\nreservoir between an occlusive backing film and a rate controlling micropore\nmembrane, the under surface  of which is smeared with an adhesive\nimpregnated with priming dose of the drug. The adhesive layer  is protected\nby another film that is to be peeled off just before application. The drug is\ndelivered at the skin surface by diffusion for percutaneous absorption into\ncirculation. The micropore mem brane is such that rate of drug delivery to\nskin surface is less than the slowest rate of absorption from the skin. This\noffsets any variation in the rate of absorption according to the properties of\ndifferent sites. As such, the drug is delivered at a constant and predictable\nrate irrespective of site of appli cation. Usually chest, abdomen, upper arm,\nlower back, buttock or mastoid region are utilized.\nTransdermal patches of GTN, fentanyl, nicotine and estradiol are\navailable in India, while those of isosorbide dinitrate, hyoscine, and\nclonidine are marketed elsewhere. For different drugs, TTS have been\ndesigned to last for 1\u20133 days. Though more expensive, they provide smooth\nplasma concentrations of the drug without fluctuations; minimize\ninterindividual variations (drug is subjected to little first pass metabolism)\nand side effects. They are also more convenient\u2014many patients prefer\ntransdermal patches to oral tablets of the same drug; patient compliance is\nbetter . Local irritation and erythema occurs in some subjects, but is generally\nmild; can be minimized by changing the site of application each time by\nrotation. Discontinuation has been necessary in only 2\u20137% cases.", "start_char_idx": 0, "end_char_idx": 1898, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "371511b2-0237-4c51-911b-0a47b10145a7": {"__data__": {"id_": "371511b2-0237-4c51-911b-0a47b10145a7", "embedding": null, "metadata": {"page_label": "58", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "fe2767ca-bcbe-4841-a796-5de28f1391e7", "node_type": "4", "metadata": {"page_label": "58", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fca1a004100f88d5f934983b685195a9468f30310a54be80b3890f54983cbe74", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "75f19480-687e-4c61-bca3-a48aca157562", "node_type": "1", "metadata": {"page_label": "57", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b459a404837db7a9a2d1f9d6e2b9703ad7161eeb6ba42e6035f709e3f9dd8038", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d0bd5f58-03f9-4e15-a8bc-fcaed8e77d6b", "node_type": "1", "metadata": {}, "hash": "fe41f16e144463dfafd1cbe725ddce4cffcbcad3dd5e965b872d728321a58253", "class_name": "RelatedNodeInfo"}}, "text": "", "start_char_idx": 0, "end_char_idx": 0, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d0bd5f58-03f9-4e15-a8bc-fcaed8e77d6b": {"__data__": {"id_": "d0bd5f58-03f9-4e15-a8bc-fcaed8e77d6b", "embedding": null, "metadata": {"page_label": "59", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3823decb-ee25-45da-9706-27f65d0fb331", "node_type": "4", "metadata": {"page_label": "59", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "81265f169c13f0c24d9338e7e3f87fa2923d2027a2cff0c1563a3765f070e6d4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "371511b2-0237-4c51-911b-0a47b10145a7", "node_type": "1", "metadata": {"page_label": "58", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fca1a004100f88d5f934983b685195a9468f30310a54be80b3890f54983cbe74", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2039c74c-e3f7-484c-b828-8d60d39586d4", "node_type": "1", "metadata": {}, "hash": "6cfc6d5eef556677daabe72ab42fc8641b56301d12f968372d10743c562867b8", "class_name": "RelatedNodeInfo"}}, "text": "Fig. 1.2: Illustration of a transdermal drug delivery system\n5.Inhalation\nVolatile liquids and gases are given by inhalation for systemic  action, e.g.\ngeneral anaesthe tics. Absorption takes place from the vast surface of alveoli\n\u2014action is very rapid. When administration is discontinued the drug diffuses\nback and is rapidly eliminated in expired air. Thus, controlled administration\nis possi ble with moment to moment adjustment. Irritant vapours (ether)\ncause inflammation of respiratory tract and increase secretion.\n6.Nasal\nThe mucous membrane of the nose can readily absorb many drugs; digestive\njuices and liver are bypassed. However , only certain drugs like GnRH\nagonists, calcito nin and desmopressin applied as a spray or nebulized\nsolution have been used by this route. This route is being tried for some\nother peptide drugs like insulin, as well as to bypass the blood-brain barrier .\n7.Parenteral\n(Par\u2014beyond, enteral \u2014intestinal)\nConventionally , parenteral refers to administration by injection which takes\nthe drug directly into the tissue  fluid or blood without having to cross the\nenteral mucosa. The limitations of oral administration are circumvented.\nDrug action is faster and surer (valuable in emer gencies). Gastric\nirritation and vomiting are not provoked. Parenteral routes can be employed\neven in unconscious, uncoope rative or vomiting patient. There are no\nchances of interference by food or digestive juices. Liver is bypassed.\nDisadvantages of parenteral routes are\u2014the preparation has to be\nsterilized and is costlier , the technique is invasive and painful, assistance of\nanother person is mostly needed (though self injection is possible, e.g.\ninsulin by diabe tics), there are chances of local tissue injury and, in general,\nparenteral route is more risky than oral. The important parenteral routes are:\n(i) Subcutaneous (s.c.)  The drug is deposited in the loose subcutaneous\ntissue which is richly supplied by nerves (irritant drugs cannot  be injected)\nbut is less vascular (absorption is slower than intramuscular) . Only small\nvolumes can be injected s.c. Self-injection is possible because deep", "start_char_idx": 0, "end_char_idx": 2139, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2039c74c-e3f7-484c-b828-8d60d39586d4": {"__data__": {"id_": "2039c74c-e3f7-484c-b828-8d60d39586d4", "embedding": null, "metadata": {"page_label": "60", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5d53fa1e-a0a6-4b05-9541-efab54285edf", "node_type": "4", "metadata": {"page_label": "60", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "c9bd1988b8cb25402b21bedd18262439e7c716c473e8cb4d2d986360cb4a8146", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d0bd5f58-03f9-4e15-a8bc-fcaed8e77d6b", "node_type": "1", "metadata": {"page_label": "59", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "81265f169c13f0c24d9338e7e3f87fa2923d2027a2cff0c1563a3765f070e6d4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9fce5ad9-406d-40b6-be98-fe6ef376954d", "node_type": "1", "metadata": {}, "hash": "6faf8753d3a2be52caaa17ceabb417bfe63fce4fe7eb8a827a8929233382178e", "class_name": "RelatedNodeInfo"}}, "text": "penetration is not needed. This route should be avoided in shock patients\nwho are vasoconstricted\u2014absorption will be delayed. Repository (depot)\npreparations that are aqueous suspensions can be injected for prolonged\naction. Some special forms of this route are:\n(a) Dermojet  In this method needle is not used; a high velocity jet of drug\nsolution is projected from a microfine orifice using a gun like implement.\nThe solution passes through the superficial layers and gets deposited in the\nsubcutaneous tissue. It is essentially painless and suited for mass\ninoculations.\n(b) Pellet  implanta tion The drug in the form of a solid pellet is introduced\nwith a trochar and cannula. This provides sustained release of the drug over\nweeks and months, e.g. DOCA, testosterone.\n(c)Sialistic (nonbiodegradable) and biodegradable implants\nCrystalline drug is packed in tubes or capsules made of suitable materials\nand implanted under the skin. Slow and uniform leaching of the drug occurs\nover months providing constant blood levels. The nonbiodegradable implant\nhas to be remove d later on but not the biodegradable one. This has been tried\nfor hormones and contraceptives (e.g. NORPLANT).\n(ii) Intramuscular (i.m.) The drug is injected in one of the large skeletal\nmuscles\u2014deltoid, triceps, gluteus maximus, rectus femoris, etc. Muscle is\nless richly supplied with sensory nerves (mild irritants can be injected) and is\nmore vascular (absorption of drugs in aqueous solution is faster). It is less\npainful, but self injection is often impracticable because deep penetration is\nneeded. Depot preparations (oily solutions, aqueous suspensions) can be\ninjected by this route. Intramuscular injections should be avoided in\nanticoagulant treated patients, because it can produce local haematoma.\n(iii) Intravenous (i.v.) The drug is injected as a bolus (Greek: bolos \u2013lump)\nor infused slowly over hours in one of the superficial veins. The drug\nreaches directly into the blood stream and effects are produced immediately\n(great value in emer gency). The intima of veins is insensitive and drug gets\ndiluted with blood, therefore, even highly irritant drugs can be injected i.v.,", "start_char_idx": 0, "end_char_idx": 2168, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9fce5ad9-406d-40b6-be98-fe6ef376954d": {"__data__": {"id_": "9fce5ad9-406d-40b6-be98-fe6ef376954d", "embedding": null, "metadata": {"page_label": "61", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "6b741be5-f451-4b46-af0a-78678fd1eea6", "node_type": "4", "metadata": {"page_label": "61", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "928d7796d3e30e99b5ce5da10ce5f54142fb308cd73c23571da708eaff9f3a8b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2039c74c-e3f7-484c-b828-8d60d39586d4", "node_type": "1", "metadata": {"page_label": "60", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "c9bd1988b8cb25402b21bedd18262439e7c716c473e8cb4d2d986360cb4a8146", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "62363b93-e892-4170-a664-520cd5e97444", "node_type": "1", "metadata": {}, "hash": "f86ae3dbbe99751766c6709b6cb6d3692e88c3c913066b63ff689372fc717502", "class_name": "RelatedNodeInfo"}}, "text": "but hazards are\u2014thrombophleb itis of the injected vein and necrosis of\nadjoining tissues if extravasation occurs. These complications can be\nminimized by diluting the drug or injecting it into a running i.v. line. Only\naqueous solutions (not suspensions, because drug particles can cause\nembolism) are to be injected i.v. and there are no depot preparations for this\nroute. Chances of causing air embolism is another risk. The dose of the drug\nrequired is smallest (bioavailabi lity is 100%) and even large volumes can be\ninfused. One big advantage with this route is\u2014in case response is accurately\nmeasurable (e.g. BP) and the drug short acting (e.g. sodium nitroprusside),\ntitration of the dose with the response is possible. However , this is the most\nrisky route\u2014vital organs like heart, brain, etc. get exposed to high\nconcentrations of the drug.\n(iv) Intradermal injection The drug is injected into the skin raising a bleb\n(e.g. BCG vaccine, sensitivity testing) or scarring/multiple punctur e of the\nepidermis through a drop of the drug is done. This route is employed for\nspecific purposes only .", "start_char_idx": 0, "end_char_idx": 1104, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "62363b93-e892-4170-a664-520cd5e97444": {"__data__": {"id_": "62363b93-e892-4170-a664-520cd5e97444", "embedding": null, "metadata": {"page_label": "62", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "c88d1376-886b-494a-ad5e-6b74033bd3e9", "node_type": "4", "metadata": {"page_label": "62", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "909a39c0cfb7be10ba648a1fbd8fe613762866383d9e5787fc0084742f280257", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9fce5ad9-406d-40b6-be98-fe6ef376954d", "node_type": "1", "metadata": {"page_label": "61", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9fa258b705c60df70d6c04edf07e5854c0539f4fe9f558ebfd076a52d9b82813", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "86cddc1a-fe1a-4ead-bf3a-27518a8820c4", "node_type": "1", "metadata": {}, "hash": "1c3e04d35c727d8b608a78f3e9eeb362a22fac64bc2b6c3caf99d854aee5ccd3", "class_name": "RelatedNodeInfo"}}, "text": "Pharmacokinetics is the quantita tive study of drug movement in, through and\nout of the body. The overall scheme of pharmacokinetic processes is\ndepicted in Fig. 2.1. The intensity of response is related to concentration of\nthe drug at the site of action, which in turn is dependent on its\npharmacokinetic properties. Pharmacokinetic considerations, therefore,\ndetermine the route(s) of administration, dose, latency of onset, time of peak\naction, duration of action and frequency of administration of a drug.\nAll pharmacokinetic processes involve transport of the drug across\nbiological membranes.\nBiological membrane  This is a bilayer (about 100 \u00c5 thick) of\nphospholipid and cholesterol molecules, the polar groups (glyceryl\nphosphate attached to ethanolamine/choline or hydroxyl group of\ncholesterol) of these are oriented at the two surfaces and the nonpolar\nhydrocarbon chains are embedded in the matrix to form a conti nuous sheet.\nThis imparts high electrical resistance and relative impermea bility to the\nmembrane. Extrinsic and intrinsic protein molecules are adsorbed on the\nlipid bilayer (Fig. 2.2). Glycoproteins or glycolipids are formed on the\nsurface by attach ment to polymeric sugars, aminosugars   or sialic acids. The\nspecific lipid and protein composition of different membranes differs\naccording to the cell or the organelle type. The proteins are able to freely\nfloat through the membrane: associate and organize or vice versa. Some of\nthe intrin sic ones, which extend through the full thickness of the membrane,\nsurround fine aqueous pores. Paracellular spaces or channels also exist\nbetween certain epithelial/endothelial cells. Other adsorbed proteins have\nenzymatic, carrier , receptor or signal transduction properties. Lipid", "start_char_idx": 0, "end_char_idx": 1755, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "86cddc1a-fe1a-4ead-bf3a-27518a8820c4": {"__data__": {"id_": "86cddc1a-fe1a-4ead-bf3a-27518a8820c4", "embedding": null, "metadata": {"page_label": "63", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "a712ff43-7bca-43bf-868a-89d9bf93e48d", "node_type": "4", "metadata": {"page_label": "63", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "76a753e061bb0c217fc54d22e81738472a0fd1c92615cbf61bb61353197c7598", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "62363b93-e892-4170-a664-520cd5e97444", "node_type": "1", "metadata": {"page_label": "62", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "909a39c0cfb7be10ba648a1fbd8fe613762866383d9e5787fc0084742f280257", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "26ed5b32-2c9a-4f54-bff3-ab70398191c3", "node_type": "1", "metadata": {}, "hash": "ea625185db64acd44b788081c8c03e165931cfb66738acf79bfc6c3eb3273e4f", "class_name": "RelatedNodeInfo"}}, "text": "molecules also are capable of lateral movement. Thus, biological membranes\nare highly dynamic structures.", "start_char_idx": 0, "end_char_idx": 105, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "26ed5b32-2c9a-4f54-bff3-ab70398191c3": {"__data__": {"id_": "26ed5b32-2c9a-4f54-bff3-ab70398191c3", "embedding": null, "metadata": {"page_label": "64", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "4a2f804a-1695-411c-b9b7-8ac1dfc803a6", "node_type": "4", "metadata": {"page_label": "64", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a4be04b004a49ef5f8e67fd99326b16f6c12001d73f5e2e11d9a819c9e55ac04", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "86cddc1a-fe1a-4ead-bf3a-27518a8820c4", "node_type": "1", "metadata": {"page_label": "63", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2ba8976e7e005e61be64bffbab6cf4e5f649c4083b6e5e0b036ec5b60adb6199", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5af1c24c-31f5-4068-ba14-11a10282d4c8", "node_type": "1", "metadata": {}, "hash": "0e24295cf8041b8fe43adb3596d3ddbc57039fbde72f0af703310a411c907f8c", "class_name": "RelatedNodeInfo"}}, "text": "Drugs are transported across the membranes by:\n(a) Passive dif fusion and filtration\n(b) Specialized transport\nPassive diffusion\nThe drug diffuses across the membrane in the direction of its concentration\ngradient (high to low), the membrane playing no active role in the process.\nThis is the most important mechanism for majority of drugs; drugs are\nforeign substances  (xenobiotics), and specialized mechanisms are developed\nby the body primarily for normal metabolites.\nLipid soluble drugs diffuse by dissolving in the lipoidal matrix of the\nmembrane (Fig.  2.3), the rate of transport being proportional to the lipid :\nwater partition coefficient of the drug. A more lipid-soluble drug attains\nhigher concentration in the membrane and diffuses quickly . Also, greater the\ndifference in the concentration of the drug on the two sides of the membrane,\nfaster is its dif fusion.", "start_char_idx": 0, "end_char_idx": 879, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5af1c24c-31f5-4068-ba14-11a10282d4c8": {"__data__": {"id_": "5af1c24c-31f5-4068-ba14-11a10282d4c8", "embedding": null, "metadata": {"page_label": "65", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5cd068ef-971d-4cf2-9818-f4a8ec479d6e", "node_type": "4", "metadata": {"page_label": "65", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "eebe00df479792697f65b2ce25a8efd873131748003d2cd8b6a123d17f3c9b96", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "26ed5b32-2c9a-4f54-bff3-ab70398191c3", "node_type": "1", "metadata": {"page_label": "64", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a4be04b004a49ef5f8e67fd99326b16f6c12001d73f5e2e11d9a819c9e55ac04", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f3ac06f2-a882-4b8b-baa1-09bf99655095", "node_type": "1", "metadata": {}, "hash": "ea88ad9f3fea148bda758fd00accd7664b41852ecd2cec09783ec85be694b7c0", "class_name": "RelatedNodeInfo"}}, "text": "In\ufb02uence of pH Most drugs are weak electrolytes, i.e. their ionization is\npH dependent (contrast strong electrolytes that are nearly completely ionized\nat acidic as well as alkaline pH). The ionization of a weak acid HA is given\nby the equation:\npKa is the negative logarithm of acidic dissociation constant of the weak\nelectrolyte. If the concentration of ionized drug [A\u00af ] is equal to\nconcentration of unionized drug [HA], then\nsince log 1 is 0, under this condition\npH = pKa ...(2)\nThus, pKa is numerically equal to the pH at which the drug is 50% ionized.\nIf pH is increased by 1 scale, then\u2014\nlog [A\u00af ]/[HA] = 1  or  [A\u00af ]/[HA] = 10\nSimilarly , if pH is reduced by 1 scale, then\u2014\n[A\u00af ]/[HA] = 1/10\nThus, weakly acidic drugs, which form salts with cations, e.g. sod.\nphenobarbitone, sod. sulfadiazine, pot. penicillin-V , etc. ionize more at\nalkaline pH and 1 scale change in pH causes 10 fold change in ionization.\nWeakly basic drugs, which form salts with anions, e.g. atropine sulfate ,\nephedrine HCl, chloroq uine phosphate,  etc. conversely ionize more at acidic\npH. Ions being lipid insoluble, do not diffuse and a pH difference across a\nmembrane can cause differentia l distribution of weakly acidic and weakly\nbasic drugs on the two sides (Fig. 2.4).", "start_char_idx": 0, "end_char_idx": 1262, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f3ac06f2-a882-4b8b-baa1-09bf99655095": {"__data__": {"id_": "f3ac06f2-a882-4b8b-baa1-09bf99655095", "embedding": null, "metadata": {"page_label": "66", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "dfe25b23-0dc4-4553-a8f3-fe559fd3dd5d", "node_type": "4", "metadata": {"page_label": "66", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4be0b6138f1575bde18d82dec116a10020758a9ada12cce672fb5280db40f593", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5af1c24c-31f5-4068-ba14-11a10282d4c8", "node_type": "1", "metadata": {"page_label": "65", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "eebe00df479792697f65b2ce25a8efd873131748003d2cd8b6a123d17f3c9b96", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b5b5ca50-c970-4d36-b0b9-1e5aca132300", "node_type": "1", "metadata": {}, "hash": "a87c127e2e045b9481069cb950c9b6f3b79619f45f1a322fd2a7996d42977f11", "class_name": "RelatedNodeInfo"}}, "text": "Implications of this consideration are:\n(a) Acidic drugs, e.g. aspirin (pKa 3.5) are largely unionized at acid gastric\npH and are absorbed from stomach, while bases, e.g. atropine (pKa 10) are\nlargely ionized and are absorbed only when they reach the intestines.\n(b) The unionized form of acidi c drugs which crosses the surface membrane\nof gastric mucosal cell, reverts to the ionized form within the cell (pH 7.0)\nand then only slowly passes to the extracellular fluid. This is called ion\ntrapping , i.e. a weak electrolyte crossing a membrane to encounter a pH\nfrom which it is not able to escape easily . This may contribute to gastric\nmucosal cell damage caused by aspirin.\n(c) Basic drugs attain higher concentration intracellularly (pH 7.0 vs 7.4 of\nplasma).\n(d) Acidic drugs are ionized more in alkaline urine\u2014do not back diffuse in\nthe kidney tubules and are excreted faster . Accordingly , basic drugs are\nexcreted faster if urine is acidified.\nLipid-soluble nonelectrolytes (e.g. ethanol, diethyl-ether) readily cross\nbiological membranes and their transport is pH independent.\nFiltration", "start_char_idx": 0, "end_char_idx": 1099, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b5b5ca50-c970-4d36-b0b9-1e5aca132300": {"__data__": {"id_": "b5b5ca50-c970-4d36-b0b9-1e5aca132300", "embedding": null, "metadata": {"page_label": "67", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "6c7d00d7-118a-499e-999c-be29d4e0207b", "node_type": "4", "metadata": {"page_label": "67", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "d68d35170f5fca10fb896392dc9309922658c6174c0778e298abda2b65609fa4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f3ac06f2-a882-4b8b-baa1-09bf99655095", "node_type": "1", "metadata": {"page_label": "66", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4be0b6138f1575bde18d82dec116a10020758a9ada12cce672fb5280db40f593", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "afb1f413-1a30-42ed-8ffb-39eb6ba26c07", "node_type": "1", "metadata": {}, "hash": "80071a791599034b9f04cc930462ece134e6fdd654f7040ad5c5236c2b7a93b5", "class_name": "RelatedNodeInfo"}}, "text": "Filtration is passage of drugs through aqueous pores in the membrane or\nthrough paracellular spaces. This can be accelerated if hydrodynamic flow of\nthe solvent is occurring under hydrostatic or osmotic pressure gradient, e.g.\nacross most capillaries includi ng glomeruli. Lipid-insoluble drugs cross\nbiological memb ranes by filtration if their molecular size is smaller than the\ndiameter of the pores (Fig. 2.3). Majority of cells (intestinal mucosa, RBC,\netc.) have very small pores (4 \u00c5) and drugs with MW > 100 or 200 are not\nable to penetrat e. However , capillaries (except those in brain) have large\nparacellular spaces (40 \u00c5) and most drugs (even albumin) can filter through\nthese (Fig. 2.8). As such, diffusion of drugs across capillaries is dependent\non rate of blood flow through them rather than on lipid solubility of the drug\nor pH of the medium.\nSpecialized transport\nThis can be carrier mediated  or by vesicular transport (endocytosis,\nexocytosis).\nCarrier transport", "start_char_idx": 0, "end_char_idx": 984, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "afb1f413-1a30-42ed-8ffb-39eb6ba26c07": {"__data__": {"id_": "afb1f413-1a30-42ed-8ffb-39eb6ba26c07", "embedding": null, "metadata": {"page_label": "68", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ff8e3a3b-163e-4483-96b4-7350fb2222d0", "node_type": "4", "metadata": {"page_label": "68", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "696d81695e7f1335c42fb0cd5e90066f0feb46c27708a75ddbc4d8d4a78067b8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b5b5ca50-c970-4d36-b0b9-1e5aca132300", "node_type": "1", "metadata": {"page_label": "67", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "d68d35170f5fca10fb896392dc9309922658c6174c0778e298abda2b65609fa4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "af9b4130-cd7a-4cef-972e-fff90bbb81d3", "node_type": "1", "metadata": {}, "hash": "d7e622588376a275d032c35b77c0e0a5dc0ef46feaff1683d9652529b1a8cb40", "class_name": "RelatedNodeInfo"}}, "text": "All cell membra nes express a host of transmembrane proteins which serve as\ncarriers or transporters for physiologically important ions, nutrients,\nmetabolites, transmitters, etc. across the membrane. At some sites, certain\ntransporters also translocate xenobiotics, including drugs and their\nmetabolites. In contrast to chan nels, which open for a finite time and allow\npassage of specific ions, transpo rters combine transiently with their substrate\n(ion or organic compound)\u2014under go a conformational change carrying the\nsubstrate to the other side of the membrane where the substrate dissociates\nand the transporter returns back to its original state (Fig. 2.5). Carrier\ntransport is specific for the substrate (or the type of substrate, e.g. an organic\nanion), saturable, competitively inhibited by analogues which utilize the", "start_char_idx": 0, "end_char_idx": 831, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "af9b4130-cd7a-4cef-972e-fff90bbb81d3": {"__data__": {"id_": "af9b4130-cd7a-4cef-972e-fff90bbb81d3", "embedding": null, "metadata": {"page_label": "69", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "bf0af623-9cfd-48f5-90c2-c6b724a2761f", "node_type": "4", "metadata": {"page_label": "69", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5c742aabc21c2cf496a86d8c153201a39fa5adf8a2e91daa82a6cb1b0ad49eba", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "afb1f413-1a30-42ed-8ffb-39eb6ba26c07", "node_type": "1", "metadata": {"page_label": "68", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "696d81695e7f1335c42fb0cd5e90066f0feb46c27708a75ddbc4d8d4a78067b8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "08af050f-6429-4516-9d65-2fe8422ea4e4", "node_type": "1", "metadata": {}, "hash": "df8a4da3333ffc1fbc1e35d4018f1755c8e9ca6f60487932ff6f4c087a919d6d", "class_name": "RelatedNodeInfo"}}, "text": "same transporte r, and is much slower than the flux throug h channels.\nDepending on requirement of ener gy, carrier transport is of two types:\na. Facilitated  diffusion  The transporter , belonging to the super -family of\nsolute carrier (SLC) transporters, operates passively without needing energy\nand translocates the substrate in the direction of its electrochemical gradient,\ni.e. from higher to lower conc entration (Fig. 2.5A). It merely facilitates\npermeation of a poorly diffusible substrate, e.g. the entry of glucose into\nmuscle and fat cells by the glucose transporter GLUT  4.\nb. Active  transport  It requires energy, is inhibited by metabolic poisons, and\ntransports the solute against its electrochemical gradient (low to high),\nresulting in selective accumulation of the substance on one side of the\nmembrane. Drugs related to normal metabolites can utilize the transport\nprocesses meant for these, e.g. levodopa and methyl dopa are actively\nabsorbed from the gut by the aromatic amino acid transporter . In addition,\nthe body has developed some relatively nonselective transporters, like P-\nglycopr otein  (P-gp),  to deal with xenobiotics. Active transport can be\nprimary or secondary depending on the source of the driving force.\ni. Primary  active  transport  Energy is obtained directly by the hydrolysis of\nATP (Fig. 2.5B). The transporters belong to the superfamily of ATP binding\ncassettee (ABC) transporters whose intracellular loops have ATPase activity .\nThey mediate only efflux of the solute from the cytoplas m, either to\nextracellular fluid or into an intracellular organelli (endoplasmic reticulum,\nmitochondria, etc.)\nEncoded by the multidrug resistance 1 (MDR1) gene, P-gp is the most well known\nprimary active transporter expressed in the intestinal mucosa, renal tubules, bile canaliculi,\nchoroidal epithelium, astrocyte foot processes around brain capillaries (the blood-brain\nbarrier), testicular and placental microvessels, which pumps out many drugs/metabolites and\nthus limits their intestinal absorption, penetration into brain, testes and foetal tissues as well\nas promotes biliary and renal elimination. Many xenobiotics which induce or inhibit P-gp\nalso have a similar effect on the drug metabolizing isoenzyme CYP3A4, indicating their\nsynergistic role in detoxification of xenobiotics.\nOther primary active transporters of pharmacological significance are multidrug\nresistance associated protein 2 (MRP 2) and breast cancer resistance protein (BCRP).", "start_char_idx": 0, "end_char_idx": 2496, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "08af050f-6429-4516-9d65-2fe8422ea4e4": {"__data__": {"id_": "08af050f-6429-4516-9d65-2fe8422ea4e4", "embedding": null, "metadata": {"page_label": "70", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "c2dd27c3-92f2-422f-8d08-1e9d6a58f358", "node_type": "4", "metadata": {"page_label": "70", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "dda6abdc1857e841cf9463ee193dfc82ccc8fed90472ab9a19859f81db23e087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "af9b4130-cd7a-4cef-972e-fff90bbb81d3", "node_type": "1", "metadata": {"page_label": "69", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5c742aabc21c2cf496a86d8c153201a39fa5adf8a2e91daa82a6cb1b0ad49eba", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "31ff8b85-79af-47a2-92ae-19a05f7f774c", "node_type": "1", "metadata": {}, "hash": "0fc66b2d72d75fa0e39c1b58fdcbb0a491a9c290ca44a0dee3d4fef61e282834", "class_name": "RelatedNodeInfo"}}, "text": "ii. Secondary  active  transport  In this type of active transport effected by\nanother set of SLC transporters , the energy to pump one solute is derived\nfrom the downhill movement of another solute (mostly Na+). When the\nconcentration gradients are such that both the solutes move in the same\ndirection (Fig. 2.5C), it is called symport or cotransport , but when they\nmove in opposite directions (Fig. 2.5D), it is termed antiport  or exchange\ntransport . Metabolic energy (from hydrolysis of ATP) is spent in\nmaintaining high transmembra ne electrochemical gradient of the second\nsolute (generally Na+). The SLC trans porters mediate  both uptake and efflux\nof drugs and metabolites.\nThe organic anion transporting polypeptide (OATP) and organic cation transporter\n(OCT), highly expressed in liver canaliculi and renal tubules, are secondary active\ntransporters important in the metabolism and excretion of drugs and metabolites (especially\nglucuronides). The Na+,Cl\u2013 dependent neurotransmitter transporters for norepinephrine,\nserotonin and dopamine (NET, SERT and DAT) are active SLC transporters that are targets\nfor action of drugs like tricyclic antidepressants, selective serotonin reuptake inhibitors\n(SSRIs), cocaine, etc. Similarly, the Vesicular monoamine transporter (VMAT-2) of\nadrenergic and serotonergic storage vesicles transports catecholamines and 5-HT into the\nvesicles by exchanging with H+ions, and is inhibited by reserpine. The absorption of\nglucose in intestines and renal tubules is through secondary active transport by sodium-\nglucose transporters (SGLT1 and SGLT2).\nAs indicated earlier , carrier trans port (both facilitated diffusion and active\ntransport) is saturable and follows the Michaelis-Menten kinetics. The\nmaximal rate of transport is dependent on the density of the transporter in a\nparticular mem brane, and its rate constant (Km), i.e. the substrate\nconcentration at which rate of transport is half maximal, is governed by its\naffinity for the substrate. Genetic polymorphism can alter both the density\nand affinity of the transporter protein for different substrates and thus affect\nthe pharmacokinetics of drugs. Moreover , tissue specific drug distribution\ncan occur due to the presence of specific transporters in certain cells.\nVesicular transport (endocytosis, exocytosis)\nCertain substances with very large or impermeable molecules are transported\ninside the cell (endocytosis ) or extruded from it (exocytosis ) by enclosing\ntheir particles into tiny vesicles. A binding protein located on the membrane", "start_char_idx": 0, "end_char_idx": 2554, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "31ff8b85-79af-47a2-92ae-19a05f7f774c": {"__data__": {"id_": "31ff8b85-79af-47a2-92ae-19a05f7f774c", "embedding": null, "metadata": {"page_label": "71", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "6ab7796c-e87a-49ee-b455-b323139a8c57", "node_type": "4", "metadata": {"page_label": "71", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f18847547bef93cc1598edc6507a56968faef1155b741ec0df85ad7ee533ea0c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "08af050f-6429-4516-9d65-2fe8422ea4e4", "node_type": "1", "metadata": {"page_label": "70", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "dda6abdc1857e841cf9463ee193dfc82ccc8fed90472ab9a19859f81db23e087", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d33fb733-f0ad-43bb-baec-a265f0b89868", "node_type": "1", "metadata": {}, "hash": "1a7e8f573b54e8f837812e0c4960289b6950be20da4324f3e4129c36cdc76eb5", "class_name": "RelatedNodeInfo"}}, "text": "complexes with the substance and initiates vesicle formation (Fig. 2.6). The\nvesicle then detaches from the membrane and may remain stored within the\ncell, or it may release the substance in the cytoplasm, or it may move to the\nopposite membrane fuse with it to release the substance across the cell\n(exocytosis). \nVesicular transp ort is applicable to proteins and other big mole cules, and\ncontributes little to transport of most drugs, barring few like vit B12 which is\nabsorbed from the gut after binding to intrinsic factor (a protein). Most\nhormones (insu lin, etc.) and neurotransmitters, like noradr enaline, are\nsecreted/released from the cell/n erve ending by exocytosis. Activation of the", "start_char_idx": 0, "end_char_idx": 699, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d33fb733-f0ad-43bb-baec-a265f0b89868": {"__data__": {"id_": "d33fb733-f0ad-43bb-baec-a265f0b89868", "embedding": null, "metadata": {"page_label": "72", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "944aa216-249d-4790-aa83-4b89d655ade2", "node_type": "4", "metadata": {"page_label": "72", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "63c0a72588c019fca1f7daa42fc7780864e4c49d25639981aa152fbd8402ff89", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "31ff8b85-79af-47a2-92ae-19a05f7f774c", "node_type": "1", "metadata": {"page_label": "71", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f18847547bef93cc1598edc6507a56968faef1155b741ec0df85ad7ee533ea0c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8a0be426-a2ab-4e48-a552-4f39752ab754", "node_type": "1", "metadata": {}, "hash": "b3507077a47ec968e6fb03f51537483f34ec1da9c7b36a79568a97aca9ea7434", "class_name": "RelatedNodeInfo"}}, "text": "secretory cell/nerve ending prompts fusion of the storage vesicle to the\nsurface membra ne followed by extrusion of its contents into the extracellular\nspace.\nABSORPTION\nAbsorption is movement of the drug from its site of administration into the\ncirculation. Not only the fraction of the administered dose that gets\nabsorbed, but also the rate of absorption is important. Except when given\ni.v., the drug has to cross biological membranes; absorption is governed by\nthe above described principles. Other factors af fecting absorption are:\nAqueous  solub ility Drugs given in solid form must dissolve in the aqueous\nbiophase before they are absorbed. For poorly water soluble drugs (aspirin,\ngriseofulvin) rate of dissolution governs rate of absorption. Ketoconazole\ndissolves at low pH: gastric acid is needed for its absorption. Obviously , a\ndrug given as watery solution is absorbed faster than when the same is given\nin solid form or as oily solution.\nConcentration  Passive diffusion depends on concentration gradient; drug\ngiven as concentrated solution is absorbed faster than from dilute solution.\nArea  of  absorbing  surface  Larger is the surface area, faster is the\nabsorption.\nVascularity  of  the  absorbing  surface  Blood circulatio n removes the drug\nfrom the site of absorption and maintains the concentration gradient across\nthe absorbing surface. Increased  blood flow hastens drug absor ption just as\nwind hastens drying of clothes.\nRoute  of  administration  This affects drug absorption, because each route\nhas its own peculiarities.\nOral\nThe effective barrier to orally administered drugs is the epithelial lining of\nthe gastrointesti nal tract, which is lipoidal. Nonionized lipid soluble drugs,", "start_char_idx": 0, "end_char_idx": 1720, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8a0be426-a2ab-4e48-a552-4f39752ab754": {"__data__": {"id_": "8a0be426-a2ab-4e48-a552-4f39752ab754", "embedding": null, "metadata": {"page_label": "73", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "20a8b136-ad7e-45e8-b769-ea2f70521e74", "node_type": "4", "metadata": {"page_label": "73", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "54ccf6323166aa8e1c6b5eaa82881c4ede68c2bf90ad32da2181405918c3f36b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d33fb733-f0ad-43bb-baec-a265f0b89868", "node_type": "1", "metadata": {"page_label": "72", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "63c0a72588c019fca1f7daa42fc7780864e4c49d25639981aa152fbd8402ff89", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "891afd6e-bbe8-4845-a310-f9d4ab71cfe0", "node_type": "1", "metadata": {}, "hash": "8b7ec80d7175f8c8faae8478bd8de1f6a7cffaa0b7dbf40878aa84c8927dab7e", "class_name": "RelatedNodeInfo"}}, "text": "e.g. ethanol are readily absorbed from stomach as well as intestine at rates\nproportional to their lipid : water partition coefficient. Acidic drugs, e.g.\nsalicylates, barbiturates, etc. are predominantly unionized in the acid gastric\njuice and are absorbed from stomach, while basic drugs, e.g. morphine,\nquinine, etc. are largely ionize d and are absorbed only on reaching the\nduodenum. How ever, even for acidic drugs absorption from stomach is\nslower , because the mucosa is thick, covered with mucus and the surface\narea is small. Absorbing surface area is much larger in the small intestine\ndue to villi. Thus, faster gastric emptying accelerates drug absorption in\ngeneral. Dissolution is a surface phenomenon, therefore, particle size of the\ndrug in solid dosage form governs rate of dissolution and in turn rate of\nabsorption.\nPresence of food dilutes the drug and retards absorption. Further , certain\ndrugs form poorly absorbed complexes with food constituents, e.g.\ntetracyclines with calcium present in milk; moreover food delays gastric\nemptying. Thus,  most drugs are absorbed better if taken in empty stomach.\nHowever , there  are some exceptions, e.g. fatty food greatly enhances\nlumefantrine absorption. Highly  ionized drugs, e.g. gentamicin, neostigmine\nare poorly absorbed when given orally .\nCertain drugs are degraded in the gastrointestinal tract, e.g. penicillin G\nby acid, insulin by peptidases, and are ineffective orally . Enteric coated\ntablets (having acid resistant coating) and sustained release preparations\n(drug particles coated with slowly dissolving material) can be used to\novercome acid lability , gastric irritancy and brief duration of action.\nThe oral absorption of certain drugs is low because a fraction of the\nabsorbed drug is extruded back into the intestinal lumen by the efflux\ntransporter P-gp  located in the gut epithelium. The low oral bioavailability of\ndigoxin and cyclosporine is partly accounted by this mechanism. Inhibitors\nof P-gp like quinidine, verapam il, erythromycin, etc. enhance , while P-gp\ninducers like rifampin and phen obarbitone reduce the oral bioavailability of\nthese drugs.\nAbsorption of a drug can be affected by other concurrently ingested\ndrugs. This may be a luminal effect : formation of insoluble comple xes, e.g.\ntetracyclines and iron preparations with calcium salts and antacids,", "start_char_idx": 0, "end_char_idx": 2363, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "891afd6e-bbe8-4845-a310-f9d4ab71cfe0": {"__data__": {"id_": "891afd6e-bbe8-4845-a310-f9d4ab71cfe0", "embedding": null, "metadata": {"page_label": "74", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "25bedbc1-a1b1-496f-8351-f2950dde364c", "node_type": "4", "metadata": {"page_label": "74", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "36e4304bfbfecfb3f383dcb6af5e6d8c0bfd7c173263b3586802b730d731d99d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8a0be426-a2ab-4e48-a552-4f39752ab754", "node_type": "1", "metadata": {"page_label": "73", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "54ccf6323166aa8e1c6b5eaa82881c4ede68c2bf90ad32da2181405918c3f36b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0decf59f-7481-4ffc-abd1-6d6dfbb29db3", "node_type": "1", "metadata": {}, "hash": "5d9095b998b18438c3bcd8662b831fad3aa9f91ece98430aa4085e491b786e24", "class_name": "RelatedNodeInfo"}}, "text": "phenytoin with sucralfate. Such interaction can be minimized by\nadministering the two drugs at 2\u20133 hr intervals. Alteration of gut flora by\nantibiotics may disrupt the enterohepatic cycling of oral contraceptives and\ndigoxin. Drugs can also alter absorption by gut wall effects : altering  motility\n(anticholiner gics, tricyclic antidepressants, opioids retard motility while\nmetoclopramide enhances it) or causing mucosal damage (neomycin,\nmethotrexate, vinblastine).\nSubcutaneous and Intramuscular\nBy these routes the drug is deposited directly in the vicinity of the\ncapillaries. Lipid soluble drugs pass readily across the whole surface of the\ncapillary endothelium. Capillaries having large paracellular spaces do not\nobstruct absorption of even large lipid insoluble molecules or ions (Fig.\n2.9A). Very large molecules are absorbed through lymphatics. Thus, many\ndrugs not absorbed orally are absorbed parenterally . Absorption from s.c. site\nis slower than that from i.m. site, but both are generally faster and more\nconsistent/ predictable than oral absorption. Application of heat and\nmuscular exercis e accelerate drug absorption by increasing blood flow, while\nvasoconstrictors, e.g. adrenaline injected with the drug (local anaesthetic)\nretard absorption . Incorporation  of hyaluronidase facilitates drug absorption\nfrom s.c. injection by promoting spread. Many depot preparations, e.g.\nbenzathine penicillin, protamine  zinc insulin, depot progestins, etc. can be\ngiven by these routes.\nTopical sites (skin, cornea, mucous membranes)\nSystemic absorption after topical application depends primarily on lipid\nsolubility of drugs. However , only few drugs significantly penetrate intact\nskin. Hyoscine, fentanyl, GTN,  nicotine, testosterone, and estradiol (see p.\n12) have  been used in this manner . Corticosteroids applied over extensive\nareas of skin can produce systemic effects and pituitary-adrenal suppression.\nAbsorption can be promoted by rubbing the drug incorporated in an\nolegenous base or by use of occlusive dressing which increases hydration of\nthe skin. Organophosphate insecticides coming in contact with skin can", "start_char_idx": 0, "end_char_idx": 2142, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0decf59f-7481-4ffc-abd1-6d6dfbb29db3": {"__data__": {"id_": "0decf59f-7481-4ffc-abd1-6d6dfbb29db3", "embedding": null, "metadata": {"page_label": "75", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5c907214-4dcb-4631-9957-626adebadc17", "node_type": "4", "metadata": {"page_label": "75", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "0adbe920c17df874ea7fae2dbd8a31d751a4af18839d5158b33f8b7697bb5e6f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "891afd6e-bbe8-4845-a310-f9d4ab71cfe0", "node_type": "1", "metadata": {"page_label": "74", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "36e4304bfbfecfb3f383dcb6af5e6d8c0bfd7c173263b3586802b730d731d99d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4e4a559d-7c6c-4a06-b5e0-db68264135ef", "node_type": "1", "metadata": {}, "hash": "cb70d1ab2c33772a34a33a6dead1825230292828de830ac9b3f1b946ab64dc7b", "class_name": "RelatedNodeInfo"}}, "text": "produce systemi c toxicity . Abraded surfaces readily absorb drugs, e.g. tannic\nacid applied over burnt skin has produced hepatic necrosis.\nCornea is permeable to lipid soluble, unionized physostigmine but not to\nhighly ionized neostigmine. Drugs applied as eye drops may get absorbed\nthrough the nasolacrimal duct, e.g. timolol eye drops can produce\nbradycardia and precipitate asthma. Mucous membranes of mouth, rectum,\nvagina absorb lipophilic drugs: estrogen cream applied vaginally has\nproduced gynaecomastia in the male partner .\nBioavailability\nBioavailability refers to the rate and extent of absorption of a drug from a\ndosage form administered by any route, as determined by its concentration-\ntime curve in blood or by its excretion in urine (Fig. 2.7). It is a measure of\nthe fraction (F ) of administere d dose of a drug that reaches the systemic\ncirculation in the unchanged form. Bioavailability of drug injected i.v. is\n100%, but is frequently lower after oral ingestion because\u2014", "start_char_idx": 0, "end_char_idx": 995, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4e4a559d-7c6c-4a06-b5e0-db68264135ef": {"__data__": {"id_": "4e4a559d-7c6c-4a06-b5e0-db68264135ef", "embedding": null, "metadata": {"page_label": "76", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "edc21a16-ad60-4160-84de-767d35769250", "node_type": "4", "metadata": {"page_label": "76", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "0e782e1e54eecfa4ea151cf7498a06d74b55cec01ba872dbe28508ab8263c279", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0decf59f-7481-4ffc-abd1-6d6dfbb29db3", "node_type": "1", "metadata": {"page_label": "75", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "0adbe920c17df874ea7fae2dbd8a31d751a4af18839d5158b33f8b7697bb5e6f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c26282cb-dad0-4940-b60d-2f4e55d3fee7", "node_type": "1", "metadata": {}, "hash": "3048ff70c220d2818d19927041b4ff8fca614f6cd9b51ee69d075940af0a00e2", "class_name": "RelatedNodeInfo"}}, "text": "(a) the drug may be incompletely absorbed.\n(b) the absorbed drug may under go first pass metabolism in the intestinal\nwall/liver or be excreted in bile.\nIncomplete bioavailability after s.c. or i.m. injection is less common, but\nmay occur due to local binding of the drug.\nBioequivalence  Oral formulations of a drug from different manufacturers\nor different batches from the same manufacturer may have the same amount\nof the drug (chemically equivale nt) but may not yield the same blood levels\n\u2014biologically inequivalent .  Two preparations of a drug are considered\nbioequivalent when the rate and extent of bioavailability of the active drug\nfrom them is not significantly dif ferent under suitable test conditions.\nBefore a drug administered orally in solid dosage form can be absorbed,\nit must break into individual particles of the active drug (disintegration).", "start_char_idx": 0, "end_char_idx": 867, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c26282cb-dad0-4940-b60d-2f4e55d3fee7": {"__data__": {"id_": "c26282cb-dad0-4940-b60d-2f4e55d3fee7", "embedding": null, "metadata": {"page_label": "77", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ac053143-cab9-4794-8cbb-15156f592723", "node_type": "4", "metadata": {"page_label": "77", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "82c6af2ac86722ade3e0276c56035303d31cca4f0d1b48044d8dd6ab70d02368", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4e4a559d-7c6c-4a06-b5e0-db68264135ef", "node_type": "1", "metadata": {"page_label": "76", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "0e782e1e54eecfa4ea151cf7498a06d74b55cec01ba872dbe28508ab8263c279", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e4454d62-e57d-4189-af5c-8bcfbd551852", "node_type": "1", "metadata": {}, "hash": "4d1d48c67313fd281132c0ce464a74649650cb73de9e9f88f5ec8496323965b8", "class_name": "RelatedNodeInfo"}}, "text": "Tablets and capsules contain a number of other materials\u2014diluents,\nstabilizing agen ts, binders, lubricants, etc. The nature of these as well as\ndetails of the manufacture proce ss, e.g. force used in compressing the tablet,\nmay affect disintegration . The released drug must then dissolve  in the\naqueous gastroin testinal contents. The rate of dissolution is governed by the\ninherent solubili ty, particle size, crystal form and other physical properties of\nthe drug. Differences in bioav ailability may arise due to variations in\ndisintegration and dissolution rates.\nDifferences in bioavailability are seen mostly with poorly soluble and\nslowly absorbed drugs. Reduction in particle size increases the rate of\nabsorption of aspirin (microfin e tablets). The amount of griseofulvin and\nspironolactone in the tablet can be reduced to half if the drug particle is\nmicrofined. There is no need to reduce the particle size of freely water\nsoluble drugs, e.g. paracetamol.\nBioavailability variation assumes practical significance for drugs with\nlow safety margin (digoxin) or where dosage needs precise control (oral\nhypoglycaemics, oral anticoagulants). It may also be responsible for success\nor failure of an antimicrobial regimen.\nHowever , in the case of a large number of drugs bioavailability\ndifferences are negligible and the risks of changing from branded to generic\nproduct or to another brand of the same drug have often been exaggerated.\nDISTRIBUTION\nOnce a drug has gained access to the blood stream, it gets distributed to\nother tissues that initially had no drug, concentration gradient being in the\ndirection of plasma to tissues. The extent of distribution of a drug and its\npattern of tissue distribution depends on its:\n\u2022lipid solubility\n\u2022ionization at physiological pH (a function of its pKa)\n\u2022extent of binding to plasma and tissue proteins\n\u2022presence of tissue-specific transporters \n\u2022differences in regional blood flow .", "start_char_idx": 0, "end_char_idx": 1940, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e4454d62-e57d-4189-af5c-8bcfbd551852": {"__data__": {"id_": "e4454d62-e57d-4189-af5c-8bcfbd551852", "embedding": null, "metadata": {"page_label": "78", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "077baa37-fe87-4b00-9673-cf101b756606", "node_type": "4", "metadata": {"page_label": "78", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "16b587ba22906137f5efee47d7377b4432b8e1f7eebb1c01280cd790a2f65729", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c26282cb-dad0-4940-b60d-2f4e55d3fee7", "node_type": "1", "metadata": {"page_label": "77", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "82c6af2ac86722ade3e0276c56035303d31cca4f0d1b48044d8dd6ab70d02368", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "07c73815-1a2b-4645-ab83-691a97dc5304", "node_type": "1", "metadata": {}, "hash": "74e7a14e34b2c43737ed402217ffc1da3ecda27121015d04774e0d96814e9e1a", "class_name": "RelatedNodeInfo"}}, "text": "Movement of drug proceeds until an equilibrium is established between\nunbound drug in the plasma and the tissue fluids. Subsequent ly, there is a\nparallel decline in both due to elimination.\nAppar ent volume of distribution  (V) Presuming that the body behaves as a\nsingle homogeneous compartment with volume V into which the drug gets\nimmediately and uniformly distributed\nSince in the example shown in Fig. 2.8, the drug does not actually distribute\ninto 20 L of body water , with the exclusion of the rest of it, this is only an\napparent volume of distribution which can be defined as \u201cthe volume that\nwould accommodate all the drug in the body , if the concentration throughout\nwas the same as in plasma\u201d. Thus, it describes amount of the drug present in\nthe body as a multiple of that contained in a unit volume of plasma.\nConsidered together with drug clearance, this is a very useful\npharmacokinetic concept.", "start_char_idx": 0, "end_char_idx": 915, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "07c73815-1a2b-4645-ab83-691a97dc5304": {"__data__": {"id_": "07c73815-1a2b-4645-ab83-691a97dc5304", "embedding": null, "metadata": {"page_label": "79", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b2301267-058e-4170-be09-c8814850cb66", "node_type": "4", "metadata": {"page_label": "79", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f1162e24b9da61a1cd562048456cf85fedcb2e4db54b23ed8ef0e581ac56ea57", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e4454d62-e57d-4189-af5c-8bcfbd551852", "node_type": "1", "metadata": {"page_label": "78", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "16b587ba22906137f5efee47d7377b4432b8e1f7eebb1c01280cd790a2f65729", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c7e8d315-c913-4e47-998a-50863c967507", "node_type": "1", "metadata": {}, "hash": "59babaebcaec929056956623653f02d4320087cdce0546a342639129300275ca", "class_name": "RelatedNodeInfo"}}, "text": "Factors governing volume of drug distribution\n\u2022Lipid: water partition coef\ufb01cient of the drug\n\u2022pKa value of the drug\n\u2022Degree of plasma protein binding\n\u2022Af\ufb01nity for different tissues\n\u2022Fat: lean body mass ratio, which can vary with age, sex, obesity, etc.\n\u2022Diseases like CHF, uremia, cirrhosis\nLipid-insoluble drugs do not enter cells\u2014 V approximates extracellular\nfluid volume, e.g. streptomycin, gentamicin 0.25 L/kg.\nDistribution is not only a matter of dilution, but also binding and\nsequestration. Drugs extensively bound to plasma proteins are largely", "start_char_idx": 0, "end_char_idx": 554, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c7e8d315-c913-4e47-998a-50863c967507": {"__data__": {"id_": "c7e8d315-c913-4e47-998a-50863c967507", "embedding": null, "metadata": {"page_label": "80", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "8a1d622b-d868-4ed7-b7b1-4172498f64b9", "node_type": "4", "metadata": {"page_label": "80", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "d28fb3a93b0d98eb5d3565404676fa87a35d578b25436013c821b9f353236479", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "07c73815-1a2b-4645-ab83-691a97dc5304", "node_type": "1", "metadata": {"page_label": "79", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f1162e24b9da61a1cd562048456cf85fedcb2e4db54b23ed8ef0e581ac56ea57", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ef84c6d4-a3dd-42de-873b-9bc4688edfcf", "node_type": "1", "metadata": {}, "hash": "a5e08c74ebd8b9bce0859787b409a24720543f4a9971cf034a6bbe48d48d61db", "class_name": "RelatedNodeInfo"}}, "text": "restricted to the vascular compartment and have low values of V, e.g.\ndiclofenac and warfarin (99% bound) V = 0.15 L/kg.\nA large value of V indicates that larger quantity of drug is present in\nextravascular tissue. Drugs sequestrated in other tissues may have, V much\nmore than total body water or even body mass, e.g. digoxin 6 L/kg,\npropranolol 4 L/kg, morphine 3.5 L/kg, because most of the drug is present\nin other tissues, and plasma concentration is low. Therefore , in case of\npoisoning, drugs  with large volumes of distribution are not easily removed\nby haemodialysis.\nPathological states, e.g. congestive heart failure, uraemia, cirrhosis of\nliver, etc. can alter the V of many drugs by altering distribution of body\nwater , permeability of membran es, binding proteins or by accumulation of\nmetabolites that displace the drug from binding sites.\nMore precise multiple compartment models for drug distribution have\nbeen worked out, but the singl e compartment model, described above, is\nsimple and fairly accurate for many drugs.\nRedistribution  Highly lipid-soluble drugs get initially distributed to organs\nwith high blood  flow, i.e. brain , heart, kidney , etc. Later , less vascular but\nmore bulky tissues (muscle, fat) take up the drug\u2014plasma concentration\nfalls and the drug is withdrawn from the highly perfused sites. If the site of\naction of the drug was in one of the highly perfused organs, redistribution\nresults in termin ation of drug action. Greater the lipid solubility of the drug,\nfaster is its redis tribution. Anaesthetic action of thiopentone sod. injected i.v.\nis terminated in few minutes due to redistribution. A relatively short hypnotic\naction lasting 6\u20138 hours is exerted by oral diazepam or nitraz epam due to\nredistribution despite their elimination t\u00bd of > 30 hr. However , when the\nsame drug is given repeatedly or continuously over long periods, the low\nperfusion high capacity sites get progressively filled up and the drug\nbecomes longer acting.\nPenetration into brain and CSF The capillary endothelial cells in brain\nhave tight junctions and lack large paracellular spaces. Further , an\ninvestment of neural tissue (Fig. 2.9B) covers the capillaries. Together they\nconstitute the so called blood-brain barrier (BBB).  A similar blood-CSF", "start_char_idx": 0, "end_char_idx": 2283, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ef84c6d4-a3dd-42de-873b-9bc4688edfcf": {"__data__": {"id_": "ef84c6d4-a3dd-42de-873b-9bc4688edfcf", "embedding": null, "metadata": {"page_label": "81", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "6c5abbfb-a73f-4161-ae7d-1bf6a4e47e83", "node_type": "4", "metadata": {"page_label": "81", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "643e403b98323d29ca6fc64a34ebb1a0a900eecc2cc6f34d9515e72926b07bc9", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c7e8d315-c913-4e47-998a-50863c967507", "node_type": "1", "metadata": {"page_label": "80", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "d28fb3a93b0d98eb5d3565404676fa87a35d578b25436013c821b9f353236479", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "29010343-be09-4744-b3c4-eedd60d6a740", "node_type": "1", "metadata": {}, "hash": "136297a524f306a2b46b486798fcf6c250422d0024b2bf269a8b21aa66a0caba", "class_name": "RelatedNodeInfo"}}, "text": "barrier  is located in the choroid plexus: capillaries are lined by choroidal\nepithelium havin g tight junctions. Both these barriers are lipoidal and limit\nthe entry  of nonlipid-soluble drugs, e.g. streptomycin, neostigmi ne, etc. Only\nlipid-soluble drugs, therefore, are able to penetrate and have action on the\ncentral nervous system. In addition, efflux transporters like P-gp and anion\ntransporter (OATP) present in brain and choroidal vessels extrude many\ndrugs that enter brain by other processes and serve to augment the protective\nbarrier against potentially harmful xenobiotics. Dopamine does not enter\nbrain but its precursor levodopa does; as such, the latter is used in\nparkinsonism. Inflammation of meninges or brain increases permeability of\nthese barriers. It has been proposed that some drugs accumulate in the brain\nby utilizing the transporters for endogenous substances.\nThere is also an enzymatic BBB: Monoamine oxidase (MAO),\ncholinesterase and some other enzymes are present in the capil lary walls or\nin the cells lining them. They do not allow catecholamines, 5-HT ,\nacetylcholine, etc. to enter brain in the active form.\nThe BBB is deficient at the CTZ in the medulla oblongata (even lipid-\ninsoluble drugs are emetic) and at certain periventricular sites\u2014(anterior\nhypothalamus).\nExit of drugs from the CSF and brain, however , is not dependent on\nlipid-solubility and is rather unrestricted. This is due to bulk flow of CSF\n(alongwith the drug dissolved in it) back into blood through the arachnoid", "start_char_idx": 0, "end_char_idx": 1527, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "29010343-be09-4744-b3c4-eedd60d6a740": {"__data__": {"id_": "29010343-be09-4744-b3c4-eedd60d6a740", "embedding": null, "metadata": {"page_label": "82", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "01afdae3-d63e-47aa-8035-030db717e995", "node_type": "4", "metadata": {"page_label": "82", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4092929166caf77b9fb53d19708353eaed74ca2f52b3da2070911e37beaebc9b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ef84c6d4-a3dd-42de-873b-9bc4688edfcf", "node_type": "1", "metadata": {"page_label": "81", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "643e403b98323d29ca6fc64a34ebb1a0a900eecc2cc6f34d9515e72926b07bc9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "91eb9e17-b3a5-400f-988d-02a6e33bc242", "node_type": "1", "metadata": {}, "hash": "edee774f72d2cfd2cc81bbcab07a71aa62c6ee104bac175598c1ab674b7bf892", "class_name": "RelatedNodeInfo"}}, "text": "villi. Further , nonspecific organic anion and cation transport processes\n(similar to those in renal tubule) operate at the choroid plexus.\nPassage across placenta  Placental membranes are lipoidal and allow\nfree passage of lipophilic drugs, while restricting hydrophilic drugs. The\nplacental efflux P-gp and other transporters like BCRP , MRP3 also serve to\nlimit foetal exposure to materna lly administered drugs. Placenta  is a site for\ndrug metabolism as well, which may lower/modify exposure of the foetus to\nthe administered drug. However , restricted amounts of nonlipid-soluble\ndrugs, when present in high concentration or for long periods  in maternal\ncirculation, gain access to the foetus. Some influx transporters also operate\nat the placenta. Thus, it is an incomplete barrier and almost any drug taken\nby the mother can affect the foetus or the newborn (drug taken just before\ndelivery , e.g. morphine).\nPlasma protein binding\nMost drugs possess physicoche mical affinity for plasma proteins and get\nreversibly bound to these. Acidic drugs generally bind to plasma albumin\nand basic drugs to \u03b11 acid glycoprotein. Binding to albumin (which is more\nabundant) is quantitatively more  important. Extent of binding depends on the\nindividual compound; no generalization for a pharmacological or chemical\nclass can be made (even small chemical change can markedly alter protein\nbinding), for example the binding percentage of some benzodiazepines is:\nFlurazepam 10% Alprazolam 70%\nLorazepam 90% Diazepam 99%\nIncreasing concentrations of the drug can progressively saturate the\nbinding sites: fractional binding  may be lower when large amounts of the\ndrug are given. The generally expressed percentage binding refers to the\nusual therapeutic plasma concen trations of a drug. The clinically significant\nimplications of plasma protein binding are:\n(i) High ly plasm a protein bound drugs are largely restricted to the vascular\ncompartment  because protein bound drug does not cross membranes (except\nthrough large paracellular spaces, such as in capillaries). They tend to have\nsmaller volumes of distribution.", "start_char_idx": 0, "end_char_idx": 2117, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "91eb9e17-b3a5-400f-988d-02a6e33bc242": {"__data__": {"id_": "91eb9e17-b3a5-400f-988d-02a6e33bc242", "embedding": null, "metadata": {"page_label": "83", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "39f313ef-ca56-4d8c-b05f-42a91d42863e", "node_type": "4", "metadata": {"page_label": "83", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "df14cacd31da377a863c97fa388d1ddf28703731d0660e30e418760d99c12e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "29010343-be09-4744-b3c4-eedd60d6a740", "node_type": "1", "metadata": {"page_label": "82", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4092929166caf77b9fb53d19708353eaed74ca2f52b3da2070911e37beaebc9b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "48aacfbe-71bd-419b-a806-66ccddcbf4f7", "node_type": "1", "metadata": {}, "hash": "b462e3485fc31064033a2b549192f405a6da3cd1f63e551ef44b563fe628e7a4", "class_name": "RelatedNodeInfo"}}, "text": "Drugs highly bound to plasma protein\n\uf054 \uf06f \uf020 \uf061 \uf06c \uf062 \uf075 \uf06d \uf069 \uf06e \uf054 \uf06f \uf020\u03b1\uf031 \uf02d \uf061 \uf063 \uf069 \uf064 \uf020 \uf067 \uf06c \uf079 \uf063 \uf06f \uf070 \uf072 \uf06f \uf074 \uf065 \uf069 \uf06e\nBarbiturates \u03b2-blockers\nBenzodiazepines Bupivacaine\nNSAIDs Lidocaine\nValproic acid Disopyramide\nPhenytoin Imipramine\nPenicillins Methadone\nSulfonamides Prazosin\nTetracyclines Quinidine\nTolbutamide Verapamil\nWarfarin\n(ii) The bound fraction is not available for action. However , it is in\nequilibrium with the free drug in plasma and dissoc iates when the\nconcentration of the latter is reduced due to elimination. Plasma protein\nbinding thus tantamounts to temporary storage of the drug.\n(iii) High degree of protein binding generally makes the drug long acting,\nbecause bound fraction is not available for metabolism or excret ion, unless it\nis active ly extracted by liver or by kidney tubules. Glomerular filtration does\nnot reduce the concentration of the free form in the efferent vessels, because\nwater is also filtered. Active tubular secretion, however , remo ves the drug\nwithout the attendant solvent \u2192 concentration of free drug falls \u2192 bound\ndrug dissociates and is eliminated resulting in a higher renal clearance value\nof the drug than the total renal blood flow (see Fig. 3.3). The same is true of\nactive transport of highly extracted drugs in liver. Plasma protein binding in\nthis situation acts as a carrier mechanism and hastens drug elimination, e.g.\nexcretion of penicillin (elimination t\u00bd is 30 min); metabolism of lidocaine.\nHighly protein bound drugs are not removed by haemodialysis and need\nspecial techniques for treatment of poisoning.", "start_char_idx": 0, "end_char_idx": 1563, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "48aacfbe-71bd-419b-a806-66ccddcbf4f7": {"__data__": {"id_": "48aacfbe-71bd-419b-a806-66ccddcbf4f7", "embedding": null, "metadata": {"page_label": "84", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "363c52e6-82ab-4c47-a8d5-dc1c1e6baed3", "node_type": "4", "metadata": {"page_label": "84", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "097eb3ff5dea02ac39965d113cabbe78a77d792bcff8225e7018226d12dc8a2d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "91eb9e17-b3a5-400f-988d-02a6e33bc242", "node_type": "1", "metadata": {"page_label": "83", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "df14cacd31da377a863c97fa388d1ddf28703731d0660e30e418760d99c12e22", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "52108760-f15f-4428-aa83-976be2b2c5e5", "node_type": "1", "metadata": {}, "hash": "be8ee299af097f7ae90a3a33d024f0f54f70b7c5dea71dad95e7fdffe455df90", "class_name": "RelatedNodeInfo"}}, "text": "(iv) The generally expressed plasma concentrations of the drug refer to\nbound as well as free drug. Degree of protein binding should be taken into\naccount while relating these to concentrations of the drug that are active in\nvitro, e.g. MIC of an antimicrobial.\n(v) One drug can bind to many sites on the albumin molecule. Conversely ,\nmore than one drug can bind to the same site. This can give rise to\ndisplacement interactions among drugs bound to the same site(s). The drug\nbound with higher affinity will displace that bound with lower  affinity and\ntend to increase  the concentration of its free form. This, however , is often\ntransient because the displaced drug will diffuse into the tissues as well as\nget metabolized  or excreted: the new steady-state free drug concentration is\nonly marginally higher unless the displacement extends to tissue binding or\nthere is concurre nt inhibition of metabolism and/or excretion reducing drug\nclearance. The overall impact of many displacement interactions is minimal;\nexcept when the interaction is more complex. Moreover , two highly bound\ndrugs do not necessarily displace each other\u2014their binding sites may not\noverlap, e.g. probenecid and indomethacin are highly bound to albumin but\ndo not displace each other . Similarly , acidic drugs do not generally displace\nbasic drugs and vice versa .\nDrugs concentrated in tissues\n\uf053 \uf06b \uf065 \uf06c \uf065 \uf074 \uf061 \uf06c\n\uf06d \uf075 \uf073 \uf063 \uf06c \uf065 \uf02c \uf020 \uf068 \uf065 \uf061 \uf072 \uf074\u2014 digoxin, emetine (bound to muscle proteins).\n\uf04c \uf069 \uf076 \uf065 \uf072 \u2014 chloroquine, tetracyclines, emetine, digoxin.\n\uf04b \uf069 \uf064 \uf06e \uf065 \uf079 \u2014 digoxin, chloroquine, emetine.\n\uf054 \uf068 \uf079 \uf072 \uf06f \uf069 \uf064 \u2014 iodine.\n\uf042 \uf072 \uf061 \uf069 \uf06e \u2014 chlorpromazine, acetazolamide, isoniazid.\n\uf052 \uf065 \uf074 \uf069 \uf06e \uf061 \u2014 chloroquine (bound to nucleoproteins).\n\uf049 \uf072 \uf069 \uf073 \u2014 ephedrine, atropine (bound to melanin).\n\uf042 \uf06f \uf06e \uf065 \uf020 \uf061 \uf06e \uf064 \uf020 \uf074 \uf065 \uf065 \uf074 \uf068 \u2014 tetracyclines, heavy metals (bound to\nmucopolysaccharides of\nconnective tissue), bisphosphonates (bound to\nhydroxyapatite).", "start_char_idx": 0, "end_char_idx": 1903, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "52108760-f15f-4428-aa83-976be2b2c5e5": {"__data__": {"id_": "52108760-f15f-4428-aa83-976be2b2c5e5", "embedding": null, "metadata": {"page_label": "85", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "133886d3-8f01-4983-9821-52af09f60bb1", "node_type": "4", "metadata": {"page_label": "85", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "0c64f5ba239b0d347ceae92b408e5111886048763231fd326b52a9ef79d51f49", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "48aacfbe-71bd-419b-a806-66ccddcbf4f7", "node_type": "1", "metadata": {"page_label": "84", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "097eb3ff5dea02ac39965d113cabbe78a77d792bcff8225e7018226d12dc8a2d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "87ac8fc3-187b-4db7-ac2a-263b0418e086", "node_type": "1", "metadata": {}, "hash": "0244fdfbc7ae0d796ad042fce4f52a14d76e5983260ce0b14c61be5013389756", "class_name": "RelatedNodeInfo"}}, "text": "\uf041 \uf064 \uf069 \uf070 \uf06f \uf073 \uf065 \uf020 \uf074 \uf069 \uf073 \uf073 \uf075 \uf065\u2014 thiopentone, ether, minocycline,\nphenoxybenzamine, DDT\ndissolve in neutral fat due to high lipid-solubility;\nremain\nstored due to poor blood supply of fat.\n(vi) In hypoalbumin emia, binding may be reduced and high conce ntrations\nof free drug may be attained, e.g. phenytoin and furosemide. Other diseases\nmay also alter drug binding, e.g.  phenytoin and pethidine binding is reduced\nin uraem ia; propranolol bindin g is increased in pregnant women and in\npatients with inflammatory disease (acute phase reactant \u03b11 acid-\nglycoprotein increases).\nTissue storage  Drugs may also accumulate in specific organs by active\ntransport or get bound to specific tissue constituents ( see box).\nDrugs sequestra ted in various tissues are unequally distributed, tend to\nhave larger volume of distributi on and longer duration of action . Some may\nexert local toxic ity due to high concentration, e.g. tetracyclines on bone and\nteeth, chloroquine on retina, streptomycin on vestibular apparatus, emetine\non heart  and skeletal muscle. Drugs may also selectively bind to specific\nintracellular organelle, e.g. tetracycline to mitochondria, chloroquine to\nnuclei.", "start_char_idx": 0, "end_char_idx": 1178, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "87ac8fc3-187b-4db7-ac2a-263b0418e086": {"__data__": {"id_": "87ac8fc3-187b-4db7-ac2a-263b0418e086", "embedding": null, "metadata": {"page_label": "86", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "24b94878-1d06-4153-be06-28484bcf7d9b", "node_type": "4", "metadata": {"page_label": "86", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "7bdefbf42641073e7918fb1f2bd485714c927871929e73475a4a1e4e4de5872a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "52108760-f15f-4428-aa83-976be2b2c5e5", "node_type": "1", "metadata": {"page_label": "85", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "aa14bd02d4c640a73f48bac62a32e7a6f9deb8c25beee385d033ed8ac9d9de78", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "04eec1fb-8277-4365-809d-3c19d0dcdc93", "node_type": "1", "metadata": {}, "hash": "2bab4c817d4a1effd3462f5c390cb3c547edd9e47dfbd455236f3d5d2391a94e", "class_name": "RelatedNodeInfo"}}, "text": "BIOTRANSFORMATION (Metabolism)\nBiotransformation means chemical alteration of the drug in\nthe body. It is needed to render nonpolar (lipid-soluble)\ncompounds polar (lipid-insoluble) so that they are not\nreabsorbed in the renal tubules and are excreted. In the\nabsence of metabolism, body will not be able to get rid of\nlipophylic substances, and they will become very long acting.\nMost hydrophilic drugs, e.g. streptomycin, neostigmine,\npancuronium, etc. are little biotransformed and are largely\nexcreted unchanged. Mechanisms which metabolize drugs\n(essentially foreign substances or Xenobiotics) have developed\nto protect the body from ingested toxins and other\nenvironmental chemicals.\nThe primary site for drug metabolism is liver; others are\u2014\nkidney, intestine, lungs and plasma. Biotransformation of\ndrugs may lead to the following.\n(i) Inactivation Most drugs and their active metabolites are\nrendered inactive or less active, e.g. ibuprofen, paracetamol,\nlidocaine, chloramphenicol, propranolol and its active", "start_char_idx": 0, "end_char_idx": 1018, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "04eec1fb-8277-4365-809d-3c19d0dcdc93": {"__data__": {"id_": "04eec1fb-8277-4365-809d-3c19d0dcdc93", "embedding": null, "metadata": {"page_label": "87", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "669a6811-520b-4bb0-94a1-980ed87c01bb", "node_type": "4", "metadata": {"page_label": "87", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "78598c7a48f4874002b954bee3fafc5ef24ed950b1319a21056b50cc4c8d0125", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "87ac8fc3-187b-4db7-ac2a-263b0418e086", "node_type": "1", "metadata": {"page_label": "86", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "7bdefbf42641073e7918fb1f2bd485714c927871929e73475a4a1e4e4de5872a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ba8b2fc2-6060-4d5c-aed2-f53ac50710d5", "node_type": "1", "metadata": {}, "hash": "e811ed8f17f7ffb2c268191aa3c4a55e9ccc5055c5453fbd6ba67d7551472594", "class_name": "RelatedNodeInfo"}}, "text": "metabolite 4-hydroxypropranolol. Thus, biotransformation\nprovides an alternative method of terminating drug action to\nexcretion.\n(ii) Active  metabolite  from  an  active  drug  Many drugs have\nbeen found to be partially converted to one or more active\nmetabolite; the effects observed are the sumtotal of that due to\nthe parent drug and its active metabolite(s) (see box).\n(iii) Activation  of  inactive  drug Few drugs are inactive as\nsuch and need conversion in the body to one or more active\nmetabolites. Such a drug is called a prodrug (see box). The\nprodrug may offer advantages over the active form in being\nmore stable, having better bioavailability or other desirable\npharmacokinetic properties or less side effects and toxicity.\nSome prodrugs are activated selectively at the site of action.\nActive drug Active metabolite\nMorphine \u2014 Morphine-6-glucuronide\nCefotaxime \u2014 Desacetyl cefotaxime\nAllopurinol \u2014 Alloxanthine\nProcainamide \u2014 N-acetyl procainamide\u00a0\nPrimidone \u2014 Phenobarbitone,\nphenylethylmalonamide\nDiazepam \u2014 Desmethyl-diazepam, oxazepam\nDigitoxin \u2014 Digoxin\nImipramine \u2014 Desipramine", "start_char_idx": 0, "end_char_idx": 1099, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ba8b2fc2-6060-4d5c-aed2-f53ac50710d5": {"__data__": {"id_": "ba8b2fc2-6060-4d5c-aed2-f53ac50710d5", "embedding": null, "metadata": {"page_label": "88", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "57dd980d-abd9-4522-9681-924aca506a48", "node_type": "4", "metadata": {"page_label": "88", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "cd1e22e602574a56742ac04f66ad32a1cc877ced9999c3302beb6391824ff568", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "04eec1fb-8277-4365-809d-3c19d0dcdc93", "node_type": "1", "metadata": {"page_label": "87", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "78598c7a48f4874002b954bee3fafc5ef24ed950b1319a21056b50cc4c8d0125", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7ddc064b-f8fa-48fc-a8df-fa3f163df329", "node_type": "1", "metadata": {}, "hash": "86aed02fa79bd24c2086a94492c1a5d2cb9b4f69b0a529545c7728a814ee550d", "class_name": "RelatedNodeInfo"}}, "text": "Amitriptyline \u2014 Nortriptyline\nCodeine \u2014 Morphine\nSpironolactone \u2014 Canrenone\nLosartan \u2014 E 3174\nBiotransformation reactions can be classified into:\n(a) Nonsynthetic/Phase I/Functionalization reactions: a\nfunctional group (\u2013OH, \u2013COOH, \u2013CHO, \u2013NH2, \u2013SH) is\ngenerated or exposed\u2014metabolite may be active or inactive.\n(b) Synthetic/Conjugation/ Phase II reactions: an endogenous\nradical is conjugated to the drug\u2014metabolite is mostly\ninactive; except few drugs, e.g. glucuronide conjugate of\nmorphine and sulfate conjugate of minoxidil are active.\nCertain drugs already have functional groups and are directly\nconjugated, while others undergo a phase I reaction first\nfollowed by a phase II reaction (see Fig. 3.1).\nProdrug Active form\nLevodopa \u2014 Dopamine\nEnalapril \u2014 Enalaprilat\n\uf061-Methyldopa \u2014 \uf061-methylnorepinephrine\nDipivefrine \u2014 Epinephrine\nProguanil \u2014 Cycloguanil\nPrednisone \u2014 Prednisolone\nClopidogrel \u2014 Thiol metabolite\nBacampicillin \u2014 Ampicillin", "start_char_idx": 0, "end_char_idx": 944, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7ddc064b-f8fa-48fc-a8df-fa3f163df329": {"__data__": {"id_": "7ddc064b-f8fa-48fc-a8df-fa3f163df329", "embedding": null, "metadata": {"page_label": "89", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "223937cc-b6c4-46df-b45b-a51c0909b466", "node_type": "4", "metadata": {"page_label": "89", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "151700da6b2dbaccb4ffe64700adc6241dbe5f35698f47183867248a7057db97", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ba8b2fc2-6060-4d5c-aed2-f53ac50710d5", "node_type": "1", "metadata": {"page_label": "88", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "cd1e22e602574a56742ac04f66ad32a1cc877ced9999c3302beb6391824ff568", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "72f9549a-7d8a-477b-9c57-1cfd5523aa19", "node_type": "1", "metadata": {}, "hash": "0f52598f6fdfcd2bd2f6334d7f4f4c2de3eec0e31089abbcf5723f419cd331b5", "class_name": "RelatedNodeInfo"}}, "text": "Sulfasalazine \u2014 5-Aminosalicylic acid\nCyclophos-\nphamide\u2014 Aldophosphamide,\nphosphoramide mustard,\nacrolein\nFluorouracil \u2014 Fluorouridine monophosphate\nMercaptopurine \u2014 Methylmercaptopurine\nribonucleotide\nAcyclovir \u2014 Acyclovir triphosphate\nNonsynthetic reactions\n(i) Oxidation This reaction involves addition of\noxygen/negatively charged radical or removal of\nhydrogen/positively charged radical. Oxidations are the most\nimportant drug metabolizing reactions. Various oxidation\nreactions are:\nhydroxylation; oxygenation at C, N or S atoms; N or O-\ndealkylation, oxidative deamination, etc.\nIn many cases the initial insertion of oxygen atom into the\ndrug molecule produces short lived highly reactive\nquinone/epoxide/superoxide intermediates which then convert\nto more stable compounds.\nOxidative reactions are mostly carried out by a group of\nmonooxygenases in the liver, which in the final step involve a\ncytochrome P-450 haemoprotein, NADPH, cytochrome P-450\nreductase and molecular O2. More than 100 cytochrome P-450\n(CYP) isoenzymes differing in their affinity for various\nsubstrates (drugs), have been identified. The CYP isoenzymes", "start_char_idx": 0, "end_char_idx": 1136, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "72f9549a-7d8a-477b-9c57-1cfd5523aa19": {"__data__": {"id_": "72f9549a-7d8a-477b-9c57-1cfd5523aa19", "embedding": null, "metadata": {"page_label": "90", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "397922e5-e697-4b6f-9f2e-a096009ab5d1", "node_type": "4", "metadata": {"page_label": "90", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a1330926616ec6183e4ceba44df202ce72f2dc30c863d79ce256dc77f95ecd74", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7ddc064b-f8fa-48fc-a8df-fa3f163df329", "node_type": "1", "metadata": {"page_label": "89", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "151700da6b2dbaccb4ffe64700adc6241dbe5f35698f47183867248a7057db97", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "75667090-8348-4dc4-9973-97a8a9ce7247", "node_type": "1", "metadata": {}, "hash": "c308e08ee0580099094b5a0ff0b4ff521f94cd36f8514fdc5124269cacffed3d", "class_name": "RelatedNodeInfo"}}, "text": "important for drug metabolism in humans, along with their\nclinically relevant substrate drugs, inhibitors and inducers are\nlisted in Table 3.1\nDepending upon the extent of amino acid sequence homology , the cytochrome\nP-450 (CYP) isoenzymes are grouped into families designated by numerals (1, 2,\n3.....), each having several sub-families designated by capita l letters (A, B,\nC.....), while individual isoenzy mes are again alloted numerals (1, 2, 3....). In\nhuman beings, only a few members of three isoenzyme families (CYP  1, 2 and\n3) carryout metabolism of most of the drugs, and many drugs such as\ntolbutamide, barbiturates, phenytoin, paracetamol are substrates for more than\none isoform. The CYP  isoenzymes important in man are:\nCYP3A4/5  Carryout biotransformation of largest number (nearly 50%) of drugs.\nIn addition to liver, these isoforms are expressed in intestine (responsible for first\npass metabolism  at this site) and kidney as well. Inhibition of this isoenzyme by\nerythromycin, clarithromycin, ketoconazole, itraconazole is responsible for the\nimportant drug interaction with terfenadine, astemizole and cisapride (see p.\n181) which are its substrates. Verapamil, ritonavir and a constituent of grape fruit\njuice are other important inhibitors.\nCYP2D6  This is the next most important CYP  isoform which metabolizes  nearly\n20% drugs including tricyclic antidepressants, selective serotonin reuptake\ninhibitors, many neuroleptics, antiarrhythmics, codeine, debrisoquine,\nmetoprolol. Inhibition of this enzyme by quinidine results in failure of\nconversion of codeine to morphine \u2192 analgesic effect of codeine is lost. Human\nsubjects can be grouped into \u2018extensive \u2019 or \u2018poor \u2019 metabolizers of metoprolol and\ndebrisoquin. The poor metabolizers have an altered CYP2D6 enzyme and\nexhibit low capacity to hydro xylate many drugs. An ultrarapid metabolizer\ngenotype of CYP2D6 has also been identified.\nCYP2C8/9  Importa nt in the biotransformation of >15 commonly used drugs\nincluding phenytoin, carbamazepine, warfarin which are narrow safety margin\ndrugs.\nCYP2C19  Metabolizes > 12 frequently used drugs including omeprazole,\nlansoprazole, phenytoin, diazepam. Omeprazole and fluconazole are its", "start_char_idx": 0, "end_char_idx": 2213, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "75667090-8348-4dc4-9973-97a8a9ce7247": {"__data__": {"id_": "75667090-8348-4dc4-9973-97a8a9ce7247", "embedding": null, "metadata": {"page_label": "91", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "6a8d4880-6edd-4f2c-93d2-deb8a85cdaf2", "node_type": "4", "metadata": {"page_label": "91", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b5909475757fb7d731bb23aaf25a6311a2270b851f5a0d69b5199563fc0c4a3a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "72f9549a-7d8a-477b-9c57-1cfd5523aa19", "node_type": "1", "metadata": {"page_label": "90", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a1330926616ec6183e4ceba44df202ce72f2dc30c863d79ce256dc77f95ecd74", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3fc51538-e0d9-442c-85bb-f0b627074000", "node_type": "1", "metadata": {}, "hash": "f06fd26188b7f5a6e32eaad1c53d1f2a3075b4e42a85b5050011f60862871290", "class_name": "RelatedNodeInfo"}}, "text": "inhibitors.\nCYP1A1/2 Though this subfamily particip ates in the metabolism of only few\ndrugs like theophylline, caffeine, paracetamol, carbamazepine, it is more\nimportant for activation of procarcinogens. Polycyclic hydrocarbons, cigarette\nsmoke and charbroiled meat are its potent inducers.\nCYP2E1  It catalyses oxidation of alcohol, holothane, and formation of minor\nmetabolites of few drugs, notably the hepatotoxic N-acetyl benzoquinoneimine\nfrom paracetamol; chronic alcoholism induces this isoenzyme.\nThe relative amount of different cytochrome P-450s differs\namong species and among individuals of the same species.\nThese differences largely account for the marked interspecies\nand interindividual differences in rate of metabolism of drugs.\nTable 3.1: Major drug metabolizing CYP450 isoenzymes in humans\nwith their important substrate drugs, inhibitors and inducers\n\uf043\uf059\uf050\uf02d\uf034\uf035\uf030\n\uf069\uf073\uf06f\uf065\uf06e\uf07a\uf079\uf06d\uf065\uf044\uf072\uf075\uf067\uf073\uf020\uf06d\uf065\uf074\uf061\uf062\uf06f\uf06c\uf069\uf07a\uf065\uf064 \uf049\uf06e\uf068\uf069\uf062\uf069\uf074\uf06f\uf072\uf073 \uf049\uf06e\uf064\uf075\uf063\uf065\uf072\uf073\n\uf043\uf059\uf050\uf033\uf041\uf034\n\uf043\uf059\uf050\uf033\uf041\uf035\uf054\uf065\uf072\uf066\uf065\uf06e\uf061\uf064\uf069\uf06e\uf065\uf02c\n\uf041\uf073\uf074\uf065\uf06d\uf069\uf07a\uf06f\uf06c\uf065\n\uf043\uf069\uf073\uf061\uf070\uf072\uf069\uf064\uf065\uf02c\n\uf04c\uf06f\uf073\uf061\uf072\uf074\uf061\uf06e\n\uf043\uf061\uf072\uf062\uf061\uf06d\uf061\uf07a\uf065\uf070\uf069\uf06e\uf065\uf02c\n\uf048\uf079\uf064\uf072\uf06f\uf063\uf06f\uf072\uf074\uf069\uf073\uf06f\uf06e\uf065\n\uf050\uf061\uf072\uf061\uf063\uf065\uf074\uf061\uf06d\uf06f\uf06c\uf02c\n\uf044\uf069\uf061\uf07a\uf065\uf070\uf061\uf06d\n\uf042\uf075\uf073\uf070\uf069\uf072\uf06f\uf06e\uf065\uf02c\n\uf04d\uf069\uf066\uf065\uf070\uf072\uf069\uf073\uf074\uf06f\uf06e\uf065\n\uf052\uf069\uf074\uf06f\uf06e\uf061\uf076\uf069\uf072\uf02c\n\uf053", "start_char_idx": 0, "end_char_idx": 1074, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3fc51538-e0d9-442c-85bb-f0b627074000": {"__data__": {"id_": "3fc51538-e0d9-442c-85bb-f0b627074000", "embedding": null, "metadata": {"page_label": "91", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "6a8d4880-6edd-4f2c-93d2-deb8a85cdaf2", "node_type": "4", "metadata": {"page_label": "91", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b5909475757fb7d731bb23aaf25a6311a2270b851f5a0d69b5199563fc0c4a3a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "75667090-8348-4dc4-9973-97a8a9ce7247", "node_type": "1", "metadata": {"page_label": "91", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "047f30fc4843b209d98a97b56c8a101f13ff00c15869c78a6def005e54528cf8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a9d94fcb-f072-4315-a9cf-7ccb3cb6473a", "node_type": "1", "metadata": {}, "hash": "4fdbd015c85ca5e6e450623e42f7c66437fcba58a8ecaa6e2f7e7ac9f584e35f", "class_name": "RelatedNodeInfo"}}, "text": "\uf061\uf071\uf075\uf069\uf06e\uf061\uf076\uf069\uf072\n\uf053\uf069\uf06d\uf076\uf061\uf073\uf074\uf061\uf074\uf069\uf06e\uf02c\n\uf051\uf075\uf069\uf06e\uf069\uf064\uf069\uf06e\uf065\n\uf056\uf065\uf072\uf061\uf070\uf061\uf06d\uf069\uf06c\uf02c\n\uf04c\uf069\uf064\uf06f\uf063\uf061\uf069\uf06e\uf065\uf045\uf072\uf079\uf074\uf068\uf072\uf06f\uf06d\uf079\uf063\uf069\uf06e\n\uf043\uf06c\uf061\uf072\uf069\uf074\uf068\uf072\uf06f\uf06d\uf079\uf063\uf069\uf06e\n\uf04b\uf065\uf074\uf06f\uf063\uf06f\uf06e\uf061\uf07a\uf06f\uf06c\uf065\n\uf049\uf074\uf072\uf061\uf063\uf06f\uf06e\uf061\uf07a\uf06f\uf06c\uf065\n\uf056\uf065\uf072\uf061\uf070\uf061\uf06d\uf069\uf06c\n\uf052\uf069\uf074\uf06f\uf06e\uf061\uf076\uf069\uf072\n\uf046\uf06c\uf075\uf06f\uf078\uf065\uf074\uf069\uf06e\uf065\n\uf047\uf072\uf061\uf070\uf065\uf020 \uf066\uf072\uf075\uf069\uf074\n\uf06a\uf075\uf069\uf063\uf065\uf042\uf061\uf072\uf062\uf069\uf074\uf075\uf072\uf061\uf074\uf065\uf073\n\uf050\uf068\uf065\uf06e\uf079\uf074\uf06f\uf069\uf06e\n\uf043\uf061\uf072\uf062\uf061\uf06d\uf061\uf07a\uf065\uf070\uf069\uf06e\uf065\n\uf052\uf069\uf066\uf061\uf06d\uf070\uf069\uf06e\n\uf047\uf06c\uf075\uf063\uf06f\uf063\uf06f\uf072\uf074\uf069\uf063\uf06f\uf069\uf064\uf073\n\uf04e\uf065\uf076\uf069\uf072\uf061\uf070\uf069\uf06e\uf065", "start_char_idx": 1075, "end_char_idx": 1303, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a9d94fcb-f072-4315-a9cf-7ccb3cb6473a": {"__data__": {"id_": "a9d94fcb-f072-4315-a9cf-7ccb3cb6473a", "embedding": null, "metadata": {"page_label": "92", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "1b37ce62-c95f-45ec-b969-fb3d633d0da7", "node_type": "4", "metadata": {"page_label": "92", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9cd523388a364eaa2ccb82be6b47f72c1cc0d1054334c81d87947012425b734f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3fc51538-e0d9-442c-85bb-f0b627074000", "node_type": "1", "metadata": {"page_label": "91", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "da49ef10edd9c415172a2df37d3b65587f112225c10310ac8be9203a90e2fdfd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bc7976fa-8dd8-4236-b239-f1ee9c8936dc", "node_type": "1", "metadata": {}, "hash": "169e9ffda6d2769d7e4e69a0a15d4d906e3a8edbee061f3cd8a9aab35a4d0537", "class_name": "RelatedNodeInfo"}}, "text": "\uf044\uf061\uf070\uf073\uf06f\uf06e\uf065\uf02c\n\uf04e\uf065\uf076\uf069\uf072\uf061\uf070\uf069\uf06e\uf065\n\uf043\uf059\uf050\uf032\uf044\uf036 \uf04d\uf065\uf074\uf06f\uf070\uf072\uf06f\uf06c\uf06f\uf06c\uf02c\n\uf044\uf065\uf062\uf072\uf069\uf073\uf06f\uf071\uf075\uf069\uf06e\uf065\n\uf04e\uf065\uf062\uf069\uf076\uf06f\uf06c\uf06f\uf06c\uf02c\n\uf041\uf06d\uf069\uf074\uf072\uf079\uf070\uf074\uf079\uf06c\uf069\uf06e\uf065\n\uf043\uf06c\uf06f\uf06d\uf069\uf070\uf072\uf061\uf06d\uf069\uf06e\uf065\uf02c\n\uf046\uf06c\uf075\uf06f\uf078\uf065\uf074\uf069\uf06e\uf065\n\uf050\uf061\uf072\uf06f\uf078\uf065\uf074\uf069\uf06e\uf065\uf02c\n\uf056\uf065\uf06e\uf06c\uf061\uf066\uf061\uf078\uf069\uf06e\uf065\n\uf048\uf061\uf06c\uf06f\uf070\uf065\uf072\uf069\uf064\uf06f\uf06c\uf02c\n\uf043\uf06c\uf06f\uf07a\uf061\uf070\uf069\uf06e\uf065\n\uf052\uf069\uf073\uf070\uf065\uf072\uf069\uf064\uf06f\uf06e\uf065\uf02c\n\uf043\uf06f\uf064\uf065\uf069\uf06e\uf065\n\uf050\uf072\uf06f\uf070\uf061\uf066\uf065\uf06e\uf06f\uf06e\uf065\uf02c\n\uf046\uf06c\uf065\uf063\uf061\uf069\uf06e\uf069\uf064\uf065\uf051\uf075\uf06e\uf069\uf064\uf069\uf06e\uf065\n\uf046\uf06c\uf075\uf06f\uf078\uf065\uf074\uf069\uf06e\uf065\n\uf050\uf061\uf072\uf06f\uf078\uf065\uf074\uf069\uf06e\uf065\uf050\uf068\uf065\uf06e\uf06f\uf062\uf061\uf072\uf062\uf069\uf074\uf06f\uf06e\uf065\n\uf052\uf069\uf066\uf061\uf06d\uf070\uf069\uf06e\n\uf043\uf059\uf050\uf032\uf043\uf038\n\uf043\uf059\uf050\uf032\uf043\uf039\uf050\uf068\uf065\uf06e\uf079\uf074\uf06f\uf069\uf06e\uf02c\n\uf043\uf061\uf072\uf062\uf061\uf06d\uf061\uf07a\uf065\uf070\uf069\uf06e\uf065\n\uf057\uf061\uf072\uf066\uf061\uf072\uf069\uf06e\uf02c\n\uf054\uf06f\uf06c\uf062\uf075\uf074\uf061\uf06d\uf069\uf064\uf065\n\uf052\uf065\uf070\uf061\uf067\uf06c\uf069\uf06e\uf069\uf064\uf065\uf02c\n\uf050\uf069\uf06f\uf067\uf06c\uf069\uf074\uf061\uf07a\uf06f\uf06e\uf065\n\uf044\uf069\uf063\uf06c\uf06f\uf066\uf065\uf06e\uf061\uf063\uf02c\n\uf049", "start_char_idx": 0, "end_char_idx": 346, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "bc7976fa-8dd8-4236-b239-f1ee9c8936dc": {"__data__": {"id_": "bc7976fa-8dd8-4236-b239-f1ee9c8936dc", "embedding": null, "metadata": {"page_label": "92", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "1b37ce62-c95f-45ec-b969-fb3d633d0da7", "node_type": "4", "metadata": {"page_label": "92", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9cd523388a364eaa2ccb82be6b47f72c1cc0d1054334c81d87947012425b734f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a9d94fcb-f072-4315-a9cf-7ccb3cb6473a", "node_type": "1", "metadata": {"page_label": "92", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "741c6feed539351c92b600a53a1d68a71e3628683c664d8cd30ae88294cec0fa", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d7cdbb8e-7c87-44dd-8020-893ce648d497", "node_type": "1", "metadata": {}, "hash": "c7fa0d4a79a39eed8fa1782996c5b4d5c84621ffe70d77995e09da91194a67a1", "class_name": "RelatedNodeInfo"}}, "text": "\uf06d\uf061\uf07a\uf065\uf070\uf069\uf06e\uf065\n\uf057\uf061\uf072\uf066\uf061\uf072\uf069\uf06e\uf02c\n\uf054\uf06f\uf06c\uf062\uf075\uf074\uf061\uf06d\uf069\uf064\uf065\n\uf052\uf065\uf070\uf061\uf067\uf06c\uf069\uf06e\uf069\uf064\uf065\uf02c\n\uf050\uf069\uf06f\uf067\uf06c\uf069\uf074\uf061\uf07a\uf06f\uf06e\uf065\n\uf044\uf069\uf063\uf06c\uf06f\uf066\uf065\uf06e\uf061\uf063\uf02c\n\uf049\uf062\uf075\uf070\uf072\uf06f\uf066\uf065\uf06d\n\uf04c\uf06f\uf073\uf061\uf072\uf074\uf061\uf06e\uf046\uf06c\uf075\uf076\uf06f\uf078\uf061\uf06d\uf069\uf06e\uf065\n\uf046\uf06c\uf075\uf063\uf06f\uf06e\uf061\uf07a\uf06f\uf06c\uf065\n\uf047\uf065\uf06d\uf066\uf069\uf062\uf072\uf06f\uf07a\uf069\uf06c\n\uf054\uf072\uf069\uf06d\uf065\uf074\uf068\uf06f\uf070\uf072\uf069\uf06d\uf050\uf068\uf065\uf06e\uf06f\uf062\uf061\uf072\uf062\uf069\uf074\uf06f\uf06e\uf065\n\uf043\uf061\uf072\uf062\uf061\uf06d\uf061\uf07a\uf065\uf070\uf069\uf06e\uf065\n\uf052\uf069\uf066\uf061\uf06d\uf070\uf069\uf06e\n\uf043\uf059\uf050\uf032\uf043\uf031\uf039", "start_char_idx": 276, "end_char_idx": 456, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d7cdbb8e-7c87-44dd-8020-893ce648d497": {"__data__": {"id_": "d7cdbb8e-7c87-44dd-8020-893ce648d497", "embedding": null, "metadata": {"page_label": "92", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "1b37ce62-c95f-45ec-b969-fb3d633d0da7", "node_type": "4", "metadata": {"page_label": "92", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9cd523388a364eaa2ccb82be6b47f72c1cc0d1054334c81d87947012425b734f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bc7976fa-8dd8-4236-b239-f1ee9c8936dc", "node_type": "1", "metadata": {"page_label": "92", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5cae4b449b5a83326106d83b1ff90f90ac5676dbf1bf59a6e6bc20021032e7fc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6a3cc64b-c46e-439e-ac00-14b9431ac5dc", "node_type": "1", "metadata": {}, "hash": "cc6b33f0c03b8cc3d2b41dc77009c8b7880b55cf3037155e395b995bae2b6571", "class_name": "RelatedNodeInfo"}}, "text": "\uf047\uf065\uf06d\uf066\uf069\uf062\uf072\uf06f\uf07a\uf069\uf06c\n\uf054\uf072\uf069\uf06d\uf065\uf074\uf068\uf06f\uf070\uf072\uf069\uf06d\uf050\uf068\uf065\uf06e\uf06f\uf062\uf061\uf072\uf062\uf069\uf074\uf06f\uf06e\uf065\n\uf043\uf061\uf072\uf062\uf061\uf06d\uf061\uf07a\uf065\uf070\uf069\uf06e\uf065\n\uf052\uf069\uf066\uf061\uf06d\uf070\uf069\uf06e\n\uf043\uf059\uf050\uf032\uf043\uf031\uf039 \uf04f\uf06d\uf065\uf070\uf072\uf061\uf07a\uf06f\uf06c\uf065\uf02c\n\uf04c\uf061\uf06e\uf073\uf06f\uf070\uf072\uf061\uf07a\uf06f\uf06c\uf065\n\uf041\uf06d\uf069\uf074\uf072\uf069\uf070\uf074\uf079\uf06c\uf069\uf06e\uf065\uf02c\n\uf043\uf069\uf074\uf061\uf06c\uf06f\uf070\uf072\uf061\uf06d\n\uf050\uf068\uf065\uf06e\uf079\uf074\uf06f\uf069\uf06e\uf02c\n\uf044\uf069\uf061\uf07a\uf065\uf070\uf061\uf06d\n\uf050\uf072\uf06f\uf070\uf072\uf061\uf06e\uf06f\uf06c\uf06f\uf06c\uf02c\n\uf043\uf06c\uf06f\uf070\uf069\uf064\uf06f\uf067\uf072\uf065\uf06c\uf04f\uf06d\uf065\uf070\uf072\uf061\uf07a\uf06f\uf06c\uf065\n\uf046\uf06c\uf075\uf063\uf06f\uf06e\uf061\uf07a\uf06f\uf06c\uf065\uf043\uf061\uf072\uf062\uf061\uf06d\uf061\uf07a\uf065\uf070\uf069\uf06e\uf065\n\uf052\uf069\uf066\uf061\uf06d\uf070\uf069\uf06e\n\uf043\uf059\uf050\uf031\uf041\uf031\n\uf043\uf059\uf050\uf031\uf041\uf032\uf054\uf068\uf065\uf06f\uf070\uf068\uf079\uf06c\uf06c\uf069\uf06e\uf065\uf02c\n\uf043\uf061\uf066\uf066\uf065\uf069\uf06e\uf065\uf046\uf06c\uf075\uf076\uf06f\uf078\uf061\uf06d\uf069\uf06e\uf065\n\uf046\uf06c\uf075\uf06f\uf078\uf065\uf074\uf069\uf06e\uf065\uf050\uf06f\uf06c\uf079\uf063\uf079\uf063\uf06c\uf069\uf063\n\uf068\uf079\uf064\uf072\uf06f\uf063\uf061\uf072\uf062\uf06f\uf06e\uf073\n\uf043\uf069\uf067\uf061\uf072\uf065\uf074\uf074\uf065\uf020\uf073\uf06d\uf06f\uf06b\uf065", "start_char_idx": 387, "end_char_idx": 693, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6a3cc64b-c46e-439e-ac00-14b9431ac5dc": {"__data__": {"id_": "6a3cc64b-c46e-439e-ac00-14b9431ac5dc", "embedding": null, "metadata": {"page_label": "93", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5d4ccc26-021d-4f7b-a807-eeab1972a4de", "node_type": "4", "metadata": {"page_label": "93", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5ba0080cd94f74d3eeeaad0d7a0413a70ae1d29ec9a78fcddec955b40331ea38", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d7cdbb8e-7c87-44dd-8020-893ce648d497", "node_type": "1", "metadata": {"page_label": "92", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "486f65efc777dfb40d26c14ad5feaaa87b74e979b1938cd768532f5f66318abd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eb20ac43-7c88-49a6-8556-9de55aa92ffa", "node_type": "1", "metadata": {}, "hash": "698da70ec0e18c144211115fcf6a960950e9accc3717c504b65e1b0b8ec239af", "class_name": "RelatedNodeInfo"}}, "text": "\uf050\uf061\uf072\uf061\uf063\uf065\uf074\uf061\uf06d\uf06f\uf06c\uf02c\n\uf057\uf061\uf072\uf066\uf061\uf072\uf069\uf06e\n\uf043\uf061\uf072\uf062\uf061\uf06d\uf061\uf07a\uf065\uf070\uf069\uf06e\uf065\uf043\uf068\uf061\uf072\uf062\uf072\uf06f\uf069\uf06c\uf065\uf064\uf020\uf06d\uf065\uf061\uf074\n\uf052\uf069\uf066\uf061\uf06d\uf070\uf069\uf06e\n\uf043\uf061\uf072\uf062\uf061\uf06d\uf061\uf07a\uf065\uf070\uf069\uf06e\uf065\n\uf043\uf059\uf050\uf032\uf045\uf031 \uf041\uf06c\uf063\uf06f\uf068\uf06f\uf06c\uf02c\n\uf048\uf061\uf06c\uf06f\uf074\uf068\uf061\uf06e\uf065\n\uf050\uf061\uf072\uf061\uf063\uf065\uf074\uf061\uf06d\uf06f\uf06c\uf02a\uf044\uf069\uf073\uf075\uf06c\uf066\uf069\uf072\uf061\uf06d\n\uf046\uf06f\uf06d\uf065\uf070\uf069\uf07a\uf06f\uf06c\uf065\uf043\uf068\uf072\uf06f\uf06e\uf069\uf063\n\uf061\uf06c\uf063\uf06f\uf068\uf06f\uf06c\uf069\uf073\uf06d\n\uf049\uf073\uf06f\uf06e\uf069\uf061\uf07a\uf069\uf064\n\uf043\uf059\uf050\uf032\uf042\uf036 \uf045\uf066\uf061\uf076\uf069\uf072\uf065\uf06e\uf07a\uf02c\n\uf04e\uf065\uf076\uf069\uf072\uf061\uf070\uf069\uf06e\uf065\n\uf043\uf079\uf063\uf06c\uf06f\uf070\uf068\uf06f\uf073\uf070\uf068\uf061\uf06d\uf069\uf064\uf065\uf02c\n\uf04d\uf065\uf074\uf068\uf061\uf064\uf06f\uf06e\uf065\n\uf053\uf065\uf072\uf074\uf072\uf061\uf06c\uf069\uf06e\uf065\uf02c\n\uf043\uf06c\uf06f\uf070\uf069\uf064\uf06f\uf067\uf072\uf065\uf06c\uf050\uf061\uf072\uf06f\uf078\uf065\uf074\uf069\uf06e\uf065\n\uf053\uf065\uf072\uf074\uf072\uf061\uf06c\uf069\uf06e\uf065\n\uf043\uf06c\uf06f\uf070\uf069\uf064\uf06f\uf067\uf072\uf065\uf06c\uf050 \uf068\uf065\uf06e\uf06f\uf062\uf061\uf072\uf062\uf069\uf074\uf06f\uf06e\uf065\n\uf043\uf079\uf063\uf06c\uf06f\uf070\uf068\uf06f\uf073\uf070\uf068\uf061\uf06d\uf069\uf064\uf065\n\uf02a\uf020\uf047\uf065\uf06e\uf065\uf072\uf061\uf074\uf065\uf073\uf020\uf074\uf06f\uf078\uf069\uf063\uf020\uf06d\uf065\uf074\uf061\uf062\uf06f\uf06c\uf069\uf074\uf065\uf020 \uf04e", "start_char_idx": 0, "end_char_idx": 340, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "eb20ac43-7c88-49a6-8556-9de55aa92ffa": {"__data__": {"id_": "eb20ac43-7c88-49a6-8556-9de55aa92ffa", "embedding": null, "metadata": {"page_label": "93", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5d4ccc26-021d-4f7b-a807-eeab1972a4de", "node_type": "4", "metadata": {"page_label": "93", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5ba0080cd94f74d3eeeaad0d7a0413a70ae1d29ec9a78fcddec955b40331ea38", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6a3cc64b-c46e-439e-ac00-14b9431ac5dc", "node_type": "1", "metadata": {"page_label": "93", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "1fe2c4fdec0719599adecf5423ed9d61e16e33f27506cc712863f9a904a2b2ee", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "885d3304-5c6b-4eb3-82bd-9722cdf60b86", "node_type": "1", "metadata": {}, "hash": "1a6d6b65e8f5b482859a8276da7e0915e931532d2ea7bffe3bb93dbad6da7c2f", "class_name": "RelatedNodeInfo"}}, "text": "\uf068\uf065\uf06e\uf06f\uf062\uf061\uf072\uf062\uf069\uf074\uf06f\uf06e\uf065\n\uf043\uf079\uf063\uf06c\uf06f\uf070\uf068\uf06f\uf073\uf070\uf068\uf061\uf06d\uf069\uf064\uf065\n\uf02a\uf020\uf047\uf065\uf06e\uf065\uf072\uf061\uf074\uf065\uf073\uf020\uf074\uf06f\uf078\uf069\uf063\uf020\uf06d\uf065\uf074\uf061\uf062\uf06f\uf06c\uf069\uf074\uf065\uf020 \uf04e \uf02d\uf061\uf063\uf065\uf074\uf079\uf06c\uf02d\uf070\uf02d\uf062\uf065\uf06e\uf07a\uf06f\uf071\uf075\uf069\uf06e\uf06f\uf06e\uf065\uf069\uf06d\uf069\uf06e\uf065\uf020\uf028\uf04e\uf041\uf042\uf051\uf049\uf029\nBarbiturates, phenothiazines, imipramine, propranolol,\nibuprofen, paracetamol, steroids, phenytoin, benzodiazepines,\ntheophylline and many other drugs are oxidized in this way by\nCYP450. In addition few drugs like cimetidine, ranitidine,\nclozapine are oxidized at their N, P or S atoms by a group of\nflavin-monooxygenases that are also located on hepatic\nendoplasmic reticulum, but are distinct from CYP enzymes.\nThese enzymes are not susceptible to induction or inhibition\nby other drugs, and thus are not involved in drug interactions.\nSome other drugs, e.g. adrenaline, alcohol, mercaptopurine are\noxidized by mitochondrial or cytoplasmic enzymes.\n(ii) Reduction This reaction is the converse of oxidation and\ninvolves cytochrome P-450 enzymes working in the opposite\ndirection. Alcohols, aldehydes, quinones are reduced. Drugs\nprimarily reduced are chloralhydrate, chloramphenicol,\nhalothane, warfarin.", "start_char_idx": 278, "end_char_idx": 1283, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "885d3304-5c6b-4eb3-82bd-9722cdf60b86": {"__data__": {"id_": "885d3304-5c6b-4eb3-82bd-9722cdf60b86", "embedding": null, "metadata": {"page_label": "94", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "d56b54e7-c3d8-4185-b725-5093d27b1629", "node_type": "4", "metadata": {"page_label": "94", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "7af4898d4300f0d1356706d7ecac7f51cb9703ce49de6edb013d649b2df0562a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eb20ac43-7c88-49a6-8556-9de55aa92ffa", "node_type": "1", "metadata": {"page_label": "93", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "c80031a78e0fc2132dd67d43b3812872b84c5c532d39242465b26e66c6bcf195", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "26a045a0-bf4b-4366-94eb-24c9ed86fa37", "node_type": "1", "metadata": {}, "hash": "0d5044d79700c77307dcf4bc8d9312220cf5b12dcefc696615a26a3b23b821e6", "class_name": "RelatedNodeInfo"}}, "text": "(iii) Hydrolysis This is cleavage of drug molecule by taking\nup a molecule of water.\nesterase\nEster + H2O Acid + Alcohol\nSimilarly, amides and polypeptides are hydrolysed by\namidases and peptidases. In addition, there are epoxide\nhydrolases which detoxify epoxide metabolites of some drugs\ngenerated by CYP oxygenases. Hydrolysis occurs in liver,\nintestines, plasma and other tissues. Examples of hydrolysed\ndrugs are choline esters, procaine, lidocaine, procainamide,\naspirin, indomethacin, carbamazepine-epoxide, pethidine,\noxytocin.\n(iv) Cyclization This is formation of ring structure from a\nstraight chain compound, e.g. cycloguanil from proguanil.\n(v) Decyclization This implies opening up of ring structure of\nthe cyclic drug molecule, such as barbiturates, phenytoin. This\nis generally a minor pathway.\nSynthetic reactions\nThese reactions involve conjugation of the drug or its phase I\nmetabolite with an endogenous substrate, usually derived from\ncarbohydrate or amino acid, to form a polar highly ionized\norganic acid, which is easily excreted in urine or bile.\nConjugation reactions have high energy requirement and are\ngenerally faster than phase I reactions.", "start_char_idx": 0, "end_char_idx": 1171, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "26a045a0-bf4b-4366-94eb-24c9ed86fa37": {"__data__": {"id_": "26a045a0-bf4b-4366-94eb-24c9ed86fa37", "embedding": null, "metadata": {"page_label": "95", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "e5c630d4-ae50-4f77-ab50-87d38da1fb0e", "node_type": "4", "metadata": {"page_label": "95", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "38ccd03f869899b6a0625eb328ade777bd52095e5d21b67a5d9b20d044c657a6", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "885d3304-5c6b-4eb3-82bd-9722cdf60b86", "node_type": "1", "metadata": {"page_label": "94", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "7af4898d4300f0d1356706d7ecac7f51cb9703ce49de6edb013d649b2df0562a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b40bc3cf-8641-4aae-ad6b-314bd034c9c0", "node_type": "1", "metadata": {}, "hash": "bedb5476aa799bec8631dbd16105d7068e810468a5d0124fffd1410c0132d1c2", "class_name": "RelatedNodeInfo"}}, "text": "(i) Glucuronide  conjugation This is the most important\nsynthetic reaction carriedout by a group of UDP-glucuronosyl\ntransferases (UGTs). Compounds with a hydroxyl or\ncarboxylic acid group are easily conjugated with glucuronic\nacid which is derived from glucose. Examples are\u2014\nchloramphenicol, aspirin, paracetamol, diazepam, lorazepam,\nmorphine, metronidazole. Not only drugs but endogenous\nsubstrates like bilirubin, steroidal hormones and thyroxine\nutilize this pathway. Glucuronidation increases the molecular\nweight of the drug which favours its excretion in bile. Drug\nglucuronides excreted in bile can be hydrolysed by bacteria in\nthe gut\u2014the liberated drug is reabsorbed and undergoes the\nsame fate. This enterohepatic cycling (see Fig. 3.2) of the drug\nprolongs its action, e.g. phenolphthalein, oral contraceptives.\n(ii) Acetylation Compounds having amino or hydrazine\nresidues are conjugated with the help of acetyl coenzyme-A,\ne.g. sulfonamides, isoniazid, PAS, dapsone, hydralazine,\nclonazepam, procainamide. Multiple genes control the N-\nacetyl transferases (NATs), and rate of acetylation shows\ngenetic polymorphism (slow and fast acetylators).\n(iii) Methylation The amines and phenols can be methylated\nby methyl transferases (MT); methionine and cysteine acting\nas methyl donors, e.g. adrenaline, histamine, nicotinic acid,\nmethyldopa, captopril, mercaptopurine.\n(iv) Sulfate  conjugation The phenolic compounds and\nsteroids are sulfated by sulfotransferases (SULTs), e.g.", "start_char_idx": 0, "end_char_idx": 1489, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b40bc3cf-8641-4aae-ad6b-314bd034c9c0": {"__data__": {"id_": "b40bc3cf-8641-4aae-ad6b-314bd034c9c0", "embedding": null, "metadata": {"page_label": "96", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "73a64b70-8c31-4f10-b492-7d2d2afd8efb", "node_type": "4", "metadata": {"page_label": "96", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "265dbee6a6d99aec197e423072e7e75268ba2c87497afeb381553e420fd6a287", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "26a045a0-bf4b-4366-94eb-24c9ed86fa37", "node_type": "1", "metadata": {"page_label": "95", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "38ccd03f869899b6a0625eb328ade777bd52095e5d21b67a5d9b20d044c657a6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f87d4879-36ff-4bee-9281-5f9767f9de70", "node_type": "1", "metadata": {}, "hash": "cab4d9faddccc8ce68643c60117059e3e72a359f2fa549ff8671eb86b96b778a", "class_name": "RelatedNodeInfo"}}, "text": "chloramphenicol, methyldopa, adrenal and sex steroids.\n(v) Glycine  conjugation Salicylates, nicotinic acid and other\ndrugs having carboxylic acid group are conjugated with\nglycine, but this is not a major pathway of metabolism.\n(vi) Glutathione  conjugation This is carried out by\nglutathione-S-transferase (GST) forming a mercapturate. It is\nnormally a minor pathway. However, it serves to inactivate\nhighly reactive quinone or epoxide intermediates formed\nduring metabolism of certain drugs, e.g. paracetamol. When\nlarge amount of such intermediates are formed (in poisoning\nor after enzyme induction), glutathione supply falls short\u2014\ntoxic adducts are formed with tissue constituents resulting in\nhepatic, renal and other tissue damage.\n(vii) Ribonucleoside / nucleotide  synthesis  This pathway is\nimportant for the activation of many purine and pyrimidine\nantimetabolites used in cancer chemotherapy.", "start_char_idx": 0, "end_char_idx": 906, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f87d4879-36ff-4bee-9281-5f9767f9de70": {"__data__": {"id_": "f87d4879-36ff-4bee-9281-5f9767f9de70", "embedding": null, "metadata": {"page_label": "97", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "0cda9d94-b603-40f1-820c-838ab5efd6d3", "node_type": "4", "metadata": {"page_label": "97", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b061502f6b95636b6d80f3c2fd6842e8639c0589297840d237e58ecbc69f0ec0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b40bc3cf-8641-4aae-ad6b-314bd034c9c0", "node_type": "1", "metadata": {"page_label": "96", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "265dbee6a6d99aec197e423072e7e75268ba2c87497afeb381553e420fd6a287", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d011d1db-a927-4742-99f7-a8b3e23b1637", "node_type": "1", "metadata": {}, "hash": "e1f9642550bd4545cd839c9e295827ba5ec81beb0d382a41191ad79d8caadd9e", "class_name": "RelatedNodeInfo"}}, "text": "Most  drugs  are  metabolized  by  multiple  pathways ,\nsimultaneously  or  sequentially  as  illustrated  in  Fig . 3.1.\nRates  of  reaction  by  different  pathways  often  vary\nconsiderably . A  variety  of  metabolites  ( some  more , some\nless) of  a  drug  may  be  produced . Stereoisomers  of  a\ndrug  may  be  metabolized  differently  and  at  different\nrates , e . g . S-warfarin  rapidly  undergoes  ring  oxidation ,\nwhile  R-warfarin  is  slowly  degraded  by  sidechain\nreduction .\nOnly a few drugs are metabolized by enzymes of\nintermediary metabolism, e.g. alcohol by dehydrogenase,\nallopurinol by xanthine oxidase, succinylcholine and procaine\nby plasma cholinesterase, adrenaline by monoamine oxidase.\nMajority of drugs are acted on by relatively nonspecific\nenzymes which are directed to types of molecules rather than\nto specific drugs. The same enzyme can metabolize many", "start_char_idx": 0, "end_char_idx": 893, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d011d1db-a927-4742-99f7-a8b3e23b1637": {"__data__": {"id_": "d011d1db-a927-4742-99f7-a8b3e23b1637", "embedding": null, "metadata": {"page_label": "98", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "e8a3013c-aac6-4742-9a66-a601dd8d98f8", "node_type": "4", "metadata": {"page_label": "98", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "57406cf83528838302426e4a8f3621c1f32d2a2f0999ef51554c1b42663cabe8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f87d4879-36ff-4bee-9281-5f9767f9de70", "node_type": "1", "metadata": {"page_label": "97", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b061502f6b95636b6d80f3c2fd6842e8639c0589297840d237e58ecbc69f0ec0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8bef4b59-9f6f-44a9-bed3-5cddc0cd642b", "node_type": "1", "metadata": {}, "hash": "ec603b20e78e28b81678843b11ef0bdab7b1e2b21906cbde6cc64d2c04199557", "class_name": "RelatedNodeInfo"}}, "text": "drugs. The drug metabolising enzymes are divided into two\ntypes:\nMicrosomal  enzymes These are located on smooth\nendoplasmic reticulum (a system of microtubules inside the\ncell), primarily in liver, also in kidney, intestinal mucosa and\nlungs. The monooxygenases, cytochrome P450, UGTs,\nepoxide hydrolases, etc. are microsomal enzymes.\nThey catalyse most of the oxidations, reductions,\nhydrolysis and glucuronide conjugation. Microsomal enzymes\nare inducible by drugs, certain dietary constituents, and other\nagencies.\nNonmicrosomal  enzymes  These are present in the\ncytoplasm and mitochondria of hepatic cells as well as in\nother tissues including plasma. The esterases, amidases, some\nflavoprotein oxidases and most conjugases are\nnonmicrosomal. React ions catalysed are:\nSome oxidations and reductions, many hydrolytic\nreactions and all conjugations except glucuronidation.\nThe nonmicrosomal enzymes are not inducible but many\nshow genetic polymorphism (acetyl transferase,\npseudocholinesterase) similar to the microsomal enzymes.\nBoth microsomal and nonmicrosomal enzymes are\ndeficient in the newborn, especially premature, making them\nmore susceptible to many drugs, e.g. chloramphenicol,\nopioids. This deficit is made up in the first few months, more\nquickly in case of oxidation and other phase I reactions than in", "start_char_idx": 0, "end_char_idx": 1322, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8bef4b59-9f6f-44a9-bed3-5cddc0cd642b": {"__data__": {"id_": "8bef4b59-9f6f-44a9-bed3-5cddc0cd642b", "embedding": null, "metadata": {"page_label": "99", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5513dd0e-bccc-4598-b687-14f0b19bbac4", "node_type": "4", "metadata": {"page_label": "99", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8e32fc6ed8a79cfb9cf8e9ccfe26700d8257ff857023b4a0df0ad46a9832bef4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d011d1db-a927-4742-99f7-a8b3e23b1637", "node_type": "1", "metadata": {"page_label": "98", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "57406cf83528838302426e4a8f3621c1f32d2a2f0999ef51554c1b42663cabe8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aaa069bc-8aac-4ca1-8030-22c72cc207f4", "node_type": "1", "metadata": {}, "hash": "2ac0fce7b8bf66d3ac2bbac5a22544a60032ac93e2a3059d205fed4d840968e3", "class_name": "RelatedNodeInfo"}}, "text": "case of glucuronide and other conjugations which take 3 or\nmore months to reach adult levels.\nThe amount and kind of drug metabolizing enzymes is\ncontrolled genetically and is also altered by diet,\nenvironmental factors. Thus, marked interspecies and\ninterindividual differences are seen, e.g. cats are deficient in\nUGTs while dogs are deficient in NATs. Upto 6-fold\ndifference in the rate of metabolism of a drug among normal\nhuman adults may be observed. This is one of the major\ncauses of individual variation in drug response.\nHofmann elimination This refers to inactivation of the drug\nin the body fluids by spontaneous molecular rearrangement\nwithout the agency of any enzyme, e.g. atracurium.\nInhibition of Drug Metabolism\nAzole antifungal drugs, macrolide antibiotics and some other\ndrugs bind to the heme iron in CYP450 and inhibit the\nmetabolism of many drugs, as well as some endogenous\nsubstances like steroids, bilirubin. One drug can competitively\ninhibit the metabolism of another if it utilizes the same\nenzyme or cofactors. However, such interactions are not as\ncommon as one would expect, because often different drugs\nare substrates for different CYP-450 isoenzymes. It is thus\nimportant to know the CYP isoenzyme(s) that carry out the\nmetabolism of a particular drug. A drug may be the substrate\nas well as inhibitor of the same CYP isoenzyme. In case the\ndrug inhibits its own metabolism, the oral bioavailability is", "start_char_idx": 0, "end_char_idx": 1437, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "aaa069bc-8aac-4ca1-8030-22c72cc207f4": {"__data__": {"id_": "aaa069bc-8aac-4ca1-8030-22c72cc207f4", "embedding": null, "metadata": {"page_label": "100", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "41e310b3-1208-46cf-83ef-64aba2ad4382", "node_type": "4", "metadata": {"page_label": "100", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "cfac4221eb272c390b11c9d4a475812abde5bbf85fec64b1d3cb549538686918", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8bef4b59-9f6f-44a9-bed3-5cddc0cd642b", "node_type": "1", "metadata": {"page_label": "99", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8e32fc6ed8a79cfb9cf8e9ccfe26700d8257ff857023b4a0df0ad46a9832bef4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2455e69c-84ea-41ff-b41f-fdd092624fbc", "node_type": "1", "metadata": {}, "hash": "906d539bdcb2c7707c8221bc3bcc45a9d9e0a91de75ffa22070365bd4e718044", "class_name": "RelatedNodeInfo"}}, "text": "likely to increase (for high first pass metabolism drugs), while\nsystemic clearance is likely to decrease, prolonging plasma\nhalf life. On chronic dosing, the oral bioavailability of\nverapamil is nearly doubled and t\u00bd is prolonged, because it\ninhibits its own metabolism. A drug may also inhibit one\nisoenzyme while being itself a substrate of another isoenzyme,\ne.g. quinidine is metabolized mainly by CYP3A4 but inhibits\nCYP2D6. Moreover, majority of drugs, at therapeutic\nconcentrations, are metabolized by non-saturation kinetics, i.e.\nthe enzyme is present in excess. Clinically significant\ninhibition of drug metabolism occurs in case of drugs having\naffinity for the same isoenzyme, specially if they are\nmetabolized by saturation kinetics or if kinetics changes from\nfirst order to zero order over the therapeutic range (capacity\nlimited metabolism). The \u2018boosted\u2019 HIV-protease inhibitor\n(PI) strategy utilizes the potent CYP3A4 inhibitory action of\nlow dose ritonavir to lower the dose of other PIs like\natazanavir, lopinavir, saquinavir given concurrently.\nObviously, inhibition of drug metabolism occurs in a dose\nrelated manner and can precipitate toxicity of the object drug\n(whose metabolism has been inhibited).\nBecau se enzyme inhibition occurs by direct effect on the\nenzyme, it has a fast time course (within hours) compared to\nenzyme induction (see below).\nMetabolism of drugs with high hepatic extraction is\ndependent on liver blood flow (blood flow limited\nmetabolism). Propranolol reduces rate of lidocaine", "start_char_idx": 0, "end_char_idx": 1528, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2455e69c-84ea-41ff-b41f-fdd092624fbc": {"__data__": {"id_": "2455e69c-84ea-41ff-b41f-fdd092624fbc", "embedding": null, "metadata": {"page_label": "101", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "c6a2b542-e34b-45cd-8789-bccf83a33a0f", "node_type": "4", "metadata": {"page_label": "101", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9d8199b6f9a1915e3679e1b99ae0d6da2283aa2fa920b5cfd01ff79da4cb8207", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aaa069bc-8aac-4ca1-8030-22c72cc207f4", "node_type": "1", "metadata": {"page_label": "100", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "cfac4221eb272c390b11c9d4a475812abde5bbf85fec64b1d3cb549538686918", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e84d4ae5-33dc-44f6-8734-084f81c8a0a1", "node_type": "1", "metadata": {}, "hash": "fa386c27fa375db809d82f9056aaf143d311508d3c83ca6c4d243b7c2040f3eb", "class_name": "RelatedNodeInfo"}}, "text": "metabolism by decreasing hepatic blood flow. Some other\ndrugs whose rate of metabolism is limited by hepatic blood\nflow are morphine, propranolol, verapamil and imipramine.\nMicrosomal Enzyme Induction\nMany drugs, insecticides and carcinogens interact with DNA\nand increase the synthesis of microsomal enzyme protein,\nespecially cytochrome P-450 and UGTs. As a result the rate of\nmetabolism of inducing drug itself (autoinduction) and/or\nsome other coadministered drugs is accelerated.\nDifferent inducers are relatively selective for certain\ncytochrome P-450 isoenzyme families, e.g.:\n\u2022Anticonvulsants (phenobarbitone, phenytoin,\ncarbamazepine), rifampin, glucocorticoids induce CYP3A\nisoenzymes.\n\u2022Phenobarbitone and rifampin also induce CYP2D6 and\nCYP2C8/9.\n\u2022Carbamazepine and rifampin, in addition, induce CYP2C19\nand CYP1A1/2.\n\u2022Isoniazid and chronic alcohol consumption induce\nCYP2E1.\n\u2022Polycyclic hydrocarbons like 3-methylcholanthrene and\nbenzopyrene found in cigarette smoke, charcoalbroiled\nmeat, omeprazole and industrial pollutants induce CYP1A\nisoenzymes.\n\u2022Other enzyme inducers are: chronic alcoholism, nevirapine,\ngriseofulvin, DDT.", "start_char_idx": 0, "end_char_idx": 1142, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e84d4ae5-33dc-44f6-8734-084f81c8a0a1": {"__data__": {"id_": "e84d4ae5-33dc-44f6-8734-084f81c8a0a1", "embedding": null, "metadata": {"page_label": "102", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "dc16d311-1fc6-4485-897e-9b8d3095cfbc", "node_type": "4", "metadata": {"page_label": "102", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "18cbccd1f1285cfc551a687d1f00ff0dd6ca575a6fdae8b266ca8cfb0ac91dce", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2455e69c-84ea-41ff-b41f-fdd092624fbc", "node_type": "1", "metadata": {"page_label": "101", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9d8199b6f9a1915e3679e1b99ae0d6da2283aa2fa920b5cfd01ff79da4cb8207", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ac093db4-59ca-4c1d-8e89-d393daf03d29", "node_type": "1", "metadata": {}, "hash": "e4d9827a1b75e1442e5edbad3fbf8e0fc44dc3e7b94a5c53701f2d8d5e99b35f", "class_name": "RelatedNodeInfo"}}, "text": "Since different CYP isoenzymes are involved in the\nmetabolism of different drugs, every inducer increases\nbiotransformation of certain drugs but not that of others.\nHowever, phenobarbitone like inducers of CYP3A and\nCYP2D6 affect the metabolism of a large number of drugs,\nbecause these isoenzymes act on many drugs. On the other\nhand induction by polycyclic hydrocarbons is limited to few\ndrugs (like theophylline, warfarin) because CYP1A isoenzyme\nmetabolizes only few drugs.\nDrugs that inhibit drug metabolizing enzymes\nAllopurinol Amiodarone\nOmeprazole Propoxyphene\nErythromycin Isoniazid\nClarithromycin Cimetidine\nChloramphenicol Quinidine\nKetoconazole Disul\ufb01ram\nItraconazole Diltiazem\nMetronidazole Verapamil\nCipro\ufb02oxacin MAO inhibitors\nFluoxetine (and\nother SSRIs)Ritonavir (and other\nHIV protease inhibitors)\nInduction involves microsomal enzymes in liver as well as\nother organs and increases the rate of metabolism by 2\u20134 fold.\nInduction takes 4\u201314 days to reach its peak and is maintained", "start_char_idx": 0, "end_char_idx": 999, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ac093db4-59ca-4c1d-8e89-d393daf03d29": {"__data__": {"id_": "ac093db4-59ca-4c1d-8e89-d393daf03d29", "embedding": null, "metadata": {"page_label": "103", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "c98ec416-926c-49dc-811e-9bb662b3d812", "node_type": "4", "metadata": {"page_label": "103", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "cfa185f6dce1d8a11e5bf229c4a1c56d49c2b243ff4a95004975373eb69e09c5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e84d4ae5-33dc-44f6-8734-084f81c8a0a1", "node_type": "1", "metadata": {"page_label": "102", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "18cbccd1f1285cfc551a687d1f00ff0dd6ca575a6fdae8b266ca8cfb0ac91dce", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bc60cbdf-1089-47fa-9bf6-1f8d28e82387", "node_type": "1", "metadata": {}, "hash": "4db8987361b763b29b4153f2451db1336713a4e1a5ea3470251be979a24af713", "class_name": "RelatedNodeInfo"}}, "text": "till the inducing agent is being given. Thereafter the enzymes\nreturn to their original value over 1\u20133 weeks.\nConsequences  of  microsomal  enzyme  induction\n1. Decreased intensity and/or duration of action of drugs that\nare inactivated by metabolism, e.g. failure of contraception\nwith oral contraceptives and loss of anti-HIV action of\nnevirapine due to rifampin coadministration.\n2. Increased intensity of action of drugs that are activated by\nmetabolism. Acute paracetamol toxicity is due to one of its\nmetabolites\u2014toxicity occurs at lower doses in patients\nreceiving enzyme inducers.\n3. Tolerance\u2014if the drug induces its own metabolism\n(autoinduction), e.g. carbamazepine, rifampin; nevirapine dose\nneeds to be doubled after 2 weeks.\n4. Some endogenous substrates (steroids, bilirubin) are also\nmetabolized faster.\n5. Precipitation of acute intermittent porphyria: enzyme\ninduction increases porphyrin synthesis by derepressing \u03b4-\naminolevulinic acid synthetase.\n6. Intermittent use of an inducer may interfere with adjustment\nof dose of another drug prescribed on regular basis, e.g. oral\nanticoagulants, oral hypoglycaemics, antiepileptics,\nantihypertensives.\n7. Interference with chronic toxicity testing in animals.\nDrugs whose metabolism is significantly affected by\nenzyme induction are\u2014phenytoin, carbamazepine,", "start_char_idx": 0, "end_char_idx": 1323, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "bc60cbdf-1089-47fa-9bf6-1f8d28e82387": {"__data__": {"id_": "bc60cbdf-1089-47fa-9bf6-1f8d28e82387", "embedding": null, "metadata": {"page_label": "104", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "6ad48f98-c5d5-4d91-a107-aea4beabbedd", "node_type": "4", "metadata": {"page_label": "104", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "549bcaf8fac276f31eb4b7b79a0458c302b64f8bd688930ae5bbd5097b84b355", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ac093db4-59ca-4c1d-8e89-d393daf03d29", "node_type": "1", "metadata": {"page_label": "103", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "cfa185f6dce1d8a11e5bf229c4a1c56d49c2b243ff4a95004975373eb69e09c5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "588f19ce-0a52-4d00-84c5-b03ea11a3952", "node_type": "1", "metadata": {}, "hash": "bbb04bb9288e1d4c5ae6231d8a0715ae86a260c0be460b74bfeff3bee9e08bbb", "class_name": "RelatedNodeInfo"}}, "text": "antidepressants, warfarin, tolbutamide, oral contraceptives,\nchloramphenicol, doxycycline, theophylline, griseofulvin,\nnevirapine.\nPossible  uses  of  enzyme  induction\n1. Congenital nonhaemolytic jaundice: It is due to deficient\nglucuronidation of bilirubin; phenobarbitone hastens clearance\nof jaundice.\n2. Cushing\u2019s syndrome: phenytoin may reduce the\nmanifestations by enhancing degradation of adrenal steroids\nwhich are produced in excess.\n3. Chronic poisonings: by faster metabolism of the\naccumulated poisonous substance.\n4. Liver disease.\nFirst-pass (Presystemic) Metabolism\nThis refers to metabolism of a drug during its passage from\nthe site of absorption into the systemic circulation. All orally\nadministered drugs are exposed to drug metabolizing enzymes\nin the intestinal wall and liver (where they first reach through\nthe portal vein). Presystemic metabolism in the gut and liver\ncan be avoided by administering the drug through sublingual,\ntransdermal or parenteral routes. However, limited\npresystemic metabolism can occur in the skin (transdermally\nadministered drug) and in lungs (for drug reaching venous\nblood through any route). The extent of first pass metabolism", "start_char_idx": 0, "end_char_idx": 1185, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "588f19ce-0a52-4d00-84c5-b03ea11a3952": {"__data__": {"id_": "588f19ce-0a52-4d00-84c5-b03ea11a3952", "embedding": null, "metadata": {"page_label": "105", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "7ee4fb5d-64d0-4585-a93f-964612a920fd", "node_type": "4", "metadata": {"page_label": "105", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "42e35a94141b4d69c1a6b13c62fecca4e9299acb642762119a39265e07dcdacd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bc60cbdf-1089-47fa-9bf6-1f8d28e82387", "node_type": "1", "metadata": {"page_label": "104", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "549bcaf8fac276f31eb4b7b79a0458c302b64f8bd688930ae5bbd5097b84b355", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eba0d3b4-ebd9-42a2-be7f-240449f16fb3", "node_type": "1", "metadata": {}, "hash": "49691bec3f8c757e399e15d77906e125ddf97096374b68ddde72c58159c7e3a7", "class_name": "RelatedNodeInfo"}}, "text": "differs for different drugs (Table 3.2) and is an important\ndeterminant of oral bioavailability.\nA drug can also be excreted as such into bile. The hepatic\nextraction ratio () of a drug is the fraction of the absorbed\ndrug prevented by the liver from reaching systemic\ncirculation. Both presystemic metabolism as well as direct\nexcretion into bile determine , which is given by the equation:\nERLiver\nERLiver\nAccordingly the systemic bioavailability (F) of an orally\nadministered drug will be:\nF = fractional absorption \u00d7 (I\u2013ER)..(2)\nWhen a drug with high first pass metabolism is given orally at higher dose to\nachieve therapeutic blood levels , the plasma concentration of its metabolites will\nbe much higher compared to those resulting from parenteral dosing of the drug\nfor the same therapeutic level. If the metabolites contribute to the adverse effects\nof the drug, oral dosing will be less safe than parenteral.", "start_char_idx": 0, "end_char_idx": 917, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "eba0d3b4-ebd9-42a2-be7f-240449f16fb3": {"__data__": {"id_": "eba0d3b4-ebd9-42a2-be7f-240449f16fb3", "embedding": null, "metadata": {"page_label": "106", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "172c4df3-08ac-4064-b3c1-bb670ebe08a3", "node_type": "4", "metadata": {"page_label": "106", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "700b34e99412106e7d11ae4768c056e01e90eff6feb315f32648dc9e84bfcd52", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "588f19ce-0a52-4d00-84c5-b03ea11a3952", "node_type": "1", "metadata": {"page_label": "105", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "26224fd1a8687e5a17116dc74bb3c195659d7dad718302566d7813298a68db12", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "374c6610-3aa3-4f55-9966-fcde9e53ad74", "node_type": "1", "metadata": {}, "hash": "41dd76881bdd851884488ceff16db3aa53e6221d001ce308de7ae84f18eb2150", "class_name": "RelatedNodeInfo"}}, "text": "Attributes  of  drugs  with  high  \ufb01rst  pass  metabolism :\n(a) Oral dose is considerably higher than sublingual or\nparenteral dose.\n(b) There is marked individual variation in the oral dose due to\ndifferences in the extent of first pass metabolism.\n(c) Oral bioavailability is apparently increased in patients with\nsevere liver disease.\n(d) Oral bioavailability of a drug is increased if another drug\ncompeting with it in first pass metabolism is given\nconcurrently, e.g. chlorpromazine and propranolol.\nEXCRETION\nExcretion is the passage out of systemically absorbed drug.\nDrugs and their metabolites are excreted in:\n1.Urine Drug excretion in urine occurs via the kidney. It is\nthe most important channel of excretion for majority of drugs\n(see below).\n2.Faeces Apart from the unabsorbed fraction, most of the\ndrug present in faeces is derived from bile. Liver actively\ntransports into bile organic acids (especially drug glucuronides\nby OATP and MRP2), organic bases (by OCT), other\nlipophilic drugs (by P-gp) and steroids by distinct nonspecific\nactive transport mechanisms. Relatively larger molecules\n(MW > 300) are preferentially eliminated in the bile. Most of\nthe free drug in the gut, including that released by\ndeconjugation of glucuronides by enteric bacteria is", "start_char_idx": 0, "end_char_idx": 1275, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "374c6610-3aa3-4f55-9966-fcde9e53ad74": {"__data__": {"id_": "374c6610-3aa3-4f55-9966-fcde9e53ad74", "embedding": null, "metadata": {"page_label": "107", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "07fdca8e-6ff5-48f8-9e87-ef347722e862", "node_type": "4", "metadata": {"page_label": "107", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "311186dc908b79e9d7a636013ab7d40c7880ed27c3a5df49ecca14e44a03fa8c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eba0d3b4-ebd9-42a2-be7f-240449f16fb3", "node_type": "1", "metadata": {"page_label": "106", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "700b34e99412106e7d11ae4768c056e01e90eff6feb315f32648dc9e84bfcd52", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d5b230e0-73de-4564-b741-5d0b697c287c", "node_type": "1", "metadata": {}, "hash": "a9479917479f8024edd70771d770cb61f6a1a87c25b46e8a96d7429439215090", "class_name": "RelatedNodeInfo"}}, "text": "reabsorbed (enterohepatic cycling) and ultimate excretion\noccurs in urine (Fig. 3.2). Only the remaining is excreted in\nthe faeces. Enterohepatic cycling contributes to longer stay of\nthe drug in the body. Drugs that attain high concentrations in\nbile include erythromycin, ampicillin, rifampin, tetracycline,\noral contraceptives, vecuronium, phenolphthalein.\nCertain drugs are excreted directly in colon, e.g. anthracene\npurgatives, heavy metals.\n3.Exhaled air Gases and volatile liquids (general\nanaesthetics, alcohol) are eliminated by lungs, irrespective of\ntheir lipid solubility. Alveolar transfer of the gas/vapour\ndepends on its partial pressure in the blood. Lungs also serve\nto trap and extrude any particulate matter that enters\ncirculation.\n4.Saliva and sweat These are of minor importance for\ndrug excretion. Lithium, pot. iodide, rifampin and heavy\nmetals are present in these secretions in significant amounts.\nMost of the saliva along with the drug in it, is swallowed and\nmeets the same fate as orally taken drug.\n5.Milk The excretion of drug in milk is not important for the\nmother, but the suckling infant inadvertently receives the drug.\nMost drugs enter breast milk by passive diffusion. As such,\nmore lipid soluble and less protein bound drugs cross better.\nMilk has a lower pH (7.0) than plasma, basic drugs are\nsomewhat more concentrated in it. However, the total amount\nof drug reaching the infant through breast feeding is generally", "start_char_idx": 0, "end_char_idx": 1458, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d5b230e0-73de-4564-b741-5d0b697c287c": {"__data__": {"id_": "d5b230e0-73de-4564-b741-5d0b697c287c", "embedding": null, "metadata": {"page_label": "108", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3f6bc6d9-92f4-4dc4-ab73-f5bd6ade218b", "node_type": "4", "metadata": {"page_label": "108", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "96f0283437ad2f9e6e758f2df2cc8835687eee35db4fbbd0be097691d2e6127b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "374c6610-3aa3-4f55-9966-fcde9e53ad74", "node_type": "1", "metadata": {"page_label": "107", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "311186dc908b79e9d7a636013ab7d40c7880ed27c3a5df49ecca14e44a03fa8c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "06504210-8fd0-4029-a41d-f6722897dc06", "node_type": "1", "metadata": {}, "hash": "b9c122a1e85485cf2aa2071970ce11f3085f56dd1ad9eb23013a1f42c50ff193", "class_name": "RelatedNodeInfo"}}, "text": "small and majority of drugs can be given to lactating mothers\nwithout ill effects on the infant. Nevertheless, it is advisable to\nadminister any drug to a lactating woman only when essential.\nDrugs that are safe, as well as those contraindicated during\nbreast feeding or need special caution are given in Appendix-3\nat the end of the book.\nRENAL EXCRETION\nThe kidney is responsible for excreting all water soluble\nsubstances. The amount of drug or its metabolites ultimately", "start_char_idx": 0, "end_char_idx": 474, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "06504210-8fd0-4029-a41d-f6722897dc06": {"__data__": {"id_": "06504210-8fd0-4029-a41d-f6722897dc06", "embedding": null, "metadata": {"page_label": "109", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "0e520528-c00f-4d9a-b25a-98ba87ec44c9", "node_type": "4", "metadata": {"page_label": "109", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b863d4c6c8a55ade1937efae4626f01c811ecec62ffd595a44958a0bd958bd11", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d5b230e0-73de-4564-b741-5d0b697c287c", "node_type": "1", "metadata": {"page_label": "108", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "96f0283437ad2f9e6e758f2df2cc8835687eee35db4fbbd0be097691d2e6127b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "786d1f6b-8ec0-41bb-9dc9-62340c1a73a0", "node_type": "1", "metadata": {}, "hash": "5ac958511b57ebac84ebee439ce8a8d24097ec17c83369c15e608c4d833bcd8d", "class_name": "RelatedNodeInfo"}}, "text": "present in urine is the sum total of glomerular filtration,\ntubular reabsorption and tubular secretion (Fig. 3.3).\nNet renal excretion=(Glomerular filtration + tubular\nsecretion) \u2013 tubular reabsorption\nGlomerular \ufb01ltration Glomerular capillaries have pores\nlarger than usual; all nonprotein bound drug (whether lipid-\nsoluble or insoluble) presented to the glomerulus is filtered.\nThus, glomerular filtration of a drug depends on its plasma\nprotein binding and renal blood flow. Glomerular filtration\nrate (g.f.r.), normally ~ 120 ml/min, declines progressively\nafter the age of 50, and is low in renal failure. Glomerular\nfiltration of drugs declines in parallel.\nTubular reabsorption This occurs by passive diffusion and\ndepends on the lipid solubility and ionization of the drug at the\nexisting urinary pH. Lipid-soluble drugs filtered at the\nglomerulus back diffuse in the tubules because 99% of\nglomerular filtrate is reabsorbed, but nonlipid-soluble and\nhighly ionized drugs are unable to do so. Thus, rate of\nexcretion of such drugs, e.g. aminoglycoside antibiotics,\nquaternary ammonium compounds parallels g.f.r. (or\ncreatinine clearance). Changes in urinary pH affect tubular\nreabsorption of drugs that are partially ionized\u2014", "start_char_idx": 0, "end_char_idx": 1234, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "786d1f6b-8ec0-41bb-9dc9-62340c1a73a0": {"__data__": {"id_": "786d1f6b-8ec0-41bb-9dc9-62340c1a73a0", "embedding": null, "metadata": {"page_label": "110", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f9dbc250-95fc-4441-9450-1b1013fc6d65", "node_type": "4", "metadata": {"page_label": "110", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9961d78bedb700f4592af043c947fee089d99f11eef26d6f19b51a1b940e5284", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "06504210-8fd0-4029-a41d-f6722897dc06", "node_type": "1", "metadata": {"page_label": "109", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b863d4c6c8a55ade1937efae4626f01c811ecec62ffd595a44958a0bd958bd11", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ad7761cb-a80c-4fd7-b5e6-fdf9c4f5a725", "node_type": "1", "metadata": {}, "hash": "2a5151a2a0d6053f61675e2228a1fe84044bd8cded07d1dffbb620e7dee129cc", "class_name": "RelatedNodeInfo"}}, "text": "\u2022Weak bases ionize more and are less reabsorbed in acidic\nurine.\n\u2022Weak acids ionize more and are less reabsorbed in alkaline\nurine.\nThis principle is utilized for facilitating elimination of the\ndrug in poisoning, i.e. urine is alkalinized in barbiturate and\nsalicylate poisoning. Though elimination of weak bases", "start_char_idx": 0, "end_char_idx": 313, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ad7761cb-a80c-4fd7-b5e6-fdf9c4f5a725": {"__data__": {"id_": "ad7761cb-a80c-4fd7-b5e6-fdf9c4f5a725", "embedding": null, "metadata": {"page_label": "111", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "e4be75e7-986d-4392-b013-12931743b84b", "node_type": "4", "metadata": {"page_label": "111", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "299f4e84dcfc690e1fc20c0d65d394fe9e71904207a78a3d6314fcb39b0e7647", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "786d1f6b-8ec0-41bb-9dc9-62340c1a73a0", "node_type": "1", "metadata": {"page_label": "110", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9961d78bedb700f4592af043c947fee089d99f11eef26d6f19b51a1b940e5284", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "88a3501f-2878-42f6-8b83-9c0caa8df869", "node_type": "1", "metadata": {}, "hash": "f59d619ee74c0910a85e936f7b63263eb4d138c2415d50a02819ff45b8a075bc", "class_name": "RelatedNodeInfo"}}, "text": "(morphine, amphetamine) can be enhanced by acidifying\nurine, this is not practiced clinically, because acidosis can\ninduce rhabdomyolysis, cardiotoxicity and actually worsen\noutcome. The effect of changes in urinary pH on drug\nexcretion is greatest for those having pKa values between 5 to\n8, because only in their case pH dependent passive\nreabsorption is significant.\nTubular secretion This is the active transfer of organic\nacids and bases by two separate classes of relatively\nnonspecific transporters (OAT and OCT) which operate in the\nproximal tubules. In addition, efflux transporters P-gp and\nMRP2 are located in the luminal membrane of proximal\ntubular cells. If renal clearance of a drug is greater than 120\nmL/min (g.f.r.), additional tubular secretion can be assumed to\nbe occurring.\nActive transport of the drug across tubules reduces\nconcentration of its free form in the tubular vessels and\npromotes dissociation of protein bound drug, which then\nbecomes available for secretion (Fig. 3.3). Thus, protein\nbinding, which is a hindrance for glomerular filtration of the\ndrug, is not so (may even be facilitatory) to excretion by\ntubular secretion.\n(a) Organic  acid  transport  (through OATP) operates for\npenicillin, probenecid, uric acid, salicylates, indomethacin,\nsulfinpyrazone, nitrofurantoin, methotrexate, drug\nglucuronides and sulfates, etc.", "start_char_idx": 0, "end_char_idx": 1363, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "88a3501f-2878-42f6-8b83-9c0caa8df869": {"__data__": {"id_": "88a3501f-2878-42f6-8b83-9c0caa8df869", "embedding": null, "metadata": {"page_label": "112", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "378475f0-c937-49fd-a3bc-036d9f2d20bc", "node_type": "4", "metadata": {"page_label": "112", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a07690d4ea6c9d27039adba1705dc2a4adc5471cbc3bf9fa881f27dd70ce5d89", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ad7761cb-a80c-4fd7-b5e6-fdf9c4f5a725", "node_type": "1", "metadata": {"page_label": "111", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "299f4e84dcfc690e1fc20c0d65d394fe9e71904207a78a3d6314fcb39b0e7647", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cf5b6ee8-7970-47ef-8abe-b1810ee95725", "node_type": "1", "metadata": {}, "hash": "1233f9dd1fc4b58fb67a7a6e661e80bdd8748c7bc4587690ae4ff0bf94066b20", "class_name": "RelatedNodeInfo"}}, "text": "(b) Organic  base  transport  (through OCT) operates for\nthiazides, amiloride, triamterene, furosemide, quinine,\nprocainamide, choline, cimetidine, etc.\nInherently both transport processes are bidirectional, i.e.\nthey can transport their substrates from blood to tubular fluid\nand vice versa. However, for drugs and their metabolites\n(exogenous substances) secretion into the tubular lumen\npredominates, whereas an endogenous substrate like uric acid\nis predominantly reabsorbed.\nDrugs utilizing the same active transport compete with\neach other. Probenecid is an organic acid which has high\naffinity for the tubular OATP. It blocks the active transport of\nboth penicillin and uric acid, but whereas the net excretion of\nthe former is decreased, that of the latter is increased. This is\nbecause penicillin is primarily secreted while uric acid is\nprimarily reabsorbed. Many drug interactions occur due to\ncompetition for tubular secretion, e.g.\n(i) Aspirin blocks uricosuric action of probenecid and\nsulfinpyrazone and decrease tubular secretion of methotrexate.\n(ii) Probenecid decreases the concentration of nitrofurantoin in\nurine, increases the duration of action of penicillin/ampicillin\nand impairs secretion of methotrexate.\n(iii) Sulfinpyrazone inhibits excretion of tolbutamide.\n(iv) Quinidine decreases renal and biliary clearance of digoxin\nby inhibiting efflux carrier P-gp.\nTubular  transport  mechanisms  are  not  well  developed\nat birth . As  a  result , duration  of  action  of  many  drugs , e . g .", "start_char_idx": 0, "end_char_idx": 1519, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "cf5b6ee8-7970-47ef-8abe-b1810ee95725": {"__data__": {"id_": "cf5b6ee8-7970-47ef-8abe-b1810ee95725", "embedding": null, "metadata": {"page_label": "113", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "7d04bc77-6a78-4880-95f8-426df12ad9e1", "node_type": "4", "metadata": {"page_label": "113", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4d78ff01c1536cb1600bbc8a84a3da4474245d9a6ebaf2bbc1b0a18a260ef8fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "88a3501f-2878-42f6-8b83-9c0caa8df869", "node_type": "1", "metadata": {"page_label": "112", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a07690d4ea6c9d27039adba1705dc2a4adc5471cbc3bf9fa881f27dd70ce5d89", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1b6caeb9-9654-42bd-99df-bf9330a09a07", "node_type": "1", "metadata": {}, "hash": "82b2ed5aa49ea8acbe0133fe1093c9579cfc9705608756804cff63a658b26e8c", "class_name": "RelatedNodeInfo"}}, "text": "penicillin , cephalosporins , aspirin  is  longer  in  neonates .\nThese  systems  mature  during  infancy . Renal  function\nagain  progressively  declines  after  the  age  of  50 years ;\nrenal  clearance  of  most  drugs  is  substantially  lower  in  the\nelderly  (>75 yr ).\nKINETICS OF ELIMINATION\nThe knowledge of kinetics of elimination of a drug provides\nthe basis for, as well as serves to devise rational dosage\nregimens and to modify them according to individual needs.\nThere are three fundamental pharmacokinetic parameters, viz.\nbioavailability (F), volume of distribution (V) and clearance\n(CL) which must be understood. The first two have already\nbeen considered.\nDrug elimination is the sumtotal of metabolic inactivation\nand excretion. As depicted in Fig. 2.1, drug is eliminated only\nfrom the central compartment (blood) which is in equilibrium\nwith peripheral compartments including the site of action.\nDepending upon the ability of the body to eliminate a drug, a\ncertain fraction of the central compartment may be considered\nto be totally \u2018cleared\u2019 of that drug in a given period of time to\naccount for elimination over that period.\nClearance (CL) The clearance of a drug is the theoretical\nvolume of plasma from which the drug is completely removed\nin unit time (analogy creatinine clearance; Fig. 3.4). It can be\ncalculated as:", "start_char_idx": 0, "end_char_idx": 1348, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1b6caeb9-9654-42bd-99df-bf9330a09a07": {"__data__": {"id_": "1b6caeb9-9654-42bd-99df-bf9330a09a07", "embedding": null, "metadata": {"page_label": "114", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "c6c47d52-c707-413c-98d4-8a4f4b51eb1d", "node_type": "4", "metadata": {"page_label": "114", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "d52dfb7c7677299c0ec9f127f0590dc584ce1d50084654f23fc3c3cfdbe6246c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cf5b6ee8-7970-47ef-8abe-b1810ee95725", "node_type": "1", "metadata": {"page_label": "113", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4d78ff01c1536cb1600bbc8a84a3da4474245d9a6ebaf2bbc1b0a18a260ef8fc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fcbf9325-5c46-4cdc-8227-bb53ee90bac1", "node_type": "1", "metadata": {}, "hash": "889922067e00a855675040c629645cca7892b56d494375fbc0dda2fb4af3bfae", "class_name": "RelatedNodeInfo"}}, "text": "CL = Rate of elimination/C ...(3)\nwhere  C is the  plasma  concentration .\nFor majority  of  drugs  the  processes  involved  in\nelimination  are  not  saturated  over  the  clinically  obtained\nconcentrations , they  follow :\nFirst  order  kinetics The rate of elimination is directly\nproportional to the drug concentration, CL remains constant;\nor a constant fraction of the drug present in the body is\neliminated in unit time. This applies to majority of drugs\nwhich do not saturate the elimination processes (transporters,\nenzymes, blood flow, etc.) over the therapeutic concentration\nrange. However, if the dose is high enough, elimination\npathways of all drugs will get saturated.\nFew drugs normally saturate eliminating mechanisms and\nare handled by\u2014\nZero  order  kinetics  The rate of elimination remains constant\nirrespective of drug concentration, CL decreases with increase\nin concentration; or a constant amount of the drug is\neliminated in unit time, e.g. ethyl alcohol. This is also called\ncapacity limited elimination or Michaelis-Menten elimination.", "start_char_idx": 2, "end_char_idx": 1067, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "fcbf9325-5c46-4cdc-8227-bb53ee90bac1": {"__data__": {"id_": "fcbf9325-5c46-4cdc-8227-bb53ee90bac1", "embedding": null, "metadata": {"page_label": "115", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "17b7bf61-fce0-4bba-818c-b4e2a3235982", "node_type": "4", "metadata": {"page_label": "115", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a788600796e0290054dfcd353227f5cf95e53296e9ee374422530a6d90c1057e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1b6caeb9-9654-42bd-99df-bf9330a09a07", "node_type": "1", "metadata": {"page_label": "114", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3ecbf3b6cc0ad2edccf0dd7806680033573c166bb2317d0e6c96a940709b15c5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "97f0e2ad-6974-4e6c-be99-c3939cd10301", "node_type": "1", "metadata": {}, "hash": "9a10bbce950baa7ebd7a4385150a0bf06b7de9d7075e0bdb82b8d7cb27a03632", "class_name": "RelatedNodeInfo"}}, "text": "The elimination of some drugs approaches saturation over\nthe therapeutic range, kinetics changes from first order to zero\norder at higher doses. As a result plasma concentration\nincreases disproportionately with increase in dose (see Fig.\n3.6), as occurs in case of phenytoin, tolbutamide, theophylline,\nwarfarin. Since the dose rate-plasma concentration plot in this\ncase is curved, it is also called \u2018nonlinear elimination\u2019.\nBlood  \ufb02ow  dependent  elimination For few drugs the\neliminating capacity of an organ of elimination (kidney, liver)\nfar exceeds the amount of drug normally presented to it by\nblood circulation. The elimination of such a drug becomes\nblood flow dependent. These highly extracted drugs are", "start_char_idx": 0, "end_char_idx": 715, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "97f0e2ad-6974-4e6c-be99-c3939cd10301": {"__data__": {"id_": "97f0e2ad-6974-4e6c-be99-c3939cd10301", "embedding": null, "metadata": {"page_label": "116", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "e796e9b8-11ec-41e8-8bd8-36b0face1cac", "node_type": "4", "metadata": {"page_label": "116", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3ef86034be68103e438c44cee94eb392543a6726a29b0607224f519ebc2c39f7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fcbf9325-5c46-4cdc-8227-bb53ee90bac1", "node_type": "1", "metadata": {"page_label": "115", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a788600796e0290054dfcd353227f5cf95e53296e9ee374422530a6d90c1057e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ba49c84f-eedd-48ca-9211-5cfa528b03b1", "node_type": "1", "metadata": {}, "hash": "0d751620b3c80407a8bb11e549e257c843a4b7ffe3fcdf13445c2da3d27b3289", "class_name": "RelatedNodeInfo"}}, "text": "almost completely eliminated in a single passage through the\norgan of elimination.\nPlasma half-life The Plasma half-life (t\u00bd) of a drug is the\ntime taken for its plasma concentration to be reduced to half of\nits original value.\nTaking the simplest case of a drug which has rapid one\ncompartment distribution and first order elimination, and is\ngiven i.v. a semilog plasma concentration-time plot as shown\nin Fig. 3.5 is obtained. The plot has two slopes.\n\u2022initial rapidly declining (\u03b1) phase\u2014due to distribution.\n\u2022later less declined (\u03b2) phase\u2014due to elimination.\nAt least two half-lives (distribution t\u00bd and elimination t\u00bd) can\nbe calculated from the two slopes. The elimination half life\nderived from the \u03b2 slope is simply called the \u2018half life\u2019 of the\ndrug.\nMost drugs infact have multicompartment distribution and multiexponential\ndecay of plasma concentration-time plot. Half-lives calculated from the terminal\nslopes (when plasma concentrations are very low) are exceptionally long,\nprobably due to release of the drug from slow equilibrating tissues, enterohepatic\ncirculation, etc. Only the t\u00bd calculated over the steady-state plasma\nconcentration range is clinically relevant. It is this t\u00bd whic h is commonly\nmentioned.\nSince first order kinetics is an exponential process,\nmathematically, the elimination t\u00bd is\nln2\nt\u00bd = \u2014\u2014 ...(4)\nk", "start_char_idx": 0, "end_char_idx": 1342, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ba49c84f-eedd-48ca-9211-5cfa528b03b1": {"__data__": {"id_": "ba49c84f-eedd-48ca-9211-5cfa528b03b1", "embedding": null, "metadata": {"page_label": "117", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ad4d6008-a56f-4251-bb50-973032e3da0e", "node_type": "4", "metadata": {"page_label": "117", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "65fde018d77b921924f67d8ed712a891f8f847f53765ec30cff6283d91d543a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "97f0e2ad-6974-4e6c-be99-c3939cd10301", "node_type": "1", "metadata": {"page_label": "116", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3ef86034be68103e438c44cee94eb392543a6726a29b0607224f519ebc2c39f7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e1472f17-927b-451b-952a-6e76e0460da9", "node_type": "1", "metadata": {}, "hash": "7d4b6506e23b5c44c7c94fa52b87fb38211c18d4a8f843c6950a7c02114f4516", "class_name": "RelatedNodeInfo"}}, "text": "Where ln2 is the natural logarithm of 2 (or 0.693) and k is the\nelimination rate constant of the drug, i.e. the fraction of the\ntotal amount of drug in the body which is removed per unit\ntime. For example, if 2 g of the drug is present in the body and\n0.1 g is eliminated every hour, then\nk = 0.1/2 = 0.05 or 5% per hour.\nIt is calculated as:\nAs such, half-life is a derived parameter from two variables V\nand CL, both of which may change independently. It,\ntherefore, is not an exact index of drug elimination.\nNevertheless, it is a simple and useful guide to the sojourn of\nthe drug in the body, i.e. after\n1 t\u00bd\u201350% drug is eliminated.\n2 t\u00bd\u201375% (50 + 25) drug is eliminated.", "start_char_idx": 0, "end_char_idx": 676, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e1472f17-927b-451b-952a-6e76e0460da9": {"__data__": {"id_": "e1472f17-927b-451b-952a-6e76e0460da9", "embedding": null, "metadata": {"page_label": "118", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "acc3e2b5-a73f-4956-b639-e2e68ffa66db", "node_type": "4", "metadata": {"page_label": "118", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "50123068af407cc6f152c0e0b78af79a9ca74a5e5f6351b2242aa9d23b119c2b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ba49c84f-eedd-48ca-9211-5cfa528b03b1", "node_type": "1", "metadata": {"page_label": "117", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "65fde018d77b921924f67d8ed712a891f8f847f53765ec30cff6283d91d543a8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "22144d89-14ca-452a-8dde-fff54b9836b0", "node_type": "1", "metadata": {}, "hash": "36ce2c7aea90f110566441967f0a4c7c135d0c6b941b9d6b6b4461fb40908ec4", "class_name": "RelatedNodeInfo"}}, "text": "3 t\u00bd\u201387.5% (50 + 25 + 12.5) drug is   eliminated.\n4 t\u00bd\u201393.75% (50 + 25 + 12.5 + 6.25) drug is\neliminated.\nThus, nearly complete drug elimination occurs in 4\u20135 half\nlives.\nFor drugs eliminated by\u2014\nFirst order kinetics\u2014t\u00bd remains constant because V and CL\ndo not change with dose.\nZero order kinetics\u2014t\u00bd gets prolonged with dose because CL\nprogressively decreases as dose is increased. In fact, the", "start_char_idx": 0, "end_char_idx": 396, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "22144d89-14ca-452a-8dde-fff54b9836b0": {"__data__": {"id_": "22144d89-14ca-452a-8dde-fff54b9836b0", "embedding": null, "metadata": {"page_label": "119", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f87bf786-411e-4465-be96-e0942af05730", "node_type": "4", "metadata": {"page_label": "119", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f35f93b89aac91a5517f1c14fa9267e30b0ea18550eeeff967aa2dfbc96994dd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e1472f17-927b-451b-952a-6e76e0460da9", "node_type": "1", "metadata": {"page_label": "118", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "50123068af407cc6f152c0e0b78af79a9ca74a5e5f6351b2242aa9d23b119c2b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1fd1266c-bb2a-40a5-afa2-a5fd76d9fe1f", "node_type": "1", "metadata": {}, "hash": "b49e546c4cabd3740cc918444befa720c1c0b6ee8808bc79a4bcd29659781cfe", "class_name": "RelatedNodeInfo"}}, "text": "concept of t\u00bd is meaningless for such drugs, because, it is not\na fixed value.\nHalf life of some representative drugs\nAspirin 4 hr Digoxin 40 hr\nPenicillin-G 30 min Digitoxin 7 days\nDoxycycline 20 hr Phenobarbitone 90 hr\nRepeated drug administration\nWhen a drug is repeated at relatively short intervals, it\naccumulates in the body until elimination balances input and a\nsteady state plasma concentration (Cpss) is attained\u2014\nFrom this equation it is implied that doubling the dose rate\nwould double the average Cpss and so on. Further, if the\ntherapeutic plasma concentration of the drug has been worked\nout and its CL is known, the dose rate needed to achieve the\ntarget Cpss can be determined\u2014\nDose rate = target Cpss \u00d7 CL ...(8)\nAfter oral administration, often only a fraction (F) of the dose\nreaches systemic circulation in the active form. In such a case\n\u2014", "start_char_idx": 0, "end_char_idx": 862, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1fd1266c-bb2a-40a5-afa2-a5fd76d9fe1f": {"__data__": {"id_": "1fd1266c-bb2a-40a5-afa2-a5fd76d9fe1f", "embedding": null, "metadata": {"page_label": "120", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3db65f1a-9619-4ffc-abda-cbe795458fdb", "node_type": "4", "metadata": {"page_label": "120", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e894852e287b8b33aa2a3049e4a22a860ca842ecbdd3f9b4fe3aa6a0d5619c2a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "22144d89-14ca-452a-8dde-fff54b9836b0", "node_type": "1", "metadata": {"page_label": "119", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f35f93b89aac91a5517f1c14fa9267e30b0ea18550eeeff967aa2dfbc96994dd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c91e46e8-1c03-480a-8db2-2ecbd5d01094", "node_type": "1", "metadata": {}, "hash": "3e014cc4682d496f7e61ff4c0bdb443a982b03555e9286921d03d3142ad84a5b", "class_name": "RelatedNodeInfo"}}, "text": "The dose rate-Cpss relationship is linear only in case of drugs\neliminated by first order kinetics. For drugs (e.g. phenytoin)\nwhich follow Michaelis Menten kinetics, elimination changes\nfrom first order to zero order kinetics over the therapeutic\nrange. Increase in their dose beyond saturation levels causes\nan increase in Cpss which is out of proportion to the change in\ndose rate (Fig. 3.6). In their case:\n   (Vmax) (C)\nRate of drug elimination = \u2014\u2014\u2014\u2014 ...(10)\n   Km + C\nwhere C is the plasma concentration of the drug, Vmax is the\nmaximum rate of drug elimination, and Km is the plasma\nconcentration at which elimination rate is half maximal.\nPlateau principle\nWhen constant dose of a drug is repeated before the expiry of\n4 t\u00bd, it would achieve higher peak concentration, because\nsome remnant of the previous dose will be present in the body.\nThis continues with every dose until progressively increasing\nrate of elimination (which increases with increase in\nconcentration) balances the amount administered over the\ndose interval. Subsequently plasma concentration plateaus and\nfluctuates about an average steady-state level. This is known", "start_char_idx": 0, "end_char_idx": 1145, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c91e46e8-1c03-480a-8db2-2ecbd5d01094": {"__data__": {"id_": "c91e46e8-1c03-480a-8db2-2ecbd5d01094", "embedding": null, "metadata": {"page_label": "121", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "8c3ec96d-940a-4e53-b79f-6c89426de550", "node_type": "4", "metadata": {"page_label": "121", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "006edfd14ac03afbf7ad245bd4c2dfcbe56915b22d2ba5e9d1806fbd36e08817", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1fd1266c-bb2a-40a5-afa2-a5fd76d9fe1f", "node_type": "1", "metadata": {"page_label": "120", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e894852e287b8b33aa2a3049e4a22a860ca842ecbdd3f9b4fe3aa6a0d5619c2a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5eea5ef0-47fd-416e-aa3d-6506e698417f", "node_type": "1", "metadata": {}, "hash": "525303ce4aac4eab9f9443a09cb154b881ab2c805f95e63ad7e48aaa928c2dca", "class_name": "RelatedNodeInfo"}}, "text": "as the plateau principle of drug accumulation. Steady-state is\nreached in 4\u20135 half lives unless dose interval is very much\nlonger than t\u00bd (Fig. 3.7).", "start_char_idx": 0, "end_char_idx": 149, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5eea5ef0-47fd-416e-aa3d-6506e698417f": {"__data__": {"id_": "5eea5ef0-47fd-416e-aa3d-6506e698417f", "embedding": null, "metadata": {"page_label": "122", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "8e670da0-9b15-4e03-86f5-810517dd7da9", "node_type": "4", "metadata": {"page_label": "122", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2e647612ed618be78d1d9abd4473fe0628f5357e8ad50814f3c0ab38c4893d2f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c91e46e8-1c03-480a-8db2-2ecbd5d01094", "node_type": "1", "metadata": {"page_label": "121", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e82c6eba2a56980d92b74155bdc804eef0500e7d54998731eac7244891ea726b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e2d3cde8-10ee-4377-9d2c-8db35e4b7b08", "node_type": "1", "metadata": {}, "hash": "a0f4b9fc0389ab7c16594b7e39e71dd1e4387cf515a32d5de3b493bfcddb8709", "class_name": "RelatedNodeInfo"}}, "text": "The amplitude of fluctuations in plasma concentration at\nsteady-state depends on the dose interval relative to the t\u00bd, i.e.\nthe difference between the maximum and minimum levels is\nless if smaller doses are repeated more frequently (dose rate\nremaining constant). Dose intervals are generally a\ncompromise between what amplitude of fluctuations is\nclinically acceptable (because of loss of efficacy at troughs\nand side effects at peaks) and what frequency of dosing is\nconvenient. However, if the dose rate is changed, a new\naverage Cpss is attained over the next 4\u20135 half lives. When the\ndrug is administered orally (absorption takes some time),", "start_char_idx": 0, "end_char_idx": 646, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e2d3cde8-10ee-4377-9d2c-8db35e4b7b08": {"__data__": {"id_": "e2d3cde8-10ee-4377-9d2c-8db35e4b7b08", "embedding": null, "metadata": {"page_label": "123", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3da9bd7c-b6bf-4a50-a71e-1c7cd9b402c7", "node_type": "4", "metadata": {"page_label": "123", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "800efade94957adb55e8b271ea9048210588e48fa8dacdd0b8f494757aaa1259", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5eea5ef0-47fd-416e-aa3d-6506e698417f", "node_type": "1", "metadata": {"page_label": "122", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2e647612ed618be78d1d9abd4473fe0628f5357e8ad50814f3c0ab38c4893d2f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "be844d6a-f89b-424f-894f-4c0a12182fec", "node_type": "1", "metadata": {}, "hash": "ce7c386f271a6ae04ccf0fcbc40f82b601b035de71d238541ec4788a7bc9832c", "class_name": "RelatedNodeInfo"}}, "text": "average Cpss is approximately 1/3 of the way between the\nminimal and maximal levels in a dose interval.\nTarget level strategy For drugs whose effects are not easily\nquantifiable and safety margin is not big, e.g. anticonvulsants,\nantidepressants, lithium, antiarrhythmics, theophylline, some\nantimicrobials, etc. or those given to prevent an event, it is\nbest to aim at achieving a certain plasma concentration which\nhas been defined to be in the therapeutic range; such data are\nnow available for most drugs of this type.\nDrugs with short t\u00bd (upto 2\u20133 hr) administered at\nconventional intervals (6\u201312 hr) achieve the target levels only\nintermittently and fluctuations in plasma concentration are\nmarked. In case of many drugs (penicillin, ampicillin,\nchloramphenicol, erythromycin, propranolol) this however is\ntherapeutically acceptable.\nFor drugs with longer t\u00bd a dose that is sufficient to attain\nthe target concentration after single administration, if repeated\nwill accumulate according to plateau principle and produce\ntoxicity later on. On the other hand, if the dosing is such as to\nattain target level at steady state, the therapeutic effect will be\ndelayed by about 4 half lives (this may be clinically\nunacceptable). Such drugs are often administered by initial\nloading and subsequent maintenance doses.\nLoading dose This is a single or few quickly repeated doses\ngiven in the beginning to attain target concentration rapidly. It\nmay be calculated as\u2014", "start_char_idx": 0, "end_char_idx": 1463, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "be844d6a-f89b-424f-894f-4c0a12182fec": {"__data__": {"id_": "be844d6a-f89b-424f-894f-4c0a12182fec", "embedding": null, "metadata": {"page_label": "124", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "02a60eb7-b165-40e4-af38-f4898efca15a", "node_type": "4", "metadata": {"page_label": "124", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a31c08e75bbfb1f2a94b9e4266c20cb5c99d7380026a846e9c1ef18c8833114d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e2d3cde8-10ee-4377-9d2c-8db35e4b7b08", "node_type": "1", "metadata": {"page_label": "123", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "800efade94957adb55e8b271ea9048210588e48fa8dacdd0b8f494757aaa1259", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d8b9388a-1750-472e-b1a3-fbc493045a79", "node_type": "1", "metadata": {}, "hash": "cabcc30f0acad204d2de914297b4a6d4b15cccd0879a90be13dc71b20893db22", "class_name": "RelatedNodeInfo"}}, "text": "Thus, loading dose is governed only by V and not by CL or\nt\u00bd.\nMaintenance dose This dose is one that is to be repeated at\nspecified intervals after the attainment of target Cpss so as to\nmaintain the same by balancing elimination. The maintenance\ndose rate is computed by equation (9) and is governed by CL\n(or t\u00bd) of the drug. If facilities for measurement of drug\nconcentration are available, attainment of target level in a\npatient can be verified subsequently and dose rate adjusted if\nrequired.\nSuch two phase dosing provides rapid therapeutic effect\nwith long term safety; frequently applied to digoxin,\nchloroquine, long-acting sulfonamides, doxycycline,\namiodarone, etc. However, if there is no urgency, maintenance\ndoses can be given from the beginning. The concept of\nloading and maintenance dose is valid also for short t\u00bd drugs\nand i.v. administration in critically ill patients, e.g. lidocaine\n(t\u00bd 1.5 hr) used for cardiac arrhythmias is given as an i.v.\nbolus dose followed by slow i.v. infusion or intermittent\nfractional dosing.", "start_char_idx": 0, "end_char_idx": 1044, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d8b9388a-1750-472e-b1a3-fbc493045a79": {"__data__": {"id_": "d8b9388a-1750-472e-b1a3-fbc493045a79", "embedding": null, "metadata": {"page_label": "125", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ea261dc5-38d3-4fcd-96a5-e2b852b482a4", "node_type": "4", "metadata": {"page_label": "125", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "cb844c03f2043d4ce6f7c6f07c047d213c2d0ffa59cd084628b83bbb12fa7032", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "be844d6a-f89b-424f-894f-4c0a12182fec", "node_type": "1", "metadata": {"page_label": "124", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a31c08e75bbfb1f2a94b9e4266c20cb5c99d7380026a846e9c1ef18c8833114d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "086de2c2-c9b7-4ad4-ade5-6aae324119fd", "node_type": "1", "metadata": {}, "hash": "2d88aead26ca9520777b8a19d90deabb7f43466e33476e30387b19916f778753", "class_name": "RelatedNodeInfo"}}, "text": "Monitoring of plasma concentration of drugs It is clear\nfrom the above considerations that the Cpss of a drug attained\nin a given patient depends on its F, V and CL in that patient.\nBecau se each of these parameters varies considerably among\nindividuals, the actual Cpss in a patient may be 1/3 to 3 times\nthat calculated on the basis of population data. Measurement\nof plasma drug concentration can give an estimate of the\npharmacokinetic variables in that patient and the magnitude of\ndeviation from the \u2018average patient\u2019, so that appropriate\nadjustments in the dosage regimen can be made.\nIn case of drugs obeying first order kinetics:\nTherapeutic drug monitoring (TDM) is particularly useful in\nthe following situations:\n1.Drugs with low safety margin, e.g. \u2014digoxin,\nanticonvulsants, antiarrhythmics, theophylline,\naminoglycoside antibiotics, lithium, tricyclic\nantidepressants.\n2.If individual variations are large, e.g.\u2014antidepressants,\nlithium.\n3.Potentially toxic drugs used in the presence of renal failure,\ne.g. \u2014aminoglycoside antibiotics, vancomycin.\n4.In case of poisoning.\n5.In case of failure of response without any apparent reason,\ne.g. \u2014antimicrobials.", "start_char_idx": 0, "end_char_idx": 1171, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "086de2c2-c9b7-4ad4-ade5-6aae324119fd": {"__data__": {"id_": "086de2c2-c9b7-4ad4-ade5-6aae324119fd", "embedding": null, "metadata": {"page_label": "126", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3d74a877-8dd5-4a30-96ba-7cff3f8a41b0", "node_type": "4", "metadata": {"page_label": "126", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "45995b2f13f8eac3f28700e2c15148a8e5349a707254c6b1283ef410b875f3d2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d8b9388a-1750-472e-b1a3-fbc493045a79", "node_type": "1", "metadata": {"page_label": "125", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "cb844c03f2043d4ce6f7c6f07c047d213c2d0ffa59cd084628b83bbb12fa7032", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a136851a-b9eb-4113-8f31-bd99aba2628b", "node_type": "1", "metadata": {}, "hash": "b1174cdb66e9365f74502dbd5d130fe8d9783d0497fbec3859bf0adc31847de0", "class_name": "RelatedNodeInfo"}}, "text": "6.To check patient compliance, e.g. \u2014\npsychopharmacological agents.\nSelection of the correct interva l between drug administration  and drawing of\nblood sample for TDM is critica l, and depends on the purpose of TDM as well as\nthe nature of the drug.\na.When the purpose is dose adjustment : In case of drugs which need to act\ncontinuously (relatively long-acting drugs), it is prudent to measure the\ntrough steady-state blood levels, i.e. just prior to the next dose, because this\nis governed by both V and CL. On the other hand, for short-acting drugs\nwhich achieve therapeutic levels only intermittently (e.g. ampicillin,\ngentamicin), sampling is done in the immediate post-absorptive phase\n(usually after 1\u20132 hours of oral/i.m. dosing) to reflect the peak levels.\nb.In case of poisoning : Blood for drug level estimatio n should be taken at the\nearliest to confir m the poisoning and to assess its seriousness. It should then\nbe repeated at intervals to estimate the drug clearance in the affected patient,\nand the need to hasten elimination (e.g. by haemodialysis).\nc.For checking compliance to medication : Even random blood sampling  can\nbe informative.\nMonitoring of plasma concentration is of no value for\n1.Drugs whose response is easily measurable, e.g.\u2014\nantihypertensives, hypoglycaemics, diuretics, oral\nanticoagulants, inhalational general anaesthetics.\n2.Drugs activated in the body, e.g.\u2014levodopa.\n3.\u2018Hit and run drugs\u2019 (whose effect lasts much longer than\nthe drug itself), e.g.\u2014reserpine, guanethidine, MAO\ninhibitors, omeprazole.\n4.Drugs with irreversible action, e.g.\u2014organophosphate\nanticholinesterases, phenoxybenzamine.\nPROLONGATION OF DRUG ACTION", "start_char_idx": 0, "end_char_idx": 1669, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a136851a-b9eb-4113-8f31-bd99aba2628b": {"__data__": {"id_": "a136851a-b9eb-4113-8f31-bd99aba2628b", "embedding": null, "metadata": {"page_label": "127", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "a0c81d9c-c7a1-46b5-b811-9659373da46f", "node_type": "4", "metadata": {"page_label": "127", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4ec2a0117a2b38b6b9896cb7c2cf8ae6ea9487993ed93b7bbcb13bdaa1572fad", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "086de2c2-c9b7-4ad4-ade5-6aae324119fd", "node_type": "1", "metadata": {"page_label": "126", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "45995b2f13f8eac3f28700e2c15148a8e5349a707254c6b1283ef410b875f3d2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d7da607f-cc31-4804-9b23-02f157a01fb7", "node_type": "1", "metadata": {}, "hash": "136df16328e8e132ed7a510e26a624455e6b720317237c5e3f038221c90d51fd", "class_name": "RelatedNodeInfo"}}, "text": "It is sometimes advantageous to modify a drug in such a way\nthat it acts for a longer period. By doing so:\n(i) Frequency of administration is reduced\u2014more convenient.\n(ii) Improved patient compliance\u2014a single morning dose is\nless likely to be forgotten/omitted than a 6 or 8 hourly\nregimen; a monthly or quarterly administered contraceptive\nover one that has to be taken daily.\n(iii) Large fluctuations in plasma concentration are avoided\u2014\nside effects related to high peak plasma level just after a dose\n(e.g. nifedipine) would be minimized; better round-the-clock\ncontrol of blood sugar level, etc.\n(iv) Drug effect could be maintained overnight without\ndisturbing sleep, e.g. antiasthmatics, anticonvulsants, etc.\nHowever, all drugs do not need to be made long acting, e.g.\nthose used for brief therapeutic effect (sleep-inducing\nhypnotic, headache remedy) or those with inherently long\nduration of action (doxycycline, omeprazole, digoxin,\namlodipine). Drugs with t\u00bd < 4 hr are suitable for controlled\nrelease formulations, while there is no need of such\nformulations for drugs with t\u00bd >12 hr. Methods utilized for\nprolonging drug action are summarised below. Some of these\nhave already been described.\n1. By prolonging absorption from site of administration\n(a) Oral Sustained release tablets, spansule capsules, etc.;\ndrug particles are coated with resins, plastic materials or other\nsubstances which temporally disperse release of the active", "start_char_idx": 0, "end_char_idx": 1448, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d7da607f-cc31-4804-9b23-02f157a01fb7": {"__data__": {"id_": "d7da607f-cc31-4804-9b23-02f157a01fb7", "embedding": null, "metadata": {"page_label": "128", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9692a391-075f-4f0b-98d2-4f8f725480a8", "node_type": "4", "metadata": {"page_label": "128", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3acf46da25ef511543cb12db6de55920f379d9cef3d521a81cae84698199a3dc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a136851a-b9eb-4113-8f31-bd99aba2628b", "node_type": "1", "metadata": {"page_label": "127", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4ec2a0117a2b38b6b9896cb7c2cf8ae6ea9487993ed93b7bbcb13bdaa1572fad", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eb1cd267-e344-4453-b477-2c3064243332", "node_type": "1", "metadata": {}, "hash": "07a8087646070df3b9cd081dce46d48f41ff62a91a22a35738e96748d99f4400", "class_name": "RelatedNodeInfo"}}, "text": "ingredient in the g.i.t. Another technique (controlled release\ntablet/capsule; Fig. 3.8) utilizes a semipermeable membrane to\ncontrol the release of drug from the dosage form. Such\npreparations prolong the action by 4 to 8 hours and no more,\nbecause in that time drug particles reach the colon. Also, the\ndrug release pattern and consequently the attained blood levels\nof the drug may be more variable than the regular tablet of the\nsame drug.\n(b) Parenteral The s.c. and i.m. injection of drug in insoluble\nform (benzathine penicillin, lente insulin) or as oily solution\n(depot progestins); pellet implantation, sialistic and\nbiodegradable implants can provide for its absorption over a\ncouple of days to several months or even years. Inclusion of a\nvasoconstrictor with the drug also delays absorption\n(adrenaline with local anaesthetics).\n(c) Transdermal  drug  delivery  systems The drug\nimpregnated in adhesive patches, strips or as ointment applied\non skin is utilized in some cases to prolong drug action, e.g.\nGTN (see p. 12).\n2. By increasing plasma protein binding\nDrug congeners have been prepared which are highly bound to\nplasma protein and are slowly released in the free active form,\ne.g. sulfadoxine.\n3. By retarding rate of metabolism Small chemical\nmodification can markedly affect the rate of metabolism", "start_char_idx": 0, "end_char_idx": 1322, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "eb1cd267-e344-4453-b477-2c3064243332": {"__data__": {"id_": "eb1cd267-e344-4453-b477-2c3064243332", "embedding": null, "metadata": {"page_label": "129", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9c3b9bca-c8d2-4e65-bf4d-2b816ea6cc62", "node_type": "4", "metadata": {"page_label": "129", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8e30ca8300bc0a9204f566d566eecfb64fceed08e73bba3ba7e2ed6e9b651b30", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d7da607f-cc31-4804-9b23-02f157a01fb7", "node_type": "1", "metadata": {"page_label": "128", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3acf46da25ef511543cb12db6de55920f379d9cef3d521a81cae84698199a3dc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f7f67e78-e038-4129-a82c-9fc06c925527", "node_type": "1", "metadata": {}, "hash": "717f3b90893920c8e749b03bb295e5933a92931512c60e2389884ce651172f54", "class_name": "RelatedNodeInfo"}}, "text": "without affecting the biological action, e.g. addition of ethinyl\ngroup to estradiol (ethinyl estradiol) makes it longer acting\nand suitable for use as oral contraceptive. Inhibition of\nspecific enzyme by one drug can prolong the action of another\ndrug, e.g. allopurinol inhibits the degradation of 6-\nmercaptopurine, ritonavir boosts the levels of\natazanavir/lopinavir/saquinavir, cilastatin protects imipenem\nfrom degradation in kidney.\n4. By retarding renal excretion The tubular secretion of\ndrug being an active process, can be suppressed by a\ncompeting substance, e.g. probenecid prolongs duration of\naction of penicillin, ampicillin and amoxicillin.\nTargeted drug delivery devices\nSome new devices have been invented (and many are under\ndevelopment) to localise and prolong the delivery of the\ncontained drug to a specific target organ. The ones already in\nuse are:\n1. Liposomes  These are unilamellar or bilamellar nano-\nvesicles (60\u201380 nM) produced by sonication of lecithin or\nother biodegradable phospholipids. Since liposomes injected\ni.v. are selectively taken up by reticuloendothelial cells,\nespecially liver and spleen, and some malignant cells, the drug\nincorporated in them gets selectively delivered to these cells.\nLiposomal amphotericin B is being used in Kala azar and\nsome serious cases of systemic mycosis. Antibody tagging of", "start_char_idx": 0, "end_char_idx": 1350, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f7f67e78-e038-4129-a82c-9fc06c925527": {"__data__": {"id_": "f7f67e78-e038-4129-a82c-9fc06c925527", "embedding": null, "metadata": {"page_label": "130", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "2b37ed4a-3ae2-4d24-a45f-7ffb0e19330e", "node_type": "4", "metadata": {"page_label": "130", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "62ba376c1171a1031598e5193e0844c78c5ee09f590f588ee20fa8b29b44097a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eb1cd267-e344-4453-b477-2c3064243332", "node_type": "1", "metadata": {"page_label": "129", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8e30ca8300bc0a9204f566d566eecfb64fceed08e73bba3ba7e2ed6e9b651b30", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "82294db1-ce50-46e8-8f5f-12ba8c882bd0", "node_type": "1", "metadata": {}, "hash": "44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a", "class_name": "RelatedNodeInfo"}}, "text": "liposomes is being tried as a means to target other specific\ntissues.\n2. Drug  releasing  implants The implant is coated with the\ndrug using special techniques and then placed in the target\norgan to provide prolonged delivery of minute quantities of\nthe drug by slow release. Progestin impregnated intrauterine\ncontraceptive device (IUCD) affords protection for upto 5\nyears. It is also being tried for other gynaecological problems.\nAntithrombotic drug coated stents (devices placed in the\nthrombosed coronary artery after balloon angioplasty to keep\nit patent) are in use to prevent restenosis and failure of\nangioplasty.", "start_char_idx": 0, "end_char_idx": 623, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "82294db1-ce50-46e8-8f5f-12ba8c882bd0": {"__data__": {"id_": "82294db1-ce50-46e8-8f5f-12ba8c882bd0", "embedding": null, "metadata": {"page_label": "131", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ab182a08-8508-4847-862e-4108710f3148", "node_type": "4", "metadata": {"page_label": "131", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "edae17af9ed6f190be405a70559ce201d7e4b993cbb6ff895ceb8acc3afba6f7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f7f67e78-e038-4129-a82c-9fc06c925527", "node_type": "1", "metadata": {"page_label": "130", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "62ba376c1171a1031598e5193e0844c78c5ee09f590f588ee20fa8b29b44097a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0f03ae1e-da80-49fb-b968-f332810a2037", "node_type": "1", "metadata": {}, "hash": "5e7f14e54bf957945f076317f174a0c7df05ce499ee3120f192fa54ecc56262e", "class_name": "RelatedNodeInfo"}}, "text": "", "start_char_idx": 0, "end_char_idx": 0, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0f03ae1e-da80-49fb-b968-f332810a2037": {"__data__": {"id_": "0f03ae1e-da80-49fb-b968-f332810a2037", "embedding": null, "metadata": {"page_label": "132", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "1b5ff0c6-0c8b-4ba4-bab7-3e599bc10011", "node_type": "4", "metadata": {"page_label": "132", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "25924140c2bb27948cc319f430a4fd6063c3f6b74b94874d5c860764e7f5708b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "82294db1-ce50-46e8-8f5f-12ba8c882bd0", "node_type": "1", "metadata": {"page_label": "131", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "edae17af9ed6f190be405a70559ce201d7e4b993cbb6ff895ceb8acc3afba6f7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c6175a71-6558-4421-a995-f68383221ed5", "node_type": "1", "metadata": {}, "hash": "e58d3ee563fa62a7d34568a3ddf39c373dbfe8c79e4ea1da43df0b94e3671eae", "class_name": "RelatedNodeInfo"}}, "text": "Pharmacodynamics is the study of drug effects. It starts with describing what the drugs do, and\ngoes on to explain how they do it. Thus, it attempts to elucidate the complete action-ef fect\nsequence and the dose-ef fect relationship. Modification of the action of one drug by another\ndrug is also an aspect of pharmacodynamics.\nPRINCIPLES OF DRUG ACTION\nDrugs (except those gene based) do not impart new functions  to any system, organ or cell;\nthey only alter the pace of ongoing activity . However , this alone  can have profound medicinal\nas well as toxicological impact. The basic types of drug action can be broadly classed as:\n1. Stimulation It refers to selective enhancement of the level of activity of specialized cells, e.g. adrenaline\nstimulates heart, pilocarpine stimulates salivary glands. However, excessive stimulation is often followed by\ndepression of that function, e.g. high dose of picrotoxin, a central nervous system (CNS) stimulant, produces\nconvulsions followed by coma and respiratory depression.\n2. Depression It means selective diminution of activity of specialized cells, e.g. barbiturates depress CNS,\nquinidine depresses heart, omeprazole depresses gastric acid secretion. Certain drugs stimulate one type of cells\nbut depress the other, e.g. acetylcholine stimulates intestinal smooth muscle but depresses SA node in heart. Thus,\nmost drugs cannot be simply classed as stimulants or depressants.\n3. Irritation This connotes a nonselective, often noxious effect and is particularly applied to less specialized cells\n(epithelium, connective tissue). Strong irritation results in inflammation, corrosion, necrosis and morphological\ndamage. This may result in diminution or loss of function.\n4. Replacement This refers to the use of natural metabolites, hormones or their congeners in deficiency states,\ne.g. levodopa in parkinsonism, insulin in diabetes mellitus, iron in anaemia.\n5. Cytotoxic action Selective cytotoxic action on invading parasites or cancer cells, attenuating them without\nsignificantly affecting the host cells is utilized for cure/palliation of infections and neoplasms, e.g. penicillin,\nchloroquine, zidovudine, cyclophosphamide, etc.\nMECHANISM OF DRUG ACTION\nOnly a handful of drugs act by virtue of their simple physical or chemical property; examples\nare:\n\u2022Bulk laxatives (ispaghula)\u2014physical mass\n\u2022Dimethicone, petroleum jelly\u2014physical form, opacity\n\u2022Paraamino benzoic acid\u2014absorption of UV  rays\n\u2022Activated charcoal\u2014adsorptive property\n\u2022Mannitol, mag. sulfate\u2014osmotic activity\n\u2022 131I and other radioisotopes\u2014radioactivity", "start_char_idx": 0, "end_char_idx": 2577, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c6175a71-6558-4421-a995-f68383221ed5": {"__data__": {"id_": "c6175a71-6558-4421-a995-f68383221ed5", "embedding": null, "metadata": {"page_label": "133", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "370ad65f-d6bb-4518-a92e-229fba23c55f", "node_type": "4", "metadata": {"page_label": "133", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2001d0e09597c30670e67703c25cd7cad05bb72998227bbeb86bca30391211cd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0f03ae1e-da80-49fb-b968-f332810a2037", "node_type": "1", "metadata": {"page_label": "132", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "25924140c2bb27948cc319f430a4fd6063c3f6b74b94874d5c860764e7f5708b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "06a94c96-5ff3-41dd-8937-5d6e6c270d7c", "node_type": "1", "metadata": {}, "hash": "44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a", "class_name": "RelatedNodeInfo"}}, "text": "\u2022Antacids\u2014neutralization of gastric HCl\n\u2022Pot. permanganate\u2014oxidizing property\n\u2022Chelating agents (EDT A, dimercaprol)\u2014chelation of heavy metals.\n\u2022Cholestyramine\u2014sequestration of bile acids and cholesterol in the gut\n\u2022Mesna\u2014Scavenging of vasicotoxic reactive metabolites of cyclophosphamide\nMajority of drugs produce their effects by interacting with a discrete target biomolecules,\nwhich usually are proteins. Such mechanism confers selectivity of action to the drug.\nFunctional prote ins that are targets of drug action can be grouped into four major categories ,\nviz. enzyme s, ion channels, transpo rters and receptors (see Fig. 4.1). Howev er, a few drugs do\nact on other proteins (e.g. colchicine, vinca alkaloids, taxanes  bind to the structural protein\ntubulin) or on nucleic acids (alkylating agents).\nI. ENZYMES\nAlmost all biological reactions are carried out under catalytic influence of enzymes; hence,\nenzymes are a very important target of drug action. Drugs can either increase or decrease the\nrate of enzymati cally mediated reactions. However , in physiological systems enzyme activities\nare often optimally set. Thus, stimulation of enzymes by drugs, that are truly foreign\nsubstances, is unusual. Enzyme stimulation is relevant to some  natural metabolites only, e.g. \npyridoxine acts as a cofactor and increases decarboxylase activity . Several enzymes are\nstimulated throu gh receptors and second messengers, e.g. adrenaline stimulates hepatic\nglycogen phosphorylase through \u03b2 recepto rs and cyclic AMP . Stimulation of an enzyme\nincreases its affinity for the substrate so that rate constant (kM) of the reaction is lowered (Fig.\n4.2).\nApparent increa se in enzyme activity can also occur by enzyme inductio n, i.e. synthesis of\nmore enzyme protein. This cannot be called stimulation because the kM does not change.\nMany drugs induce microsomal enzymes ( see p. 33).", "start_char_idx": 0, "end_char_idx": 1886, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "06a94c96-5ff3-41dd-8937-5d6e6c270d7c": {"__data__": {"id_": "06a94c96-5ff3-41dd-8937-5d6e6c270d7c", "embedding": null, "metadata": {"page_label": "134", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b57a3c3c-4ffc-4e09-90b1-c1d06a66013f", "node_type": "4", "metadata": {"page_label": "134", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "72480e70522d862449da1ed04314cdf3eef9f50054a103f7944f5706dc29b0df", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c6175a71-6558-4421-a995-f68383221ed5", "node_type": "1", "metadata": {"page_label": "133", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2001d0e09597c30670e67703c25cd7cad05bb72998227bbeb86bca30391211cd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "094c40b5-e4b3-41f3-86e9-92a92e1b7561", "node_type": "1", "metadata": {}, "hash": "7292defc9f76d01b9b0f2b9a03e262e57969b5b54efac8d0c380f8cbefcd1732", "class_name": "RelatedNodeInfo"}}, "text": "", "start_char_idx": 0, "end_char_idx": 0, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "094c40b5-e4b3-41f3-86e9-92a92e1b7561": {"__data__": {"id_": "094c40b5-e4b3-41f3-86e9-92a92e1b7561", "embedding": null, "metadata": {"page_label": "135", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "7b4e3869-a70b-4da9-ab75-a91ef80b3856", "node_type": "4", "metadata": {"page_label": "135", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a0c14c93a889d31e680cf7ac85da66d64c87ee0044665100e565beaa26a73191", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "06a94c96-5ff3-41dd-8937-5d6e6c270d7c", "node_type": "1", "metadata": {"page_label": "134", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "72480e70522d862449da1ed04314cdf3eef9f50054a103f7944f5706dc29b0df", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cc37bf71-a09b-4821-8e8b-29181dd76790", "node_type": "1", "metadata": {}, "hash": "c2fe9e55f12b56179f247c77a013fc860538ba35ef8d45196ec0ed08285f2e55", "class_name": "RelatedNodeInfo"}}, "text": "Enzyme Endogenous\u00a0 substrate Competitive\ninhibitor\nCholinesterase Acetylcholine\u00a0 \u00a0 Physostigmine,\nNeostigmine\nMonoamine-oxidase A (MAO-A) Catecholamines Moclobemide\nDopa decarboxylase Levodopa Carbidopa, Benserazide\nXanthine oxidase Hypoxanthine Allopurinol\nAngiotensin converting\u00a0 enzyme\n(ACE)Angiotensin-1 Captopril\n5\u03b1-Reductase Testosterone Finasteride\nAromatase Testosterone,\nAndrostenedioneLetrozole, Anastrozole\nBacterial folate synthase Para-amino benzoic acid\n(PABA)Sulfadiazine\nEnzyme inhibition\nSome chemicals  (heavy metal salts, strong acids and alkalies, formaldehyde, phenol, etc.)\ndenature proteins and inhibit all enzymes nonselectively . They have limited medicinal value", "start_char_idx": 0, "end_char_idx": 688, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "cc37bf71-a09b-4821-8e8b-29181dd76790": {"__data__": {"id_": "cc37bf71-a09b-4821-8e8b-29181dd76790", "embedding": null, "metadata": {"page_label": "136", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3996f212-626a-4ffc-b429-8889f30f4bcb", "node_type": "4", "metadata": {"page_label": "136", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3f38690b28e6f53474c5138f6a3b492698fc9a79187ad441e3e2ee15b0cc2610", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "094c40b5-e4b3-41f3-86e9-92a92e1b7561", "node_type": "1", "metadata": {"page_label": "135", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a0c14c93a889d31e680cf7ac85da66d64c87ee0044665100e565beaa26a73191", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "165129f6-27e1-43ff-8a7a-bd4387182fce", "node_type": "1", "metadata": {}, "hash": "b148a42e9b3b6fa41f93bc15491162e66b4cb828a948afed928957e6468a0a11", "class_name": "RelatedNodeInfo"}}, "text": "restricted to external application  only. However , selective inhibition of a particular enzyme is a\ncommon mode of drug action. Such inhibition is either competitive or noncompetitive.\n(i) Com petitive (equilibrium  type ) The drug  being structurally similar competes with the\nnormal substrate for the catalytic binding site of the enzyme so that the product is not formed\nor a nonfunctional product is formed (Fig. 4.1A), and a new equilibrium is achieved in the\npresence of the drug. Such inhibitors increase the kM but the Vmax  remains unchanged (Fig.\n4.2), i.e. higher concentration of the substrate is required to achieve \u00bd maximal reaction\nvelocity , but if substrate concen tration is sufficiently increased , it can displace the inhibitor\nand the same maximal reaction velocity can be attained. Examples are given in the box above.\nA nonequilibrium  type of enzyme inhibition can also occur with drugs which react with\nthe same catalytic site of the enzyme but either form strong covalent bonds or have such high\naffinity for the enzyme that the normal substrate is not able to displace the inhibitor , e.g.\n\u2022Organophosphates react covalently with the esteretic site of the enzyme cholinesterase.\n\u2022Methotrexate has 50,000 times higher affinity for dihydrofolate  reductase than the normal\nsubstrate DHF A.\nIn these situations, kM is increased and Vmax  is reduced.\n(ii) Noncompetitive  The inhibitor reacts with an adjacent site and not with the catalytic site,\nbut alters the enzyme in such a way that it loses its catalytic property . Thus, kM is uncha nged\nbut Vmax  is reduced. Examples are given in the box.\nNoncompetitive inhibitor Enzyme\nAcetazolamide \u2014 Carbonic anhydrase\nAspirin, indomethacin \u2014 Cyclooxygenase\nDisul\ufb01ram \u2014 Aldehyde\u00a0 dehydrogenase\nOmeprazole \u2014 H+ K+ ATPase\nDigoxin \u2014 Na+ K+ ATPase\nTheophylline \u2014 Phosphodiesterase\nPropylthiouracil \u2014 Peroxidase in thyroid\nLovastatin \u2014 HMG-CoA reductase\nSildena\ufb01l \u2014 Phosphodiesterase-5\nII. ION CHANNELS\nProteins which act as ion selective channels participate in transmembrane signaling and\nregulate intracel lular ionic composition. This makes them a common target of drug action\n(Fig. 4.1B). Drugs can affect ion channels, some of which actua lly are receptors, because they\nare operated by specific signal molecules either directly and are called ligand gated channels\n(e.g. nicotinic receptor , see Fig. 4.4) or through G-proteins and are termed G-pr otein regulated\nchannels (e.g. cardiac \u03b21 adrener gic receptor activated Ca2+ channel, see Table 4.1). Drugs can", "start_char_idx": 0, "end_char_idx": 2534, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "165129f6-27e1-43ff-8a7a-bd4387182fce": {"__data__": {"id_": "165129f6-27e1-43ff-8a7a-bd4387182fce", "embedding": null, "metadata": {"page_label": "137", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b6cd6c7b-8bf5-4087-be57-529c062dd6c9", "node_type": "4", "metadata": {"page_label": "137", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "80edb3279489bbae821324cf6fe5abf51a49a5fdcf3f127b005be90a3868d4d9", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cc37bf71-a09b-4821-8e8b-29181dd76790", "node_type": "1", "metadata": {"page_label": "136", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3f38690b28e6f53474c5138f6a3b492698fc9a79187ad441e3e2ee15b0cc2610", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dd11df96-a684-4447-9909-080c254e68aa", "node_type": "1", "metadata": {}, "hash": "3c6650fa1aef21b33d735c303288aec6fca48890adc9aac118fd69c19a89d9c4", "class_name": "RelatedNodeInfo"}}, "text": "also act on voltage operated and stretch sensitive channels by directly binding to the channel\nand affecting ion movement through it, e.g. local anaesthetics which  obstruct voltage sensitive\nNa+ channels (see Ch. 26). In addition, certain drugs modulate opening and closing of the\nchannels, e.g.:\n\u2022Quinidine blocks myocardial Na+ channels.\n\u2022Dofetilide and amiodarone block myocardial delayed rectifier K+ channel.\n\u2022Nifedipine blocks L-type of voltage sensitive Ca2+ channel.\n\u2022Nicorandil opens ATP-sensitive K+ channels.\n\u2022Sulfonylurea hypoglycaemics inhibit pan-creatic ATP-sensitive K+ channels ( see Fig. 19.6).\n\u2022Amiloride inhibits renal epithelial Na+ channels ( see Fig. 42.3).\n\u2022Phenytoin modulates (prolongs the inactivated state of) volta ge sensitive neuronal Na+\nchannel (Fig. 30.1).\n\u2022Ethosuximide inhibits T-type of Ca2+ channels in thalamic neurones.\nIII. TRANSPORTERS\nSeveral substrates are transloc ated across membranes by binding to specific transporters\n(carriers) which either facilitate diffusion in the direction of the concentration gradient or\npump the metab olite/ion against  the concentration gradient using metabolic energy (see p. 18\u2013\n19; Fig. 2.5). Many drugs produce their action by directly interacting with the solute carrier\n(SLC) class of transporter proteins to inhibit the ongoing physiological transport of the\nmetabolite/ion (Fig. 4.1C). Examples are:\n\u2022Desipramine and cocaine block  neuronal reuptake of noradrenaline by interacting with\nnorepinephrine transporter (NET) as depicted in Fig. 9.4.\n\u2022Fluoxetine (and other SSRIs) inhibit neuronal reuptake of 5-HT  by interacting with\nserotonin transporter (SER T), Fig. 33.1.\n\u2022Amphetamines selectively block dopamine reuptake in brain neurons by dopamine\ntransporter (DA T).\n\u2022Reserpine block s the vesicular reuptake of noradrenaline and 5-HT  by the vesicular mono-\namine transporter (VMA T-2), see Fig. 9.4.\n\u2022Hemicholinium blocks choline uptake into choliner gic neurones  and depletes acetylcholine\n(see Fig. 7.1).\n\u2022The anticonvulsant tiagabine acts by inhibiting reuptake of GABA into brain neurones by\nGABA  transporter GA T1 (see Fig. 30.1).\n\u2022Furosemide inhibits the Na+K+2Cl\u00af cotransporter in the ascending limb of loop of Henle\n(see Fig. 42.1).\n\u2022Hydrochlorothiazide inhibits the Na+Cl\u00af  symporter in the early distal tubule (see Fig.\n42.2).\n\u2022Probenecid inhibits active transport of organic acids (uric acid, penicillin) in renal tubules\nby interacting with or ganic anion transporter ( OAT).\nIV. RECEPT ORS", "start_char_idx": 0, "end_char_idx": 2497, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "dd11df96-a684-4447-9909-080c254e68aa": {"__data__": {"id_": "dd11df96-a684-4447-9909-080c254e68aa", "embedding": null, "metadata": {"page_label": "138", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f543d312-d064-4f4c-b941-f1f44e6a03ee", "node_type": "4", "metadata": {"page_label": "138", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "72906c22bef50e258853e2b165b985ff7d2f2e98995188f279e5e0b2e627ab3f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "165129f6-27e1-43ff-8a7a-bd4387182fce", "node_type": "1", "metadata": {"page_label": "137", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "80edb3279489bbae821324cf6fe5abf51a49a5fdcf3f127b005be90a3868d4d9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "29a64b12-37e0-434a-aaa6-45e43d80917c", "node_type": "1", "metadata": {}, "hash": "06e5264a0fd031e2d08835e6a1dc28c8c846b048bbd468ec468f3b146e7fcd3a", "class_name": "RelatedNodeInfo"}}, "text": "The largest number of drugs do not bind directly to the effectors, viz. enzymes, channels,\ntransporters, structural proteins, template biomolecules, etc. but act through specific regulatory\nmacromolecules which control the above listed effectors. These  regulatory macromolecules or\nthe sites on them which associate with and interact with the drug are called \u2018receptors\u2019.\nReceptor : It is defined as a macr omolecule or binding site located on the surface or inside the\neffector cell that serves to recog nize the signal molecule/drug and initiate the response to it,\nbut itself has no other function .\nThough, in a broad sense all types of target biomolecules, including the effectors (enzymes, channels,\ntransporters, etc.) with which a drug can bind to produce its action have been denoted as \u2018receptors\u2019 by some\nauthors, such designation tends to steal the specific meaning of this important term. If so applied, xanthine\noxidase would be the \u2018receptor\u2019 for allopurinol, L-type Ca2+ channel would be the \u2018receptor\u2019 for nifedipine,\nserotonin transporter (SERT) would be the \u2018receptor\u2019 for fluoxetine; a connotation not in consonence with the\ngeneral understanding of the term \u2018receptor\u2019. It is therefore better to reserve the term \u2018receptor\u2019 for purely\nregulatory macromolecules which combine with and mediate the action of signal molecules including drugs.\nThe following terms are used in describing drug-receptor interaction:\nAgonist  An agent which activates a receptor to produce an effect similar to that of the\nphysiological signal molecule.\nInverse  agonist  An agent which activates a receptor to produce an effect in the opposite\ndirection to that of the agonist.\nAntagonist  An agent which  prevents the action of an agonist on a receptor or the subsequent\nresponse, but does not have any ef fect of its own.\nPartial  agonist  An agent which activates a receptor to produce submaxim al effect but\nantagonizes the action of a full agonist.\nLigand  (Latin: ligar e\u2014to bind) Any molecule which attaches selectively to particular\nreceptors or sites. The term only indicates affinity or ability to bind without regard to\nfunctional change: agonists and competitive antagonists are both ligands of the same receptor .\nThe overall scheme of drug action through receptors is depicted in Fig. 4.1D.\nBasic evidences for drug action through receptors\n(i) Many drugs exhibit structural specificity of action, i.e. specific chemical configuration is associated with a\nparticular action, e.g. isopropyl substitution on the ethylamine side chain of sympathetic drugs produces\ncompounds with marked cardiac and bronchial activity\u2014most \uf062 adrenergic agonists and antagonists have this\nsubstitution. A 3 carbon internitrogen separation in the side chain of phenothiazines results in antidopaminergic-\nantipsychotic compounds, whereas 2 carbon separation produces anticholinergic-antihistaminic compounds.\nFurther, chiral drugs show stereospecificity in action, e.g. levo noradrenaline is 10 times more potent than dextro\nnoradrenaline; d-propranolol is about 100 times less potent in blocking \u03b2 receptors than the l-isomer, but both are\nequipotent local anaesthetics.\nThus, the cell must have some mechanism to recognize a particular chemical configuration and three\ndimensional structure.", "start_char_idx": 0, "end_char_idx": 3284, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "29a64b12-37e0-434a-aaa6-45e43d80917c": {"__data__": {"id_": "29a64b12-37e0-434a-aaa6-45e43d80917c", "embedding": null, "metadata": {"page_label": "139", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b77f5397-d305-46d3-8437-90cb3f7dd3ca", "node_type": "4", "metadata": {"page_label": "139", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "d6eec574c646a81acfbb2e2e31f4fe72a9c720ded47e42a7c7953f5aa926cd31", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dd11df96-a684-4447-9909-080c254e68aa", "node_type": "1", "metadata": {"page_label": "138", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "72906c22bef50e258853e2b165b985ff7d2f2e98995188f279e5e0b2e627ab3f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d7f9b65b-fe0e-407d-a907-3ed9071c1670", "node_type": "1", "metadata": {}, "hash": "ac7a349776a7c1fe9cce7edde29a53d929fea92668457e2e457b01dd08b13406", "class_name": "RelatedNodeInfo"}}, "text": "(ii) Competitive antagonism is seen between specific agonists and antagonists. Langley in 1878 was so impressed\nby the mutual antagonism among two alkaloids pilocarpine and atropine that he proposed that both reacted with\nthe same \u2018receptive substance\u2019 on the cell. Ehrlich (1900) observed quantitative neutralization between toxins and\nantitoxins and designated \u2018receptor\u2019 to be the anchoring group of the protoplasmic molecule for the administered\ncompound.\n(iii) It was calculated by Clark that adrenaline and acetylcholine produce their maximal effect on frog\u2019s heart by\noccupying only 1/6000th of the cardiac cell surface\u2014thus, special regions of reactivity to such drugs must be\npresent on the cell.\nReceptor occupation theory\nAfter studying quantitative aspects of drug action, Clark (1937 ) propounded a theory of drug\naction based on occupation of receptors by specific drugs and that the pace of a cellular\nfunction can be altered by interaction of these receptors with drugs which, in fact, are small\nmolecular ligand s. He perceived the interaction between the two molecular species, viz. drug\n(D ) and receptor (R) to be governed  by the law of mass action, and the effect (E) to be a direct\nfunction of the drug-receptor complex ( DR) formed:\nSubsequently , it was realized that occupa tion of the receptor is essential but not itself\nsufficient to elicit a response; the agonist must also be able to activate (induce a\nconformational change in) the receptor . The ability to bind with the receptor designated as\naffinity , and the capacity  to induce a functional change in the receptor designated as intrinsic\nactivity (IA) or efficacy are independent properties.\nAffinity  of a drug for a receptor determines its concetration around the receptor required to\nform a certain number of drug-receptor associations (DRs). Higher affinity implies that the\nsame number of DRs will be formed at lower concentrations of the drug, compared to another\ndrug which has lower af finity .", "start_char_idx": 0, "end_char_idx": 1990, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d7f9b65b-fe0e-407d-a907-3ed9071c1670": {"__data__": {"id_": "d7f9b65b-fe0e-407d-a907-3ed9071c1670", "embedding": null, "metadata": {"page_label": "140", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "22176fa3-040f-47bc-8580-93df4aa4ac27", "node_type": "4", "metadata": {"page_label": "140", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6cfa945c69cdb63f5534e01788f032656ec44cdbffaa77490492d8b2a0df0f04", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "29a64b12-37e0-434a-aaa6-45e43d80917c", "node_type": "1", "metadata": {"page_label": "139", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "d6eec574c646a81acfbb2e2e31f4fe72a9c720ded47e42a7c7953f5aa926cd31", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5f272308-106c-49f3-a80d-2263ec4bb409", "node_type": "1", "metadata": {}, "hash": "4794146b60817cc378a6dc5c00fc0af74545037e4953bc29cca499d34830b291", "class_name": "RelatedNodeInfo"}}, "text": "Intrinsic activity  of a drug is a measure of its ability to induce a functional change in the\nreceptor which could vary from 0 to 1 (nil to maximal).\nCompetitive antagonists occupy the receptor but do not activat e it, while certain drugs are\npartial agonists which occupy and submaximally activate the receptor . An all or none action is\nnot a must at the receptor . A theoretical quantity (S) denoting strength of stimulus imparted to\nthe cell was interposed in the Clark\u2019 s equation:\nDepending on the agonist, DR could generate a stronger or weaker S, probably as a\nfunction of the degree of conformational change brought about by the agonist in the receptor .\nAccordingly:\nAgonists  have both affinity and maximal intrinsic activity (IA = 1), e.g. adrenaline, histamine,\nmorphine.\nCompetitive  antagonists  have affinity but no intrinsic activity (IA = 0), e.g. proprano lol,\natropine, chlorpheniramine, naloxone.\nPartial  agonist s have affinity and submaximal intrinsic activity (IA between 0 and 1), e.g.\ndichloroisoproterenol (on \u03b2 adrener gic receptor), buspirone on 5-HT1A receptor .\nThe lower ceiling response to a partial agonist is not because of lower affinity for the\nreceptor . In fact some partial agonists have higher affinity and are dose-to-dose more potent\nthan the full agonist, e.g. buprenorphine is 25 times more potent than morphine (full agonist of\n\uf06d opioid receptor) but is a partial agonist and cannot relieve very severe pain or deeply depress\nrespiration.\nPartial agonists also antagonize the effects of a full agonist, because they occupy a large\npopulation of the receptors (while producing small response)  and leave fewer receptors to\ninteract with the full agonist. As such, buprenorphine precipitates withdrawal symptoms in a\nhighly morphine dependent subject, but can substitute for it at lower levels of morphine\ndependence.\nInverse  agonis ts have affinity but intrinsic activity with a minus sign (IA between 0 and \u20131).\nInverse agonism is manifest only in case of some receptors which show certain degree of\nConstitutive activation , i.e. they are partially active even in the basal state (complete absence\nof any agonist). In other words they are tonically active. The benzodiazepine receptor (see Fig.\n29.3) is one such  receptor , and DMCM is its inverse agonist. However , majority of receptors\n(like the NM nicotinic receptor) are totally inactive in the absence of an agonist, and there is\nno scope for inverse agonism.\nIt has also been demonstrated that many full agonists can produce maximal response even\nwhile occupying  <1% of the available receptors. A large receptor reserve exists in their case,\nor a number of spare receptors are present. On the other hand, for certain drugs, the total\nnumber of receptors may limit the maximal response, and there are no space receptors.", "start_char_idx": 0, "end_char_idx": 2828, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5f272308-106c-49f3-a80d-2263ec4bb409": {"__data__": {"id_": "5f272308-106c-49f3-a80d-2263ec4bb409", "embedding": null, "metadata": {"page_label": "141", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "75398f3a-efa2-4310-8423-dd4d7a1f8355", "node_type": "4", "metadata": {"page_label": "141", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e72e55a9d0f4b728ff8fd73f73141ba14b4f59ede9a1546ce192b695360c7826", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d7f9b65b-fe0e-407d-a907-3ed9071c1670", "node_type": "1", "metadata": {"page_label": "140", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6cfa945c69cdb63f5534e01788f032656ec44cdbffaa77490492d8b2a0df0f04", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "abd7070d-e56b-4d48-ba16-34e3fb2b83fe", "node_type": "1", "metadata": {}, "hash": "4c8af2be1013bf0ef8df0bad78a344751a38050a511683772bd8f9d8310d949d", "class_name": "RelatedNodeInfo"}}, "text": "The two-state receptor model\nAn attractive alternative model for explaining the action of agonists, antagonists, partial\nagonists and inverse agonists has been proposed.\nThe receptor is believed to exist in two interchangeable states:  Ra (active) and Ri (inactive)\nwhich are in equilibrium. In the case of majority of receptors, the Ri state is favoured at\nequilibrium\u2014no/very weak signal is generated in the absence of the agonist\u2014the receptor\nexhibits no constitutive activati on (Fig. 4.3I). The agonist (A) binds preferentially to the Ra\nconformation and shifts the equilibrium \u2192 Ra predominates and a response is generated (Fig.\n4.3II) depending on the concentration of A. The competitive antagonist (B) binds to Ra and Ri\nwith equal affinity \u2192 the equilibrium is not altered \u2192 no response is generated (Fig. 4.3 III),\nand when the agonist is applied fewer Ra are available to bind it\u2014response to agonist is\ndecreased. If an agonist has only slightly greater affinity for Ra than for Ri, the equilibrium is\nonly  modestly  shifted towards Ra (Fig. 4.3 IV) even at saturating concentrations \u2192 a\nsubmaximal response is produc ed and the drug is called a partial agonist (C). The inverse\nagonist (D) has high affinity for the Ri state (Fig. 4.3V), therefore it can produce an opposite\nrespon se, provided the resting equilibrium was in favour of the Ra state. Certain ion channel\nreceptors such as benzodiazepine receptor and some G-protein coupled receptors like\nhistamine H2, angiotensin AT1, adrenergic \u03b21 and cannabinoid receptors exhibit constitutive\nactivation, i.e. an appreciable intensity signal is generated even in the basal state (no agonist\npresent). In their case the inver se agonist stabilizes the receptor in the inactive conformation\nresulting in an opposite response. Only few inverse agonists are known at present.\nThis model provides an explan ation for the phenomenon of positive cooperativity often\nseen with neuro transmitters, and is supported by studies of conforma tional mutants of the\nreceptor with altered equilibrium. However , receptors are now known to be capable of\nadopting not just two, but multiple active and inactive confor mations favoured by different\nligands.\nNature of receptors\nReceptors are regulatory macromolecules, mostly proteins, though nucleic acids may also\nserve as receptors. Hundreds of receptor proteins have been isolated, purified, cloned and their\nprimary amino acid (AA) sequence has been worked out. Molec ular cloning has also helped in\nobtaining the receptor protein in larger quantity to study its structure and properties, and in\nsubclassifying receptors. The cell surface receptors with their coupling and effector proteins\nare considered to be floating in a sea of membrane lipids; the folding, orientation and\ntopography of the system being determined by interactions between the lipophilic and\nhydrophilic domains of the peptide chains with solvent molecules (water on one side and\nlipids on the other). Nonpolar portions of the AA chain tend to bury within the membrane,\nwhile polar groups tend to come out in the aqueous medium. In such a delicately balanced\nsystem, it is not difficult to visualize that a small molecular ligand binding to one site in the\nreceptor molecule could be capable of tripping the balance (by altering distribution of charges,\netc.) and bringing about confo rmational changes at distant sites. Each of the five major\nfamilies of receptors (described later) have a well defined comm on structural motif, while the", "start_char_idx": 0, "end_char_idx": 3513, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "abd7070d-e56b-4d48-ba16-34e3fb2b83fe": {"__data__": {"id_": "abd7070d-e56b-4d48-ba16-34e3fb2b83fe", "embedding": null, "metadata": {"page_label": "142", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "24b01b60-52aa-45a9-980f-d067873580aa", "node_type": "4", "metadata": {"page_label": "142", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fc14fdaf1ef39a6bec9484bf9c417b84d49ee441ec2e985dfc613deb0f4415c8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5f272308-106c-49f3-a80d-2263ec4bb409", "node_type": "1", "metadata": {"page_label": "141", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e72e55a9d0f4b728ff8fd73f73141ba14b4f59ede9a1546ce192b695360c7826", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "29a64d15-9d47-4713-a5c7-2fa3e61274ba", "node_type": "1", "metadata": {}, "hash": "845a1930af2486b93065b620c2a5223d975b92782ade62f2a4be0f63abf07f17", "class_name": "RelatedNodeInfo"}}, "text": "individual recep tors differ in the details of amino acid sequencin g, length of intra/extracellular\nloops, etc. Majority of recepto r molecules are made up of several non-identical subunits\n(heteropolymeric), and agonist binding has been shown to bring about changes in their\nquaternary struc ture or relative alignment of the subunits, e.g. on activation the subunits of\nnicotinic receptor move apart opening a centrally located cation channel.\nMany clinically useful drugs act upon physiological receptors which mediate responses to\ntransmitters, hormones, autacoids and other endogenous signal molecules; examples are\ncholiner gic, adrener gic, histaminer gic, steroid, leukotriene, insulin and other such receptors. In\naddition, now some truly drug receptors have been described for which there are no known\nphysiological ligands, e.g. benzodiazepine receptor , sulfonylu rea receptor .  Receptors for\nwhich no endogenous mediator  or ligand is at present known are called \u2018Orphan receptors\u2019 .\nThey , nevertheless, may prove to be tar gets for novel drugs yet to be developed.\nReceptor subtypes\nThe delineation of multiple types and subtypes of receptors for signal molecules has played an\nimportant role in the developme nt of a number of targeted and more selective drugs. Even at", "start_char_idx": 0, "end_char_idx": 1287, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "29a64d15-9d47-4713-a5c7-2fa3e61274ba": {"__data__": {"id_": "29a64d15-9d47-4713-a5c7-2fa3e61274ba", "embedding": null, "metadata": {"page_label": "143", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9e82187d-b01c-42e8-a42d-2001eec664aa", "node_type": "4", "metadata": {"page_label": "143", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5640125a65c5109f4ad4e83e7f8f96cd0609f039d4d6b9fbaebf15de2f94473b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "abd7070d-e56b-4d48-ba16-34e3fb2b83fe", "node_type": "1", "metadata": {"page_label": "142", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fc14fdaf1ef39a6bec9484bf9c417b84d49ee441ec2e985dfc613deb0f4415c8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "40036c76-8a47-4e32-bae1-0ca74c4b2f2e", "node_type": "1", "metadata": {}, "hash": "3933745407643320be04b339fb13ceca02b46a55c0ec30828fac3c9f5ef3d093", "class_name": "RelatedNodeInfo"}}, "text": "an early stage of evolution of receptor pharmacology , it was observed that actions of\nacetylcholine could be grouped into \u2018muscarinic\u2019  and \u2018nicotinic\u2019  depending upon whether they\nwere mimicked by the then known alkaloids muscarine or nicotine. Accordingly , they were\nsaid to be mediated by two types of choliner gic receptors, viz. muscarinic (M) or nicotinic (N);\na concept strengthened by the finding that muscarinic actions were blocked by atropine, while\nnicotinic action s were blocked by curare. In a landmark study , Ahlquist (1948) divided\nadrener gic receptors into \u2018\u03b1\u2019 and \u2018\u03b2\u2019 on the basis of two distinct rankorder of potencies of\nadrener gic agon ists. These receptors have now been further subdivided (M1, M2 \u2026.M5), (NM,\nNN) (\u03b11, \u03b12) (\u03b21, \u03b22, \u03b23). Multiple subtypes of receptors for practically all transmitters,\nautacoids, horm ones, etc. are now known and have paved the way for introduction of\nnumerous clinically superior drugs. In many cases, receptor classification has provided sound\nexplanation for dif ferences observed in the actions of closely related drugs.\nThe following criteria have been utilized in classifying receptors:\na.Pharmacological  criteria Classification is based on relative potencies of selective agonists and antagonists.\nThis is the classical and oldest approach with direct clinical bearing; was used in delineating M and N\ncholinergic, \u03b1 and \u03b2 adrenergic, H1 and H2 histaminergic receptors, etc.\nb.Tissue  distribution The relative organ/tissue distribution is the basis for designating the subtype, e.g. the\ncardiac \u03b2 adrenergic receptors as \u03b21, while bronchial as \u03b22. This division was confirmed by selective agonists and\nantagonists as well as by molecular cloning.\nc.Ligand  binding Measurement of specific binding of high affinity radio-labelled ligand to cellular fragments\n(usually membranes) in vitro, and its displacement by various selective agonists/antagonists is used to delineate\nreceptor subtypes. Multiple 5-HT receptors were distinguished by this approach. Autoradiography has helped in\nmapping distribution of receptor subtypes in the brain and other organs.\nd.Transducer  pathway Receptor subtypes may be distinguished by the mechanism through which their\nactivation is linked to the response, e.g. M cholinergic receptor acts through G-proteins, while N cholinergic\nreceptor gates influx of Na+ ions; \u03b1 adrenergic receptor acts via IP3-DAG pathway and by decreasing cAMP,\nwhile \u03b2 adrenergic receptor increases cAMP; GABAA receptor is a ligand gated Cl\u2013 channel, while GABAB\nreceptor increases K+ conductance through a G-protein.\ne.Molecular  cloning The receptor protein is cloned and its detailed amino acid sequence as well as three\ndimentional structure is worked out. Subtypes are designated on the basis of sequence homology. This approach\nhas in the recent years resulted in a flood of receptor subtypes and several isoforms (which do not differ in ligand\nselectivity) of each subtype. The functional significance of many of these subtypes/isoforms is dubious. Even\nreceptors without known ligands (orphan receptors) have been described.\nApplication of so many approa ches has thrown up several detailed, confusing and often\nconflicting class ifications of receptors in the past. However , a consensus receptor classification\nis now decided on a continuin g basis by an expert group of the International Union of\nPharmacological Sciences (IUPHAR).\nSilent  receptors These are sites which bind specific drugs but no pharmacological response is elicited. They\nare better called inert binding sites or sites of loss, e.g. plasma proteins which have binding sites for many drugs.\nTo avoid confusion, the term receptor should be restricted to those regulatory binding sites which are capable of\ngenerating a response.\nACTION-EFFECT  SEQUENCE", "start_char_idx": 0, "end_char_idx": 3811, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "40036c76-8a47-4e32-bae1-0ca74c4b2f2e": {"__data__": {"id_": "40036c76-8a47-4e32-bae1-0ca74c4b2f2e", "embedding": null, "metadata": {"page_label": "144", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f4c08827-a5e4-4ce3-8276-edb53456d0b0", "node_type": "4", "metadata": {"page_label": "144", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9bbbc2e24b496e3614eaed1bafb04529b960ec3c2fa8cac3031e912553eb3edf", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "29a64d15-9d47-4713-a5c7-2fa3e61274ba", "node_type": "1", "metadata": {"page_label": "143", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5640125a65c5109f4ad4e83e7f8f96cd0609f039d4d6b9fbaebf15de2f94473b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c0a1db20-e1b1-421a-96a6-5e0c94ff9218", "node_type": "1", "metadata": {}, "hash": "24e21dfeec9d7dcc5b5787dba0d12dfa4e266b02bcb518de524bacba1df9d212", "class_name": "RelatedNodeInfo"}}, "text": "\u2018Drug action\u2019  and \u2018drug effect\u2019 are often loosely used interchangeably , but are not\nsynonymous.\nDrug  action  It is the initial combination of the drug with its recepto r resulting in a\nconformational change in the latter (in case of agonists), or prevention of conformational\nchange through exclusion of the agonist (in case of antagonists).\nDrug  effect It is the ultimate change in biological function brought about as a consequence of\ndrug action, through a series of intermediate steps (transducer).\nReceptors subse rve two essential functions, viz, recognition of the specific ligand molecule\nand transduction of the signal into a response. Accordingly , the receptor molecule has a ligand\nbinding domain (spatially and energetically suitable for binding the specific ligand) and an\neffector domain (Fig.  4.4) which under goes a functional conformational change. These\ndomains have now actually been  identified in some receptors. The perturbation in the receptor\nmolecule is variously translated  into the response. The sequen tial relationship between drug\naction, transducer and drug ef fect can be seen in Fig. 4.1D and 4.6.", "start_char_idx": 0, "end_char_idx": 1137, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c0a1db20-e1b1-421a-96a6-5e0c94ff9218": {"__data__": {"id_": "c0a1db20-e1b1-421a-96a6-5e0c94ff9218", "embedding": null, "metadata": {"page_label": "145", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b981cfd8-6cf9-44de-963e-8a5972d7ca37", "node_type": "4", "metadata": {"page_label": "145", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5bf1d22b7120d4311613940846d5099db59dfa1bfb259a123d82ea22933b100d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "40036c76-8a47-4e32-bae1-0ca74c4b2f2e", "node_type": "1", "metadata": {"page_label": "144", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "7296a192e324571f3bffcd029eed66eea94200815fa46ca4af3413d41dbc75e4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d3562c47-c8ca-4a67-94ba-78348b99ceff", "node_type": "1", "metadata": {}, "hash": "f284a3451abf452b682780242c6ac24e5b64dae818944c55fe01b965fa4ec453", "class_name": "RelatedNodeInfo"}}, "text": "TRANSDUCER MECHANISMS\nConsiderable progress has been made in the understanding of transducer mechanisms which in\nmost instances have been found to be highly complex multistep processes that provide for\namplification of the signal, as well as integration of concurrently received extra- and intra-\ncellular signals at each step. Because only a handful of transducer pathways are shared by a\nlarge number of receptors, the cell is able to generate an integrated response reflecting the sum\ntotal of diverse signal inputs. The transducer mechanisms can be grouped into 5 major\ncategories. Rece ptors falling in one category also possess considerable structural homology ,\nand belong to one super -family of receptors.\n1. G-protein coupled receptors (GPCRs)\u00a0\nThese are a large family of cell membrane receptors which are linked to the effector\n(enzyme/channel/transporter) through one or more GTP-activated proteins (G-proteins) for\nresponse effectu ation. All such receptors have a common pattern of structural organization\n(Fig. 4.5). The molecule has 7 \u03b1-helical membra ne spanning hydrophobic amino acid (AA)\nsegments which  run into 3 extracellular and 3 intracellular loops. The agonist binding site is\nlocated somewhere between the helices on the extracellular face, while another recognition\nsite form ed by cytosolic segments binds the coupling G-protein. The G-proteins float in the\nmembrane with their exposed domain lying in the cytoso l, and are heterotrimeric in\ncomposition (\u03b1, \u03b2 and \u03b3  subunits). In the inactive state GDP  is bound to the \u03b1 \uf020subunit  at the\nexposed domain; activation through the receptor leads to displ acement of GDP  by GTP. The", "start_char_idx": 0, "end_char_idx": 1661, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d3562c47-c8ca-4a67-94ba-78348b99ceff": {"__data__": {"id_": "d3562c47-c8ca-4a67-94ba-78348b99ceff", "embedding": null, "metadata": {"page_label": "146", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "113d8581-213f-43e8-aed5-900ff192ff09", "node_type": "4", "metadata": {"page_label": "146", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "1058c88ea41f71e4807fb24a694b5427b649d7bf22a1d8eea3ca46e455f355dd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c0a1db20-e1b1-421a-96a6-5e0c94ff9218", "node_type": "1", "metadata": {"page_label": "145", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5bf1d22b7120d4311613940846d5099db59dfa1bfb259a123d82ea22933b100d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7ee3ca39-91c7-4c89-a98e-ed303f7d1195", "node_type": "1", "metadata": {}, "hash": "e5aaefb67115cb887b0a0546088d57e6cca840556cfb103c41a20d71f0c2a6fe", "class_name": "RelatedNodeInfo"}}, "text": "activated \u03b1-subunit carryin g GTP dissociates from the other two subunits and either activates\nor inhibits the effector . The \u03b2\u03b3 \uf020diamer has also been shown to activate receptor -operated K+\nchannels, to inhibit voltage gated Ca2+ channels and to promote GPCR desensitization at\nhigher rates of activation.\nA numb er  of  G  proteins  distin guished  by  their  \u03b1 subuni ts  have  been  described . The\nimportant  ones  with  their  action  on  the  effector  are :\nGs :Adenylyl cyclase activation, Ca2+ channel opening\nGi :Adenylyl cyclase inhibition, K+ channel opening\nGo :Ca2+ channel inhibition\nGq :Phospholipase C activation\nA limited number of G-proteins are shared between different receptors and one receptor can\nutilize more than one G-protein (agonist pleotropy), e.g. the following couplers have been\nassociated with dif ferent receptors.\nReceptor Coupler\nMuscarinic M2 Gi, Go\nMuscarinic M1, M3 Gq\nDopamine D2 Gi, Go\n\u03b2-adrener gic Gs\n\u03b11-adrener gic Gq\n\u03b12-adrener gic Gi, Go\nGABAB Gi, Go\nSerotonin 5-HT1 Gi, Go\nSerotonin 5-HT2 Gq\nProstanoid Gs, Gi, Gq\nIn addition , Gs  is  the  coupler  for  histamine  H2, serotonin  5 HT4 -7, gluca gon ,\nthyrotropin  ( TSH ) and  many  other  hormones , while  Gi  is  utilized  by  opioid , cannabinoid\nand some  other  receptors . Moreover , a  receptor  can  utilize  different  biochemical\npathways  in  different  tissues .\nThe \u03b1-subunit  has  GTPase  activity : the  bound  GTP  is  slowly  hydrolysed  to  GDP :\nthe \u03b1-subunit  then  dissociates  from  the  effector  to  rejoin  its  other  subunits , but  not\nbefore  the  effector  has  been  activated / inhibited  for  several  seconds  ( much  longer  than\nthe life-time  of  the  activated  receptor , which  is  in  milliseconds ) and  the  signal  has  been\ngreatly  ampli\ufb01e d . The  rate  of  GTP  hydrolysis  by  the  \u03b1 subunit  and  thus  the  period  for\nwhich  it  remains  activated  is  regulated  by  another  protein  called  \u2018regulator  of  G  protein\nsignaling\u2019  ( RGS ). The  onset  time  of  response  through  GPCRs  is  in  seconds .\nThere are three major ef fector pathways (T able 4.1) through which GPCRs function.", "start_char_idx": 0, "end_char_idx": 2145, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7ee3ca39-91c7-4c89-a98e-ed303f7d1195": {"__data__": {"id_": "7ee3ca39-91c7-4c89-a98e-ed303f7d1195", "embedding": null, "metadata": {"page_label": "147", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "2acdd4ac-f378-4deb-aea3-929789f17c98", "node_type": "4", "metadata": {"page_label": "147", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "34a90f02a9026380ece88bb6612ccfdeee7e00820b9ee4821e3ae79445066464", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d3562c47-c8ca-4a67-94ba-78348b99ceff", "node_type": "1", "metadata": {"page_label": "146", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "1058c88ea41f71e4807fb24a694b5427b649d7bf22a1d8eea3ca46e455f355dd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d914f180-feea-4ce8-9135-5136a55a1003", "node_type": "1", "metadata": {}, "hash": "0f87081b98d74ebb6bf5f331a3bcd9764e3f4974dc0b9764907a5a87809341fb", "class_name": "RelatedNodeInfo"}}, "text": "(a) Adenylyl  cyclase : cAMP  pathway  Activation of AC results in intracellular accumulation\nof secon d messenger cAMP  (Fig. 4.6) which functions mainly through cAMP-dependent\nprotein kinase (PKA). The PKA phosphorylates and alters the function of many enzymes, ion\nchannels, transp orters, transcription factors and structural proteins to manifest as increased\ncontractility/impulse generation (heart), relaxation (smooth muscle), glycogenolysis, lipolysis,\ninhibition of secretion/mediator release, modulation of junctional transmission, water\nconservation by kidney , steroid hormone synthesis, etc. In addition, cAMP  directly opens a\nspecific type of membrane Ca2+ channel  called cyclic nucleotide gated channel  (CNG) in the\nheart, brain and kidney . The other mediators of cellular actions of cAMP  are: cAMP  response\nelement binding protein (CREB)  which is a transcription factor , cAMP  regulated guanine\nnucleotide exchange factors called EPACs and certain transporters. Responses opposite to the\nabove are produced when AC is inhibited through inhibitory Gi-protein.\nThe action of cAMP  is terminated intracellularly by phosph odiesterases (PDEs) which\nhydrolyse it to 5-AMP . Some isoforms of PDE (PDE3, PDE4) are selective for cAMP , while\nPDE5 is selective for cGMP .\nCyclic GMP  (cGMP) as a second messenger\nTable 4.1:  Major functional pathways of G-protein coupled receptor transduction\n\uf041 \uf064 \uf065 \uf06e \uf079 \uf06c \uf079 \uf06c \uf020 \uf063 \uf079 \uf063 \uf06c \uf061 \uf073 \uf065 \uf03a \uf020 \uf063 \uf041 \uf04d \uf050 \uf050 \uf068 \uf06f \uf073 \uf070 \uf068 \uf06f \uf06c \uf069 \uf070 \uf061 \uf073 \uf065 \u2014\n\uf049 \uf050\uf033 \uf02f \uf044 \uf041 \uf047\uf043 \uf068 \uf061 \uf06e \uf06e \uf065 \uf06c \uf020 \uf072 \uf065 \uf067 \uf075 \uf06c \uf061 \uf074 \uf069 \uf06f \uf06e\n\uf061 \uf063 \uf074 \uf069 \uf076 \uf061 \uf074 \uf069 \uf06f \uf06e \uf069 \uf06e \uf068 \uf069 \uf062 \uf069 \uf074 \uf069 \uf06f \uf06e \uf061 \uf063 \uf074 \uf069 \uf076 \uf061 \uf074 \uf069 \uf06f \uf06e \uf043 \uf061\uf032 \uf02b\n\uf06f \uf070 \uf065 \uf06e \uf069 \uf06e \uf067\uf043 \uf061\uf032 \uf02b\uf020 \uf063 \uf06c \uf06f \uf073 \uf069 \uf06e \uf067 \uf04b\uf02b\uf020 \uf06f \uf070 \uf065 \uf06e \uf069 \uf06e \uf067\n\uf041 \uf064 \uf072 \uf065 \uf06e \uf065 \uf072 \uf067 \uf069 \uf063 \uf02d\u03b2 \uf041 \uf064 \uf072 \uf065 \uf06e \uf065 \uf072 \uf067 \uf069 \uf063 \uf02d\u03b1\uf032 \uf041 \uf064 \uf072 \uf065 \uf06e \uf065 \uf072 \uf067 \uf069 \uf063 \uf02d\u03b1\uf031 \uf041 \uf064 \uf072 \uf065 \uf06e \uf065 \uf072 \uf067 \uf069 \uf063 \uf02d\n\u03b2\uf031\uf044 \uf06f \uf070 \uf061 \uf06d \uf069 \uf06e \uf065 \uf02d \uf044 \uf032 \uf041 \uf064 \uf072 \uf065 \uf06e \uf065 \uf072 \uf067 \uf069 \uf063 \uf02d\n\u03b1\uf032\n\uf048 \uf069 \uf073 \uf074 \uf061 \uf06d \uf069 \uf06e \uf065 \uf02d \uf048\uf032", "start_char_idx": 0, "end_char_idx": 1813, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d914f180-feea-4ce8-9135-5136a55a1003": {"__data__": {"id_": "d914f180-feea-4ce8-9135-5136a55a1003", "embedding": null, "metadata": {"page_label": "147", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "2acdd4ac-f378-4deb-aea3-929789f17c98", "node_type": "4", "metadata": {"page_label": "147", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "34a90f02a9026380ece88bb6612ccfdeee7e00820b9ee4821e3ae79445066464", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7ee3ca39-91c7-4c89-a98e-ed303f7d1195", "node_type": "1", "metadata": {"page_label": "147", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "61fa1d16a8ece8194ba5ec1150967adc85c9200064a7b154dc6b3880548b1745", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "88abf969-cfef-4b19-968b-526c8d899f3c", "node_type": "1", "metadata": {}, "hash": "8feb6d12c8435258553912fb58595b0e1b65320165c0e40e759abb54d5f0cd59", "class_name": "RelatedNodeInfo"}}, "text": "\uf067 \uf069 \uf063 \uf02d\u03b1\uf032 \uf041 \uf064 \uf072 \uf065 \uf06e \uf065 \uf072 \uf067 \uf069 \uf063 \uf02d\u03b1\uf031 \uf041 \uf064 \uf072 \uf065 \uf06e \uf065 \uf072 \uf067 \uf069 \uf063 \uf02d\n\u03b2\uf031\uf044 \uf06f \uf070 \uf061 \uf06d \uf069 \uf06e \uf065 \uf02d \uf044 \uf032 \uf041 \uf064 \uf072 \uf065 \uf06e \uf065 \uf072 \uf067 \uf069 \uf063 \uf02d\n\u03b1\uf032\n\uf048 \uf069 \uf073 \uf074 \uf061 \uf06d \uf069 \uf06e \uf065 \uf02d \uf048\uf032 \uf04d \uf075 \uf073 \uf063 \uf061 \uf072 \uf069 \uf06e \uf069 \uf063 \uf02d \uf04d\uf032 \uf048 \uf069 \uf073 \uf074 \uf061 \uf06d \uf069 \uf06e \uf065 \uf02d \uf048\uf031 \uf047 \uf041 \uf042 \uf041\uf042 \uf04d \uf075 \uf073 \uf063 \uf061 \uf072 \uf069 \uf06e \uf069 \uf063 \uf02d\n\uf04d\uf032\n\uf044 \uf06f \uf070 \uf061 \uf06d \uf069 \uf06e \uf065 \uf02d \uf044 \uf031 \uf044 \uf06f \uf070 \uf061 \uf06d \uf069 \uf06e \uf065 \uf02d \uf044 \uf032 \uf04d \uf075 \uf073 \uf063 \uf061 \uf072 \uf069 \uf06e \uf069 \uf063 \uf02d \uf04d\uf031 \uf02c\n\uf04d\uf033\uf04f \uf070 \uf069 \uf06f \uf069 \uf064 \uf02d\u03ba \uf044 \uf06f \uf070 \uf061 \uf06d \uf069 \uf06e \uf065 \uf02d \uf044 \uf032\n\uf047 \uf06c \uf075 \uf063 \uf061 \uf067 \uf06f \uf06e \uf035 \uf02d \uf048 \uf054\uf031 \uf035 \uf02d \uf048 \uf054\uf032 \uf041 \uf064 \uf065 \uf06e \uf06f \uf073 \uf069 \uf06e \uf065 \uf02d \uf041\uf031 \uf035 \uf02d \uf048 \uf054\uf031 \uf041\n\uf046 \uf053 \uf048 \uf020 \uf026 \uf020 \uf04c \uf048 \uf047 \uf041 \uf042 \uf041\uf042 \uf056 \uf061 \uf073 \uf06f \uf070 \uf072 \uf065 \uf073 \uf073 \uf069 \uf06e \uf02d\n\uf04f \uf078 \uf079 \uf074 \uf06f \uf063 \uf069 \uf06e\uf053 \uf06f \uf06d \uf061 \uf074 \uf06f \uf073 \uf074 \uf061 \uf074 \uf069 \uf06e \uf047 \uf041 \uf042 \uf041\uf042", "start_char_idx": 1686, "end_char_idx": 2170, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "88abf969-cfef-4b19-968b-526c8d899f3c": {"__data__": {"id_": "88abf969-cfef-4b19-968b-526c8d899f3c", "embedding": null, "metadata": {"page_label": "148", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ed66f241-e2d1-4430-b8e6-023fe20e6e5b", "node_type": "4", "metadata": {"page_label": "148", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "cdd7d8adbf4177d3e10a7d4e559866457d3b9c1b32856c2e4f7b11f22d86c0a9", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d914f180-feea-4ce8-9135-5136a55a1003", "node_type": "1", "metadata": {"page_label": "147", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fcc7bb1c574633c899458ed46d82185a7732dedddabc47791f1fc9532bb19339", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6ca52343-cda5-4b77-8da1-152957e331a4", "node_type": "1", "metadata": {}, "hash": "67a4dce1f00874ce50aaff8e2a5c15fb07c8b9c35f634154bc25e70216e703d3", "class_name": "RelatedNodeInfo"}}, "text": "\uf041 \uf043 \uf054 \uf048 \uf04f \uf070 \uf069 \uf06f \uf069 \uf064 \uf02d \uf0b5 \uf02c \uf020\u03b4 \uf042 \uf072 \uf061 \uf064 \uf079 \uf06b \uf069 \uf06e \uf069 \uf06e \uf02d \uf042\uf032 \uf04f \uf070 \uf069 \uf06f \uf069 \uf064 \uf02d \uf0b5 \uf02c \uf020\u03b4\n\uf054 \uf053 \uf048 \uf041 \uf06e \uf067 \uf069 \uf06f \uf074 \uf065 \uf06e \uf073 \uf069 \uf06e \uf02d\n\uf041 \uf054\uf031\uf041 \uf06e \uf067 \uf069 \uf06f \uf074 \uf065 \uf06e \uf073 \uf069 \uf06e \uf02d \uf041 \uf054\uf031 \uf041 \uf064 \uf065 \uf06e \uf06f \uf073 \uf069 \uf06e \uf065 \uf02d\n\uf041\uf031\n\uf050 \uf072 \uf06f \uf073 \uf074 \uf061 \uf067 \uf06c \uf061 \uf06e \uf064 \uf069 \uf06e \uf02d\n\uf045 \uf050\uf032\uf050 \uf072 \uf06f \uf073 \uf074 \uf061 \uf067 \uf06c \uf061 \uf06e \uf064 \uf069 \uf06e \uf02d\n\uf045 \uf050\uf033\uf050 \uf072 \uf06f \uf073 \uf074 \uf061 \uf067 \uf06c \uf061 \uf06e \uf064 \uf069 \uf06e \uf02d\n\uf046 \uf050 \uf02c \uf020 \uf045 \uf050\uf031 \uf02c \uf020 \uf045 \uf050\uf033\n\uf050 \uf072 \uf06f \uf073 \uf074 \uf061 \uf063 \uf079 \uf063 \uf06c \uf069 \uf06e \uf02d\n\uf049 \uf050\uf053 \uf06f \uf06d \uf061 \uf074 \uf06f \uf073 \uf074 \uf061 \uf074 \uf069 \uf06e \uf054 \uf068 \uf072 \uf06f \uf06d \uf062 \uf06f \uf078 \uf061 \uf06e \uf065 \uf02d \uf054 \uf050\n\uf041 \uf064 \uf065 \uf06e \uf06f \uf073 \uf069 \uf06e \uf065 \uf02d \uf041\uf032 \uf041 \uf064 \uf065 \uf06e \uf06f \uf073 \uf069 \uf06e \uf065 \uf02d \uf041\uf031 \uf04c \uf065 \uf075 \uf06b \uf06f \uf074 \uf072 \uf069 \uf065 \uf06e \uf065 \uf020 \uf042 \uf04c \uf054 \uf02c\n\uf063 \uf079 \uf073 \uf020 \uf04c \uf054\n\uf043 \uf068 \uf06f \uf06c \uf065 \uf063 \uf079 \uf073 \uf074 \uf06f \uf06b \uf069 \uf06e \uf069 \uf06e \uf02d\n\uf047 \uf061 \uf073 \uf074 \uf072 \uf069 \uf06e\n\uf050 \uf041 \uf046", "start_char_idx": 0, "end_char_idx": 497, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6ca52343-cda5-4b77-8da1-152957e331a4": {"__data__": {"id_": "6ca52343-cda5-4b77-8da1-152957e331a4", "embedding": null, "metadata": {"page_label": "149", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "13ae48cf-d631-4a98-a8ea-475ed4ba429d", "node_type": "4", "metadata": {"page_label": "149", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b5aef1a3dae47c0a63b55eb70f917967aa00c347b62cb1399b627456026ea72d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "88abf969-cfef-4b19-968b-526c8d899f3c", "node_type": "1", "metadata": {"page_label": "148", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "7ebc556232877a53d4d6f9a5643c5db0928e00d446817d7d1dce978e53eaeac0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "308b7ae3-d6c5-4417-a817-077160743786", "node_type": "1", "metadata": {}, "hash": "76968761d9574ea4911ab9e56058684db9137a9d47bad4abfe35af1d4a8a9046", "class_name": "RelatedNodeInfo"}}, "text": "In contrast to cAMP , the cGMP  serves as an intracellular second messenger only in a limited\nnumber of tissues, such as vascular smooth muscle, intestinal mucosal cell and kidney . In these\ntissues it respectively mediates relaxation, inhibition of salt and water absorption as well as\nanion secretion, and natriuresis (mainly due to reduced proximal tubular Na+ reabsorption).\nThere are two principal forms of guanylyl cyclases (GC) which generate cGMP , one cell\nmembrane bound and the other cytosolic. However , none of these is regulated by a GPCR. The\ncell mem brane bound GC is regulated by a transmembrane enzyme-linked receptor (described\non p.58) for atrial natriuretic peptide (ANP). The cytosolic soluble GC in vascular smooth\nmuscle is activa ted  by nitric oxide (NO). After generation by the vascular endothelium NO\ndiffuses into the adjacent smooth muscle cell and stimulates the soluble GC. Increased cGMP\ndephosphorylates myosin light chain kinase (MLCK) through PKG and induces relaxation (see\nFig. 40.3). This pathway is utilized by glyceryl trinitrate, sod. nitroprusside, etc.\n(b) Phospholip ase  C : IP3-DAG  pathway  Activation of phospholipase C\u03b2 \uf020(PLc\u03b2) by the\nactivate d GTP carrying \u03b1 subunit of Gq hydrolyses the membrane phospholipid phosphatidyl\ninositol 4,5-bisphosphate (PIP2) to gene rate the second messeng ers inositol 1,4,5-trisphosphate\n(IP3) and diacylglycerol (DAG). The IP3 being water soluble diffuses to the cytosol and\nmobilizes Ca2+ from endoplas mic reticular depots (Fig. 4.7). The lipophilic DAG remains\nwithin the mem brane, but recruits protein kinase C (PKc) and activates it with the help of", "start_char_idx": 0, "end_char_idx": 1643, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "308b7ae3-d6c5-4417-a817-077160743786": {"__data__": {"id_": "308b7ae3-d6c5-4417-a817-077160743786", "embedding": null, "metadata": {"page_label": "150", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "c3413b1e-a206-4df8-bda3-47659c92df1e", "node_type": "4", "metadata": {"page_label": "150", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "068d04f01e8ae84d5e79ce630870c7f193af2117b1a4dfa0aac4eaa02961921b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6ca52343-cda5-4b77-8da1-152957e331a4", "node_type": "1", "metadata": {"page_label": "149", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b5aef1a3dae47c0a63b55eb70f917967aa00c347b62cb1399b627456026ea72d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "499a76c2-35d4-49ca-9a60-f7b40a258cb1", "node_type": "1", "metadata": {}, "hash": "f956994028264db65d5a2b952f3a9d3cd69416db53e58de480e8ca6ceb42978f", "class_name": "RelatedNodeInfo"}}, "text": "Ca2+. The activated PKc phosphorylates many intracellular proteins (depending  on the type of\neffector cell) and mediates various physiological responses. So that it can serve signaling\nfunctions, the cytosolic concentration of Ca2+ is kept very low (~ 100 nM) by specific pumps\nlocat ed at the plasma membrane and at the endoplasmic reticulu m. Triggered by IP3, the\nreleased Ca2+ (third messenger in this setting) acts as a highly versatile regulator acting\nthrough calmodulin (CAM), PKc and other effectors\u2014 mediates/modulates smooth muscle,\ncontraction, glandular secretion/transmitter release, eicosanoid synthesis, neuronal excitability ,\nintracellular movements, memb rane function, metabolism, cell proliferation, etc. Signaling in\nthis pathway is terminated by degradation of the second messengers. The IP3 is\ndephosphorylated to inositol which is reutilized in the synthesis of PIP2 (see Fig. 32.1), while\nDAG is partly converted back to phospholipids, and partly deacylated to arachidonic acid.\nIntracellular Ca2+ release has been found to occur in waves (Ca2+ mediated Ca2+ release from successive pools\nfacilitated by inositol 1, 3, 4, 5-tetrakisphosphate\u2014IP4) and exhibits a variety of agonist and concentration\ndependent oscillatory patterns. The activation of different effectors may depend on the amplitude and pattern of\nthese oscillations. Thus, the same intracellular messenger can trigger different responses depending on the nature\nand strength of the extracellular signal.\n(c) Channel  regulation  The activated G-proteins (Gs, Gi, Go) can also open or inhibit ionic\nchannels specific for Ca2+ and K+, withou t the intervention of any second messenger like\ncAMP  or IP3, and bring about hyperpolarization/depolarization/changes in intracellular Ca2+\nconcentration. The Gs opens Ca2+ channel s in myocardium and skeletal muscles, while Gi and\nGo open K+ channels in heart and smooth muscle as well as inhibit neuronal Ca2+ channels.\nDirect channel regulation is mostly the function of the \u03b2\u03b3 \uf020dimer of the dissociated G protein.\nPhysiological responses like changes in inotropy , chronotropy , transmitter release, neuronal\nactivity and smooth muscle relaxation follow . Receptors found to regulate ionic channels\nthrough G-proteins are listed in Table 4.1.\n2. Ion channel receptors\nThese cell surface receptors, also called ligand gated ion channels, enclose ion selective\nchannels (for Na+, K+, Ca2+ or Cl\u00af) within their molecules. Agonist binding opens the chan nel\n(Fig. 4.4) and causes depolarization/hyperpolarization/changes in cytosolic ionic composition,\ndepending on the ion that flows through. The nicotinic choliner gic, GABAA, glycine\n(inhibitory AA), excitatory AA-glutamate (kainate, NMDA  and AMP A) and 5HT3 receptors\nfall in this category , and a large number of clinically useful drugs act through this type of\nreceptors.\nThe receptor is usually a pentameric protein; all subunits, in addition to large intra- and extracellular segments,\ngenerally have four membrane spanning helical domains. The subunits are mostly arranged round the channel like\na rosette and the \u03b1 subunits usually bear the agonist binding sites.\nCertain receptor-operated (or ligand-gated) ion channels also have secondary ligands which bind to an allosteric\nsite and modulate the gating of the channel by the primary ligand, e.g. the benzodiazepine receptor modulates", "start_char_idx": 0, "end_char_idx": 3381, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "499a76c2-35d4-49ca-9a60-f7b40a258cb1": {"__data__": {"id_": "499a76c2-35d4-49ca-9a60-f7b40a258cb1", "embedding": null, "metadata": {"page_label": "151", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "41617a3d-7bbc-44b2-9432-80a50602173a", "node_type": "4", "metadata": {"page_label": "151", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8e9e1502f3e765882d3d504c7e6880880634bd1722ef5c20903cf4e845713615", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "308b7ae3-d6c5-4417-a817-077160743786", "node_type": "1", "metadata": {"page_label": "150", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "068d04f01e8ae84d5e79ce630870c7f193af2117b1a4dfa0aac4eaa02961921b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "78ad3b48-d9b9-4ab5-9373-56599d31dfe8", "node_type": "1", "metadata": {}, "hash": "35895286f5236e3b0995d54beccf913c7dd6da2134d7fdee6383ca7cb2cd6799", "class_name": "RelatedNodeInfo"}}, "text": "GABAA gated Cl\u00af channel.\nThus, in these receptors the agonist directly operates ion channe ls, without the intervention\nof any coupling  protein or second messenger . The onset and offset of responses through this\nclass of receptors is the fastest (in milliseconds).\n3. Transmembrane enzyme-linked receptors\nThis class of receptors are utilized primarily by peptide hormones, and are made up of a large\nextracellular ligand binding domain connected through a single transmembrane helical peptide\nchain to an intracellular subunit having enzymatic property . The enzyme at the cytosolic side\nis gener ally a protein kinase, but can also be guanylyl cyclase in few cases. The commonest\nprotein kinases are the ones which phosphorylate tyrosine residues on the substrate proteins\nand are called \u2018receptor tyrosine kinases\u2019  (RTKs), see Fig. 4.8. Examples are\u2014insulin,\nepidermal grow th factor (EGF), nerve growth factor (NGF) and many other growth factor\nreceptors. Inhibi tors of specific RTKs involved in growth facto r signaling are a new class of\ntargeted antican cer drugs. However , the transforming growth factor (TGF) receptor and few\nothers are serine/threonine kinases\u2014which phosphorylate serine/threonine residues of the\ntarget proteins.\nIn the unliganded monomeric state, the kinase remains inactive. Hormone binding induces\ndimerization of receptor molec ules, brings about conformatio n changes which activate the\nkinase to autophosphorylate tyrosine residues on each other , increasing their affinity for\nbinding substra te proteins which have SH2 domains. These are then phosphorylated and\nreleased to carry forward the cascade of phosphorylations leading to the response.", "start_char_idx": 0, "end_char_idx": 1685, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "78ad3b48-d9b9-4ab5-9373-56599d31dfe8": {"__data__": {"id_": "78ad3b48-d9b9-4ab5-9373-56599d31dfe8", "embedding": null, "metadata": {"page_label": "152", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b88d8e37-166c-4243-9e61-36643f6cb217", "node_type": "4", "metadata": {"page_label": "152", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "0280708caf2090d490532dc770c8d8fadf03e0f88530a43c02c9d3d70af69d4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "499a76c2-35d4-49ca-9a60-f7b40a258cb1", "node_type": "1", "metadata": {"page_label": "151", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8e9e1502f3e765882d3d504c7e6880880634bd1722ef5c20903cf4e845713615", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "636ba1da-5a62-4daf-891d-1cad6f8c435c", "node_type": "1", "metadata": {}, "hash": "a57c5dc12d714ff6f43fa54d5c0fb6c17a319d8687aa3d26820c8163698dba81", "class_name": "RelatedNodeInfo"}}, "text": "A large number of intracellular signaling proteins have SH2 domains. Thus, by controlling\nphosphorylation of key enzymes , ion channels, transporters, etc. the RTKs are able to regulate\ndiverse cellular functions includ ing metabolic reactions, cell growth and differentiation. One\nof the SH2 domain  enzyme s is phospholipase c\u03b3 (PLc \u03b3) which is activated by certain RTKs,\nand which, like PLc \u03b2, generates IP3 and DAG as second messengers for response ef fectuation.\nThe transmembrane enzyme-linked receptors transduce responses in a matter of few\nminutes to few hours.\nAnother feature of this class of receptors is that their dimerization also promotes receptor\ninternalization, degradation in lysosomes and down regulation  if activation is fast enough.\nMutations interfering with such down-regulation contribute to development of certain\nmalignancies.\nIn place of prote in kinase the enzyme can also be guanylyl cyclase (GC), as in the case of\natrial natriuretic peptide (ANP) . Agonist activation of the receptor generates cGMP  in the\ncytosol as a second messenger , which in turn activates cGMP-d ependent protein kinase (PKG)\nand modulates cellular activity .", "start_char_idx": 0, "end_char_idx": 1167, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "636ba1da-5a62-4daf-891d-1cad6f8c435c": {"__data__": {"id_": "636ba1da-5a62-4daf-891d-1cad6f8c435c", "embedding": null, "metadata": {"page_label": "153", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "750638f3-f142-4260-90ae-2a01cd8f6a98", "node_type": "4", "metadata": {"page_label": "153", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "147ac963dd1a21a2f6c4cc3f1e91ae1d792222baba8caa1680ce9703264d1634", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "78ad3b48-d9b9-4ab5-9373-56599d31dfe8", "node_type": "1", "metadata": {"page_label": "152", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5475692bcc299c9359abd20cbe637306c6c4fd910a7172c8e6e3aebcad4aab4e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "00159d76-a4ac-4f09-a8a8-26beaba8d229", "node_type": "1", "metadata": {}, "hash": "c0d642008bc813718d036e063c091da1e61f35e9c81f92b5ffcd3dca4fc60d78", "class_name": "RelatedNodeInfo"}}, "text": "4. Transmembrane JAK-ST AT binding receptors\nThese receptors  differ from RTKs in not having any intrinsic catalytic domain. Agonist-\ninduced dimerization alters the intracellular domain conformation to increase its affinity for a\ncytosolic tyrosine protein kinase JAK (Janus Kinase). On binding, JAK gets activated and\nphosphorylates tyrosine residues  of the receptor , which now bind another free moving protein\nSTAT (signal transducer and activator of transcription). This is also phosphorylated by JAK.\nPairs of phosphorylated STAT dimerize and translocate to the nucleus to regulate gene\ntranscription resulting in a biological response. Many cytokine s, growth hormone, prolactin,\ninterferons, etc. act through this type of receptor .\n5.Receptors regulating gene expression (T ranscription factors, Nuclear\nreceptors)\nIn contrast to the above 4 classes of receptors, these are intracellular (cytoplasmic or nuclear)\nsoluble proteins  which respond to lipid soluble chemical messengers that penetrate the cell\n(Fig. 4.10). The receptor protein  (specific for each hormone/regulator) is inherently capable of\nbinding to specific genes, but its attached proteins HSP-90 and may be some others prevent it\nfrom adopting the configuration  needed for binding to DNA. When the hormone binds near\nthe carboxy terminus of the receptor , the restricting proteins (HSP-90, etc.) are released, the\nreceptor dimeriz es and the DNA  binding regulatory segment located in the middle of the\nmolecule folds into the function ally active configuration. The liganded receptor dimer moves\nto the nucleus and binds other co-activator/co-repressor prote ins which have a modulatory\ninfluence on its capacity to alter gene function. The whole complex then attaches to specific\nDNA  sequences (hormone response elements) of the target genes and facilitates or represses\ntheir expression so that specific mRNA  is synthesized/repressed on the template of the gene.\nThis mRNA moves to the ribosomes and directs synthesis of specific proteins which regulate\nactivity of the tar get cells.\nAll steroidal hormones (gluc ocorticoids, mineralocorticoid s, androgens, estrogens,\nprogesterone), thyroxine, vit D and vit A function in this manner . Different steroidal hormones\naffect different target cells and produce different effects because each one binds to its own\nreceptor and directs a unique pattern of synthesis of specific proteins. The specificity as to\nwhich hormone will be bound is provided by the hormone binding domain, while that as to\nwhich gene will be activated or repressed is a function of the DNA  binding/N-terminus\ndomain. Different ligands of the same nuclear receptor have been found to induce ligand-\nspecific conform ations of the receptor so that different combinations of co-activators and co-\nrepressors may be bound in different target tissues, e.g. selective  estrogen receptor modulators\n(SERMs) tamox ifen and raloxifene have differing patterns of action on various estrogenic\ntarget organs. Chimeric receptors have also been produced which respond to one hormone, but\nproduce the ef fects of the other hormone.\nThis transduction mechanism is the slowest in its time course of action (takes hours)\nbecause adequat e quantity of the effector protein will have to be produced before the response\noccurs. The effects also gener ally out last the signal (hormone), because majority of the", "start_char_idx": 0, "end_char_idx": 3395, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "00159d76-a4ac-4f09-a8a8-26beaba8d229": {"__data__": {"id_": "00159d76-a4ac-4f09-a8a8-26beaba8d229", "embedding": null, "metadata": {"page_label": "154", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "859e2ece-4a3a-4e53-a5cb-e288ae111f9a", "node_type": "4", "metadata": {"page_label": "154", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9a0d304a6348fb3384d882fd687777d57968da900c63c27deed89f839ae3ecfc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "636ba1da-5a62-4daf-891d-1cad6f8c435c", "node_type": "1", "metadata": {"page_label": "153", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "147ac963dd1a21a2f6c4cc3f1e91ae1d792222baba8caa1680ce9703264d1634", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b33f57f4-9b43-4a5c-8aef-5e71df639fce", "node_type": "1", "metadata": {}, "hash": "8a18ba8c1cb119653ad7697b2a7e06516bf1270c475ea9b2a0979929fb6ff44b", "class_name": "RelatedNodeInfo"}}, "text": "generated effector proteins have slow turnover , and persist in the body even after the hormone\nhas been eliminated.\nRegulation of receptors\nReceptors exist in a dynamic state; their density and efficacy to elicit the response is subject to\nregulation by the level of on-go ing activity , feedback from their own signal output and other\nphysiopathological influences, e.g. estrogens increase the densit y of oxytocin receptors on the\nmyometrium. The sensitivity of uterus to contractile action of oxytocin increases progressively\nduring the third trimester of pregnancy , especially near term. In tonically active systems,\nprolonged depri vation of the agonist (by denervation or continued use of an antagonist or a\ndrug which reduces input) results in supersensitivity of the receptor as well as the effector\nsystem to the agonist. This has clinical relevance in clonidine/CNS depressant/opioid\nwithdrawal synd romes, sudden discontinuation of propranolo l in angina pectoris, etc. The\nmechanisms involved may be unmasking of receptors or their proliferation (up regulation ) or\naccentuation of signal amplification by the transducer .", "start_char_idx": 0, "end_char_idx": 1136, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b33f57f4-9b43-4a5c-8aef-5e71df639fce": {"__data__": {"id_": "b33f57f4-9b43-4a5c-8aef-5e71df639fce", "embedding": null, "metadata": {"page_label": "155", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "69f580a2-14cd-4a85-a9dd-92a6da0f8c40", "node_type": "4", "metadata": {"page_label": "155", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "069cdbd148c9140c6dec6a5dc888d6adf63b3c741b72a4c42c056a6c8ad7c3ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "00159d76-a4ac-4f09-a8a8-26beaba8d229", "node_type": "1", "metadata": {"page_label": "154", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9a0d304a6348fb3384d882fd687777d57968da900c63c27deed89f839ae3ecfc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4ec3ec63-0cf7-43d7-8123-63f45e2230e7", "node_type": "1", "metadata": {}, "hash": "8e1f2a914bf7754f2b8fdc007b5daaa8933a7bfaa692ff8aa256342c3fb4f6be", "class_name": "RelatedNodeInfo"}}, "text": "Conversely , continued/intense receptor stimulation causes desensitization or refractoriness:\nthe receptor becomes less efficient in transducing response to the agonist. This can be easily\ndemonstrated experimentally (Fig. 4.11); clinical examples are bronchial asthma patients\ntreated continuo usly with \u03b2 adrenergic agonists and parkin sonian patients treated with high\ndoses of levodopa gradually become less responsive. The changes may be brought about by:\n(i) Mask ing or internalization of the receptor (it becomes inaccessible to the agonist) or\nimpaired couplin g of the transducer to the receptor . In this case refractoriness develops as well\nas fades quickly .\nIn the case of \u03b2 adrenergic receptor, it has been found that high rate of agonist binding promotes phosphorylation\nof its serine residues near the intracellular carboxy terminus by an enzyme \u03b2 adrenergic receptor kinase (\u03b2ARK),", "start_char_idx": 0, "end_char_idx": 899, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4ec3ec63-0cf7-43d7-8123-63f45e2230e7": {"__data__": {"id_": "4ec3ec63-0cf7-43d7-8123-63f45e2230e7", "embedding": null, "metadata": {"page_label": "156", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "19bc9688-6990-4081-97a5-719003016d34", "node_type": "4", "metadata": {"page_label": "156", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a73e6f0808ac36764db4fcebd90e521f9282520322e6f50b996fd4616e8ff1fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b33f57f4-9b43-4a5c-8aef-5e71df639fce", "node_type": "1", "metadata": {"page_label": "155", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "069cdbd148c9140c6dec6a5dc888d6adf63b3c741b72a4c42c056a6c8ad7c3ea", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0ede72ee-3f39-4e10-9a6d-79498f4dec67", "node_type": "1", "metadata": {}, "hash": "c716c34ffc6e876ad77e294cfe88680e4f1b840e1fff5be2b284d4af9807b15c", "class_name": "RelatedNodeInfo"}}, "text": "allowing it to bind a protein called \u03b2-arrestin (\u03b2\u2212arr) which hinders its interaction with Gs \u2192 receptor\ntransduction is impaired. When the \u03b2-agonist is removed, the serine residues are dephosphorylated by cellular\nphosphatases, and receptor mediated activation of Gs is restored. However, in case of excessive/prolonged\nactivation, the phosphorylated \u03b2 adrenergic GPCR is internalized and largely moved to the lysosomes, where they\nare degraded, rather than returning back to the surface membrane. This results in receptor down regulation.\n(ii) Decreased synthesis/increase d destruction of the receptor (down regulation ): refractoriness\ndevelops over weeks or months and recedes slowly . Receptor down regulation is particularly\nexhibited by the tyrosine kinase receptors and some GPCRs. Similarly , the transducer and\neffector proteins are also up or down regulated.\nSome times response to all agonists which act through different receptors but produce the\nsame overt effect (e.g. histamine and acetylcholine both contract intestinal smooth muscle) is\ndecreased by exposure to any one of these agonists (heterolog ous desensitization), showing\nthat mechanism s of response effectuation have become less efficient. However , often\ndesensitization is limited to agonists of the same receptor that is being repeatedly activated\n(homologous desensitization).\nBoth homologous and heterologous desensitization has been observed in the case of GPCRs. The BARK \u03b2-\narrestin mechanism described above produces homologous desensitization. The GPCRs transduce many\nresponses by activating PKA and PKC. These kinases phosphorylate many GPCRs rather nonselectively (at a site\ndifferent from that of BARK) and hinder their interaction with G-proteins, resulting in heterologous\ndesensitization.\nFunctions of receptors\nThese can be summarized as:", "start_char_idx": 0, "end_char_idx": 1834, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0ede72ee-3f39-4e10-9a6d-79498f4dec67": {"__data__": {"id_": "0ede72ee-3f39-4e10-9a6d-79498f4dec67", "embedding": null, "metadata": {"page_label": "157", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ad99c96e-9493-40f0-be70-451826ad991d", "node_type": "4", "metadata": {"page_label": "157", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "c252e84c52b9e39fefaa85f48cda0bc2e910c1ac9e076def02e8725a3bae1c1c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4ec3ec63-0cf7-43d7-8123-63f45e2230e7", "node_type": "1", "metadata": {"page_label": "156", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a73e6f0808ac36764db4fcebd90e521f9282520322e6f50b996fd4616e8ff1fb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8e9f9677-6643-4a80-b827-8ee5ba2fd4fe", "node_type": "1", "metadata": {}, "hash": "5b689e8131b51699eb02a2f255c483eaea308fecfad63819c56aba9fb7e605e6", "class_name": "RelatedNodeInfo"}}, "text": "(a) To propagate regulatory signals from outside to inside the effector cell when the molecular\nspecies carrying the signal cannot itself penetrate the cell membrane.\n(b) To amplify the signal.\n(c) To integrate various extracellular and intracellular regulatory signals.\n(d) To adapt to short term and long term changes in the regulatory melieu and maintain\nhomeostasis.\nNonreceptor-mediated drug action\nThis refers to drugs which do not act by binding to specific regulatory macromolecules. Drug\naction by purely physical or chemical means, interactions with small molecules or ions\n(antacids, chelat ing agents, cholestyramine, etc.), as well as direct interaction with enzymes,\nionic channels and transporters has already been described. In addition, there are drugs like\nalkylating agents which react covalently with several critical biomolecules, especially nucleic\nacids, and have cytotoxic proper ty useful in the treatment of cancer . Another important class of\ndrugs are the antimetabolites (purine/pyrimidine analogues) which lead to production of\nnonfunctional or dysfunctional cellular components that exert antineoplastic, antiviral and\nimmunosuppressant activity .\nDOSE-RESPONSE RELA TIONSHIP\nWhen a drug is administered systemically , the dose-response relationship has two components:\ndose-plasma concentration relationship and plasma concentr ation-r esponse relationship. The", "start_char_idx": 0, "end_char_idx": 1393, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8e9f9677-6643-4a80-b827-8ee5ba2fd4fe": {"__data__": {"id_": "8e9f9677-6643-4a80-b827-8ee5ba2fd4fe", "embedding": null, "metadata": {"page_label": "158", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "914db214-79cb-4a8d-ba6b-c305915eec32", "node_type": "4", "metadata": {"page_label": "158", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "7875c0daf4812c7da4423549521fa71be98204fc2b939f3a726a4330d8858273", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0ede72ee-3f39-4e10-9a6d-79498f4dec67", "node_type": "1", "metadata": {"page_label": "157", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "c252e84c52b9e39fefaa85f48cda0bc2e910c1ac9e076def02e8725a3bae1c1c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ab44cfea-2a59-4300-9c76-32519d9c60be", "node_type": "1", "metadata": {}, "hash": "a407d631a221aaae327e896489b223935e163d96147507158105141abcceacc1", "class_name": "RelatedNodeInfo"}}, "text": "former is determined by pharmacokinetic considerations and ordinarily , descriptions of dose-\nresponse relationship refer to the latter , which can be more easily studied in vitr o.\nGenerally , the intensity of response increases with increase in dose (or more precisely\nconcentration at the receptor), but at higher doses, the increase in response progressively\nbecomes less marked and the dose-response curve is a rectangular hyperbola (Fig. 4.12). This\nis because drug-receptor interaction obeys law of mass actio n, which is described by the\nequation (3) and is applicable to interaction between any two molecules having a given affinity\nfor each other .\nWhere E is the observed effect at a dose [D] of the drug, Emax is the maximal response, KD\nis the dissociation constant of the drug-receptor complex, which is a measure of the affinity\nbetween the two, and is equal to the dose of the drug at which half maximal response is\nproduced. If the dose is plotted on a logarithmic scale, the curve becomes sigmoid and a linear\nrelationship between log of dose and the response is seen in the intermediate (30\u201370%\nresponse) zone, as can be predic ted from equation (3). This is not peculiar to drugs. In fact all\nstimuli are graded biologically by the fractional change in stimulus intensity , e.g. 1 kg and 2\nkg weig hts held in two hands can be easily differentiated, but not 10 kg and 11 kg weights.\nThough the absolute difference in both cases remains 1 kg, there is a 100% fractional change\nin the former case but only 10% change in the latter case. In other words, response is\nproportional to an exponential function (log) of the dose.\nOther advantages of plotting log dose-response curves (DRC) are:\n\u2022A wide range of drug doses can be easily displayed on a graph.\n\u2022Comparison between agonists and study of antagonists becomes easier .\nThe log dose-response curve (DRC) can be characterized by its shape (slope and maxima)\nand position on the dose axis.", "start_char_idx": 0, "end_char_idx": 1959, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ab44cfea-2a59-4300-9c76-32519d9c60be": {"__data__": {"id_": "ab44cfea-2a59-4300-9c76-32519d9c60be", "embedding": null, "metadata": {"page_label": "159", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "88219d14-c539-4858-9a96-3235d32521dc", "node_type": "4", "metadata": {"page_label": "159", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f1ae722070cb1fab0cbd5e66bdfcc712d0cd972e2c831ad4301768f6f63b214f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8e9f9677-6643-4a80-b827-8ee5ba2fd4fe", "node_type": "1", "metadata": {"page_label": "158", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e0b249a0ffa8fd2d7f1915ce9f1f4809a0657b06c7c58cf5e95921854bc5e4aa", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5bd50250-1640-40b6-8280-d64da0eb0f4a", "node_type": "1", "metadata": {}, "hash": "9c1eb47fe5ba92bf318efb1010520b971b5ed9ac80d4eca6421d54b4c741f6a1", "class_name": "RelatedNodeInfo"}}, "text": "Drug potency and ef\ufb01cacy\nThe position of DRC on the dose axis is the index of drug potency which refers to the amount\nof drug needed to produce a certain response. A DRC positioned rightward indicates lower\npotency (Fig. 4.13). Relative potency is often more meaningful than absolute potency , and is\ngenerally defined by comparing  the dose (concentration) of the two agonists at which they\nelicit half maximal response (EC50). Thus, if 10 mg of morphine = 100 mg of pethidine as\nanalgesic, morphine is 10 times more potent than pethidine. However , a higher potency , in\nitself, does not confer clinical superiority unless the potency for therapeutic effect is\nselectively incre ased over potency for adverse effect. Drug potency is clearly a factor in\nchoosing the dose of a drug.\nThe upper limit of DRC is the index of drug efficacy and refers to the maximal response\nthat can be elicited by the drug, e.g. morphine produces a degree of analgesia not obtainable\nwith any dose of aspirin\u2014morphine is more efficacious than aspirin. Efficacy is a more\ndecisive factor in the choice of a drug.\nOften the terms \u2018drug potency\u2019  and \u2018drug efficacy\u2019  are used interchangeably , but these are\nnot synonymous and refer to different characteristics of the drug. The two can vary\nindependently:\n(a) Aspirin is less potent as well as less ef ficacious analgesic than morphine.\n(b) Pethidine is less potent but equally ef ficacious analgesic as morphine.\n(c) Furosemide is less potent but more ef ficacious diuretic than metolazone.\n(d) Diazepam is more potent but less ef ficacious CNS depressant than pentobarbitone.\nDepending on the type of drug, both higher efficacy (as in the case of furosemide confering\nutility for mobilizing edema fluid and in renal failure) or lower efficacy (as in the case of\ndiazepam confering safety in over -dose) could be clinically advantageous.\nThe slope of the DRC is also important. A steep slope indicates that a moderate increase in\ndose will markedly increase the response (dose needs individualization), while a flat one\nimplies that little increase in response will occur over a wide dose range (standard doses can\nbe given to most patients). Hydralazine has a steep, while hydrochlorothiazide has a flat DRC\nof antihypertensive ef fect (Fig. 4.14).", "start_char_idx": 0, "end_char_idx": 2281, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5bd50250-1640-40b6-8280-d64da0eb0f4a": {"__data__": {"id_": "5bd50250-1640-40b6-8280-d64da0eb0f4a", "embedding": null, "metadata": {"page_label": "160", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "0d02bd28-1c95-43f7-bc8d-7bfe6b6ee33d", "node_type": "4", "metadata": {"page_label": "160", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "84c51a50c95b6f2146de916fe2fd40b9b332a29a8236ad87a6b725928a4a0175", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ab44cfea-2a59-4300-9c76-32519d9c60be", "node_type": "1", "metadata": {"page_label": "159", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f1ae722070cb1fab0cbd5e66bdfcc712d0cd972e2c831ad4301768f6f63b214f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "099ab0f6-d7e5-4474-9886-e28f5111aa38", "node_type": "1", "metadata": {}, "hash": "4a7a7fbc17c00d95f1e934f85619369037c70de1f7b0f479bc211321ce66c94c", "class_name": "RelatedNodeInfo"}}, "text": "Therapeutic ef\ufb01cacy", "start_char_idx": 0, "end_char_idx": 19, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "099ab0f6-d7e5-4474-9886-e28f5111aa38": {"__data__": {"id_": "099ab0f6-d7e5-4474-9886-e28f5111aa38", "embedding": null, "metadata": {"page_label": "161", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "6fa9c138-fc86-4e30-950f-7c7e2d4184a2", "node_type": "4", "metadata": {"page_label": "161", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "81d5a2241fe94a3b7b4371c6a53a2d4c670e4b7f407ee47826670f53e8ddaa0a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5bd50250-1640-40b6-8280-d64da0eb0f4a", "node_type": "1", "metadata": {"page_label": "160", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "84c51a50c95b6f2146de916fe2fd40b9b332a29a8236ad87a6b725928a4a0175", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "16d0ecdd-3e3f-49a4-9c14-e57ebcfccfce", "node_type": "1", "metadata": {}, "hash": "bc3dc934b8af803148767ec8ccc07edb5de9b19913dacdfbfb84ad6812aa4971", "class_name": "RelatedNodeInfo"}}, "text": "The \u2018therapeutic efficacy\u2019  or \u2018clinical effectiveness\u2019  is a composite attribute of a drug different\nfrom the foregoing pharmacolo gical description of \u2018potency\u2019  and \u2018efficacy\u2019. It depends not\nonly on the relative potency and efficacy of the drug, but on many pharmacokinetic and\npathophysiological variables as well. It is often expressed  in terms of (a) degree of\nbenefit/relief afforded by the drug (in the recommended dose range) i.e. graded dose-r esponse\nrelationship . For example, the degree of relief in parkinsonian symptoms afforded by\nlevodopa-carbidopa is much greater than that possible with trihexyphenidyl: the former has\nhigher therapeutic ef ficacy than the latter .\nThe other method of expressing therapeutic efficacy is in terms of (b) success rate in\nachieving a defined therapeutic  end point, i.e. quantal dose-r esponse relationship , e.g. an\nantibiotic which cures 95% cases of gonorrhoea is a more efficacious antigonococcal drug\nthan one which cures only 75% patients. Similarly , a drug which  makes a higher percentage of\nepileptic patients totally seizure free than another drug, is the more therapeutically effective\nantiepileptic.\nDrug selectivity\nDrugs seldom produce just one action: the DRCs for different effects of a drug may be\ndifferent. The extent of separation of DRCs of a drug for different effects is a measure of its\nselectivity , e.g. the DRCs for bronchodilatation and cardiac stimulation (Fig. 4.15) are quite\nsimilar in case of isoprenaline, but far apart in case of salbutamol\u2014the latter is a more\nselective bronchodilator drug.\nThe gap between the therapeutic effect DRC and the adverse effect DRC defines the safety\nmargin or the therapeutic index of a drug. In experimental anim als, therapeutic index is often\ncalculated as:\nwhere: Median effective dose (ED50) is the dose which produces the specified effect in 50%\nindividuals and median lethal dose (LD50) is the dose which kills 50% of the recipients.  \nBut this is irrelevant in the clinical set up where the therapeutic rang e, also called the\n\u2018therapeutic window\u2019  is bounded by the dose which produces minimal therapeutic effect and\nthe dose which produces maxim al acceptable adverse effect (Fig. 4.16). Because of individual\nvariability , the effective dose for some subjects may be toxic for others; defining the\ntherapeutic range for many drugs is a challenging task. A drug may be capable of inducing a\nhigher therapeutic response (have higher efficacy) but development of intolerable adverse\neffects may preclude use of higher doses, e.g. prednisolone in bronchial asthma.\nRisk-bene\ufb01t  ratio This term is very frequently  used, and conveys a judgement on the\nestimated harm (adverse effects, cost, inconvenience) vs expecte d advantages (relief of\nsymptoms, cure, reduction of complications/mortality , improvem ent in quality of life). A drug", "start_char_idx": 0, "end_char_idx": 2863, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "16d0ecdd-3e3f-49a4-9c14-e57ebcfccfce": {"__data__": {"id_": "16d0ecdd-3e3f-49a4-9c14-e57ebcfccfce", "embedding": null, "metadata": {"page_label": "162", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "407584b0-9976-4a08-ae1b-d68443db299a", "node_type": "4", "metadata": {"page_label": "162", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5325a551886fe7baa0f2b02531cef3d3ea66f2c2160f969e9423268b8634cdfc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "099ab0f6-d7e5-4474-9886-e28f5111aa38", "node_type": "1", "metadata": {"page_label": "161", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "81d5a2241fe94a3b7b4371c6a53a2d4c670e4b7f407ee47826670f53e8ddaa0a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "37682d3a-e813-418c-8f09-9f2e3a03927d", "node_type": "1", "metadata": {}, "hash": "306c77e152fab5a22dbecbe8198bc3b1fbc28f3b30776c529c1a8475373e41db", "class_name": "RelatedNodeInfo"}}, "text": "should be prescribed only when the benefits outweigh the risks. However , risk-benefit ratio\ncan hardly ever be accurately measured for each instance of drug use, because \u2018risk\u2019  is the\nprobability of harm; and harm has to be qualified by its nature, quantum, time-course\n(transient to life-long) as well as the value that the particular patient attaches to it. None of\nthese can be precisely ascertained beforehand in an individual patient. As such, the physician\nhas to rely on data from use of drugs in large populations (pharmacoepidemiology) and his\nown experience of the drug and the patient.\nDrug speci\ufb01city\nSpecificity of a drug refers to the range of actions produced by it. Certain drugs produce just\none or a limited number of actions, while others have widespr ead effects on many organs of\nthe body . Specificity is governed by:\n(a)whether a drug acts on a single receptor/tar get or on many tar gets, and\n(b)how widely the tar get is distributed in the body .\nOmeprazole (and other proton pump inhibitors) is an example of a highly specific drug. The\nsingular perceptible action in therapeutic doses is inhibition of gastric acid secretion, because\nit acts only on one target molecule H+K+ ATPase (proton pump) which is localized to the\ngastric parietal cells. An exampl e of a drug acting on multiple targets is chlorpromazine which\nhas antagonistic action on dopamine D2, \u03b1-adrener gic, muscarinic choliner gic, histamine H1\nand some 5-HT  receptors. It also has Na+ channel blocking action. As a result, it produces a\nwide range of actions. Another case is dexamethasone which is an agonist only of\nglucocorticoid receptor , but produces effects involving many organs and tissues, because the\nglucocorticoid receptor is expressed by practically every cell of the body . Drugs with all\ngrades of specificity are available.", "start_char_idx": 0, "end_char_idx": 1838, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "37682d3a-e813-418c-8f09-9f2e3a03927d": {"__data__": {"id_": "37682d3a-e813-418c-8f09-9f2e3a03927d", "embedding": null, "metadata": {"page_label": "163", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5558df91-61ef-4f67-845c-f300b390814b", "node_type": "4", "metadata": {"page_label": "163", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "773dea400721cdae63b0c23653257f59cfaaf4968293ea76c75426f22f2a1909", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "16d0ecdd-3e3f-49a4-9c14-e57ebcfccfce", "node_type": "1", "metadata": {"page_label": "162", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "7e5056506cdf8b838fcf3dbd925b63a0014bf6902469eeced9fd09ebae9829b8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6356dc5f-9e9a-40af-9974-75015522595d", "node_type": "1", "metadata": {}, "hash": "4396049861ea2032f3d37568eab659ecb148ac60aa469b7a3e93165a9a19b213", "class_name": "RelatedNodeInfo"}}, "text": "DRUG SYNERGISM AND ANTAGONISM\nWhen two or more drugs are given simultaneously or in quick succession, they may be either\nindifferent to each other or exhibit syner gism or antagonism . The interaction may take place at\npharmacokinetic level ( see Ch. 2 and 3) or at pharmacodynamic level.\nSYNERGISM (Greek: Syn\u2014together; ergon \u2014work)\nWhen the action of one drug is facilitated or increased by the other , they are said to be\nsyner gistic. In a syner gistic pair, both the drugs can have action in the same direction or given\nalone one may be inactive but still enhance the action of the other when given together .\nSyner gism can be:\n(a) Additive  The ef fect of the two drugs is in the same direction and simply adds up:\neffect of drugs A + B =effect of drug A + effect of drug B\nAdditive drug combinations\nAspirin + paracetamol as analgesic/antipyretic\nNitrous oxide + halothane as general anaesthetic\nAmlodipine + atenolol as antihypertensive\nGlibenclamide + metformin as hypoglycaemic\nEphedrine + theophylline as bronchodilator", "start_char_idx": 0, "end_char_idx": 1031, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6356dc5f-9e9a-40af-9974-75015522595d": {"__data__": {"id_": "6356dc5f-9e9a-40af-9974-75015522595d", "embedding": null, "metadata": {"page_label": "164", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3d4f1712-1c60-41f0-b5f5-46d7dece8a03", "node_type": "4", "metadata": {"page_label": "164", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "91cbce29d6c1db81f1832359528af9e54ad5454bc5e0e5e3d1e9e7296994d017", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "37682d3a-e813-418c-8f09-9f2e3a03927d", "node_type": "1", "metadata": {"page_label": "163", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "773dea400721cdae63b0c23653257f59cfaaf4968293ea76c75426f22f2a1909", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "789f8674-a309-4d58-85b9-929eaf08a7fc", "node_type": "1", "metadata": {}, "hash": "951cacabf306d81e3c035fbdd2a39c4320e3105c788230fc890765579fc487c0", "class_name": "RelatedNodeInfo"}}, "text": "Side effects of the components of an additive pair may be different\u2014do not add up. Thus,\nthe combination is better tolerated than higher dose of one component.\n(b) Supraadditive  ( potentiation ) The effect of combination is greater than the individual\neffects of the components:\neffect of drug A + B > ef fect of drug A + \\ef fect of drug B\nThis is always the case when one component given alone produces no effect, but enhances the\neffect of the other (potentiation). Examples are given in the box. Additive syner gism and\npotentiation are depicted diagrammatically in Fig. 4.17.\nSupraadditive drug combinations\n\uf044 \uf072 \uf075 \uf067 \uf020 \uf070 \uf061 \uf069 \uf072 \uf042 \uf061 \uf073 \uf069 \uf073 \uf020 \uf06f \uf066 \uf020 \uf070 \uf06f \uf074 \uf065 \uf06e \uf074 \uf069 \uf061 \uf074 \uf069 \uf06f \uf06e\nAcetylcholine + Inhibition of break\nphysostigmine down\nLevodopa + carbidopa/ Inhibition of peripheral\nbenserazide metabolism\nAdrenaline + cocaine/\ndesipramineInhibition of\nneuronal uptake\nSulfamethoxazole + Sequential blockade", "start_char_idx": 0, "end_char_idx": 900, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "789f8674-a309-4d58-85b9-929eaf08a7fc": {"__data__": {"id_": "789f8674-a309-4d58-85b9-929eaf08a7fc", "embedding": null, "metadata": {"page_label": "165", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "7a76f0c3-6db5-46b2-b6c6-f1fcdf1c3160", "node_type": "4", "metadata": {"page_label": "165", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f083e2964003e4d25522c0b2753586f39a1f9b440f63e520f08045315e4010dd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6356dc5f-9e9a-40af-9974-75015522595d", "node_type": "1", "metadata": {"page_label": "164", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "91cbce29d6c1db81f1832359528af9e54ad5454bc5e0e5e3d1e9e7296994d017", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0274a2be-b083-4f35-9298-334313bcd0b0", "node_type": "1", "metadata": {}, "hash": "e0d464ddae2909cbff28e740effdbea9a25df703fe27ee851c2d08a39f8cce61", "class_name": "RelatedNodeInfo"}}, "text": "trimethoprim\nAntihypertensives (enalapril+\nhydrochlorothiazide)Tackling two contributory factors\nTyramine + MAO\ninhibitorsIncreasing releaseable\nCA store\nANTAGONISM\nWhen one drug decreases or abolishes the action of another , they are said to be antagonistic:\neffect of drugs A + B < effect of drug A + effect of drug B\nUsually  in  an  antagonistic  pair  one  drug  is  inactive  as  such  but  decreases  the  effect\nof the  other . Depending  on  the  mechanism  involved , antagonism  may  be :\n(a) Physical antagonism\nBased on the physical property of the drugs, e.g. charcoal adsorbs alkaloids and can prevent\ntheir absorption\u2014used in alkaloidal poisonings.\n(b) Chemical antagonism\nThe two drugs react chemically and form an inactive product, e.g.\n\u2022KMnO4 oxidizes alkaloids\u2014used for gastric lavage in poisoning.\n\u2022Tannins + alkaloids\u2014insoluble alkaloidal tannate is formed.\n\u2022Chelating agents (BAL, Cal. disod. edetate) complex toxic metals (As, Pb).\n\u2022Nitrites form methaemoglobin which reacts with cyanide radical.\nDrugs may react when mixed in the same syringe or infusion bottle:\n\u2022Thiopentone sod. + succinylcholine chloride\n\u2022Penicillin-G sod. + succinylcholine chloride\n\u2022Heparin + penicillin/tetracyclines/streptomycin/hydrocortisone\n(c) Physiological/functional antagonism\u00a0\u00a0\nThe two drugs act on different receptors or by different mechanisms, but have opposite overt\neffects on the same physiological function, i.e. have pharma cological effects in opposite\ndirection, e.g.\n\u2022Histamine and adrenaline on bronchial muscles and on BP .\n\u2022Hydrochlorothiazide and amiloride on  urinary K+ excretion.\n\u2022Glucagon and insulin on blood sugar level.\n(d) Receptor antagonism\nOne drug (antag onist) blocks the receptor action of the other (agonist). This is a very important\nmechanism of drug action, because physiological signal molecu les act through their receptors,\nblockade of which can produce specific and often profound pharmacological effects. Receptor\nantagonists are selective (relatively), i.e. an anticholiner gic will oppose contraction of", "start_char_idx": 0, "end_char_idx": 2050, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0274a2be-b083-4f35-9298-334313bcd0b0": {"__data__": {"id_": "0274a2be-b083-4f35-9298-334313bcd0b0", "embedding": null, "metadata": {"page_label": "166", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "068f1722-7396-4b97-8aa0-e9ee7ad4c701", "node_type": "4", "metadata": {"page_label": "166", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b70f9373c1b746077b8c7d9124c40dc5e39dea2d786e4ee6ab20354191ea5cdd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "789f8674-a309-4d58-85b9-929eaf08a7fc", "node_type": "1", "metadata": {"page_label": "165", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f083e2964003e4d25522c0b2753586f39a1f9b440f63e520f08045315e4010dd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8cfb4edd-4173-4f75-b1b9-7cd63b047c6f", "node_type": "1", "metadata": {}, "hash": "44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a", "class_name": "RelatedNodeInfo"}}, "text": "intestinal smooth  muscle induced by choliner gic agonists, but not that induced by histamine or\n5-HT  (they act through a different set of receptors). Receptor antagonism can be competitive\nor noncompetitive.\nCompetitive  antagonism  ( equilibrium  type ) The antagonist is chemically similar to the\nagonist, compet es with it (Fig. 4.18 A, D) and binds to the same site to the exclusion of the\nagonist molecul es. Because the antagonist has affinity but no intrinsic activity (see p. 50), no\nresponse is produced and the log DRC of the agonist is shifted to the right. Since antagonist\nbinding is reversible and depends on the relative concentration of the agonist and antagonist\nmolecules, higher concentration of the agonist progressively overcomes the block\u2014a parallel\nshift of the agon ist DRC with no suppression of maximal response is obtained (Fig. 4.19A).\nThe extent of shift is dependent on the af finity and concentration of the antagonist.\nA partial agonist (Fig. 4.18 C), having affinity for the same receptor , also competes with\nand antagonizes a full agonist, while producing a submaximal response of its own.", "start_char_idx": 0, "end_char_idx": 1126, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8cfb4edd-4173-4f75-b1b9-7cd63b047c6f": {"__data__": {"id_": "8cfb4edd-4173-4f75-b1b9-7cd63b047c6f", "embedding": null, "metadata": {"page_label": "167", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "2f6dff5f-1a35-423a-9f23-2640a124e973", "node_type": "4", "metadata": {"page_label": "167", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e51979564273396713c39148fb2dfff29ed84d2c4d42eb50cc426987ff11ea08", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0274a2be-b083-4f35-9298-334313bcd0b0", "node_type": "1", "metadata": {"page_label": "166", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b70f9373c1b746077b8c7d9124c40dc5e39dea2d786e4ee6ab20354191ea5cdd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ed92e13a-961d-4c45-b4d3-5dd749dad14a", "node_type": "1", "metadata": {}, "hash": "95990bb0aba9e1d42793a8d1bd5f3b29d2f8da94527c31a776d1307dca08ffc3", "class_name": "RelatedNodeInfo"}}, "text": "", "start_char_idx": 0, "end_char_idx": 0, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ed92e13a-961d-4c45-b4d3-5dd749dad14a": {"__data__": {"id_": "ed92e13a-961d-4c45-b4d3-5dd749dad14a", "embedding": null, "metadata": {"page_label": "168", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "bef26e38-21ed-4aa3-8548-ad97fd0db6e3", "node_type": "4", "metadata": {"page_label": "168", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6224520969d87416f9970ba2709475ed35705728925c203368e72210013d97da", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8cfb4edd-4173-4f75-b1b9-7cd63b047c6f", "node_type": "1", "metadata": {"page_label": "167", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e51979564273396713c39148fb2dfff29ed84d2c4d42eb50cc426987ff11ea08", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7d9e8e0b-bbf0-4b23-a243-f8c918abf811", "node_type": "1", "metadata": {}, "hash": "9db9b97f6a838582453f130f1ff7d22273815bb4718268b3d67ed29274da6155", "class_name": "RelatedNodeInfo"}}, "text": "Noncompetitive  antagonism  The antagonist is chemically unrelated to the agonist, binds to a\ndifferent allosteric site altering the receptor in such a way that it is unable to combine with the\nagonist (Fig. 4.18E), or is unab le to transduce the response, so that the downstream chain of\nevents are uncoupled. This is also called allosteric antagonism . Because the agonist and the\nantagonist are combining with different sites, there is no competition between them\u2014even\nhigh agonist concentration is unable to reverse the block completely . Increasing concentrations\nof the antagon ist progressivel y flatten the agonist DRC (Fig. 4.19B). Noncompetitive\nantagonists have been produced experimentally , but are not in clinical use.\nNonequilibrium   antagonism  Certain antagon ists bind to the receptor with strong (covalent)\nbonds or dissociate from it slow ly (due to very high affinity) so that agonist molecules are\nunable to reduce receptor occupancy of the antagonist molecules\u2014law  of mass action cannot\napply\u2014an irreversible or nonequilibrium antagonism is produced. The agonist DRC is shifted\nto the right and the maximal response is lowered (if spare receptors are few). Since in this\nsituation the agonist molecules are not able to compete with the antagonist molecules and\nflattening of agonist DRC is a feature of noncompetitive antagonism;  nonequilibrium\nantagonism has also been called  \u2018a type of noncompetitive antag onism\u2019. Phenoxybenzamine is\na nonequilibrium antagonist of adrenaline at the \u03b1 adrener gic receptors.\nCompetitive\u00a0 (equilibrium type) Noncompetitive\n1. Antagonist binds with the same receptor\nas the agonistBinds to another site of receptor\n2. Antagonist resembles chemically with the\nagonistDoes not resemble\n3. Parallel rightward shift of agonist DRC Flattening of agonist DRC\n4. The same maximal response can be\nattained by increasing dose of agonist\n(surmountable antagonism)Maximal response is suppressed\n(unsurmountable antagonism)", "start_char_idx": 0, "end_char_idx": 1972, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7d9e8e0b-bbf0-4b23-a243-f8c918abf811": {"__data__": {"id_": "7d9e8e0b-bbf0-4b23-a243-f8c918abf811", "embedding": null, "metadata": {"page_label": "169", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "4404dd4d-1ba0-46fb-9f9c-4b28c4d5ca73", "node_type": "4", "metadata": {"page_label": "169", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8980c41d1cb1b45a43c49a2a0c75b921ebbf899303dd60450e54d621d7435705", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ed92e13a-961d-4c45-b4d3-5dd749dad14a", "node_type": "1", "metadata": {"page_label": "168", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6224520969d87416f9970ba2709475ed35705728925c203368e72210013d97da", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0f1e51a3-e754-45b9-ac17-ceb06bce494f", "node_type": "1", "metadata": {}, "hash": "a8fe6f780bc202c395581fd2458846dc260670b80f13a788bfaaf95baeb1cf5f", "class_name": "RelatedNodeInfo"}}, "text": "5. Intensity of response depends on the\nconcentration of both agonist and\nantagonistMaximal response depends only on the\nconcentration of antagonist\n6. Examples: ACh\u2014Atropine Morphine\u2014\nNaloxoneDiazepam\u2014Bicuculline\nFeatures of competitive and noncompetitive antagonism are compared on previous page.", "start_char_idx": 0, "end_char_idx": 298, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0f1e51a3-e754-45b9-ac17-ceb06bce494f": {"__data__": {"id_": "0f1e51a3-e754-45b9-ac17-ceb06bce494f", "embedding": null, "metadata": {"page_label": "170", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b35da6f0-720d-4d34-a925-5c98c6b06b48", "node_type": "4", "metadata": {"page_label": "170", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "df07943a12dccbd4eb9e39e06110c03cfdfc3959f998d96e9aab7872b82456cc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7d9e8e0b-bbf0-4b23-a243-f8c918abf811", "node_type": "1", "metadata": {"page_label": "169", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "ea7414a584d196ae42bd60623471b50e35bea29568cc0bc169411f824b982927", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3e1ce26e-1547-44b9-abf0-e7a372f3b4c8", "node_type": "1", "metadata": {}, "hash": "9dd60e64ecfc35f012b89cb39d8f1efe202a80ebb4ca19242a62dd126ea5267c", "class_name": "RelatedNodeInfo"}}, "text": "Pharmaco- (drug) therapy is dynamic and an ever evolving\nscience. It requires understanding of the drug, the disease,\nthe patient and the milieu in which it is undertaken. As\nsuch, in addition to knowledge of drug action, mechanisms\nand pharmacokinetics, several aspects like drug dosage,\nsources of variability in drug response, pharmacogenetics,\ninfluence of disease on drug action, etc. are important for\notimum drug therapy.\nDRUG DOSAGE\n\u2018Dose\u2019 is the appropriate amount of a drug needed to\nproduce a certain degree of response in a given patient.\nAccordingly, dose of a drug has to be qualified in terms\nof the chosen response, e.g. the analgesic dose of aspirin\nfor headache is 0.3\u20130.6 g, its antiplatelet dose is 60\u2013150\nmg/day, while its antiinflammatory dose for rheumatoid\narthritis is 3\u20135 g per day. Similarly there could be a\nprophylactic dose, a therapeutic dose or a toxic dose of the\nsame drug.", "start_char_idx": 0, "end_char_idx": 907, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3e1ce26e-1547-44b9-abf0-e7a372f3b4c8": {"__data__": {"id_": "3e1ce26e-1547-44b9-abf0-e7a372f3b4c8", "embedding": null, "metadata": {"page_label": "171", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "7a320830-44b5-4f52-a45b-baf28b810782", "node_type": "4", "metadata": {"page_label": "171", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5d0cca1378024cf49a6c6c8b6fef2ee09511f8f56027875447cb7f063aea3e28", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0f1e51a3-e754-45b9-ac17-ceb06bce494f", "node_type": "1", "metadata": {"page_label": "170", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "df07943a12dccbd4eb9e39e06110c03cfdfc3959f998d96e9aab7872b82456cc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d1307b8b-a92e-4222-bfa6-3aee2c75b68b", "node_type": "1", "metadata": {}, "hash": "9d289b6cf1a09255cdd8786eaeaac87c08401dc927708b426d126c5c58adf1e2", "class_name": "RelatedNodeInfo"}}, "text": "The dose of a drug is governed by its inherent potency,\ni.e. the concentration at which it should be present at the\ntarget site, and its pharmacokinetic characteristics. The\nrecommended doses are based on population data and cater\nto an \u2018average\u2019 patient. However, individual patients may\nnot be \u2018average\u2019 in respect to a number of pharmacokinetic\nand pharmacodynamic parameters, emphasizing the need\nfor individualizing drug dose. The strategies adopted for\ndifferent types of drugs and conditions are:\n1.Standard dose The same dose is appropriate for\nmost patients\u2014individual variations are minor or the drug\nhas a wide safety margin so that a large enough dose can be\ngiven to cover them, e.g. oral contraceptives, penicillin,\nchloroquine, mebendazole, hydrochlorothiazide.\n2.Regulated dose The drug modifies a finely regulated\nbody function which can be easily measured. The dosage is\naccurately adjusted by repeated measurement of the\naffected physiological parameter, e.g. antihypertensives,\nhypoglycaemics, anticoagulants, diuretics, general\nanaesthetics. In their case, measurement of plasma drug\nconcentration is not needed.\n3.Target level dose (see p. 41) The response is not\neasily measurable but has been demonstrated to be\nobtained at a certain range of drug concentration in plasma.", "start_char_idx": 0, "end_char_idx": 1296, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d1307b8b-a92e-4222-bfa6-3aee2c75b68b": {"__data__": {"id_": "d1307b8b-a92e-4222-bfa6-3aee2c75b68b", "embedding": null, "metadata": {"page_label": "172", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "c45b799f-fe40-4f2f-bc79-032d33924c03", "node_type": "4", "metadata": {"page_label": "172", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "56abd08723cde46415ac5c53576af2e896da5950ab6a9c2f8c691637b83c5c37", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3e1ce26e-1547-44b9-abf0-e7a372f3b4c8", "node_type": "1", "metadata": {"page_label": "171", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5d0cca1378024cf49a6c6c8b6fef2ee09511f8f56027875447cb7f063aea3e28", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b139a041-da70-4a3e-9b93-db6d841032df", "node_type": "1", "metadata": {}, "hash": "b9f57cb5796378979545b5661e9f60649cf555d1d14c89558d5f8943d7d82eb1", "class_name": "RelatedNodeInfo"}}, "text": "An empirical dose aimed at attaining the target level is\ngiven in the beginning and adjustments are made later by\nactual monitoring of plasma concentrations. When facilities\nfor drug level monitoring are not available, crude\nadjustments are made by observing the patient at relatively\nlong intervals, e.g. antidepressants, antiepileptics, digoxin,\ntheophylline.\n4.Titrated dose The dose needed to produce maximal\ntherapeutic effect cannot be given because of intolerable\nadverse effects. Optimal dose is arrived at by titrating it\nwith an acceptable level of adverse effect. Low initial dose\nand upward titration (in most non-critical situations) or\nhigh initial dose and downward titration (in critical\nsituations) can be practised. Often a compromise between\nsubmaximal therapeutic effect but tolerable side effects can\nbe struck, e.g. anticancer drugs, corticosteroids, levodopa.\nFixed dose combinations (FDCs) of drugs\nA large number of pharmaceutical preparations contain two\nor more drugs in a fixed dose ratio. Advantages offered by\nthese are:\n1.Convenience and better patient compliance\u2014when all\nthe components present in the FDC are actually needed\nby the patient and their amounts are appropriate. It may", "start_char_idx": 0, "end_char_idx": 1214, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b139a041-da70-4a3e-9b93-db6d841032df": {"__data__": {"id_": "b139a041-da70-4a3e-9b93-db6d841032df", "embedding": null, "metadata": {"page_label": "173", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "02f2e1fa-f441-468f-9d72-5ccacdba6435", "node_type": "4", "metadata": {"page_label": "173", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "314c220ac6247fb8a4d04515f5681304b6cb62085ac0ac1a01fba3f0e305ff00", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d1307b8b-a92e-4222-bfa6-3aee2c75b68b", "node_type": "1", "metadata": {"page_label": "172", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "56abd08723cde46415ac5c53576af2e896da5950ab6a9c2f8c691637b83c5c37", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8b8394d1-eaa9-4815-8f94-6d55b517882c", "node_type": "1", "metadata": {}, "hash": "29bd6de9c0cbed577e276aed509826e5811b4e15849e0767de5ac1b59bfc84eb", "class_name": "RelatedNodeInfo"}}, "text": "also be cost saving compared to both/all the components\nadministered separately.\n2.Certain drug combinations are synergistic,  e.g.\nsulfamethoxazole + trimethoprim; levodopa +\ncarbidopa/benserazide; combination oral contraceptives,\nisoniazid + rifampin.\n3.The therapeutic effect of two components being same\nmay add up while the side effects being different may\nnot. For this the components of the FDC should act by\ndifferent mechanisms, e.g. amlodipine + atenolol as\nantihypertensive.\n4.The side effect of one component may be counteracted\nby the other, e.g. a thiazide + a potassium sparing\ndiuretic. However, the amount of the latter may not be\nsufficient in all cases.\n5.Combined formulation ensures that a single drug will\nnot be administered. This is important in the treatment\nof tuberculosis, HIV-AIDS and falciparum malaria.\nBefore prescribing a combination, the physician must\nconsider whether any of the ingredients is unnecessary; if it\nis, the combination should not be prescribed. It can never\nbe justified that a drug is given to a patient who does not\nneed it in order to provide him another, one that he needs.\nThere are many inbuilt disadvantages of FDCs:", "start_char_idx": 0, "end_char_idx": 1173, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8b8394d1-eaa9-4815-8f94-6d55b517882c": {"__data__": {"id_": "8b8394d1-eaa9-4815-8f94-6d55b517882c", "embedding": null, "metadata": {"page_label": "174", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f976e342-68b6-4d58-a9f5-b317cb5dae73", "node_type": "4", "metadata": {"page_label": "174", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "850af3c39d3990091007a35367a8d27fb6398866c30a158df03be8659954f7db", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b139a041-da70-4a3e-9b93-db6d841032df", "node_type": "1", "metadata": {"page_label": "173", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "314c220ac6247fb8a4d04515f5681304b6cb62085ac0ac1a01fba3f0e305ff00", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1797c6c0-231d-4976-bc2b-9508e8df93f0", "node_type": "1", "metadata": {}, "hash": "ff9d3e777aae47fc469370caae48de289dfce9585555938fc8648807dea69952", "class_name": "RelatedNodeInfo"}}, "text": "1.The patient may not actually need all the drugs present\nin a combination: he is subjected to additional side\neffects and expense (often due to ignorance of the\nphysician about the exact composition of the combined\nformulations).\n2.The dose of most drugs needs to be adjusted and\nindividualised. When a combined formulation is used,\nthis cannot be done without altering the dose of the\nother component(s). However, few combinations are\navailable at more than one dose ratios, e.g. levodopa\n(100 mg) + Carbidopa (10 mg or 25 mg), amoxicillin\n(250 mg or 500 mg) + clavulanic acid (125 mg).\n3.The time course of action of the components may be\ndifferent: administering them at the same intervals may\nbe inappropriate.\n4.Altered renal or hepatic function of the patient may\ndifferently affect the pharmacokinetics of the\ncomponents.\n5.Adverse effect, when it occurs, cannot be easily ascribed\nto the particular drug causing it.\n6.Contraindication to one component (allergy, other\nconditions) contraindicates the whole product.\n7.Confusion of therapeutic aims and false sense of\nsuperiority of two drugs over one is fostered, specially\nin case of antimicrobials whose combinations should be\navoided. Corticosteroids should never be combined with", "start_char_idx": 0, "end_char_idx": 1241, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1797c6c0-231d-4976-bc2b-9508e8df93f0": {"__data__": {"id_": "1797c6c0-231d-4976-bc2b-9508e8df93f0", "embedding": null, "metadata": {"page_label": "175", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "e22f2699-412d-493e-9015-854ae6d940f2", "node_type": "4", "metadata": {"page_label": "175", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3a3f4ad87f3eac0ff5eaacfa9d4bc70b86eed0df4310bec7da851abe19cc1e1b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8b8394d1-eaa9-4815-8f94-6d55b517882c", "node_type": "1", "metadata": {"page_label": "174", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "850af3c39d3990091007a35367a8d27fb6398866c30a158df03be8659954f7db", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3b77a8e7-38d9-4870-b541-2327fd89904b", "node_type": "1", "metadata": {}, "hash": "efd69ebc349eb4284d6a35174dc757987ed8c778260a92a1a73bae1d09e555c7", "class_name": "RelatedNodeInfo"}}, "text": "any other drug meant for internal use. Drug\ncombinations that are banned in India are listed in\nAppendix-4.\nThus, only a handful of FDCs are rational and justified,\nwhile far too many are produced and vigorously promoted\nby the pharmaceutical industry. In fact, the latest (2017)\nWHO essential medicines list incorporates only 25 FDCs,\nand the NLEM (2015) of India has only 20 FDCs. In\naddition to the previously banned FDCs, recently 344 other\nirrational FDCs have been banned in India.\nFACTORS MODIFYING DRUG ACTION\nVariation in response to the same dose of a drug between\ndifferent patients and even in the same patient on different\noccasions is a rule rather than exception. One or more of\nthe following categories of differences among individuals\nare responsible for the variations in drug response:\n(1) Individuals differ in pharmacokinetic handling of drugs:\nattain varying plasma/target site concentration of the drug.\nThis is more marked for drugs disposed by metabolism\n(e.g. propranolol) than for drugs excreted unchanged (e.g.\natenolol).\n(2) Variations in number or state of receptors, coupling\nproteins or other components of response effectuation.", "start_char_idx": 0, "end_char_idx": 1161, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3b77a8e7-38d9-4870-b541-2327fd89904b": {"__data__": {"id_": "3b77a8e7-38d9-4870-b541-2327fd89904b", "embedding": null, "metadata": {"page_label": "176", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "a0732593-97f7-43f2-8f50-afcadb61c019", "node_type": "4", "metadata": {"page_label": "176", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6ac250e1514dd357ad604915dd8cf5f1692ebea2a6f2dd318bedc95620332545", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1797c6c0-231d-4976-bc2b-9508e8df93f0", "node_type": "1", "metadata": {"page_label": "175", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3a3f4ad87f3eac0ff5eaacfa9d4bc70b86eed0df4310bec7da851abe19cc1e1b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "130c87c8-187a-4a53-a5fe-0f5db8ebca9c", "node_type": "1", "metadata": {}, "hash": "b2ee8e651ee2716c821befdf6f233d46066f5857d35acb8fc7d4b373e66412d1", "class_name": "RelatedNodeInfo"}}, "text": "(3) Variations in neurogenic/hormonal tone or\nconcentrations of specific constituents, e.g. atropine\ntachycardia depends on vagal tone, propranolol bradycardia\ndepends on sympathetic tone, captopril hypotension\ndepends on body Na+ status.\nA multitude of host and external factors influence drug\nresponse. They fall in two categories viz genetic and\nnongenetic including all environmental, circumstantial and\npersonal variables. Though individual variation cannot be\ntotally accounted for by these factors, their understanding\ncan guide the choice of appropriate drug and dose for an\nindividual patient. However, final adjustments have to be\nmade by observing the response in a given patient on a\ngiven occasion.\nThe factors modify drug action either:\n(a)Quantitatively The plasma concentration and/or the\naction of the drug is increased or decreased. Most of the\nfactors introduce this type of change and can be dealt with\nby adjustment of drug dosage.\n(b)Qualitatively The type of response is altered, e.g. drug\nallergy or idiosyncrasy. This is less common but often\nprecludes further use of that drug in the affected patient.\nThe various factors are discussed below\u2014", "start_char_idx": 0, "end_char_idx": 1168, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "130c87c8-187a-4a53-a5fe-0f5db8ebca9c": {"__data__": {"id_": "130c87c8-187a-4a53-a5fe-0f5db8ebca9c", "embedding": null, "metadata": {"page_label": "177", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b945d56d-bb36-4ef8-9dae-b23aa4d6e3c1", "node_type": "4", "metadata": {"page_label": "177", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fc02ac775a317956bc33033d7756a27d9888fa2e5fd3e91fab8155cbd21b2e3d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3b77a8e7-38d9-4870-b541-2327fd89904b", "node_type": "1", "metadata": {"page_label": "176", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6ac250e1514dd357ad604915dd8cf5f1692ebea2a6f2dd318bedc95620332545", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9e571175-d241-4ff4-8671-be5730b434d8", "node_type": "1", "metadata": {}, "hash": "765765d6bde080c4b3008e8224c6cbbafad94e3c2c0f3030459bd2fa7261f580", "class_name": "RelatedNodeInfo"}}, "text": "1. Body size It influences the concentration of the drug\nattained at the site of action. The average adult dose refers\nto individuals of medium built. For exceptionally obese or\nlean individuals and for children dose may be calculated on\nbody weight (BW) basis:\nIt has been argued that body surface area (BSA) provides a\nmore accurate basis for dose calculation, because total\nbody water, extracellular fluid volume and metabolic\nactivity are better paralleled by BSA.\nThe BSA of an individual can be calculated from Dubois\nformula:\nor obtained from chart-form or slide-rule nomograms based\non BW and height.\nHowever, dose recommendations in terms of BSA are\navailable only for anticancer and a handful of other drugs:\nfor the rest BW has been used as the index. Thus,", "start_char_idx": 0, "end_char_idx": 768, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9e571175-d241-4ff4-8671-be5730b434d8": {"__data__": {"id_": "9e571175-d241-4ff4-8671-be5730b434d8", "embedding": null, "metadata": {"page_label": "178", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "67d933a3-a709-451f-b837-e1e825e3010a", "node_type": "4", "metadata": {"page_label": "178", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e3617acf0c8a43bf8b3019c8d2955a5b73ed63832a2772ab47f52a884cc546f9", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "130c87c8-187a-4a53-a5fe-0f5db8ebca9c", "node_type": "1", "metadata": {"page_label": "177", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fc02ac775a317956bc33033d7756a27d9888fa2e5fd3e91fab8155cbd21b2e3d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f51f6974-ed6d-4488-bd3e-752ce70d4483", "node_type": "1", "metadata": {}, "hash": "8f8a1acea6c9dec7f17df6f2a3025aa180103fe5eb85ec775990b8b1bf9aaa3d", "class_name": "RelatedNodeInfo"}}, "text": "prescribing on BSA basis suffers from lack of data base, is\nmore cumbersome and has not thrived, except in few cases.\n2. Age The dose of a drug for children is often calculated\nfrom the adult dose. Some age based formulae for\ncalculating child dose from the adult dose have been\nframed, but are not in use now. Child dose is better\ncalculated more accurately on BW basis. For many drugs,\nmanufacturers give dosage recommendations on mg/kg\nbasis. Average figures for children are given in the chart\nbelow.\nBody weight (Kg)* %\nofAge Boys Girls Adult dose\nNewborn 3.5 3.4 12.5\n1 month 4.8 4.5 15\n3 months 6.4 5.8 18\n6 months 8.1 7.4 22\n1 year 10.5 9.7 25\n3 years 14.3 13.8 33\n5 years 18.5 18.2 40\n7 years 23.1 22.9 50\n9 years 28.7 29.1 60\n12 years 40.7 41.8 75", "start_char_idx": 0, "end_char_idx": 757, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f51f6974-ed6d-4488-bd3e-752ce70d4483": {"__data__": {"id_": "f51f6974-ed6d-4488-bd3e-752ce70d4483", "embedding": null, "metadata": {"page_label": "179", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "105d2be9-d4c2-4bdc-b09f-ca1f1a04e0d3", "node_type": "4", "metadata": {"page_label": "179", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2993782963367f645050d5da95892d0b603f883d2b1ee049cd234eab7c8b0f72", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9e571175-d241-4ff4-8671-be5730b434d8", "node_type": "1", "metadata": {"page_label": "178", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e3617acf0c8a43bf8b3019c8d2955a5b73ed63832a2772ab47f52a884cc546f9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8c4740ea-586b-4b71-80e2-1144e7b86821", "node_type": "1", "metadata": {}, "hash": "bb3a003cfbd08d733045ea6511bec5c285072b75aa957c37239f3cd03927a663", "class_name": "RelatedNodeInfo"}}, "text": "*50th percentil e body weight of Indian boys and girls as per CDC\n2000 guidelines.\nHowever, infants and children are not small adults. They\nhave important physiological differences from adults. The\nnewborn has low g.f.r. and tubular transport is immature.\nAs such, the t\u00bd of drugs excreted by glomerular filtration\n(gentamicin) and tubular secretion (penicillin) is prolonged\nby 3 to 5 times. Glomerular filtration reaches adult rates by\n5 month of age and tubular secretion takes about 7 months\nto mature. Similarly, hepatic drug metabolizing system is\ninadequate in newborns \u2014chloramphenicol can produce\ngray baby syndrome (see Ch. 53). Blood-brain barrier is\nmore permeable\u2014drugs attain higher concentration in the\nCNS (easy entry of unconjugated bilirubin in brain causes\nkernicterus). These defects are exaggerated in the\npremature infant. Drug absorption may also be altered in\ninfants because of lower gastric acidity and slower\nintestinal transit. Transdermal absorption however, is faster\nbecause infant skin is thin and more permeable. Rectal\nabsorption is fast and more predictable in infants and\nyoung children. Taking advantage of this fact, diazepam\nsolution is given rectally to control febrile seizures in\nchildren < 5 years. Therefore, infant doses must be learned\nas such and not derived from any formula.\nAfter the first year of life, drug metabolism is often\nfaster than in adults. Accordingly, the t\u00bd of theophylline,", "start_char_idx": 0, "end_char_idx": 1438, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8c4740ea-586b-4b71-80e2-1144e7b86821": {"__data__": {"id_": "8c4740ea-586b-4b71-80e2-1144e7b86821", "embedding": null, "metadata": {"page_label": "180", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "4456f49d-4efb-4041-98ac-c657c9f9f4dd", "node_type": "4", "metadata": {"page_label": "180", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8e5a7156f496844feccf41642c32bf39f8de0c342964f5c619afd076a48e67ba", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f51f6974-ed6d-4488-bd3e-752ce70d4483", "node_type": "1", "metadata": {"page_label": "179", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2993782963367f645050d5da95892d0b603f883d2b1ee049cd234eab7c8b0f72", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "38c696e4-9d0b-4443-8e58-0cee68586adb", "node_type": "1", "metadata": {}, "hash": "bad4f48beb51504f0812a3628e7c40d7c1d5c6fe33938403e487838ae2919f61", "class_name": "RelatedNodeInfo"}}, "text": "phenytoin, carbamazepine is shorter in children than in\nadults. Also, higher per kg dose is needed in children for\ndrugs which are primarily excreted unchanged by kidney,\ne.g. daily dose of digoxin is about 8\u201312 \u00b5g/kg compared to\nadult dose of 3\u20135 \u00b5g/kg.\nSolid dosage forms and metered dose inhalers are\ndifficult to administer to young children.\nChildren are growing and are susceptible to special\nadverse effects of drugs, e.g. suppression of growth can\noccur with corticosteroids; androgens may promote early\nfusion of epiphysis resulting in stunting of stature;\ntetracyclines get deposited in growing teeth and\ndiscolour/deform them. Dystonic reactions to\nphenothiazines are more common in children.\nElderly In the elderly, renal function progressively declines\n(intact nephron loss) so that g.f.r. is ~ 75% at 50 years and\n~ 50% at 75 years age compared to young adults. Drug\ndoses have to be reduced, e.g. daily dose of streptomycin is\n0.75 g after 50 years and 0.5 g after 70 years of age\ncompared to 1 g for young adults. There is also a reduction\nin the hepatic microsomal drug metabolizing activity and\nliver blood flow: oral bioavailability of drugs with high\nhepatic extraction is generally increased, but the overall\neffects on drug metabolism are not uniform. Due to lower\nrenal as well as metabolic clearance, the elderly are prone", "start_char_idx": 0, "end_char_idx": 1346, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "38c696e4-9d0b-4443-8e58-0cee68586adb": {"__data__": {"id_": "38c696e4-9d0b-4443-8e58-0cee68586adb", "embedding": null, "metadata": {"page_label": "181", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5461ee63-5766-428e-a45b-a9a4005935be", "node_type": "4", "metadata": {"page_label": "181", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fd5d8c76530691d61fee4d7c8ec7a33dc1baec7203b58aa6b65ffaaa3107bf0f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8c4740ea-586b-4b71-80e2-1144e7b86821", "node_type": "1", "metadata": {"page_label": "180", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8e5a7156f496844feccf41642c32bf39f8de0c342964f5c619afd076a48e67ba", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "51510684-50c3-4045-8bbf-925a7c10ac56", "node_type": "1", "metadata": {}, "hash": "73686bd686695d1f82ca7d8f883cb7e01131514a94003c77b65b30aa18d0fb13", "class_name": "RelatedNodeInfo"}}, "text": "to develop cumulative toxicity while receiving prolonged\nmedication. Other affected aspects of drug handling are:\n\u2022slower absorption due to reduced gut motility as well as\nblood flow to intestines,\n\u2022lesser plasma protein binding due to lower plasma\nalbumin,\n\u2022increased or decreased volume of distribution of\nlipophilic and hydrophilic drugs respectively.\nAged are relatively intolerant to digitalis. The\nresponsiveness of \u03b2 adrenergic receptors to both agonists\nand antagonists is reduced in the elderly and sensitivity to\nother drugs also may be altered. Due to prostatism in\nelderly males, even mild anticholinergic activity of the\ndrug can accentuate bladder voiding difficulty. Elderly are\nalso likely to be on multiple drug therapy for hypertension,\nischaemic heart disease, diabetes, arthritis, etc. which\nincreases many fold the chances of drug interactions. They\nare more prone to develop postural instability, giddiness\nand mental confusion. In general, the incidence of adverse\ndrug reactions is much higher in the elderly.\n3. Sex Females have smaller body size and require doses\nthat are on the lower side of the range. Subjective effects of\ndrugs may differ in females because of their mental\nmakeup. Maintenance treatment of heart failure with\ndigoxin is reported to be associated with higher mortality", "start_char_idx": 0, "end_char_idx": 1315, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "51510684-50c3-4045-8bbf-925a7c10ac56": {"__data__": {"id_": "51510684-50c3-4045-8bbf-925a7c10ac56", "embedding": null, "metadata": {"page_label": "182", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "85e0af80-6850-49fd-94e7-a230a676ad63", "node_type": "4", "metadata": {"page_label": "182", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "16fde08b694a1121af1064192571e79abe3ed5928c43166dcd1ea8d3589dfd38", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "38c696e4-9d0b-4443-8e58-0cee68586adb", "node_type": "1", "metadata": {"page_label": "181", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fd5d8c76530691d61fee4d7c8ec7a33dc1baec7203b58aa6b65ffaaa3107bf0f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "82eb2c76-5674-4eb1-aa5d-5917b567f8b8", "node_type": "1", "metadata": {}, "hash": "4930a438a668d84456845d5e0fe0a32494b1bac890c6b67b58d6b13512686b9b", "class_name": "RelatedNodeInfo"}}, "text": "among women than among men. A number of\nantihypertensives (clonidine, methyldopa, \u03b2-blockers,\ndiuretics) have potential to interfere with sexual function in\nmales but not in females. Gynaecomastia is a side effect (of\nketoconazole, metoclopramide, chlorpromazine, digitalis)\nthat can occur only in men. Ketoconazole causes loss of\nlibido in men but not in women. Obviously androgens are\nunacceptable to women and estrogens to men. In women\nconsideration must also be given to menstruation,\npregnancy and lactation.\nDrugs given during pregnancy can affect the foetus (see\nCh. 6 and Appendix-2). There are marked and progressive\nphysiological changes during pregnancy, especially in the\nthird trimester, which can alter drug disposition.\n(i)Gastrointestinal motility is reduced \u2192 delayed\nabsorption of orally administered drug.\n(ii)Plasma and extracellular fluid volume expands\u2014\nvolume of drug distribution may increase.\n(iii)While plasma albumin level falls, that of \u03b11 acid\nglycoprotein increases\u2014the unbound fraction of acidic\ndrugs increases but that of basic drugs decreases.\n(iv)Renal blood flow increases markedly\u2014polar drugs are\neliminated faster.\n(v)Hepatic microsomal enzymes undergo induction\u2014\nmany drugs are metabolized faster.", "start_char_idx": 0, "end_char_idx": 1237, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "82eb2c76-5674-4eb1-aa5d-5917b567f8b8": {"__data__": {"id_": "82eb2c76-5674-4eb1-aa5d-5917b567f8b8", "embedding": null, "metadata": {"page_label": "183", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "7f47ff51-a533-480d-9484-d036e9228603", "node_type": "4", "metadata": {"page_label": "183", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "02a0cf886295c49ca5bf5b34dc74be4f610225e91d664d78d6d80b9ac8ea849f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "51510684-50c3-4045-8bbf-925a7c10ac56", "node_type": "1", "metadata": {"page_label": "182", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "16fde08b694a1121af1064192571e79abe3ed5928c43166dcd1ea8d3589dfd38", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c9beac63-c6f6-4118-8761-ea1dfe5e5e13", "node_type": "1", "metadata": {}, "hash": "a8a776c8bc6738da29e65a0f3233c5322fa2252ed6ff22369e53f4f7adb7ba75", "class_name": "RelatedNodeInfo"}}, "text": "Thus, the overall effect on drug disposition is complex\nand often difficult to predict.\n4. Species and race There are many examples of\ndifferences in responsiveness to drugs among different\nspecies; rabbits are resistant to atropine, rats and mice are\nresistant to digitalis and rat is more sensitive to curare than\ncat. These differences are important while extrapolating\nresults from experimental animals to man.\nAmong human beings some racial differences have been\nobserved, e.g. blacks require higher and Mongols require\nlower concentrations of atropine and ephedrine to dilate\ntheir pupil. \u03b2-blockers are less effective as antihypertensive\nin Afro-Caribbeans. Considering the widespread use of\nchloramphenicol in India and Hong Kong between 1950\u2013\n1980, relatively few cases of aplastic anaemia have been\nreported compared to its incidence in the west. Similarly,\nquiniodochlor related cases of subacute myelooptic\nneuropathy (SMON) occurred in epidemic proportion in\nJapan, but there is no confirmed report of its occurrence in\nIndia despite extensive use.\n5. Genetics The dose of a drug to produce the same effect\nmay vary by 4\u20136 fold among different individuals. All key\ndeterminants of drug response, viz. transporters,\nmetabolizing enzymes, ion channels, receptors with their\ncouplers and effectors are controlled genetically. Hence, a", "start_char_idx": 0, "end_char_idx": 1344, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c9beac63-c6f6-4118-8761-ea1dfe5e5e13": {"__data__": {"id_": "c9beac63-c6f6-4118-8761-ea1dfe5e5e13", "embedding": null, "metadata": {"page_label": "184", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "2b53c61f-8374-4a6c-8411-f368cfb2feb1", "node_type": "4", "metadata": {"page_label": "184", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f07a032e8df97c8a235c65ac96d10acb19ff64ea9ce99a8c354080f21c32598d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "82eb2c76-5674-4eb1-aa5d-5917b567f8b8", "node_type": "1", "metadata": {"page_label": "183", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "02a0cf886295c49ca5bf5b34dc74be4f610225e91d664d78d6d80b9ac8ea849f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ac068792-b29e-416e-bf56-ece21004c45b", "node_type": "1", "metadata": {}, "hash": "99b145021817d52c0815f12f43df84fd6a0529b8a85ffcf9021ff1f2ec638236", "class_name": "RelatedNodeInfo"}}, "text": "great deal of individual variability can be traced to the\ngenetic composition of the subject.\nPharmacogenetics The study of genetic basis for\nvariability in drug response is called \u2018Pharmacogenetics\u2019.\nIt deals with genetic influences on drug action as well as on\ndrug handling by the body. As the genomic technology has\nadvanced and the human genome project has been\nundertaken, gene libraries and huge data bases (like\n\u2018pharmacogenetics and pharmacogenomics knowledge\nbase\u2019, \u2018Human genome variation database\u2019, etc.) have been\ncreated aiming at improving precision in drug therapy.\nPharmacogenomics is the use of genetic information to\nguide the choice of drug and dose on an individual basis.\nA relationship is drawn between how a patient responds\nto a drug with his genetic makeup. The purpose is to\nidentify individuals who are either more likely or less\nlikely to respond to a drug, as well as those who require\naltered dose of certain drugs. Attempt is made to define the\ngenetic basis of an individual\u2019s profile of drug response and\nto predict the best treatment option for him/her. So far, this\nhas been applied largely to patients with known genetic\nabnormalities, but the goal is \u2018personalized medicine\u2019 on a\nwide scale. However, the basis of a large proportion of\ngenetic variability still remains unexplained.", "start_char_idx": 0, "end_char_idx": 1320, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ac068792-b29e-416e-bf56-ece21004c45b": {"__data__": {"id_": "ac068792-b29e-416e-bf56-ece21004c45b", "embedding": null, "metadata": {"page_label": "185", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "13bcf40e-6107-4bf3-a587-1df5f08557d7", "node_type": "4", "metadata": {"page_label": "185", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "337e963a6f6309509585c2a0cbab9713d97b298e4672a26513c642136a8f0d6a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c9beac63-c6f6-4118-8761-ea1dfe5e5e13", "node_type": "1", "metadata": {"page_label": "184", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f07a032e8df97c8a235c65ac96d10acb19ff64ea9ce99a8c354080f21c32598d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ec75fe94-bd3c-4150-86cf-367b2f03bed4", "node_type": "1", "metadata": {}, "hash": "b0c9a47e56a7660da320bb6e3f09de7ba155790bec7b51cf77299c3c2c79b11e", "class_name": "RelatedNodeInfo"}}, "text": "A continuous variation with bell-shaped Gaussian\nfrequency distribution is seen in the case of most drugs. In\naddition, there are some specific genetic defects which lead\nto discontinuous variation in drug responses, e.g.\u2014\n1.Atypical pseudocholinesterase results in prolonged\nsuccinylcholine apnoea.\n2.G-6PD deficiency is responsible for haemolysis with\nprimaquine and other oxidizing drugs. This X-linked\nmonogenic trait is more common in the Mediterranean,\nAfrican and Southeast Asian races. The haemolysis is\nlargely dose related. Several variants of the G-6PD\ngene occur in the population resulting in differing\nseverity of haemolysis triggered by different oxidizing\ndrugs. Haemolysis is severe in homozygous deficient\nindividuals of certain genotypes. Important drugs\nreported to cause haemolysis in G-6PD deficient\nsubjects are listed in the box.\nDrugs with potential* to cause haemolysis in G-6PD\nde\ufb01cient individuals\n\uf050\uf072\uf069\uf06d\uf061\uf071\uf075\uf069\uf06e\uf065 \uf04e\uf061\uf06c\uf069\uf064\uf069\uf078\uf069\uf063\uf020\uf061\uf063\uf069\uf064\nChloroquine \uf046\uf06c\uf075\uf06f\uf072\uf06f\uf071\uf075\uf069\uf06e\uf06f\uf06c\uf06f\uf06e\uf065\uf073\nQuinine/Quinidine Chloramphenicol\nProguanil \uf04e\uf069\uf074\uf072\uf06f\uf066\uf075\uf072\uf061\uf06e\uf074\uf06f\uf069\uf06e\nPyrimethamine Furazolidone", "start_char_idx": 0, "end_char_idx": 1066, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ec75fe94-bd3c-4150-86cf-367b2f03bed4": {"__data__": {"id_": "ec75fe94-bd3c-4150-86cf-367b2f03bed4", "embedding": null, "metadata": {"page_label": "186", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "8195be23-c577-4652-9cf8-b9bfcaf2ef57", "node_type": "4", "metadata": {"page_label": "186", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f13d3b3b244649163a45be3b68c69eb26c5c0cf76ecd2821f819e6e9c39d2b1d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ac068792-b29e-416e-bf56-ece21004c45b", "node_type": "1", "metadata": {"page_label": "185", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "337e963a6f6309509585c2a0cbab9713d97b298e4672a26513c642136a8f0d6a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9aa55370-666a-4378-9b77-4368fbca90b6", "node_type": "1", "metadata": {}, "hash": "ca792f0ebf7889e6d94c6c91f469111c98f4f913aeb62379f0765e266157e3cf", "class_name": "RelatedNodeInfo"}}, "text": "\uf044\uf061\uf070\uf073\uf06f\uf06e\uf065 Menadione\n\uf053\uf075\uf06c\uf066\uf06f\uf06e\uf061\uf06d\uf069\uf064\uf065\uf073 \uf04d\uf065\uf074\uf068\uf079\uf06c\uf064\uf06f\uf070\uf061\n\uf043\uf06f\uf074\uf072\uf069\uf06d\uf06f\uf078\uf061\uf07a\uf06f\uf06c\uf065 Hydralazine\n\uf053\uf075\uf06c\uf066\uf061\uf073\uf061\uf06c\uf061\uf07a\uf069\uf06e\uf065 Procainamide\nSulfonylureas Probenecid\nThiazide diuretics Colchicine\nAspirin \uf04d\uf065\uf074\uf068\uf079\uf06c\uf065\uf06e\uf065\uf020\uf062\uf06c\uf075\uf065\n* Drugs carrying higher risk are italicized.\n3.The low activity CYP2C9 variants metabolize warfarin\nat a slow rate and are at higher risk of bleeding.\n4.Thiopurine methyl transferase (TPMT) deficiency\nincreases risk of severe bone marrow toxicity of 6-\nmercaptopurine and azathioprine.\n5.Irinotecan induced neutropenia and diarrhoea is more\nin patients with UGT1A1 *28 allele of glucuronyl\ntransferase.\n6.Severe 5-fluorouracil toxicity occurs in patients with\ndihydropyrimidine dehydrogenase (DPD) deficiency.\n7.Over expression of P-gp results in tumour resistance to\nmany cancer chemotherapeutic drugs, because it\npumps out the drug from the tumour cells.\n8.Polymorphism of N-acetyl transferase 2 (NAT2) gene\nresults in rapid and slow acetylator status. Isoniazid", "start_char_idx": 0, "end_char_idx": 937, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9aa55370-666a-4378-9b77-4368fbca90b6": {"__data__": {"id_": "9aa55370-666a-4378-9b77-4368fbca90b6", "embedding": null, "metadata": {"page_label": "187", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "984e1d7e-ffff-43c8-bfda-43b4b3d8df75", "node_type": "4", "metadata": {"page_label": "187", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b68403236ef685f62c62f4c85ebb7b638183695c122dfcd33b8db2c93bf3eb99", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ec75fe94-bd3c-4150-86cf-367b2f03bed4", "node_type": "1", "metadata": {"page_label": "186", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f13d3b3b244649163a45be3b68c69eb26c5c0cf76ecd2821f819e6e9c39d2b1d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "74424296-8f38-49bd-861f-234d3e4713cd", "node_type": "1", "metadata": {}, "hash": "6a803b1cb8db17a81c965d2b9acf74d8f142cfdc331094cbd22452486271b6b9", "class_name": "RelatedNodeInfo"}}, "text": "neuropathy, procainamide and hydralazine induced\nlupus occurs mainly in slow acetylators.\n9.Acute intermittent porphyria\u2014precipitated by\nbarbiturates is due to genetic defect in repression of\nporphyrin synthesis.\n10.CYP2D6 abnormality causes poor\nmetoprolol/debrisoquin metabolizer status. Since\nseveral antidepressants and antipsychotics also are\nsubstrates of CYP2D6, deficient patients are more\nlikely to experience their toxicity. Codeine fails to\nproduce analgesia in CYP2D6 deficient, because this\nenzyme generates morphine from codeine.\n11.Malignant hyperthermia after halothane is due to\nabnormal Ca2+ release channel (ryanodine receptor) in\nthe sarcoplasmic reticulum of skeletal muscles.\n12.Inability to hydroxylate phenytoin results in toxicity at\nusual doses.\n13.Resistance to coumarin anticoagulants is due to an\nabnormal enzyme vitamin  K epoxide reductase\n(VKOR) that regenerates the reduced form of vit. K.\nThis form has low affinity for the coumarins.\n14.Attack of angle closure glaucoma is precipitated by\nmydriatics in individuals with narrow iridocorneal\nangle.\nGenetic variability in drug response could be due to\nsingle gene mutation or polygenic.  Genotype to phenotype", "start_char_idx": 0, "end_char_idx": 1192, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "74424296-8f38-49bd-861f-234d3e4713cd": {"__data__": {"id_": "74424296-8f38-49bd-861f-234d3e4713cd", "embedding": null, "metadata": {"page_label": "188", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "396a89f9-dff1-42a1-83ee-79e3394a5e3f", "node_type": "4", "metadata": {"page_label": "188", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fb15d61e7a24e5ef2b92f4339a99f6495e527e5358cad2cb6251f8324bb60baf", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9aa55370-666a-4378-9b77-4368fbca90b6", "node_type": "1", "metadata": {"page_label": "187", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b68403236ef685f62c62f4c85ebb7b638183695c122dfcd33b8db2c93bf3eb99", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "341b1d43-56e1-4780-aa5f-0bbbe1a01eb5", "node_type": "1", "metadata": {}, "hash": "2407238c85602ccb0c4019dbe14192560e808755744a0fb65f3c25552b3a0294", "class_name": "RelatedNodeInfo"}}, "text": "predictability is much better in monogenic phenotypic traits\nsuch as G-6PD, CYP2D6, TPMT, etc., than for multigenic\ntraits, which are clinically less significant. Majority of gene\npolymorphisms are due to substitution of a single base pair\nby another. When found in the population at a frequency of\n>1%, these are called \u2018Single neucleotide polymorphisms\u2019\n(SNPs). Gene polymorphisms are often encountered at\ndifferent frequencies among different ethnic/geographical\ngroups.\nDespite accumulation of considerable pharmacogenomic\ndata and the fact that genotyping of the individual needs to\nbe done only once, its practical application in routine\npatient care is at present limited due to prerequirement of\nmultiple drug specific genotypic screening. Simple spot\ntests for some, e.g. G-6 PD deficiency are currently in use.\n6. Route of administration Route of administration\ngoverns the speed and intensity of drug response (see Ch.\n1). Parenteral administration is often resorted to for more\nrapid, more pronounced and more predictable drug action.\nA drug may have entirely different uses through different\nroutes, e.g. magnesium sulfate given orally causes\npurgation, applied on sprained joints it decreases swelling,\nwhile intravenously it produces CNS depression and\nhypotension.", "start_char_idx": 0, "end_char_idx": 1280, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "341b1d43-56e1-4780-aa5f-0bbbe1a01eb5": {"__data__": {"id_": "341b1d43-56e1-4780-aa5f-0bbbe1a01eb5", "embedding": null, "metadata": {"page_label": "189", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "438a5bdc-9619-4337-acee-05db1751c58c", "node_type": "4", "metadata": {"page_label": "189", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "1c505e7d865fbccfc725229e7eb253a20a2513d92e7948cb57ab70b02fa6dd54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "74424296-8f38-49bd-861f-234d3e4713cd", "node_type": "1", "metadata": {"page_label": "188", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fb15d61e7a24e5ef2b92f4339a99f6495e527e5358cad2cb6251f8324bb60baf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3e5f718d-645a-4684-bcba-32af96bc0e9d", "node_type": "1", "metadata": {}, "hash": "ba1ffbd7be2117cf9c46aefb4397135ea961ef97680caf3f9b4497cde72d27f9", "class_name": "RelatedNodeInfo"}}, "text": "7. Environmental factors and time of\nadministration Several environmental factors affect drug\nresponses. Exposure to insecticides, carcinogens, tobacco\nsmoke and consumption of charcoal broiled meat are well\nknown to induce drug metabolism. Type of diet and\ntemporal relation between drug ingestion and meals can\nalter drug absorption, e.g. food interferes with absorption\nof ampicillin, but a fatty meal enhances absorption of\ngriseofulvin and lumefantrine. Subjective effects of a drug\nmay be markedly influenced by the setup in which it is\ntaken. Hypnotics taken at night and in quiet, familiar\nsurroundings may work more easily. Statins cause greater\ninhibition of cholesterol synthesis when taken in the late\nevening. It has been shown that corticosteroids taken as a\nsingle morning dose cause less pituitary-adrenal\nsuppression.\n8. Psychological factor Efficacy of a drug can be\naffected by the patient\u2019s beliefs, attitudes and expectations.\nThis is particularly applicable to centrally acting drugs, e.g.\na nervous and anxious patient requires more general\nanaesthetic; alcohol generally impairs performance but if\npunishment (which induces anxiety) is introduced, it may\nactually improve performance by relieving anxiety.\nPlacebo This is an inert substance which is given in the\ngarb of a medicine. It works by psychodynamic rather than", "start_char_idx": 0, "end_char_idx": 1344, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3e5f718d-645a-4684-bcba-32af96bc0e9d": {"__data__": {"id_": "3e5f718d-645a-4684-bcba-32af96bc0e9d", "embedding": null, "metadata": {"page_label": "190", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f980618a-31d1-4b6f-868b-8abcdcb5cc2b", "node_type": "4", "metadata": {"page_label": "190", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "1a5d4008b5977b1d5b0a92c68b8278b859c19b424e7182768466d3319b23e9e6", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "341b1d43-56e1-4780-aa5f-0bbbe1a01eb5", "node_type": "1", "metadata": {"page_label": "189", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "1c505e7d865fbccfc725229e7eb253a20a2513d92e7948cb57ab70b02fa6dd54", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ad4fd311-6c35-4208-a421-12eadca740b3", "node_type": "1", "metadata": {}, "hash": "a595bdd6354a8a76c313d1219de13ebe4dba0ff82967ecbc82b6bdf5f339a165", "class_name": "RelatedNodeInfo"}}, "text": "pharmacodynamic means and often produces responses\nequivalent to the active drug. Some individuals are more\nsuggestible and easily respond to a placebo: and are called\n\u2018placebo reactors\u2019. Placebos are used in two situations:\n1.As a control device in clinical trial of drugs (dummy\nmedication).\n2.To treat a patient who, in the opinion of the physician,\ndoes not require an active drug.\nPlacebo is a Latin word meaning \u2018I shall please\u2019. A\npatient responds to the whole therapeutic setting; placebo-\neffect largely depends on the physician-patient relationship.\nPlacebos do induce physiological responses, e.g. they\ncan release endorphins in brain\u2014causing analgesia.\nNaloxone, an opioid antagonist, blocks placebo analgesia.\nWhen an active drug is administered, it produces effects\nboth due to its pharmacodynamic action as well as the\npsychodynamic effect of the act of medication. Placebo\neffects can thus supplement pharmacological effects of\nactive medicines. However, placebo effects are highly\nvariable even in the same individual, e.g. a placebo may\ninduce sleep on the first night, but not subsequently. Thus,\nit has a very limited role in practical therapeutics.\nSubstances commonly used as placebo are lactose\ntablets/capsules and distilled water injection. Multivitamin\npreparations are often misused as placebos when no\nmedication is needed.", "start_char_idx": 0, "end_char_idx": 1351, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ad4fd311-6c35-4208-a421-12eadca740b3": {"__data__": {"id_": "ad4fd311-6c35-4208-a421-12eadca740b3", "embedding": null, "metadata": {"page_label": "191", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "05bfc3ca-b0a9-4cde-87a2-d7a00c2d177b", "node_type": "4", "metadata": {"page_label": "191", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "7dd373bba69c2f54c656bd8d4674b3199cb1f23c5af76bd08e16900ff674e8e9", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3e5f718d-645a-4684-bcba-32af96bc0e9d", "node_type": "1", "metadata": {"page_label": "190", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "1a5d4008b5977b1d5b0a92c68b8278b859c19b424e7182768466d3319b23e9e6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7c0a7b41-2d43-4c9c-b051-53b95739c7a1", "node_type": "1", "metadata": {}, "hash": "2dc6a9b56e52220218a96034c01665f87a090a8d5a05069d6c7f8dee955ab276", "class_name": "RelatedNodeInfo"}}, "text": "Nocebo It is the converse of placebo, and refers to negative psychodynamic\neffect evoked by the pessimistic attitude of the patient, or by loss of faith in\nthe medication and/or the physician. Nocebo effect can oppose the\ntherapeutic ef fect of active medication.\n9. Pathological states Not only drugs modify disease\nprocesses, several diseases can influence drug disposition\nand drug action:\nGastrointestinal  ( g . i .) diseases Certain g.i. diseases can\nalter absorption of orally administered drugs. The changes\nare complex and drug absorption can  increase or decrease,\ne.g. in coeliac disease absorption of amoxicillin is\ndecreased but that of cephalexin and cotrimoxazole is\nincreased. Thus, malabsorption syndrome does not\nnecessarily reduce absorption of all drugs. Gastric stasis\noccurring during migraine attack retards the absorption of\ningested drugs. Achlorhydria decreases aspirin absorption\nby favouring its ionization. NSAIDs can aggravate peptic\nulcer disease.\nLiver  disease  Liver disease (especially cirrhosis) can\ninfluence drug disposition in several ways:\n\u2022Bioavailability of drugs having high first pass\nmetabolism (see Ch. 3) is increased due to loss of\nhepatocellular function and portocaval shunting.\n\u2022Serum albumin is reduced\u2014protein binding of acidic\ndrugs (diclofenac, warfarin, etc.) is reduced and more", "start_char_idx": 0, "end_char_idx": 1335, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7c0a7b41-2d43-4c9c-b051-53b95739c7a1": {"__data__": {"id_": "7c0a7b41-2d43-4c9c-b051-53b95739c7a1", "embedding": null, "metadata": {"page_label": "192", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "9cd7dfaf-a8e6-4308-8ff3-7bc1e967895d", "node_type": "4", "metadata": {"page_label": "192", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4151240fbe4e7d6987cfbec0539f2abaf1b37e230ef55ee94534bdb88ca529b8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ad4fd311-6c35-4208-a421-12eadca740b3", "node_type": "1", "metadata": {"page_label": "191", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "7dd373bba69c2f54c656bd8d4674b3199cb1f23c5af76bd08e16900ff674e8e9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "02296e0d-7d54-42f2-a853-001c11ab08ba", "node_type": "1", "metadata": {}, "hash": "813a076904f59b6a4234af5d258e9897b3eb308972dd9348f750d16ffbb2772f", "class_name": "RelatedNodeInfo"}}, "text": "drug is present in the free form.\n\u2022Metabolism and elimination of some drugs (morphine,\nlidocaine, propranolol) is decreased\u2014their dose should\nbe reduced. Alternative drugs that do not depend on\nhepatic metabolism for elimination and/or have shorter\nt\u00bd should be preferred, e.g. oxazepam or lorazepam in\nplace of diazepam; atenolol as \u03b2-blocker.\n\u2022Prodrugs needing hepatic metabolism for activation, e.g.\nbacampicillin are less effective and should be avoided.\nThe changes in drug metabolism due to liver disease are\ncomplex and there is no simple test (like creatinine\nclearance for renal disease) to estimate the extent of\nalteration in drug disposition. Moreover, the kinetics of\ndifferent drugs is affected to different extents.\nNot only disposition, but action as well of certain drugs\nmay be altered in liver disease, e.g.\n\u2022The sensitivity of brain to depressant action of morphine\nand barbiturates is markedly increased in cirrhotics\u2014\nnormal doses can produce coma.\n\u2022Brisk diuresis can precipitate mental changes in patients\nwith impending hepatic encephalopathy, because\ndiuretics cause hypokalemic alkalosis which favours\nconversion of NH+\uf0204 to NH3. Ammonia enters brain easily\nand causes mental derangement.\n\u2022Oral anticoagulants can markedly prolong prothrombin\ntime, because clotting factors are already low.", "start_char_idx": 0, "end_char_idx": 1317, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "02296e0d-7d54-42f2-a853-001c11ab08ba": {"__data__": {"id_": "02296e0d-7d54-42f2-a853-001c11ab08ba", "embedding": null, "metadata": {"page_label": "193", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "d1f02a0d-6f60-445a-90c2-3ad6413d5483", "node_type": "4", "metadata": {"page_label": "193", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6f5c5fbfc4ddd90e1cc75386fe536d573fc717cfb74e445445bc0d0d468d37c2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7c0a7b41-2d43-4c9c-b051-53b95739c7a1", "node_type": "1", "metadata": {"page_label": "192", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4151240fbe4e7d6987cfbec0539f2abaf1b37e230ef55ee94534bdb88ca529b8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f41c09a0-95a1-4984-8783-33e34bca8fac", "node_type": "1", "metadata": {}, "hash": "c8190b5c176b2a21dc3b24c86fba313ba9e752dab0968ef28835ad6c42b14709", "class_name": "RelatedNodeInfo"}}, "text": "\u2022Fluid retaining action of phenylbutazone  (other\nNSAIDs as well), and lactic acidosis due to metformin\nare accentuated.\nHepatotoxic drugs should be avoided in liver disease.\nKidney disease It markedly affects the pharmacokinetics\nof many drugs as well as alters the effects of some drugs.\nClearance of drugs that are primarily excreted\nunchanged (aminoglycosides, digoxin, phenobarbitone) is\nreduced parallel to decrease in creatinine clearance (CLcr).\nLoading dose of such a drug is not altered (unless edema is\npresent), but maintenance doses should be reduced or dose\ninterval prolonged proportionately. A rough guideline is\ngiven in the box:\nCLcr (patient) Dose rate to be reduced to\n50\u201370 ml / min 70%\n30\u201350 ml / min 50%\n10\u201330 ml / min 30%\n5\u201310 ml / min 20%\nDose rate of drugs only partly excreted unchanged in\nurine also needs reduction, but to lesser extents. If the t\u00bd of\nthe drug is prolonged, attainment of steady-state plasma\nconcentration with maintenance doses is delayed\nproportionately.", "start_char_idx": 0, "end_char_idx": 1002, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f41c09a0-95a1-4984-8783-33e34bca8fac": {"__data__": {"id_": "f41c09a0-95a1-4984-8783-33e34bca8fac", "embedding": null, "metadata": {"page_label": "194", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "90e386fd-a358-4593-9f25-96d85c673a06", "node_type": "4", "metadata": {"page_label": "194", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4d73177ec2d4673d400c9d3fa9111593f029ee4fcf3afa1cd0ffd069a1729865", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "02296e0d-7d54-42f2-a853-001c11ab08ba", "node_type": "1", "metadata": {"page_label": "193", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6f5c5fbfc4ddd90e1cc75386fe536d573fc717cfb74e445445bc0d0d468d37c2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "49855995-a31b-4a72-9fb8-b000f644b317", "node_type": "1", "metadata": {}, "hash": "683d4929e9f8d06861f2f44565f30efa91349e9169d4597194215b7c79d9eeb7", "class_name": "RelatedNodeInfo"}}, "text": "Plasma proteins, especially albumin, are often low or\naltered in structure in patients with renal disease\u2014binding\nof acidic drugs is reduced, but that of basic drugs is not\nmuch affected.\nThe permeability of blood-brain barrier is increased in\nrenal failure; opiates, barbiturates, phenothiazines,\nbenzodiazepines, etc. produce more CNS depression.\nPethidine should be avoided because its metabolite nor-\npethidine can accumulate on repeated dosing and cause\nseizures. The target organ sensitivity may also be\nincreased. Antihypertensive drugs produce greater postural\nhypotension in patients with renal insufficiency.\nCertain drugs worsen the existing clinical condition in\nrenal failure, e.g.\n\u2022Tetracyclines have an anti-anabolic effect and\naccentuate uraemia.\n\u2022NSAIDs cause more fluid retention.\nAntimicrobials needing dose reduction in renal failure\n\uf045\uf076\uf065\uf06e\uf020\uf069\uf06e\uf020\uf06d\uf069\uf06c\uf064\uf020\uf066\uf061\uf069\uf06c\uf075\uf072\uf065 \uf04f\uf06e\uf06c\uf079\uf020\uf069\uf06e\uf020\uf073\uf065\uf076\uf065\uf072\uf065\uf020\uf066\uf061\uf069\uf06c\uf075\uf072\uf065\nAminoglycosides Cotrimoxazole\nCephalexin Carbenicillin\nEthambutol Cefotaxime\nVancomycin Nor\ufb02oxacin\nAmphotericin  B Cipro\ufb02oxacin\nAcyclovir Metronidazole", "start_char_idx": 0, "end_char_idx": 1049, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "49855995-a31b-4a72-9fb8-b000f644b317": {"__data__": {"id_": "49855995-a31b-4a72-9fb8-b000f644b317", "embedding": null, "metadata": {"page_label": "195", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "c9fa4afd-c702-4f97-8091-445e9de12d5d", "node_type": "4", "metadata": {"page_label": "195", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4ba45cc58f4ca33047bf32b34bbcb5cef90b8119bd4607fd8dc0a470d9389485", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f41c09a0-95a1-4984-8783-33e34bca8fac", "node_type": "1", "metadata": {"page_label": "194", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4d73177ec2d4673d400c9d3fa9111593f029ee4fcf3afa1cd0ffd069a1729865", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "de7a3bee-82c4-4285-bdef-f9e2e6fe1efd", "node_type": "1", "metadata": {}, "hash": "c476635eef16acec46ee7f179b2144862134ac6859f3ff5538cb884055250bf1", "class_name": "RelatedNodeInfo"}}, "text": "\u2022Potentially nephrotoxic drugs, e.g. aminoglycosides,\ntetracyclines (except  doxycycline), sulfonamides\n(crystalluria),  vancomycin, nitrofurantoin,\ncyclosporine, amphotericin B should be avoided.\nThiazide diuretics tend to reduce g.f.r. They are\nineffective in renal failure and can worsen uraemia;\nfurosemide should be used instead. Potassium sparing\ndiuretics are contraindicated because they can cause\nhyperkalemia \u2192 cardiac depression. Repeated doses of\npethidine are likely to cause muscle twitching and seizures\ndue to accumulation of its excitatory metabolite\nnorpethidine.\nUrinary antiseptics like nalidixic acid, nitrofurantoin\nand methenamine mandelate fail to achieve high\nconcentration in urine and are likely to produce systemic\ntoxicity.\nCongestive heart failure It can alter drug kinetics by\u2014\n(i)Decreasing drug absorption from g.i.t. due to mucosal\nedema and splanchnic vasoconstriction. A significant\nreduction in procainamide and hydrochlorothiazide\nabsorption has been documented.\n(ii)Altering volume of distribution which can increase for\nsome drugs due to expansion of extracellular fluid\nvolume or decrease for others as a result of decreased", "start_char_idx": 0, "end_char_idx": 1165, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "de7a3bee-82c4-4285-bdef-f9e2e6fe1efd": {"__data__": {"id_": "de7a3bee-82c4-4285-bdef-f9e2e6fe1efd", "embedding": null, "metadata": {"page_label": "196", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "60859022-89f9-4c0a-a8c9-964cdc288b51", "node_type": "4", "metadata": {"page_label": "196", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "82ab0a613b88b7bd4acbd402fcbb25e639efcaaac67b544b6b5ffdda72934e4f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "49855995-a31b-4a72-9fb8-b000f644b317", "node_type": "1", "metadata": {"page_label": "195", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4ba45cc58f4ca33047bf32b34bbcb5cef90b8119bd4607fd8dc0a470d9389485", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6d5511e7-9eaa-40be-a452-caa349dca783", "node_type": "1", "metadata": {}, "hash": "eec4c7699f05dc34d154ed7255e48b5248a09fe1f332b8725d5dbc2351e6b209", "class_name": "RelatedNodeInfo"}}, "text": "tissue perfusion. For example, loading doses of drugs\nlike lidocaine and procainamide should be lowered.\n(iii)Retarding drug elimination as a result of decreased\nperfusion and congestion of liver, reduced glomerular\nfiltration rate and increased tubular reabsorption;\ndosing rate of drugs  may need reduction, as for\nlidocaine, procainamide, theophylline.\n(iv)The decompensated heart is more sensitive to digitalis\naction.\nThyroid disease The hypothyroid patients are more\nsensitive to digoxin, morphine and CNS depressants.\nHyperthyroid patients are relatively resistant to inotropic\naction of digoxin, but more prone to its arrhythmogenic\naction. The clearance of digoxin is roughly proportional to\nthyroid function, but this only partially accounts for the\nobserved changes in sensitivity.\nOther examples of modification of drug response by\npathological states are:\n\u2022Antipyretics lower body temperature only when it is\nraised (fever).\n\u2022Thiazides induce more marked diuresis in edematous\npatients.\n\u2022Myocardial infarction patients are more prone to\nadrenaline and digitalis induced cardiac arrhythmias.", "start_char_idx": 0, "end_char_idx": 1103, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6d5511e7-9eaa-40be-a452-caa349dca783": {"__data__": {"id_": "6d5511e7-9eaa-40be-a452-caa349dca783", "embedding": null, "metadata": {"page_label": "197", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "e95b1f92-2b42-4a47-ba8e-9e93e16644c8", "node_type": "4", "metadata": {"page_label": "197", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5fa8597d7b6a0729f8a5ed16d5b98d8fb0e4bdbeec5b8d8aefc91a870f0408bb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "de7a3bee-82c4-4285-bdef-f9e2e6fe1efd", "node_type": "1", "metadata": {"page_label": "196", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "82ab0a613b88b7bd4acbd402fcbb25e639efcaaac67b544b6b5ffdda72934e4f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d0c99200-9795-4e9e-bd19-54dd1e5afb11", "node_type": "1", "metadata": {}, "hash": "8762b053814f12b922f42ae8184f6a05a3250bd37d2088da3bca66277a30730a", "class_name": "RelatedNodeInfo"}}, "text": "\u2022Myasthenic patients are very sensitive to curare. In them\nweakness is aggravated by quinine. \n\u2022Schizophrenics tolerate large doses of phenothiazines.\n\u2022Head injury patients are prone to go into respiratory\nfailure with normal doses of morphine.\n\u2022Atropine, tricyclic antidepressants, furosemide can\ncause urinary retention in individuals with prostatic\nhypertrophy.\n\u2022Hypnotics given to a patient in severe pain may cause\nmental confusion and delirium.\n\u2022Cotrimoxazole produces a higher incidence of adverse\nreactions in AIDS patients.\n10. Other drugs Drugs can modify the response to each\nother by pharmacokinetic or pharmacodynamic interaction\nbetween them. Many ways in which drugs can interact\nhave already been considered (see Ch. 2, 3, 4), and a\ncomprehensive account of clinically important drug\ninteractions is presented in Ch. 71.\n11. Cumulation Any drug will cumulate in the body if\nrate of administration is more than the rate of elimination.\nHowever, slowly eliminated drugs are particularly liable to\ncause cumulative toxicity, e.g. prolonged use of\nchloroquine causes retinal damage.\n\u2022Full loading dose of digoxin should not be given if\npatient has received it within the past week.", "start_char_idx": 0, "end_char_idx": 1193, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d0c99200-9795-4e9e-bd19-54dd1e5afb11": {"__data__": {"id_": "d0c99200-9795-4e9e-bd19-54dd1e5afb11", "embedding": null, "metadata": {"page_label": "198", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "92318769-4207-46b6-89ec-25dc17a3dcad", "node_type": "4", "metadata": {"page_label": "198", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b4b6ddbeb26f2670a1438ef34308980b63260d17e0c81d55e3a89f813495ae78", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6d5511e7-9eaa-40be-a452-caa349dca783", "node_type": "1", "metadata": {"page_label": "197", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5fa8597d7b6a0729f8a5ed16d5b98d8fb0e4bdbeec5b8d8aefc91a870f0408bb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9f11e30e-f8fe-4013-a99b-fdddeb7027c1", "node_type": "1", "metadata": {}, "hash": "6563dd62824bbac88a62680f25f65e726c0c21c6031a1c424c01f08bd8dc85a5", "class_name": "RelatedNodeInfo"}}, "text": "\u2022A course of emetine should not be repeated within 6\nweeks.\n12. Tolerance It refers to the requirement of higher dose\nof a drug to produce a given response. Tolerance is a\nwidely occurring adaptive biological phenomenon. Loss of\ntherapeutic efficacy after prolonged/intensive use of a drug\n(e.g. of sulfonylureas in type 2 diabetes, or of \u03b22 agonists in\nbronchial asthma), is generally called \u2018refractoriness\u2019.\nDrug tolerance may be:\nNatural The species/individual is inherently less sensitive\nto the drug, e.g. rabbits are tolerant to atropine; black races\nare tolerant to mydriatics. Certain individuals in any\npopulation are hyporesponders to certain drugs, e.g. some\nsubjects can consume large quantity of alcohol without\ngetting inebriated; or some hypertensives do not respond to\n\u03b2 adrenergic blockers.\nAcquired Acquired tolerance occurs by repeated use of a\ndrug in an individual who was initially responsive. Body is\ncapable of developing tolerance to most drugs, but the\nphenomenon is very easily recognized in the case of CNS\ndepressants. An uninterrupted presence of the drug in the\nbody favours development of tolerance. However,\nsignificant tolerance does not develop to atropine, digoxin,\ncocaine, sodium nitroprusside, etc. Tolerance need not", "start_char_idx": 0, "end_char_idx": 1257, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9f11e30e-f8fe-4013-a99b-fdddeb7027c1": {"__data__": {"id_": "9f11e30e-f8fe-4013-a99b-fdddeb7027c1", "embedding": null, "metadata": {"page_label": "199", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "38348290-10ad-4e34-bbf4-982f05f95872", "node_type": "4", "metadata": {"page_label": "199", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "375d3f0c3e6c54cac6bb7ff6027c6136f2cf249365fa2268d2ca652fa5c9d340", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d0c99200-9795-4e9e-bd19-54dd1e5afb11", "node_type": "1", "metadata": {"page_label": "198", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b4b6ddbeb26f2670a1438ef34308980b63260d17e0c81d55e3a89f813495ae78", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "55ae0dd8-359b-4b5f-b075-30edd2b25d67", "node_type": "1", "metadata": {}, "hash": "7c9181c63ff6e11a67173e7286380a5365071c4ca1bfa860a66c5453b82f1e93", "class_name": "RelatedNodeInfo"}}, "text": "develop equally to all actions of a drug, consequently\ntherapeutic index of a drug may increase or decrease with\nprolonged use, e.g.:\n\u2022Tolerance develops to the sedative action of\nchlorpromazine but not to its antipsychotic action.\n\u2022Tolerance occurs to the sedative action of\nphenobarbitone but not as much to its antiepileptic\naction.\n\u2022Tolerance occurs to analgesic and euphoric action of\nmorphine, but not as much to its constipating and miotic\nactions.\nCross  tolerance It is the development of tolerance to\npharmacologically related drugs, e.g. alcoholics are\nrelatively tolerant to barbiturates and general anaesthetics.\nCloser the two drugs are, more complete is the cross\ntolerance between them, e.g.\u2014\nThere is partial cross tolerance between morphine and\nbarbiturates but complete cross tolerance between\nmorphine and pethidine.\nMechanisms of tolerance The mechanisms responsible\nfor development of tolerance are incompletely understood.\nHowever, tolerance may be:\n(i)Pharmacokinetic/drug disposition tolerance\u2014the\neffective concentration of the drug at the site of action\nis decreased, mostly due to enhancement of drug", "start_char_idx": 0, "end_char_idx": 1128, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "55ae0dd8-359b-4b5f-b075-30edd2b25d67": {"__data__": {"id_": "55ae0dd8-359b-4b5f-b075-30edd2b25d67", "embedding": null, "metadata": {"page_label": "200", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f82a4845-b5d7-48a8-b656-39dd8e3cfd18", "node_type": "4", "metadata": {"page_label": "200", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "bc02fe3fd2dab430a794be4777376c214b7f7dd8a870721e8e3c66db9c59fb5a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9f11e30e-f8fe-4013-a99b-fdddeb7027c1", "node_type": "1", "metadata": {"page_label": "199", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "375d3f0c3e6c54cac6bb7ff6027c6136f2cf249365fa2268d2ca652fa5c9d340", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4a8b0eb3-49f3-46e6-be04-668f49323d20", "node_type": "1", "metadata": {}, "hash": "5840e691f0146afe9f7d6c873b62c505fc8ccb02637188ad1dcf08b2baad9923", "class_name": "RelatedNodeInfo"}}, "text": "elimination on chronic use, e.g. barbiturates and\ncarbamazepine induce their own metabolism, while\nrenal excretion of amphetamine is accelerated after\nregular intake.\n(ii)Pharmacodynamic/cellular tolerance\u2014drug action is\nlessened; cells of the target organ become less\nresponsive, e.g. morphine, barbiturates, nitrates. This\nmay be due to desensitization/down regulation of\nreceptors (see p. 62), or weakening of response\neffectuation.\nTachyphylaxis (Tachy-fast, phylaxis-protection) It refers\nto rapid development of tolerance when doses of a drug\nrepeated in quick succession result in marked reduction in\nresponse. This is usually seen with indirectly acting drugs,\nsuch as ephedrine, tyramine, nicotine. These drugs act by\nreleasing catecholamines in the body, synthesis of which is\nunable to match the rate of release: stores get depleted.\nOther mechanisms like slow dissociation of the drug from\nits receptor, desensitization/internalization or down\nregulation of receptor, etc. (see p. 62) and/or compensatory\nhomeostatic adaptation.\nDrug resistance It refers to tolerance of microorganisms\nto inhibitory action of antimicrobials, e.g. Staphylococci to\npenicillin. This phenomenon is described in Ch. 50).", "start_char_idx": 0, "end_char_idx": 1212, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4a8b0eb3-49f3-46e6-be04-668f49323d20": {"__data__": {"id_": "4a8b0eb3-49f3-46e6-be04-668f49323d20", "embedding": null, "metadata": {"page_label": "201", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "2d5ca64f-835e-4902-8691-22c9fe80852e", "node_type": "4", "metadata": {"page_label": "201", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "31edf8e65d5dd8dea7a56e5700459bac512bdf83ee5ad8e7ab1fa494e0ce8b0e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "55ae0dd8-359b-4b5f-b075-30edd2b25d67", "node_type": "1", "metadata": {"page_label": "200", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "bc02fe3fd2dab430a794be4777376c214b7f7dd8a870721e8e3c66db9c59fb5a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2ce14f58-c38a-471c-b185-30bb5616be8d", "node_type": "1", "metadata": {}, "hash": "f8464b9a9c08f119e40f402a6d1b1811e3ff45a6c7593955404d7dc6912aa622", "class_name": "RelatedNodeInfo"}}, "text": "RATIONAL USE OF MEDICINES\nIt is widely assumed that use of drugs by qualified doctors\nof modern medicine would be rational. However, in reality,\nirrationality abounds in almost every aspect of drug use.\nMedically inappropriate, ineffective and economically\ninefficient use of drugs occurs all over the world, more so\nin the developing countries.\nAs per the WHO \u2014 \u2018rational use of medicines requires\nthat the patients receive medication appropriate to their\nclinical needs, in doses that meet their own individual\nrequirements for an adequate period of time, and at the\nlowest cost to them and to their community\u2019.\nRational use of medicines addresses every step in the\nsupply-use chain of drugs, i.e. selection, procurement,\nstorage, prescribing, dispensing, monitoring and feedback.\nHowever, only rational prescribing and related aspects are\ndealt here.\nRational prescribing\nRational prescribing is not just the choice of a correct drug\nfor a disease, or mere matching of drugs with diseases, but\nalso the appropriateness of the whole therapeutic set up\nalong with follow up of the outcome. The criteria to\nevaluate rational prescribing are:\n\u2022Appropriate indication: the reason to prescribe the\nmedicine is based on sound medical considerations.", "start_char_idx": 0, "end_char_idx": 1245, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2ce14f58-c38a-471c-b185-30bb5616be8d": {"__data__": {"id_": "2ce14f58-c38a-471c-b185-30bb5616be8d", "embedding": null, "metadata": {"page_label": "202", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "462ed390-a5bb-4a88-bed2-14e6d58c8574", "node_type": "4", "metadata": {"page_label": "202", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "35405c3fc757f8832b3d17059e71fb76e5cd7a8392f75fb0c6449c4a1527dbf6", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4a8b0eb3-49f3-46e6-be04-668f49323d20", "node_type": "1", "metadata": {"page_label": "201", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "31edf8e65d5dd8dea7a56e5700459bac512bdf83ee5ad8e7ab1fa494e0ce8b0e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e5b1ae4a-d45f-452f-85d9-51a5f3911554", "node_type": "1", "metadata": {}, "hash": "2ab7b38362b9b8ef2234950807967ec9a87134d5055fffc11338108d18f146df", "class_name": "RelatedNodeInfo"}}, "text": "\u2022Appropriate drug in efficacy, tolerability, safety, and\nsuitability for the patient.\n\u2022Appropriate dose, route and duration according to\nspecific features of the patient.\n\u2022Appropriate patient: no contraindications exist and the\ndrug is acceptable to the patient; likelihood of adverse\neffect is minimal and less than the expected benefit.\n\u2022Correct dispensing with appropriate\ninformation/instruction to the patient.\n\u2022Adequate monitoring of patient\u2019s adherence to\nmedication, as well as of anticipated beneficial and\nuntoward effects of the medication.\nThere is no doubt that knowledge of the prescriber about\ndrugs and disease is the most important determinant of\nhis/her prescribing pattern, but it has been demonstrated\ntime and again that simply improving knowledge has failed\nto promote rational drug use. A variety of other factors\ninfluence prescribing as summarized in the box.\nFactors in\ufb02uencing prescribing\n\u2022Knowledge of the prescriber .\n\u2022Role  models : one  tends  to  follow  prescribing  practices  of\none\u2019s  teachers  or  senior / popular  physicians .\n\u2022Patient  load : heavy  load  tends  to  foster  routinized\nsymptom  based  prescribing .\n\u2022Attitude  to  afford  prompt  symptomatic  relief  at  all  cost .", "start_char_idx": 0, "end_char_idx": 1223, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e5b1ae4a-d45f-452f-85d9-51a5f3911554": {"__data__": {"id_": "e5b1ae4a-d45f-452f-85d9-51a5f3911554", "embedding": null, "metadata": {"page_label": "203", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "bddf7fe1-3aa8-43f7-86bb-45ac65f51e93", "node_type": "4", "metadata": {"page_label": "203", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a6d3cd321454ac3d784643fbe6c43cf68eb0e21475c2c2bf0f7964f09161a7ad", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2ce14f58-c38a-471c-b185-30bb5616be8d", "node_type": "1", "metadata": {"page_label": "202", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "35405c3fc757f8832b3d17059e71fb76e5cd7a8392f75fb0c6449c4a1527dbf6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9436c9c3-79cf-44d9-a0e2-47181fadc0a2", "node_type": "1", "metadata": {}, "hash": "3f412005b4f0b9d5b633d677a3f102641c0e1da50d3cd10046a4dc9bffff4c47", "class_name": "RelatedNodeInfo"}}, "text": "\u2022Imprecise  diagnosis : medication  is  given  to  cover  all\npossible  causes  of  the  illness .\n\u2022Drug  promotion  and  unrealistic  claims  by  manufacturers .\n\u2022Unethical  inducements  ( gifts , dinner  parties , conference\ndelegation , etc .).\n\u2022Patient\u2019 s  demands : many  patients  are  not  satis\ufb01ed  unless\nmedication  is  prescribed ; misconceptions , unrealistic\nexpectations , \u2018pill  for  every  ill\u2019  belief .\nIrrationalities in prescribing\nIt is helpful to know the commonly encountered\nirrationalities in prescribing so that a conscious effort is\nmade to avoid them.\n\u2022Use of drug when none is needed; e.g. antibiotics for\nviral fevers and nonspecific diarrhoeas.\n\u2022Compulsive coprescription of vitamins/tonics.\n\u2022Use of drugs not related to the diagnosis, e.g.\nampicillin/ciprofloxacin for any fever, proton pump\ninhibitors for any abdominal symptom.\n\u2022Selection of wrong drug, e.g. tetracycline/ciprofloxacin\nfor pharyngitis, \u03b2 blocker as antihypertensive for\nasthmatic patient.\n\u2022Prescribing ineffective/doubtful efficacy drugs, e.g.\nantioxidants, cough mixtures, memory enhancers, oral\nserratiopeptidase for injuries/swellings, etc.", "start_char_idx": 0, "end_char_idx": 1144, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9436c9c3-79cf-44d9-a0e2-47181fadc0a2": {"__data__": {"id_": "9436c9c3-79cf-44d9-a0e2-47181fadc0a2", "embedding": null, "metadata": {"page_label": "204", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "e026b4f4-63cd-4564-b258-fbc67235ebed", "node_type": "4", "metadata": {"page_label": "204", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "d028441ad86778e941ddc9a42775330f3df158d3353c3ce4b77178bc89c2851d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e5b1ae4a-d45f-452f-85d9-51a5f3911554", "node_type": "1", "metadata": {"page_label": "203", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a6d3cd321454ac3d784643fbe6c43cf68eb0e21475c2c2bf0f7964f09161a7ad", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "352f9e8c-3bda-4239-8a64-84d06fcc5386", "node_type": "1", "metadata": {}, "hash": "3d4e7594236921cf8a247595208f455f4324eb10e77ebda8257dff618ef9e210", "class_name": "RelatedNodeInfo"}}, "text": "\u2022Incorrect route of administration: injection when the\ndrug can be given orally.\n\u2022Incorrect dose: either underdosing or overdosing; more\nprevalent in drug prescribing for children.\n\u2022Incorrect duration of treatment, e.g. prolonged\npostsurgical use of antibiotics or stoppage of antibiotics\nas soon as relief is obtained, such as in tuberculosis.\n\u2022Unnecessary use of drug combinations, e.g.\nciprofloxacin + tinidazole for any case of diarrhoea,\nampicillin + cloxacillin for staphylococcal infection,\nroutine use of ibuprofen + paracetamol as analgesic.\n\u2022Unnecessary use of expensive medicines when cheaper\ndrugs are equally effective; craze for latest drugs, e.g.\nroutine use of newer antibiotics.\n\u2022Unsafe use of drugs, e.g. corticosteroids for fever,\nanabolic steroids in children, use of a single\nantitubercular drug.\n\u2022Polypharmacy without regard to drug interactions: each\nprescription on an average has 3\u20134 drugs, some may\nhave as many as 10\u201312 drugs, of which many are\ncombinations.\nIrrational prescribing has a number of adverse\nconsequences for the patient as well as the community. The\nimportant ones are:\nImpact of irrational prescribing", "start_char_idx": 0, "end_char_idx": 1144, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "352f9e8c-3bda-4239-8a64-84d06fcc5386": {"__data__": {"id_": "352f9e8c-3bda-4239-8a64-84d06fcc5386", "embedding": null, "metadata": {"page_label": "205", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "6148d7d0-45ea-49b9-870a-26229e3fbd66", "node_type": "4", "metadata": {"page_label": "205", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "896aeb99b40266917d2a454110d417164c1d42c0be02ca1e88967fdc9e4f8870", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9436c9c3-79cf-44d9-a0e2-47181fadc0a2", "node_type": "1", "metadata": {"page_label": "204", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "d028441ad86778e941ddc9a42775330f3df158d3353c3ce4b77178bc89c2851d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dc95ac83-2f5a-488e-8082-b92e44ff8bef", "node_type": "1", "metadata": {}, "hash": "6f1d9edbbdb35574fec82730bbd6def726e2916308982e3c3ce88c04fd3f7840", "class_name": "RelatedNodeInfo"}}, "text": "\u2022Delay / inability  in  affording  relief / cure  of  disease .\n\u2022More  adverse  drug  effects .\n\u2022Prolongation  of  hospitalization ; loss  of  man  days .\n\u2022Increased  morbidity  and  mortality .\n\u2022Emergence  of  microbial  resistance .\n\u2022Financial  loss  to  the  patient / community .\n\u2022Loss  of  patient\u2019 s  con\ufb01dence  in  the  doctor .\n\u2022Lowering  of  health  standards  of  patients / community .\n\u2022Perpetuation  of  public  health  problem .\nRational prescribing is a stepwise process of\nscientifically analyzing the therapeutic set up based on\nrelevant inputs about the patient as well as the drug, and\nthen taking appropriate decisions. It does not end with\nhanding over the prescription to the patient, but extends to\nsubsequent monitoring, periodic evaluations and\nmodifications as and when needed, till the therapeutic goals\nare achieved. The important steps are summarized in the\nbox.", "start_char_idx": 0, "end_char_idx": 890, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "dc95ac83-2f5a-488e-8082-b92e44ff8bef": {"__data__": {"id_": "dc95ac83-2f5a-488e-8082-b92e44ff8bef", "embedding": null, "metadata": {"page_label": "206", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f11a0740-be04-4b51-8324-bd5471caec14", "node_type": "4", "metadata": {"page_label": "206", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f1e056be804534ca16e801eb4e61381b965c1684a6488046a2246ce1c1b84614", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "352f9e8c-3bda-4239-8a64-84d06fcc5386", "node_type": "1", "metadata": {"page_label": "205", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "896aeb99b40266917d2a454110d417164c1d42c0be02ca1e88967fdc9e4f8870", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a3dfcd71-ddf9-4f04-b94b-47c847275f8a", "node_type": "1", "metadata": {}, "hash": "5329125843e64bed31bde4d743b8c1c4c29c1b2f5216abac0e2b4e91bba44806", "class_name": "RelatedNodeInfo"}}, "text": "Information/instructions to the patient\nRational prescribing also includes giving relevant and\nadequate information to the patient about the drug(s) and\ndisease, as well as necessary instructions to be followed.", "start_char_idx": 0, "end_char_idx": 211, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a3dfcd71-ddf9-4f04-b94b-47c847275f8a": {"__data__": {"id_": "a3dfcd71-ddf9-4f04-b94b-47c847275f8a", "embedding": null, "metadata": {"page_label": "207", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "a76c8d73-b0ac-4a1b-a1fa-ba10358c253f", "node_type": "4", "metadata": {"page_label": "207", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "54b01e1251827ee88e1938846faf1f8d62f988c80103939678f65bc90823d5a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dc95ac83-2f5a-488e-8082-b92e44ff8bef", "node_type": "1", "metadata": {"page_label": "206", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f1e056be804534ca16e801eb4e61381b965c1684a6488046a2246ce1c1b84614", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "db5b2c2f-f47a-4871-9ab3-d513bc79059c", "node_type": "1", "metadata": {}, "hash": "9d1ba2ce1fb7da8706d16821488e5bc20ea30f9c1d9481a8ca452763519e6fc8", "class_name": "RelatedNodeInfo"}}, "text": "Effects  of  the  drug Which symptom is expected to\ndisappear and when (e.g. antidepressant will take weeks to\nact); whether disease will be cured or not (e.g. diabetes,\nparkinsonism can only be ameliorated, but not cured), what\nhappens if the drug is not taken as advised (e.g.\ntuberculosis will worsen and may prove fatal).\nSide effects There is considerable debate as to how much\nthe patient should be told about the side effects. Detailed\ndescriptions may have a suggestive effect or may scare the\npatient and dissuade him from taking the drug, while not\ninforming tantamounts to negligence. The side effect, when\nit occurs, may upset the uninformed patient.\nCommunicating the common side effects without\ndiscouraging the patient is a skill to be developed.\nInstructions How and when to take the drug (special\ndosage forms like inhalers, transdermal patches, etc. may\nneed demonstration); how long to take the drug; when to\ncome back to the doctor; instructions about diet and\nexercise if needed; what laboratory tests are needed, e.g.\nprothrombin time with coumarine anticoagulants, leucocyte\ncount with anticancer drugs.\nPrecautions / warnings What precautions to take; what not\nto do, e.g. driving (with conventional antihistaminics) or\ndrinking (with metronidazole), or standing still (after", "start_char_idx": 0, "end_char_idx": 1299, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "db5b2c2f-f47a-4871-9ab3-d513bc79059c": {"__data__": {"id_": "db5b2c2f-f47a-4871-9ab3-d513bc79059c", "embedding": null, "metadata": {"page_label": "208", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "c88540a3-b0fb-4c20-81db-2eb46d946c3c", "node_type": "4", "metadata": {"page_label": "208", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6de056215618ce7ea16f9336f021975a5851d1d6d03b1a685ca9c8ad1d163ed1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a3dfcd71-ddf9-4f04-b94b-47c847275f8a", "node_type": "1", "metadata": {"page_label": "207", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "54b01e1251827ee88e1938846faf1f8d62f988c80103939678f65bc90823d5a8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e21214e3-9842-4833-bf63-07416ea6c064", "node_type": "1", "metadata": {}, "hash": "2eb923459a3b684cce269d749cbbc269cd998b5a7d4f0c7c616c06340e7c0099", "class_name": "RelatedNodeInfo"}}, "text": "sublingual glyceryl trinitrate); risk of allergy or any serious\nreaction, etc.\nIn the end it should be ensured that the instructions have\nbeen properly understood by the patient. Rational\nprescribing, thus, is a comprehensive process.\nEXPI RY DATE OF PHARMACEUTICALS\nIt is a legal requirement that all pharmaceutical products must carry the date\nof manufacture and date of expiry on their label. The period between the two\ndates is called the \u2018life perio d\u2019 or \u2018shelf-life\u2019  of the medicine. Under\nspecified storage conditions, the product is expected to remain stable (retain\n>95% potency) during this period. In India, the schedule P (Rule 96) of\nDrugs and Cosm etics Act (1940) specifies the life period (mostly 1\u20135 years)\nof medi cinal products and the conditions of storage. The expiry of other\nmedicines has to be specified by the manufacturer , but cann ot exceed 5\nyears, unless permitted by the licencing authority on the basis of satisfactory\nstability proof.\nThe shelf-life of a medicine is determined by real time stability studies or by\nextrapolation from accelerated degradation studies. The expiry date does not\nmean that the medicine has actually been found to lose potency or become\ntoxic after it, but simply that quality of the medicine is not assured beyond\nthe expiry date, and the manufa cturer is not liable if any harm arises from\nthe use of the product. Infact, studies have shown that majority  of solid oral\ndosage forms (tablets/capsules, etc.) stored under ordinary conditions in\nunopened containers remained stable for 1\u20135 years (some even up to 25\nyears) after the expiry date. Liquid formulations (oral and parenteral) are less\nstable. Suspensions clump by freezing. Injectable solutions may develop\nprecipitates, become cloudy or discoloured by prolonged storage. Adrenaline\ninjection (in ampoules) has been found to lose potency few months after the\nexpiry date of 1 year (it gets oxidized).", "start_char_idx": 0, "end_char_idx": 1925, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e21214e3-9842-4833-bf63-07416ea6c064": {"__data__": {"id_": "e21214e3-9842-4833-bf63-07416ea6c064", "embedding": null, "metadata": {"page_label": "209", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "51b81ab6-1c4b-41ba-8b28-7e8f6ddd8f36", "node_type": "4", "metadata": {"page_label": "209", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e80ab3dcf029e133d9adb6537d836481c067a9a1289b833b0c14de92d93eb13a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "db5b2c2f-f47a-4871-9ab3-d513bc79059c", "node_type": "1", "metadata": {"page_label": "208", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6de056215618ce7ea16f9336f021975a5851d1d6d03b1a685ca9c8ad1d163ed1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3b040bb7-cecc-402a-8576-3183143cee74", "node_type": "1", "metadata": {}, "hash": "f8a5f515045b98ad65767da3ec4c4302f5142191e7acd372d7e4d6d491000187", "class_name": "RelatedNodeInfo"}}, "text": "There is hardly any report of toxicity of expired medicines. The degradation\nproduct of only one drug (tetrac ycline) has caused toxicity in man. Outdated\ntetracycline capsules produced renal tubular damage resembling Fanconi\nsyndrome in the early 1960s. The capsules have now been reform ulated to\nminimize degradation.\nLoss of potency  beyond the \u2018life period\u2019  of the formulation depends on the\ndrug as well as the storage conditions. High humidity and temperature\naccelerate degradation of many drugs. Though, majority of medicines,\nespecially solid oral dosage forms, remain safe and active years after the\nstated expiry date, their use cannot be legally allowed beyond this date.\nEVIDENCE-BASED MEDICINE\nExtensive scientific investigation of drugs in man and\nintroduction of numerous new drugs over the past few\ndecades is gradually transforming the practice of medicine\nfrom \u2018experience based\u2019 wherein clinical decisions are\nmade based on the experience (or rather impression) of the\nphysician to \u2018evidence-based\u2019 wherein the same are guided\nby scientifically credible evidence from well designed\nclinical studies.\nEvidence-based medicine is the process of\nsystematically finding, evaluating and using contemporary\nresearch findings as the basis of clinical decisions.\nResults of well designed multicentric interventional\ntrials are forming the basis of constantly evolving\nguidelines for disease management. Today\u2019s physician has\nto be skilled in the new techniques of searching and\nevaluating the literature on efficacy, safety and", "start_char_idx": 0, "end_char_idx": 1540, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3b040bb7-cecc-402a-8576-3183143cee74": {"__data__": {"id_": "3b040bb7-cecc-402a-8576-3183143cee74", "embedding": null, "metadata": {"page_label": "210", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ab2b6bf3-cc66-41cc-be09-e6fac8cf5437", "node_type": "4", "metadata": {"page_label": "210", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "7803ba2d80bb2ae935305baf0499443ee5f4e1f80579f96bded702a717a33b0b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e21214e3-9842-4833-bf63-07416ea6c064", "node_type": "1", "metadata": {"page_label": "209", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e80ab3dcf029e133d9adb6537d836481c067a9a1289b833b0c14de92d93eb13a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0118e949-2b66-4b9c-812b-bac2caa41c4a", "node_type": "1", "metadata": {}, "hash": "d6bb6032803124bd9b496cf0815ea0b013cc451fec5494d2e56adb79dcc80428", "class_name": "RelatedNodeInfo"}}, "text": "appropriateness of a particular therapeutic measure (drug).\nTherapeutic evaluation of a drug includes:\n\u2022Quantitation of benefit afforded by it.\n\u2022The best way (dosage, duration, patient selection, etc.)\nto use it.\n\u2022How it compares with other available drugs.\n\u2022Surveillance of adverse effects produced by it.\nClinical studies are basically of the following three types:\na.Clinical trials\nb.Cohort studies\nc.Case control studies.\nClinical trial\nClinical trial is a prospective ethically designed\ninvestigation in human subjects to objectively\ndiscover/verify/compare the results of two or more\ntherapeutic measures (drugs).\nClinical trials are designed to answer one or more\nprecisely framed questions about the value of treating\nequivalent groups of patients by two or more modalities\n(drugs, dosage regimens, other interventions). Depending\non the objective of the study, clinical trial may be\nconducted in healthy volunteers or in volunteer patients.\nHealthy volunteers may be used to determine\npharmacokinetic characteristics, tolerability, safety and for", "start_char_idx": 0, "end_char_idx": 1056, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0118e949-2b66-4b9c-812b-bac2caa41c4a": {"__data__": {"id_": "0118e949-2b66-4b9c-812b-bac2caa41c4a", "embedding": null, "metadata": {"page_label": "211", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f95c2d56-fba8-413f-bb76-539a46eae194", "node_type": "4", "metadata": {"page_label": "211", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3f52babb5695cc86b823928536ee2c0422d39258bd2fc8839c994b05fad3695d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3b040bb7-cecc-402a-8576-3183143cee74", "node_type": "1", "metadata": {"page_label": "210", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "7803ba2d80bb2ae935305baf0499443ee5f4e1f80579f96bded702a717a33b0b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "50a4baf7-c459-4764-8b33-b606430bea79", "node_type": "1", "metadata": {}, "hash": "edc98f2e4720d20f7b15e52d692d168d6f17bbdca62c2778fe3a1fa4f5663a47", "class_name": "RelatedNodeInfo"}}, "text": "certain type of drugs (e.g. hypoglycaemic, hypnotic,\ndiuretic) even efficacy. For majority of drugs (e.g.\nantiepileptic, antipsychotic, antiinflammatory,\nantitubercular, etc.) therapeutic efficacy can only be\nassessed in patients.\nEthical  considerations All clinical trials must be\nconducted only after scrutiny and approval by an\nindependent ethics committee as per the \u2018Good Clinical\nPractice\u2019 (GCP) guidelines. In India, the ICMR (2006) has\nbrought out \u2018Ethical guidelines, for biomedical research on\nhuman participants\u2019. A proper written Informed consent of\nthe patient/trial subject must be obtained. The ethics\ncommittee has to ensure that the study does not breach the\nethical principles of:\nAutonomy: Freedom, dignity and confidentiality of the\nsubject; the right to choose whether or not to participate in\nthe trial or to continue with it.\nBeneficence: Motive to do good to the subject and/or the\nsociety at large.\nNon-maleficence: Not to do harm or put the participant at\nundue risk/disadvantage.\nJustice: Observance of fairness, honesty and impartiality in\nobtaining, analysing and communicating the data.", "start_char_idx": 0, "end_char_idx": 1117, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "50a4baf7-c459-4764-8b33-b606430bea79": {"__data__": {"id_": "50a4baf7-c459-4764-8b33-b606430bea79", "embedding": null, "metadata": {"page_label": "212", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "17c30727-0599-43b5-a11f-d1b0c0e13349", "node_type": "4", "metadata": {"page_label": "212", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "0747c26f7b0375b24c11522dcbb1c3ccf2710da964b234a6beec52f0fda14118", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0118e949-2b66-4b9c-812b-bac2caa41c4a", "node_type": "1", "metadata": {"page_label": "211", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3f52babb5695cc86b823928536ee2c0422d39258bd2fc8839c994b05fad3695d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a9b8c8ac-64d2-4339-9faa-466970e58fab", "node_type": "1", "metadata": {}, "hash": "5982aec941d5aa72703edec4b54a1ef46bbce859557b58e9caf5a47946ecb39a", "class_name": "RelatedNodeInfo"}}, "text": "Controlled  trial The inclusion of a proper comparator\n(control) group in clinical trials is crucial. The control\ngroup, which should be as similar to the test group as\npossible, receives either a placebo (if ethically permissible)\nor the existing standard treatment (active control). Separate\ntest and control groups may run simultaneously (parallel\ngroup design), or all the subjects may be treated by the two\noptions one after the other (cross over design) so that the\nsame subjects serve as their own controls. Individual\nvariation in response is thus avoided and sample size may\nbe reduced. In the cross over design, some patients are\ntreated first by drug \u2018A\u2019 followed by drug \u2018B\u2019, while in\nothers the order is reversed. This nullifies the effect (if any)\nof order of treatment. However, there may still be \u2018carry\nover\u2019 effects. This design is applicable only to certain\nchronic diseases which remain stable over long periods.\nWhen one drug is compared to another drug or to a\nplacebo, the dosage regimen (dose, frequency, duration) of\nthe drug is decided in advance. The trial results are\napplicable only to this chosen regimen. No conclusions can\nbe drawn about a higher or a lower dose. To determine the\nmost appropriate dose, separate dose-ranging studies\n(trials) have to be performed.\nIt is well known that both the participants and the\ninvestigators of the trial are susceptible to conscious as\nwell as unconscious bias in favour of or against the test", "start_char_idx": 0, "end_char_idx": 1465, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a9b8c8ac-64d2-4339-9faa-466970e58fab": {"__data__": {"id_": "a9b8c8ac-64d2-4339-9faa-466970e58fab", "embedding": null, "metadata": {"page_label": "213", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "84080f9b-e594-4495-be61-bda43cb86874", "node_type": "4", "metadata": {"page_label": "213", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a6dfae0807e2fe7fc17fed3e753346271ce1292b683c730a3332411b15ca4852", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "50a4baf7-c459-4764-8b33-b606430bea79", "node_type": "1", "metadata": {"page_label": "212", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "0747c26f7b0375b24c11522dcbb1c3ccf2710da964b234a6beec52f0fda14118", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "da22d960-0b73-465d-8068-c22cbd2fdb31", "node_type": "1", "metadata": {}, "hash": "569330655872bed162f0f714258e83b380c3170aea01fa740278221c2dddf4e6", "class_name": "RelatedNodeInfo"}}, "text": "drug. The greatest challenge in the conduct of clinical trial\nis the elimination of bias. The credibility of the trial\ndepends on the measures that are taken to minimize bias.\nThe two basic strategies for minimizing bias are\n\u2018randomization\u2019 and concealment or \u2018blinding\u2019.\nRandomization The subjects are allocated to either group\nusing a preselected random number table or computer\nprogramme so that any subject has equal chance of being\nassigned to the test or the control group. Discretion (and\nlikely bias) of the investigator/subject in treatment\nallocation is thus avoided. If considered necessary,\nstratified randomization according to age/sex/disease\nseverity/other patient variable may be adopted.\nBlinding  ( masking ) This refers to concealment of the\nnature of treatment (test or control) from the subject (single\nblind) or both the subject as well as the investigator\n(double blind). For this purpose the two medications have\nto appear similar in looks, number, weight, taste, etc. and\nare to be supplied in unlabelled packets marked for each\npatient. In double blind, the key/code to treatment\nallocation is kept by a third \u2018data management\u2019 party who\nis not involved in treating or recording observations. The\ncode is broken at the completion of the trial and the results\nare analysed according to prespecified statistical method.\nHowever, all clinical trials need not be blinded. Those in", "start_char_idx": 0, "end_char_idx": 1402, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "da22d960-0b73-465d-8068-c22cbd2fdb31": {"__data__": {"id_": "da22d960-0b73-465d-8068-c22cbd2fdb31", "embedding": null, "metadata": {"page_label": "214", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f1a83297-364c-4d19-960a-5849cfeb2cd4", "node_type": "4", "metadata": {"page_label": "214", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "1878f167d5c93165418c91319be2ad5c67f6ef91cb188530dc428701ff28660d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a9b8c8ac-64d2-4339-9faa-466970e58fab", "node_type": "1", "metadata": {"page_label": "213", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a6dfae0807e2fe7fc17fed3e753346271ce1292b683c730a3332411b15ca4852", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "861d6feb-6dce-4ff6-8d34-96136e858581", "node_type": "1", "metadata": {}, "hash": "ea48cd17c1b187d58e0c5ce751146348c158d68648bd139a9911d52165dbc0b0", "class_name": "RelatedNodeInfo"}}, "text": "which the nature of treatment is not concealed are called\n\u2018open\u2019 trials.\nRandomized controlled double blind trial (RCT) is the\nmost credible method of obtaining evidence of efficacy,\nsafety or comparative value of treatments.\nInclusion / exclusion  criteria The characteristics of the\nsubject/patient (age, sex, disease/symptom, severity and/or\nduration of illness, coexistent and past diseases,\nconcurrent/preceeding drug therapy, etc.) who are to be\nrecruited in the trial or excluded from it must be decided in\nadvance. The trial results are applicable only to the\npopulation specified by these criteria.\nEnd point The primary and secondary (if any) end points\n(cure, degree of improvement, symptom relief, surrogate\nmarker, avoidance of complication, curtailment of\nhospitalization, survival, quality of life, etc.) of the trial\nmust be specified in advance. The results are analysed in\nrelation to the specified end points.\nHigher efficacy may not always be the aim of a clinical\ntrial. A trial may be designed to prove \u2018non-inferiority\u2019 (of\nthe new drug) to the existing treatment, and possibly afford\nadvantages in terms of tolerability, safety, convenience,\ncost or applicability to special patient subgroup(s).", "start_char_idx": 0, "end_char_idx": 1219, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "861d6feb-6dce-4ff6-8d34-96136e858581": {"__data__": {"id_": "861d6feb-6dce-4ff6-8d34-96136e858581", "embedding": null, "metadata": {"page_label": "215", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "8c9596dc-dc72-4bf2-ae5a-40f5f3a82f82", "node_type": "4", "metadata": {"page_label": "215", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f9b059992d1161bbeeb897bf5c4f44e75a15e8470279f2ee66056b28f45f14cd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "da22d960-0b73-465d-8068-c22cbd2fdb31", "node_type": "1", "metadata": {"page_label": "214", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "1878f167d5c93165418c91319be2ad5c67f6ef91cb188530dc428701ff28660d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "31530e26-7a50-4382-b21e-08ca8dc60824", "node_type": "1", "metadata": {}, "hash": "e55ab362e43d29386d65fe3ad9d96a0676723ff783695b96c85428cfe927df45", "class_name": "RelatedNodeInfo"}}, "text": "Sample  size : Both financial and ethical considerations\ndemand that the number of subjects in the trial be the\nminimum needed for a valid result. The minimum number\nof subjects for obtaining a decisive conclusion (test better\nthan control/control better than test/no difference between\nthe two) must be calculated statistically beforehand.\nBecau se the trial is conducted on a sample of the whole\npatient population, there is always a chance that the sample\nwas not representative of the population. Thus, the results\ncannot be absolutely conclusive. \nTwo types of errors are possible:\nType  I  (\u03b1) error : a difference is found between the two groups while none\nexists. Its possibility is called \u2018significance\u2019  of the result, e.g. if test drug is\nfound to be better than control at a significance level of 0.05, it means that\nthere is 5% chance that this is not real.\nType  II  (\u03b2) error : no difference is found while it really exists. The\nprobability of failing to detect an actual difference is expre ssed by the\n\u2018power \u2019 of the trial. A power of 0.9 means that there is 10% chance of\nmissing a real dif ference.\nThe sample size of the trial depends on the desired level\nof significance and power. The other input needed for\ncalculation of sample size is the magnitude of difference\nbetween the two groups that is expected or is considered\nclinically significant, e.g. a 10% reduction in pain intensity\nmay not be considered clinically significant, while a 10%\nreduction in mortality may be worthwhile. Larger sample", "start_char_idx": 0, "end_char_idx": 1522, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "31530e26-7a50-4382-b21e-08ca8dc60824": {"__data__": {"id_": "31530e26-7a50-4382-b21e-08ca8dc60824", "embedding": null, "metadata": {"page_label": "216", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ac278cc6-3d41-4874-b1a5-a98b50157c11", "node_type": "4", "metadata": {"page_label": "216", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3391f767ae003bafacd60e64610ef9e6e748d18d1f1d00ef526320984906dc7d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "861d6feb-6dce-4ff6-8d34-96136e858581", "node_type": "1", "metadata": {"page_label": "215", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f9b059992d1161bbeeb897bf5c4f44e75a15e8470279f2ee66056b28f45f14cd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aa3d75b3-8c4f-4ee6-82fc-c2e842f245d8", "node_type": "1", "metadata": {}, "hash": "d46685f453a977e175edcf36c5da4cbb038abad8c6301485884f510e239a4430", "class_name": "RelatedNodeInfo"}}, "text": "size is required to detect smaller difference. Also, higher\nthe significance and power level desired, greater is the\nnumber of subjects. The variability of response in terms of\nthe primary end point also affects the sample size.\nResponses that show greater individual variation need\nlarger number of subjects to achieve the desired\nsignificance and power levels.\nMany large scale trials are subje cted to interim analysis from time to time as\nthe trial progres ses by an indep endent committee which can order an early\ntermination if a decisive result (positive or negative) is obtained; because it\nwould be unethi cal to subject some of the remaining patients to a treatment\n(test or control) which has been found inferior .\nMulticentric  trial  Many large trials are conducted at more\nthan one centre by as many teams of investigators,\nsometimes spread over several countries. The advantages\nare:\n\u2022Larger number of patients can be recruited in a shorter\nperiod of time.\n\u2022Results are applicable to a wider population base which\nmay cover several countries/ethnic groups.\n\u2022Regulatory requirements of several countries may be\nsatisfied.\n\u2022Credibility of the trial is enhanced.\nThe phase III trials are generally multicentric.\nSequential trial", "start_char_idx": 0, "end_char_idx": 1240, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "aa3d75b3-8c4f-4ee6-82fc-c2e842f245d8": {"__data__": {"id_": "aa3d75b3-8c4f-4ee6-82fc-c2e842f245d8", "embedding": null, "metadata": {"page_label": "217", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "88b19485-8cd8-46a4-bac8-5fc415d55591", "node_type": "4", "metadata": {"page_label": "217", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "811d44402902416dee0f69fde9bab892daa3f4b64eb6600acddc563aa0e632cc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "31530e26-7a50-4382-b21e-08ca8dc60824", "node_type": "1", "metadata": {"page_label": "216", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "3391f767ae003bafacd60e64610ef9e6e748d18d1f1d00ef526320984906dc7d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7df63099-eacc-450a-a5fa-29df87a03ff9", "node_type": "1", "metadata": {}, "hash": "ca76d2242e85d3cce90f4655787b7e2a2b2abe4d13a265b0ec8c5e33f973c4be", "class_name": "RelatedNodeInfo"}}, "text": "This design attempts to detect a significant result as soon as it is achieved,\nminimizing the number of subjects. The trial is conducted on matched pairs\nof subjects and is scored as \u2018A\u2019 treatment better than \u2018B\u2019 or \u2018B\u2019 better than\n\u2018A\u2019 or no difference. This is plotted continuously as the trial proceeds till the\nboundries of predetermined level of significant superiority/i nferiority/no\ndifference are touched. The trial is then terminated. This design is applicable\nonly to certain types of drugs and diseases for which clinical end points are\nachieved quickly and paired comparisons are possible. Moreover , it may not\nalways be practicable to recruit matching pairs of trial subjects.\nMeta-analysis\nThis is an exercise in which data from several similarly\nconducted randomized controlled clinical trials with the\nsame drug (or class of drugs) examining the same clinical\nend point(s) is pooled to bring out the overall balance of\nevidence by enlarging the number of test and control\nsubjects and increasing the significance and power of the\nconclusions. Becau se individual trials are often conducted\non relatively smaller number of patients, some may fail to\ndetect a significant difference, while others may find it.\nDiscordant results are published which confuse the medical\npractitioner. There are many criticisms of meta-analysis,\nsuch as:\na.bias in the selection of trials for analysis (selection\nbias);\nb.unintentional exclusion of negative results which are\nless likely to be published (publication bias);", "start_char_idx": 0, "end_char_idx": 1519, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7df63099-eacc-450a-a5fa-29df87a03ff9": {"__data__": {"id_": "7df63099-eacc-450a-a5fa-29df87a03ff9", "embedding": null, "metadata": {"page_label": "218", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "54dc3ec4-edc5-4178-a51b-622c5b46fa8c", "node_type": "4", "metadata": {"page_label": "218", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b7bba3a301d5dafde50423d12dc7efa7427f5e6eb5f8a45e6bedd1c1943158ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aa3d75b3-8c4f-4ee6-82fc-c2e842f245d8", "node_type": "1", "metadata": {"page_label": "217", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "811d44402902416dee0f69fde9bab892daa3f4b64eb6600acddc563aa0e632cc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b1639628-9303-4ad6-af88-6185579a0e7b", "node_type": "1", "metadata": {}, "hash": "aafd3b43a83fe0cae76a12a5c32ac834c401e4a4f89bdc5b994596198932d278", "class_name": "RelatedNodeInfo"}}, "text": "c.nonuniformity of the trials in details of methodology\nand conduct.\nNevertheless, meta-analysis is a useful tool to arrive at\nconclusions that may influence medical practice. For\nexample, meta-analysis of trials has strongly supported the\nuse of \u03b2-adrenergic blockers in heart failure and use of\nstatins to reduce risk of coronary artery disease.\nTo be reliable, the meta-analysis should observe the following:\n\u2022Comprehensive search of the literature to identify all eligible trials.\n\u2022Use objective criteria in selecting the trials for inclusion.\n\u2022Include only randomized trials of assured quality .\n\u2022Employ proper statistical metho ds in pooling and treating the data from\nindividual trials.\nMeta-analysis are now frequently published on\ncontemporary therapeutic issues.\nCohort study\nThis is a type of observational study in which no\nintervention for the sake of the study is done. \u2018Cohort\u2019 is a\ngroup of individuals having some common features. In the\ncontext of drug research, the common feature is that all\nstudy subjects have taken a particular drug. Occurrence of\nevents (beneficial or adverse) in users and nonusers of the\ndrug is compared. Prescription event monitoring is a cohort\nstudy. The cohort study can be a prospective or a\nretrospective study. In the prospective design, all patients\nwho receive the study drug are followed up for therapeutic", "start_char_idx": 0, "end_char_idx": 1360, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b1639628-9303-4ad6-af88-6185579a0e7b": {"__data__": {"id_": "b1639628-9303-4ad6-af88-6185579a0e7b", "embedding": null, "metadata": {"page_label": "219", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "111546b9-b54c-4275-8e79-faec495b1eca", "node_type": "4", "metadata": {"page_label": "219", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "52e67c3445f15d31e0d90eb1eaf00d21f2f08f5500804959a96aa0e2f8253d66", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7df63099-eacc-450a-a5fa-29df87a03ff9", "node_type": "1", "metadata": {"page_label": "218", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "b7bba3a301d5dafde50423d12dc7efa7427f5e6eb5f8a45e6bedd1c1943158ea", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d2c5f090-6a34-4a4f-b77f-09114c236969", "node_type": "1", "metadata": {}, "hash": "f885be098d7611753342eed6edbaa3f726a624c45c7f32a7efd2e333841b3217", "class_name": "RelatedNodeInfo"}}, "text": "outcomes or adverse effects. A matching group of patients\nwho have not received the drug is identified and followed\nup to serve as control. Cohort studies are primarily used to\ndiscover uncommon adverse effects that may be missed\nduring formal therapeutic trials which involve fewer\npatients and often exclude certain type of patients who may\nbe susceptible to that adverse effect. Its value for defining\ntherapeutic outcomes is less credible. The limitations of\ncohort studies are that controls included may not be\nappropriate, and relatively long period of follow up is\nneeded.\nGrades of strength of evidence\nGrade\nISystematic reviews/Meta-\nanalysisMost reliable, may form\nthe basis of clinical\ndecisions\nGrade\nIIWell powered randomized\ncontrolled trial/more than\none trialsReliable, but may be\nsupported or refuted by\nsimilar studies\nGrade\nIIIOpen label trials/pilot\nstudies/observational\n(cohort and case-control)\nstudies (prospective or\nretrospective)Less reliable, need more\nrigorous testing, may\nindicate further\ninvestigation\nGrade\nIVCase  reports / anecdotal\nreports / clinical  experienceLeast  reliable ; may  serve\nas pointers  to  initiate\nformal  studies", "start_char_idx": 0, "end_char_idx": 1168, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d2c5f090-6a34-4a4f-b77f-09114c236969": {"__data__": {"id_": "d2c5f090-6a34-4a4f-b77f-09114c236969", "embedding": null, "metadata": {"page_label": "220", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "d6887eba-e990-4502-8d6b-543335713268", "node_type": "4", "metadata": {"page_label": "220", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e4a0d68a9bf795489b71103063671ccfc6c970fc6b9b1a3138ed09c70c0e2acd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b1639628-9303-4ad6-af88-6185579a0e7b", "node_type": "1", "metadata": {"page_label": "219", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "52e67c3445f15d31e0d90eb1eaf00d21f2f08f5500804959a96aa0e2f8253d66", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c4d883b6-7d29-4d9a-98bb-f4279e5d6656", "node_type": "1", "metadata": {}, "hash": "33d3774eba9a48434c760046338257489cf1607f8902e74abfb069230a384f10", "class_name": "RelatedNodeInfo"}}, "text": "In the retrospective cohort study, health records of a\npopulation are scrutinized for exposure to the study drug\nand the subsequent beneficial/adverse events. Its value is\nquestionable because many events may have been missed\nin the records and several unknown factors may have\ncontributed to the findings. However, it may serve as\npointer, or to arouse suspicion.\nCase control study\nThis type of observational study is used mainly to reveal\nassociation of a suspected rare adverse event with the use\nof a particular drug. Cases of the suspected adverse event\n(e.g. agranulocytosis) are collected from hospital records or\ndisease registries, etc. A matched control group similar in\nother respects but not having the adverse event is selected.\nDrug histories of both groups are traced backwards to\ncompare exposure to the indicated drug (e.g.\nphenylbutazone) among patients with the adverse event to\nthose without it. The suspicion is strengthened if high\nassociation is found. Though case control studies can be\nperformed rather quickly because the number of patients\nanalysed is small compared to the cohort design, they do\nnot prove causality. Moreover, the causative drug and the\nadverse event have to be suspected first to plan the study,\nwhereas cohort study can reveal unsuspected adverse\nevents. Variable accuracy of retrospective records, non-", "start_char_idx": 0, "end_char_idx": 1351, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c4d883b6-7d29-4d9a-98bb-f4279e5d6656": {"__data__": {"id_": "c4d883b6-7d29-4d9a-98bb-f4279e5d6656", "embedding": null, "metadata": {"page_label": "221", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "32add051-8455-4359-a8f8-249140afe9ac", "node_type": "4", "metadata": {"page_label": "221", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "52eb895b55b202edb09fb5dfcfe272a7052734b2954beb5129b16e56d37b0f04", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d2c5f090-6a34-4a4f-b77f-09114c236969", "node_type": "1", "metadata": {"page_label": "220", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e4a0d68a9bf795489b71103063671ccfc6c970fc6b9b1a3138ed09c70c0e2acd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "566ac0ee-590b-434a-8852-b0be8cbaed02", "node_type": "1", "metadata": {}, "hash": "5cfb229dea9534f1d4461b2241e258d64559d92b5cde6464215bb247841a46dd", "class_name": "RelatedNodeInfo"}}, "text": "randomly selected control group, chances of bias and a\nvariety of unknown factors make the case control study a\nweak instrument for affording convincing evidence.\nGrading strength of evidence\nThe strength of evidence from the conclusions of various\nkinds of trials, studies and reports has been graded from\nstrong to weak as presented in the box.\nNEW DRUG DEVEL OPMENT\nIn this era of bewildering new drug introduction and rapid\nattrition of older drugs, the doctor needs to have an overall\nidea of the manner in which new drugs are developed and\nmarketed. Drug development now is a highly complex,\ntedious, competitive, costly and commercially risky\nprocess. From the synthesis/identification of the molecule\nto marketing, a new drug takes at least 10 years and costs\n500\u20131000 million US$. As such, invention and\ndevelopment of new drugs is now possible only in the set\nup of big pharmaceutical houses that alone have the\nresources, infrastructure and dedicated teams of scientists\nto carry out the multiple specialized stages of the process.\nThough the pharmaceutical industry is often regarded\ncunning, greedy, unscrupulous, deceptive and fleecing the\npeople, there is no denying that it is responsible for most of", "start_char_idx": 0, "end_char_idx": 1216, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "566ac0ee-590b-434a-8852-b0be8cbaed02": {"__data__": {"id_": "566ac0ee-590b-434a-8852-b0be8cbaed02", "embedding": null, "metadata": {"page_label": "222", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5f4a2e13-28a6-4ea4-8137-406cdee5896a", "node_type": "4", "metadata": {"page_label": "222", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8faec1e3beb97dc2d1ba982afdec40721c96eb96b3652e04b2e83f64183a9de8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c4d883b6-7d29-4d9a-98bb-f4279e5d6656", "node_type": "1", "metadata": {"page_label": "221", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "52eb895b55b202edb09fb5dfcfe272a7052734b2954beb5129b16e56d37b0f04", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0fdf221a-5862-43dc-954b-94cbf4016b83", "node_type": "1", "metadata": {}, "hash": "aa65dfe7639a57471dedc00cacf8f3d56bd7ebdad3ae469d49046d5b431c100e", "class_name": "RelatedNodeInfo"}}, "text": "the progress in therapeutics as well as pharmacological\nknowledge of today. \nStages in new drug development\nSynthesis/isolation of the compound: (1\u20132 years)\nPreclinical studies: screening, evaluation,\npharmacokinetic and short-term toxicity\ntesting in animals:(2\u20134 years)\nScrutiny and grant of permission for clinical\ntrials:(3\u20136 months)\nPharmaceutical formulation, standardization\nof chemical/biological/immuno-assay of the\ncompound:(0.5\u20131 year)\nClinical studies: phase I, phase II, phase III\ntrials; long-term animal toxicity testing:(3\u201310 years)\nReview and grant of marketing permission: (0.5\u20132 years)\nPostmarketing surveillance: (phase IV\nstudies)\nThe major steps/stages in the development of a new\ndrug are given in the box.\nApproaches to drug discovery/invention\nExploration  of  natural  source s  Plants are the oldest source of medicines.\nClues about these have been obtained from traditional systems of medicine\nprevalent in various parts of the world; Opium (morphine), Ephedra\n(ephedrine), Cinchona (quinine), curare (tubocurarine), belladonna", "start_char_idx": 0, "end_char_idx": 1055, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0fdf221a-5862-43dc-954b-94cbf4016b83": {"__data__": {"id_": "0fdf221a-5862-43dc-954b-94cbf4016b83", "embedding": null, "metadata": {"page_label": "223", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "fe19bb90-70c7-4019-ac18-4a5c7e25a9c8", "node_type": "4", "metadata": {"page_label": "223", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2474b319d6dd37657ca00a4f1f146c9c19e52e8e31e096678f72965caa3ccf1c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "566ac0ee-590b-434a-8852-b0be8cbaed02", "node_type": "1", "metadata": {"page_label": "222", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8faec1e3beb97dc2d1ba982afdec40721c96eb96b3652e04b2e83f64183a9de8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b6f2aa94-3581-4c5d-8eda-2937db37cea5", "node_type": "1", "metadata": {}, "hash": "85783a19b2622c2288106653b8e77bf024bf68578f2e5fc98911347ae475278c", "class_name": "RelatedNodeInfo"}}, "text": "(atropine), Quin ghaosu (artemisinin) are the outstanding examples. Though\nanimal parts have been used as cures since early times, it was physiological\nexperiments performed in the 19th and early 20th century that led to\nintroduction of some animal products into medicine, e.g. adrenaline,\nthyroxine, insulin, liver extract, antisera, etc. Few minerals (iron/calcium\nsalts, etc.) are the other natur al medicinal substances. The discovery of\npenicillin (1941) opened the flood-gates of a vast source\u2014 microorganisms\n\u2014of a new kind of drugs (antibi otics). The use of microbes for production of\nvaccines is older than their use to produce antibiotics.\nThough few drugs are now produced from plants, animals or microbes,\nthese sources of medicines are by no means exhausted. However , they\nmostly serve as lead compounds.\nRandom  or  targeted  chemical  synthesis  Synthetic chemistry made its\ndebut in the 19th century and is now the largest source of medicines.\nRandomly synthesized compounds can be tested for a variety of\npharmacological activities. Though some useful drugs (barbiturates,\nchlorpromazine) have been produced serendipitously by this approach, it has\nvery low probability of hitting at the right activity in the right compound;\nrarely employed now .\nLead optimizati on A more practical approach is to synthesize chemical\ncongeners of natural products/synthetic compounds with known\npharmacological activity in the hope of producing more selective/superior\ndrugs. Many families of clinically useful drugs have been father ed by a \u2018lead\ncompound\u2019 . Often only \u2018me too\u2019 drugs are produced, but sometime s\nbreakthroughs are achieved, e.g. thiazide diuretics from acetazolamide,\ntricyclic antidepressants from phenothiazines.\nStudy of several congeners of the lead compound can delineate molecular\nfeatures respons ible for a partic ular property . Application of this structur e-\nactivity relationship information has proven useful on many occasions, e.g.\nselective \u03b22 agonist s (salbu tamol) and \u03b2 blocker s (prop ranolol, etc.) have\nbeen produced by modifying the structure of isoprenaline, H2 blockers by\nmodifying the side chain of histamine, ethinyl-estradiol by introducing a", "start_char_idx": 0, "end_char_idx": 2194, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b6f2aa94-3581-4c5d-8eda-2937db37cea5": {"__data__": {"id_": "b6f2aa94-3581-4c5d-8eda-2937db37cea5", "embedding": null, "metadata": {"page_label": "224", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "163fe919-1f08-4992-8524-378994cf2710", "node_type": "4", "metadata": {"page_label": "224", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "1107f3f57f7ac3222da1e67d22273f3818619fb6699ef835275bd1411b27bdc5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0fdf221a-5862-43dc-954b-94cbf4016b83", "node_type": "1", "metadata": {"page_label": "223", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2474b319d6dd37657ca00a4f1f146c9c19e52e8e31e096678f72965caa3ccf1c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2d9a7a2b-a754-4a21-93a3-189320b32eea", "node_type": "1", "metadata": {}, "hash": "b33889fcbbaf2765e2a06d3f57ad0e3d00c62703abf567f4af433bc132e27f82", "class_name": "RelatedNodeInfo"}}, "text": "substitution that resists metabolic degradation, mesoprostol (more stable) by\nesterifying PGE1.\nMore common ly now, as described later in the rational approach,\nidentification of the target biom olecule is the starting point for new drug\ninvention. A lead compound capable of interacting with the target is searched\nby applying diverse approaches described above and below . The affinity and\nselectivity of the lead compou nd for the target is determine d. It is then\nchemically modified to optimise these parameters as well as\npharmacokinetic, pharmaceutic al, toxicological and other characteristics.\nMore suitable candidate drug(s) may thus emer ge for further development.\nSingle  enantiomers  Many drugs are chiral compounds. Because\npharmacological activity depends on three dimensional interaction of drug\nmolecules with their target biom olecules, the enantiomers (R and S forms or\nd and l isomers) of chiral drugs differ in biological activity , metabolic\ndegradation, etc. Often only one of the enantiomers is active. Single\nenantiomer drug could be superior to its racemate, because the additional\nenantiomer may not only be a \u2018silent passenger \u2019 but contri bute to side\neffects, toxicity (dextro-dopa is more toxic than levo-dop a), load on\nmetabolism or even antagonize the active enantiomer . Regulatory authorities\nin many countries, led by US-FDA, have mandated separate investigation of\nthe enantiomers  in case the new drug is a chiral molecule. Approval is\nwithheld unless  the pure enant iomers are shown to be no better than the\nracemate. Several drugs, originally introduced as racemates, have now been\nmade available as single enantiomer preparations as well ( see box).\nDrugs marketed as single enantiomers\n\uf045\uf06e\uf061\uf06e\uf074\uf069\uf06f\uf06d\uf065\uf072 \uf041\uf064\uf076\uf061\uf06e\uf074\uf061\uf067\uf065\uf020\uf063\uf06c\uf061\uf069\uf06d\uf065\uf064\n(S) atenolol half dose , better  tolerated\n(S) metoprolol half dose\n(S) amlodipine half dose , less  peripheral\nedema", "start_char_idx": 0, "end_char_idx": 1877, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2d9a7a2b-a754-4a21-93a3-189320b32eea": {"__data__": {"id_": "2d9a7a2b-a754-4a21-93a3-189320b32eea", "embedding": null, "metadata": {"page_label": "225", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "5571b7ae-8a7a-4e48-ba72-d69822e2b5ac", "node_type": "4", "metadata": {"page_label": "225", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4a5b918635cc5f3bd5df491a738ae164be96360377bb0dab5b09c7a74c3837ce", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b6f2aa94-3581-4c5d-8eda-2937db37cea5", "node_type": "1", "metadata": {"page_label": "224", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "1107f3f57f7ac3222da1e67d22273f3818619fb6699ef835275bd1411b27bdc5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d11bb011-74a5-4565-9551-196b9746519b", "node_type": "1", "metadata": {}, "hash": "c84668cfddecf396c26d4846a8e8d49221004b722f154d22d0d0041a8538b33e", "class_name": "RelatedNodeInfo"}}, "text": "(S) omeprazole     \n(esomeprazole )better  oral  bioavailability\n(S) pantoprazole more  potent\n(R) salbutamol more  active , ( S ) may\nantagonize  ( R )\n(S) citalopram     \n(escitalopram )lower  dose , less  side  effects\n(S) naproxen\n   \ncisatracuriumless burden  on  kidney  ( but\ninversion  occurs  \uf069\uf06e\uf020\uf076\uf069\uf076\uf06f )\n4\u00d7 more  potent , less\nhistamine  release\nlevo\ufb02oxacin more  active , slower\nelimination\nlevocetirizine  ( R ) half dose , only  ( R ) form  active\ndesloratadine half dose\nRational  appro ach This depends on sound physio logical, biochemical,\npathological knowledge and identification of specific target for drug action.\nTruly new classes of drugs generally follow the identification of a novel\ntarget for drug action, such as H+K+ATPase for gastric acid suppres sion or\nglycoprotein IIa/IIIb receptor for platelet function inhibition.The drug is\naimed at mitigating the derangement caused by the disease, e.g. levodopa\nwas tried in parkinsonism based on the finding that the condition resulted\nfrom deficiency of dopamine in the striatum. The purine, pyrimidine, folate\nantimetabolites were introduced in cancer chemotherapy after elucidation of\nkey role of these metabolites in cell proliferation. Because virus directed\nreverse transcr iptase is unique to retroviruses, its inhibitors have been\ndeveloped as anti-HIV  drugs. This approach is very attractive but requires a\nlot of basic research.", "start_char_idx": 0, "end_char_idx": 1409, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d11bb011-74a5-4565-9551-196b9746519b": {"__data__": {"id_": "d11bb011-74a5-4565-9551-196b9746519b", "embedding": null, "metadata": {"page_label": "226", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "6a6bd0f6-1a54-4c5d-8788-dcb74dd37050", "node_type": "4", "metadata": {"page_label": "226", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2b72ade134625859fe08c26d846d04468c10da4c95ec9daba360340a8557b373", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2d9a7a2b-a754-4a21-93a3-189320b32eea", "node_type": "1", "metadata": {"page_label": "225", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4a5b918635cc5f3bd5df491a738ae164be96360377bb0dab5b09c7a74c3837ce", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5d7c4e22-bbc4-4349-93b8-e4dd4ac0af89", "node_type": "1", "metadata": {}, "hash": "0d8eb74c3e4c6d558127854252724091a1ed768a21037d5086da5acf97379f83", "class_name": "RelatedNodeInfo"}}, "text": "Molecular  modelling  Advances in protein chemistry and computer aided\nelucidation of three-dimensional structure of key receptors, enzymes, etc.\nhas permitted designing of targeted compounds. Suitabl e computer\nprogrammes are being used to optimise the three-dimensional  structure of\nthe cand idate drug to fit the identified target site(s) and/or have optimum\npharmacokinetics. The designing of selective COX-2 inhibitors was\nprompted by the comparative configuration of COX-1 and COX-2\nisoenzyme molecules. Study of drug binding to mutated receptors and\nelucidation of configuration of drug-receptor complexes is now guiding\nproduction of improved drugs. Attempts are being made to produce\nindividualized drugs according to pharmacogenomic suitability .\nCombinatorial  chemistry  Chemical groups are combined in a random\nmanner to yield innumerable compounds and subjected to high-thr oughput\nscreening on cells, genetically engineered microbes, receptors, enzymes, etc.\nin robotically controlled automated assay systems. Computerized analysis is\nused to identify the so called \u2018hits.\u2019 These compounds are then subjected to\nconventional tests. This new approach has vast potentials, but failure rates\nare high.\nBiotechnology  Several drugs are now being produced by recombinant DNA\ntechnology , e.g. human growth hormone, human insulin, interferon, etc.\nSome monoclonal and chimeral antibodies have been introduced as drugs.\nNew molecules,  especially antibiotics, regulatory peptides, growth factors,\ncytokines, etc. produced by biotechnological methods can be evaluated as\nputative drugs. Other experimental approaches in new drug development are\nantisense oligonucleotides and gene therapy .\nPreclinical studies\nAfter synthesizing/identifying a prospective compound, it\nis tested on animals to expose the whole pharmacological\nprofile. Experiments are generally performed on a rodent\n(mouse, rat, guinea pig, hamster, rabbit) and then on a", "start_char_idx": 0, "end_char_idx": 1946, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5d7c4e22-bbc4-4349-93b8-e4dd4ac0af89": {"__data__": {"id_": "5d7c4e22-bbc4-4349-93b8-e4dd4ac0af89", "embedding": null, "metadata": {"page_label": "227", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "fa0bbb43-4ab6-4b41-9642-bc97fa14c77e", "node_type": "4", "metadata": {"page_label": "227", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "995c5ef76de6fd0827f166045aa47f81826c34dbbe0ed8c4b047a3bc1ba9592c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d11bb011-74a5-4565-9551-196b9746519b", "node_type": "1", "metadata": {"page_label": "226", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2b72ade134625859fe08c26d846d04468c10da4c95ec9daba360340a8557b373", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "948de473-a10e-4aeb-8662-6f946e0aa8c1", "node_type": "1", "metadata": {}, "hash": "a925f6e02868296e662093b77c13aeb67ce98b48b2d08e0326878543f2a2b01a", "class_name": "RelatedNodeInfo"}}, "text": "larger animal (cat, dog, monkey). As the evaluation\nprogresses unfavourable compounds get rejected at each\nstep, so that only a few out of thousands reach the stage\nwhen administration to man is considered.\nThe following types of tests are performed.\n1.Screening  tests  These are simple and rapidly performed tests to\nindicate presence or absence of a particular pharmacodynamic activity\nthat is sought for , e.g. analgesic or hypoglycaemic activity .\n2.Tests  on  isolated  organs , bacterial  cultures , etc . These also are\npreliminary tests to detect specific activity , such as antihistaminic,\nantisecretory , vasodilator , antibacterial, etc.\n3.Tests  on  animal  models  of  human  disease  Such as kindled seizures\nin rats, spontaneously (genetically) hypertensive rats, exper imental\ntuberculosis in mouse, alloxan induced diabetes in rat or dog, etc.\n4.Con\ufb01rmatory  tests  and  analogous  activities  Compounds found\nactive are taken up for detailed study by more elaborate tests which\nconfirm and characterize the activity . Other related activities, e.g.\nantipyretic and anti-inflammatory activity in an analgesic are tested.\n5.Systemic  pharmacology  Irrespective of the primary action of the\ndrug, its effects on major organ systems such as nervous,\ncardiovascular , respiratory , renal, g.i.t are worked out. Mechanism of\naction, including additional mechanisms, e.g. \u03b1 adrenergic blockade,\ncalcium chan nel blockade, nitro-vasodilatation, etc. in a \u03b2 adrener gic\nblocker antihypertensive, are elucidated.\n6.Quantitative  tests  The dose-response relationship, maximal effect and\ncomparative potency/ef ficacy with existing drugs is ascertained.\n7.Pharmacokinetics   The absorption, volume of distribution,\nmetabolism, excretion, pattern of tissue distribution and plasma half-\nlife of the drug are quantified.\n8.Toxicity  tests  The aim is to determine safety of the compound in at\nleast 2 animal species, one rodent and one nonrodent, e.g. mouse/rat\nand dog by oral and parenteral routes.", "start_char_idx": 0, "end_char_idx": 2006, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "948de473-a10e-4aeb-8662-6f946e0aa8c1": {"__data__": {"id_": "948de473-a10e-4aeb-8662-6f946e0aa8c1", "embedding": null, "metadata": {"page_label": "228", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b338830a-ecbc-4f18-89c9-adcad2e2717e", "node_type": "4", "metadata": {"page_label": "228", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "1820ff678c6e3803cba643d44a4120ed20be204a04cec3e9b6966b1394467b47", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5d7c4e22-bbc4-4349-93b8-e4dd4ac0af89", "node_type": "1", "metadata": {"page_label": "227", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "995c5ef76de6fd0827f166045aa47f81826c34dbbe0ed8c4b047a3bc1ba9592c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "449dcd49-684e-4ac5-85e1-cb16cfdceb99", "node_type": "1", "metadata": {}, "hash": "bbb19232114758e77241911275060c556c0d60d03d9ff4914523389406cd6790", "class_name": "RelatedNodeInfo"}}, "text": "Acute toxicity: Single escalating doses are given to small groups of animals\nthat are observed for overt effects and mortality for 1\u20133 days. The dose\nwhich kills 50% animals (LD50) is calculated. Organ toxicity is examined by\nhistopathology on all animals.\nSubacute toxicit y: Repeated doses are given for 2\u201312 weeks depending on\nthe duration of intended treatment in man. Doses are selected on the basis of\nED50 and LD50. Animals are examined for overt effects, food intake, body\nweight, haematology , etc. and or gan toxicity .\nChronic toxicity : The drug is given for 6\u201312 months and effects are studied\nas in subacute toxicity . This is generally undertaken concurrently with early\nclinical trials.\nRepr oduction and teratogenici ty: Effects on spermatogenesis, ovulation,\nfertility and developing foetus are studied.\nMutagenicity: Ability of the drug to induce genetic damage is assessed in\nbacteria (Ames test), mammalian cell cultures and in intact rodents.\nCarcinogenicity: Drug is given for long-term, even the whole life of the\nanimal and they are watched for development of tumours.\nStandardised procedures under  \u2018Good Laborato ry Practices\u2019  (GLP) have\nbeen laid down for the conduct of animal experiments, especially toxicity\ntesting.\nClinical trials\nWhen a compound deserving trial in man is identified by\nanimal studies, the regulatory authorities are approached\nwho on satisfaction issue an \u2018investigational new drug\u2019\n(IND) licence. The drug is formulated into a suitable\ndosage form and clinical trials are conducted in a logical\nphased manner. To minimize any risk, initially few subjects\nreceive the drug under close supervision. Later, larger", "start_char_idx": 0, "end_char_idx": 1663, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "449dcd49-684e-4ac5-85e1-cb16cfdceb99": {"__data__": {"id_": "449dcd49-684e-4ac5-85e1-cb16cfdceb99", "embedding": null, "metadata": {"page_label": "229", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "290c0cf8-b856-4044-9072-5c0048c37a43", "node_type": "4", "metadata": {"page_label": "229", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6c67aa4ffb473b49fd68da32dc1e4b8ef0f3abbc654ad715c6ff84b8ca267108", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "948de473-a10e-4aeb-8662-6f946e0aa8c1", "node_type": "1", "metadata": {"page_label": "228", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "1820ff678c6e3803cba643d44a4120ed20be204a04cec3e9b6966b1394467b47", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7b317736-f021-43db-8e9c-8d0a3bef5d29", "node_type": "1", "metadata": {}, "hash": "1e63d10cf1253649fd4c97cb8d3c0e6d04e91e8eaa4c894b7cb8b5085478cf56", "class_name": "RelatedNodeInfo"}}, "text": "numbers are treated with only relevant monitoring. \nStandards for the design, ethics, conduct, monitoring,\nauditing, recording and analyzing data and reporting of\nclinical trials have been laid down in the form of \u2018Good\nClinical Practice\u2019 (GCP) guidelines by an International\nConference on Harmonization (ICH). National agencies in\nmost countries, including ICMR in India, have also framed\nethical guidelines for clinical trials. Adherence to these\nprovides assurance that the data and reported results are\ncredible and accurate, and that the rights, integrity and\nconfidentiality of trial subjects are protected as enunciated\nin the Helsinki Declaration of the World Medical\nAssociation. The requirements and regulations for the\nconduct of clinical trials on a new drug in India have been\nlaid down in the schedule Y of the Drugs and Cosmetics\nRules.\nThe clinical studies are conventionally divided into 4\nphases.\nPhase  I : Human  pharmacology  and  safety\nThe first human administration of the drug is carried out by\nqualified clinical pharmacologists/trained physicians in a\nsetting where all vital functions are monitored and\nemergency/resuscitative facilities are available. Subjects\n(mostly healthy volunteers, sometimes patients) are\nexposed to the drug one by one (total 20\u201380 subjects),", "start_char_idx": 0, "end_char_idx": 1296, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7b317736-f021-43db-8e9c-8d0a3bef5d29": {"__data__": {"id_": "7b317736-f021-43db-8e9c-8d0a3bef5d29", "embedding": null, "metadata": {"page_label": "230", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "4825ba3c-d08c-4d41-9223-a08769c775d9", "node_type": "4", "metadata": {"page_label": "230", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fa2a63f70dc9b787d4689b168a08b4f589d77f8f50d878c247d3ce4407fba345", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "449dcd49-684e-4ac5-85e1-cb16cfdceb99", "node_type": "1", "metadata": {"page_label": "229", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6c67aa4ffb473b49fd68da32dc1e4b8ef0f3abbc654ad715c6ff84b8ca267108", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "68ce89b4-b29b-4d46-8ace-a8f672f83059", "node_type": "1", "metadata": {}, "hash": "589f8c346b0793b2e5bb71752bcdd4206fbead71c69efbb232bfc3f1a9011cfb", "class_name": "RelatedNodeInfo"}}, "text": "starting with the lowest estimated dose (generally 1/100 to\n1/10 of the highest dose producing no toxicity in animals)\nand increasing stepwise to achieve the effective dose. An\nattempt is made to determine the dose range that may be\nused in further studies. The emphasis is on safety,\ntolerability, and to detect any potentially dangerous effects\non vital functions, such as precipitous fall/rise in blood\npressure or heart rate, arrhythmias, bronchospasm,\nseizures, kidney/liver damage, etc. Unpleasant side effects\nare noted and an attempt is made to observe the\npharmacodynamic effects in man. The human\npharmacokinetic parameters of the drug are measured for\nthe first time. No blinding is done: the study is open label.\nPhase  0: Microdosing  study\nThis is a new strategy being developed to reduce the cost and time of the\ndrug development process. The rate of rejection of candidate drugs at\nvarious stages of clinical development has progressively increased recently ,\ndiscouraging pharmaceutical companies to venture into the risky  business of\nnew drug invention. This has alarmed the FDA  (USA) and the European\nMedicines Agency to encourage novel cost-cutting approaches in drug\ndevelopment. One such tool is the microdosing human study undertaken\nbefore phase-1 trial, and is also called phase \u20180\u2019  study .\nMany candidate  drugs fail during clinical trials due to sub-op timal human\npharmacokinetics. Very low doses, generally about 1/100th of the estimated\nhuman dose, or a maximum of 100 \uf0b5g total dose of candidate drug, are\nadministered to healthy volunteers and pharmacokinetics is worked out\nusing highly sophisticated instrumentation, such as Accel erator mass\nspectrometry (AMS) with radiolabelled drug, or LC-T andem mass", "start_char_idx": 0, "end_char_idx": 1741, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "68ce89b4-b29b-4d46-8ace-a8f672f83059": {"__data__": {"id_": "68ce89b4-b29b-4d46-8ace-a8f672f83059", "embedding": null, "metadata": {"page_label": "231", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "d8d38062-f3eb-4835-ae36-dd0d7fd6d183", "node_type": "4", "metadata": {"page_label": "231", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "461be3d0337e19b58ac7892b46f579a08d7de229446220d916922713bdec4a2e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7b317736-f021-43db-8e9c-8d0a3bef5d29", "node_type": "1", "metadata": {"page_label": "230", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fa2a63f70dc9b787d4689b168a08b4f589d77f8f50d878c247d3ce4407fba345", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b8f129de-39c3-40c1-ae83-0a158653cfb0", "node_type": "1", "metadata": {}, "hash": "7beb82d692c2a116c132ad48317cb55a41075832bcb5208050270fe6e82bb5bc", "class_name": "RelatedNodeInfo"}}, "text": "spectrometry (LC-MS-MS) to measure ultra low drug levels. These\nsubpharmacological doses are not expected to produce any therapeutic or\ntoxic effects, but yield human pharmacokinetic information. These studies\nmay obviate the need for animal pharmacokinetic studies and can be\nundertaken before extensive animal toxicity tests. Thus, elaborate animal\nstudies and costly phase 1 human trials could be avoided for candidate drugs\nwhich would have later failed due to unsuitable human pharm acokinetics.\nMoreover , the pharmacokinetic 0 phase data could be useful in more precise\nselection of doses for phase 1 study .\nThe major objection against phase \u20180\u2019 study is that the microdose\npharmacokinetics may be quite different from that at pharmacological doses,\nsince body may handle such divergent doses in different ways. The phase 0\nstudies have not yet been technically fully developed or adequately\nevaluated. They  are neither established nor mandatory . However , they are\npromising, and most regulatory authorities are willing to allow and consider\nthem.\nPhase  II : Therapeutic  exploration  and  dose  ranging\nThis is conducted by physicians who are trained as clinical\ninvestigators, and involve 100\u2013500 patients selected\naccording to specific inclusion and exclusion criteria. The\nprimary aim is establishment of therapeutic efficacy, dose\nrange and ceiling effect in a controlled setting. Tolerability\nand pharmacokinetics are studied as extension of phase I.\nThe study is mostly controlled and randomized, and may\nbe blinded or open label. It is generally carried out at 2\u20134\ncentres. The candidate drug may get dropped at this stage if\nthe desired level of clinical efficacy is not obtained.", "start_char_idx": 0, "end_char_idx": 1701, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b8f129de-39c3-40c1-ae83-0a158653cfb0": {"__data__": {"id_": "b8f129de-39c3-40c1-ae83-0a158653cfb0", "embedding": null, "metadata": {"page_label": "232", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "4564a9dd-e429-4ed5-9825-0c0771978963", "node_type": "4", "metadata": {"page_label": "232", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "264a50fb7bdc6969947d53deac614047216e8a2bce12fe30ea7cc3f228b5e833", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "68ce89b4-b29b-4d46-8ace-a8f672f83059", "node_type": "1", "metadata": {"page_label": "231", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "461be3d0337e19b58ac7892b46f579a08d7de229446220d916922713bdec4a2e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f8b6fa31-eb40-4074-af9f-c19eb78e0c08", "node_type": "1", "metadata": {}, "hash": "890e9d2abfab1c17ad60227c78dc24207e919ca3df32601a6203a31b2843de32", "class_name": "RelatedNodeInfo"}}, "text": "Phase  III : Therapeutic  con\ufb01rmation / comparison\nGenerally these are randomized double blind comparative\ntrials conducted on a larger patient population (500\u20133000)\nby several physicians (usually specialists in treating the\ntarget disease) at many centres. The aim is to establish the\nvalue of the drug in relation to existing therapy. Safety and\ntolerability are assessed on a wider scale, while\npharmacokinetic studies may be conducted on some of the\nparticipants to enlarge the population base of\npharmacokinetic data. Indications are finalized and\nguidelines for therapeutic use are formulated. A \u2018new drug\napplication\u2019 (NDA) is submitted to the licencing authority\n(like FDA), who if convinced give marketing permission.\nRestricted marketing permission for use only in hospitals\nwith specific monitoring facilities, or only by specially\ntrained physicians may be granted in case of toxic drugs\nwhich are found useful in serious or otherwise incurable\ndiseases.\nPhase  IV : Postmarketing  surveillance / data  gathering\nstudies\nAfter the drug has been marketed for general use,\npracticing physicians are identified through whom data are\ncollected on a structured proforma about the efficacy,\nacceptability and adverse effects of the drug in the real", "start_char_idx": 0, "end_char_idx": 1254, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f8b6fa31-eb40-4074-af9f-c19eb78e0c08": {"__data__": {"id_": "f8b6fa31-eb40-4074-af9f-c19eb78e0c08", "embedding": null, "metadata": {"page_label": "233", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "bd99c20f-69e8-43d3-930d-accf25948f7b", "node_type": "4", "metadata": {"page_label": "233", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9720bb7bf7fc20d2cb389c1c7b41a14dbf28be301a29c4b47254f352f83e15fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b8f129de-39c3-40c1-ae83-0a158653cfb0", "node_type": "1", "metadata": {"page_label": "232", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "264a50fb7bdc6969947d53deac614047216e8a2bce12fe30ea7cc3f228b5e833", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1441fca2-ea62-4593-9448-a20ef29dbf38", "node_type": "1", "metadata": {}, "hash": "4623f6245939847a5639feb11498481ce3f3dc1e598cadc7ae77a03cb759b695", "class_name": "RelatedNodeInfo"}}, "text": "field situation (similar to prescription event monitoring).\nPatients treated in the normal course form the study\npopulation: numbers therefore are much larger.\nUncommon/idiosyncratic adverse effects, or those that\noccur only after long-term use and unsuspected drug\ninteractions are detected at this stage. Patterns of drug\nutilization and additional indications may emerge from the\nsurveillance data.\nFurther therapeutic trials involving special groups like\nchildren, elderly, pregnant/lactating women, patients with\nrenal/hepatic disease, etc. (which are generally excluded\nduring clinical trials) may be undertaken at this stage.\nModified release dosage forms, additional routes of\nadministration, fixed dose drug combinations, etc. may be\nexplored.\nAs such, most drugs continue their development even\nafter marketing.", "start_char_idx": 0, "end_char_idx": 821, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1441fca2-ea62-4593-9448-a20ef29dbf38": {"__data__": {"id_": "1441fca2-ea62-4593-9448-a20ef29dbf38", "embedding": null, "metadata": {"page_label": "234", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b982f1eb-bb73-4014-b42c-0d9ead91f208", "node_type": "4", "metadata": {"page_label": "234", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4e4bee43a4e71894f011b6dab0cb12a7671f6dba87ad4085e4d51fe5dee992a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f8b6fa31-eb40-4074-af9f-c19eb78e0c08", "node_type": "1", "metadata": {"page_label": "233", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "965facc7d0cece5b579b37b6bc1b9f069358fcade258e29745adeebb3845cc6a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9e90fd0d-24b2-4c49-8339-ee28ecd16ab4", "node_type": "1", "metadata": {}, "hash": "8ad8ac872496f4e46d05f7fc264ce9407ab68649a8bb290e1230a2fd0462b589", "class_name": "RelatedNodeInfo"}}, "text": "Adverse effect is \u2018any undesirable or unintended\nconsequence of drug administration\u2019. It is a broad term,\nincludes all kinds of noxious effect\u2014trivial, serious or\neven fatal.\nFor the purposes of detecting and quantifying only those\nadverse effects of a drug which are of some import and\noccur in ordinary therapeutic setting, the term adverse drug\nreaction (ADR) has been defined as \u2018any noxious change\nwhich is suspected to be due to a drug, occurs at doses\nnormally used in man, requires treatment or decrease in\ndose or indicates caution in the future use of the same\ndrug\u2019. This definition excludes trivial or expected side\neffects and poisonings or overdose.\nAnother  term  \u2018adverse drug event\u2019  (ADE ) has  been  used  to  mean\n\u2018any untoward  medical  occurrence  that  may  present  during  treatment\nwith a  medicine , but  which  does  not  necessarily  have  a  causal\nrelationship  with  the  treatme nt\u2019 . The  idea  is  to  record  all  adverse\nevents  \ufb01rst , and  look  for  causality  only  while  analyzing  pooled  data .\nAll drugs are capable of producing adverse effects, and\nwhenever a drug is given a risk is taken. The magnitude of\nrisk has to be considered along with the magnitude of", "start_char_idx": 0, "end_char_idx": 1207, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9e90fd0d-24b2-4c49-8339-ee28ecd16ab4": {"__data__": {"id_": "9e90fd0d-24b2-4c49-8339-ee28ecd16ab4", "embedding": null, "metadata": {"page_label": "235", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "4d56c719-303e-4690-b1dc-7d3d7f15121d", "node_type": "4", "metadata": {"page_label": "235", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "ad93ed0bbca5f7cafd33297db83bdd0347c66307c09e0f9264ec6c1d45143ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1441fca2-ea62-4593-9448-a20ef29dbf38", "node_type": "1", "metadata": {"page_label": "234", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4e4bee43a4e71894f011b6dab0cb12a7671f6dba87ad4085e4d51fe5dee992a8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b1cc1b11-6027-4e0c-989e-c030e463856a", "node_type": "1", "metadata": {}, "hash": "f247fd5c87797603a94a43c34030ce3c00fc550d764c4a25373f550b78a9c3b0", "class_name": "RelatedNodeInfo"}}, "text": "expected therapeutic benefit in deciding whether to use or\nnot to use a particular drug in a given patient, e.g. even risk\nof bone marrow depression may be justified in treating\ncancer, while mild drowsiness caused by an antihistaminic\nin treating common cold may be unacceptable.\nAdverse effects may develop promptly or only after\nprolonged medication or even after stoppage of the drug.\nAdverse effects are not rare; an incidence of 10\u201325% has\nbeen documented in different clinical settings. They are\nmore common with multiple drug therapy and in the\nelderly. Adverse effects have been classified in many ways.\nOne may divide them into:\nPredictable  ( Type  A  or  Augmented ) reactions\n(mechanism based adverse reactions) These are based\non the pharmacological properties of the drug, which\nmeans that they are augmented, but qualitatively normal\nresponse to the drug; include side effects, toxic effects and\nconsequences of drug withdrawal. They are more common,\ndose related and mostly preventable and reversible.\nUnpredictable  ( Type  B  or  Bizarre ) reactions  These are\nbased on peculiarities of the patient and not on drug\u2019s\nknown actions; include allergy and idiosyncrasy. They are\nless common, often non-dose related, generally more\nserious and require withdrawal of the drug. Some of these\nreactions can be predicted and prevented if their genetic", "start_char_idx": 0, "end_char_idx": 1361, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b1cc1b11-6027-4e0c-989e-c030e463856a": {"__data__": {"id_": "b1cc1b11-6027-4e0c-989e-c030e463856a", "embedding": null, "metadata": {"page_label": "236", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "64b1c8b3-ffbd-4c4d-addc-28037590e6b3", "node_type": "4", "metadata": {"page_label": "236", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fa929325d99cbc2cdd11c3f92b2111b055bd06ead08165447fc958091b2d8e39", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9e90fd0d-24b2-4c49-8339-ee28ecd16ab4", "node_type": "1", "metadata": {"page_label": "235", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "ad93ed0bbca5f7cafd33297db83bdd0347c66307c09e0f9264ec6c1d45143ace", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a28bd6c0-a7f4-47f4-a047-1807b23819d3", "node_type": "1", "metadata": {}, "hash": "67582321380a60033d362a5c04194ca5e13bb45156725fbf55260960667d9a64", "class_name": "RelatedNodeInfo"}}, "text": "basis is known and suitable test to characterize the\nindividual\u2019s phenotype is performed.\nSeverity  of  adverse  drug  reactions has been graded as:\nMinor: No therapy, antidote or prolongation of\nhospitalization is required.\nModerate: Requires change in drug therapy, specific\ntreatment or prolongs hospital stay by at least one day.\nSevere: Potentially life-threatening, causes permanent\ndamage or requires intensive medical treatment.\nLethal: Directly or indirectly contributes to death of the\npatient.\nPharmacovigilance\nPharmacovigilance has been defined by the WHO (2002)\nas the \u2018science and activities relating to the detection,\nassessment, understanding and prevention of adverse\neffects or any other drug related problems.\u2019 The\ninformation generated by pharmacovigilance is useful in\neducating doctors about ADRs and in the official regulation\nof drug use. Its main purpose is to reduce the risk of drug-\nrelated harm to the patient. It has an important role in the\nrational use of medicines, as it provides the basis for\nassessing safety of medicines.\nThe activities involved in pharmacovigilance are:", "start_char_idx": 0, "end_char_idx": 1109, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a28bd6c0-a7f4-47f4-a047-1807b23819d3": {"__data__": {"id_": "a28bd6c0-a7f4-47f4-a047-1807b23819d3", "embedding": null, "metadata": {"page_label": "237", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "0ef94bf5-5747-4298-a23a-72933e177f4c", "node_type": "4", "metadata": {"page_label": "237", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5c83466a743f76bd675e29f86686b2146245532cd67b9a3dd9a980896cc64d2c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b1cc1b11-6027-4e0c-989e-c030e463856a", "node_type": "1", "metadata": {"page_label": "236", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fa929325d99cbc2cdd11c3f92b2111b055bd06ead08165447fc958091b2d8e39", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bfcbb936-6fb9-4229-8728-d2673cc235c8", "node_type": "1", "metadata": {}, "hash": "90d97fe739bae7c735284a416d5b708afe07dc64c5bb5597e00f1475256d5bc2", "class_name": "RelatedNodeInfo"}}, "text": "a.Postmarketing surveillance and other methods of ADR\nmonitoring such as voluntary reporting by doctors (e.g.\nyellow card system of UK), prescription event\nmonitoring, computerized medical record linkage and\nother cohort/case control studies as well as anecdotal\ncase reports by doctors.\nVoluntary reporting depends on the initiative and\nwillingness of the health professionals. It is minimal in\nIndia, while even in the developed countries only ~10%\nADRs are reported voluntarily. Immediately occurring\nreactions and those that are dramatic are mostly\nreported. Though even rare reactions can be detected by\nthis method, it does not provide incidence of the\nreaction.\nb.Dissemination of ADR data through \u2018drug alerts\u2019,\n\u2018medical letters\u2019, advisories sent to doctors by\npharmaceuticals and regulatory agencies (such as FDA\nin USA, committee on safety of medicines in UK).\nc.Changes in the labelling of medicines indicating\nrestrictions in use or statuary warnings, precautions, or\neven withdrawal of the drug, by the regulatory decision\nmaking authority.\nPharmacovigilance  centres  have  been  set  up  in  most  countries .\nThe Uppsala  Monitoring  Centre  ( Sweden ) is  the  international\ncollaborating  centre . In  India , the  Central  Drugs  Standard  Control\nOrganization  ( CDSCO ) is  coordinating  the  pharmacovigilance\nprogramme , under  which  peripheral , regional  and  zonal  monitoring", "start_char_idx": 0, "end_char_idx": 1403, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "bfcbb936-6fb9-4229-8728-d2673cc235c8": {"__data__": {"id_": "bfcbb936-6fb9-4229-8728-d2673cc235c8", "embedding": null, "metadata": {"page_label": "238", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "869bebde-2aea-4092-a1a7-d4be83b672bc", "node_type": "4", "metadata": {"page_label": "238", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8f31bce105b3f337de35ef7700ca067c2286da4dea3e55a67d696a1ce58b3a4c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a28bd6c0-a7f4-47f4-a047-1807b23819d3", "node_type": "1", "metadata": {"page_label": "237", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "5c83466a743f76bd675e29f86686b2146245532cd67b9a3dd9a980896cc64d2c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5067b158-148c-46af-9065-f9d897c3d64b", "node_type": "1", "metadata": {}, "hash": "3a894fd2e49c9e5997a121192661bfc88fe8797414cbb09caf7a2f751494abd8", "class_name": "RelatedNodeInfo"}}, "text": "centres  have  been  set  up  along  with  a  National  Pharma covigilance\nadvisory  committee . The  pharmacovigilance  centres  collect ,\ncommunicate  and  disseminate  ADR  data  by  linking  with  hospitals  as\nwell as  practitioners  and  are  also  expected  to  provide  expertise  for\nassessing  causality  and  severity  of  ADRs  by  using  standard\nalgorithms  and  rating  scales  like  the  \u2018Naranjo  algorithm\u2019  ( causalilty\nassessment ) and  modi\ufb01ed  Hartwig  scale  ( severity  grading ).\nCausality  assessment\nWhen  a  patient  undergoing  drug  therapy  experiences  an  adverse\nevent , it  may  be  due  to  the  drug , or  the  disease  or  some  other  causes .\nMost  of  the  time , a  clear-cu t  \u2018yes / no\u2019  cause  and  effect  relationship\nbetween  a  drug  and  the  adverse  event  cannot  be  pronounced .\nCausality  is  assessed  on  the  basis  of :\n\u2022Temporal relationship: How the time-sequence of the event is related to\ndrug administration.\n\u2022Previous knowledge: Whether the drug is known to produce the event in\nearlier recipients with a certain degree of consistency .\n\u2022Dechallenge: Whether the event subsided on stopping the drug.\n\u2022Rechallenge: Whether the event reappeared when the drug was\nadministered again after a gap during which the event had subsided.\nMany times rechallenge is unethical/dangerous, and is not done.\nAssessed on the basis of the above criteria, causality has been graded as:\n1.Definite: Causality is proven.\n2.Probable:  Though not proven, drug is the likely cause of the event.\n3.Possible: Drug as well as other causes could be responsible for the event.\n4.Doubtful: Drug unlikely to be the cause, but cannot be ruled out.\nPrevention  of  adverse  effects  to  drugsAdverse drug\neffects can be minimized but not altogether eliminated by\nobserving the following practices:", "start_char_idx": 0, "end_char_idx": 1831, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5067b158-148c-46af-9065-f9d897c3d64b": {"__data__": {"id_": "5067b158-148c-46af-9065-f9d897c3d64b", "embedding": null, "metadata": {"page_label": "239", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "e56251b3-3291-4ffe-af1f-005219432fc4", "node_type": "4", "metadata": {"page_label": "239", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fdd265400d53b1b249206029a5a06df1227107b0dccb7984ce6b6137b7a4bbe6", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bfcbb936-6fb9-4229-8728-d2673cc235c8", "node_type": "1", "metadata": {"page_label": "238", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8f31bce105b3f337de35ef7700ca067c2286da4dea3e55a67d696a1ce58b3a4c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "56a06701-37d5-46ad-b161-8ff168b102c3", "node_type": "1", "metadata": {}, "hash": "964c501bdab2c6236cbf04378e5f671fcc4dc065cacd01bb90765503d25f11f7", "class_name": "RelatedNodeInfo"}}, "text": "1.Avoid all inappropriate use of drugs in the context of\npatient\u2019s clinical condition.\n2.Use appropriate dose, route and frequency of drug\nadministration based on patient\u2019s specific variables.\n3.Elicit and take into consideration previous history of\ndrug reactions.\n4.Elicit history of allergic diseases and exercise caution\n(drug allergy is more common in patients with allergic\ndiseases).\n5.Rule out possibility of drug interactions when more than\none drug is prescribed.\n6.Adopt correct drug administration technique (e.g.\nintravenous injection of vancomycin must be slow).\n7.Carry out appropriate laboratory monitoring (e.g.\nprothrombin time with warfarin, serum drug levels with\nlithium).\nAdverse drug effects may be categorized into:\n1. Side effects\nThese are unwanted but often unavoidable\npharmacodynamic effects that occur at therapeutic doses.\nGenerally, they are not serious but may occasionally be\nhazardous, e.g. postural hypotension caused by prazosin as\na side effect may result in fall and fracture neck femur in\nan elderly patient. Side effects can be predicted from the", "start_char_idx": 0, "end_char_idx": 1087, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "56a06701-37d5-46ad-b161-8ff168b102c3": {"__data__": {"id_": "56a06701-37d5-46ad-b161-8ff168b102c3", "embedding": null, "metadata": {"page_label": "240", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "c8a6723f-d212-419e-b817-541a220052f2", "node_type": "4", "metadata": {"page_label": "240", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8405848e01a08079a117934080a0bfc7a8602277d09c5c9b582fd1f8ec1bab65", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5067b158-148c-46af-9065-f9d897c3d64b", "node_type": "1", "metadata": {"page_label": "239", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "fdd265400d53b1b249206029a5a06df1227107b0dccb7984ce6b6137b7a4bbe6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "41b5d28a-be93-41da-9a5c-d8f59a9f5ae9", "node_type": "1", "metadata": {}, "hash": "9d80b55117e132aefb13b90d88258ecbd24b742cdf533039dd029cbce84eb399", "class_name": "RelatedNodeInfo"}}, "text": "pharmacological profile of a drug and are known to  occur\nin a given percentage of drug recipients. Reduction in dose,\nusually ameliorates the symptoms.\nA side effect may be based on the same action as the\ntherapeutic effect, e.g. atropine is used in preanaesthetic\nmedication for its antisecretory action. The same action\nproduces dryness of mouth as a side effect. Glyceryl\ntrinitrate relieves angina pectoris by dilating peripheral\nvasculature which is also responsible for postural\nhypotension and throbbing headache.\nThe side effect may also be based on a different facet of\naction, e.g. promethazine produces sedation which is\nunrelated to its antiallergic action; estrogens cause nausea\nwhich is unrelated to their antiovulatory action.\nAn effect may be therapeutic in one context but side\neffect in another context, e.g. codeine used for cough\nproduces constipation as a side effect, but the latter is its\ntherapeutic effect in traveller\u2019s diarrhoea; depression of A-\nV conduction is the desired effect of digoxin in atrial\nfibrillation, but the same may be undesirable when it is\nused for CHF.\nMany drugs have been developed from observation of\nside effects, e.g. early sulfonamides used as antibacterial\nwere found to produce hypoglycaemia and acidosis as side\neffects which directed research resulting in the", "start_char_idx": 0, "end_char_idx": 1319, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "41b5d28a-be93-41da-9a5c-d8f59a9f5ae9": {"__data__": {"id_": "41b5d28a-be93-41da-9a5c-d8f59a9f5ae9", "embedding": null, "metadata": {"page_label": "241", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "e87140bc-4f35-47f1-88a9-8aa52fceb6c4", "node_type": "4", "metadata": {"page_label": "241", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "ca27a87801faed28c873018b59a9e42f5cad0dfad933a67a6f5f592e66d9b689", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "56a06701-37d5-46ad-b161-8ff168b102c3", "node_type": "1", "metadata": {"page_label": "240", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8405848e01a08079a117934080a0bfc7a8602277d09c5c9b582fd1f8ec1bab65", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a33cda8a-fbc7-4f38-ac42-6a3487588add", "node_type": "1", "metadata": {}, "hash": "d7a27b1fa00d674d5cdd6a06949765daf7cabdceb99124ec03d4294958f25adb", "class_name": "RelatedNodeInfo"}}, "text": "development of hypoglycaemic sulfonylureas and the\ncarbonic anhydrase inhibitor\u2014acetazolamide.\n2. Secondary effects\nThese are indirect consequences of a primary action of the\ndrug, e.g. suppression of bacterial flora by tetracyclines\npaves the way for superinfections; corticosteroids weaken\nhost defence mechanisms so that latent tuberculosis gets\nactivated.\n3. Toxic effects\nThese are the result of excessive pharmacological action of\nthe drug due to overdosage or prolonged use. Overdosage\nmay be absolute (accidental, homicidal, suicidal) or relative\n(i.e. usual dose of gentamicin in presence of renal failure).\nThe manifestations are predictable and dose related. They\nresult from functional alteration (high dose of atropine\ncausing delirium) or drug induced tissue damage (hepatic\nnecrosis from paracetamol overdosage). The CNS, CVS,\nkidney, liver, lung, skin and blood forming organs are most\ncommonly involved in drug toxicity.\nToxicity may result from extension of the therapeutic\neffect itself, e.g. coma by barbiturates, complete A-V block\nby digoxin, bleeding due to heparin.\nAnother action of the drug can also be responsible for\ntoxicity, e.g.\u2014", "start_char_idx": 0, "end_char_idx": 1160, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a33cda8a-fbc7-4f38-ac42-6a3487588add": {"__data__": {"id_": "a33cda8a-fbc7-4f38-ac42-6a3487588add", "embedding": null, "metadata": {"page_label": "242", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "efe228b3-a57b-4c88-bda8-cfedc4b6c827", "node_type": "4", "metadata": {"page_label": "242", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a4fe82de102b668a3e1172a4dda5de5669dc112c9db3d5e04b2278e646568848", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "41b5d28a-be93-41da-9a5c-d8f59a9f5ae9", "node_type": "1", "metadata": {"page_label": "241", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "ca27a87801faed28c873018b59a9e42f5cad0dfad933a67a6f5f592e66d9b689", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "880771ee-5196-467b-8816-80d435831e61", "node_type": "1", "metadata": {}, "hash": "d8092b83ff1801b1e4c62652d10071030769fc20729b8c63a28c7cc8aaa4f78a", "class_name": "RelatedNodeInfo"}}, "text": "\u2022Morphine (analgesic) causes respiratory failure in\noverdosage.\n\u2022Imipramine (antidepressant) overdose causes cardiac\narrhythmia.\n\u2022Streptomycin (antitubercular) causes vestibular damage\non prolonged use.\nPoisoning In a broad sense, poisoning implies harmful\neffects of a chemical on a biological system. It may result\nfrom large doses of drugs because \u2018it is the dose which\ndistinguishes a drug from a poison\u2019. Poison is a \u2018substance\nwhich endangers life by severely affecting one or more\nvital functions\u2019. Poisons derived from biologic sources are\nalso referred to as \u2018toxins\u2019. Not only drugs, but other\nhousehold, environmental and industrial chemicals,\ninsecticides, etc. are frequently involved in poisonings.\nSpecific antidotes such as receptor antagonists, chelating\nagents or specific antibodies are available only for few\npoisons. General supportive and symptomatic treatment, as\nthe need arises, is all that can be done for others, and this is\nalso important for poisons which have a selective\nantagonist.\nThe general detoxification and supportive measures are:\n1. Resuscitation  and  maintenance  of  vital  functions", "start_char_idx": 0, "end_char_idx": 1126, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "880771ee-5196-467b-8816-80d435831e61": {"__data__": {"id_": "880771ee-5196-467b-8816-80d435831e61", "embedding": null, "metadata": {"page_label": "243", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "45ec8dfb-9ae1-4a87-9dfb-0fdabda8c13c", "node_type": "4", "metadata": {"page_label": "243", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "cceeb2c7acf41e0280b1c744b2ad07aa791e8e269ba741f7d6524a11a46667af", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a33cda8a-fbc7-4f38-ac42-6a3487588add", "node_type": "1", "metadata": {"page_label": "242", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a4fe82de102b668a3e1172a4dda5de5669dc112c9db3d5e04b2278e646568848", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0bbd60e0-004c-4eb7-ac3f-8de695a557b5", "node_type": "1", "metadata": {}, "hash": "cfbf11a0eacf23256f3566c30bd39c34176b5dd900d2f4b82eb617bedf10c28d", "class_name": "RelatedNodeInfo"}}, "text": "a.Ensure patent airway, adequate ventilation, give\nartificial respiration/100% oxygen inhalation as needed.\nThis is important because severe poisoning often makes\nthe patient comatose; protective airway reflexes and\nrespiratory drive are lost.\nb.Maintain blood pressure and heart beat by fluid and\ncrystalloid infusion, pressor agents, cardiac stimulants,\npacing, defibrillation, etc, as needed. Hypotension, often\nprolonged, is common in severe poisonings.\nc.Prevent and manage seizures (with i.v. lorazepam).\nd.Maintain body temperature.\ne.Maintain blood sugar level by dextrose infusion,\nespecially in patients with altered sensorium.\n2. Termination  of  exposure  ( decontamination )\nDecontamination procedures should be started concurrently\nwith the above supportive measures. It is done by removing\nthe patient to fresh air (for inhaled poisons), removing\ncontaminated clothing and washing the skin and eyes (for\npoisons entering from the surface), induction of emesis\nwith syrup ipecac or gastric lavage (for ingested poisons).\nEmesis should not be attempted in comatose or\nhaemodynamically unstable patient, as well as for kerosene\npoisoning due to risk of aspiration into lungs. These\nprocedures are also contraindicated in corrosive and CNS\nstimulant poisoning. Emesis/gastric lavage is not", "start_char_idx": 0, "end_char_idx": 1300, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0bbd60e0-004c-4eb7-ac3f-8de695a557b5": {"__data__": {"id_": "0bbd60e0-004c-4eb7-ac3f-8de695a557b5", "embedding": null, "metadata": {"page_label": "244", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "1f29fbc4-24eb-4f26-88e9-28bdb11415e5", "node_type": "4", "metadata": {"page_label": "244", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4fec3f5f37563cd42d846ea9cc41a191a600089533a3ce348fbc63b80d927096", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "880771ee-5196-467b-8816-80d435831e61", "node_type": "1", "metadata": {"page_label": "243", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "cceeb2c7acf41e0280b1c744b2ad07aa791e8e269ba741f7d6524a11a46667af", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "edf0e5b9-ffdb-4f7b-936d-b034dd8535d6", "node_type": "1", "metadata": {}, "hash": "e8ca9ae76a4ba4b3f7d4266420747a5a5a7a346d27dd1673bef927c6928be501", "class_name": "RelatedNodeInfo"}}, "text": "recommended if the patient presents > 2 hours after\ningesting the poison;  if the poison/its dose ingested are\nknown to be non-life-threatening, or if the patient has\nvomited after consuming the poison. Thus, induction of\nvomiting or gastric lavage is useful only in very few cases\nof poisoning.\n3. Prevention  of  absorption  of  ingested  poisons  A\nsuspension of 20\u201340 g (or 1g/ kg body weight) of activated\ncharcoal, which has large surface area and can adsorb many\nchemicals, should be administered in 200 ml of water.\nHowever, strong acids and alkalies, metallic salts, iodine,\ncyanide, caustics, alcohol, hydrocarbons and other organic\nsolvents are not adsorbed by charcoal. Charcoal should not\nbe administered if there is paralytic ileus or intestinal\nobstruction or when the patient reports > 2 hours after\ningesting the poison.\n4. Hastening  elimination of the poison by inducing\ndiuresis (furosemide, mannitol) or altering urinary pH\n(alkalinization for acidic drugs, e.g. barbiturates, aspirin).\nHowever, excretion of many poisons, especially those\nwhich are eliminated mainly by hepatic metabolism, is not\nenhanced by forced diuresis and risk of fluid\noverload/electrolyte imbalance outweighs the benefit. This\nprocedure is generally not employed now. Haemodialysis is\nmore efficacious in hastening elimination of many drugs,", "start_char_idx": 0, "end_char_idx": 1338, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "edf0e5b9-ffdb-4f7b-936d-b034dd8535d6": {"__data__": {"id_": "edf0e5b9-ffdb-4f7b-936d-b034dd8535d6", "embedding": null, "metadata": {"page_label": "245", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "10a6be7f-cb03-4852-824c-03c8bade70e2", "node_type": "4", "metadata": {"page_label": "245", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2e1ade715b6ac1385736f5c7cce7d7ecad41b7c1eb70b3d62b48fde1a54a060e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0bbd60e0-004c-4eb7-ac3f-8de695a557b5", "node_type": "1", "metadata": {"page_label": "244", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "4fec3f5f37563cd42d846ea9cc41a191a600089533a3ce348fbc63b80d927096", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8838655a-63a4-4dc2-8c1f-522bde4f0740", "node_type": "1", "metadata": {}, "hash": "8787f8051ac25e9f8d3e14c0df366c006929668ab1ef3f2c397e14e02c35e9a8", "class_name": "RelatedNodeInfo"}}, "text": "including phenobarbitone, carbamazepine, valproate,\nlithium, salicylate, theophylline, etc.\n4. Intolerance\nIt is the appearance of characteristic toxic effects of a drug\nin an individual at therapeutic doses. It is the converse of\ntolerance and indicates a low threshold of the individual to\nthe action of a drug. Such subjects are individuals who fall\non the extreme left side of the Gaussian frequency\ndistribution curve for sensitivity to the drug. Examples are:\n\u2022A single dose of triflupromazine induces muscular\ndystonias in some individuals, specially children.\n\u2022Only few doses of carbamazepine may cause ataxia in\nsome people.\n\u2022One tablet of chloroquine may cause vomiting and\nabdominal pain in an occasional patient.\n5. Idiosyncrasy\nIdiosyncrasy refers to genetically determined abnormal\nreactivity to a chemical. The drug interacts with some\nunique feature of the individual, not found in majority of\nsubjects, and produces the uncharacteristic reaction. As\nsuch, the type of reaction is restricted to individuals with a\nparticular genotype (see p. 76). In addition, certain bizarre\ndrug effects due to peculiarities of an individual (for which", "start_char_idx": 0, "end_char_idx": 1153, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8838655a-63a4-4dc2-8c1f-522bde4f0740": {"__data__": {"id_": "8838655a-63a4-4dc2-8c1f-522bde4f0740", "embedding": null, "metadata": {"page_label": "246", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b4b4f95b-1bc0-435f-92e6-a6e40f047db9", "node_type": "4", "metadata": {"page_label": "246", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "aa82641905b4d64b21501f84f1fb757ae15eb8f1ce760f9c1c6f627b155c919e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "edf0e5b9-ffdb-4f7b-936d-b034dd8535d6", "node_type": "1", "metadata": {"page_label": "245", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2e1ade715b6ac1385736f5c7cce7d7ecad41b7c1eb70b3d62b48fde1a54a060e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "28feba2c-891d-47cb-be2b-a86a3aa49e82", "node_type": "1", "metadata": {}, "hash": "9640522187dfde82c3ea9dfa5b58963a5c02c7b4c4bc1e3420db6ad129816c9d", "class_name": "RelatedNodeInfo"}}, "text": "no definite genotype has been described) are included\namong idiosyncratic reactions, e.g.:\n\u2022Barbiturates cause excitement and mental confusion in\nsome individuals.\n\u2022Quinine/quinidine cause cramps, diarrhoea, purpura,\nasthma, angioedema of face and hypotension in some\npatients.\n\u2022Chloramphenicol produces nondose-related serious\naplastic anaemia in rare individuals.\n6. Drug allergy (hypersensitivity)\nIt is an immunologically mediated reaction producing\nstereotype symptoms which are unrelated to the\npharmacodynamic profile of the drug. The symptoms may\nappear even with much smaller doses and have a different\ntime course of onset and duration. This is also called drug\nhypersensitivity; but does not refer to increased response\nwhich is called supersensitivity. The target organs primarily\naffected in drug allergy are skin, airways, blood vessels,\nblood cells  and gastrointestinal tract.\nAllergic reactions occur only in a small proportion of\nthe population exposed to the drug and cannot be produced\nin other individuals at any dose. Prior sensitization is\nneeded and a latent period of at least 1\u20132 weeks is required\nafter the first exposure. However, the sensitizing exposure\nmay go unnoticed or may be environmental. The drug or its", "start_char_idx": 0, "end_char_idx": 1241, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "28feba2c-891d-47cb-be2b-a86a3aa49e82": {"__data__": {"id_": "28feba2c-891d-47cb-be2b-a86a3aa49e82", "embedding": null, "metadata": {"page_label": "247", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "a6f7d8b1-e438-4501-b9c1-657ce418aaa3", "node_type": "4", "metadata": {"page_label": "247", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "47f79bb7c4b93abb8f712663e81eabc81f238e841a79f960f61fc718eabeaa68", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8838655a-63a4-4dc2-8c1f-522bde4f0740", "node_type": "1", "metadata": {"page_label": "246", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "aa82641905b4d64b21501f84f1fb757ae15eb8f1ce760f9c1c6f627b155c919e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0d4967bb-8653-4066-8855-2d396f9b6cd2", "node_type": "1", "metadata": {}, "hash": "622a08470201049c0d254682fd1b6262c78032e32e0de9d0670b7be9903a1cf9", "class_name": "RelatedNodeInfo"}}, "text": "metabolite acts as an antigen (AG), or more commonly a\nhapten (incomplete antigen: drugs have small molecules\nwhich become antigenic only after binding with an\nendogenous protein) and induce production of antibody\n(AB)/sensitized lymphocytes. Presence of AB to a drug is\nnot necessarily followed by allergy to it. Chemically\nrelated drugs often show cross sensitivity. A particular drug\ncan produce different types of allergic reactions in different\nindividuals, while widely different drugs can produce\nsimilar reaction. The course of drug allergy is variable; an\nindividual previously sensitive to a drug may subsequently\ntolerate it without a reaction and vice versa.\nCardinal features of drug allergy\n\u2022Manifestations unrelated to the pharmacodynamic actions\nof the drug.\n\u2022Manifestations similar to food/protein allergy , allergic\ndiseases.\n\u2022Severity of reaction poorly correlated with dose of the\ndrug; even small dose may trigger severe reaction.\n\u2022Occur only in few recipients, cannot be produced in other\nindividuals.\n\u2022Prior sensitization (known/unknown) is needed.\n\u2022Positive dechallenge (on withdrawal of drug) and\nrechallenge (even with small dose).\nMechanism and types of allergic reactions", "start_char_idx": 0, "end_char_idx": 1199, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0d4967bb-8653-4066-8855-2d396f9b6cd2": {"__data__": {"id_": "0d4967bb-8653-4066-8855-2d396f9b6cd2", "embedding": null, "metadata": {"page_label": "248", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "cf95c651-0940-4453-9031-d404c5bd9598", "node_type": "4", "metadata": {"page_label": "248", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f1b8b6d00e559b3398101353c47a68e79154f36d8076906f10665cf7ce76cccc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "28feba2c-891d-47cb-be2b-a86a3aa49e82", "node_type": "1", "metadata": {"page_label": "247", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "47f79bb7c4b93abb8f712663e81eabc81f238e841a79f960f61fc718eabeaa68", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "06c5d04a-0b1b-40e3-a870-80cad3495820", "node_type": "1", "metadata": {}, "hash": "bec59128d441ce01f6bfaf2adf5a6d6a098b986be5e5054aab2240d5a1141584", "class_name": "RelatedNodeInfo"}}, "text": "A.Humoral\nType-I  ( anaphylactic ) reactions Reag inic antibodies\n(IgE) are produced which get fixed to the mast cells and\nbasophils. On exposure to the drug, AG: AB reaction takes\nplace on the mast cell surface (see Fig. 11.2) releasing\nmediators like histamine, 5-HT, leukotrienes (especially\nLT-C4 and D4), prostaglandins, PAF, etc. resulting in\nurticaria, itching, angioedema, bronchospasm, rhinitis or\nanaphylactic shock. Anaphylaxis is usually heralded by\nparesthesia, flushing, swelling of lips, generalized itching,\nwheezing, palpitation followed by syncope. The\nmanifestations occur quickly (within minutes to few hours)\nafter challenge and are called immediate hypersensitivity.\nAntihistaminic drugs are beneficial in some of these\nreactions.\nType-II  ( cytolytic ) reactions Drug + component of a\nspecific tissue cell act as AG. The resulting antibodies\n(IgG, IgM) bind to the target cells; on reexposure AG: AB\nreaction takes place on the surface of these cells,\ncomplement is activated and cytolysis occurs resulting in\none or more of thrombocytopenia, agranulocytosis, aplastic\nanaemia, haemolysis, organ damage (liver, kidney, muscle),\nsystemic lupus erythematosus.", "start_char_idx": 0, "end_char_idx": 1180, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "06c5d04a-0b1b-40e3-a870-80cad3495820": {"__data__": {"id_": "06c5d04a-0b1b-40e3-a870-80cad3495820", "embedding": null, "metadata": {"page_label": "249", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "38c22982-47f7-4f18-8756-a7dce0ba4c52", "node_type": "4", "metadata": {"page_label": "249", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "67b155cc75f40050a9a77313dc4b076b61b44dd4e74f45e1a33c48485d104da6", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0d4967bb-8653-4066-8855-2d396f9b6cd2", "node_type": "1", "metadata": {"page_label": "248", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "f1b8b6d00e559b3398101353c47a68e79154f36d8076906f10665cf7ce76cccc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a8a43b54-5850-4afa-8b76-436577015868", "node_type": "1", "metadata": {}, "hash": "ccaab3b645972f5de0005ff5b34ef950539db55503f61e6083e2c8759f322bce", "class_name": "RelatedNodeInfo"}}, "text": "\uf054 \uf079 \uf070 \uf065 \uf02d \uf049 \uf049 \uf049 \uf020(retarded , Arthus ) reactions These are\nmediated by circulating antibodies (predominantly IgG,\nmopping AB). AG: AB complexes bind complement and\nprecipitate on vascular endothelium and basement\nmembrane in tissues, release chemotactic mediators and\nlytic enzymes giving rise to a destructive inflammatory\nresponse. Manifestations are rashes, serum sickness (fever,\narthralgia, lymphadenopathy), polyarteritis nodosa,\nStevens-Johnson syndrome (erythema multiforme, arthritis,\nnephritis, myocarditis, mental symptoms). The reaction\ndevelops in 3\u20134 days after exposure, and usually subsides\nin 1\u20132 weeks.\nB. Cell  mediated\nType-IV  ( delayed  hypersensitivity ) reactions     These\nare mediated through production of sensitized T-\nlymphocytes carrying receptors for the AG. On contact\nwith the AG these T cells produce lymphokines which\nattract granulocytes and generate an inflammatory\nresponse, causing contact dermatitis, certain types of\nrashes, fever, photosensitization. The reaction generally\ntakes 2\u20133 days to develop.\nTreatment of drug allergy\nThe offending drug must be immediately stopped. Most\nmild reactions (like skin rashes) subside by themselves and", "start_char_idx": 0, "end_char_idx": 1180, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a8a43b54-5850-4afa-8b76-436577015868": {"__data__": {"id_": "a8a43b54-5850-4afa-8b76-436577015868", "embedding": null, "metadata": {"page_label": "250", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "26b8c868-564d-4499-8164-7a8fd9197c72", "node_type": "4", "metadata": {"page_label": "250", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "48f23045db86f734d12066ee841ec8eabaf5f6c4bccf2b1c0ebb9484487638b6", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "06c5d04a-0b1b-40e3-a870-80cad3495820", "node_type": "1", "metadata": {"page_label": "249", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "67b155cc75f40050a9a77313dc4b076b61b44dd4e74f45e1a33c48485d104da6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "addc2b18-f78a-4fc2-8f81-f83921e99b14", "node_type": "1", "metadata": {}, "hash": "d943c30e412fa530464b863174c1db6b86e5562bc4fb162f26cbb8fb79ac6cf4", "class_name": "RelatedNodeInfo"}}, "text": "donot require specific treatment. Antihistamines (H1) are\nbeneficial in some type I reactions (itching, urticaria,\nrhinitis, swelling of lips, etc.) and some skin rashes (see p.\n182). In case of anaphylactic shock or angioedema of\nlarynx the resuscitation council of UK has recommended\nthe following measures:\n\u2022Put the patient in reclining position, administer oxygen\nat high flow rate and perform cardiopulmonary\nresuscitation if required.\n\u2022Inject adrenaline 0.5 mg (0.5 ml of 1 in 1000 solution\nfor adult, 0.3 ml for child 6-12 years and 0.15 ml for\nchild upto 6 years) i.m.; repeat every 5\u201310 min in case\npatient does not improve or improvement is transient.\nThis is the only life saving measure. Adrenaline should\nnot be injected i.v. (can itself be fatal) unless shock is\nimmediately life threatening. If adrenaline is to be\ninjected i.v., it should be diluted to 1:10,000 or\n1:100,000 and infused slowly with constant monitoring.\n\u2022Administer a H1 antihistaminic (pheniramine 20\u201340 mg\nor chlorpheniramine 10\u201320 mg) i.m./slow i.v. It may\nhave adjuvant value.\n\u2022Intravenous glucocorticoid (hydrocortisone sod.\nsuccinate 200 mg) should be added in severe/recurrent\ncases. It acts slowly, but is specially valuable for\nprolonged reactions and in asthmatics. It may be\nfollowed by oral prednisolone for 3 days.", "start_char_idx": 0, "end_char_idx": 1309, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "addc2b18-f78a-4fc2-8f81-f83921e99b14": {"__data__": {"id_": "addc2b18-f78a-4fc2-8f81-f83921e99b14", "embedding": null, "metadata": {"page_label": "251", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "8b0e86ab-d39a-4503-982f-90873d989124", "node_type": "4", "metadata": {"page_label": "251", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "c76ec2d585bb5423a8cff56d8482322b59d5b3de07966c596ddd51d52ef557de", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a8a43b54-5850-4afa-8b76-436577015868", "node_type": "1", "metadata": {"page_label": "250", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "48f23045db86f734d12066ee841ec8eabaf5f6c4bccf2b1c0ebb9484487638b6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ad528551-8a0b-4482-889b-6ff37c204d1e", "node_type": "1", "metadata": {}, "hash": "46a806afe357d8ec7c0a035a1cb55f38ad2ed6604cd91a7652158bc9ac76cc83", "class_name": "RelatedNodeInfo"}}, "text": "Drugs frequently causing allergic reactions\nPenicillins Aspirin\nCephalosporins Indomethacin\nSulfonamides Carbamazepine\nTetracyclines Allopurinol\nQuinolones ACE inhibitors\nMetronidazole Methyldopa\nAbacavir Hydralazine\nAntitubercular drugs Local anaesthetics\nPhenothiazines\nAdrenaline followed by a short course of\nglucocorticoids is indicated for bronchospasm attending\ndrug hypersensitivity. Glucocorticoids are the only drug\neffective in type II, type III and type IV reactions.\nSkin tests (intradermal, patch) or intranasal tests may\nforewarn in case of Type I hypersensitivity, but not in case\nof other types. However, these tests are not entirely reliable\n\u2014false positive and false negative results are not rare.\n7. Photosensitivity\nIt is a cutaneous reaction resulting from drug induced\nsensitization of the skin to UV radiation. The reactions are\nof two types:", "start_char_idx": 0, "end_char_idx": 866, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ad528551-8a0b-4482-889b-6ff37c204d1e": {"__data__": {"id_": "ad528551-8a0b-4482-889b-6ff37c204d1e", "embedding": null, "metadata": {"page_label": "252", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "774b0d83-dda4-4600-85b2-e2b74373fda7", "node_type": "4", "metadata": {"page_label": "252", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8e4b4a318de3b0b40ae9f2bc469d1daddaacedf230e854a958be1fe121f02fdd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "addc2b18-f78a-4fc2-8f81-f83921e99b14", "node_type": "1", "metadata": {"page_label": "251", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "c76ec2d585bb5423a8cff56d8482322b59d5b3de07966c596ddd51d52ef557de", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "501d9510-273f-408e-a2a9-f81f3a2a8614", "node_type": "1", "metadata": {}, "hash": "9072dd594d7f9a3cabc543bc62d841d7b43a30528f1fd81c064dac250a3080d9", "class_name": "RelatedNodeInfo"}}, "text": "(a) Phototoxic Drug or its metabolite accumulates in the\nskin, absorbs light and undergoes a photochemical reaction\nfollowed by a photobiological reaction resulting in local\ntissue damage (sunburn-like), i.e. erythema, edema,\nvesicular eruption, blistering which have fast onset and\nshorter duration after exposure ends. This is followed by\nhyperpigmentation and desquamation. The lesions may be\nmore severe with larger doses of the drug. The shorter\nwave lengths (290\u2013320 nm, UV-B) are responsible. Drugs\ninvolved in acute phototoxic reactions are tetracyclines\n(especially demeclocycline) and tar products. Drugs\ncausing chronic and low grade sensitization are nalidixic\nacid, fluoroquinolones, dapsone, sulfonamides,\nphenothiazines, thiazides, amiodarone. This type of\nreaction is more common than photoallergic reaction.\n(b) Photoallergic\u00a0 Drug or its metabolite induces a cell\nmediated immune response which on exposure to light of\nlonger wave lengths (320\u2013400 nm, UV-A) produces a\npapular or eczematous contact dermatitis like picture that\nmay persist long after exposure. Occasionally, antibodies\nmay also mediate photoallergy and the reaction takes the\nform of immediate flare, itching and wheal on exposure to\nsun. Even small doses may trigger the reaction and lesions\nmay extend beyond the exposed area. Drugs involved are", "start_char_idx": 0, "end_char_idx": 1332, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "501d9510-273f-408e-a2a9-f81f3a2a8614": {"__data__": {"id_": "501d9510-273f-408e-a2a9-f81f3a2a8614", "embedding": null, "metadata": {"page_label": "253", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "2170c093-23f7-496e-905c-fb5c4467743b", "node_type": "4", "metadata": {"page_label": "253", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9c7c427b3b54b679ef837c5019e566a227359f48d5e905e85df68c76620229de", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ad528551-8a0b-4482-889b-6ff37c204d1e", "node_type": "1", "metadata": {"page_label": "252", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "8e4b4a318de3b0b40ae9f2bc469d1daddaacedf230e854a958be1fe121f02fdd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e063b7fe-b88f-405b-a1dd-30f131e979b5", "node_type": "1", "metadata": {}, "hash": "1e380e87b4d5625852eb9b4bacdff407d2a52eb542583ef3bafb841b95115c86", "class_name": "RelatedNodeInfo"}}, "text": "sulfonamides, sulfonylureas, griseofulvin, chloroquine,\nchlorpromazine, carbamazepine.\nPhotosensitivity reactions can be prevented or\nminimized by avoidance of exposure to sun and effective\nuse of topical sun screens (SPF 15\u201360; see Ch. 66). Local\ntreatment of acute sun burn and blistering consists of\nsoothing lotions (e.g. calamine lotion), wet dressings and\nmild topical steroids. Strong topical steroids are needed for\nphotoallergy; severe cases may require systemic steroid\ntherapy. \n8. Drug dependence and drug addiction\nDrugs capable of altering mood and feelings are liable to\nrepetitive use to derive euphoria, recreation, withdrawal\nfrom reality, social adjustment, etc. Some subjects who\ntake the drug repeatedly for personal gratification, progress\nin indulgence with the drug and start according higher\npriority to taking the drug than to other basic needs, often\nin the face of known risks to health. Many of these drugs\nalso induce adaptive physiological changes which result in\nescalation of the dose needed to produce the same effect.\nThus, \u2018tolerance\u2019 develops and physiological equilibrium is\ndisturbed when the drug is not present. Confusing\nterminology, viz\u2018dependence\u2019, \u2018physical dependence\u2019,\n\u2018psychological dependence\u2019, \u2018addiction\u2019, \u2018habituation\u2019,\n\u2018drug abuse\u2019 has been used over the past to describe the", "start_char_idx": 0, "end_char_idx": 1328, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e063b7fe-b88f-405b-a1dd-30f131e979b5": {"__data__": {"id_": "e063b7fe-b88f-405b-a1dd-30f131e979b5", "embedding": null, "metadata": {"page_label": "254", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "225b05f5-8121-42e9-ab24-7704615575cb", "node_type": "4", "metadata": {"page_label": "254", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a192d3f1c6dc5e23ccedd84fd98f55940cdb475dfd4f6ec8bcec6afab4e5552e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "501d9510-273f-408e-a2a9-f81f3a2a8614", "node_type": "1", "metadata": {"page_label": "253", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "9c7c427b3b54b679ef837c5019e566a227359f48d5e905e85df68c76620229de", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1c393afd-c939-4f78-b6d7-c5dd369dd304", "node_type": "1", "metadata": {}, "hash": "f079924051afa953e4c85fe5e8a016eb3c2df8ad3aa400a13052f4ecacc10ab4", "class_name": "RelatedNodeInfo"}}, "text": "above phenomena. The terms as understood and applied\ncurrently are briefly explained below.\nDrug dependence It is an altered physiological state\nproduced by repeated administration of a drug which\nnecessitates the continued presence of the drug to maintain\nphysiological equilibrium. Discontinuation of the drug\nresults in a characteristic withdrawal (abstinence)\nsyndrome. This has been earlier termed \u2018physical\ndependence\u2019, but is now simply called \u2018dependence\u2019. Since\nthe essence of the process is adaptation of the nervous\nsystem to function normally in the presence of the drug, it\nhas been also called \u2018neuroadaptation\u2019.\nDrugs producing dependence are\u2014opioids, barbiturates\nand other depressants including alcohol and\nbenzodiazepines. Stimulant drugs, e.g. amphetamines,\ncocaine produce minimal or no dependence.\nDrug addiction A person is said to have developed \u2018drug\naddiction\u2019 when he/she believes that optimal state of well\nbeing is achieved only through the actions of the drug. The\nsubject feels emotionally distressed if the drug is not taken.\nIt often starts as liking for the drug effects and progresses\nto compulsive drug use in some individuals who lose\ncontrol and cannot stop taking the drug, even if they known\nit to be harmful. This was earlier termed \u2018psychological", "start_char_idx": 0, "end_char_idx": 1287, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1c393afd-c939-4f78-b6d7-c5dd369dd304": {"__data__": {"id_": "1c393afd-c939-4f78-b6d7-c5dd369dd304", "embedding": null, "metadata": {"page_label": "255", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "bbc855ec-480a-4ef3-9766-7b13b5820bee", "node_type": "4", "metadata": {"page_label": "255", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "608f7944df64984b1d5ab3777090858be33a0e363fc0b36225e0498922bd9562", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e063b7fe-b88f-405b-a1dd-30f131e979b5", "node_type": "1", "metadata": {"page_label": "254", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "a192d3f1c6dc5e23ccedd84fd98f55940cdb475dfd4f6ec8bcec6afab4e5552e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d20d728f-ca6e-4544-ab08-e609eb9c2b75", "node_type": "1", "metadata": {}, "hash": "a50d3d85d539600755ddd7a9dd5f23fdf8fdbd4ec0990d2e5885f7a5d05caf65", "class_name": "RelatedNodeInfo"}}, "text": "dependence\u2019. However, to avoid confusion, the widely\nunderstood term \u2018drug addiction\u2019 is used now.\nDrug addiction is a pattern of compulsive drug use\ncharacterized by overwhelming involvement with the use\nof a drug. Procuring the drug and using it takes precedence\nover other activities. Even after withdrawal most addicts\ntend to relapse. Dependence, though a strong impetus for\ncontinued drug use, is not an essential feature of addiction.\nAmphetamines, cocaine, cannabis, LSD are drugs which\nproduce addiction but little/no dependence. Moreover,\ndrugs like nalorphine produce dependence without\nimparting addiction in the sense that there is little drug\nseeking behaviour.\nReinforcement It is the ability of the drug to produce\neffects that the user enjoys and which make him/her wish\nto take it again or to induce drug seeking behaviour.\nCertain drugs (opioids, cocaine) are strong reinforcers,\nwhile others (benzodiazepines) are weak reinforcers. Faster\nthe drug acts, more reinforcing it is. Thus, inhaled drugs\nand those injected i.v. are highly reinforcing\u2013produce an\nintense \u2018high\u2019 in dependent individuals.\nDrug  habituation This term has been used to denote less\nintensive involvement with the drug, so that its withdrawal\nproduces only mild discomfort. Dependence is absent.\nConsumption of tea, coffee, tobacco, social drinking are", "start_char_idx": 0, "end_char_idx": 1343, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d20d728f-ca6e-4544-ab08-e609eb9c2b75": {"__data__": {"id_": "d20d728f-ca6e-4544-ab08-e609eb9c2b75", "embedding": null, "metadata": {"page_label": "256", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "0f4cf36a-9b29-4764-9dc8-8a63dcbfe60d", "node_type": "4", "metadata": {"page_label": "256", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e88d5d033935b4231ed1b9d5dd74293b0d7aff5c3694162b4b8519ab099ea706", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1c393afd-c939-4f78-b6d7-c5dd369dd304", "node_type": "1", "metadata": {"page_label": "255", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "608f7944df64984b1d5ab3777090858be33a0e363fc0b36225e0498922bd9562", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f8723fa3-40cd-40a1-b08d-367612dc9172", "node_type": "1", "metadata": {}, "hash": "66474201f91459cdd4373db0e323ad41aa6559bc55ef08b636a8b2f9f499ca63", "class_name": "RelatedNodeInfo"}}, "text": "regarded habituating but not addicting. Thus, the difference\nbetween addiction and habituation is only quantitative. It is\ndifficult to delineate when \u2018desire\u2019 turns into \u2018craving\u2019. As\nsuch, it is better to avoid using the term \u2018habituation\u2019 as a\ndistinct phenomenon.\nDrug abuse This is another frequently used term which\nrefers to use of a drug by self medication in a manner and\namount that deviates from the approved medical and social\npatterns in a given culture at a given time. The term\nconveys social disapproval of the manner and purpose of\ndrug use. For regulatory agencies, drug abuse refers to any\nuse of an ilicit drug.\nThe two major patterns of drug abuse are:\na.Continuous use: The drug is taken regularly, the subject\nwishes to continuously remain under the influence of\nthe drug, e.g. opioids, alcohol, sedatives.\nb.Occasional use: The drug is taken off-and-on to obtain\npleasure or high, recreation (as in rave parties) or\nenhancement of sexual experience, e.g. cocaine,\namphetamines, psychedelics, binge drinking (a pattern\nof excessive alcohol drinking), cannabis, solvents\n(inhalation), etc.    \n9. Drug withdrawal reactions", "start_char_idx": 0, "end_char_idx": 1144, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f8723fa3-40cd-40a1-b08d-367612dc9172": {"__data__": {"id_": "f8723fa3-40cd-40a1-b08d-367612dc9172", "embedding": null, "metadata": {"page_label": "257", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "515acc1f-8e5f-47fc-a2d0-e5b8b4933852", "node_type": "4", "metadata": {"page_label": "257", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "7bea6e5f0b7b5f30fe2d03d9079f76ba0cd78bf05130fa6711d80e5e83c62eb8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d20d728f-ca6e-4544-ab08-e609eb9c2b75", "node_type": "1", "metadata": {"page_label": "256", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "e88d5d033935b4231ed1b9d5dd74293b0d7aff5c3694162b4b8519ab099ea706", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fbdcfa95-0a3c-4567-ba7f-cc4bf217e145", "node_type": "1", "metadata": {}, "hash": "cfbd3c976d5084f3c248b07698d8efee2382b7d01ae714308dfc9cfdb6f88373", "class_name": "RelatedNodeInfo"}}, "text": "Apart from drugs that are usually recognised as producing\ndependence, sudden interruption of therapy with certain\nother drugs also results in adverse consequences, mostly in\nthe form of worsening of the clinical condition for which\nthe drug was being used, e.g.:\n\u2022Acute adrenal insufficiency may be precipitated by\nabrupt cessation of corticosteroid therapy.\n\u2022Severe hypertension, restlessness and sympathetic\noveractivity may occur shortly after discontinuing\nclonidine.\n\u2022Worsening of angina pectoris, precipitation of\nmyocardial infarction may result from stoppage of \u03b2\nblockers.\n\u2022Frequency of seizures may increase on sudden\nwithdrawal of an antiepileptic.\nThese manifestations are also due to adaptive changes,\nand can be minimized by gradual withdrawal.\nHuman teratogenic drugs\n\uf044\uf072\uf075\uf067 \uf041\uf062\uf06e\uf06f\uf072\uf06d\uf061\uf06c\uf069\uf074\uf079\nThalidomide phocomelia, multiple defects of\ninternal organs\nAnticancer drugs\n(methotrexate)cleft palate, hydrocephalus, multiple\ndefects, foetal death\nAndrogens virilization; limb, esophageal, cardiac\ndefects", "start_char_idx": 0, "end_char_idx": 1008, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "fbdcfa95-0a3c-4567-ba7f-cc4bf217e145": {"__data__": {"id_": "fbdcfa95-0a3c-4567-ba7f-cc4bf217e145", "embedding": null, "metadata": {"page_label": "258", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ecc8cbb9-08ed-4bab-9dcb-89d340a64efb", "node_type": "4", "metadata": {"page_label": "258", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2b63759bfd71ce5af1e69dcf70817bbd008ba05c2ead0db9a3bea5e88dc5a74e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f8723fa3-40cd-40a1-b08d-367612dc9172", "node_type": "1", "metadata": {"page_label": "257", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "7bea6e5f0b7b5f30fe2d03d9079f76ba0cd78bf05130fa6711d80e5e83c62eb8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a5a41298-6212-4c95-946b-f6a7b30b96c6", "node_type": "1", "metadata": {}, "hash": "bb301c3a9886346b5646a4850251baa41395182face5cc5fff5212fe6fff3501", "class_name": "RelatedNodeInfo"}}, "text": "Progestins virilization of female foetus\nStilboestrol vaginal carcinoma in teenage female\noffspring\nTetracyclines discoloured and deformed teeth,\nretarded bone growth\nWarfarin depressed nose; eye and hand\ndefects, growth retardation\nPhenytoin hypoplastic phalanges, cleft lip/palate,\nmicrocephaly\nPhenobarbitone various malformations\nCarbamazepine neural tube defects, assorted\nabnormalities\nValproate sod. spina bi\ufb01da and other neural tube\ndefects, heart and limb abnormalities\nAlcohol low IQ baby , growth retardation, foetal\nalcohol syndrome\nACE inhibitors hypoplasia of organs, growth\nretardation, foetal loss\u00a0\nLithium foetal goiter , cardiac and other\nabnormalities\nAntithyroid drugs foetal goiter and hypothyroidism\nIndomethacin/aspirin premature closure of ductus\narteriosus\nIsotretinoin craniofacial, heart and CNS defects,\nhydrocephalus\n10. Teratogenicity", "start_char_idx": 0, "end_char_idx": 864, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a5a41298-6212-4c95-946b-f6a7b30b96c6": {"__data__": {"id_": "a5a41298-6212-4c95-946b-f6a7b30b96c6", "embedding": null, "metadata": {"page_label": "259", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "4533ece0-9fe7-42a8-abac-0031b6877b63", "node_type": "4", "metadata": {"page_label": "259", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "d08ff5ad6bb4e262e8182ad1cb1587d2fba22bd73b93ae29f630acb3baedb806", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fbdcfa95-0a3c-4567-ba7f-cc4bf217e145", "node_type": "1", "metadata": {"page_label": "258", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2b63759bfd71ce5af1e69dcf70817bbd008ba05c2ead0db9a3bea5e88dc5a74e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1368478b-4d6d-4185-9682-a1d74521aa60", "node_type": "1", "metadata": {}, "hash": "998d764eb487f4d6e69ee23861c6b8a4a4d7c013123ec42bc9390a1dbf6c5ad2", "class_name": "RelatedNodeInfo"}}, "text": "It refers to the capacity of a drug to cause foetal\nabnormalities when administered to the pregnant mother.\nThe placenta does not constitute a strict barrier, and any\ndrug can cross it to a greater or lesser extent. The embryo is\none of the most dynamic biological systems and in contrast\nto adults, drug effects are often irreversible. The\nthalidomide disaster (1958\u201361) resulting in thousands of\nbabies born with phocomelia (seal like limbs) and other\ndefects focused attention onto this type of adverse effect.\nIn 1959 and subsequent couple of years, the incidence\nof  a rare birth defect phocomelia (hands and feet arising\nalmost directly from shoulders and pelvis, similar to\nflippers of a seal) shot up sharply in Europe. Other birth\ndefects also increased considerably. Soon it was noticed\nthat all mothers with malformed babies had taken a new\nsedative\u2014anti-morning sickness drug thalidomide (which\nwas marketed in 1957) during early pregnancy.\nEpidemiological studies confirmed that intake of\nthalidomide in the first trimester of pregnancy was\nresponsible for the birth defects, and the drug was\nimmediately banned worldwide. It has now been marketed\nagain for restricted use as adjuvant in cancer\nchemotherapy. \nDrugs can affect the foetus at 3 stages\u2014", "start_char_idx": 0, "end_char_idx": 1263, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1368478b-4d6d-4185-9682-a1d74521aa60": {"__data__": {"id_": "1368478b-4d6d-4185-9682-a1d74521aa60", "embedding": null, "metadata": {"page_label": "260", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "65f9abd4-acec-4ef8-9ecb-3f847693ab1c", "node_type": "4", "metadata": {"page_label": "260", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "94fcddecd16b315e7e306df88916ba33386d97ec21653162d93205852ab0052a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a5a41298-6212-4c95-946b-f6a7b30b96c6", "node_type": "1", "metadata": {"page_label": "259", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "d08ff5ad6bb4e262e8182ad1cb1587d2fba22bd73b93ae29f630acb3baedb806", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "84734668-bcdb-476f-bb27-4073ab6eab26", "node_type": "1", "metadata": {}, "hash": "ab23227cac66d6303c825080302469bbf8ebf3fac56faa9adf5f916ced747565", "class_name": "RelatedNodeInfo"}}, "text": "(i)Fertilization and implantation\u2014conception to 17 days\n\u2014failure of pregnancy which often goes unnoticed.\n(ii)Organogenesis\u201418 to 55 days of gestation\u2014most\nvulnerable period, deformities are produced.\n(iii)Growth and development\u201456 days onwards \u2014\ndevelopmental and functional abnormalities can occur,\ne.g. ACE  inhibitors can cause hypoplasia of organs,\nespecially of lungs and kidneys; NSAIDs may induce\npremature closure of ductus arteriosus; androgens and\nprogestins cause masculanization of female foetus,\nantithyroid drugs and lithium cause foetal goiter.\nThe type of malformation depends on the drug as well as\nthe stage at which exposure to the teratogen occurred.\nFoetal exposure depends on the blood level and duration\nfor which the drug remains in maternal circulation. The\nteratogenic potential of a drug is to be considered against\nthe background of congenital abnormalities occurring\nspontaneously, which is ~ 2% of all pregnancies. Majority\nof implicated drugs are low grade teratogens, i.e. increase\nthe incidence of malformations only slightly, which may be\nvery difficult to detect, confirm or refute. Nevertheless,\nsome drugs have been clearly associated with causing\nfoetal abnormalities in human beings. These are listed in\nthe box on p.100. However, only few mothers out of all\nthose who receive these drugs during the vulnerable period", "start_char_idx": 0, "end_char_idx": 1357, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "84734668-bcdb-476f-bb27-4073ab6eab26": {"__data__": {"id_": "84734668-bcdb-476f-bb27-4073ab6eab26", "embedding": null, "metadata": {"page_label": "261", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "6423f481-8855-43ec-a5f4-01dce88c1d16", "node_type": "4", "metadata": {"page_label": "261", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "81f3cce634fbaea3ffec80bfcb81e3454b0bbd4c7be384a78d70c047ed0278d5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1368478b-4d6d-4185-9682-a1d74521aa60", "node_type": "1", "metadata": {"page_label": "260", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "94fcddecd16b315e7e306df88916ba33386d97ec21653162d93205852ab0052a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5ff8c0db-b1aa-4435-a1cc-8f78a58db3a5", "node_type": "1", "metadata": {}, "hash": "b405aa4faa6fbbf5cee731b905c51f65159a5463bae1592a65d22322dfbd404a", "class_name": "RelatedNodeInfo"}}, "text": "will get a deformed baby, but the exact risk posed by a drug\nis difficult to estimate.\nThe US-FDA has graded the documentation of risk for\ncausing birth defects into five categories viz. A, B, C, D\nand X, indicating a range from A (safe) to X\n(contraindicated). Beca use evidence on teratogenic\npotential of drugs keeps accumulating, the FDA grading\nhas become out-dated in many cases, and its utility is being\nquestioned. The FDA is likely to change this grading\nsystem soon.\nIt is, therefore, wise to avoid all drugs during pregnancy,\nunless compelling reasons exist for their use, regardless of\nthe assigned pregnancy category, or presumed safety (also\nsee Appendix-2).\nFrequency of spontaneous as well as drug induced\nmalformations, especially neural tube defects, may be\nreduced by folate therapy during pregnancy.\n11. Mutagenicity and Carcinogenicity\nIt refers to capacity of a drug to cause genetic defects and\ncancer respectively. Usually oxidation of the drug results in\nthe production of reactive intermediates which affect genes\nand may cause structural changes in the chromosomes.\nCovalent interaction with DNA can modify it to induce\nmutations, which may manifest as heritable defects in the\nnext generation. If the modified DNA sequences code for", "start_char_idx": 0, "end_char_idx": 1260, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5ff8c0db-b1aa-4435-a1cc-8f78a58db3a5": {"__data__": {"id_": "5ff8c0db-b1aa-4435-a1cc-8f78a58db3a5", "embedding": null, "metadata": {"page_label": "262", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b3aeb5e9-c5a2-45a8-9032-fa277a8e2eb3", "node_type": "4", "metadata": {"page_label": "262", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2bc85d33c64ae87a122b9e2c01e6e9682ac26e33b0ed9aef324282f5a874df70", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "84734668-bcdb-476f-bb27-4073ab6eab26", "node_type": "1", "metadata": {"page_label": "261", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "81f3cce634fbaea3ffec80bfcb81e3454b0bbd4c7be384a78d70c047ed0278d5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d46081fe-63fd-4365-8ac5-29b3202e5af4", "node_type": "1", "metadata": {}, "hash": "44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a", "class_name": "RelatedNodeInfo"}}, "text": "factors that regulate cell proliferation/growth, i.e. are\nprotooncogenes, or for proteins that inhibit transcription of\nprotooncogenes, a tumour (cancer) may be produced. Even\nwithout interacting directly with DNA, certain chemicals\ncan promote malignant change in genetically damaged\ncells, resulting in carcinogenesis. Chemical carcinogenesis\ngenerally takes several (10\u201340) years to develop. Drugs\nimplicated in these adverse effects are\u2014anticancer drugs,\nradioisotopes, estrogens, tobacco. Generally, drugs which\nshow mutagenic or carcinogenic potential are not approved\nfor marketing/are withdrawn, unless they are useful in life-\nthreatening conditions.\n12. Drug induced diseases\nThese are also called iatrogenic (physician induced)\ndiseases, and are functional disturbances (disease) caused\nby drugs which persist even after the offending drug has\nbeen withdrawn and largely eliminated, e.g.:\nPeptic ulcer by NSAIDs and corticosteroids.\nParkinsonism by phenothiazines and other\nantipsychotics.\nHepatitis by isoniazid.\nDLE by hydralazine.", "start_char_idx": 0, "end_char_idx": 1044, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d46081fe-63fd-4365-8ac5-29b3202e5af4": {"__data__": {"id_": "d46081fe-63fd-4365-8ac5-29b3202e5af4", "embedding": null, "metadata": {"page_label": "263", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "32d1ba11-f5b9-4f6d-b62b-4f51ff921348", "node_type": "4", "metadata": {"page_label": "263", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "6113c4de486e74f2e9d19fac3f4cfa6d90998c5b973872fdfcd72fa8b404f92c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5ff8c0db-b1aa-4435-a1cc-8f78a58db3a5", "node_type": "1", "metadata": {"page_label": "262", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}, "hash": "2bc85d33c64ae87a122b9e2c01e6e9682ac26e33b0ed9aef324282f5a874df70", "class_name": "RelatedNodeInfo"}}, "text": "", "start_char_idx": 0, "end_char_idx": 0, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}}, "docstore/ref_doc_info": {"14a6ccf9-adc4-49e5-8ca3-54cf2c0b395f": {"node_ids": ["5b9de05c-8e61-433c-81e3-45a681f844fd"], "metadata": {"page_label": "1", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "a9fb00aa-ed49-403e-93cc-d511dd652924": {"node_ids": ["d44e44d7-acb2-4066-acac-43712b67d6e1"], "metadata": {"page_label": "2", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "00e1f4d8-40cb-4a8d-b9b7-0ffe5460772b": {"node_ids": ["e2598b0a-70c2-49da-8e9b-2340df10d018"], "metadata": {"page_label": "3", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "f61aac9e-9e13-4680-a4a7-e6e8edf56f44": {"node_ids": ["9ce308a7-7c62-4f88-8ea4-e84ee55b203f"], "metadata": {"page_label": "4", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "1e26bc5e-ec2f-42ef-a8f1-e9b0f103b8b7": {"node_ids": ["f31d1314-4835-4048-8c93-178e3cd9539e"], "metadata": {"page_label": "5", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "9e571879-7779-4973-a26f-9bee54e85581": {"node_ids": ["499d84ea-f66f-4c05-b834-13e4c69dc3fe"], "metadata": {"page_label": "6", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "fb385b04-79a7-422b-8990-982752371c7f": {"node_ids": ["355ae47d-b296-4f5d-8eee-9ed53ebf5685"], "metadata": {"page_label": "7", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "122c97e3-dffe-41ad-8437-e8fa89545303": {"node_ids": ["e341e24e-dca5-4588-9a8f-dd011a23fe25"], "metadata": {"page_label": "8", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "2ae5c64b-1b24-4b85-96da-80e4cc7fa0a8": {"node_ids": ["13150958-1f72-4aaa-80bb-d92bfe3fa600"], "metadata": {"page_label": "9", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "693c0b06-9719-4c6a-960c-02a03da16a44": {"node_ids": ["199be439-d1c3-49e1-9448-4030456eeb1d"], "metadata": {"page_label": "10", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "17e044ef-066c-41ff-871f-e0521f9e11a2": {"node_ids": ["fc9a2506-a7cd-4b5e-a8f7-805f43620ccb"], "metadata": {"page_label": "11", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "37877ff9-a8e5-48df-8380-a14845889323": {"node_ids": ["dbb58f28-9c73-4da0-95d7-ce5b96d718b7"], "metadata": {"page_label": "12", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "5aad9db2-a8ef-4d10-8fec-22e3cc7e59d3": {"node_ids": ["e123f864-afc2-4f86-8543-9e19a264e685"], "metadata": {"page_label": "13", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "e31cf697-ce51-425a-ba7c-87c8f39163d3": {"node_ids": ["b3a59439-9b24-43cb-8f16-9339d2bb3637"], "metadata": {"page_label": "14", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "0593823f-38af-4861-a0ac-b7fbd48f155c": {"node_ids": ["4fde79cb-ef57-4e7c-917a-04af6e2ffb02"], "metadata": {"page_label": "15", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "95ed1103-1d3e-455f-ab65-7c4779688d72": {"node_ids": ["f00b6c7e-0d0c-47c9-8275-81d75a67fa11"], "metadata": {"page_label": "16", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "96de02c3-7291-4c16-a959-608f2779e66b": {"node_ids": ["456b7755-9d8e-45ce-b52f-5046da1d73d3"], "metadata": {"page_label": "17", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "f1b6245f-2382-4a9f-b060-90a84d6742f3": {"node_ids": ["491e6864-618b-4449-9f79-d72ad9982619"], "metadata": {"page_label": "18", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "2b000c16-d6dc-4446-bdab-61871dc53a76": {"node_ids": ["f3a9969b-3680-4bad-96fc-127b6e513428"], "metadata": {"page_label": "19", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "9488d511-9dc9-477f-a799-b6a4fee59970": {"node_ids": ["d11e61cb-76d3-42dc-90f8-5358177a5566"], "metadata": {"page_label": "20", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "3cdb199d-1952-45a3-b6ca-2f012fe1af8c": {"node_ids": ["e376dcf7-d9c5-40ec-8489-fdf7c1b5a651"], "metadata": {"page_label": "21", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "c67cf8e8-af7d-48fa-882e-4e1b65246104": {"node_ids": ["b942ba09-b042-47be-a5bd-ec8716c913a9"], "metadata": {"page_label": "22", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "958c632e-ed1b-4ba4-8ad2-23b364d5f283": {"node_ids": ["4a2fcf76-4fa5-4eaa-b308-505371eceba1"], "metadata": {"page_label": "23", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "da866fec-39a7-4a28-b0a8-05a51084e888": {"node_ids": ["7806fe8a-1036-4865-a05b-abe2458d9d37"], "metadata": {"page_label": "24", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "ae7c1f30-0982-4e52-b224-b864a35abc84": {"node_ids": ["a38a1f8e-4f52-4369-bf3c-759dcfdcd828"], "metadata": {"page_label": "25", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "c022ff7d-f31e-41c8-b753-1a7fd81eb16e": {"node_ids": ["fda6dfaf-b1f2-45c6-99dc-5b988448ce81"], "metadata": {"page_label": "26", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "6f487232-6a67-4731-a5d3-463a05e75cd5": {"node_ids": ["5cd2b523-c57c-4310-bb88-72df7e964eef"], "metadata": {"page_label": "27", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "ec47f9ad-0af7-443e-8359-54ce633c73af": {"node_ids": ["06ce1a05-76b7-4b2f-8f94-1f8e8866cd21"], "metadata": {"page_label": "28", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "775d6a96-770e-45ad-abca-3894a3ef93c6": {"node_ids": ["fbd1da7f-c1a4-43f9-a516-febd99ccda80"], "metadata": {"page_label": "29", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "9beb1dff-f168-4190-b166-3e06141aeab6": {"node_ids": ["cd6af016-65d6-41b2-8eae-c784b98416b7"], "metadata": {"page_label": "30", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "7e9e1716-b5b1-4b20-8557-86a59094c763": {"node_ids": ["a6be55c2-99c4-464f-8d32-587c63ce7e95"], "metadata": {"page_label": "31", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "40281847-c6e5-4259-a23a-40c4410315bc": {"node_ids": ["e63f217a-4d26-4651-b103-00c10ef0afd8"], "metadata": {"page_label": "32", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "66a20f6a-c2a9-420d-942a-a990d4a07454": {"node_ids": ["950f8555-3a2d-4fed-9715-0f10800ee457"], "metadata": {"page_label": "33", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "99d8fa96-6e3d-4d13-ab2f-981aa9c2a2d4": {"node_ids": ["6886b43e-80eb-40eb-a9b3-536244565b66"], "metadata": {"page_label": "34", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "6383d4b6-dd4c-465d-85b6-9b42d91ad314": {"node_ids": ["a7c5dbc2-3ee4-4e0d-b4cd-2310eb2e5aaf"], "metadata": {"page_label": "35", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "d1bc3755-3354-4d41-aadb-b136b720c67a": {"node_ids": ["bcb81a3a-8a38-485f-a506-eb9d6c507bce"], "metadata": {"page_label": "36", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "b8d4fa21-687c-4c6e-a931-7421435cd0c4": {"node_ids": ["a5d261ee-2fe7-4be0-82b8-1d37b9e09c0f"], "metadata": {"page_label": "37", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "28432a3b-116a-41ed-a5ad-4000fc2acd67": {"node_ids": ["541f4c3b-28fa-4359-aac4-992e92a12818"], "metadata": {"page_label": "38", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "84d024b3-a8e4-42d5-9186-068470ec2916": {"node_ids": ["0a324b6f-42cd-41d5-8210-0560b7b7fc08"], "metadata": {"page_label": "39", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "cbba637d-3358-4caa-b535-81736f6b7c31": {"node_ids": ["fe72fe8a-bf31-408b-b0df-918828ba00f9"], "metadata": {"page_label": "40", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "4c2e3729-00b3-46f1-96b4-ed4c443cd555": {"node_ids": ["80808fcb-9373-4a96-9903-254e430c48a4"], "metadata": {"page_label": "41", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "924975dc-8582-4cb5-b2af-8c0da4679147": {"node_ids": ["f416e33e-f7e5-41ec-bf99-71838b49db18"], "metadata": {"page_label": "42", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "d86e3078-b409-44ee-9eec-f0262d5918b6": {"node_ids": ["807165dc-083c-41db-b7df-db046d43c262"], "metadata": {"page_label": "43", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "b39def78-d8b1-4463-8f00-d3a34e39fc34": {"node_ids": ["e1f62f4a-5c0d-49dd-b70f-0b5792dac4e5"], "metadata": {"page_label": "44", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "c33a6a4a-e602-444a-b61a-a3aea69fa36c": {"node_ids": ["b0a1bc6d-a78c-4b5e-844e-7b3e97a04521"], "metadata": {"page_label": "45", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "3ddf33ea-bbd8-40cf-9a40-a13154eb2d8a": {"node_ids": ["772bc3ab-7f54-4b60-bae5-2420580a57fe"], "metadata": {"page_label": "46", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "683f29fd-bf98-4be1-bff0-144acc3b7aba": {"node_ids": ["18abd933-b6fd-46d2-af2a-1bb78fd37f14"], "metadata": {"page_label": "47", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "af112b94-50a8-4d69-9356-ecb9508f779a": {"node_ids": ["32daf703-5842-4b49-87f5-e283aa213afb"], "metadata": {"page_label": "48", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "1827f261-8016-4b22-9002-27725a06e5a8": {"node_ids": ["675a222f-64af-498d-a6d9-ab968ae48c9a"], "metadata": {"page_label": "49", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "434e9b90-49e9-4270-8fd8-8c7f8355b1b9": {"node_ids": ["945f092e-bc44-4d3d-bbb8-fd802d8120e3"], "metadata": {"page_label": "50", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "d55832e2-38b5-4d77-8206-3ba586cdab85": {"node_ids": ["2ac9fb92-6f75-4c17-8f95-d219482d99e5"], "metadata": {"page_label": "51", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "a4442ea6-1ec2-433a-a1f6-222537c6037c": {"node_ids": ["46825d9a-c860-4fc0-8047-ef43f21754df"], "metadata": {"page_label": "52", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "a9fcdd22-4318-4c21-9297-ad33b3ab05e6": {"node_ids": ["d76045c4-3a5a-412a-86d8-62c155d082dd"], "metadata": {"page_label": "53", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "787f824b-6dcf-4e21-9fc2-2214c55a8f82": {"node_ids": ["ea5e9aa9-af54-4dea-9388-41cf6899147c"], "metadata": {"page_label": "54", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "220f95f8-ab72-4570-ace2-8cad2bf17f12": {"node_ids": ["ec78ce0c-894f-4996-8e64-9096fea9d4d0"], "metadata": {"page_label": "55", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "8fa1a5cb-702f-44ed-8d20-15cf24fd6712": {"node_ids": ["0ce92ee2-a14b-4dbd-8cf5-88cf7d97ffb6"], "metadata": {"page_label": "56", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "4801dd2e-a9a8-4f1a-8c33-f7672fc5af5c": {"node_ids": ["75f19480-687e-4c61-bca3-a48aca157562"], "metadata": {"page_label": "57", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "fe2767ca-bcbe-4841-a796-5de28f1391e7": {"node_ids": ["371511b2-0237-4c51-911b-0a47b10145a7"], "metadata": {"page_label": "58", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "3823decb-ee25-45da-9706-27f65d0fb331": {"node_ids": ["d0bd5f58-03f9-4e15-a8bc-fcaed8e77d6b"], "metadata": {"page_label": "59", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "5d53fa1e-a0a6-4b05-9541-efab54285edf": {"node_ids": ["2039c74c-e3f7-484c-b828-8d60d39586d4"], "metadata": {"page_label": "60", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "6b741be5-f451-4b46-af0a-78678fd1eea6": {"node_ids": ["9fce5ad9-406d-40b6-be98-fe6ef376954d"], "metadata": {"page_label": "61", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "c88d1376-886b-494a-ad5e-6b74033bd3e9": {"node_ids": ["62363b93-e892-4170-a664-520cd5e97444"], "metadata": {"page_label": "62", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "a712ff43-7bca-43bf-868a-89d9bf93e48d": {"node_ids": ["86cddc1a-fe1a-4ead-bf3a-27518a8820c4"], "metadata": {"page_label": "63", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "4a2f804a-1695-411c-b9b7-8ac1dfc803a6": {"node_ids": ["26ed5b32-2c9a-4f54-bff3-ab70398191c3"], "metadata": {"page_label": "64", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "5cd068ef-971d-4cf2-9818-f4a8ec479d6e": {"node_ids": ["5af1c24c-31f5-4068-ba14-11a10282d4c8"], "metadata": {"page_label": "65", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "dfe25b23-0dc4-4553-a8f3-fe559fd3dd5d": {"node_ids": ["f3ac06f2-a882-4b8b-baa1-09bf99655095"], "metadata": {"page_label": "66", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "6c7d00d7-118a-499e-999c-be29d4e0207b": {"node_ids": ["b5b5ca50-c970-4d36-b0b9-1e5aca132300"], "metadata": {"page_label": "67", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "ff8e3a3b-163e-4483-96b4-7350fb2222d0": {"node_ids": ["afb1f413-1a30-42ed-8ffb-39eb6ba26c07"], "metadata": {"page_label": "68", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "bf0af623-9cfd-48f5-90c2-c6b724a2761f": {"node_ids": ["af9b4130-cd7a-4cef-972e-fff90bbb81d3"], "metadata": {"page_label": "69", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "c2dd27c3-92f2-422f-8d08-1e9d6a58f358": {"node_ids": ["08af050f-6429-4516-9d65-2fe8422ea4e4"], "metadata": {"page_label": "70", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "6ab7796c-e87a-49ee-b455-b323139a8c57": {"node_ids": ["31ff8b85-79af-47a2-92ae-19a05f7f774c"], "metadata": {"page_label": "71", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "944aa216-249d-4790-aa83-4b89d655ade2": {"node_ids": ["d33fb733-f0ad-43bb-baec-a265f0b89868"], "metadata": {"page_label": "72", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "20a8b136-ad7e-45e8-b769-ea2f70521e74": {"node_ids": ["8a0be426-a2ab-4e48-a552-4f39752ab754"], "metadata": {"page_label": "73", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "25bedbc1-a1b1-496f-8351-f2950dde364c": {"node_ids": ["891afd6e-bbe8-4845-a310-f9d4ab71cfe0"], "metadata": {"page_label": "74", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "5c907214-4dcb-4631-9957-626adebadc17": {"node_ids": ["0decf59f-7481-4ffc-abd1-6d6dfbb29db3"], "metadata": {"page_label": "75", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "edc21a16-ad60-4160-84de-767d35769250": {"node_ids": ["4e4a559d-7c6c-4a06-b5e0-db68264135ef"], "metadata": {"page_label": "76", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "ac053143-cab9-4794-8cbb-15156f592723": {"node_ids": ["c26282cb-dad0-4940-b60d-2f4e55d3fee7"], "metadata": {"page_label": "77", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "077baa37-fe87-4b00-9673-cf101b756606": {"node_ids": ["e4454d62-e57d-4189-af5c-8bcfbd551852"], "metadata": {"page_label": "78", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "b2301267-058e-4170-be09-c8814850cb66": {"node_ids": ["07c73815-1a2b-4645-ab83-691a97dc5304"], "metadata": {"page_label": "79", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "8a1d622b-d868-4ed7-b7b1-4172498f64b9": {"node_ids": ["c7e8d315-c913-4e47-998a-50863c967507"], "metadata": {"page_label": "80", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "6c5abbfb-a73f-4161-ae7d-1bf6a4e47e83": {"node_ids": ["ef84c6d4-a3dd-42de-873b-9bc4688edfcf"], "metadata": {"page_label": "81", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "01afdae3-d63e-47aa-8035-030db717e995": {"node_ids": ["29010343-be09-4744-b3c4-eedd60d6a740"], "metadata": {"page_label": "82", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "39f313ef-ca56-4d8c-b05f-42a91d42863e": {"node_ids": ["91eb9e17-b3a5-400f-988d-02a6e33bc242"], "metadata": {"page_label": "83", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "363c52e6-82ab-4c47-a8d5-dc1c1e6baed3": {"node_ids": ["48aacfbe-71bd-419b-a806-66ccddcbf4f7"], "metadata": {"page_label": "84", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "133886d3-8f01-4983-9821-52af09f60bb1": {"node_ids": ["52108760-f15f-4428-aa83-976be2b2c5e5"], "metadata": {"page_label": "85", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "24b94878-1d06-4153-be06-28484bcf7d9b": {"node_ids": ["87ac8fc3-187b-4db7-ac2a-263b0418e086"], "metadata": {"page_label": "86", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "669a6811-520b-4bb0-94a1-980ed87c01bb": {"node_ids": ["04eec1fb-8277-4365-809d-3c19d0dcdc93"], "metadata": {"page_label": "87", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "57dd980d-abd9-4522-9681-924aca506a48": {"node_ids": ["ba8b2fc2-6060-4d5c-aed2-f53ac50710d5"], "metadata": {"page_label": "88", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "223937cc-b6c4-46df-b45b-a51c0909b466": {"node_ids": ["7ddc064b-f8fa-48fc-a8df-fa3f163df329"], "metadata": {"page_label": "89", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "397922e5-e697-4b6f-9f2e-a096009ab5d1": {"node_ids": ["72f9549a-7d8a-477b-9c57-1cfd5523aa19"], "metadata": {"page_label": "90", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "6a8d4880-6edd-4f2c-93d2-deb8a85cdaf2": {"node_ids": ["75667090-8348-4dc4-9973-97a8a9ce7247", "3fc51538-e0d9-442c-85bb-f0b627074000"], "metadata": {"page_label": "91", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "1b37ce62-c95f-45ec-b969-fb3d633d0da7": {"node_ids": ["a9d94fcb-f072-4315-a9cf-7ccb3cb6473a", "bc7976fa-8dd8-4236-b239-f1ee9c8936dc", "d7cdbb8e-7c87-44dd-8020-893ce648d497"], "metadata": {"page_label": "92", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "5d4ccc26-021d-4f7b-a807-eeab1972a4de": {"node_ids": ["6a3cc64b-c46e-439e-ac00-14b9431ac5dc", "eb20ac43-7c88-49a6-8556-9de55aa92ffa"], "metadata": {"page_label": "93", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "d56b54e7-c3d8-4185-b725-5093d27b1629": {"node_ids": ["885d3304-5c6b-4eb3-82bd-9722cdf60b86"], "metadata": {"page_label": "94", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "e5c630d4-ae50-4f77-ab50-87d38da1fb0e": {"node_ids": ["26a045a0-bf4b-4366-94eb-24c9ed86fa37"], "metadata": {"page_label": "95", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "73a64b70-8c31-4f10-b492-7d2d2afd8efb": {"node_ids": ["b40bc3cf-8641-4aae-ad6b-314bd034c9c0"], "metadata": {"page_label": "96", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "0cda9d94-b603-40f1-820c-838ab5efd6d3": {"node_ids": ["f87d4879-36ff-4bee-9281-5f9767f9de70"], "metadata": {"page_label": "97", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "e8a3013c-aac6-4742-9a66-a601dd8d98f8": {"node_ids": ["d011d1db-a927-4742-99f7-a8b3e23b1637"], "metadata": {"page_label": "98", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "5513dd0e-bccc-4598-b687-14f0b19bbac4": {"node_ids": ["8bef4b59-9f6f-44a9-bed3-5cddc0cd642b"], "metadata": {"page_label": "99", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "41e310b3-1208-46cf-83ef-64aba2ad4382": {"node_ids": ["aaa069bc-8aac-4ca1-8030-22c72cc207f4"], "metadata": {"page_label": "100", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "c6a2b542-e34b-45cd-8789-bccf83a33a0f": {"node_ids": ["2455e69c-84ea-41ff-b41f-fdd092624fbc"], "metadata": {"page_label": "101", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "dc16d311-1fc6-4485-897e-9b8d3095cfbc": {"node_ids": ["e84d4ae5-33dc-44f6-8734-084f81c8a0a1"], "metadata": {"page_label": "102", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "c98ec416-926c-49dc-811e-9bb662b3d812": {"node_ids": ["ac093db4-59ca-4c1d-8e89-d393daf03d29"], "metadata": {"page_label": "103", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "6ad48f98-c5d5-4d91-a107-aea4beabbedd": {"node_ids": ["bc60cbdf-1089-47fa-9bf6-1f8d28e82387"], "metadata": {"page_label": "104", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "7ee4fb5d-64d0-4585-a93f-964612a920fd": {"node_ids": ["588f19ce-0a52-4d00-84c5-b03ea11a3952"], "metadata": {"page_label": "105", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "172c4df3-08ac-4064-b3c1-bb670ebe08a3": {"node_ids": ["eba0d3b4-ebd9-42a2-be7f-240449f16fb3"], "metadata": {"page_label": "106", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "07fdca8e-6ff5-48f8-9e87-ef347722e862": {"node_ids": ["374c6610-3aa3-4f55-9966-fcde9e53ad74"], "metadata": {"page_label": "107", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "3f6bc6d9-92f4-4dc4-ab73-f5bd6ade218b": {"node_ids": ["d5b230e0-73de-4564-b741-5d0b697c287c"], "metadata": {"page_label": "108", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "0e520528-c00f-4d9a-b25a-98ba87ec44c9": {"node_ids": ["06504210-8fd0-4029-a41d-f6722897dc06"], "metadata": {"page_label": "109", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "f9dbc250-95fc-4441-9450-1b1013fc6d65": {"node_ids": ["786d1f6b-8ec0-41bb-9dc9-62340c1a73a0"], "metadata": {"page_label": "110", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "e4be75e7-986d-4392-b013-12931743b84b": {"node_ids": ["ad7761cb-a80c-4fd7-b5e6-fdf9c4f5a725"], "metadata": {"page_label": "111", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "378475f0-c937-49fd-a3bc-036d9f2d20bc": {"node_ids": ["88a3501f-2878-42f6-8b83-9c0caa8df869"], "metadata": {"page_label": "112", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "7d04bc77-6a78-4880-95f8-426df12ad9e1": {"node_ids": ["cf5b6ee8-7970-47ef-8abe-b1810ee95725"], "metadata": {"page_label": "113", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "c6c47d52-c707-413c-98d4-8a4f4b51eb1d": {"node_ids": ["1b6caeb9-9654-42bd-99df-bf9330a09a07"], "metadata": {"page_label": "114", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "17b7bf61-fce0-4bba-818c-b4e2a3235982": {"node_ids": ["fcbf9325-5c46-4cdc-8227-bb53ee90bac1"], "metadata": {"page_label": "115", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "e796e9b8-11ec-41e8-8bd8-36b0face1cac": {"node_ids": ["97f0e2ad-6974-4e6c-be99-c3939cd10301"], "metadata": {"page_label": "116", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "ad4d6008-a56f-4251-bb50-973032e3da0e": {"node_ids": ["ba49c84f-eedd-48ca-9211-5cfa528b03b1"], "metadata": {"page_label": "117", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "acc3e2b5-a73f-4956-b639-e2e68ffa66db": {"node_ids": ["e1472f17-927b-451b-952a-6e76e0460da9"], "metadata": {"page_label": "118", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "f87bf786-411e-4465-be96-e0942af05730": {"node_ids": ["22144d89-14ca-452a-8dde-fff54b9836b0"], "metadata": {"page_label": "119", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "3db65f1a-9619-4ffc-abda-cbe795458fdb": {"node_ids": ["1fd1266c-bb2a-40a5-afa2-a5fd76d9fe1f"], "metadata": {"page_label": "120", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "8c3ec96d-940a-4e53-b79f-6c89426de550": {"node_ids": ["c91e46e8-1c03-480a-8db2-2ecbd5d01094"], "metadata": {"page_label": "121", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "8e670da0-9b15-4e03-86f5-810517dd7da9": {"node_ids": ["5eea5ef0-47fd-416e-aa3d-6506e698417f"], "metadata": {"page_label": "122", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "3da9bd7c-b6bf-4a50-a71e-1c7cd9b402c7": {"node_ids": ["e2d3cde8-10ee-4377-9d2c-8db35e4b7b08"], "metadata": {"page_label": "123", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "02a60eb7-b165-40e4-af38-f4898efca15a": {"node_ids": ["be844d6a-f89b-424f-894f-4c0a12182fec"], "metadata": {"page_label": "124", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "ea261dc5-38d3-4fcd-96a5-e2b852b482a4": {"node_ids": ["d8b9388a-1750-472e-b1a3-fbc493045a79"], "metadata": {"page_label": "125", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "3d74a877-8dd5-4a30-96ba-7cff3f8a41b0": {"node_ids": ["086de2c2-c9b7-4ad4-ade5-6aae324119fd"], "metadata": {"page_label": "126", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "a0c81d9c-c7a1-46b5-b811-9659373da46f": {"node_ids": ["a136851a-b9eb-4113-8f31-bd99aba2628b"], "metadata": {"page_label": "127", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "9692a391-075f-4f0b-98d2-4f8f725480a8": {"node_ids": ["d7da607f-cc31-4804-9b23-02f157a01fb7"], "metadata": {"page_label": "128", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "9c3b9bca-c8d2-4e65-bf4d-2b816ea6cc62": {"node_ids": ["eb1cd267-e344-4453-b477-2c3064243332"], "metadata": {"page_label": "129", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "2b37ed4a-3ae2-4d24-a45f-7ffb0e19330e": {"node_ids": ["f7f67e78-e038-4129-a82c-9fc06c925527"], "metadata": {"page_label": "130", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "ab182a08-8508-4847-862e-4108710f3148": {"node_ids": ["82294db1-ce50-46e8-8f5f-12ba8c882bd0"], "metadata": {"page_label": "131", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "1b5ff0c6-0c8b-4ba4-bab7-3e599bc10011": {"node_ids": ["0f03ae1e-da80-49fb-b968-f332810a2037"], "metadata": {"page_label": "132", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "370ad65f-d6bb-4518-a92e-229fba23c55f": {"node_ids": ["c6175a71-6558-4421-a995-f68383221ed5"], "metadata": {"page_label": "133", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "b57a3c3c-4ffc-4e09-90b1-c1d06a66013f": {"node_ids": ["06a94c96-5ff3-41dd-8937-5d6e6c270d7c"], "metadata": {"page_label": "134", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "7b4e3869-a70b-4da9-ab75-a91ef80b3856": {"node_ids": ["094c40b5-e4b3-41f3-86e9-92a92e1b7561"], "metadata": {"page_label": "135", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "3996f212-626a-4ffc-b429-8889f30f4bcb": {"node_ids": ["cc37bf71-a09b-4821-8e8b-29181dd76790"], "metadata": {"page_label": "136", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "b6cd6c7b-8bf5-4087-be57-529c062dd6c9": {"node_ids": ["165129f6-27e1-43ff-8a7a-bd4387182fce"], "metadata": {"page_label": "137", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "f543d312-d064-4f4c-b941-f1f44e6a03ee": {"node_ids": ["dd11df96-a684-4447-9909-080c254e68aa"], "metadata": {"page_label": "138", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "b77f5397-d305-46d3-8437-90cb3f7dd3ca": {"node_ids": ["29a64b12-37e0-434a-aaa6-45e43d80917c"], "metadata": {"page_label": "139", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "22176fa3-040f-47bc-8580-93df4aa4ac27": {"node_ids": ["d7f9b65b-fe0e-407d-a907-3ed9071c1670"], "metadata": {"page_label": "140", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "75398f3a-efa2-4310-8423-dd4d7a1f8355": {"node_ids": ["5f272308-106c-49f3-a80d-2263ec4bb409"], "metadata": {"page_label": "141", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "24b01b60-52aa-45a9-980f-d067873580aa": {"node_ids": ["abd7070d-e56b-4d48-ba16-34e3fb2b83fe"], "metadata": {"page_label": "142", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "9e82187d-b01c-42e8-a42d-2001eec664aa": {"node_ids": ["29a64d15-9d47-4713-a5c7-2fa3e61274ba"], "metadata": {"page_label": "143", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "f4c08827-a5e4-4ce3-8276-edb53456d0b0": {"node_ids": ["40036c76-8a47-4e32-bae1-0ca74c4b2f2e"], "metadata": {"page_label": "144", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "b981cfd8-6cf9-44de-963e-8a5972d7ca37": {"node_ids": ["c0a1db20-e1b1-421a-96a6-5e0c94ff9218"], "metadata": {"page_label": "145", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "113d8581-213f-43e8-aed5-900ff192ff09": {"node_ids": ["d3562c47-c8ca-4a67-94ba-78348b99ceff"], "metadata": {"page_label": "146", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "2acdd4ac-f378-4deb-aea3-929789f17c98": {"node_ids": ["7ee3ca39-91c7-4c89-a98e-ed303f7d1195", "d914f180-feea-4ce8-9135-5136a55a1003"], "metadata": {"page_label": "147", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "ed66f241-e2d1-4430-b8e6-023fe20e6e5b": {"node_ids": ["88abf969-cfef-4b19-968b-526c8d899f3c"], "metadata": {"page_label": "148", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "13ae48cf-d631-4a98-a8ea-475ed4ba429d": {"node_ids": ["6ca52343-cda5-4b77-8da1-152957e331a4"], "metadata": {"page_label": "149", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "c3413b1e-a206-4df8-bda3-47659c92df1e": {"node_ids": ["308b7ae3-d6c5-4417-a817-077160743786"], "metadata": {"page_label": "150", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "41617a3d-7bbc-44b2-9432-80a50602173a": {"node_ids": ["499a76c2-35d4-49ca-9a60-f7b40a258cb1"], "metadata": {"page_label": "151", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "b88d8e37-166c-4243-9e61-36643f6cb217": {"node_ids": ["78ad3b48-d9b9-4ab5-9373-56599d31dfe8"], "metadata": {"page_label": "152", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "750638f3-f142-4260-90ae-2a01cd8f6a98": {"node_ids": ["636ba1da-5a62-4daf-891d-1cad6f8c435c"], "metadata": {"page_label": "153", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "859e2ece-4a3a-4e53-a5cb-e288ae111f9a": {"node_ids": ["00159d76-a4ac-4f09-a8a8-26beaba8d229"], "metadata": {"page_label": "154", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "69f580a2-14cd-4a85-a9dd-92a6da0f8c40": {"node_ids": ["b33f57f4-9b43-4a5c-8aef-5e71df639fce"], "metadata": {"page_label": "155", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "19bc9688-6990-4081-97a5-719003016d34": {"node_ids": ["4ec3ec63-0cf7-43d7-8123-63f45e2230e7"], "metadata": {"page_label": "156", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "ad99c96e-9493-40f0-be70-451826ad991d": {"node_ids": ["0ede72ee-3f39-4e10-9a6d-79498f4dec67"], "metadata": {"page_label": "157", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "914db214-79cb-4a8d-ba6b-c305915eec32": {"node_ids": ["8e9f9677-6643-4a80-b827-8ee5ba2fd4fe"], "metadata": {"page_label": "158", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "88219d14-c539-4858-9a96-3235d32521dc": {"node_ids": ["ab44cfea-2a59-4300-9c76-32519d9c60be"], "metadata": {"page_label": "159", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "0d02bd28-1c95-43f7-bc8d-7bfe6b6ee33d": {"node_ids": ["5bd50250-1640-40b6-8280-d64da0eb0f4a"], "metadata": {"page_label": "160", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "6fa9c138-fc86-4e30-950f-7c7e2d4184a2": {"node_ids": ["099ab0f6-d7e5-4474-9886-e28f5111aa38"], "metadata": {"page_label": "161", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "407584b0-9976-4a08-ae1b-d68443db299a": {"node_ids": ["16d0ecdd-3e3f-49a4-9c14-e57ebcfccfce"], "metadata": {"page_label": "162", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "5558df91-61ef-4f67-845c-f300b390814b": {"node_ids": ["37682d3a-e813-418c-8f09-9f2e3a03927d"], "metadata": {"page_label": "163", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "3d4f1712-1c60-41f0-b5f5-46d7dece8a03": {"node_ids": ["6356dc5f-9e9a-40af-9974-75015522595d"], "metadata": {"page_label": "164", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "7a76f0c3-6db5-46b2-b6c6-f1fcdf1c3160": {"node_ids": ["789f8674-a309-4d58-85b9-929eaf08a7fc"], "metadata": {"page_label": "165", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "068f1722-7396-4b97-8aa0-e9ee7ad4c701": {"node_ids": ["0274a2be-b083-4f35-9298-334313bcd0b0"], "metadata": {"page_label": "166", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "2f6dff5f-1a35-423a-9f23-2640a124e973": {"node_ids": ["8cfb4edd-4173-4f75-b1b9-7cd63b047c6f"], "metadata": {"page_label": "167", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "bef26e38-21ed-4aa3-8548-ad97fd0db6e3": {"node_ids": ["ed92e13a-961d-4c45-b4d3-5dd749dad14a"], "metadata": {"page_label": "168", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "4404dd4d-1ba0-46fb-9f9c-4b28c4d5ca73": {"node_ids": ["7d9e8e0b-bbf0-4b23-a243-f8c918abf811"], "metadata": {"page_label": "169", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "b35da6f0-720d-4d34-a925-5c98c6b06b48": {"node_ids": ["0f1e51a3-e754-45b9-ac17-ceb06bce494f"], "metadata": {"page_label": "170", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "7a320830-44b5-4f52-a45b-baf28b810782": {"node_ids": ["3e1ce26e-1547-44b9-abf0-e7a372f3b4c8"], "metadata": {"page_label": "171", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "c45b799f-fe40-4f2f-bc79-032d33924c03": {"node_ids": ["d1307b8b-a92e-4222-bfa6-3aee2c75b68b"], "metadata": {"page_label": "172", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "02f2e1fa-f441-468f-9d72-5ccacdba6435": {"node_ids": ["b139a041-da70-4a3e-9b93-db6d841032df"], "metadata": {"page_label": "173", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "f976e342-68b6-4d58-a9f5-b317cb5dae73": {"node_ids": ["8b8394d1-eaa9-4815-8f94-6d55b517882c"], "metadata": {"page_label": "174", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "e22f2699-412d-493e-9015-854ae6d940f2": {"node_ids": ["1797c6c0-231d-4976-bc2b-9508e8df93f0"], "metadata": {"page_label": "175", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "a0732593-97f7-43f2-8f50-afcadb61c019": {"node_ids": ["3b77a8e7-38d9-4870-b541-2327fd89904b"], "metadata": {"page_label": "176", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "b945d56d-bb36-4ef8-9dae-b23aa4d6e3c1": {"node_ids": ["130c87c8-187a-4a53-a5fe-0f5db8ebca9c"], "metadata": {"page_label": "177", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "67d933a3-a709-451f-b837-e1e825e3010a": {"node_ids": ["9e571175-d241-4ff4-8671-be5730b434d8"], "metadata": {"page_label": "178", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "105d2be9-d4c2-4bdc-b09f-ca1f1a04e0d3": {"node_ids": ["f51f6974-ed6d-4488-bd3e-752ce70d4483"], "metadata": {"page_label": "179", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "4456f49d-4efb-4041-98ac-c657c9f9f4dd": {"node_ids": ["8c4740ea-586b-4b71-80e2-1144e7b86821"], "metadata": {"page_label": "180", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "5461ee63-5766-428e-a45b-a9a4005935be": {"node_ids": ["38c696e4-9d0b-4443-8e58-0cee68586adb"], "metadata": {"page_label": "181", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "85e0af80-6850-49fd-94e7-a230a676ad63": {"node_ids": ["51510684-50c3-4045-8bbf-925a7c10ac56"], "metadata": {"page_label": "182", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "7f47ff51-a533-480d-9484-d036e9228603": {"node_ids": ["82eb2c76-5674-4eb1-aa5d-5917b567f8b8"], "metadata": {"page_label": "183", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "2b53c61f-8374-4a6c-8411-f368cfb2feb1": {"node_ids": ["c9beac63-c6f6-4118-8761-ea1dfe5e5e13"], "metadata": {"page_label": "184", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "13bcf40e-6107-4bf3-a587-1df5f08557d7": {"node_ids": ["ac068792-b29e-416e-bf56-ece21004c45b"], "metadata": {"page_label": "185", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "8195be23-c577-4652-9cf8-b9bfcaf2ef57": {"node_ids": ["ec75fe94-bd3c-4150-86cf-367b2f03bed4"], "metadata": {"page_label": "186", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "984e1d7e-ffff-43c8-bfda-43b4b3d8df75": {"node_ids": ["9aa55370-666a-4378-9b77-4368fbca90b6"], "metadata": {"page_label": "187", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "396a89f9-dff1-42a1-83ee-79e3394a5e3f": {"node_ids": ["74424296-8f38-49bd-861f-234d3e4713cd"], "metadata": {"page_label": "188", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "438a5bdc-9619-4337-acee-05db1751c58c": {"node_ids": ["341b1d43-56e1-4780-aa5f-0bbbe1a01eb5"], "metadata": {"page_label": "189", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "f980618a-31d1-4b6f-868b-8abcdcb5cc2b": {"node_ids": ["3e5f718d-645a-4684-bcba-32af96bc0e9d"], "metadata": {"page_label": "190", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "05bfc3ca-b0a9-4cde-87a2-d7a00c2d177b": {"node_ids": ["ad4fd311-6c35-4208-a421-12eadca740b3"], "metadata": {"page_label": "191", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "9cd7dfaf-a8e6-4308-8ff3-7bc1e967895d": {"node_ids": ["7c0a7b41-2d43-4c9c-b051-53b95739c7a1"], "metadata": {"page_label": "192", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "d1f02a0d-6f60-445a-90c2-3ad6413d5483": {"node_ids": ["02296e0d-7d54-42f2-a853-001c11ab08ba"], "metadata": {"page_label": "193", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "90e386fd-a358-4593-9f25-96d85c673a06": {"node_ids": ["f41c09a0-95a1-4984-8783-33e34bca8fac"], "metadata": {"page_label": "194", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "c9fa4afd-c702-4f97-8091-445e9de12d5d": {"node_ids": ["49855995-a31b-4a72-9fb8-b000f644b317"], "metadata": {"page_label": "195", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "60859022-89f9-4c0a-a8c9-964cdc288b51": {"node_ids": ["de7a3bee-82c4-4285-bdef-f9e2e6fe1efd"], "metadata": {"page_label": "196", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "e95b1f92-2b42-4a47-ba8e-9e93e16644c8": {"node_ids": ["6d5511e7-9eaa-40be-a452-caa349dca783"], "metadata": {"page_label": "197", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "92318769-4207-46b6-89ec-25dc17a3dcad": {"node_ids": ["d0c99200-9795-4e9e-bd19-54dd1e5afb11"], "metadata": {"page_label": "198", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "38348290-10ad-4e34-bbf4-982f05f95872": {"node_ids": ["9f11e30e-f8fe-4013-a99b-fdddeb7027c1"], "metadata": {"page_label": "199", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "f82a4845-b5d7-48a8-b656-39dd8e3cfd18": {"node_ids": ["55ae0dd8-359b-4b5f-b075-30edd2b25d67"], "metadata": {"page_label": "200", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "2d5ca64f-835e-4902-8691-22c9fe80852e": {"node_ids": ["4a8b0eb3-49f3-46e6-be04-668f49323d20"], "metadata": {"page_label": "201", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "462ed390-a5bb-4a88-bed2-14e6d58c8574": {"node_ids": ["2ce14f58-c38a-471c-b185-30bb5616be8d"], "metadata": {"page_label": "202", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "bddf7fe1-3aa8-43f7-86bb-45ac65f51e93": {"node_ids": ["e5b1ae4a-d45f-452f-85d9-51a5f3911554"], "metadata": {"page_label": "203", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "e026b4f4-63cd-4564-b258-fbc67235ebed": {"node_ids": ["9436c9c3-79cf-44d9-a0e2-47181fadc0a2"], "metadata": {"page_label": "204", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "6148d7d0-45ea-49b9-870a-26229e3fbd66": {"node_ids": ["352f9e8c-3bda-4239-8a64-84d06fcc5386"], "metadata": {"page_label": "205", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "f11a0740-be04-4b51-8324-bd5471caec14": {"node_ids": ["dc95ac83-2f5a-488e-8082-b92e44ff8bef"], "metadata": {"page_label": "206", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "a76c8d73-b0ac-4a1b-a1fa-ba10358c253f": {"node_ids": ["a3dfcd71-ddf9-4f04-b94b-47c847275f8a"], "metadata": {"page_label": "207", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "c88540a3-b0fb-4c20-81db-2eb46d946c3c": {"node_ids": ["db5b2c2f-f47a-4871-9ab3-d513bc79059c"], "metadata": {"page_label": "208", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "51b81ab6-1c4b-41ba-8b28-7e8f6ddd8f36": {"node_ids": ["e21214e3-9842-4833-bf63-07416ea6c064"], "metadata": {"page_label": "209", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "ab2b6bf3-cc66-41cc-be09-e6fac8cf5437": {"node_ids": ["3b040bb7-cecc-402a-8576-3183143cee74"], "metadata": {"page_label": "210", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "f95c2d56-fba8-413f-bb76-539a46eae194": {"node_ids": ["0118e949-2b66-4b9c-812b-bac2caa41c4a"], "metadata": {"page_label": "211", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "17c30727-0599-43b5-a11f-d1b0c0e13349": {"node_ids": ["50a4baf7-c459-4764-8b33-b606430bea79"], "metadata": {"page_label": "212", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "84080f9b-e594-4495-be61-bda43cb86874": {"node_ids": ["a9b8c8ac-64d2-4339-9faa-466970e58fab"], "metadata": {"page_label": "213", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "f1a83297-364c-4d19-960a-5849cfeb2cd4": {"node_ids": ["da22d960-0b73-465d-8068-c22cbd2fdb31"], "metadata": {"page_label": "214", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "8c9596dc-dc72-4bf2-ae5a-40f5f3a82f82": {"node_ids": ["861d6feb-6dce-4ff6-8d34-96136e858581"], "metadata": {"page_label": "215", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "ac278cc6-3d41-4874-b1a5-a98b50157c11": {"node_ids": ["31530e26-7a50-4382-b21e-08ca8dc60824"], "metadata": {"page_label": "216", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "88b19485-8cd8-46a4-bac8-5fc415d55591": {"node_ids": ["aa3d75b3-8c4f-4ee6-82fc-c2e842f245d8"], "metadata": {"page_label": "217", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "54dc3ec4-edc5-4178-a51b-622c5b46fa8c": {"node_ids": ["7df63099-eacc-450a-a5fa-29df87a03ff9"], "metadata": {"page_label": "218", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "111546b9-b54c-4275-8e79-faec495b1eca": {"node_ids": ["b1639628-9303-4ad6-af88-6185579a0e7b"], "metadata": {"page_label": "219", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "d6887eba-e990-4502-8d6b-543335713268": {"node_ids": ["d2c5f090-6a34-4a4f-b77f-09114c236969"], "metadata": {"page_label": "220", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "32add051-8455-4359-a8f8-249140afe9ac": {"node_ids": ["c4d883b6-7d29-4d9a-98bb-f4279e5d6656"], "metadata": {"page_label": "221", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "5f4a2e13-28a6-4ea4-8137-406cdee5896a": {"node_ids": ["566ac0ee-590b-434a-8852-b0be8cbaed02"], "metadata": {"page_label": "222", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "fe19bb90-70c7-4019-ac18-4a5c7e25a9c8": {"node_ids": ["0fdf221a-5862-43dc-954b-94cbf4016b83"], "metadata": {"page_label": "223", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "163fe919-1f08-4992-8524-378994cf2710": {"node_ids": ["b6f2aa94-3581-4c5d-8eda-2937db37cea5"], "metadata": {"page_label": "224", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "5571b7ae-8a7a-4e48-ba72-d69822e2b5ac": {"node_ids": ["2d9a7a2b-a754-4a21-93a3-189320b32eea"], "metadata": {"page_label": "225", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "6a6bd0f6-1a54-4c5d-8788-dcb74dd37050": {"node_ids": ["d11bb011-74a5-4565-9551-196b9746519b"], "metadata": {"page_label": "226", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "fa0bbb43-4ab6-4b41-9642-bc97fa14c77e": {"node_ids": ["5d7c4e22-bbc4-4349-93b8-e4dd4ac0af89"], "metadata": {"page_label": "227", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "b338830a-ecbc-4f18-89c9-adcad2e2717e": {"node_ids": ["948de473-a10e-4aeb-8662-6f946e0aa8c1"], "metadata": {"page_label": "228", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "290c0cf8-b856-4044-9072-5c0048c37a43": {"node_ids": ["449dcd49-684e-4ac5-85e1-cb16cfdceb99"], "metadata": {"page_label": "229", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "4825ba3c-d08c-4d41-9223-a08769c775d9": {"node_ids": ["7b317736-f021-43db-8e9c-8d0a3bef5d29"], "metadata": {"page_label": "230", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "d8d38062-f3eb-4835-ae36-dd0d7fd6d183": {"node_ids": ["68ce89b4-b29b-4d46-8ace-a8f672f83059"], "metadata": {"page_label": "231", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "4564a9dd-e429-4ed5-9825-0c0771978963": {"node_ids": ["b8f129de-39c3-40c1-ae83-0a158653cfb0"], "metadata": {"page_label": "232", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "bd99c20f-69e8-43d3-930d-accf25948f7b": {"node_ids": ["f8b6fa31-eb40-4074-af9f-c19eb78e0c08"], "metadata": {"page_label": "233", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "b982f1eb-bb73-4014-b42c-0d9ead91f208": {"node_ids": ["1441fca2-ea62-4593-9448-a20ef29dbf38"], "metadata": {"page_label": "234", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "4d56c719-303e-4690-b1dc-7d3d7f15121d": {"node_ids": ["9e90fd0d-24b2-4c49-8339-ee28ecd16ab4"], "metadata": {"page_label": "235", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "64b1c8b3-ffbd-4c4d-addc-28037590e6b3": {"node_ids": ["b1cc1b11-6027-4e0c-989e-c030e463856a"], "metadata": {"page_label": "236", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "0ef94bf5-5747-4298-a23a-72933e177f4c": {"node_ids": ["a28bd6c0-a7f4-47f4-a047-1807b23819d3"], "metadata": {"page_label": "237", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "869bebde-2aea-4092-a1a7-d4be83b672bc": {"node_ids": ["bfcbb936-6fb9-4229-8728-d2673cc235c8"], "metadata": {"page_label": "238", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "e56251b3-3291-4ffe-af1f-005219432fc4": {"node_ids": ["5067b158-148c-46af-9065-f9d897c3d64b"], "metadata": {"page_label": "239", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "c8a6723f-d212-419e-b817-541a220052f2": {"node_ids": ["56a06701-37d5-46ad-b161-8ff168b102c3"], "metadata": {"page_label": "240", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "e87140bc-4f35-47f1-88a9-8aa52fceb6c4": {"node_ids": ["41b5d28a-be93-41da-9a5c-d8f59a9f5ae9"], "metadata": {"page_label": "241", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "efe228b3-a57b-4c88-bda8-cfedc4b6c827": {"node_ids": ["a33cda8a-fbc7-4f38-ac42-6a3487588add"], "metadata": {"page_label": "242", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "45ec8dfb-9ae1-4a87-9dfb-0fdabda8c13c": {"node_ids": ["880771ee-5196-467b-8816-80d435831e61"], "metadata": {"page_label": "243", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "1f29fbc4-24eb-4f26-88e9-28bdb11415e5": {"node_ids": ["0bbd60e0-004c-4eb7-ac3f-8de695a557b5"], "metadata": {"page_label": "244", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "10a6be7f-cb03-4852-824c-03c8bade70e2": {"node_ids": ["edf0e5b9-ffdb-4f7b-936d-b034dd8535d6"], "metadata": {"page_label": "245", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "b4b4f95b-1bc0-435f-92e6-a6e40f047db9": {"node_ids": ["8838655a-63a4-4dc2-8c1f-522bde4f0740"], "metadata": {"page_label": "246", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "a6f7d8b1-e438-4501-b9c1-657ce418aaa3": {"node_ids": ["28feba2c-891d-47cb-be2b-a86a3aa49e82"], "metadata": {"page_label": "247", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "cf95c651-0940-4453-9031-d404c5bd9598": {"node_ids": ["0d4967bb-8653-4066-8855-2d396f9b6cd2"], "metadata": {"page_label": "248", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "38c22982-47f7-4f18-8756-a7dce0ba4c52": {"node_ids": ["06c5d04a-0b1b-40e3-a870-80cad3495820"], "metadata": {"page_label": "249", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "26b8c868-564d-4499-8164-7a8fd9197c72": {"node_ids": ["a8a43b54-5850-4afa-8b76-436577015868"], "metadata": {"page_label": "250", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "8b0e86ab-d39a-4503-982f-90873d989124": {"node_ids": ["addc2b18-f78a-4fc2-8f81-f83921e99b14"], "metadata": {"page_label": "251", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "774b0d83-dda4-4600-85b2-e2b74373fda7": {"node_ids": ["ad528551-8a0b-4482-889b-6ff37c204d1e"], "metadata": {"page_label": "252", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "2170c093-23f7-496e-905c-fb5c4467743b": {"node_ids": ["501d9510-273f-408e-a2a9-f81f3a2a8614"], "metadata": {"page_label": "253", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "225b05f5-8121-42e9-ab24-7704615575cb": {"node_ids": ["e063b7fe-b88f-405b-a1dd-30f131e979b5"], "metadata": {"page_label": "254", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "bbc855ec-480a-4ef3-9766-7b13b5820bee": {"node_ids": ["1c393afd-c939-4f78-b6d7-c5dd369dd304"], "metadata": {"page_label": "255", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "0f4cf36a-9b29-4764-9dc8-8a63dcbfe60d": {"node_ids": ["d20d728f-ca6e-4544-ab08-e609eb9c2b75"], "metadata": {"page_label": "256", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "515acc1f-8e5f-47fc-a2d0-e5b8b4933852": {"node_ids": ["f8723fa3-40cd-40a1-b08d-367612dc9172"], "metadata": {"page_label": "257", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "ecc8cbb9-08ed-4bab-9dcb-89d340a64efb": {"node_ids": ["fbdcfa95-0a3c-4567-ba7f-cc4bf217e145"], "metadata": {"page_label": "258", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "4533ece0-9fe7-42a8-abac-0031b6877b63": {"node_ids": ["a5a41298-6212-4c95-946b-f6a7b30b96c6"], "metadata": {"page_label": "259", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "65f9abd4-acec-4ef8-9ecb-3f847693ab1c": {"node_ids": ["1368478b-4d6d-4185-9682-a1d74521aa60"], "metadata": {"page_label": "260", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "6423f481-8855-43ec-a5f4-01dce88c1d16": {"node_ids": ["84734668-bcdb-476f-bb27-4073ab6eab26"], "metadata": {"page_label": "261", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "b3aeb5e9-c5a2-45a8-9032-fa277a8e2eb3": {"node_ids": ["5ff8c0db-b1aa-4435-a1cc-8f78a58db3a5"], "metadata": {"page_label": "262", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}, "32d1ba11-f5b9-4f6d-b62b-4f51ff921348": {"node_ids": ["d46081fe-63fd-4365-8ac5-29b3202e5af4"], "metadata": {"page_label": "263", "file_name": "Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_path": "/Users/qurratulain/vs-code-projects/ex-rag/files/Essentials of Medical Pharmacology - KD Tripathi-1-263.pdf", "file_type": "application/pdf", "file_size": 28793025, "creation_date": "2024-03-27", "last_modified_date": "2024-03-27"}}}}
=======
{"docstore/metadata": {"a1fafb10-f4cc-4b3c-acf4-2e86728220d4": {"doc_hash": "b59b1122e12fc4dd7206d819085abf6b212f2c0b951396870cbaf467d41a2ea6"}, "f4beade6-4e5e-45c4-aad1-630269ea9560": {"doc_hash": "32ad0c6cc91108812c4f1e39a166ad1fb74621f744af75d6d2891595aad8be54"}, "3e67ad5a-b7cb-4ecb-bdba-e6fc5883cc63": {"doc_hash": "cdb21a46ca7dd3721195c84313d651d5688dc4de4dc6f51be81a87e9f3be568d"}, "1c40f162-4c91-4112-9f1b-ca25c7c1d18e": {"doc_hash": "e2a1d5cb8b245f338eb6bb037ac5b90b83c4986e71f0bc078e61d495b1eea185"}, "e64ebcd5-1011-4371-be1d-ff70f488b706": {"doc_hash": "c6bb48ed795324acc0ad5efdcb9bf83c3238ce0858a8dfac3c799fcb25eda515"}, "ec5c7536-0c5c-4298-911e-e05c5de3f9e6": {"doc_hash": "54e17d8074c00d99b80290d5d370d05a92fdc1faf05943c50e044804dc327312"}, "79fd1ca9-b5ff-4495-8dbf-8958948f3845": {"doc_hash": "2f8f2a1bd5323d384b705addd4dc01051fab5db8a136ae0900c95b1b8f25ec7f"}, "105f0eb9-201f-432e-b97d-0a647cc7e1ae": {"doc_hash": "110137175e659cbfad4cf96292c84a4fd81dbcc4c310c21085e34eb6e7e41052"}, "c053c445-3aa6-4340-8d92-ef44b61380c2": {"doc_hash": "9731dba88e57d8d42b460d61e2da67a798a0e6b79aecc4199eb76dd03f07aa38"}, "b58de147-ea3f-4288-b28d-10f75f118894": {"doc_hash": "b59b1122e12fc4dd7206d819085abf6b212f2c0b951396870cbaf467d41a2ea6", "ref_doc_id": "a1fafb10-f4cc-4b3c-acf4-2e86728220d4"}, "7a025889-449f-472f-86f5-922c31ba38ce": {"doc_hash": "32ad0c6cc91108812c4f1e39a166ad1fb74621f744af75d6d2891595aad8be54", "ref_doc_id": "f4beade6-4e5e-45c4-aad1-630269ea9560"}, "d6b047f2-88aa-42bb-8a8c-71384e96fc7f": {"doc_hash": "3991e242f7a5584bbc6ca29b1659c79df8c8f23bb8e1b5b3dcae326b4750f229", "ref_doc_id": "3e67ad5a-b7cb-4ecb-bdba-e6fc5883cc63"}, "4c7b087e-4c82-464e-8e54-6d0edec3f882": {"doc_hash": "2d2f869c5482ed4abe2351de703a7044a2a01fd2f63e70007efc8521e8aa7372", "ref_doc_id": "3e67ad5a-b7cb-4ecb-bdba-e6fc5883cc63"}, "3d07ac7b-2eeb-40f7-b291-97dfbfc65337": {"doc_hash": "e2a1d5cb8b245f338eb6bb037ac5b90b83c4986e71f0bc078e61d495b1eea185", "ref_doc_id": "1c40f162-4c91-4112-9f1b-ca25c7c1d18e"}, "9951cdb5-ac5f-449b-ade5-930405b25047": {"doc_hash": "c6bb48ed795324acc0ad5efdcb9bf83c3238ce0858a8dfac3c799fcb25eda515", "ref_doc_id": "e64ebcd5-1011-4371-be1d-ff70f488b706"}, "9d81b67f-68eb-44c6-a180-3a0c61828d6b": {"doc_hash": "54e17d8074c00d99b80290d5d370d05a92fdc1faf05943c50e044804dc327312", "ref_doc_id": "ec5c7536-0c5c-4298-911e-e05c5de3f9e6"}, "70bb61ac-2e15-465c-956a-25efca079888": {"doc_hash": "81a9153582ec135c6e640510255e9b6c17ab43c4b75f4c06e8c50823025f6604", "ref_doc_id": "79fd1ca9-b5ff-4495-8dbf-8958948f3845"}, "e485db60-e108-4031-93ee-fd86d602dbb7": {"doc_hash": "2a78a6c819f3bf551b91ae6c65b40927b6c53c01bad82380408eb56bac2a3a1b", "ref_doc_id": "79fd1ca9-b5ff-4495-8dbf-8958948f3845"}, "2778c601-1261-44e8-962e-bd8d30e9e93a": {"doc_hash": "110137175e659cbfad4cf96292c84a4fd81dbcc4c310c21085e34eb6e7e41052", "ref_doc_id": "105f0eb9-201f-432e-b97d-0a647cc7e1ae"}, "3ead0b94-a851-4176-b2b2-5f1dc8e1cf9a": {"doc_hash": "7e13e4699e91b8c8cf35d87cf4aee774cb72b19869b72aa3d0452d5d22cd9029", "ref_doc_id": "c053c445-3aa6-4340-8d92-ef44b61380c2"}}, "docstore/data": {"b58de147-ea3f-4288-b28d-10f75f118894": {"__data__": {"id_": "b58de147-ea3f-4288-b28d-10f75f118894", "embedding": null, "metadata": {"page_label": "1", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "a1fafb10-f4cc-4b3c-acf4-2e86728220d4", "node_type": "4", "metadata": {"page_label": "1", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "b59b1122e12fc4dd7206d819085abf6b212f2c0b951396870cbaf467d41a2ea6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7a025889-449f-472f-86f5-922c31ba38ce", "node_type": "1", "metadata": {}, "hash": "8893ac156338f00f5aee9e91cb9c6756465e3e00d2e5e14c80777ccc792e0e44", "class_name": "RelatedNodeInfo"}}, "text": "The Era of 1-bit LLMs:\nAll Large Language Models are in 1.58 Bits\nShuming Ma\u2217Hongyu Wang\u2217Lingxiao Ma Lei Wang Wenhui Wang\nShaohan Huang Li Dong Ruiping Wang Jilong Xue Furu Wei\u22c4\nhttps://aka.ms/GeneralAI\nAbstract\nRecent research, such as BitNet [ WMD+23], is paving the way for a new era of 1-\nbit Large Language Models (LLMs). In this work, we introduce a 1-bit LLM variant,\nnamely BitNet b1.58 , in which every single parameter (or weight) of the LLM is\nternary {-1, 0, 1}. It matches the full-precision (i.e., FP16 or BF16) Transformer\nLLM with the same model size and training tokens in terms of both perplexity\nand end-task performance, while being significantly more cost-effective in terms\nof latency, memory, throughput, and energy consumption. More profoundly, the\n1.58-bit LLM defines a new scaling law and recipe for training new generations of\nLLMs that are both high-performance and cost-effective. Furthermore, it enables\na new computation paradigm and opens the door for designing specific hardware\noptimized for 1-bit LLMs.\n0.2961 -0.0495\n0.0413 ...\u2026 -0.4765\n0.2812 0.2403\n-0.1808 0.1304\n-0.4809 \u2026\u2026 -0.1771\n-0.1741 -0.3853Transformer LLMs\n16-bit Float ( FP16/BF16)\nCost\nPerformance\n1 -1\n0\u2026\u2026 1\n-1 -1\n-1 1\n-1\u2026\u2026 0\n0 -1BitNet b1.58 (This Work)\n{-1, 0, 1}\nW=Pareto Improvement\nW=\n0.0413 0.3397 0.2812 0.2403\n-0.1808 0.1304\n-0.4809 0.32440.4322 -0.1771\n-0.1741 -0.38530.2961 -0.0495 -0.0924 -0.4765 \ud835\udc99\ud835\udfce\n\ud835\udc99\ud835\udfcf\n\ud835\udc99\ud835\udfd0\n\ud835\udc99\ud835\udfd1\ud835\udfce.\ud835\udfd0\ud835\udfd7\ud835\udfd4\ud835\udfcf\ud835\udc99\ud835\udfce\u2212\ud835\udfce.\ud835\udfce\ud835\udfd2\ud835\udfd7\ud835\udfd3\ud835\udc99\ud835\udfcf\u2212\ud835\udfce.\ud835\udfce\ud835\udfd7\ud835\udfd0\ud835\udfd2\ud835\udc99\ud835\udfd0\u2212\ud835\udfce.\ud835\udfd2\ud835\udfd5\ud835\udfd4\ud835\udfd3\ud835\udc99\ud835\udfd1\n\u2026\n1 -1\n0 1-1 1\n-1 -1\n-1 0\n-1 11 -1\n1 0\ud835\udc99\ud835\udfce\u2212\ud835\udc99\ud835\udfcf\u2212\ud835\udc99\ud835\udfd0+\ud835\udc99\ud835\udfd1\n\u2026\ud835\udc99\ud835\udfce\n\ud835\udc99\ud835\udfcf\n\ud835\udc99\ud835\udfd0\n\ud835\udc99\ud835\udfd11(.58) -bitFP16Model W Input X Output Y Y = f(W, X)\nGPU\nNew \nHardware \nFigure 1: 1-bit LLMs (e.g., BitNet b1.58 ) provide a Pareto solution to reduce inference cost (latency,\nthroughput, and energy) of LLMs while maintaining model performance. The new computation\nparadigm of BitNet b1.58 calls for actions to design new hardware optimized for 1-bit LLMs.\n\u2217Equal contribution. \u22c4Corresponding author. S. Ma, L. Ma, L. Wang, W. Wang, S. Huang, L. Dong, J. Xue,\nF. Wei are with Microsoft Research. H. Wang and R. Wang are with University of Chinese Academy of Sciences.arXiv:2402.17764v1  [cs.CL]  27 Feb 2024", "start_char_idx": 0, "end_char_idx": 2123, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7a025889-449f-472f-86f5-922c31ba38ce": {"__data__": {"id_": "7a025889-449f-472f-86f5-922c31ba38ce", "embedding": null, "metadata": {"page_label": "2", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f4beade6-4e5e-45c4-aad1-630269ea9560", "node_type": "4", "metadata": {"page_label": "2", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "32ad0c6cc91108812c4f1e39a166ad1fb74621f744af75d6d2891595aad8be54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b58de147-ea3f-4288-b28d-10f75f118894", "node_type": "1", "metadata": {"page_label": "1", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "b59b1122e12fc4dd7206d819085abf6b212f2c0b951396870cbaf467d41a2ea6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d6b047f2-88aa-42bb-8a8c-71384e96fc7f", "node_type": "1", "metadata": {}, "hash": "335724bc8ef23bc292f629781bf76e4d9b56fb8e8385569fcc4e2591da2bd3b0", "class_name": "RelatedNodeInfo"}}, "text": "1 The Era of 1-bit LLMs\nIn recent years, the field of AI has seen a rapid growth in the size and capabilities of Large Language\nModels (LLMs). These models have demonstrated remarkable performance in a wide range of natural\nlanguage processing tasks, but their increasing size has posed challenges for deployment and raised\nconcerns about their environmental and economic impact due to high energy consumption. One\napproach to address these challenges is to use post-training quantization to create low-bit models\nfor inference [ XLS+23,FAHA23 ,CCKS23 ,TCS+24]. This technique reduces the precision of\nweights and activations, significantly reducing the memory and computational requirements of LLMs.\nThe trend has been to move from 16 bits to lower bits, such as 4-bit variants [ FAHA23 ,LTT+23].\nHowever, post-training quantization is sub-optimal, even though it is widely used in industry LLMs.\nRecent work on 1-bit model architectures, such as BitNet [ WMD+23], presents a promising direction\nfor reducing the cost of LLMs while maintaining their performance. Vanilla LLMs are in 16-bit\nfloating values (i.e., FP16 or BF16), and the bulk of any LLMs is matrix multiplication. Therefore,\nthe major computation cost comes from the floating-point addition and multiplication operations. In\ncontrast, the matrix multiplication of BitNet only involves integer addition, which saves orders of\nenergy cost for LLMs. As the fundamental limit to compute performance in many chips is power, the\nenergy savings can also be translated into faster computation.\nIn addition to computation, the process of transferring model parameters from DRAM to the memory\nof an on-chip accelerator (e.g., SRAM) can be expensive during inference. There have been attempts\nto enlarge SRAM to improve throughput, but this introduces significantly higher costs than DRAM.\nCompared to full-precision models, 1-bit LLMs have a much lower memory footprint from both a\ncapacity and bandwidth standpoint. This can significantly reduce the cost and time of loading weights\nfrom DRAM, leading to faster and more efficient inference.\nIn this work, we introduce a significant 1-bit LLM variant called BitNet b1.58 , where every parameter\nis ternary, taking on values of {-1, 0, 1}. We have added an additional value of 0 to the original 1-bit\nBitNet, resulting in 1.58 bits in the binary system. BitNet b1.58 retains all the benefits of the original\n1-bit BitNet, including its new computation paradigm, which requires almost no multiplication\noperations for matrix multiplication and can be highly optimized. Additionally, it has the same energy\nconsumption as the original 1-bit BitNet and is much more efficient in terms of memory consumption,\nthroughput and latency compared to FP16 LLM baselines. Furthermore, BitNet b1.58 offers two\nadditional advantages. Firstly, its modeling capability is stronger due to its explicit support for feature\nfiltering, made possible by the inclusion of 0 in the model weights, which can significantly improve\nthe performance of 1-bit LLMs. Secondly, our experiments show that BitNet b1.58 can match full\nprecision (i.e., FP16) baselines in terms of both perplexity and end-task performance, starting from a\n3B size, when using the same configuration (e.g., model size, training tokens, etc.).\n2 BitNet b1.58\nBitNet b1.58 is based on the BitNet architecture, which is a Transformer that replaces nn.Linear with\nBitLinear . It is trained from scratch, with 1.58-bit weights and 8-bit activations. Compared to the\noriginal BitNet, it introduces some modifications that we summarize below.\nQuantization Function. To constrain the weights to -1, 0, or +1, we adopt an absmean quantization\nfunction. It first scales the weight matrix by its average absolute value, and then round each value to\nthe nearest integer among {-1, 0, +1}:\nfW= RoundClip(W\n\u03b3+\u03f5,\u22121,1), (1)\nRoundClip( x, a, b ) = max( a,min(b,round( x))), (2)\n\u03b3=1\nnmX\nij|Wij|. (3)\nThe quantization function for activations follows the same implementation in BitNet, except that\nwe do not scale the activations before the non-linear functions to the range [0, Qb]. Instead, the\n2", "start_char_idx": 0, "end_char_idx": 4132, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d6b047f2-88aa-42bb-8a8c-71384e96fc7f": {"__data__": {"id_": "d6b047f2-88aa-42bb-8a8c-71384e96fc7f", "embedding": null, "metadata": {"page_label": "3", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3e67ad5a-b7cb-4ecb-bdba-e6fc5883cc63", "node_type": "4", "metadata": {"page_label": "3", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "cdb21a46ca7dd3721195c84313d651d5688dc4de4dc6f51be81a87e9f3be568d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7a025889-449f-472f-86f5-922c31ba38ce", "node_type": "1", "metadata": {"page_label": "2", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "32ad0c6cc91108812c4f1e39a166ad1fb74621f744af75d6d2891595aad8be54", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4c7b087e-4c82-464e-8e54-6d0edec3f882", "node_type": "1", "metadata": {}, "hash": "4d66543d9cc0db22c98fb6511934fe60cc4f668d95faf63012b6a3792c3dadf7", "class_name": "RelatedNodeInfo"}}, "text": "Models Size Memory (GB) \u2193 Latency (ms) \u2193 PPL\u2193\nLLaMA LLM 700M 2.08 (1.00x) 1.18 (1.00x) 12.33\nBitNet b1.58 700M 0.80 (2.60x) 0.96 (1.23x) 12.87\nLLaMA LLM 1.3B 3.34 (1.00x) 1.62 (1.00x) 11.25\nBitNet b1.58 1.3B 1.14 (2.93x) 0.97 (1.67x) 11.29\nLLaMA LLM 3B 7.89 (1.00x) 5.07 (1.00x) 10.04\nBitNet b1.58 3B 2.22 (3.55x) 1.87 (2.71x) 9.91\nBitNet b1.58 3.9B 2.38 (3.32x) 2.11 (2.40x) 9.62\nTable 1: Perplexity as well as the cost of BitNet b1.58 and LLaMA LLM.\nModels Size ARCe ARCc HS BQ OQ PQ WGe Avg.\nLLaMA LLM 700M 54.7 23.0 37.0 60.0 20.2 68.9 54.8 45.5\nBitNet b1.58 700M 51.8 21.4 35.1 58.2 20.0 68.1 55.2 44.3\nLLaMA LLM 1.3B 56.9 23.5 38.5 59.1 21.6 70.0 53.9 46.2\nBitNet b1.58 1.3B 54.9 24.2 37.7 56.7 19.6 68.8 55.8 45.4\nLLaMA LLM 3B 62.1 25.6 43.3 61.8 24.6 72.1 58.2 49.7\nBitNet b1.58 3B 61.4 28.3 42.9 61.5 26.6 71.5 59.3 50.2\nBitNet b1.58 3.9B 64.2 28.7 44.2 63.5 24.2 73.2 60.5 51.2\nTable 2: Zero-shot accuracy of BitNet b1.58 and LLaMA LLM on the end tasks.\nactivations are all scaled to [\u2212Qb, Qb]per token to get rid of the zero-point quantization. This is\nmore convenient and simple for both implementation and system-level optimization, while introduces\nnegligible effects to the performance in our experiments.\nLLaMA-alike Components. The architecture of LLaMA [ TLI+23,TMS+23] has been the de-\nfacto backbone for open-source LLMs. To embrace the open-source community, our design\nofBitNet b1.58 adopts the LLaMA-alike components. Specifically, it uses RMSNorm [ ZS19 ],\nSwiGLU [ Sha20 ], rotary embedding [ SAL+24], and removes all biases. In this way, BitNet b1.58\ncan be integrated into the popular open-source software (e.g., Huggingface, vLLM [ KLZ+23], and\nllama.cpp2) with minimal efforts.\n3 Results\nWe compared BitNet b1.58 to our reproduced FP16 LLaMA LLM in various sizes. To ensure a fair\ncomparison, we pre-trained the models on the RedPajama dataset [ Com23 ] for 100 billion tokens.\nWe evaluated the zero-shot performance on a range of language tasks, including ARC-Easy [ YBS19 ],\nARC-Challenge [ YBS19 ], Hellaswag [ ZHB+19], Winogrande [ SBBC20 ], PIQA [ BZB+19], Open-\nbookQA [ MCKS18 ], and BoolQ [ CLC+19]. We also reported the validation perplexity on the\nWikiText2 [MXBS16] and C4 [RSR+19] datasets.", "start_char_idx": 0, "end_char_idx": 2231, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4c7b087e-4c82-464e-8e54-6d0edec3f882": {"__data__": {"id_": "4c7b087e-4c82-464e-8e54-6d0edec3f882", "embedding": null, "metadata": {"page_label": "3", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "3e67ad5a-b7cb-4ecb-bdba-e6fc5883cc63", "node_type": "4", "metadata": {"page_label": "3", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "cdb21a46ca7dd3721195c84313d651d5688dc4de4dc6f51be81a87e9f3be568d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d6b047f2-88aa-42bb-8a8c-71384e96fc7f", "node_type": "1", "metadata": {"page_label": "3", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "3991e242f7a5584bbc6ca29b1659c79df8c8f23bb8e1b5b3dcae326b4750f229", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3d07ac7b-2eeb-40f7-b291-97dfbfc65337", "node_type": "1", "metadata": {}, "hash": "861c0bf40b5b496b1fca6e8e761fccd360f0fa0fbe9e5aa1ab345d90bf8d01ff", "class_name": "RelatedNodeInfo"}}, "text": "3 Results\nWe compared BitNet b1.58 to our reproduced FP16 LLaMA LLM in various sizes. To ensure a fair\ncomparison, we pre-trained the models on the RedPajama dataset [ Com23 ] for 100 billion tokens.\nWe evaluated the zero-shot performance on a range of language tasks, including ARC-Easy [ YBS19 ],\nARC-Challenge [ YBS19 ], Hellaswag [ ZHB+19], Winogrande [ SBBC20 ], PIQA [ BZB+19], Open-\nbookQA [ MCKS18 ], and BoolQ [ CLC+19]. We also reported the validation perplexity on the\nWikiText2 [MXBS16] and C4 [RSR+19] datasets.\nWe compared the runtime GPU memory and latency of both LLaMA LLM andBitNet b1.58 . The\nresults were measured using the FasterTransformer3codebase, which is well-optimized for LLM\ninference latency on GPU devices. The 2-bit kernel from Ladder [ WMC+23] is also integrated for\nBitNet b1.58. We reported the time per output token, as it is the major cost for inference.\nTable 1 summarizes the perplexity and the cost for BitNet b1.58 andLLaMA LLM . It shows that\nBitNet b1.58 starts to match full precision LLaMA LLM at 3B model size in terms of perplexity,\nwhile being 2.71 times faster and using 3.55 times less GPU memory. In particular, BitNet b1.58 with\na 3.9B model size is 2.4 times faster, consumes 3.32 times less memory, but performs significantly\nbetter than LLaMA LLM 3B.\n2https://github.com/ggerganov/llama.cpp\n3https://github.com/NVIDIA/FasterTransformer\n3", "start_char_idx": 1707, "end_char_idx": 3099, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3d07ac7b-2eeb-40f7-b291-97dfbfc65337": {"__data__": {"id_": "3d07ac7b-2eeb-40f7-b291-97dfbfc65337", "embedding": null, "metadata": {"page_label": "4", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "1c40f162-4c91-4112-9f1b-ca25c7c1d18e", "node_type": "4", "metadata": {"page_label": "4", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "e2a1d5cb8b245f338eb6bb037ac5b90b83c4986e71f0bc078e61d495b1eea185", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4c7b087e-4c82-464e-8e54-6d0edec3f882", "node_type": "1", "metadata": {"page_label": "3", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "2d2f869c5482ed4abe2351de703a7044a2a01fd2f63e70007efc8521e8aa7372", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9951cdb5-ac5f-449b-ade5-930405b25047", "node_type": "1", "metadata": {}, "hash": "23e4b8c778f34475832e77b702e51ea6c22718b1d56db1832468cf3efb048c38", "class_name": "RelatedNodeInfo"}}, "text": "1.3B 3B 7B 13B 70B\nModel Size100101102Latency (ms)\n1.67x2.71x2.90x3.68x4.10xBitNet b1.58\nLLaMA\n1.3B 3B 7B 13B 70B\nModel Size100101102Memory (GB)\n2.93x3.55x4.40x5.12x7.16xBitNet b1.58\nLLaMAFigure 2: Decoding latency (Left) and memory consumption (Right) of BitNet b1.58 varying the\nmodel size.\nModels Size Max Batch Size Throughput (tokens/s)\nLLaMA LLM 70B 16 (1.0x) 333 (1.0x)\nBitNet b1.58 70B 176 (11.0x) 2977 (8.9x)\nTable 3: Comparison of the throughput between BitNet b1.58 70B and LLaMA LLM 70B.\nTable 2 reports the detailed results of the zero-shot accuracy on the end tasks. We followed the pipeline\nfrom lm-evaluation-harness4to perform the evaluation. The results show that the performance gap\nbetween BitNet b1.58 andLLaMA LLM narrows as the model size increases. More importantly,\nBitNet b1.58 can match the performance of the full precision baseline starting from a 3B size. Similar\nto the observation of the perplexity, the end-task results reveal that BitNet b1.58 3.9B outperforms\nLLaMA LLM 3B with lower memory and latency cost. This demonstrates that BitNet b1.58 is a\nPareto improvement over the state-of-the-art LLM models.\nMemory and Latency We further scaled up the model size to 7B, 13B, and 70B and evaluated the\ncost. Figure 2 illustrates the trends of latency and memory, showing that the speed-up increases as the\nmodel size scales. In particular, BitNet b1.58 70B is 4.1 times faster than the LLaMA LLM baseline.\nThis is because the time cost for nn.Linear grows with the model size. The memory consumption\nfollows a similar trend, as the embedding remains full precision and its memory proportion is smaller\nfor larger models. Both latency and memory were measured with a 2-bit kernel, so there is still room\nfor optimization to further reduce the cost.\nEnergy We also estimate the arithmetic operations energy consumption of both BitNet b1.58 and\nLLaMA LLM . We focus mainly on the calculation for matrix multiplication, since it contributes\nthe most to the cost of LLMs. Figure 3 illustrates the composition of the energy cost. The majority\nofBitNet b1.58 is INT8 addition calculation, while LLaMA LLM consists of both FP16 addition\nand FP16 multiplication. According to the energy model in [ Hor14 ,ZZL22 ],BitNet b1.58 saves\n71.4 times arithmetic operations energy consumption for matrix multiplication on 7nm chips. We\nfurther reported the end-to-end energy cost for models with 512 tokens. Our results show that as the\nmodel size scales, BitNet b1.58 becomes increasingly more efficient in terms of energy consumption\ncompared to the FP16 LLaMA LLM baseline. This is due to the fact that the percentage of nn.Linear\ngrows with the model size, while the cost from other components is smaller for larger models.\nThroughput We compare the throughput of BitNet b1.58 andLLaMA LLM with 70B parameters\non two 80GB A100 cards, using pipeline parallelism [ HCB+19] so that LLaMA LLM 70B could be\nrun on the devices. We increased the batch size until the GPU memory limit was reached, with a\nsequence length of 512. Table 3 shows that BitNet b1.58 70B can support up to 11 times the batch\nsize of LLaMA LLM, resulting an 8.9 times higher throughput.\n4https://github.com/EleutherAI/lm-evaluation-harness\n4", "start_char_idx": 0, "end_char_idx": 3228, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9951cdb5-ac5f-449b-ade5-930405b25047": {"__data__": {"id_": "9951cdb5-ac5f-449b-ade5-930405b25047", "embedding": null, "metadata": {"page_label": "5", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "e64ebcd5-1011-4371-be1d-ff70f488b706", "node_type": "4", "metadata": {"page_label": "5", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "c6bb48ed795324acc0ad5efdcb9bf83c3238ce0858a8dfac3c799fcb25eda515", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3d07ac7b-2eeb-40f7-b291-97dfbfc65337", "node_type": "1", "metadata": {"page_label": "4", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "e2a1d5cb8b245f338eb6bb037ac5b90b83c4986e71f0bc078e61d495b1eea185", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9d81b67f-68eb-44c6-a180-3a0c61828d6b", "node_type": "1", "metadata": {}, "hash": "b9ffa2955d98aaa741e2c118337411f986a7ece544f36dbe9aa96562978348a0", "class_name": "RelatedNodeInfo"}}, "text": "BitNet b1.58 LLaMA0.00.10.20.30.40.57nm Energy Cost (pJ)71.4xINT8 Add\nFP16 Add\nFP16 Mul\n1.3B 3B 7B 13B 70B\nModel Size101\n100101Energy (J)\n18.6x21.7x29.1x32.9x41.2xBitNet b1.58\nLLaMAFigure 3: Energy consumption of BitNet b1.58 compared to LLaMA LLM at 7nm process nodes. On\nthe left is the components of arithmetic operations energy. On the right is the end-to-end energy cost\nacross different model sizes.\nModels Tokens Winogrande PIQA SciQ LAMBADA ARC-easy Avg.\nStableLM-3B 2T 64.56 76.93 90.75 66.09 67.78 73.22\nBitNet b1.58 3B 2T 66.37 78.40 91.20 67.63 68.12 74.34\nTable 4: Comparison of BitNet b1.58 with StableLM-3B with 2T tokens.\nBitNet b1.58 is enabling a new scaling law with respect to model performance and inference\ncost. As a reference, we can have the following equivalence between different model sizes in 1.58-bit\nand 16-bit based on the results in Figure 2 and 3.\n\u202213B BitNet b1.58 is more efficient, in terms of latency, memory usage and energy consump-\ntion, than 3B FP16 LLM.\n\u202230B BitNet b1.58 is more efficient, in terms of latency, memory usage and energy consump-\ntion, than 7B FP16 LLM.\n\u202270B BitNet b1.58 is more efficient, in terms of latency, memory usage and energy consump-\ntion, than 13B FP16 LLM.\nTraining with 2T Tokens The number of training tokens is a crucial factor for LLMs. To test\nthe scalability of BitNet b1.58 in terms of tokens, we trained a BitNet b1.58 model with 2T to-\nkens following the data recipe of StableLM-3B [ TBMR ], which is the state-of-the-art open-source\n3B model. Both models were evaluated on a benchmark that consists of Winogrande [ SBBC20 ],\nPIQA [ BZB+19], SciQ [ WLG17 ], LAMBADA [ PKL+16], and ARC-easy [ YBS19 ]. We reported\nthe zero-shot accuracy in Table 4. For tasks measured with accuracy and normalized accuracy, we\ntake the average of the two. The results of StableLM 3b at 2T tokens are taken directly from its\ntechnical report. Our findings shows that BitNet b1.58 achieves a superior performance on all end\ntasks, indicating that 1.58-bit LLMs also have strong generalization capabilities.\n4 Discussion and Future Work\n1-bit Mixture-of-Experts (MoE) LLMs\nMixture-of-Experts (MoE) have proven to be a cost-effective approach for LLMs. While it signifi-\ncantly reduces the computation FLOPs, the high memory consumption and inter-chip communication\noverhead limit its deployment and application. These challenges can be addressed by 1.58-bit LLMs.\nFirstly, the reduced memory footprint reduces the number of devices required to deploy MoE models.\nMoreover, it significantly reduces the overhead of transferring activations across networks. Ultimately,\nthere would be no overhead if the entire models could be placed on a single chip.\n5", "start_char_idx": 0, "end_char_idx": 2710, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9d81b67f-68eb-44c6-a180-3a0c61828d6b": {"__data__": {"id_": "9d81b67f-68eb-44c6-a180-3a0c61828d6b", "embedding": null, "metadata": {"page_label": "6", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ec5c7536-0c5c-4298-911e-e05c5de3f9e6", "node_type": "4", "metadata": {"page_label": "6", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "54e17d8074c00d99b80290d5d370d05a92fdc1faf05943c50e044804dc327312", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9951cdb5-ac5f-449b-ade5-930405b25047", "node_type": "1", "metadata": {"page_label": "5", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "c6bb48ed795324acc0ad5efdcb9bf83c3238ce0858a8dfac3c799fcb25eda515", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "70bb61ac-2e15-465c-956a-25efca079888", "node_type": "1", "metadata": {}, "hash": "800fbbc1f0b01711d34265b78327fba742f5a72ad77fa378684d0228c7bcedf3", "class_name": "RelatedNodeInfo"}}, "text": "Native Support of Long Sequence in LLMs\nIn the era of LLMs, the ability to handle long sequence has become a critical demand. One major\nchallenge for long sequence inference is the memory consumption introduced by the KV caches.\nBitNet b1.58 represents a significant step towards native support for long sequences, as it reduces the\nactivations from 16 bits to 8 bits, allowing the context length to be doubled given the same resources.\nThis can be further losslessly compressed to 4 bits or even lower for 1.58-bit LLMs, which we leave\nas future work.\nLLMs on Edge and Mobile\nThe use of 1.58-bit LLMs has the potential to greatly improve the performance of language models\non edge and mobile devices. These devices are often limited by their memory and computational\npower, which can restrict the performance and the scale of LLMs. However, the reduced memory and\nenergy consumption of 1.58-bit LLMs allows them to be deployed on these devices, enabling a wide\nrange of applications that were previously not possible. This can greatly enhance the capabilities\nof edge and mobile devices and enable new and exciting applications of LLMs. Moreover, 1.58-bit\nLLMs are more friendly to CPU devices, which are the main processors used in edge and mobile\ndevices. This means that BitNet b1.58 can be efficiently executed on these devices, further improving\ntheir performance and capabilities.\nNew Hardware for 1-bit LLMs\nRecent work like Groq5has demonstrated promising results and great potential for building specific\nhardware (e.g., LPUs) for LLMs. Going one step further, we envision and call for actions to design\nnew hardware and system specifically optimized for 1-bit LLMs, given the new computation paradigm\nenabled in BitNet [WMD+23].\nReferences\n[BZB+19]Yonatan Bisk, Rowan Zellers, Ronan Le Bras, Jianfeng Gao, and Yejin Choi. PIQA:\nreasoning about physical commonsense in natural language. CoRR , abs/1911.11641,\n2019.\n[CCKS23] Jerry Chee, Yaohui Cai, V olodymyr Kuleshov, and Christopher De Sa. QuIP: 2-bit\nquantization of large language models with guarantees. CoRR , abs/2307.13304, 2023.\n[CLC+19]Christopher Clark, Kenton Lee, Ming-Wei Chang, Tom Kwiatkowski, Michael Collins,\nand Kristina Toutanova. Boolq: Exploring the surprising difficulty of natural yes/no\nquestions. CoRR , abs/1905.10044, 2019.\n[Com23] Together Computer. Redpajama: an open dataset for training large language models,\n2023.\n[FAHA23] Elias Frantar, Saleh Ashkboos, Torsten Hoefler, and Dan Alistarh. OPTQ: accurate\nquantization for generative pre-trained transformers. In The Eleventh International\nConference on Learning Representations , 2023.\n[HCB+19]Yanping Huang, Youlong Cheng, Ankur Bapna, Orhan Firat, Dehao Chen, Mia Xu Chen,\nHyoukJoong Lee, Jiquan Ngiam, Quoc V . Le, Yonghui Wu, and Zhifeng Chen. Gpipe:\nEfficient training of giant neural networks using pipeline parallelism. In Advances in\nNeural Information Processing Systems , pages 103\u2013112, 2019.\n[Hor14] Mark Horowitz. 1.1 computing\u2019s energy problem (and what we can do about it). In 2014\nIEEE International Conference on Solid-State Circuits Conference, ISSCC 2014, Digest\nof Technical Papers, San Francisco, CA, USA, February 9-13, 2014 , pages 10\u201314, 2014.\n[KLZ+23]Woosuk Kwon, Zhuohan Li, Siyuan Zhuang, Ying Sheng, Lianmin Zheng, Cody Hao\nYu, Joseph E. Gonzalez, Hao Zhang, and Ion Stoica. Efficient memory management for\nlarge language model serving with pagedattention. In Proceedings of the ACM SIGOPS\n29th Symposium on Operating Systems Principles , 2023.\n5https://groq.com/\n6", "start_char_idx": 0, "end_char_idx": 3536, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "70bb61ac-2e15-465c-956a-25efca079888": {"__data__": {"id_": "70bb61ac-2e15-465c-956a-25efca079888", "embedding": null, "metadata": {"page_label": "7", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "79fd1ca9-b5ff-4495-8dbf-8958948f3845", "node_type": "4", "metadata": {"page_label": "7", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "2f8f2a1bd5323d384b705addd4dc01051fab5db8a136ae0900c95b1b8f25ec7f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9d81b67f-68eb-44c6-a180-3a0c61828d6b", "node_type": "1", "metadata": {"page_label": "6", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "54e17d8074c00d99b80290d5d370d05a92fdc1faf05943c50e044804dc327312", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e485db60-e108-4031-93ee-fd86d602dbb7", "node_type": "1", "metadata": {}, "hash": "f602a34e8289303194bd0103a773aeacb8613177651403bdcdfee08742acc0f5", "class_name": "RelatedNodeInfo"}}, "text": "[LTT+23]Ji Lin, Jiaming Tang, Haotian Tang, Shang Yang, Xingyu Dang, and Song Han. AWQ:\nactivation-aware weight quantization for LLM compression and acceleration. CoRR ,\nabs/2306.00978, 2023.\n[MCKS18] Todor Mihaylov, Peter Clark, Tushar Khot, and Ashish Sabharwal. Can a suit of\narmor conduct electricity? A new dataset for open book question answering. CoRR ,\nabs/1809.02789, 2018.\n[MXBS16] Stephen Merity, Caiming Xiong, James Bradbury, and Richard Socher. Pointer sentinel\nmixture models, 2016.\n[PKL+16]Denis Paperno, Germ\u00e1n Kruszewski, Angeliki Lazaridou, Quan Ngoc Pham, Raffaella\nBernardi, Sandro Pezzelle, Marco Baroni, Gemma Boleda, and Raquel Fern\u00e1ndez. The\nLAMBADA dataset: Word prediction requiring a broad discourse context. In Proceed-\nings of the 54th Annual Meeting of the Association for Computational Linguistics, ACL\n2016, August 7-12, 2016, Berlin, Germany, Volume 1: Long Papers . The Association\nfor Computer Linguistics, 2016.\n[RSR+19]Colin Raffel, Noam Shazeer, Adam Roberts, Katherine Lee, Sharan Narang, Michael\nMatena, Yanqi Zhou, Wei Li, and Peter J. Liu. Exploring the limits of transfer learning\nwith a unified text-to-text transformer. CoRR , abs/1910.10683, 2019.\n[SAL+24]Jianlin Su, Murtadha H. M. Ahmed, Yu Lu, Shengfeng Pan, Wen Bo, and Yunfeng Liu.\nRoformer: Enhanced transformer with rotary position embedding. Neurocomputing ,\n568:127063, 2024.\n[SBBC20] Keisuke Sakaguchi, Ronan Le Bras, Chandra Bhagavatula, and Yejin Choi. Wino-\nGrande: an adversarial winograd schema challenge at scale. In The Thirty-Fourth AAAI\nConference on Artificial Intelligence , pages 8732\u20138740, 2020.\n[Sha20] Noam Shazeer. GLU variants improve transformer. CoRR , abs/2002.05202, 2020.\n[TBMR] Jonathan Tow, Marco Bellagente, Dakota Mahan, and Carlos Riquelme. Stablelm 3b\n4e1t.\n[TCS+24]Albert Tseng, Jerry Chee, Qingyao Sun, V olodymyr Kuleshov, and Christopher De\nSa. Quip#: Even better LLM quantization with hadamard incoherence and lattice\ncodebooks. CoRR , abs/2402.04396, 2024.\n[TLI+23]Hugo Touvron, Thibaut Lavril, Gautier Izacard, Xavier Martinet, Marie-Anne Lachaux,\nTimoth\u00e9e Lacroix, Baptiste Rozi\u00e8re, Naman Goyal, Eric Hambro, Faisal Azhar, Aurelien\nRodriguez, Armand Joulin, Edouard Grave, and Guillaume Lample. LLaMA: open and\nefficient foundation language models. CoRR , abs/2302.13971, 2023.\n[TMS+23]Hugo Touvron, Louis Martin, Kevin Stone, Peter Albert, Amjad Almahairi, Yasmine\nBabaei, Nikolay Bashlykov, Soumya Batra, Prajjwal Bhargava, Shruti Bhosale, Dan\nBikel, Lukas Blecher, Cristian Canton Ferrer, Moya Chen, Guillem Cucurull, David\nEsiobu, Jude Fernandes, Jeremy Fu, and et al. Llama 2: open foundation and fine-tuned\nchat models. CoRR , abs/2307.09288, 2023.\n[WLG17] Johannes Welbl, Nelson F. Liu, and Matt Gardner. Crowdsourcing multiple choice\nscience questions.", "start_char_idx": 0, "end_char_idx": 2803, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e485db60-e108-4031-93ee-fd86d602dbb7": {"__data__": {"id_": "e485db60-e108-4031-93ee-fd86d602dbb7", "embedding": null, "metadata": {"page_label": "7", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "79fd1ca9-b5ff-4495-8dbf-8958948f3845", "node_type": "4", "metadata": {"page_label": "7", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "2f8f2a1bd5323d384b705addd4dc01051fab5db8a136ae0900c95b1b8f25ec7f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "70bb61ac-2e15-465c-956a-25efca079888", "node_type": "1", "metadata": {"page_label": "7", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "81a9153582ec135c6e640510255e9b6c17ab43c4b75f4c06e8c50823025f6604", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2778c601-1261-44e8-962e-bd8d30e9e93a", "node_type": "1", "metadata": {}, "hash": "1d019b966c3866aa7815f4fa81ebe1b24d6f9878060d95e7e07a37474b419b60", "class_name": "RelatedNodeInfo"}}, "text": "LLaMA: open and\nefficient foundation language models. CoRR , abs/2302.13971, 2023.\n[TMS+23]Hugo Touvron, Louis Martin, Kevin Stone, Peter Albert, Amjad Almahairi, Yasmine\nBabaei, Nikolay Bashlykov, Soumya Batra, Prajjwal Bhargava, Shruti Bhosale, Dan\nBikel, Lukas Blecher, Cristian Canton Ferrer, Moya Chen, Guillem Cucurull, David\nEsiobu, Jude Fernandes, Jeremy Fu, and et al. Llama 2: open foundation and fine-tuned\nchat models. CoRR , abs/2307.09288, 2023.\n[WLG17] Johannes Welbl, Nelson F. Liu, and Matt Gardner. Crowdsourcing multiple choice\nscience questions. In Leon Derczynski, Wei Xu, Alan Ritter, and Tim Baldwin, editors,\nProceedings of the 3rd Workshop on Noisy User-generated Text, NUT@EMNLP 2017,\nCopenhagen, Denmark, September 7, 2017 , pages 94\u2013106. Association for Computa-\ntional Linguistics, 2017.\n[WMC+23]Lei Wang, Lingxiao Ma, Shijie Cao, Ningxin Zheng, Quanlu Zhang, Jilong Xue, Ziming\nMiao, Ting Cao, , and Yuqing Yang. Ladder: Efficient tensor compilation on customized\ndata format. In OSDI , 2023.\n[WMD+23]Hongyu Wang, Shuming Ma, Li Dong, Shaohan Huang, Huaijie Wang, Lingxiao Ma,\nFan Yang, Ruiping Wang, Yi Wu, and Furu Wei. Bitnet: Scaling 1-bit transformers for\nlarge language models. CoRR , abs/2310.11453, 2023.\n7", "start_char_idx": 2238, "end_char_idx": 3482, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2778c601-1261-44e8-962e-bd8d30e9e93a": {"__data__": {"id_": "2778c601-1261-44e8-962e-bd8d30e9e93a", "embedding": null, "metadata": {"page_label": "8", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "105f0eb9-201f-432e-b97d-0a647cc7e1ae", "node_type": "4", "metadata": {"page_label": "8", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "110137175e659cbfad4cf96292c84a4fd81dbcc4c310c21085e34eb6e7e41052", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e485db60-e108-4031-93ee-fd86d602dbb7", "node_type": "1", "metadata": {"page_label": "7", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "2a78a6c819f3bf551b91ae6c65b40927b6c53c01bad82380408eb56bac2a3a1b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3ead0b94-a851-4176-b2b2-5f1dc8e1cf9a", "node_type": "1", "metadata": {}, "hash": "b8e71174a6bc015db8c55f8f06250721fe65e0f6629afaab8927337c745fbe26", "class_name": "RelatedNodeInfo"}}, "text": "[XLS+23]Guangxuan Xiao, Ji Lin, Micka\u00ebl Seznec, Hao Wu, Julien Demouth, and Song Han.\nSmoothQuant: accurate and efficient post-training quantization for large language\nmodels. In International Conference on Machine Learning, ICML 2023, 23-29 July\n2023, Honolulu, Hawaii, USA , 2023.\n[YBS19] Vikas Yadav, Steven Bethard, and Mihai Surdeanu. Quick and (not so) dirty: Unsuper-\nvised selection of justification sentences for multi-hop question answering. In Kentaro\nInui, Jing Jiang, Vincent Ng, and Xiaojun Wan, editors, EMNLP-IJCNLP , 2019.\n[ZHB+19]Rowan Zellers, Ari Holtzman, Yonatan Bisk, Ali Farhadi, and Yejin Choi. HellaSwag:\ncan a machine really finish your sentence? In Proceedings of the 57th Conference of\nthe Association for Computational Linguistics , pages 4791\u20134800, 2019.\n[ZS19] Biao Zhang and Rico Sennrich. Root mean square layer normalization. In Hanna M.\nWallach, Hugo Larochelle, Alina Beygelzimer, Florence d\u2019Alch\u00e9-Buc, Emily B. Fox,\nand Roman Garnett, editors, Advances in Neural Information Processing Systems , pages\n12360\u201312371, 2019.\n[ZZL22] Yichi Zhang, Zhiru Zhang, and Lukasz Lew. PokeBNN: A binary pursuit of lightweight\naccuracy. In IEEE/CVF Conference on Computer Vision and Pattern Recognition , pages\n12465\u201312475. IEEE, 2022.\n8", "start_char_idx": 0, "end_char_idx": 1260, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3ead0b94-a851-4176-b2b2-5f1dc8e1cf9a": {"__data__": {"id_": "3ead0b94-a851-4176-b2b2-5f1dc8e1cf9a", "embedding": null, "metadata": {"page_label": "1", "file_name": "CLASS II Syllabus.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/CLASS II Syllabus.pdf", "file_type": "application/pdf", "file_size": 85459, "creation_date": "2024-03-15", "last_modified_date": "2024-03-06"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "c053c445-3aa6-4340-8d92-ef44b61380c2", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CLASS II Syllabus.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/CLASS II Syllabus.pdf", "file_type": "application/pdf", "file_size": 85459, "creation_date": "2024-03-15", "last_modified_date": "2024-03-06"}, "hash": "9731dba88e57d8d42b460d61e2da67a798a0e6b79aecc4199eb76dd03f07aa38", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2778c601-1261-44e8-962e-bd8d30e9e93a", "node_type": "1", "metadata": {"page_label": "8", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}, "hash": "110137175e659cbfad4cf96292c84a4fd81dbcc4c310c21085e34eb6e7e41052", "class_name": "RelatedNodeInfo"}}, "text": "K.R.MANGALAM WORLD SCHOOL  \nSYLLABUS FOR CLASS II  \nLEVEL PLACEMENT TEST FOR GRADE 2  \n \nSUBJECT: ENGLISH  \nTOTAL MARKS : 10  \nTIME : 20 minutes  \n \nGRAMMAR : USE OF A / An  \nREADING COMPREHENSION  \nGENERAL AWARENESS  \n \n \n \n  MATHEMATICS S  \n \nS.NO.  \n TOPIC  WEIGHTAGE  \n \n1.  \nNumber Names up to 100   \n2 \n \n2.  \nNumber Sequencing ( Just Before, Just After and In \nBetween) for numbers up to 100   \n \n2 \n \n3.  \nComparison of numbers (Greater than, Less than & \nEqual to) up to 100  \n  \n \n2 \n \n4.  \nAddition by Forward Counting (Numbers up to \n100)  \n2 \n \n5.  \nSubtraction by Backward Counting (Numbers up to \n100)  \n2 \n \n \nTOTAL WEIGHTAGE   \n \n10 MARKS", "start_char_idx": 2, "end_char_idx": 657, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}}, "docstore/ref_doc_info": {"a1fafb10-f4cc-4b3c-acf4-2e86728220d4": {"node_ids": ["b58de147-ea3f-4288-b28d-10f75f118894"], "metadata": {"page_label": "1", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}}, "f4beade6-4e5e-45c4-aad1-630269ea9560": {"node_ids": ["7a025889-449f-472f-86f5-922c31ba38ce"], "metadata": {"page_label": "2", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}}, "3e67ad5a-b7cb-4ecb-bdba-e6fc5883cc63": {"node_ids": ["d6b047f2-88aa-42bb-8a8c-71384e96fc7f", "4c7b087e-4c82-464e-8e54-6d0edec3f882"], "metadata": {"page_label": "3", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}}, "1c40f162-4c91-4112-9f1b-ca25c7c1d18e": {"node_ids": ["3d07ac7b-2eeb-40f7-b291-97dfbfc65337"], "metadata": {"page_label": "4", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}}, "e64ebcd5-1011-4371-be1d-ff70f488b706": {"node_ids": ["9951cdb5-ac5f-449b-ade5-930405b25047"], "metadata": {"page_label": "5", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}}, "ec5c7536-0c5c-4298-911e-e05c5de3f9e6": {"node_ids": ["9d81b67f-68eb-44c6-a180-3a0c61828d6b"], "metadata": {"page_label": "6", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}}, "79fd1ca9-b5ff-4495-8dbf-8958948f3845": {"node_ids": ["70bb61ac-2e15-465c-956a-25efca079888", "e485db60-e108-4031-93ee-fd86d602dbb7"], "metadata": {"page_label": "7", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}}, "105f0eb9-201f-432e-b97d-0a647cc7e1ae": {"node_ids": ["2778c601-1261-44e8-962e-bd8d30e9e93a"], "metadata": {"page_label": "8", "file_name": "1Bit Quantization in LLMs.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/1Bit Quantization in LLMs.pdf", "file_type": "application/pdf", "file_size": 463748, "creation_date": "2024-03-15", "last_modified_date": "2024-03-04"}}, "c053c445-3aa6-4340-8d92-ef44b61380c2": {"node_ids": ["3ead0b94-a851-4176-b2b2-5f1dc8e1cf9a"], "metadata": {"page_label": "1", "file_name": "CLASS II Syllabus.pdf", "file_path": "/Users/kiwitech/Desktop/untitled folder/CLASS II Syllabus.pdf", "file_type": "application/pdf", "file_size": 85459, "creation_date": "2024-03-15", "last_modified_date": "2024-03-06"}}}}
>>>>>>> f096689d (Removed /storage from .gitignore)
